Citrus Sinensis ID: 042772
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 489 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ST27 | 907 | Phototropin-2 OS=Oryza sa | yes | no | 0.854 | 0.460 | 0.724 | 0.0 | |
| P93025 | 915 | Phototropin-2 OS=Arabidop | yes | no | 0.858 | 0.459 | 0.706 | 0.0 | |
| Q2RBR1 | 921 | Phototropin-1B OS=Oryza s | no | no | 0.856 | 0.454 | 0.586 | 1e-159 | |
| Q2QYY8 | 921 | Phototropin-1A OS=Oryza s | no | no | 0.871 | 0.462 | 0.581 | 1e-157 | |
| O48963 | 996 | Phototropin-1 OS=Arabidop | no | no | 0.836 | 0.410 | 0.600 | 1e-154 | |
| P15792 | 609 | Protein kinase PVPK-1 OS= | N/A | no | 0.382 | 0.307 | 0.529 | 8e-54 | |
| A2YBX5 | 589 | Protein kinase G11A OS=Or | N/A | no | 0.472 | 0.392 | 0.450 | 1e-53 | |
| Q0DCT8 | 589 | Protein kinase G11A OS=Or | no | no | 0.472 | 0.392 | 0.450 | 2e-53 | |
| Q9LFA2 | 934 | Serine/threonine-protein | no | no | 0.376 | 0.197 | 0.510 | 3e-50 | |
| Q05999 | 578 | Serine/threonine-protein | no | no | 0.390 | 0.330 | 0.497 | 3e-50 |
| >sp|Q9ST27|PHOT2_ORYSJ Phototropin-2 OS=Oryza sativa subsp. japonica GN=PHOT2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 668 bits (1723), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 336/464 (72%), Positives = 366/464 (78%), Gaps = 46/464 (9%)
Query: 9 NSRKSGRNSLMGLKVRSPSLAGKHEPQPSIAPEVFMTKDLKW----TDSWDRAERERDIR 64
+ RKSGR+SLMG K+ S G E + TDSW+RAERE+DIR
Sbjct: 315 SGRKSGRSSLMGFKIGKRSSVGSREAPAVVEEPAPAPPPAPEVVERTDSWERAEREKDIR 374
Query: 65 QGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYT 124
QGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTE YT
Sbjct: 375 QGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTE------------------YT 416
Query: 125 REEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREIT 184
REEILGRNC F G +DQ TV KIR+A+REQ+EIT
Sbjct: 417 REEILGRNC--------------------RFLQGP----ETDQGTVDKIREAIREQKEIT 452
Query: 185 VQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNRLSEKTEQQSAK 244
VQLINYTKSGKKFWNLFHLQPMRD KGELQYFIGVQLDGSDHVEPLRNRLSE TE QSAK
Sbjct: 453 VQLINYTKSGKKFWNLFHLQPMRDQKGELQYFIGVQLDGSDHVEPLRNRLSENTEIQSAK 512
Query: 245 IVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNSSWIAIQKITGSGEKIG 304
+VKATAENV++AVRELPDANLRPEDLWAIHS V P+PHKR+N SWIAI+K T GEKIG
Sbjct: 513 LVKATAENVDDAVRELPDANLRPEDLWAIHSMRVSPKPHKRNNPSWIAIEKATNLGEKIG 572
Query: 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD 364
L HFKP+KPLGCGDTGSVHLVELQG+GEL+AMKAM+KSVMLNRNKVHRACIEREI +LLD
Sbjct: 573 LKHFKPVKPLGCGDTGSVHLVELQGSGELFAMKAMDKSVMLNRNKVHRACIEREIYALLD 632
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYL 424
HPFLPTLY SFQT TH+CLITDFCPGGELFA+LD+QPMKIFRE+ ARFYAAEVVIGLEYL
Sbjct: 633 HPFLPTLYTSFQTPTHVCLITDFCPGGELFAVLDRQPMKIFREECARFYAAEVVIGLEYL 692
Query: 425 HCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHA 468
HCLGIIYRDLKPENILLQ DGH+VLTDFDLSF+T+ KP V ++
Sbjct: 693 HCLGIIYRDLKPENILLQADGHIVLTDFDLSFLTTSKPHVIKNS 736
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P93025|PHOT2_ARATH Phototropin-2 OS=Arabidopsis thaliana GN=PHOT2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 663 bits (1710), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 330/467 (70%), Positives = 371/467 (79%), Gaps = 47/467 (10%)
Query: 5 EAGRNSRKSGRNSL-MGLKVRSPSLAGKHEPQPSIAPEVFM--TKDLKWTDSWDRAERER 61
EA ++ R GR S G K++S + +HE + PE M T+ + DSWD ++RER
Sbjct: 315 EASKSFRTPGRVSTPTGSKLKSSN--NRHEDLLRMEPEELMLSTEVIGQRDSWDLSDRER 372
Query: 62 DIRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELT 121
DIRQGIDLATTLERIEKNFVI+DPR+PDNPIIFASDSFLELTE
Sbjct: 373 DIRQGIDLATTLERIEKNFVISDPRLPDNPIIFASDSFLELTE----------------- 415
Query: 122 EYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQR 181
Y+REEILGRNC F G +DQATV KIRDA+R+QR
Sbjct: 416 -YSREEILGRNC--------------------RFLQGP----ETDQATVQKIRDAIRDQR 450
Query: 182 EITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNRLSEKTEQQ 241
EITVQLINYTKSGKKFWNLFHLQPMRD KGELQYFIGVQLDGSDHVEPL+NRLSE+TE Q
Sbjct: 451 EITVQLINYTKSGKKFWNLFHLQPMRDQKGELQYFIGVQLDGSDHVEPLQNRLSERTEMQ 510
Query: 242 SAKIVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNSSWIAIQKITGSGE 301
S+K+VKATA NV+EAVRELPDAN RPEDLWA HS+PV+P PH ++++SW AI+KI SGE
Sbjct: 511 SSKLVKATATNVDEAVRELPDANTRPEDLWAAHSKPVYPLPHNKESTSWKAIKKIQASGE 570
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS 361
+GLHHFKPIKPLG GDTGSVHLVEL+G GELYAMKAMEK++MLNRNK HRACIEREI+S
Sbjct: 571 TVGLHHFKPIKPLGSGDTGSVHLVELKGTGELYAMKAMEKTMMLNRNKAHRACIEREIIS 630
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
LLDHPFLPTLYASFQTSTH+CLITDFCPGGELFALLD+QPMKI EDSARFYAAEVVIGL
Sbjct: 631 LLDHPFLPTLYASFQTSTHVCLITDFCPGGELFALLDRQPMKILTEDSARFYAAEVVIGL 690
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHA 468
EYLHCLGI+YRDLKPENILL+KDGH+VL DFDLSFMT+C PQ+ A
Sbjct: 691 EYLHCLGIVYRDLKPENILLKKDGHIVLADFDLSFMTTCTPQLIIPA 737
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for photo-induced movements. Mediates calcium spiking of extra- and intracellular origins in response to blue light. Involved in hypocotyl phototropism. Contributes to the chloroplast accumulation in low blue light and mediates their translocation (avoidance response) at high fluence. Regulates stomata opening and photomorphogenesis response of leaf tissue. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2RBR1|PHT1B_ORYSJ Phototropin-1B OS=Oryza sativa subsp. japonica GN=PHOT1B PE=1 SV=2 | Back alignment and function description |
|---|
Score = 562 bits (1448), Expect = e-159, Method: Compositional matrix adjust.
Identities = 279/476 (58%), Positives = 335/476 (70%), Gaps = 57/476 (11%)
Query: 10 SRKSGRNSLMGLKVRSPSLAGKHEPQPSIAPEVFMTKDLKWTDSWDRAERERDIRQGIDL 69
+RKSG + MG K+ +P + + D + +S++ R +++R+GIDL
Sbjct: 346 TRKSGLRAFMGFLGMGHGSVEKNMLKPR-DEDPLIDSDDERPESFEDEFRRKEMRRGIDL 404
Query: 70 ATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEIL 129
ATTLERIEKNFVITDPR+PDNPIIFASDSFL+LTEY REEILGRNC FL+ E
Sbjct: 405 ATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYNREEILGRNCRFLQGPE------- 457
Query: 130 GRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLIN 189
+D+ATV KIRDA+ Q E+TVQLIN
Sbjct: 458 -----------------------------------TDRATVRKIRDAIDNQAEVTVQLIN 482
Query: 190 YTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNRLSEKTEQQSAKIVKAT 249
YTKSGKKFWNLFHLQPMRD KG++QYFIGVQLDG++HV+ + ++ +VK T
Sbjct: 483 YTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVQ-------DDAAKEGVVLVKKT 535
Query: 250 AENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNSSWIAIQKITGSGEKIGLHHFK 309
A+N++EA +ELPDANLRP+DLWA HS+ V P PH +D +SW AIQK+ SGE IGL HF+
Sbjct: 536 ADNIDEAAKELPDANLRPKDLWANHSKVVLPNPHMKDTASWRAIQKVLESGESIGLKHFR 595
Query: 310 PIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLP 369
P+KPLG GDTGSVHLVEL GE +AMKAM+KS+MLNRNKVHRA ER+I+ LLDHPFLP
Sbjct: 596 PVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSIMLNRNKVHRATAERQILDLLDHPFLP 655
Query: 370 TLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGI 429
TLYASFQT THICLITD+CPGGELF LLD QP+K+ ED+ RFYAAEVV+ LEYLHC GI
Sbjct: 656 TLYASFQTKTHICLITDYCPGGELFVLLDNQPLKVLHEDAVRFYAAEVVVALEYLHCQGI 715
Query: 430 IYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFY-------HAHVNGFYFIMY 478
IYRDLKPENILL +DGH+ LTDFDLS +TSC+PQVF NG Y I +
Sbjct: 716 IYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQVFLPEDADEKKGRKNGSYPIFF 771
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QYY8|PHT1A_ORYSJ Phototropin-1A OS=Oryza sativa subsp. japonica GN=PHOT1A PE=1 SV=2 | Back alignment and function description |
|---|
Score = 556 bits (1432), Expect = e-157, Method: Compositional matrix adjust.
Identities = 281/483 (58%), Positives = 336/483 (69%), Gaps = 57/483 (11%)
Query: 3 VQEAGRNSRKSGRNSLMGLKVRSPSLAGKHEPQPSIAPEVFMTKDLKWTDSWDRAERERD 62
V + G +RKSG + MG K+ +P + + D + +S++ R ++
Sbjct: 339 VPDQGNRTRKSGLRAFMGFLGMGHGSVEKNMLKPR-DEDPLIDSDDERPESFEDEFRRKE 397
Query: 63 IRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTE 122
+R+GIDLATTLERIEKNFVITDPR+PDNPIIFASDSFL+LTE
Sbjct: 398 MRRGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTE------------------ 439
Query: 123 YTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQRE 182
Y REEILGRNC F G +D+ATV KIRDA+ Q E
Sbjct: 440 YNREEILGRNC--------------------RFLQGP----ETDRATVRKIRDAIDNQAE 475
Query: 183 ITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNRLSEKTEQQS 242
+TVQLINYTKSGKKFWNLFHLQPMRD KG++QYFIGVQLDG++HV+ + ++
Sbjct: 476 VTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVQ-------DDAAKEG 528
Query: 243 AKIVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNSSWIAIQKITGSGEK 302
+VK TA+N++EA +ELPDANLRPEDLWA HS+ V P PH +D +SW AIQK+ SGE
Sbjct: 529 VVLVKKTADNIDEAAKELPDANLRPEDLWANHSKVVLPNPHMKDTASWRAIQKVLESGES 588
Query: 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL 362
IGL HF+P+KPLG GDTGSVHLVEL GE +AMKAM+KS+MLNRNKVHRA ER+I+ L
Sbjct: 589 IGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSIMLNRNKVHRATAERQILDL 648
Query: 363 LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLE 422
LDHPFLPTLYASFQT THICLITD+CPGGELF LLD QP+K+ ED+ RFYAAEVV+ LE
Sbjct: 649 LDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKVLHEDAVRFYAAEVVVALE 708
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFY-------HAHVNGFYF 475
YLHC GIIYRDLKPENILL +DGH+ LTDFDLS +TSC+PQVF NG Y
Sbjct: 709 YLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQVFLPEDADEKKGRKNGSYP 768
Query: 476 IMY 478
I +
Sbjct: 769 IFF 771
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48963|PHOT1_ARATH Phototropin-1 OS=Arabidopsis thaliana GN=PHOT1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 546 bits (1406), Expect = e-154, Method: Compositional matrix adjust.
Identities = 280/466 (60%), Positives = 335/466 (71%), Gaps = 57/466 (12%)
Query: 8 RNSRKSGRNSLMGLKVRSPSLAGKHEPQPSIAPEV--FMTKDLKWTDSWDRAE------R 59
+ SRKS S MG+K +S SL SI + +D + +D +R E R
Sbjct: 404 KKSRKSSL-SFMGIKKKSESL------DESIDDGFIEYGEEDDEISDRDERPESVDDKVR 456
Query: 60 ERDIRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLE 119
++++R+GIDLATTLERIEKNFVITDPR+PDNPIIFASDSFLELTE
Sbjct: 457 QKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTE--------------- 501
Query: 120 LTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVRE 179
Y+REEILGRNC F G +D TV KIR+A+
Sbjct: 502 ---YSREEILGRNC--------------------RFLQGP----ETDLTTVKKIRNAIDN 534
Query: 180 QREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNRLSEKTE 239
Q E+TVQLINYTKSGKKFWN+FHLQPMRD KGE+QYFIGVQLDGS HVEP+RN + E
Sbjct: 535 QTEVTVQLINYTKSGKKFWNIFHLQPMRDQKGEVQYFIGVQLDGSKHVEPVRNVIEETAV 594
Query: 240 QQSAKIVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNSSWIAIQKITGS 299
++ +VK TA N++EAVRELPDAN+ PEDLWA HS+ V +PH++D+ WIAIQK+ S
Sbjct: 595 KEGEDLVKKTAVNIDEAVRELPDANMTPEDLWANHSKVVHCKPHRKDSPPWIAIQKVLES 654
Query: 300 GEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI 359
GE IGL HFKP+KPLG GDTGSVHLVEL G +L+AMKAM+K+VMLNRNKVHRA EREI
Sbjct: 655 GEPIGLKHFKPVKPLGSGDTGSVHLVELVGTDQLFAMKAMDKAVMLNRNKVHRARAEREI 714
Query: 360 MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVI 419
+ LLDHPFLP LYASFQT THICLITD+ PGGELF LLD+QP K+ +ED+ RFYAA+VV+
Sbjct: 715 LDLLDHPFLPALYASFQTKTHICLITDYYPGGELFMLLDRQPRKVLKEDAVRFYAAQVVV 774
Query: 420 GLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVF 465
LEYLHC GIIYRDLKPEN+L+Q +G + L+DFDLS +TSCKPQ+
Sbjct: 775 ALEYLHCQGIIYRDLKPENVLIQGNGDISLSDFDLSCLTSCKPQLL 820
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for photo-induced movements. Required for blue-light mediated mRNA destabilization. Mediates calcium spiking of extracellular origin in response to low rate of blue light. Mediates also rapid membrane depolarization and growth inhibition in response to blue light. Necessary for root phototropism. Involved in hypocotyl phototropism under low rate but not under high rate blue light. Contributes to the chloroplast accumulation but seems to be not required for chloroplast translocation. Regulates stomata opening and photomorphogenesis response of leaf tissue. Confers sensitivity to drought. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P15792|KPK1_PHAVU Protein kinase PVPK-1 OS=Phaseolus vulgaris PE=2 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (538), Expect = 8e-54, Method: Compositional matrix adjust.
Identities = 99/187 (52%), Positives = 129/187 (68%)
Query: 278 VFPRPHKRDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMK 337
V +PHK ++ W AIQ + + + HF+ +K LGCGD GSV+L EL G +AMK
Sbjct: 199 VLYKPHKANDIRWEAIQAVRTRDGMLEMRHFRLLKKLGCGDIGSVYLAELSGTRTSFAMK 258
Query: 338 AMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALL 397
M K+ + NR K+ RA EREI+ LDHPFLPTLY F+T CL+ +FCPGG+L AL
Sbjct: 259 VMNKTELANRKKLLRAQTEREILQSLDHPFLPTLYTHFETEIFSCLVMEFCPGGDLHALR 318
Query: 398 DKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457
+QP K F E + RFY AEV++ LEYLH LGIIYRDLKPEN+L+++DGH++L+DFDLS
Sbjct: 319 QRQPGKYFSEHAVRFYVAEVLLSLEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 378
Query: 458 TSCKPQV 464
S P +
Sbjct: 379 CSVSPTL 385
|
Phaseolus vulgaris (taxid: 3885) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YBX5|G11A_ORYSI Protein kinase G11A OS=Oryza sativa subsp. indica GN=OsI_021818 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (536), Expect = 1e-53, Method: Compositional matrix adjust.
Identities = 105/233 (45%), Positives = 146/233 (62%), Gaps = 2/233 (0%)
Query: 242 SAKIV--KATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNSSWIAIQKITGS 299
SA++V T E + R P + D A S +PHK ++S W AIQ I
Sbjct: 127 SARLVGRSETGERGFSSSRCRPSTSSDVSDESACSSISSVTKPHKANDSRWEAIQMIRTR 186
Query: 300 GEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI 359
+GL HFK +K LGCGD GSV+L EL G +AMK M+K+ + +R K+ RA E+EI
Sbjct: 187 DGILGLSHFKLLKKLGCGDIGSVYLSELNGTKSYFAMKVMDKASLASRKKLLRAQTEKEI 246
Query: 360 MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVI 419
+ LDHPFLPTLY F+T CL+ +FCPGG+L L +Q K F E + +FY AE+++
Sbjct: 247 LQCLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYVAEILL 306
Query: 420 GLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNG 472
+EYLH LGIIYRDLKPEN+L+++DGH++L+DFDLS + P + ++ +
Sbjct: 307 AMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIRSSNPDA 359
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0DCT8|G11A_ORYSJ Protein kinase G11A OS=Oryza sativa subsp. japonica GN=Os06g0291600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 210 bits (535), Expect = 2e-53, Method: Compositional matrix adjust.
Identities = 105/233 (45%), Positives = 146/233 (62%), Gaps = 2/233 (0%)
Query: 242 SAKIV--KATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNSSWIAIQKITGS 299
SA++V T E + R P + D A S +PHK ++S W AIQ I
Sbjct: 127 SARLVGRSETGERGFSSSRCRPSTSSDVSDESACSSISSVTKPHKANDSRWEAIQMIRTR 186
Query: 300 GEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI 359
+GL HFK +K LGCGD GSV+L EL G +AMK M+K+ + +R K+ RA E+EI
Sbjct: 187 DGILGLSHFKLLKKLGCGDIGSVYLSELSGTKSYFAMKVMDKASLASRKKLLRAQTEKEI 246
Query: 360 MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVI 419
+ LDHPFLPTLY F+T CL+ +FCPGG+L L +Q K F E + +FY AE+++
Sbjct: 247 LQCLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYVAEILL 306
Query: 420 GLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNG 472
+EYLH LGIIYRDLKPEN+L+++DGH++L+DFDLS + P + ++ +
Sbjct: 307 AMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIRSSNPDA 359
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFA2|KIPK_ARATH Serine/threonine-protein kinase KIPK OS=Arabidopsis thaliana GN=KIPK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 199 bits (507), Expect = 3e-50, Method: Compositional matrix adjust.
Identities = 94/184 (51%), Positives = 124/184 (67%)
Query: 281 RPHKRDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAME 340
+PH + W AI+ I +GL HF +K LGCGD G+V+L EL G L+A+K M+
Sbjct: 511 KPHMSMDVRWEAIKHIKVQYGSLGLRHFNLLKKLGCGDIGTVYLAELIGTNCLFAIKVMD 570
Query: 341 KSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQ 400
+ R K RA EREI+ +LDHPFLPTLYA F + CL+ ++CPGG+L L KQ
Sbjct: 571 NEFLARRKKSPRAQAEREILKMLDHPFLPTLYAQFTSDNLSCLVMEYCPGGDLHVLRQKQ 630
Query: 401 PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460
+ F E +ARFY AE+++ LEYLH LGIIYRDLKPENIL+++DGH++LTDFDLS +
Sbjct: 631 LGRCFPEPAARFYVAEILLALEYLHMLGIIYRDLKPENILVREDGHIMLTDFDLSLRCAV 690
Query: 461 KPQV 464
P +
Sbjct: 691 NPTL 694
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05999|KPK7_ARATH Serine/threonine-protein kinase AtPK7 OS=Arabidopsis thaliana GN=PK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 199 bits (507), Expect = 3e-50, Method: Compositional matrix adjust.
Identities = 96/193 (49%), Positives = 133/193 (68%), Gaps = 2/193 (1%)
Query: 281 RPHKRDNSS-WIAIQKITGS-GEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKA 338
+PH+ +N W+AIQ++ G + FK IK LG GD G+V+L EL G G +A+K
Sbjct: 153 KPHRDNNDKRWVAIQEVRSRVGSSLEAKDFKLIKKLGGGDIGNVYLAELIGTGVSFAVKV 212
Query: 339 MEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLD 398
MEK+ + R K+ RA E+EI+ LDHPFLPTLY+ F+T + CL+ +FCPGG+L +L
Sbjct: 213 MEKAAIAARKKLVRAQTEKEILQSLDHPFLPTLYSHFETEMNSCLVMEFCPGGDLHSLRQ 272
Query: 399 KQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458
KQ K F E +ARFY AEV++ +EYLH LGIIYRDLKPEN+L+++DGH++L+DFDLS
Sbjct: 273 KQRGKYFPEQAARFYVAEVLLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 332
Query: 459 SCKPQVFYHAHVN 471
+ P + A +
Sbjct: 333 AVSPTLVRFAAIT 345
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 489 | ||||||
| 255546656 | 984 | serine/threonine protein kinase, putativ | 0.858 | 0.426 | 0.773 | 0.0 | |
| 225428366 | 1001 | PREDICTED: phototropin-2 [Vitis vinifera | 0.865 | 0.422 | 0.770 | 0.0 | |
| 297744446 | 979 | unnamed protein product [Vitis vinifera] | 0.865 | 0.432 | 0.770 | 0.0 | |
| 60099458 | 996 | phototropin [Phaseolus vulgaris] | 0.867 | 0.425 | 0.760 | 0.0 | |
| 356526675 | 996 | PREDICTED: phototropin-2-like [Glycine m | 0.862 | 0.423 | 0.753 | 0.0 | |
| 401782494 | 944 | phototropin 2 [Fragaria x ananassa] | 0.858 | 0.444 | 0.750 | 0.0 | |
| 356559155 | 990 | PREDICTED: phototropin-2-like [Glycine m | 0.860 | 0.425 | 0.751 | 0.0 | |
| 457711 | 724 | protein kinase [Spinacia oleracea] | 0.840 | 0.567 | 0.739 | 0.0 | |
| 113911589 | 952 | phototropin-2 [Solanum lycopersicum] | 0.860 | 0.442 | 0.719 | 0.0 | |
| 449444602 | 921 | PREDICTED: phototropin-2-like [Cucumis s | 0.865 | 0.459 | 0.733 | 0.0 |
| >gi|255546656|ref|XP_002514387.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223546484|gb|EEF47983.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 730 bits (1884), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 358/463 (77%), Positives = 386/463 (83%), Gaps = 43/463 (9%)
Query: 4 QEAGRNSRKSGRNSLMGLKVRSPSLAGKHE-PQPSIAPEVFMTKDLKWTDSWDRAERERD 62
QEA + +RKS R S GL+ RSPS G E P PS+ PE+ MTK++K +DSWD R+RD
Sbjct: 385 QEASKKTRKSSRISFRGLQARSPSSTGIREAPPPSVDPELLMTKEIKHSDSWDPTGRDRD 444
Query: 63 IRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTE 122
IRQGIDLATTLERIEKNFVITDPR+PDNPIIFASDSFLELTE
Sbjct: 445 IRQGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTE------------------ 486
Query: 123 YTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQRE 182
YTREEILGRNC F G +D ATVSKIRDA+REQRE
Sbjct: 487 YTREEILGRNC--------------------RFLQGP----ETDLATVSKIRDAIREQRE 522
Query: 183 ITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNRLSEKTEQQS 242
ITVQLINYTKSGKKFWNLFHLQPMRD KGELQYFIGVQLDGSDHVEPLRNRLSE+TE QS
Sbjct: 523 ITVQLINYTKSGKKFWNLFHLQPMRDQKGELQYFIGVQLDGSDHVEPLRNRLSEQTELQS 582
Query: 243 AKIVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNSSWIAIQKITGSGEK 302
AK+VKATAENV+EAVRELPDANLRPEDLWAIHSQPVFPRPHKR+N SWIAI++I SGEK
Sbjct: 583 AKLVKATAENVDEAVRELPDANLRPEDLWAIHSQPVFPRPHKRENPSWIAIKEIISSGEK 642
Query: 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL 362
IGL HFKPIKPLGCGDTGSVHLVEL+G G+LYAMKAMEKS+MLNRNKVHRACIEREI+SL
Sbjct: 643 IGLQHFKPIKPLGCGDTGSVHLVELKGTGQLYAMKAMEKSMMLNRNKVHRACIEREIISL 702
Query: 363 LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLE 422
LDHPFLPTLY SFQTSTH+CLITDFCPGGELFALLD+QPMK+F+E+SARFYAAEVVIGLE
Sbjct: 703 LDHPFLPTLYTSFQTSTHVCLITDFCPGGELFALLDRQPMKLFKEESARFYAAEVVIGLE 762
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVF 465
YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM SCKPQ+
Sbjct: 763 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMASCKPQIL 805
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225428366|ref|XP_002280118.1| PREDICTED: phototropin-2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 725 bits (1872), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/466 (77%), Positives = 390/466 (83%), Gaps = 43/466 (9%)
Query: 2 SVQEAGRNSRKSGRNSLMGLKVRSPSLAGKHEPQPSIAPEVFMTKDLKWTDSWDRAERER 61
S QEAG+ SRKS R SLMG K +S S E QPSI PE+ MTKD++ +DSW+RAERER
Sbjct: 405 SRQEAGKKSRKSARISLMGFKSKSISSFSAQECQPSIEPEILMTKDIERSDSWERAERER 464
Query: 62 DIRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELT 121
DIRQGIDLATTLERIEKNFVITDPR+PDNPIIFASDSFLELTE
Sbjct: 465 DIRQGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTE----------------- 507
Query: 122 EYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQR 181
YTREEILGRNC F G +DQ TVSKIRDA+R+QR
Sbjct: 508 -YTREEILGRNC--------------------RFLQGP----ETDQGTVSKIRDAIRQQR 542
Query: 182 EITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNRLSEKTEQQ 241
EITVQLINYTKSGKKFWNLFHLQPMRD KGELQYFIGVQLDGSDH+EPLRNRLSE+TEQQ
Sbjct: 543 EITVQLINYTKSGKKFWNLFHLQPMRDQKGELQYFIGVQLDGSDHLEPLRNRLSEQTEQQ 602
Query: 242 SAKIVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNSSWIAIQKITGSGE 301
SAK+VKATAENV+EAVRELPDANLRPEDLWAIHSQPVFP+PHK++NSSWIAIQKIT E
Sbjct: 603 SAKLVKATAENVDEAVRELPDANLRPEDLWAIHSQPVFPKPHKKNNSSWIAIQKITAR-E 661
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS 361
KIGL HF PI+PLGCGDTGSVHLVEL+G+GELYAMKAM+KSVMLNRNKVHRAC+EREI+S
Sbjct: 662 KIGLSHFNPIRPLGCGDTGSVHLVELKGSGELYAMKAMDKSVMLNRNKVHRACMEREIIS 721
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
+LDHPFLPTLY+SFQT TH+CLITDF PGGELFALLDKQPMKIFRE+SARFYAAEVVIGL
Sbjct: 722 MLDHPFLPTLYSSFQTPTHVCLITDFFPGGELFALLDKQPMKIFREESARFYAAEVVIGL 781
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYH 467
EYLHCLGIIYRDLKPEN++LQKDGHVVL DFDLS MTSCKPQ+ H
Sbjct: 782 EYLHCLGIIYRDLKPENVILQKDGHVVLADFDLSLMTSCKPQIIKH 827
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297744446|emb|CBI37708.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 725 bits (1871), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/466 (77%), Positives = 390/466 (83%), Gaps = 43/466 (9%)
Query: 2 SVQEAGRNSRKSGRNSLMGLKVRSPSLAGKHEPQPSIAPEVFMTKDLKWTDSWDRAERER 61
S QEAG+ SRKS R SLMG K +S S E QPSI PE+ MTKD++ +DSW+RAERER
Sbjct: 383 SRQEAGKKSRKSARISLMGFKSKSISSFSAQECQPSIEPEILMTKDIERSDSWERAERER 442
Query: 62 DIRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELT 121
DIRQGIDLATTLERIEKNFVITDPR+PDNPIIFASDSFLELTE
Sbjct: 443 DIRQGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTE----------------- 485
Query: 122 EYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQR 181
YTREEILGRNC F G +DQ TVSKIRDA+R+QR
Sbjct: 486 -YTREEILGRNC--------------------RFLQGP----ETDQGTVSKIRDAIRQQR 520
Query: 182 EITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNRLSEKTEQQ 241
EITVQLINYTKSGKKFWNLFHLQPMRD KGELQYFIGVQLDGSDH+EPLRNRLSE+TEQQ
Sbjct: 521 EITVQLINYTKSGKKFWNLFHLQPMRDQKGELQYFIGVQLDGSDHLEPLRNRLSEQTEQQ 580
Query: 242 SAKIVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNSSWIAIQKITGSGE 301
SAK+VKATAENV+EAVRELPDANLRPEDLWAIHSQPVFP+PHK++NSSWIAIQKIT E
Sbjct: 581 SAKLVKATAENVDEAVRELPDANLRPEDLWAIHSQPVFPKPHKKNNSSWIAIQKITAR-E 639
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS 361
KIGL HF PI+PLGCGDTGSVHLVEL+G+GELYAMKAM+KSVMLNRNKVHRAC+EREI+S
Sbjct: 640 KIGLSHFNPIRPLGCGDTGSVHLVELKGSGELYAMKAMDKSVMLNRNKVHRACMEREIIS 699
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
+LDHPFLPTLY+SFQT TH+CLITDF PGGELFALLDKQPMKIFRE+SARFYAAEVVIGL
Sbjct: 700 MLDHPFLPTLYSSFQTPTHVCLITDFFPGGELFALLDKQPMKIFREESARFYAAEVVIGL 759
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYH 467
EYLHCLGIIYRDLKPEN++LQKDGHVVL DFDLS MTSCKPQ+ H
Sbjct: 760 EYLHCLGIIYRDLKPENVILQKDGHVVLADFDLSLMTSCKPQIIKH 805
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|60099458|dbj|BAD89968.1| phototropin [Phaseolus vulgaris] | Back alignment and taxonomy information |
|---|
Score = 719 bits (1857), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/467 (76%), Positives = 385/467 (82%), Gaps = 43/467 (9%)
Query: 2 SVQEAGRNSRKSGRNSLMGLKVRSPSLAGKHEPQPSIAPEVFMTKDLKWTDSWDRAERER 61
S QE R SR SGR SL G K +S S AG+ E + + PEV MTK+++W+++W+ + RER
Sbjct: 398 SNQEKSRTSR-SGRISLKGFKGKSQSSAGRDEEKTIVEPEVLMTKEIEWSNNWEHSLRER 456
Query: 62 DIRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELT 121
DIRQGIDLATTLERIEKNFVI+DPR+PDNPIIFASDSFLELTE
Sbjct: 457 DIRQGIDLATTLERIEKNFVISDPRLPDNPIIFASDSFLELTE----------------- 499
Query: 122 EYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQR 181
YTREEILGRNC F G +DQATVS+IRDA+REQR
Sbjct: 500 -YTREEILGRNC--------------------RFLQGP----ETDQATVSRIRDAIREQR 534
Query: 182 EITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNRLSEKTEQQ 241
EITVQLINYTKSGKKFWNLFHLQPMRD KGELQYFIGVQLDGSDHVEPL+NRLSE TE Q
Sbjct: 535 EITVQLINYTKSGKKFWNLFHLQPMRDQKGELQYFIGVQLDGSDHVEPLKNRLSETTEFQ 594
Query: 242 SAKIVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNSSWIAIQKITGSGE 301
SAK+VKATAENV+EAVRELPDANLRPEDLWAIHSQPVFPRPHKRDN SWIAIQK+ GE
Sbjct: 595 SAKLVKATAENVDEAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNPSWIAIQKVVARGE 654
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS 361
KIGL HF PI+PLGCGDTGSVHLVEL+G GELYAMKAMEK+VMLNRNKVHR+CIEREI+S
Sbjct: 655 KIGLQHFVPIRPLGCGDTGSVHLVELKGTGELYAMKAMEKTVMLNRNKVHRSCIEREIIS 714
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
LLDHPFLPTLY SFQTSTH+CLI+DFC GGELFALLDKQPMKIF+E+SARFYAAEVVIGL
Sbjct: 715 LLDHPFLPTLYTSFQTSTHVCLISDFCHGGELFALLDKQPMKIFKEESARFYAAEVVIGL 774
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHA 468
EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS MTSCKPQV A
Sbjct: 775 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSSMTSCKPQVVKQA 821
|
Source: Phaseolus vulgaris Species: Phaseolus vulgaris Genus: Phaseolus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356526675|ref|XP_003531942.1| PREDICTED: phototropin-2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 711 bits (1834), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/467 (75%), Positives = 381/467 (81%), Gaps = 45/467 (9%)
Query: 2 SVQEAGRNSRKSGRNSLMGLKVRSPSLAGKHEPQPSIAPEVFMTKDLKWTDSWDRAERER 61
S Q+ + S +SGR S GLK RSPS A E +P PEV MTK+++W+++ + + RER
Sbjct: 400 SSQDKSKTSSRSGRISFKGLKGRSPSSA---EEKPIFEPEVLMTKEIEWSNNLEHSLRER 456
Query: 62 DIRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELT 121
DIRQGIDLATTLERIEKNFVI+DPR+PDNPIIFASDSFLELTE
Sbjct: 457 DIRQGIDLATTLERIEKNFVISDPRLPDNPIIFASDSFLELTE----------------- 499
Query: 122 EYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQR 181
YTREEILGRNC F G +DQATVS+IRDA+REQR
Sbjct: 500 -YTREEILGRNC--------------------RFLQGP----ETDQATVSRIRDAIREQR 534
Query: 182 EITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNRLSEKTEQQ 241
EITVQLINYTKSGKKFWNLFHLQPMRD KGELQYFIGVQLDGSDHVEPL+NRLSE TEQQ
Sbjct: 535 EITVQLINYTKSGKKFWNLFHLQPMRDQKGELQYFIGVQLDGSDHVEPLKNRLSETTEQQ 594
Query: 242 SAKIVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNSSWIAIQKITGSGE 301
SAK+VKATAENV+EAVRELPDANLRPEDLWAIHSQPVFPRPHK+DN SWIAIQK+ E
Sbjct: 595 SAKLVKATAENVDEAVRELPDANLRPEDLWAIHSQPVFPRPHKKDNPSWIAIQKVAARDE 654
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS 361
KIGL HF PI+PLGCGDTGSVHLVEL+G GELYAMKAMEKSVMLNRNKVHR+CIEREI+S
Sbjct: 655 KIGLQHFVPIRPLGCGDTGSVHLVELKGTGELYAMKAMEKSVMLNRNKVHRSCIEREIIS 714
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
LLDHPFLPTLY SFQT TH+CLITDF PGGELFALLDKQPMKIF+E+ ARFYAAEVVIGL
Sbjct: 715 LLDHPFLPTLYTSFQTPTHVCLITDFFPGGELFALLDKQPMKIFKEELARFYAAEVVIGL 774
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHA 468
EYLHCLGIIYRDLKPENILLQKDGHVVL DFDLSFMTSCKPQV A
Sbjct: 775 EYLHCLGIIYRDLKPENILLQKDGHVVLADFDLSFMTSCKPQVVKQA 821
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|401782494|dbj|BAM36550.1| phototropin 2 [Fragaria x ananassa] | Back alignment and taxonomy information |
|---|
Score = 707 bits (1826), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/465 (75%), Positives = 380/465 (81%), Gaps = 45/465 (9%)
Query: 4 QEAGRNSRKSGRNSLMGLKVRSPSL-AGKHEPQPSIAPEVFMTKDLKWTDSWDRAERERD 62
Q+AG+ +KS RN +G RS SL AG+ E +P + PEV MT D++ +DSWDR ERERD
Sbjct: 347 QDAGKYPKKSERNPSLG--TRSKSLTAGRLEKEPIVEPEVLMTTDIERSDSWDRTERERD 404
Query: 63 IRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTE 122
IRQGIDLATTLERIEKNFVI+DPRIPDNPIIFASDSFLELTE
Sbjct: 405 IRQGIDLATTLERIEKNFVISDPRIPDNPIIFASDSFLELTE------------------ 446
Query: 123 YTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQRE 182
YTREEILGRNC F G +DQATV KIRDA+REQRE
Sbjct: 447 YTREEILGRNC--------------------RFLQGP----ETDQATVQKIRDAIREQRE 482
Query: 183 ITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNRLSEKTEQQS 242
ITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNRLSE+ E +S
Sbjct: 483 ITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNRLSERAELES 542
Query: 243 AKIVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNSSWIAIQKITGSGEK 302
AK+VKATA NVNEAVRELPDANLRPEDLWAIHSQPVFP+PHKRD++SW+A+Q+IT GEK
Sbjct: 543 AKVVKATAVNVNEAVRELPDANLRPEDLWAIHSQPVFPKPHKRDSASWLAMQEITSRGEK 602
Query: 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL 362
I L HFKPIKPLGCGDTGSVHLVEL+G LYAMKAMEKS+MLNRNKVHRAC EREI+S
Sbjct: 603 IDLRHFKPIKPLGCGDTGSVHLVELRGTSILYAMKAMEKSIMLNRNKVHRACTEREIISQ 662
Query: 363 LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLE 422
LDHPFLPTLY SF+TSTH+CLITDFC GGELFALLDKQPMK F+EDSARFYAAEVVI LE
Sbjct: 663 LDHPFLPTLYTSFETSTHVCLITDFCSGGELFALLDKQPMKFFKEDSARFYAAEVVIALE 722
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYH 467
YLHCLGIIYRDLKPENILLQKDGH+VLTDFDLSF+ SCKPQ+ H
Sbjct: 723 YLHCLGIIYRDLKPENILLQKDGHIVLTDFDLSFLASCKPQIIRH 767
|
Source: Fragaria x ananassa Species: Fragaria x ananassa Genus: Fragaria Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356559155|ref|XP_003547866.1| PREDICTED: phototropin-2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 704 bits (1816), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/467 (75%), Positives = 382/467 (81%), Gaps = 46/467 (9%)
Query: 2 SVQEAGRNSRKSGRNSLMGLKVRSPSLAGKHEPQPSIAPEVFMTKDLKWTDSWDRAERER 61
S Q+ R S +SGR S GLK RS S A E + + PEV MTK+++W+++ + + RER
Sbjct: 395 SSQDKSRTS-QSGRISFKGLKGRSLSSA---EEKSIVEPEVLMTKEIEWSNNLEHSLRER 450
Query: 62 DIRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELT 121
DIRQGIDLATTLERIEKNFVI+DPR+PDNPIIFASDSFLELTE
Sbjct: 451 DIRQGIDLATTLERIEKNFVISDPRLPDNPIIFASDSFLELTE----------------- 493
Query: 122 EYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQR 181
YTREEILGRNC F G +DQATVS+IRDA+REQR
Sbjct: 494 -YTREEILGRNC--------------------RFLQGP----ETDQATVSRIRDAIREQR 528
Query: 182 EITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNRLSEKTEQQ 241
EITVQLINYTKSGKKFWNLFHLQPMRD KGELQYFIGVQLDGSDHVEPL+NRLSE TEQQ
Sbjct: 529 EITVQLINYTKSGKKFWNLFHLQPMRDQKGELQYFIGVQLDGSDHVEPLKNRLSETTEQQ 588
Query: 242 SAKIVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNSSWIAIQKITGSGE 301
SAK+VKATAENV+EAVRELPDANLRPEDLWAIHSQPVFPRPHK++N SWIAIQK+ GE
Sbjct: 589 SAKLVKATAENVDEAVRELPDANLRPEDLWAIHSQPVFPRPHKKENPSWIAIQKVAARGE 648
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS 361
KIGL HF PI+PLGCGDTGSVHLVEL+G GELYAMKAMEKSVMLNRNKVHR+CIEREI+S
Sbjct: 649 KIGLQHFVPIRPLGCGDTGSVHLVELKGTGELYAMKAMEKSVMLNRNKVHRSCIEREIIS 708
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
LLDHPFLPTLY SFQT TH+CLITDF PGGELFALLDKQPMKIF+E+SARFYAAEVVIGL
Sbjct: 709 LLDHPFLPTLYTSFQTPTHVCLITDFFPGGELFALLDKQPMKIFKEESARFYAAEVVIGL 768
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHA 468
EYLHCLGIIYRDLKPENILLQKDGHVVL DFDLS+MTSCKPQV A
Sbjct: 769 EYLHCLGIIYRDLKPENILLQKDGHVVLADFDLSYMTSCKPQVVKQA 815
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|457711|emb|CAA82993.1| protein kinase [Spinacia oleracea] | Back alignment and taxonomy information |
|---|
Score = 692 bits (1787), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 337/456 (73%), Positives = 371/456 (81%), Gaps = 45/456 (9%)
Query: 14 GRNSLMGLKVRSPSLAGKHEPQPSIAPEVFMTKDLKWTDSWDRAERERDIRQGIDLATTL 73
R SL+G K RS + KHE PS PE + KD+ DSW+RAERERD+RQGIDLATTL
Sbjct: 142 ARISLLGFKGRS---SAKHERPPSPEPEFLIPKDIDRDDSWERAERERDVRQGIDLATTL 198
Query: 74 ERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNC 133
ERIEKNFVI+DPR+PDNPIIFASDSFLELTEYTREEILGRNC FL+ E
Sbjct: 199 ERIEKNFVISDPRLPDNPIIFASDSFLELTEYTREEILGRNCRFLQGPE----------- 247
Query: 134 STYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKS 193
+DQ TV KIRDA++EQR+ITVQLINYTKS
Sbjct: 248 -------------------------------TDQTTVQKIRDAIKEQRDITVQLINYTKS 276
Query: 194 GKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNRLSEKTEQQSAKIVKATAENV 253
G+KFWNLFHLQPMRD KGELQYFIGVQLDGSDHVEPLRNRLSE+TE QSAK+VKATAENV
Sbjct: 277 GRKFWNLFHLQPMRDQKGELQYFIGVQLDGSDHVEPLRNRLSERTEIQSAKVVKATAENV 336
Query: 254 NEAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNSSWIAIQKITGSGEKIGLHHFKPIKP 313
+EAVRELPDAN RPEDLWAIHS+PV+PRPHKR +SSW AIQKIT +GEK+GL HF PIKP
Sbjct: 337 DEAVRELPDANSRPEDLWAIHSEPVYPRPHKRGSSSWAAIQKITAAGEKVGLEHFNPIKP 396
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYA 373
LGCGDTGSVHLVEL+ +AMKAM+KSVMLNRNKVHRAC+EREI+S LDHPFLPTLYA
Sbjct: 397 LGCGDTGSVHLVELKVPENWFAMKAMDKSVMLNRNKVHRACVEREIISTLDHPFLPTLYA 456
Query: 374 SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRD 433
SFQTSTH+CLITDFCPGGELFALLDKQP+KIF+E+SARFYAAEVVIGLEYLHCLGIIYRD
Sbjct: 457 SFQTSTHVCLITDFCPGGELFALLDKQPLKIFKEESARFYAAEVVIGLEYLHCLGIIYRD 516
Query: 434 LKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAH 469
LKPENILLQKDGH+VLTDFDLSF+TSC P + H
Sbjct: 517 LKPENILLQKDGHLVLTDFDLSFLTSCNPHIINHPQ 552
|
Source: Spinacia oleracea Species: Spinacia oleracea Genus: Spinacia Family: Amaranthaceae Order: Caryophyllales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|113911589|gb|ABI48276.1| phototropin-2 [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 689 bits (1778), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 334/464 (71%), Positives = 382/464 (82%), Gaps = 43/464 (9%)
Query: 4 QEAGRNSRKSGRNSLMGLKVRSPSLAGKHEPQPSIAPEVFMTKDLKWTDSWDRAERERDI 63
QE G+ SRKS R SL G K R S++ E + ++ PE+ MT +++ TDSW+RAERERDI
Sbjct: 359 QELGKKSRKSSRLSLKGSKGRPSSISFPLENEENVGPEIIMT-EVERTDSWERAERERDI 417
Query: 64 RQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEY 123
RQGIDLATTLERIEKNFVITDPR+PDNPIIFASDSFLELTE +
Sbjct: 418 RQGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTE------------------F 459
Query: 124 TREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREI 183
TREEILGRNC F G +DQATV KIRDA++EQ+EI
Sbjct: 460 TREEILGRNC--------------------RFLQGP----ETDQATVQKIRDAIKEQKEI 495
Query: 184 TVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNRLSEKTEQQSA 243
TVQLINYTKSGKKFWNLFHLQPMRD KGELQYFIGVQLDGSDHVEPLRNRLSE+TE+QSA
Sbjct: 496 TVQLINYTKSGKKFWNLFHLQPMRDQKGELQYFIGVQLDGSDHVEPLRNRLSEQTEKQSA 555
Query: 244 KIVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNSSWIAIQKITGSGEKI 303
K+VKATA NV+EAVRELPDAN RPEDLWA+HS PV+PRPHKR ++ W AI K+T +GE++
Sbjct: 556 KLVKATATNVDEAVRELPDANSRPEDLWALHSLPVYPRPHKRHSALWTAIHKVTANGERL 615
Query: 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL 363
GL++FKP++PLGCGDTGSVHLVEL+G G+L+AMKAM+KS+MLNRNKVHRAC+ERE+++LL
Sbjct: 616 GLNNFKPVRPLGCGDTGSVHLVELKGTGDLFAMKAMDKSIMLNRNKVHRACVEREVIALL 675
Query: 364 DHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEY 423
DHP LPTLY+SFQT TH+CLITDFCPGGELFALLD+QPMKIF+E+SARFYAAEV+IGLEY
Sbjct: 676 DHPLLPTLYSSFQTETHVCLITDFCPGGELFALLDRQPMKIFKEESARFYAAEVLIGLEY 735
Query: 424 LHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYH 467
LHCLGIIYRDLKPENILLQ DGHVVLTDFDLSF TSCKPQV H
Sbjct: 736 LHCLGIIYRDLKPENILLQADGHVVLTDFDLSFKTSCKPQVIKH 779
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449444602|ref|XP_004140063.1| PREDICTED: phototropin-2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 687 bits (1774), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/466 (73%), Positives = 372/466 (79%), Gaps = 43/466 (9%)
Query: 7 GRNSRKSGRNSLMGLKVRSPSLAGKHEPQPSIAPEVFMTKDLKWTDSWDRAERERDIRQG 66
G+ R S R SLMG K +S S A K E PE+ MT +++ +DSWDRAERE+DIRQG
Sbjct: 328 GKKPRLSSRVSLMGFKGKSLSSARKLEVT-DFEPEILMTDEIERSDSWDRAEREKDIRQG 386
Query: 67 IDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTRE 126
IDLATTLERIEKNFVITDPR+PDNPIIFASDSFLELTE YTRE
Sbjct: 387 IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTE------------------YTRE 428
Query: 127 EILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQ 186
EILGRNC F G +DQ TVSKIRDA+REQREITVQ
Sbjct: 429 EILGRNC--------------------RFLQGP----ETDQETVSKIRDAIREQREITVQ 464
Query: 187 LINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNRLSEKTEQQSAKIV 246
LINYTK+GKKFWNLFHLQPMRD GELQYFIGVQLDGS HVEPL+NRLSE E QSAK+V
Sbjct: 465 LINYTKTGKKFWNLFHLQPMRDETGELQYFIGVQLDGSGHVEPLQNRLSETAELQSAKLV 524
Query: 247 KATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNSSWIAIQKITGSGEKIGLH 306
KATAENV+EAVRELPDANLRPEDLWAIHSQPVFPRPHK+ +SSW AIQKI G GEKIGL
Sbjct: 525 KATAENVDEAVRELPDANLRPEDLWAIHSQPVFPRPHKKHSSSWTAIQKIIGRGEKIGLK 584
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
HFKPIKPLGCGDTGSVHLVEL G ELYA+KAMEKS +LNRNKVHRACIER+I++LLDHP
Sbjct: 585 HFKPIKPLGCGDTGSVHLVELLGTSELYALKAMEKSALLNRNKVHRACIERQIIALLDHP 644
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
FLPTLY SF+T TH+CLITDFC GGELFALLDKQPMK+F+EDSARFYAAEVVIGLEYLHC
Sbjct: 645 FLPTLYTSFETPTHVCLITDFCSGGELFALLDKQPMKMFKEDSARFYAAEVVIGLEYLHC 704
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNG 472
LGIIYRDLKPENILLQKDGHV L DFDLS +TSCKPQ+ + + G
Sbjct: 705 LGIIYRDLKPENILLQKDGHVTLADFDLSLVTSCKPQIVKYPLLQG 750
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 489 | ||||||
| UNIPROTKB|Q9ST27 | 907 | PHOT2 "Phototropin-2" [Oryza s | 0.613 | 0.330 | 0.86 | 3.8e-181 | |
| TAIR|locus:2155821 | 915 | PHOT2 "phototropin 2" [Arabido | 0.621 | 0.332 | 0.838 | 1.3e-176 | |
| UNIPROTKB|Q8H935 | 963 | Vfphot1a "Phototropin" [Vicia | 0.613 | 0.311 | 0.723 | 9.5e-150 | |
| UNIPROTKB|Q2QYY8 | 921 | PHOT1A "Phototropin-1A" [Oryza | 0.601 | 0.319 | 0.710 | 6.6e-149 | |
| UNIPROTKB|Q2RBR1 | 921 | PHOT1B "Phototropin-1B" [Oryza | 0.601 | 0.319 | 0.707 | 1.6e-147 | |
| TAIR|locus:2102674 | 996 | PHOT1 "phototropin 1" [Arabido | 0.613 | 0.301 | 0.703 | 4.7e-146 | |
| UNIPROTKB|Q5I6E9 | 700 | Adi3 "AvrPto-dependent Pto-int | 0.372 | 0.26 | 0.532 | 1.1e-52 | |
| TAIR|locus:2207470 | 555 | AGC1.7 "AGC kinase 1.7" [Arabi | 0.472 | 0.416 | 0.459 | 3.5e-52 | |
| TAIR|locus:2133837 | 506 | D6PKL1 "D6 protein kinase like | 0.376 | 0.363 | 0.532 | 1.5e-51 | |
| TAIR|locus:2178388 | 498 | D6PK "D6 protein kinase" [Arab | 0.466 | 0.457 | 0.449 | 4e-51 |
| UNIPROTKB|Q9ST27 PHOT2 "Phototropin-2" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1389 (494.0 bits), Expect = 3.8e-181, Sum P(2) = 3.8e-181
Identities = 258/300 (86%), Positives = 280/300 (93%)
Query: 165 SDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGS 224
+DQ TV KIR+A+REQ+EITVQLINYTKSGKKFWNLFHLQPMRD KGELQYFIGVQLDGS
Sbjct: 433 TDQGTVDKIREAIREQKEITVQLINYTKSGKKFWNLFHLQPMRDQKGELQYFIGVQLDGS 492
Query: 225 DHVEPLRNRLSEKTEQQSAKIVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHK 284
DHVEPLRNRLSE TE QSAK+VKATAENV++AVRELPDANLRPEDLWAIHS V P+PHK
Sbjct: 493 DHVEPLRNRLSENTEIQSAKLVKATAENVDDAVRELPDANLRPEDLWAIHSMRVSPKPHK 552
Query: 285 RDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVM 344
R+N SWIAI+K T GEKIGL HFKP+KPLGCGDTGSVHLVELQG+GEL+AMKAM+KSVM
Sbjct: 553 RNNPSWIAIEKATNLGEKIGLKHFKPVKPLGCGDTGSVHLVELQGSGELFAMKAMDKSVM 612
Query: 345 LNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKI 404
LNRNKVHRACIEREI +LLDHPFLPTLY SFQT TH+CLITDFCPGGELFA+LD+QPMKI
Sbjct: 613 LNRNKVHRACIEREIYALLDHPFLPTLYTSFQTPTHVCLITDFCPGGELFAVLDRQPMKI 672
Query: 405 FREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQV 464
FRE+ ARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQ DGH+VLTDFDLSF+T+ KP V
Sbjct: 673 FREECARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQADGHIVLTDFDLSFLTTSKPHV 732
|
|
| TAIR|locus:2155821 PHOT2 "phototropin 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1385 (492.6 bits), Expect = 1.3e-176, Sum P(2) = 1.3e-176
Identities = 255/304 (83%), Positives = 282/304 (92%)
Query: 165 SDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGS 224
+DQATV KIRDA+R+QREITVQLINYTKSGKKFWNLFHLQPMRD KGELQYFIGVQLDGS
Sbjct: 434 TDQATVQKIRDAIRDQREITVQLINYTKSGKKFWNLFHLQPMRDQKGELQYFIGVQLDGS 493
Query: 225 DHVEPLRNRLSEKTEQQSAKIVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHK 284
DHVEPL+NRLSE+TE QS+K+VKATA NV+EAVRELPDAN RPEDLWA HS+PV+P PH
Sbjct: 494 DHVEPLQNRLSERTEMQSSKLVKATATNVDEAVRELPDANTRPEDLWAAHSKPVYPLPHN 553
Query: 285 RDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVM 344
++++SW AI+KI SGE +GLHHFKPIKPLG GDTGSVHLVEL+G GELYAMKAMEK++M
Sbjct: 554 KESTSWKAIKKIQASGETVGLHHFKPIKPLGSGDTGSVHLVELKGTGELYAMKAMEKTMM 613
Query: 345 LNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKI 404
LNRNK HRACIEREI+SLLDHPFLPTLYASFQTSTH+CLITDFCPGGELFALLD+QPMKI
Sbjct: 614 LNRNKAHRACIEREIISLLDHPFLPTLYASFQTSTHVCLITDFCPGGELFALLDRQPMKI 673
Query: 405 FREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQV 464
EDSARFYAAEVVIGLEYLHCLGI+YRDLKPENILL+KDGH+VL DFDLSFMT+C PQ+
Sbjct: 674 LTEDSARFYAAEVVIGLEYLHCLGIVYRDLKPENILLKKDGHIVLADFDLSFMTTCTPQL 733
Query: 465 FYHA 468
A
Sbjct: 734 IIPA 737
|
|
| UNIPROTKB|Q8H935 Vfphot1a "Phototropin" [Vicia faba (taxid:3906)] | Back alignment and assigned GO terms |
|---|
Score = 1188 (423.3 bits), Expect = 9.5e-150, Sum P(2) = 9.5e-150
Identities = 217/300 (72%), Positives = 253/300 (84%)
Query: 165 SDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGS 224
+D ATV KIR A+ Q E+TVQLINYTK+GKKFWNLFHLQPMRD KGE+QYFIGVQLDGS
Sbjct: 491 TDPATVKKIRYAIDNQTEVTVQLINYTKTGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 550
Query: 225 DHVEPLRNRLSEKTEQQSAKIVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHK 284
HVEPL N ++E T ++ +VK TAENV++A+RELPDAN++PEDLW HS+ V P+PH+
Sbjct: 551 QHVEPLHNGIAEDTAKEGENLVKKTAENVDDALRELPDANMKPEDLWMNHSKVVHPKPHR 610
Query: 285 RDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVM 344
R++S+W AIQKI SGE+IGL HFKPIKPLG GDTGSVHLVEL G +AMKAM+K VM
Sbjct: 611 REDSAWRAIQKIMESGEQIGLKHFKPIKPLGSGDTGSVHLVELCGTDHHFAMKAMDKGVM 670
Query: 345 LNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKI 404
NRNKVHRAC EREI+ +LDHPFLP LYASFQT THICLITD+CPGGELF LLD+QP K+
Sbjct: 671 PNRNKVHRACTEREILDMLDHPFLPALYASFQTKTHICLITDYCPGGELFMLLDRQPAKV 730
Query: 405 FREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQV 464
+ED+ RFYA EVV+ LEYLHC GIIYRDLKPEN+LLQ GHV LTDFDLS +TSCKP++
Sbjct: 731 LKEDAVRFYATEVVVALEYLHCQGIIYRDLKPENVLLQSTGHVSLTDFDLSCLTSCKPEL 790
|
|
| UNIPROTKB|Q2QYY8 PHOT1A "Phototropin-1A" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1171 (417.3 bits), Expect = 6.6e-149, Sum P(2) = 6.6e-149
Identities = 214/301 (71%), Positives = 251/301 (83%)
Query: 165 SDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGS 224
+D+ATV KIRDA+ Q E+TVQLINYTKSGKKFWNLFHLQPMRD KG++QYFIGVQLDG+
Sbjct: 458 TDRATVRKIRDAIDNQAEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGT 517
Query: 225 DHVEPLRNRLSEKTEQQSAKIVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHK 284
+HV+ + ++ +VK TA+N++EA +ELPDANLRPEDLWA HS+ V P PH
Sbjct: 518 EHVQ-------DDAAKEGVVLVKKTADNIDEAAKELPDANLRPEDLWANHSKVVLPNPHM 570
Query: 285 RDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVM 344
+D +SW AIQK+ SGE IGL HF+P+KPLG GDTGSVHLVEL GE +AMKAM+KS+M
Sbjct: 571 KDTASWRAIQKVLESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSIM 630
Query: 345 LNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKI 404
LNRNKVHRA ER+I+ LLDHPFLPTLYASFQT THICLITD+CPGGELF LLD QP+K+
Sbjct: 631 LNRNKVHRATAERQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKV 690
Query: 405 FREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQV 464
ED+ RFYAAEVV+ LEYLHC GIIYRDLKPENILL +DGH+ LTDFDLS +TSC+PQV
Sbjct: 691 LHEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQV 750
Query: 465 F 465
F
Sbjct: 751 F 751
|
|
| UNIPROTKB|Q2RBR1 PHOT1B "Phototropin-1B" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1167 (415.9 bits), Expect = 1.6e-147, Sum P(2) = 1.6e-147
Identities = 213/301 (70%), Positives = 251/301 (83%)
Query: 165 SDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGS 224
+D+ATV KIRDA+ Q E+TVQLINYTKSGKKFWNLFHLQPMRD KG++QYFIGVQLDG+
Sbjct: 458 TDRATVRKIRDAIDNQAEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGT 517
Query: 225 DHVEPLRNRLSEKTEQQSAKIVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHK 284
+HV+ + ++ +VK TA+N++EA +ELPDANLRP+DLWA HS+ V P PH
Sbjct: 518 EHVQ-------DDAAKEGVVLVKKTADNIDEAAKELPDANLRPKDLWANHSKVVLPNPHM 570
Query: 285 RDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVM 344
+D +SW AIQK+ SGE IGL HF+P+KPLG GDTGSVHLVEL GE +AMKAM+KS+M
Sbjct: 571 KDTASWRAIQKVLESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSIM 630
Query: 345 LNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKI 404
LNRNKVHRA ER+I+ LLDHPFLPTLYASFQT THICLITD+CPGGELF LLD QP+K+
Sbjct: 631 LNRNKVHRATAERQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKV 690
Query: 405 FREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQV 464
ED+ RFYAAEVV+ LEYLHC GIIYRDLKPENILL +DGH+ LTDFDLS +TSC+PQV
Sbjct: 691 LHEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQV 750
Query: 465 F 465
F
Sbjct: 751 F 751
|
|
| TAIR|locus:2102674 PHOT1 "phototropin 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1152 (410.6 bits), Expect = 4.7e-146, Sum P(2) = 4.7e-146
Identities = 211/300 (70%), Positives = 251/300 (83%)
Query: 165 SDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGS 224
+D TV KIR+A+ Q E+TVQLINYTKSGKKFWN+FHLQPMRD KGE+QYFIGVQLDGS
Sbjct: 520 TDLTTVKKIRNAIDNQTEVTVQLINYTKSGKKFWNIFHLQPMRDQKGEVQYFIGVQLDGS 579
Query: 225 DHVEPLRNRLSEKTEQQSAKIVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHK 284
HVEP+RN + E ++ +VK TA N++EAVRELPDAN+ PEDLWA HS+ V +PH+
Sbjct: 580 KHVEPVRNVIEETAVKEGEDLVKKTAVNIDEAVRELPDANMTPEDLWANHSKVVHCKPHR 639
Query: 285 RDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVM 344
+D+ WIAIQK+ SGE IGL HFKP+KPLG GDTGSVHLVEL G +L+AMKAM+K+VM
Sbjct: 640 KDSPPWIAIQKVLESGEPIGLKHFKPVKPLGSGDTGSVHLVELVGTDQLFAMKAMDKAVM 699
Query: 345 LNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKI 404
LNRNKVHRA EREI+ LLDHPFLP LYASFQT THICLITD+ PGGELF LLD+QP K+
Sbjct: 700 LNRNKVHRARAEREILDLLDHPFLPALYASFQTKTHICLITDYYPGGELFMLLDRQPRKV 759
Query: 405 FREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQV 464
+ED+ RFYAA+VV+ LEYLHC GIIYRDLKPEN+L+Q +G + L+DFDLS +TSCKPQ+
Sbjct: 760 LKEDAVRFYAAQVVVALEYLHCQGIIYRDLKPENVLIQGNGDISLSDFDLSCLTSCKPQL 819
|
|
| UNIPROTKB|Q5I6E9 Adi3 "AvrPto-dependent Pto-interacting protein 3" [Solanum lycopersicum (taxid:4081)] | Back alignment and assigned GO terms |
|---|
Score = 524 (189.5 bits), Expect = 1.1e-52, Sum P(2) = 1.1e-52
Identities = 97/182 (53%), Positives = 129/182 (70%)
Query: 281 RPHKRDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAME 340
+PHK ++ W AI I +G+ HFK +K LGCGD GSV+L EL G +AMK M+
Sbjct: 281 KPHKGNDPRWKAILAIRARDGILGMSHFKLLKRLGCGDIGSVYLSELSGTRCYFAMKVMD 340
Query: 341 KSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQ 400
K+ + +R K+ RA EREI+ LLDHPFLPTLY F+T CL+ ++CPGG+L L +Q
Sbjct: 341 KASLASRKKLTRAQTEREILQLLDHPFLPTLYTHFETDRFSCLVMEYCPGGDLHTLRQRQ 400
Query: 401 PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460
P K F E +ARFYAAEV++ LEYLH LG++YRDLKPEN+L++ DGH++L+DFDLS +
Sbjct: 401 PGKHFSEYAARFYAAEVLLALEYLHMLGVVYRDLKPENVLVRDDGHIMLSDFDLSLRCAV 460
Query: 461 KP 462
P
Sbjct: 461 SP 462
|
|
| TAIR|locus:2207470 AGC1.7 "AGC kinase 1.7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 541 (195.5 bits), Expect = 3.5e-52, P = 3.5e-52
Identities = 109/237 (45%), Positives = 152/237 (64%)
Query: 235 SEKTEQQSAKIVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNSSWIAIQ 294
S TE QS K N N + + R + + S P +PH + W A+
Sbjct: 79 SNMTESQSNLNTKPNNNNSNNN----SNMSSRSNSIESTSSNP--SKPHTGGDIRWDAVN 132
Query: 295 KITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRAC 354
+T G ++G+ F+ +K LG GD GSV+LVEL+G +AMK M+K+ + +RNK+ RA
Sbjct: 133 TLTSKGVQLGISDFRLLKRLGYGDIGSVYLVELRGTITYFAMKVMDKASLASRNKLLRAQ 192
Query: 355 IEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYA 414
EREI+S LDHPFLPTLY+ F+T CL+ +FC GG L++L KQP K F ED+ARF+A
Sbjct: 193 TEREILSQLDHPFLPTLYSHFETDKFYCLVMEFCGGGNLYSLRQKQPNKCFTEDAARFFA 252
Query: 415 AEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVN 471
+EV++ LEYLH LGI+YRDLKPEN+L++ DGH++L+DFDLS S P + + V+
Sbjct: 253 SEVLLALEYLHMLGIVYRDLKPENVLVRDDGHIMLSDFDLSLRCSVSPTLVKSSSVH 309
|
|
| TAIR|locus:2133837 D6PKL1 "D6 protein kinase like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 535 (193.4 bits), Expect = 1.5e-51, P = 1.5e-51
Identities = 98/184 (53%), Positives = 130/184 (70%)
Query: 281 RPHKRDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAME 340
+PHK ++ W AIQ + +GL+HF+ +K LGCGD G+VHL EL G +AMK M+
Sbjct: 96 KPHKANDVRWEAIQAVRTKHGVLGLNHFRLLKRLGCGDIGTVHLAELHGTRCFFAMKVMD 155
Query: 341 KSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQ 400
K + +R K+ RA EREI+ LDHPFLPTLY+ F+T CL+ +FCPGG+L L +Q
Sbjct: 156 KGALASRKKLLRAQTEREILQCLDHPFLPTLYSHFETEKFSCLVMEFCPGGDLHTLRQRQ 215
Query: 401 PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460
P K F E +A+FY AEV++ +EYLH LGIIYRDLKPEN+L++ DGHV+L+DFDLS +
Sbjct: 216 PGKRFSEQAAKFYVAEVLLAMEYLHMLGIIYRDLKPENVLVRDDGHVMLSDFDLSLRCTV 275
Query: 461 KPQV 464
P V
Sbjct: 276 SPTV 279
|
|
| TAIR|locus:2178388 D6PK "D6 protein kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 531 (192.0 bits), Expect = 4.0e-51, P = 4.0e-51
Identities = 103/229 (44%), Positives = 147/229 (64%)
Query: 242 SAKIVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNSSWIAIQKITGSGE 301
++KI + + R +++ E + S + +PHK ++ W AIQ +
Sbjct: 44 NSKINEQGESGKSSTCRPSTSSDISDESTCSSFSSSI-NKPHKANDVRWEAIQAVRTKHG 102
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS 361
+GL+HF+ +K LGCGD G+VHL EL G +AMK M+K+ + +R K+ RA EREI+
Sbjct: 103 GLGLNHFRLLKRLGCGDIGTVHLAELNGTRCYFAMKVMDKTALASRKKLLRAQTEREILQ 162
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
LDHPFLPTLY+ F+T CL+ +FCPGG+L L +QP K F E +A+FY AEV++ +
Sbjct: 163 CLDHPFLPTLYSHFETEKFSCLVMEFCPGGDLHTLRQRQPGKRFTEQAAKFYVAEVLLAM 222
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHV 470
EYLH LGIIYRDLKPEN+L++ DGHV+L+DFDLS + + A+V
Sbjct: 223 EYLHMLGIIYRDLKPENVLVRDDGHVMLSDFDLSLRCTVSLSIVRSANV 271
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| P93025 | PHOT2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7066 | 0.8588 | 0.4590 | yes | no |
| Q9ST27 | PHOT2_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7241 | 0.8548 | 0.4608 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00036312001 | SubName- Full=Chromosome chr3 scaffold_8, whole genome shotgun sequence; (1001 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 489 | |||
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-99 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-60 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-50 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-49 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-49 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-44 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-40 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-40 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-39 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-38 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-38 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-38 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-37 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-37 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-37 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-36 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-36 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-36 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-35 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-35 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-35 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-35 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-35 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-34 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-34 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-34 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-34 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-34 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-33 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-33 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-33 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-33 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-33 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-32 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-32 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-32 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-32 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-32 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-31 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-31 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-31 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-31 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-30 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-30 | |
| PRK13557 | 540 | PRK13557, PRK13557, histidine kinase; Provisional | 7e-30 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-30 | |
| PRK13559 | 361 | PRK13559, PRK13559, hypothetical protein; Provisio | 8e-30 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-28 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-28 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-27 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-27 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-27 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-27 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-27 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-26 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-25 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-25 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-25 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-24 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-24 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-24 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-24 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-24 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-24 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-23 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-23 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-23 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-22 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-22 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-22 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-20 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-20 | |
| PRK13558 | 665 | PRK13558, PRK13558, bacterio-opsin activator; Prov | 2e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-18 | |
| pfam13426 | 101 | pfam13426, PAS_9, PAS domain | 6e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-17 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-13 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-13 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-12 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-12 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-12 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-12 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-11 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-10 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-10 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-09 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-08 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-07 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-07 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-06 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-06 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-06 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-06 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-06 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-06 | |
| smart00086 | 43 | smart00086, PAC, Motif C-terminal to PAS motifs (l | 6e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-06 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-06 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-06 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-05 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-05 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-05 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-04 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-04 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-04 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-04 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-04 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-04 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-04 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-04 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-04 | |
| TIGR00229 | 124 | TIGR00229, sensory_box, PAS domain S-box | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 0.001 | |
| TIGR02938 | 494 | TIGR02938, nifL_nitrog, nitrogen fixation negative | 0.001 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.002 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 0.002 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.002 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.002 | |
| cd00130 | 103 | cd00130, PAS, PAS domain; PAS motifs appear in arc | 0.002 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 0.003 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.003 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 0.003 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 0.003 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.003 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 0.004 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 301 bits (774), Expect = 1e-99
Identities = 97/159 (61%), Positives = 122/159 (76%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDH 365
HFK IK LG GD G V LV L+G G+L+A+K ++K M+ RNKV R E+EI++ LDH
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
PFLPTLYASFQT T++CL+ D+CPGGELF LL +QP K E+ ARFYAAEV++ LEYLH
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 426 CLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQV 464
LGI+YRDLKPENILL + GH++L+DFDLS + +P
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 196 bits (502), Expect = 6e-60
Identities = 74/142 (52%), Positives = 98/142 (69%), Gaps = 2/142 (1%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYA 373
LG G G V LV + G+LYAMK ++K ++ R +V ER I+S ++HPF+ L+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 374 SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRD 433
+FQT + L+ ++ PGGELF+ L K+ F E+ ARFYAAE+V+ LEYLH LGIIYRD
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGR--FSEERARFYAAEIVLALEYLHSLGIIYRD 118
Query: 434 LKPENILLQKDGHVVLTDFDLS 455
LKPENILL DGH+ LTDF L+
Sbjct: 119 LKPENILLDADGHIKLTDFGLA 140
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 2e-50
Identities = 60/148 (40%), Positives = 89/148 (60%), Gaps = 4/148 (2%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
++ ++ LG G G V+L + G+L A+K ++K + + R E +I+ L HP
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
+ LY F+ + L+ ++C GG+LF LL K+ ED ARFY +++ LEYLH
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALEYLHSK 116
Query: 428 GIIYRDLKPENILLQKDGHVVLTDFDLS 455
GI++RDLKPENILL +DGHV L DF L+
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLA 144
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 5e-49
Identities = 69/145 (47%), Positives = 96/145 (66%), Gaps = 2/145 (1%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
F+ IK LG G G V LV +G+G+ YA+K + K+ ++ +V E+ I+ + HPF
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
L LY SFQ +++ L+ ++ PGGELF+ L K F E ARFYAA+VV+ LEYLH L
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 428 GIIYRDLKPENILLQKDGHVVLTDF 452
I+YRDLKPEN+LL DG++ +TDF
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 8e-49
Identities = 60/140 (42%), Positives = 93/140 (66%), Gaps = 2/140 (1%)
Query: 320 GSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379
G V L + + G++YA+K ++K+ M+ +N+V + ER+I+S P++ LY SFQ
Sbjct: 7 GRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK 66
Query: 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENI 439
++ L+ ++ PGG+L +LL+ + ED AR Y AE+V+ LEYLH GII+RDLKP+NI
Sbjct: 67 NLYLVMEYLPGGDLASLLEN--VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNI 124
Query: 440 LLQKDGHVVLTDFDLSFMTS 459
L+ +GH+ LTDF LS +
Sbjct: 125 LIDSNGHLKLTDFGLSKVGL 144
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 7e-44
Identities = 59/153 (38%), Positives = 90/153 (58%), Gaps = 3/153 (1%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HP 366
FK K +G G +V L + + + YA+K ++K ++ KV IE+E+++ L+ HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
+ LY +FQ ++ + ++ P GEL + K E RFYAAE+++ LEYLH
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHS 120
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459
GII+RDLKPENILL KD H+ +TDF + +
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 3e-43
Identities = 65/149 (43%), Positives = 97/149 (65%), Gaps = 2/149 (1%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
F+ IK +G G G V LV + G++YAMK + KS M+ RN++ ER+I++ D P+
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
+ LY SFQ H+ L+ ++ PGG+L LL + +F E++ARFY AE+V+ L+ +H L
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR--KDVFPEETARFYIAELVLALDSVHKL 120
Query: 428 GIIYRDLKPENILLQKDGHVVLTDFDLSF 456
G I+RD+KP+NIL+ DGH+ L DF L
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCK 149
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 2e-40
Identities = 55/160 (34%), Positives = 87/160 (54%), Gaps = 3/160 (1%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
++ ++ LG G G+V+ + +G G++ A+K ++K K A E I+ L HP
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE-KSKKDQTARREIRILRRLSHPN 59
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
+ L +F+ H+ L+ ++C GG+LF L + ED A+ A +++ GLEYLH
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRGLEYLHSN 117
Query: 428 GIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYH 467
GII+RDLKPENILL ++G V + DF L+
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT 157
|
Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 3e-40
Identities = 57/139 (41%), Positives = 87/139 (62%), Gaps = 2/139 (1%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYA 373
LG G G V LV+++ +A+K ++K ++ + E+EI+ +HPF+ LY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 374 SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRD 433
+F+ +I ++ ++C GGEL+ +L + + F E +ARFY A VV+ EYLH GIIYRD
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGL--FDEYTARFYIACVVLAFEYLHNRGIIYRD 118
Query: 434 LKPENILLQKDGHVVLTDF 452
LKPEN+LL +G+V L DF
Sbjct: 119 LKPENLLLDSNGYVKLVDF 137
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 73/148 (49%), Positives = 104/148 (70%), Gaps = 6/148 (4%)
Query: 311 IKPLGCGDTGSVHLV-ELQG--AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
+K LG G G V LV ++ G AG+LYAMK ++K+ + R++V R +ER+I++ ++HPF
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV-RTKMERDILAEVNHPF 59
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
+ L+ +FQT + LI DF GG+LF L K+ M F E+ +FY AE+ + L++LH L
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLHSL 117
Query: 428 GIIYRDLKPENILLQKDGHVVLTDFDLS 455
GIIYRDLKPENILL ++GH+ LTDF LS
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLS 145
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 68/180 (37%), Positives = 103/180 (57%), Gaps = 9/180 (5%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDH 365
F+ IK +G G G V LV+ + G +YAMK + KS ML + +V ER+I++ D+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
P++ LY SFQ ++ LI ++ PGG++ LL K+ F E+ RFY AE ++ ++ +H
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIH 118
Query: 426 CLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFYFIMYKWLTGYF 485
LG I+RD+KP+N+LL GH+ L+DF L C +H FY I+ L F
Sbjct: 119 KLGYIHRDIKPDNLLLDAKGHIKLSDFGL-----CTG--LKKSHRTEFYRILSHALPSNF 171
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 62/148 (41%), Positives = 92/148 (62%), Gaps = 2/148 (1%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
F IK +G G G V LV LYAMK + K+ +L RN+ ER+I++ D+
Sbjct: 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNE 61
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
++ LY SFQ ++ + D+ PGG++ +LL + + IF ED ARFY AE+ +E +H
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHK 119
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDFDL 454
+G I+RD+KP+NIL+ +DGH+ LTDF L
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 4e-38
Identities = 71/153 (46%), Positives = 98/153 (64%), Gaps = 7/153 (4%)
Query: 308 FKPIKPLGCGDTGSVHLVELQG---AGELYAMKAMEKSVMLNRNKV-HRACIEREIMSLL 363
F+ ++ LG G G V LV G AG+LYAMK ++K+ ++ + K ER+++ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 364 DH-PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLE 422
PFL TL+ +FQT T + LI D+ GGELF L ++ + F E R Y AE+V+ L+
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALD 119
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+LH LGIIYRD+K ENILL +GHVVLTDF LS
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 67/162 (41%), Positives = 95/162 (58%), Gaps = 7/162 (4%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTL 371
K LG G G V LV + G+ YAMK ++K V++ +++V E ++ HPFL L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 372 YASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIY 431
SFQT +C + ++ GGELF L ++ ++F ED ARFY AE+V L YLH ++Y
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVY 118
Query: 432 RDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGF 473
RDLK EN++L KDGH+ +TDF L CK + A + F
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGL-----CKEGISDGATMKTF 155
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-37
Identities = 65/163 (39%), Positives = 95/163 (58%), Gaps = 8/163 (4%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPT 370
K LG G G V L EL+G ELYA+K ++K V+L + V E+ +++L HPFL
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGII 430
L++ FQT + + ++ GG+L + Q F E ARFYAAE+V+GL++LH GII
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGII 118
Query: 431 YRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGF 473
YRDLK +N+LL +GH+ + DF + CK + + F
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGM-----CKEGILGGVTTSTF 156
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 9e-37
Identities = 58/151 (38%), Positives = 92/151 (60%), Gaps = 2/151 (1%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
HF+ ++ +G G G V +V+ + +++AMK M K + + V ER I+ L+HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
FL L+ SFQ ++ L+ D GG+L L ++ F E+ +F+ E+V+ LEYLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS 118
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457
GII+RD+KP+NILL + GHV +TDF+++
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIATK 149
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 68/151 (45%), Positives = 90/151 (59%), Gaps = 8/151 (5%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIM-SLLDHPFLPT 370
K +G G G V L + + G+ YA+K ++K +L + + ER ++ + HPFL
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGII 430
L+ SFQT+ + + D+ GGELF L ++ + F E ARFYAAE+ L YLH L II
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNII 118
Query: 431 YRDLKPENILLQKDGHVVLTDFDLSFMTSCK 461
YRDLKPENILL GHVVLTDF L CK
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL-----CK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 64/162 (39%), Positives = 93/162 (57%), Gaps = 11/162 (6%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIER---EIMSLLD 364
F+ + LG G G V L E + GELYA+KA++K ++ R++V E+ E +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYL 424
HPFL L+A FQT H+C + ++ GG+L + +F E A FYAA VV+GL+YL
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYL 117
Query: 425 HCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFY 466
H I+YRDLK +N+LL +G V + DF L CK + +
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGL-----CKEGMGF 154
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 4e-36
Identities = 65/167 (38%), Positives = 102/167 (61%), Gaps = 9/167 (5%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
F +K +G G G V LV+ + G++YAMK + KS M ++++ ER++++ D P+
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
+ +LY SFQ + ++ LI +F PGG+L +L K F ED RFY AE V+ +E +H L
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 428 GIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFY 474
G I+RD+KP+NIL+ + GH+ L+DF LS F+ H + +Y
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLS-------TGFHKQHDSAYY 160
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 71/161 (44%), Positives = 98/161 (60%), Gaps = 15/161 (9%)
Query: 311 IKPLGCGDTGSVHLVE-LQGA--GELYAMKAMEKSVMLNRNK--VH-RACIEREIMSLLD 364
+K LG G G V V + GA G+++AMK ++K+ ++ K H +A ER I+ +
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA--ERNILEAVK 58
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYL 424
HPF+ L +FQT + LI ++ GGELF L+++ IF ED+A FY +E+ + LE+L
Sbjct: 59 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHL 116
Query: 425 HCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVF 465
H GIIYRDLKPENILL GHV LTDF L CK +
Sbjct: 117 HQQGIIYRDLKPENILLDAQGHVKLTDFGL-----CKESIH 152
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 1e-35
Identities = 67/163 (41%), Positives = 98/163 (60%), Gaps = 8/163 (4%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL-LDHPFLPT 370
K LG G G V L EL+G E +A+KA++K V+L + V +ER +++L +HPFL
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGII 430
L+ +FQT H+ + ++ GG+L + Q F E ARFYAAE++ GL++LH GII
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIICGLQFLHKKGII 118
Query: 431 YRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGF 473
YRDLK +N+LL KDGH+ + DF + CK + + F
Sbjct: 119 YRDLKLDNVLLDKDGHIKIADFGM-----CKENMNGEGKASTF 156
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 55/145 (37%), Positives = 83/145 (57%), Gaps = 2/145 (1%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
+ IK +G G G VHLV + + YA+K M ++ + E+ ++ + HPF
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
+ L+ + + ++ ++ PGGELF+ L + F + FYA+E+V LEYLH
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 428 GIIYRDLKPENILLQKDGHVVLTDF 452
I+YRDLKPENILL K+GH+ LTDF
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 71/165 (43%), Positives = 102/165 (61%), Gaps = 9/165 (5%)
Query: 308 FKPIKPLGCGDTGSVHLVELQG---AGELYAMKAMEKSVMLNRNK-VHRACIEREIMSLL 363
F+ +K LG G G V LV G+LYAMK ++K+ ++ + K V ER ++ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 364 -DHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLE 422
PFL TL+ +FQT + LI D+ GGE+F L ++ F ED RFY+ E+++ LE
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALE 119
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS--FMTSCKPQVF 465
+LH LGI+YRD+K ENILL +GHVVLTDF LS F++ K + +
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY 164
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 7e-35
Identities = 55/139 (39%), Positives = 92/139 (66%), Gaps = 1/139 (0%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYA 373
+G G G V +V + G++YAMK M+KSV+L + V ER+I+S+ + P++P L
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 374 SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRD 433
+FQ ++ L+ ++ PGG+L +LL++ F ED A+FY AE+V+ + +H +G ++RD
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRD 127
Query: 434 LKPENILLQKDGHVVLTDF 452
+KPEN+L+ + GH+ L DF
Sbjct: 128 IKPENVLIDRTGHIKLADF 146
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 56/143 (39%), Positives = 79/143 (55%), Gaps = 4/143 (2%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYA 373
LG G G+V+L + G+ A+K ++K + + + E EI+ L+HP + LY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKE--DSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 374 SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRD 433
F+ H+ L+ ++C GG L LL + ED +++ GLEYLH GII+RD
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 434 LKPENILLQKD-GHVVLTDFDLS 455
LKPENILL D G V L DF LS
Sbjct: 118 LKPENILLDSDNGKVKLADFGLS 140
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 61/143 (42%), Positives = 88/143 (61%), Gaps = 2/143 (1%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTL 371
K LG G G V LV + G YAMK + K V++ +++V E ++ HPFL L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 372 YASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIY 431
+FQT +C + ++ GGELF L ++ ++F E+ ARFY AE+V LEYLH ++Y
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVY 118
Query: 432 RDLKPENILLQKDGHVVLTDFDL 454
RD+K EN++L KDGH+ +TDF L
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 59/156 (37%), Positives = 96/156 (61%), Gaps = 3/156 (1%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI-MSLLDHPFLP 369
+KP+ G GSV+L + + G+ +A+K ++KS M+ +N+V ER I M + P++
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 370 TLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGI 429
LY SFQ+ ++ L+ ++ GG+ +L+ + + ED A+ Y AEVV+G+E LH GI
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQYIAEVVLGVEDLHQRGI 118
Query: 430 IYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVF 465
I+RD+KPEN+L+ + GH+ LTDF LS +
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 5e-34
Identities = 57/150 (38%), Positives = 97/150 (64%), Gaps = 2/150 (1%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
F+ IK + G G+V+LV + + +AMK + K ++ RN++ + +ER+I++ ++PF
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
+ +++ SF+T H+C++ ++ GG+ LL + + D AR Y AE V+ LEYLH
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 428 GIIYRDLKPENILLQKDGHVVLTDFDLSFM 457
GI++RDLKP+N+L+ GH+ LTDF LS +
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 7e-34
Identities = 67/163 (41%), Positives = 92/163 (56%), Gaps = 10/163 (6%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIM---SLLDHPFLPT 370
+G G G V+ V + +YAMK + K ++ + +V ER I+ L + PF+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGII 430
L SFQT + + L+TD+ GGELF L K+ F ED A+FY AE+V+ LE+LH I+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR--FSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 431 YRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGF 473
YRDLKPENILL GH+ L DF LS K + + N F
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLS-----KANLTDNKTTNTF 156
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 68/169 (40%), Positives = 90/169 (53%), Gaps = 15/169 (8%)
Query: 284 KRDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSV 343
K D SSW L F+ + LG G G V + + +G GE YA+K ++K
Sbjct: 9 KPDTSSW-------------KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE 55
Query: 344 MLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMK 403
+L +V E+ I+ L HPF+ + SFQ + + +F GGELF L K
Sbjct: 56 ILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR- 114
Query: 404 IFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDF 452
F D A+FY AE+V+ EYLH IIYRDLKPEN+LL GHV +TDF
Sbjct: 115 -FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDF 162
|
Length = 329 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 57/149 (38%), Positives = 87/149 (58%), Gaps = 2/149 (1%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
F+ + +G G G V L + + GE+ A+K M+KS++ N+V ER+I++
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
+L L +FQ ++ L ++ PGG+ LL+ + + ED ARFY AE+ ++ LH
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHE 119
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDFDLS 455
LG I+RDLKPEN L+ GH+ LTDF LS
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 67/144 (46%), Positives = 88/144 (61%), Gaps = 3/144 (2%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIM-SLLDHPFLPT 370
K +G G G V L + + G YA+K ++K +L + + + ER ++ L HPFL
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGII 430
L+ SFQT+ + + D+ GGELF L ++ + F E ARFYAAEV + YLH L II
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNII 118
Query: 431 YRDLKPENILLQKDGHVVLTDFDL 454
YRDLKPENILL GHVVLTDF L
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 6e-33
Identities = 63/143 (44%), Positives = 91/143 (63%), Gaps = 2/143 (1%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTL 371
K LG G G V LV + +G+ YAMK ++K V++ +++V E ++ HPFL +L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 372 YASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIY 431
SFQT +C + ++ GGELF L ++ ++F ED RFY AE+V L+YLH I+Y
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVY 118
Query: 432 RDLKPENILLQKDGHVVLTDFDL 454
RDLK EN++L KDGH+ +TDF L
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 9e-33
Identities = 67/144 (46%), Positives = 90/144 (62%), Gaps = 3/144 (2%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIM-SLLDHPFLPT 370
K +G G G V L + + G+ YA+K ++K ++LNR + ER ++ + HPFL
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGII 430
L+ SFQT+ + + DF GGELF L ++ + F E ARFYAAE+ L YLH + I+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIV 118
Query: 431 YRDLKPENILLQKDGHVVLTDFDL 454
YRDLKPENILL GHVVLTDF L
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 68/156 (43%), Positives = 100/156 (64%), Gaps = 10/156 (6%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPT 370
K LG G G V L EL+G GE +A+KA++K V+L + V +E+ +++L ++PFL
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 371 LYASFQTSTHICLITDFCPGGEL-FALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGI 429
LY +FQT H+ + +F GG+L F + DK ++R A FYAAE+V GL++LH GI
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYR---ATFYAAEIVCGLQFLHSKGI 117
Query: 430 IYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVF 465
IYRDLK +N++L +DGH+ + DF + CK VF
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGM-----CKENVF 148
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 2e-32
Identities = 70/154 (45%), Positives = 101/154 (65%), Gaps = 7/154 (4%)
Query: 307 HFKPIKPLGCGDTGSVHLV-ELQG--AGELYAMKAMEKSVMLNRNKV-HRACIEREIMS- 361
+F+ +K LG G G V LV ++ G +G+LYAMK ++K+ ++ + K ER+++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
+ PFL TL+ +FQT T + LI D+ GGELF L ++ F+E + Y+ E+V+ L
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER--FKEQEVQIYSGEIVLAL 118
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
E+LH LGIIYRD+K ENILL +GHVVLTDF LS
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 64/163 (39%), Positives = 95/163 (58%), Gaps = 8/163 (4%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPT 370
K LG G G V L EL+G + +A+KA++K V+L + V +E+ ++SL +HPFL
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGII 430
LY +FQT ++ + ++ GG+L + Q F A FYAAE++ GL++LH GI+
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 431 YRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGF 473
YRDLK +NILL DGH+ + DF + CK + A F
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGM-----CKENMLGDAKTCTF 156
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 3e-32
Identities = 60/151 (39%), Positives = 97/151 (64%), Gaps = 2/151 (1%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
F +KP+ G G V+L + +LYA+K ++K+ M+N+N VH+ ER+ ++L PF
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
+ LY S Q++ ++ L+ ++ GG++ +LL F E+ A Y +EV + L+YLH
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLL--HIYGYFDEEMAVKYISEVALALDYLHRH 123
Query: 428 GIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458
GII+RDLKP+N+L+ +GH+ LTDF LS +T
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 9e-32
Identities = 61/142 (42%), Positives = 85/142 (59%), Gaps = 3/142 (2%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL-LDHPFLPT 370
K LG G G V L EL+G E+YA+K ++K V+L + V E+ I++L HPFL
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGII 430
L+ FQT + + ++ GG+L + Q + F E +RFYAAEV + L +LH G+I
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDL--MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVI 118
Query: 431 YRDLKPENILLQKDGHVVLTDF 452
YRDLK +NILL +GH L DF
Sbjct: 119 YRDLKLDNILLDAEGHCKLADF 140
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 63/147 (42%), Positives = 92/147 (62%), Gaps = 2/147 (1%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
F IK LG G G V L LYAMK + K +LNRN+V ER+I++ D+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
+ LY SFQ ++ + D+ PGG++ +LL + M++F E ARFY AE+ + +E +H +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKM 120
Query: 428 GIIYRDLKPENILLQKDGHVVLTDFDL 454
G I+RD+KP+NIL+ DGH+ LTDF L
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 64/147 (43%), Positives = 91/147 (61%), Gaps = 2/147 (1%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
F IK LG G G V L LYAMK + K +L RN+V ER+I++ D+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
+ LY SFQ ++ + D+ PGG++ +LL + M IF ED ARFY AE+ +E +H +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKM 120
Query: 428 GIIYRDLKPENILLQKDGHVVLTDFDL 454
G I+RD+KP+NIL+ +DGH+ LTDF L
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 63/144 (43%), Positives = 90/144 (62%), Gaps = 3/144 (2%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTL 371
K LG G G V LV+ + G YAMK ++K V++ +++V E ++ HPFL L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 372 YASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC-LGII 430
SFQT +C + ++ GGELF L ++ ++F ED ARFY AE+V L+YLH ++
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVV 118
Query: 431 YRDLKPENILLQKDGHVVLTDFDL 454
YRDLK EN++L KDGH+ +TDF L
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGL 142
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 52/160 (32%), Positives = 85/160 (53%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYA 373
LG G G V +++ G++YA K ++K + R A E++I+ + F+ +L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 374 SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRD 433
+F+T +CL+ GG+L + F E A FYAA+++ GLE+LH I+YRD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 434 LKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGF 473
LKPEN+LL G+V ++D L+ ++ A G+
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 60/159 (37%), Positives = 93/159 (58%), Gaps = 8/159 (5%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP- 366
F + LG G G V L E +G ELYA+K ++K V++ + V +E+ +++L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
FL L++ FQT + + ++ GG+L + Q + F+E A FYAAE+ IGL +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS 119
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVF 465
GIIYRDLK +N++L +GH+ + DF + CK +F
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADFGM-----CKENIF 153
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 65/153 (42%), Positives = 88/153 (57%), Gaps = 8/153 (5%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLY 372
LG G G V L L+ +G LYA+K ++K V+L + V E+ I+SL +HPFL LY
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 373 ASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYR 432
FQT + + +F GG+L + Q + F E ARFYAAE+ L +LH GIIYR
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 433 DLKPENILLQKDGHVVLTDFDLSFMTSCKPQVF 465
DLK +N+LL +GH L DF + CK +F
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGM-----CKEGIF 148
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|237425 PRK13557, PRK13557, histidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 7e-30
Identities = 57/164 (34%), Positives = 82/164 (50%), Gaps = 48/164 (29%)
Query: 81 VITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFML 140
++TDP PDNPI+FA+ +FLE+T Y EEI+G NC FL+ E
Sbjct: 44 IVTDPNQPDNPIVFANRAFLEMTGYAAEEIIGNNCRFLQGPE------------------ 85
Query: 141 YFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNL 200
+D+ATV+++RDA+ E+REI +++NY K G FWN
Sbjct: 86 ------------------------TDRATVAEVRDAIAERREIATEILNYRKDGSSFWNA 121
Query: 201 FHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNRLSEKTEQQSAK 244
+ P+ + G+L YF G QLD S R R +E +Q+ K
Sbjct: 122 LFVSPVYNDAGDLVYFFGSQLDVS------RRRDAEDALRQAQK 159
|
Length = 540 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 7e-30
Identities = 63/144 (43%), Positives = 86/144 (59%), Gaps = 3/144 (2%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIM-SLLDHPFLPT 370
K +G G G V L + + YA+K ++K +L + + ER ++ + HPFL
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGII 430
L+ SFQT+ + + D+ GGELF L ++ + F E ARFYAAE+ L YLH L I+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIV 118
Query: 431 YRDLKPENILLQKDGHVVLTDFDL 454
YRDLKPENILL GH+VLTDF L
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|237427 PRK13559, PRK13559, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 61/196 (31%), Positives = 86/196 (43%), Gaps = 45/196 (22%)
Query: 58 ERERDIRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSF 117
R+ G +E+ ITDP PD PI+ A+ +FL+LT Y EE++GRNC F
Sbjct: 34 PRDFRGASGRLFEQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRF 93
Query: 118 LELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAV 177
L+ ++D V+KIR A+
Sbjct: 94 LQ------------------------------------------GAATDPIAVAKIRAAI 111
Query: 178 REQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNRLSEK 237
+REI V+L+NY K G+ FWN HL P+ G L YF G Q D +D R E
Sbjct: 112 AAEREIVVELLNYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQWDVTDIR---AVRALEA 168
Query: 238 TEQQSAKIVKATAENV 253
E++ A+ V ++NV
Sbjct: 169 HERRLAREVDHRSKNV 184
|
Length = 361 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 58/161 (36%), Positives = 94/161 (58%), Gaps = 5/161 (3%)
Query: 292 AIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVH 351
A +KIT ++ F IK +G G G V LV + + ++YAMK + K M+ R+
Sbjct: 31 AAEKITKL--RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSA 88
Query: 352 RACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSAR 411
ER+IM+ + ++ L+ +FQ ++ ++ ++ PGG+L L+ + E AR
Sbjct: 89 FFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIP---EKWAR 145
Query: 412 FYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDF 452
FY AEVV+ L+ +H +G I+RD+KP+N+LL K GH+ L DF
Sbjct: 146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADF 186
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 50/153 (32%), Positives = 83/153 (54%), Gaps = 7/153 (4%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVML--NRNKVHRACIEREIMSLLD 364
++ IK +G G G V+LV + G+LY +K ++ S M R E +I+ L+
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN---EVKILKKLN 57
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPM--KIFREDSARFYAAEVVIGLE 422
HP + Y SF+ +C++ ++ GG+L + KQ K F E+ + ++ + L+
Sbjct: 58 HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
YLH I++RD+KP+NI L +G V L DF +S
Sbjct: 118 YLHSRKILHRDIKPQNIFLTSNGLVKLGDFGIS 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 1e-28
Identities = 57/148 (38%), Positives = 90/148 (60%), Gaps = 3/148 (2%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP- 366
F + LG G G V L E +G ELYA+K ++K V++ + V +E+ +++L D P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
FL L++ FQT + + ++ GG+L + Q + F+E A FYAAE+ +GL +LH
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAEISVGLFFLHR 119
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDFDL 454
GIIYRDLK +N++L +GH+ + DF +
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGM 147
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 56/141 (39%), Positives = 82/141 (58%), Gaps = 2/141 (1%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYA 373
+G G G V V + +YA+K + K+ +++R++V ER +++ ++ PF+ L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 374 SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRD 433
SFQ+ + L+ F GGELF L ++ F ARFY AE++ LE LH +IYRD
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGR--FDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 434 LKPENILLQKDGHVVLTDFDL 454
LKPENILL GH+ L DF L
Sbjct: 119 LKPENILLDYQGHIALCDFGL 139
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 57/147 (38%), Positives = 94/147 (63%), Gaps = 5/147 (3%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACI--EREIMSLLDH 365
F+ +K +G G G V +V+++ G++YAMK + K ML R + AC ER+++ D
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAET--ACFREERDVLVNGDR 60
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
++ L+ +FQ ++ L+ D+ GG+L LL K ++ ED ARFY AE+V+ ++ +H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL-PEDMARFYLAEMVLAIDSVH 119
Query: 426 CLGIIYRDLKPENILLQKDGHVVLTDF 452
LG ++RD+KP+N+LL K+GH+ L DF
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADF 146
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 65/174 (37%), Positives = 95/174 (54%), Gaps = 6/174 (3%)
Query: 283 HKRDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQ-GAGELYAMKAMEK 341
HK+ +S K K+ F I+ LG G G V L + A+K EK
Sbjct: 10 HKKKDS---DSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEK 66
Query: 342 SVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQP 401
S ++ + +V ER+I++ ++HPF LY SF+ +++ L+ +F GGE F L +
Sbjct: 67 SKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN- 125
Query: 402 MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
K F D FYAA++V+ EYL L I+YRDLKPEN+LL KDG + +TDF +
Sbjct: 126 -KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFA 178
|
Length = 340 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 6e-27
Identities = 57/147 (38%), Positives = 91/147 (61%), Gaps = 2/147 (1%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
F+ +K +G G G V LV+ + G +YAMK + K+ ML + +V ER+I+ D +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
+ ++ SFQ ++ LI +F PGG++ LL K+ E++ +FY AE V+ ++ +H L
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQL 120
Query: 428 GIIYRDLKPENILLQKDGHVVLTDFDL 454
G I+RD+KP+N+LL GHV L+DF L
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 66/180 (36%), Positives = 101/180 (56%), Gaps = 9/180 (5%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
F+ +K +G G G V LV+ + G +YAMK + K+ ML + +V ER+I+ D +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
+ ++ SFQ ++ LI +F PGG++ LL K+ E+ +FY AE V+ ++ +H L
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQL 120
Query: 428 GIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFYFIMYKWLTGYFTY 487
G I+RD+KP+N+LL GHV L+DF L T K AH FY + L FT+
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLC--TGLK-----KAHRTEFYRNLNHSLPSDFTF 173
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 57/148 (38%), Positives = 89/148 (60%), Gaps = 3/148 (2%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP- 366
F + LG G G V L E +G ELYA+K ++K V++ + V +E+ +++L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
FL L++ FQT + + ++ GG+L + Q + F+E A FYAAE+ IGL +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDL--MYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS 119
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDFDL 454
GIIYRDLK +N++L +GH+ + DF +
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGM 147
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 52/152 (34%), Positives = 78/152 (51%), Gaps = 9/152 (5%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI--MSLLDH 365
+ + LG G GSV+L + GEL A+K++E S ++ +EREI +S L H
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELS---GDSEEELEALEREIRILSSLQH 58
Query: 366 PFLPTLYASFQTST--HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEY 423
P + Y S + + + ++ GG L +LL K E R Y +++ GL Y
Sbjct: 59 PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAY 116
Query: 424 LHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
LH GI++RD+K NIL+ DG V L DF +
Sbjct: 117 LHSNGIVHRDIKGANILVDSDGVVKLADFGCA 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 2e-25
Identities = 57/152 (37%), Positives = 84/152 (55%), Gaps = 6/152 (3%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
++ ++ LG G G V+L + +L A+K + K + +V R E +I++ L+HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 367 -FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKI-FREDSARFYAAEVVIGLEYL 424
+ LY FQ + L+ ++ GG L LL K K E A F A+++ LEYL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 425 HCLGIIYRDLKPENILLQKDGH-VVLTDFDLS 455
H GII+RD+KPENILL +DG V L DF L+
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLA 149
|
Length = 384 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 59/180 (32%), Positives = 99/180 (55%), Gaps = 19/180 (10%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPT 370
+K +G G G V LV + + ++YAMK + K M+ R+ ER+IM+ + P++
Sbjct: 48 VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGII 430
L+ +FQ ++ ++ ++ PGG+L L+ + E A+FY AEVV+ L+ +H +G+I
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVP---EKWAKFYTAEVVLALDAIHSMGLI 164
Query: 431 YRDLKPENILLQKDGHVVLTDF------DLSFMTSC----------KPQVFYHAHVNGFY 474
+RD+KP+N+LL K GH+ L DF D + M C P+V +G+Y
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYY 224
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 52/140 (37%), Positives = 85/140 (60%), Gaps = 3/140 (2%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIM-SLLDHPFLPTLY 372
+G G V LVEL+ +YAMK ++K ++ + + E+ + + +HPFL L+
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 373 ASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYR 432
+ FQT + + + +F GG+L + +Q + E+ ARFY+AE+ + L +LH GIIYR
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 433 DLKPENILLQKDGHVVLTDF 452
DLK +N+LL +GH+ LTD+
Sbjct: 121 DLKLDNVLLDAEGHIKLTDY 140
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 55/146 (37%), Positives = 85/146 (58%), Gaps = 6/146 (4%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYA 373
LG G G V +++ G+LYA K + K + R A +E+ I++ + F+ +L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 374 SFQTSTHICLITDFCPGGEL----FALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGI 429
+FQT T +CL+ GG+L + + ++ P F E A FY A+++ GLE+LH I
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG--FPEPRACFYTAQIISGLEHLHQRRI 118
Query: 430 IYRDLKPENILLQKDGHVVLTDFDLS 455
IYRDLKPEN+LL DG+V ++D L+
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 53/145 (36%), Positives = 88/145 (60%), Gaps = 3/145 (2%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
++ +K +G G G V LV + ++YAMK + K M+ R+ ER+IM+ + P+
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
+ L+ +FQ ++ ++ ++ PGG+L L+ + E ARFY AEVV+ L+ +H +
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP---EKWARFYTAEVVLALDAIHSM 161
Query: 428 GIIYRDLKPENILLQKDGHVVLTDF 452
G I+RD+KP+N+LL K GH+ L DF
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADF 186
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-24
Identities = 53/145 (36%), Positives = 82/145 (56%), Gaps = 5/145 (3%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL---DHPFLPT 370
+G G G V+ G++YAMK ++K + + A ER ++SL+ D PF+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGII 430
+ +F T + I D GG+L L + +F E RFYAAE+++GLE++H ++
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 431 YRDLKPENILLQKDGHVVLTDFDLS 455
YRDLKP NILL + GHV ++D L+
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 57/147 (38%), Positives = 94/147 (63%), Gaps = 5/147 (3%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACI--EREIMSLLDH 365
F+ +K +G G G V +V+L+ A +++AMK + K ML R + AC ER+++ D+
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAET--ACFREERDVLVNGDN 60
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
++ TL+ +FQ ++ L+ D+ GG+L LL K ++ ED ARFY AE+VI ++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL-PEDMARFYLAEMVIAIDSVH 119
Query: 426 CLGIIYRDLKPENILLQKDGHVVLTDF 452
L ++RD+KP+NIL+ +GH+ L DF
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADF 146
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 48/149 (32%), Positives = 74/149 (49%), Gaps = 4/149 (2%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
F+ ++ +G G G V+ + G+ A+K ++ + K+ E +I+ HP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN---EIQILKKCKHP 57
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
+ Y S+ + ++ +FC GG L LL + A + E++ GLEYLH
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIA-YVCKELLKGLEYLHS 116
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDFDLS 455
GII+RD+K NILL DG V L DF LS
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLS 145
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 52/148 (35%), Positives = 82/148 (55%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
F+ + LG G G V +++ G++YA K +EK + R A E++I+ ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
+ L +++T +CL+ GG+L + F E+ A FYAAE++ GLE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 428 GIIYRDLKPENILLQKDGHVVLTDFDLS 455
+YRDLKPENILL GH+ ++D L+
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 56/147 (38%), Positives = 89/147 (60%), Gaps = 5/147 (3%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACI--EREIMSLLDH 365
F+ IK +G G G V +V+++ +YAMK + K ML R + AC ER ++ D
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAET--ACFREERNVLVNGDC 60
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
++ TL+ +FQ ++ L+ D+ GG+L LL K ++ ED ARFY AE+V+ + +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRL-PEDMARFYIAEMVLAIHSIH 119
Query: 426 CLGIIYRDLKPENILLQKDGHVVLTDF 452
L ++RD+KP+N+LL +GH+ L DF
Sbjct: 120 QLHYVHRDIKPDNVLLDMNGHIRLADF 146
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-23
Identities = 54/149 (36%), Positives = 85/149 (57%), Gaps = 2/149 (1%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
F+ + LG G G V +++ G++YA K +EK + R A E++I+ ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 368 LPTLYASFQTSTHICLITDFCPGGEL-FALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
+ +L +++T +CL+ GG+L F + + F E+ A FYAAE+ GLE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG-FDEERAVFYAAEITCGLEDLHR 120
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDFDLS 455
I+YRDLKPENILL GH+ ++D L+
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-23
Identities = 53/142 (37%), Positives = 86/142 (60%), Gaps = 3/142 (2%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLY 372
+G G V LV L+ ++YAMK ++K ++ + + E+ + +PFL L+
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 373 ASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYR 432
+ FQT++ + L+ ++ GG+L + +Q + E+ ARFYAAE+ I L +LH GIIYR
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 433 DLKPENILLQKDGHVVLTDFDL 454
DLK +N+LL DGH+ LTD+ +
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGM 142
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-22
Identities = 53/145 (36%), Positives = 82/145 (56%), Gaps = 5/145 (3%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL---DHPFLPT 370
+G G G V+ G++YAMK ++K + + A ER ++SL+ D PF+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGII 430
+ +F T +C I D GG+L L + +F E RFYA E+++GLE++H ++
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 431 YRDLKPENILLQKDGHVVLTDFDLS 455
YRDLKP NILL + GHV ++D L+
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-22
Identities = 51/142 (35%), Positives = 84/142 (59%), Gaps = 3/142 (2%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLY 372
+G G V LV L+ +YAMK ++K ++ + + E+ + +HPFL L+
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 373 ASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYR 432
+ FQT + + + ++ GG+L + +Q + E+ ARFY+AE+ + L YLH GIIYR
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 433 DLKPENILLQKDGHVVLTDFDL 454
DLK +N+LL +GH+ LTD+ +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGM 142
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 53/148 (35%), Positives = 82/148 (55%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
F+ + LG G G V +++ G++YA K +EK + R A E++I+ ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
+ +L +++T +CL+ GG+L + F E A FYAAE+ GLE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 428 GIIYRDLKPENILLQKDGHVVLTDFDLS 455
I+YRDLKPENILL GH+ ++D L+
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 1e-21
Identities = 48/160 (30%), Positives = 87/160 (54%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYA 373
LG G G V V+++ G++YA K ++K + ++ A +E+EI+ ++ PF+ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 374 SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRD 433
+F++ TH+CL+ GG+L + + + Y+A++ G+ +LH + I+YRD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 434 LKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGF 473
+KPEN+LL G+ L+D L+ + A NG+
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY 160
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 1e-20
Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 9/152 (5%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-- 364
+ +K LG G +G V+ V + G++YA+K + ++ ++ R + RE+ +L
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALK----KIHVDGDEEFRKQLLRELKTLRSCE 57
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYL 424
P++ Y +F I ++ ++ GG L LL K E + A +++ GL+YL
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYL 115
Query: 425 H-CLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
H II+RD+KP N+L+ G V + DF +S
Sbjct: 116 HTKRHIIHRDIKPSNLLINSKGEVKIADFGIS 147
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 3e-20
Identities = 52/148 (35%), Positives = 80/148 (54%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
F+ + LG G G V +++ G++YA K +EK + R A E+ I+ ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
+ +L +++T +CL+ GG+L + F E A FYAAE+ GLE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 428 GIIYRDLKPENILLQKDGHVVLTDFDLS 455
I+YRDLKPENILL GH+ ++D L+
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|237426 PRK13558, PRK13558, bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-19
Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 42/148 (28%)
Query: 81 VITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFML 140
I D +PD P+I+ +D+F +T Y+ +E+LGRNC FL+ E T EE
Sbjct: 162 TIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQ-GEDTNEE------------- 207
Query: 141 YFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNL 200
V+++R+A+ E+R +V+L NY K G FWN
Sbjct: 208 ----------------------------RVAELREAIDEERPTSVELRNYRKDGSTFWNQ 239
Query: 201 FHLQPMRDHKGELQYFIGVQLDGSDHVE 228
+ P+RD G + +++G Q D ++ E
Sbjct: 240 VDIAPIRDEDGTVTHYVGFQTDVTERKE 267
|
Length = 665 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 8e-19
Identities = 43/150 (28%), Positives = 78/150 (52%), Gaps = 3/150 (2%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
FK +K LG G GSV+ V+ + YA+K ++ M ++ + A E I++ ++HP
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPN 60
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPM--KIFREDSARFYAAEVVIGLEYLH 425
+ + +F +C++ ++ P G+L + K+ K+ E +++ GL+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 426 CLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
I++RDLK NILL + V + D +S
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGIS 150
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 48/141 (34%), Positives = 69/141 (48%), Gaps = 7/141 (4%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE--IMSLLDHPFLPTL 371
+G G G V+ GEL A+K E + N K + I E ++ LL HP L
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVK--EIRIQDNDPKTIKE-IADEMKVLELLKHPNLVKY 64
Query: 372 YASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIY 431
Y + + ++C GG L LL+ +I E R Y +++ GL YLH GI++
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVH 122
Query: 432 RDLKPENILLQKDGHVVLTDF 452
RD+KP NI L +G + L DF
Sbjct: 123 RDIKPANIFLDHNGVIKLGDF 143
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 17/167 (10%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACI---EREI--MSLLDHPFL 368
LG G GSV+ G+ +A+K + + + + + + E+EI +S L HP +
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVK---EVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 369 PTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLG 428
+ + ++ + + PGG L LL K F E R Y ++++GLEYLH
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRN 122
Query: 429 IIYRDLKPENILLQKDGHVVLTDF-------DLSFMTSCKPQVFYHA 468
++RD+K NIL+ +G V L DF + SF S K ++ A
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMA 169
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 7/152 (4%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI--MSLLD 364
++ I+ +G G T V+ E A+K ++ L + + + +E+ MS +
Sbjct: 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRID----LEKCQTSVDELRKEVQAMSQCN 57
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALLD-KQPMKIFREDSARFYAAEVVIGLEY 423
HP + Y SF + L+ + GG L ++ P E EV+ GLEY
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 424 LHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
LH G I+RD+K NILL +DG V + DF +S
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVS 149
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|222120 pfam13426, PAS_9, PAS domain | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-18
Identities = 35/146 (23%), Positives = 59/146 (40%), Gaps = 45/146 (30%)
Query: 80 FVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFM 139
++ DP D I++A+D+ L L YTREE+LG++ L
Sbjct: 1 ILVLDP---DGRIVYANDAALRLLGYTREELLGKSIRDLFGPG----------------- 40
Query: 140 LYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWN 199
D+ V+++R+A+R E+ V+L K G+ F
Sbjct: 41 -------------------------DDEEAVARLREALRNGGEVEVELELRRKDGEPFPV 75
Query: 200 LFHLQPMRDHKGELQYFIGVQLDGSD 225
L P+RD GE+ +G+ D ++
Sbjct: 76 LVSASPVRDEDGEVVGIVGILRDITE 101
|
Length = 101 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 1e-17
Identities = 41/145 (28%), Positives = 81/145 (55%), Gaps = 1/145 (0%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPT 370
+K +G G G LV+ + G+ Y +K + S M + + + E ++S + HP +
Sbjct: 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER-EESRKEVAVLSNMKHPNIVQ 63
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGII 430
SF+ + ++ ++ D+C GG+L+ ++ Q +F ED + ++ + L+++H I+
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKIL 123
Query: 431 YRDLKPENILLQKDGHVVLTDFDLS 455
+RD+K +NI L KDG + L DF ++
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIA 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 3e-17
Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 5/143 (3%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACI-EREIMSLLDHPFLPTLY 372
+G G G V+ G+ A+K + + ++ + E +++ L HP +
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEA--LKSIMQEIDLLKNLKHPNIVKYI 65
Query: 373 ASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYR 432
S +TS + +I ++ G L ++ + F E Y +V+ GL YLH G+I+R
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHR 123
Query: 433 DLKPENILLQKDGHVVLTDFDLS 455
D+K NIL KDG V L DF ++
Sbjct: 124 DIKAANILTTKDGVVKLADFGVA 146
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
+K ++ +G G +G V+ + G+ A+K M L + E IM HP
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHP 75
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
+ Y S+ + ++ ++ GG L ++ + E + EV+ GLEYLH
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS 134
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDF 452
+I+RD+K +NILL KDG V L DF
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL--DH 365
+ + LG G++G V V + G++ A+K ++ L N+ + I RE+ L +
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVK----TIRLEINEAIQKQILRELDILHKCNS 58
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
P++ Y +F + I + ++ GG L +L K+ E A V+ GL YLH
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKIL-KEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 426 -CLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
II+RD+KP NIL+ G + L DF +S
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVS 148
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 9e-17
Identities = 49/153 (32%), Positives = 86/153 (56%), Gaps = 7/153 (4%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVM--LNRNKVHRACIEREIMSLLDHPFLPTL 371
LG G G+V+LV+ + A +K +++ + LN N+ +A E +++S LDHP +
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 372 YASFQTSTHICLITDFCPGGELFALLD--KQPMKIFREDSARFYAAEVVIGLEYLHCLGI 429
+ASF C+IT++C G +L L+ K K E+ + ++++G+ Y+H I
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 430 IYRDLKPENILLQKDGHVVLTDFDLS--FMTSC 460
++RDLK +NI L+ + + + DF +S M SC
Sbjct: 128 LHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSC 159
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-16
Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 3/146 (2%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
F+ + +G G G V V + +YAMK ++ S M NR + A E +++ LD +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSY 60
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSA-RFYAAEVVIGLEYLHC 426
+ Y SF + ++ ++ G+L LL Q + ED RF+ ++++GL +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF-IQILLGLAHLHS 119
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDF 452
I++RD+K N+ L +V + D
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDL 145
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 20/153 (13%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE--IMSLLDHPFLPTL 371
LG G GSV L+ G ++A+K ++ + N + I RE I P++
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALK----TITTDPNPDLQKQILRELEINKSCKSPYIVKY 64
Query: 372 YASF--QTSTHICLITDFCPGGELFALLDKQPMKIFREDSARF-------YAAEVVIGLE 422
Y +F ++S+ I + ++C GG L ++ K ++ R A V+ GL
Sbjct: 65 YGAFLDESSSSIGIAMEYCEGGSLDSIYKK-----VKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
YLH II+RD+KP NILL + G V L DF +S
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS 152
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 42/116 (36%), Positives = 59/116 (50%), Gaps = 8/116 (6%)
Query: 355 IEREI--MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARF 412
I++EI +S P++ Y SF + + +I ++C GG LL E F
Sbjct: 46 IQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK---LDETYIAF 102
Query: 413 YAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS---FMTSCKPQVF 465
EV++GLEYLH G I+RD+K NILL ++G V L DF +S T K F
Sbjct: 103 ILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF 158
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 50/148 (33%), Positives = 78/148 (52%), Gaps = 8/148 (5%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAME-KSVMLNRNKVHRACIE---REIMSL--LDHPF 367
+G G GSV+L +GEL A+K +E SV + R+ ++ REI L L H
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
+ S + H+ + ++ PGG + ALL+ F E R + +++ GL YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNR 125
Query: 428 GIIYRDLKPENILLQKDGHVVLTDFDLS 455
GII+RD+K NIL+ G + ++DF +S
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGIS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 41/142 (28%), Positives = 72/142 (50%), Gaps = 4/142 (2%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYA 373
LG G G V+ + + G A K ++ + ++ +E +I+S HP + LY
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 374 SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRD 433
++ + ++ +FC GG L +++ + + E R+ +++ L +LH +I+RD
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRD 128
Query: 434 LKPENILLQKDGHVVLTDFDLS 455
LK NILL DG V L DF +S
Sbjct: 129 LKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 8e-15
Identities = 44/159 (27%), Positives = 84/159 (52%), Gaps = 2/159 (1%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
++ I+ +G G G VHL + +L +K + M +++ A E +++ LL HP
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPN 60
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
+ Y +F + ++ ++ PGG L + K+ + ED+ + ++++ L ++H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 428 GIIYRDLKPENILLQKDGHVV-LTDFDLSFMTSCKPQVF 465
I++RDLK +NILL K VV + DF +S + S K + +
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 44/145 (30%), Positives = 73/145 (50%), Gaps = 12/145 (8%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL---DHPFLPT 370
LG G GSV+ + G++ A+K V+ + I +EI S+L D P++
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIK-----VVPVEEDLQE--IIKEI-SILKQCDSPYIVK 62
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGII 430
Y S+ +T + ++ ++C G + ++ K K E+ + + GLEYLH I
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM-KITNKTLTEEEIAAILYQTLKGLEYLHSNKKI 121
Query: 431 YRDLKPENILLQKDGHVVLTDFDLS 455
+RD+K NILL ++G L DF +S
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL---D 364
+K IK LG G GSV+L + GEL A+K M+K RE+ SL +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKF----YSWEECMNLREVKSLRKLNE 56
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYL 424
HP + L F+ + + + ++ G L+ L+ + K F E R +++ GL ++
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 425 HCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
H G +RDLKPEN+L+ V + DF L+
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 46/148 (31%), Positives = 77/148 (52%), Gaps = 10/148 (6%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPT 370
I LG G G V+ + + G L A K +E + ++ +E EI++ +HP++
Sbjct: 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVK 73
Query: 371 LYASFQTSTHICLITDFCPGGELFAL---LDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
L +F + ++ +FCPGG + A+ LD+ E + +++ L+YLH +
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVICRQMLEALQYLHSM 129
Query: 428 GIIYRDLKPENILLQKDGHVVLTDFDLS 455
II+RDLK N+LL DG + L DF +S
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 8e-14
Identities = 41/166 (24%), Positives = 87/166 (52%), Gaps = 3/166 (1%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPT 370
++ +G G G LV+ + + YAMK + + + R E +++ + HP +
Sbjct: 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK--EAVLLAKMKHPNIVA 62
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGII 430
SF+ H+ ++ ++C GG+L + Q K+F ED+ + ++ +G++++H ++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVL 122
Query: 431 YRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFYFI 476
+RD+K +NI L ++G V L DF + + + P + +V Y++
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARLLT-SPGAYACTYVGTPYYV 167
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 8e-14
Identities = 43/148 (29%), Positives = 85/148 (57%), Gaps = 6/148 (4%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL--LDH 365
++ IK +G G G ++L + + E +K ++ + M + K ++E++ L + H
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK---EASKKEVILLAKMKH 58
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
P + T +ASFQ + + ++ ++C GG+L +++Q +F ED + ++ +GL+++H
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 426 CLGIIYRDLKPENILLQKDGHVV-LTDF 452
I++RD+K +NI L K+G V L DF
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDF 146
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 45/168 (26%), Positives = 78/168 (46%), Gaps = 16/168 (9%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIE----REIMSL--LDHPF 367
+G G G V + + GE A+K + R I REI +L HP+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV-----ALRRL--EGGIPNQALREIKALQACQHPY 60
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
+ L F + L+ ++ P L +L + + E + Y ++ G+ Y+H
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 428 GIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC-KPQVFYHAHVNGFY 474
GI++RDLKP N+L+ DG + + DF L+ + S +P+++ H +Y
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWY 166
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 46/153 (30%), Positives = 72/153 (47%), Gaps = 12/153 (7%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-- 364
++ I+ +G G G V+ GEL A+K V+ I++EI L +
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIK-----VIKLEPGDDFEIIQQEISMLKECR 58
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALLDK--QPMKIFREDSARFYAAEVVIGLE 422
HP + + S+ + ++ ++C GG L + P+ E + E + GL
Sbjct: 59 HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLS---ELQIAYVCRETLKGLA 115
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
YLH G I+RD+K NILL +DG V L DF +S
Sbjct: 116 YLHETGKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 41/153 (26%), Positives = 65/153 (42%), Gaps = 14/153 (9%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAME------KSVMLNRNKVHRACIERE--IMSL 362
K LG G G V+ G L + K++ + ++ RE IM
Sbjct: 4 GKKLGEGAFGEVYK------GTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRK 57
Query: 363 LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLE 422
LDHP + L + ++ ++ PGG+L L K K +A ++ G+E
Sbjct: 58 LDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGME 117
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
YL I+RDL N L+ ++ V ++DF LS
Sbjct: 118 YLESKNFIHRDLAARNCLVGENLVVKISDFGLS 150
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (172), Expect = 2e-13
Identities = 44/151 (29%), Positives = 71/151 (47%), Gaps = 11/151 (7%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELY----AMKAMEKSVMLNRNKVHRACIERE--IMSLLD 364
K LG G G V+ L+G GE A+K +++ + R E IM L
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGAS----EEEREEFLEEASIMKKLS 59
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYL 424
HP + L + ++T++ PGG+L L K K+ +D + A ++ G+EYL
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQM-ALQIAKGMEYL 118
Query: 425 HCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
++RDL N L+ ++ V ++DF LS
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGLS 149
|
Length = 258 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 11/151 (7%)
Query: 309 KPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE--IMSLLDHP 366
+ I LG G+ GSV V+ G + A +K V + R I RE IM P
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMA----KKVVHIGAKSSVRKQILRELQIMHECRSP 63
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQ-PMKIFREDSARFYAAEVVIGLEYLH 425
++ + Y +F +IC+ +F G L + K P+ + A VV GL YL+
Sbjct: 64 YIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPI---PVEILGKIAVAVVEGLTYLY 120
Query: 426 -CLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
I++RD+KP NIL+ G + L DF +S
Sbjct: 121 NVHRIMHRDIKPSNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 49/164 (29%), Positives = 76/164 (46%), Gaps = 12/164 (7%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL--LDH 365
++ I +G G G V+ + GEL A+K + + I REI L L H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE--KEGFPITAI-REIKLLQKLRH 57
Query: 366 PFLPTLY---ASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLE 422
P + L S + I ++ ++ +L LLD P F E + Y +++ GL+
Sbjct: 58 PNIVRLKEIVTSKGKGS-IYMVFEYMDH-DLTGLLD-SPEVKFTESQIKCYMKQLLEGLQ 114
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS-FMTSCKPQVF 465
YLH GI++RD+K NIL+ DG + L DF L+ T +
Sbjct: 115 YLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 1/149 (0%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
H+ PI+ LG G G L L K + + L+ + A E I+SLL HP
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLT-RLSEKERRDALNEIVILSLLQHP 59
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
+ Y F + + ++ GG L+ + +Q ++F E+ +Y ++V + Y+H
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDFDLS 455
GI++RD+K NI L K G + L DF +S
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGIS 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 47/150 (31%), Positives = 78/150 (52%), Gaps = 11/150 (7%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHR-----ACIEREIMSL--LDHP 366
+G G G V+L GE+ A+K +E + R + EI +L LDH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 367 FLPTLYASFQTS-THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
+ Y F+T+ ++ + ++ PGG + + L + + F E RF+ +V+ GL YLH
Sbjct: 69 NIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGR-FEEQLVRFFTEQVLEGLAYLH 125
Query: 426 CLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
GI++RDLK +N+L+ DG ++DF +S
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGIS 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 3/147 (2%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE--IMSLLDHPFL 368
K LG G G V+ +L+G G ++ K++ + ++ RE IM LDHP +
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 369 PTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLG 428
L + ++ ++ GG+L + L K K+ D F A ++ G+EYL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSF-ALQIARGMEYLESKN 122
Query: 429 IIYRDLKPENILLQKDGHVVLTDFDLS 455
I+RDL N L+ ++ V ++DF LS
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLS 149
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 17/159 (10%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQ----GAGELYAMKAMEKSVMLNRNKVHRACIEREI--M 360
H K IK LG G G V L GE A+K++ S + HR+ EREI +
Sbjct: 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS----GEEQHRSDFEREIEIL 60
Query: 361 SLLDHPFLPTL--YASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARF--YAAE 416
LDH + + LI ++ P G L L + +I + R ++++
Sbjct: 61 RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQI---NLKRLLLFSSQ 117
Query: 417 VVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ G++YL I+RDL NIL++ + V ++DF L+
Sbjct: 118 ICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 41/149 (27%), Positives = 75/149 (50%), Gaps = 7/149 (4%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL--LDH 365
++ + +G G G V+ + GE+ A+K ++ ++ REI L L+H
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLR---FESEGIPKTALREIKLLKELNH 57
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
P + L F+ + L+ +F +L+ L+ + + E + Y +++ GL + H
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCH 115
Query: 426 CLGIIYRDLKPENILLQKDGHVVLTDFDL 454
GI++RDLKPEN+L+ +G + L DF L
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGL 144
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNK-VHRACIEREIMSL--LD 364
++ K LG G V+ + G + A+K ++ ++ + REI L L
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL-REIKLLQELK 60
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEV------- 417
HP + L F ++I L+ +F D + K+ ++ S A++
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET-------DLE--KVIKDKSIVLTPADIKSYMLMT 111
Query: 418 VIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ GLEYLH I++RDLKP N+L+ DG + L DF L+
Sbjct: 112 LRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLA 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 19/160 (11%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD--- 364
F+ ++ +G G G V+ + G+L A+K M + + I+ E L
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIM------DIIEDEEEEIKEEYNILRKYSN 61
Query: 365 HPFLPTLYASFQTSTHIC------LITDFCPGG---ELFALLDKQPMKIFREDSARFYAA 415
HP + T Y +F L+ + C GG +L L K+ ++ +E+ +
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRL-KEEWIAYILR 120
Query: 416 EVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
E + GL YLH +I+RD+K +NILL K+ V L DF +S
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 39/131 (29%), Positives = 64/131 (48%), Gaps = 10/131 (7%)
Query: 322 VHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381
V LV + + +K + KS +R + I + P + L+ + +
Sbjct: 9 VLLVMDTRTQQTFILKGLRKSSEYSRER--LTIIPHCV------PNMVCLHKYIVSEDSV 60
Query: 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILL 441
L+ GG+L++ + K + I E+ + +AAE+V+ L+ LH GI+ RDL P NILL
Sbjct: 61 FLVLQHAEGGKLWSHISKF-LNI-PEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL 118
Query: 442 QKDGHVVLTDF 452
GH+ LT F
Sbjct: 119 DDRGHIQLTYF 129
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 8e-12
Identities = 35/101 (34%), Positives = 55/101 (54%), Gaps = 4/101 (3%)
Query: 357 REIMSL--LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYA 414
REI L L HP + L T + L+ ++C +L LDK+P + + +
Sbjct: 47 REISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPL-SPNLIKSIM 104
Query: 415 AEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+++ GL Y H I++RDLKP+NIL+ +DG + L DF L+
Sbjct: 105 YQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLA 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 9e-12
Identities = 40/150 (26%), Positives = 75/150 (50%), Gaps = 12/150 (8%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI--MSLLDH 365
++ ++ +G G G+V+ + G + A+K + L+ + I+RE+ +S L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIIN----LDTPDDDVSDIQREVALLSQLRQ 58
Query: 366 PFLPTL---YASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLE 422
P + Y S+ + +I ++ GG + L+ P+ E EV++ L+
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIA---EKYISVIIREVLVALK 115
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDF 452
Y+H +G+I+RD+K NIL+ G+V L DF
Sbjct: 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDF 145
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 39/158 (24%), Positives = 72/158 (45%), Gaps = 14/158 (8%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL----- 362
++ + +G G G+V+ G A+K + V L+ + + + REI L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKV--RVPLSEEGIPLSTL-REIALLKQLES 57
Query: 363 LDHPFLPTLYASFQTS-----THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEV 417
+HP + L + L+ + +L L K P ++ + ++
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 418 VIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ G+++LH I++RDLKP+NIL+ DG V + DF L+
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 45/146 (30%), Positives = 75/146 (51%), Gaps = 8/146 (5%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYA 373
LG G+ GSV+ V + G AMK E + L+ +K ++ +E +I+ P++ Y
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMK--EIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 374 SF--QTSTHICLITDFCPGGELFALLD-KQPMKIFREDSARFYAAEVVIGLEYL-HCLGI 429
+F + + ++C+ ++ G L L + ED R VV GL++L I
Sbjct: 67 AFFIEGAVYMCM--EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124
Query: 430 IYRDLKPENILLQKDGHVVLTDFDLS 455
I+RD+KP N+L+ +G V L DF +S
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 5e-11
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 10/153 (6%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE--IMSLLDHPFLP 369
K LG G G V+ +L+G A+ K++ + ++ R +E +M L HP +
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAV-KTLKEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 370 TLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARF-------YAAEVVIGLE 422
L + L+ ++ GG+L L K + + +A ++ G+E
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
YL ++RDL N L+ +D V ++DF LS
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLS 152
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 6e-11
Identities = 44/142 (30%), Positives = 67/142 (47%), Gaps = 8/142 (5%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYA 373
LG G+ G+V+ + A+K + + + K + E EI+ D P++ Y
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK--QIMSELEILYKCDSPYIIGFYG 66
Query: 374 SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRD 433
+F I + T+F GG L + K P + A VV GL YL L I++RD
Sbjct: 67 AFFVENRISICTEFMDGGSL-DVYRKIPEHVLGR-----IAVAVVKGLTYLWSLKILHRD 120
Query: 434 LKPENILLQKDGHVVLTDFDLS 455
+KP N+L+ G V L DF +S
Sbjct: 121 VKPSNMLVNTRGQVKLCDFGVS 142
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 9e-11
Identities = 39/148 (26%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE--IMSLLDHPFL 368
++ +G G G V LV + G+ Y +K + + N ++ R E+E ++S L HP +
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLN---LRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 369 PTLYASFQ-TSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
S++ + ++ FC GG+L+ L +Q K+ E+ + ++ + L+YLH
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 428 GIIYRDLKPENILLQKDGHVVLTDFDLS 455
I++RDLK +N+ L + + + D ++
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIA 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 43/145 (29%), Positives = 72/145 (49%), Gaps = 4/145 (2%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPT 370
I LG G G V+ + + G L A K ++ + ++ +E +I++ DHP +
Sbjct: 10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVK 66
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGII 430
L +F ++ ++ +FC GG + A++ + + E R + + L YLH II
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAVDAVM-LELERPLTEPQIRVVCKQTLEALNYLHENKII 125
Query: 431 YRDLKPENILLQKDGHVVLTDFDLS 455
+RDLK NIL DG + L DF +S
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 48/164 (29%), Positives = 83/164 (50%), Gaps = 14/164 (8%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL----- 362
++P+ +G G G+V+ +G A+K++ V N + + + + RE+ L
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VQTNEDGLPLSTV-REVALLKRLEA 58
Query: 363 LDHPFLPTLY---ASFQT--STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEV 417
DHP + L A+ +T T + L+ + +L LDK P ++ + +
Sbjct: 59 FDHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQF 117
Query: 418 VIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK 461
+ GL++LH I++RDLKPENIL+ G V L DF L+ + SC+
Sbjct: 118 LRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ 161
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 14/164 (8%)
Query: 292 AIQKITGSGE-KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKV 350
A+Q + G+ + L +F I G G TG V + ++ +G+L A+K M+ R +
Sbjct: 8 ALQMVVDPGDPRTYLDNFIKI---GEGSTGIVCIATVKSSGKLVAVKKMDL-----RKQQ 59
Query: 351 HRACIEREIMSLLD--HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFRED 408
R + E++ + D H + +Y S+ + ++ +F GG L ++ M E+
Sbjct: 60 RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMN---EE 116
Query: 409 SARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDF 452
V+ L LH G+I+RD+K ++ILL DG V L+DF
Sbjct: 117 QIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 38/159 (23%), Positives = 64/159 (40%), Gaps = 7/159 (4%)
Query: 315 GCGDTGSVHLVELQGAGELYAMK--AMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLY 372
D VHL + + L A+K ++ + + + I L HP +
Sbjct: 9 CFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEII---TSRQLQHPNILPYV 65
Query: 373 ASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYR 432
SF + + +++ G LL + E + F +V+ L+Y+H G I+R
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHR 125
Query: 433 DLKPENILLQKDGHVVLTDFD--LSFMTSCKPQVFYHAH 469
+K +ILL DG VVL+ +S + K Q H
Sbjct: 126 SVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 6/150 (4%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAME--KSVMLNRNKVHRACI-EREIMSLL 363
+ + LG G S + G L A+K + ++ + +V A E +M+ L
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 364 DHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEY 423
+HP + + + +H L ++ GG + LL K F+E Y +++ GL Y
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSY 118
Query: 424 LHCLGIIYRDLKPENILLQKDGHVV-LTDF 452
LH II+RD+K N+L+ G + + DF
Sbjct: 119 LHENQIIHRDVKGANLLIDSTGQRLRIADF 148
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 38/158 (24%), Positives = 75/158 (47%), Gaps = 10/158 (6%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
++ ++ +G G G+V V + G++ K ++ M + K + E I+ L HP
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-QQLVSEVNILRELKHP 59
Query: 367 FLPTLYASF--QTSTHICLITDFCPGGELFALLDK--QPMKIFREDSARFYAAEVVIGLE 422
+ Y +++ + ++ ++C GG+L L+ K + K E+ ++++ L
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 423 YLHCLG-----IIYRDLKPENILLQKDGHVVLTDFDLS 455
H +++RDLKP NI L + +V L DF L+
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 5e-10
Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 11/151 (7%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD--H 365
F+ I+ +G G G V+ GEL A+K ++ + A +++EI+ + D H
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDF-----AVVQQEIIMMKDCKH 65
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLD-KQPMKIFREDSARFYAAEVVIGLEYL 424
+ + S+ + + +FC GG L + P+ E + + E + GL YL
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLS---ESQIAYVSRETLQGLYYL 122
Query: 425 HCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
H G ++RD+K NILL +GHV L DF +S
Sbjct: 123 HSKGKMHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 43/168 (25%), Positives = 74/168 (44%), Gaps = 15/168 (8%)
Query: 308 FKPIKPLGCGDTGSVH----LVELQGAGELYAMKAM-EKSVMLNRNKVHRACIEREIMSL 362
+ IK LG G G+V+ + E + A+K + E++ ++ E +M+
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILD---EAYVMAS 65
Query: 363 LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLD--KQPMKIFREDSARFYAAEVVIG 420
+DHP + L +S LIT P G LLD + + ++ G
Sbjct: 66 VDHPHVVRLLGICLSSQV-QLITQLMPLG---CLLDYVRNHKDNIGSQYLLNWCVQIAKG 121
Query: 421 LEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHA 468
+ YL +++RDL N+L++ HV +TDF L+ + + YHA
Sbjct: 122 MSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE-YHA 168
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 6e-10
Identities = 43/149 (28%), Positives = 65/149 (43%), Gaps = 10/149 (6%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI--MSLLDHPFLP 369
K LG G G V+L G A+K + K +E EI + L H +
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 370 TLYASFQTSTHICLITDFCPGGELFALLDKQPMKIF---REDSARFYAAEVVIGLEYLHC 426
Y + + + ++ PGG + K +K + E R Y +++ G+EYLH
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSV-----KDQLKAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDFDLS 455
I++RD+K NIL G+V L DF S
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGAS 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 6e-10
Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 14/164 (8%)
Query: 292 AIQKITGSGE-KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKV 350
A+Q + G+ + L +F I G G TG V + + G A+K M+ R +
Sbjct: 7 ALQLVVDPGDPRSYLDNFVKI---GEGSTGIVCIATDKSTGRQVAVKKMDL-----RKQQ 58
Query: 351 HRACIERE--IMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFRED 408
R + E IM HP + +Y+S+ + ++ +F GG L ++ M E+
Sbjct: 59 RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMN---EE 115
Query: 409 SARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDF 452
V+ L +LH G+I+RD+K ++ILL DG V L+DF
Sbjct: 116 QIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 7e-10
Identities = 49/171 (28%), Positives = 79/171 (46%), Gaps = 22/171 (12%)
Query: 295 KITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRAC 354
I G L+ + + +G G G V+ + + G + A+K M ++ N+ + R
Sbjct: 4 TIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRIL 61
Query: 355 IEREIMSL-LDHPFLPTLYASFQTSTH--ICLITDFCPGGELFAL-LDKQPMKI---FRE 407
++ +++ D P++ Y F T + IC+ EL + LDK +I E
Sbjct: 62 MDLDVVLKSHDCPYIVKCYGYFITDSDVFICM--------ELMSTCLDKLLKRIQGPIPE 113
Query: 408 DSARFYAAEVVIGLEYL---HCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
D +V L YL H G+I+RD+KP NILL G+V L DF +S
Sbjct: 114 DILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 42/160 (26%), Positives = 73/160 (45%), Gaps = 21/160 (13%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAM------EKSVMLNRNKVHRACIEREIMS 361
F+ ++ +G G G V+ G+L A+K M E+ + L N + + R I
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNI-- 75
Query: 362 LLDHPFLPTLYASFQTST------HICLITDFCPGGELFALLDKQPMKIFREDSARFYAA 415
T Y +F + + L+ +FC G + L+ +ED +
Sbjct: 76 -------ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR 128
Query: 416 EVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
E++ GL +LH +I+RD+K +N+LL ++ V L DF +S
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 35/100 (35%), Positives = 46/100 (46%), Gaps = 1/100 (1%)
Query: 356 EREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAA 415
E IM LDH L LY T + ++T+ P G L L K + F + YA
Sbjct: 46 EAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAV 104
Query: 416 EVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
++ G+ YL I+RDL NILL D V + DF L
Sbjct: 105 QIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLM 144
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 14/164 (8%)
Query: 292 AIQKITGSGE-KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKV 350
A+Q + G+ + L F I G G TG V + + G+ A+K M+ R +
Sbjct: 10 ALQLVVSPGDPREYLDSFIKI---GEGSTGIVCIATEKHTGKQVAVKKMDL-----RKQQ 61
Query: 351 HRACIEREIMSLLD--HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFRED 408
R + E++ + D H + +Y S+ + ++ +F GG L ++ M E+
Sbjct: 62 RRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMN---EE 118
Query: 409 SARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDF 452
V+ L YLH G+I+RD+K ++ILL DG + L+DF
Sbjct: 119 QIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 48/180 (26%), Positives = 84/180 (46%), Gaps = 16/180 (8%)
Query: 280 PRPHKRDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAM 339
P P +SS + + L + + +G G G+V+ V + G LYA+K +
Sbjct: 48 PPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI 107
Query: 340 ----EKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFA 395
E +V R ++ C E EI+ ++HP + + F + I ++ +F GG L
Sbjct: 108 YGNHEDTV---RRQI---CREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL-- 159
Query: 396 LLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ I E A +++ G+ YLH I++RD+KP N+L+ +V + DF +S
Sbjct: 160 ----EGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVS 215
|
Length = 353 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 7/150 (4%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN-RNKVHRACIEREIMSLLDHP 366
F+ I LG G+ G V V+ + +G + A K + + RN++ R E +++ + P
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIR---ELQVLHECNSP 63
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYL-H 425
++ Y +F + I + + GG L +L K+ +I E + A V+ GL YL
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KEAKRIPEEILGKVSIA-VLRGLAYLRE 121
Query: 426 CLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
I++RD+KP NIL+ G + L DF +S
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 3e-09
Identities = 40/160 (25%), Positives = 73/160 (45%), Gaps = 21/160 (13%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI--MSLLD 364
++ +KP+G G G V + G A+K K + + + I REI + L
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK---KISNVFDDLIDAKRILREIKLLRHLR 57
Query: 365 HP--------FLPTLYASFQTSTHICLITDFCPGGELFALL-DKQPMKIFREDSARFYAA 415
H P F + ++T+ +L ++ QP+ +D +++
Sbjct: 58 HENIIGLLDILRPPSPEDFND---VYIVTELMET-DLHKVIKSPQPL---TDDHIQYFLY 110
Query: 416 EVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+++ GL+YLH +I+RDLKP NIL+ + + + DF L+
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-09
Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 3/100 (3%)
Query: 356 EREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAA 415
E ++S D P++ Y S+ T + +I ++ GG LL+ P+ E
Sbjct: 52 EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD---ETQIATILR 108
Query: 416 EVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
E++ GL+YLH I+RD+K N+LL + G V L DF ++
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 40/153 (26%), Positives = 76/153 (49%), Gaps = 4/153 (2%)
Query: 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACI-EREIMSLL 363
L +FK K +G G V+ G + A+K ++ M++ K + C+ E +++ L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDA-KARQDCLKEIDLLKQL 59
Query: 364 DHPFLPTLYASFQTSTHICLITDFCPGGELFALLD--KQPMKIFREDSARFYAAEVVIGL 421
DHP + ASF + + ++ + G+L ++ K+ ++ E + Y ++ L
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDL 454
E++H I++RD+KP N+ + G V L D L
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGVVKLGDLGL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 6e-09
Identities = 38/142 (26%), Positives = 67/142 (47%), Gaps = 7/142 (4%)
Query: 331 GELYAMKAMEKSVMLNRNKVHRACIEREIMSL--LDHPFLPTLYASFQTSTHICLITDFC 388
GE+ A+K ++S ++ + RE+ L L H + L +F+ + L+ ++
Sbjct: 26 GEIVAIKKFKES---EDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82
Query: 389 PGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVV 448
L LL+ P D+ R Y +++ + Y H II+RD+KPENIL+ + G +
Sbjct: 83 ER-TLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLK 140
Query: 449 LTDFDLSFMTSCKPQVFYHAHV 470
L DF + +P +V
Sbjct: 141 LCDFGFARALRARPASPLTDYV 162
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 7e-09
Identities = 43/164 (26%), Positives = 76/164 (46%), Gaps = 21/164 (12%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE-------- 358
++ + P+G G G V G A+K + + ++ +H RE
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF---QSAIHAKRTYRELRLLKHMD 72
Query: 359 ---IMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAA 415
++ LLD F P +S + + L+T G +L ++ Q + +D +F
Sbjct: 73 HENVIGLLD-VFTPA--SSLEDFQDVYLVTHLM-GADLNNIVKCQKLS---DDHIQFLVY 125
Query: 416 EVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459
+++ GL+Y+H GII+RDLKP NI + +D + + DF L+ T
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 7e-09
Identities = 35/103 (33%), Positives = 54/103 (52%), Gaps = 5/103 (4%)
Query: 355 IEREI--MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARF 412
I++EI +S D P++ Y S+ T + +I ++ GG LL P F E
Sbjct: 49 IQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIAT 105
Query: 413 YAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
E++ GL+YLH I+RD+K N+LL + G V L DF ++
Sbjct: 106 MLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 8e-09
Identities = 30/93 (32%), Positives = 43/93 (46%), Gaps = 3/93 (3%)
Query: 364 DHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEY 423
D+P LY S T LI D+ G+LF LL K+ E + ++V L
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALND 124
Query: 424 LHCLGIIYRDLKPENILL-QKDGHVVLTDFDLS 455
LH II+ D+K EN+L + + L D+ L
Sbjct: 125 LHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157
|
Length = 267 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 9e-09
Identities = 44/165 (26%), Positives = 73/165 (44%), Gaps = 23/165 (13%)
Query: 314 LGCGDTGSVHLVELQGAGEL----YAMKAMEKSVML----------NRNKVHRACIEREI 359
LG G G VHL E +G + +++ +L N+N + E +I
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 360 MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSA--------- 410
MS L P + L A TS +C+IT++ G+L L + + E +
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 411 RFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
F A ++ G++YL L ++RDL N L+ K+ + + DF +S
Sbjct: 133 IFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 34/103 (33%), Positives = 55/103 (53%), Gaps = 5/103 (4%)
Query: 355 IEREI--MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARF 412
I++EI +S D P++ Y S+ T + +I ++ GG LL P++ E
Sbjct: 49 IQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLE---ETYIAT 105
Query: 413 YAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
E++ GL+YLH I+RD+K N+LL + G V L DF ++
Sbjct: 106 ILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 9e-09
Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 6/145 (4%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPT 370
+K LG G G VHL + +G ++ A+K + + M + + A ++M L HP L
Sbjct: 9 LKELGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFIEEA----KVMMKLSHPNLVQ 63
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGII 430
LY I ++T++ G L L ++ + ++V +EYL G I
Sbjct: 64 LYGVCTKQRPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFI 122
Query: 431 YRDLKPENILLQKDGHVVLTDFDLS 455
+RDL N L+ +D V ++DF L+
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLA 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 41/147 (27%), Positives = 69/147 (46%), Gaps = 22/147 (14%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAM------EKSVMLNRNKVHRACIEREIMSLLDHPF 367
+G G +G+V+ G+ A+K M +K +++N E +M HP
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN---------EILVMRENKHPN 77
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAA--EVVIGLEYLH 425
+ S+ + ++ ++ GG L ++ + M D + A E + LE+LH
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-----DEGQIAAVCRECLQALEFLH 132
Query: 426 CLGIIYRDLKPENILLQKDGHVVLTDF 452
+I+RD+K +NILL DG V LTDF
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 42/141 (29%), Positives = 68/141 (48%), Gaps = 10/141 (7%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD--HPFLPTL 371
+G G TG V + + +G A+K M+ R + R + E++ + D H + +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDL-----RKQQRRELLFNEVVIMRDYQHQNVVEM 83
Query: 372 YASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIY 431
Y S+ + ++ +F GG AL D E+ V+ L YLH G+I+
Sbjct: 84 YKSYLVGEELWVLMEFLQGG---ALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIH 140
Query: 432 RDLKPENILLQKDGHVVLTDF 452
RD+K ++ILL DG V L+DF
Sbjct: 141 RDIKSDSILLTLDGRVKLSDF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 49/158 (31%), Positives = 74/158 (46%), Gaps = 16/158 (10%)
Query: 307 HFKPIKPLGCGDTGSVHLVE---LQ-GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL 362
H K I+ LG G+ GSV L LQ GE+ A+K ++ S H EREI L
Sbjct: 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----TAEHLRDFEREIEIL 59
Query: 363 --LDHPFLPTLYASFQTST---HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEV 417
L H + Y S ++ L+ ++ P G L L K ++ YA+++
Sbjct: 60 KSLQHDNI-VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHR-KLLLYASQI 117
Query: 418 VIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
G+EYL ++RDL NIL++ + V + DF L+
Sbjct: 118 CKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 26/161 (16%)
Query: 314 LGCGDTGSVHLVELQGAGE-LYAMKAM--------------EKSVMLNRNKVHRACIERE 358
LG G G V+ V + G+ L A+K + +KS+ + V I +E
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSI---GDIVSEVTIIKE 64
Query: 359 IMSLLDHPFLPTLYASFQTSTHICLITDF---CPGGELFALLDKQPMKIFREDSARFYAA 415
+ HP + Y +F + + ++ D P GE F L K+ + F E+
Sbjct: 65 QLR---HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSL-KEKKQRFTEERIWNIFV 120
Query: 416 EVVIGLEYLHCLG-IIYRDLKPENILLQKDGHVVLTDFDLS 455
++V+ L YLH I++RDL P NI+L +D V +TDF L+
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 47/154 (30%), Positives = 71/154 (46%), Gaps = 15/154 (9%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD--H 365
F+ + LG G+ G V V + +G + A K + L R I RE+ L +
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMA----RKLIHLEIKPAIRNQIIRELKVLHECNS 58
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQ---PMKIFREDSARFYAAEVVIGLE 422
P++ Y +F + I + + GG L +L K P I + S A V+ GL
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKIS---IA--VLRGLT 113
Query: 423 YLH-CLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
YL I++RD+KP NIL+ G + L DF +S
Sbjct: 114 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 48/198 (24%), Positives = 87/198 (43%), Gaps = 16/198 (8%)
Query: 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACI-EREIMSLL 363
L +F+ K +G G V+ G A+K ++ +++ K CI E +++ L
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDA-KARADCIKEIDLLKQL 59
Query: 364 DHPFLPTLYASFQTSTHICLITDFCPGGELFALLD--KQPMKIFREDSARFYAAEVVIGL 421
+HP + YASF + ++ + G+L ++ K+ ++ E + Y ++ L
Sbjct: 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQV--------FYHA----H 469
E++H +++RD+KP N+ + G V L D L S K +Y + H
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 470 VNGFYFIMYKWLTGYFTY 487
NG+ F W G Y
Sbjct: 180 ENGYNFKSDIWSLGCLLY 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 48/157 (30%), Positives = 75/157 (47%), Gaps = 20/157 (12%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE---IMSLLDHPF 367
I+ +G G G V+ V + G L A+K ++ ++ IE E + SL +HP
Sbjct: 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEE------IEAEYNILQSLPNHPN 80
Query: 368 LPTLYASFQTSTH-----ICLITDFCPGGELFALLDKQPMKIFREDSAR----FYAAEVV 418
+ Y F + + L+ + C GG + L+ + R D A Y A +
Sbjct: 81 VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA--L 138
Query: 419 IGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+GL++LH II+RD+K NILL +G V L DF +S
Sbjct: 139 LGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 41/162 (25%), Positives = 74/162 (45%), Gaps = 20/162 (12%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
+ ++PLGCG G V + A+K K V+ + V A E +I+ LDH
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVK---KIVLTDPQSVKHALREIKIIRRLDHDN 63
Query: 368 LPTLY-------------ASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYA 414
+ +Y T + I +L +L++ P+ E+ AR +
Sbjct: 64 IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLS---EEHARLFM 120
Query: 415 AEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVV-LTDFDLS 455
+++ GL+Y+H +++RDLKP N+ + + V+ + DF L+
Sbjct: 121 YQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA 162
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 49/159 (30%), Positives = 74/159 (46%), Gaps = 21/159 (13%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI-MSLLDHP 366
+ I+ LG G G V + G + A+K + +V N + R ++ +I M +D P
Sbjct: 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV--NSQEQKRLLMDLDISMRSVDCP 60
Query: 367 FLPTLY-ASFQT-STHICL-ITDFCPGGELFALLDK------QPMKIFREDSARFYAAEV 417
+ T Y A F+ IC+ + D LDK ED A +
Sbjct: 61 YTVTFYGALFREGDVWICMEVMDTS--------LDKFYKKVYDKGLTIPEDILGKIAVSI 112
Query: 418 VIGLEYLHC-LGIIYRDLKPENILLQKDGHVVLTDFDLS 455
V LEYLH L +I+RD+KP N+L+ ++G V L DF +S
Sbjct: 113 VKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 15/157 (9%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD--- 364
F+ ++ +G G G V+ G+L A+K M+ + I++EI L
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------GDEEEEIKQEINMLKKYSH 61
Query: 365 HPFLPTLYASFQTST------HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVV 418
H + T Y +F + L+ +FC G + L+ +E+ + E++
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 419 IGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
GL +LH +I+RD+K +N+LL ++ V L DF +S
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 42/145 (28%), Positives = 68/145 (46%), Gaps = 6/145 (4%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPT 370
+K LG G G VHL + + ++ A+KA+ + M + + A ++M L HP L
Sbjct: 9 MKELGSGQFGVVHLGKWRAQIKV-AIKAINEGAMSEEDFIEEA----KVMMKLSHPKLVQ 63
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGII 430
LY + ++T+F G L L +Q +D +V G+EYL I
Sbjct: 64 LYGVCTQQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122
Query: 431 YRDLKPENILLQKDGHVVLTDFDLS 455
+RDL N L+ G V ++DF ++
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 39/167 (23%), Positives = 80/167 (47%), Gaps = 4/167 (2%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
++ ++ LG G +V+ + + G+L A+K + + A E ++ L H
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR--LQEEEGTPFTAIREASLLKGLKHAN 64
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
+ L+ T + L+ ++ +L +DK P + ++ + + +++ GL Y+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGL-HPENVKLFLFQLLRGLSYIHQR 122
Query: 428 GIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFY 474
I++RDLKP+N+L+ G + L DF L+ S + + V +Y
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWY 169
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 13/153 (8%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN-RNKVHRACIEREIMSLLDHP 366
F+ I LG G+ G V V + +G + A K + + RN++ R E +++ + P
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIR---ELQVLHECNSP 63
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQ---PMKIFREDSARFYAAEVVIGLEY 423
++ Y +F + I + + GG L +L K P +I + S V+ GL Y
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI-----AVIKGLTY 118
Query: 424 L-HCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
L I++RD+KP NIL+ G + L DF +S
Sbjct: 119 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 4/103 (3%)
Query: 356 EREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQ--PMKIFREDSARFY 413
E + S L H + S + + + PGG L ALL + P+K E + FY
Sbjct: 55 EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKD-NEQTIIFY 113
Query: 414 AAEVVIGLEYLHCLGIIYRDLKPENILLQK-DGHVVLTDFDLS 455
+++ GL+YLH I++RD+K +N+L+ G V ++DF S
Sbjct: 114 TKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTS 156
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 4/98 (4%)
Query: 357 REIMSL--LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYA 414
REI L L HP L L F+ + L+ ++C + L+K P + E +
Sbjct: 49 REIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC-DHTVLNELEKNPRGV-PEHLIKKII 106
Query: 415 AEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDF 452
+ + + + H I+RD+KPENIL+ K G + L DF
Sbjct: 107 WQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 39/165 (23%), Positives = 70/165 (42%), Gaps = 24/165 (14%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKS---VML---------NRNKVHRACIEREIMS 361
LG G G VHL E +G E A E V++ + + E +IMS
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMK-----------IFREDSA 410
L +P + L + +C+IT++ G+L L ++ ++ + +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN-L 131
Query: 411 RFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ A ++ G++YL L ++RDL N L+ + + DF +S
Sbjct: 132 LYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 42/153 (27%), Positives = 64/153 (41%), Gaps = 8/153 (5%)
Query: 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIM 360
EK+ F ++ +G G G+V+ E+ A+K M S + K E +
Sbjct: 14 EKL----FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69
Query: 361 SLLDHPFLPTLYASFQTSTHICLITDFCPGGELFAL-LDKQPMKIFREDSARFYAAEVVI 419
L HP + L+ ++C G L + K+P+ +E +
Sbjct: 70 QQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPL---QEVEIAAICHGALQ 126
Query: 420 GLEYLHCLGIIYRDLKPENILLQKDGHVVLTDF 452
GL YLH I+RD+K NILL + G V L DF
Sbjct: 127 GLAYLHSHERIHRDIKAGNILLTEPGTVKLADF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 49/172 (28%), Positives = 77/172 (44%), Gaps = 23/172 (13%)
Query: 308 FKPIKPLGCGDTGSVH----LVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL 363
FK IK LG G G+V+ + E + A+K + ++ NK E +M+ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVMASV 66
Query: 364 DHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARF-------YAAE 416
D+P + L TST + LIT P G LLD RE + +
Sbjct: 67 DNPHVCRLLGICLTST-VQLITQLMPFG---CLLD-----YVREHKDNIGSQYLLNWCVQ 117
Query: 417 VVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHA 468
+ G+ YL +++RDL N+L++ HV +TDF L+ + + YHA
Sbjct: 118 IAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE-YHA 168
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 38/147 (25%), Positives = 66/147 (44%), Gaps = 8/147 (5%)
Query: 312 KPLGCGDTGSVH--LVELQGAGEL-YAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFL 368
K LG G+ GSV + ++ E+ A+K +++ + K E +M+ LDHP +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLR--EASVMAQLDHPCI 58
Query: 369 PTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLG 428
L + + L+ + P G L L K+ + A +V +G+ YL
Sbjct: 59 VRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH 115
Query: 429 IIYRDLKPENILLQKDGHVVLTDFDLS 455
++RDL N+LL ++DF +S
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMS 142
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 34/142 (23%), Positives = 63/142 (44%), Gaps = 6/142 (4%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYA 373
+G G+ G V L + +G + A+K ++ + E +M+ L HP L L
Sbjct: 14 IGKGEFGDVMLGDYRG--QKVAVKCLKD----DSTAAQAFLAEASVMTTLRHPNLVQLLG 67
Query: 374 SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRD 433
+ ++T++ G L L + + +A +V G+EYL ++RD
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRD 127
Query: 434 LKPENILLQKDGHVVLTDFDLS 455
L N+L+ +D ++DF L+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLA 149
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 40/148 (27%), Positives = 78/148 (52%), Gaps = 10/148 (6%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEK--SVMLNRNKVHRACIEREIMSLLDHPFL 368
++P+G G G V Q G+ A+K + K S + + +R E +++ L H +
Sbjct: 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR---ELKLLKHLRHENI 71
Query: 369 PTLYASF-QTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
+L F I +T+ G +L LL +P++ + +++ +++ GL+Y+H
Sbjct: 72 ISLSDIFISPLEDIYFVTELL-GTDLHRLLTSRPLE---KQFIQYFLYQILRGLKYVHSA 127
Query: 428 GIIYRDLKPENILLQKDGHVVLTDFDLS 455
G+++RDLKP NIL+ ++ + + DF L+
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLA 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 41/150 (27%), Positives = 73/150 (48%), Gaps = 6/150 (4%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL--LDH 365
F+ ++ +G G G V+ + GE+ A+K + + V I REI L L+H
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAI-REISLLKELNH 58
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
P + L T + L+ +F +L +D P+ + Y +++ GL + H
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 426 CLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+++RDLKP+N+L+ +G + L DF L+
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 7e-07
Identities = 42/152 (27%), Positives = 65/152 (42%), Gaps = 20/152 (13%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPT 370
+K LG G G V + +G ++ A+K +++ M + A ++M L H L
Sbjct: 9 LKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIEEA----KVMMKLSHEKLVQ 63
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAE-------VVIGLEY 423
LY I ++T++ G L L RE RF ++ V G+ Y
Sbjct: 64 LYGVCTKQRPIYIVTEYMSNGCLLNYL--------REHGKRFQPSQLLEMCKDVCEGMAY 115
Query: 424 LHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
L I+RDL N L+ G V ++DF LS
Sbjct: 116 LESKQFIHRDLAARNCLVDDQGCVKVSDFGLS 147
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 19/54 (35%), Positives = 35/54 (64%), Gaps = 3/54 (5%)
Query: 399 KQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDF 452
QP+ E+ R++ +++ GL+Y+H +I+RDLKP N+L+ +D + + DF
Sbjct: 101 DQPLT---EEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDF 151
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 9e-07
Identities = 37/142 (26%), Positives = 69/142 (48%), Gaps = 6/142 (4%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMK--AMEKSVMLNRNKVHRACIER-EIMSLLDHPFLPT 370
LG G G+V+ L G+L A+K ++ S +L K + E +++ L H +
Sbjct: 8 LGKGAYGTVYC-GLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGII 430
+ I + +F PGG + ++L++ E Y +++ G+ YLH ++
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNNCVV 124
Query: 431 YRDLKPENILLQKDGHVVLTDF 452
+RD+K N++L +G + L DF
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDF 146
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 40/145 (27%), Positives = 68/145 (46%), Gaps = 18/145 (12%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAM------EKSVMLNRNKVHRACIEREIMSLLDHPF 367
+G G +G+V+ G+ A++ M +K +++N V R I++ LD
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD--- 84
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
S+ + ++ ++ GG L ++ + M E E + LE+LH
Sbjct: 85 ------SYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALEFLHSN 135
Query: 428 GIIYRDLKPENILLQKDGHVVLTDF 452
+I+RD+K +NILL DG V LTDF
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 4/153 (2%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
F ++ +G G G+V+ E+ A+K M S + K E + + + HP
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFAL-LDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
+ L+ ++C G L + K+P++ E +A + A + GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV-EIAAITHGA--LQGLAYLHS 143
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459
+I+RD+K NILL + G V L DF + + S
Sbjct: 144 HNMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 40/145 (27%), Positives = 68/145 (46%), Gaps = 18/145 (12%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAM------EKSVMLNRNKVHRACIEREIMSLLDHPF 367
+G G +G+V+ G+ A+K M +K +++N V R I++ LD
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLD--- 83
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
S+ + ++ ++ GG L ++ + M E E + L++LH
Sbjct: 84 ------SYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALDFLHSN 134
Query: 428 GIIYRDLKPENILLQKDGHVVLTDF 452
+I+RD+K +NILL DG V LTDF
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 18/156 (11%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI--MSLLDH 365
FK ++ LG G +V+ + GE+ A+K + L+ + + REI M L H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALK----EIHLDAEEGTPSTAIREISLMKELKH 57
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSA------RFYAAEVVI 419
+ L+ T + L+ ++ +L K+ M A + + +++
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDK-DL-----KKYMDTHGVRGALDPNTVKSFTYQLLK 111
Query: 420 GLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
G+ + H +++RDLKP+N+L+ K G + L DF L+
Sbjct: 112 GIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 19/37 (51%), Positives = 28/37 (75%)
Query: 416 EVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDF 452
+V+ GL LH +GI++RD+KPEN+L+ DG V + DF
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDF 353
|
Length = 507 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 24/56 (42%), Positives = 35/56 (62%), Gaps = 1/56 (1%)
Query: 397 LDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDF 452
L+K P + E R Y +++ G+E+ H II+RD+KPENIL+ + G V L DF
Sbjct: 90 LEKYPNGL-DESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 42/153 (27%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD- 364
H ++ I+ +G G G V+ GEL A+K ++ L + I++EI + +
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK----LEPGD-DFSLIQQEIFMVKEC 63
Query: 365 -HPFLPTLYASFQTSTHICLITDFCPGGELFALLD-KQPMKIFREDSARFYAAEVVIGLE 422
H + + S+ + + + ++C GG L + P+ E + E + GL
Sbjct: 64 KHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLS---ELQIAYVCRETLQGLA 120
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
YLH G ++RD+K NILL +G V L DF ++
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 44/157 (28%), Positives = 70/157 (44%), Gaps = 15/157 (9%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQ----GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL 362
+ K I+ LG G G V L G GE+ A+K +++ + + + ++EI L
Sbjct: 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC----GQQNTSGWKKEINIL 60
Query: 363 --LDHPFLPTLYA--SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVV 418
L H + S Q + LI ++ P G L L K + + +A ++
Sbjct: 61 KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL---AQLLLFAQQIC 117
Query: 419 IGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
G+ YLH I+RDL N+LL D V + DF L+
Sbjct: 118 EGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLA 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 44/160 (27%), Positives = 72/160 (45%), Gaps = 19/160 (11%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE--IMSLLDH 365
++ + +G G G V + ++ A+K K +M N + RE I+ LL H
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALK---KVLMENEKEGFPITALREIKILQLLKH 70
Query: 366 P----------FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAA 415
T Y ++ S L+ +FC +L LL + +K F +
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGS--FYLVFEFCEH-DLAGLLSNKNVK-FTLSEIKKVMK 126
Query: 416 EVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
++ GL Y+H I++RD+K NIL+ KDG + L DF L+
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 44/161 (27%), Positives = 68/161 (42%), Gaps = 34/161 (21%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEK---SVMLNRNKVHRACIEREIM---S 361
+K + +G G V + + G+ YA+K M+K S+ N REI
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-------REIQALRR 53
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLD----------KQPMKIFREDSAR 411
L HP + L L +F L+D K+P E +
Sbjct: 54 LSPHPNILRLIEVLFDRKTGRLAL-------VFELMDMNLYELIKGRKRP---LPEKRVK 103
Query: 412 FYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDF 452
Y +++ L+++H GI +RD+KPENIL+ KD + L DF
Sbjct: 104 SYMYQLLKSLDHMHRNGIFHRDIKPENILI-KDDILKLADF 143
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 44/151 (29%), Positives = 67/151 (44%), Gaps = 10/151 (6%)
Query: 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL 362
+GLH +G G G+V+ E+ A+K M S K E + +
Sbjct: 24 VGLHE------IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQ 77
Query: 363 LDHPFLPTLYASFQTSTHICLITDFCPGGELFAL-LDKQPMKIFREDSARFYAAEVVIGL 421
L HP + L+ ++C G L + K+P++ E +A + A + GL
Sbjct: 78 LKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEV-EIAAITHGA--LQGL 134
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDF 452
YLH +I+RD+K NILL + G V L DF
Sbjct: 135 AYLHSHNMIHRDIKAGNILLTEPGQVKLADF 165
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 41/160 (25%), Positives = 66/160 (41%), Gaps = 15/160 (9%)
Query: 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI--MSL 362
L ++ + LG G G V+ G + A+K K +M N REI +
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALK---KILMHNEKDGFPITALREIKILKK 63
Query: 363 LDHP-FLPTL-----YASFQTSTHICLITDFCP--GGELFALLDKQPMKIFREDSARFYA 414
L HP +P + + P +L LL+ +K E + Y
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVT-PYMDHDLSGLLENPSVK-LTESQIKCYM 121
Query: 415 AEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDL 454
+++ G+ YLH I++RD+K NIL+ G + + DF L
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL 161
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 5e-06
Identities = 41/147 (27%), Positives = 70/147 (47%), Gaps = 22/147 (14%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAM------EKSVMLNRNKVHRACIEREIMSLLDHPF 367
+G G +G+V G+ A+K + +K +++N E +M L +P
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN---------EILVMKELKNPN 77
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAA--EVVIGLEYLH 425
+ SF + ++ ++ GG L ++ + M D A+ A E + LE+LH
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCM-----DEAQIAAVCRECLQALEFLH 132
Query: 426 CLGIIYRDLKPENILLQKDGHVVLTDF 452
+I+RD+K +N+LL DG V LTDF
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|197509 smart00086, PAC, Motif C-terminal to PAS motifs (likely to contribute to PAS structural domain) | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 6e-06
Identities = 14/42 (33%), Positives = 21/42 (50%)
Query: 184 TVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSD 225
TV+ K G W L P+RD GE++ +GV D ++
Sbjct: 1 TVEYRLRRKDGSYIWVLVSASPIRDEDGEVEGILGVVRDITE 42
|
PAC motif occurs C-terminal to a subset of all known PAS motifs. It is proposed to contribute to the PAS domain fold. Length = 43 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 44/198 (22%), Positives = 86/198 (43%), Gaps = 16/198 (8%)
Query: 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACI-EREIMSLL 363
L +F+ K +G G V+ + A+K ++ M++ K + C+ E +++ L
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDA-KARQDCVKEIDLLKQL 59
Query: 364 DHPFLPTLYASFQTSTHICLITDFCPGGELFALLD--KQPMKIFREDSARFYAAEVVIGL 421
+HP + SF + ++ + G+L ++ K+ ++ E + Y ++ +
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQV--------FYHA----H 469
E++H +++RD+KP N+ + G V L D L S K +Y + H
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 470 VNGFYFIMYKWLTGYFTY 487
NG+ F W G Y
Sbjct: 180 ENGYNFKSDIWSLGCLLY 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 39/142 (27%), Positives = 66/142 (46%), Gaps = 6/142 (4%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYA 373
+G G G V L ++ A+K + + M + + A ++M L HP L LY
Sbjct: 12 IGSGQFGLVWLGYWLEKRKV-AIKTIREGAMSEEDFIEEA----QVMMKLSHPKLVQLYG 66
Query: 374 SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRD 433
+ ICL+ +F G L L Q K F +++ +V G+ YL +I+RD
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMAYLESSNVIHRD 125
Query: 434 LKPENILLQKDGHVVLTDFDLS 455
L N L+ ++ V ++DF ++
Sbjct: 126 LAARNCLVGENQVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 42/146 (28%), Positives = 66/146 (45%), Gaps = 4/146 (2%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
F ++ +G G G+V+ E+ A+K M S + K E + L HP
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFAL-LDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
+ L+ ++C G L + K+P++ E +A + A + GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV-EIAAVTHGA--LQGLAYLHS 133
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDF 452
+I+RD+K NILL + G V L DF
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 38/112 (33%), Positives = 56/112 (50%), Gaps = 8/112 (7%)
Query: 357 REIMSLLD--HPFLPTLY--ASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARF 412
REI LL+ HP + L + I L+ ++C +L +LLD P F E +
Sbjct: 55 REITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTP-FSESQVKC 112
Query: 413 YAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS--CKP 462
+++ GL+YLH II+RDLK N+LL G + + DF L+ KP
Sbjct: 113 LMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 46/163 (28%), Positives = 75/163 (46%), Gaps = 25/163 (15%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTL-- 371
LG G TG+V + GE +A+K ++ M + +RA + E+ LL+ F +
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRA--QAEVCCLLNCDFFSIVKC 96
Query: 372 YASFQTS--------THICLITDFCPGGELFALLDKQPMK-------IFREDSARFYAAE 416
+ F I L+ D+ G+L +Q +K FRE A +
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDL-----RQEIKSRAKTNRTFREHEAGLLFIQ 151
Query: 417 VVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459
V++ + ++H +I+RD+K NILL +G V L DF S M +
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA 194
|
Length = 496 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 40/168 (23%), Positives = 67/168 (39%), Gaps = 17/168 (10%)
Query: 308 FKPI-KPLGCGDTGSVHLVELQGAGELYAMKAME-----KSVMLNRNKVHRACI------ 355
+ LG G G V G++ A+K ++ V +R V I
Sbjct: 10 YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 356 EREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDS-ARFYA 414
E +IM+ + H + L + I L+ D +L ++D+ KI +S +
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDR---KIRLTESQVKCIL 125
Query: 415 AEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKP 462
+++ GL LH ++RDL P NI + G + DF L+ P
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPP 173
|
Length = 335 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 40/151 (26%), Positives = 67/151 (44%), Gaps = 12/151 (7%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAM--EKSVMLNRNKVHRACIEREIMSLLDHPFLP 369
K LG G G V+L G A+K + + +V+ E +++ L H +
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 370 TLYASFQ--TSTHICLITDFCPGGELFALLDKQPMKIF---REDSARFYAAEVVIGLEYL 424
Y + + + ++ PGG + K +K + E+ R Y +++ G+ YL
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSI-----KDQLKAYGALTENVTRRYTRQILQGVSYL 122
Query: 425 HCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
H I++RD+K NIL G+V L DF S
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGAS 153
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 39/165 (23%), Positives = 67/165 (40%), Gaps = 23/165 (13%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELY-----AMKAMEKSVMLN-RNKVHRACIEREIMSLLD 364
++ LG G G V+ EL G E A+K ++++ + + + E E+MS L
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ---EAELMSDLQ 66
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALL--------------DKQPMKIFREDSA 410
HP + L C++ ++ G+L L D+
Sbjct: 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 411 RFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
A ++ G+EYL ++RDL N L+ + V ++DF LS
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 16/155 (10%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE---IMSLLDHPF 367
I+ +G G G V V + G A+K ++ ++ IE E + +L DHP
Sbjct: 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE------IEAEYNILKALSDHPN 76
Query: 368 LPTLYASF-----QTSTHICLITDFCPGGELFALLDKQPMKIFR--EDSARFYAAEVVIG 420
+ Y + + + L+ + C GG + L+ + R E + E ++G
Sbjct: 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136
Query: 421 LEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
L++LH I+RD+K NILL +G V L DF +S
Sbjct: 137 LQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 47/157 (29%), Positives = 72/157 (45%), Gaps = 15/157 (9%)
Query: 308 FKPIKPLGCGDTGSVHLV----ELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL- 362
K I+ LG G G V L E GE A+K+++ N H A +++EI L
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN----HIADLKKEIEILR 61
Query: 363 -LDHPFLPTLYASFQTS---THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVV 418
L H + Y T I LI +F P G L L + KI + + YA ++
Sbjct: 62 NLYHENI-VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLK-YAVQIC 119
Query: 419 IGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
G++YL ++RDL N+L++ + V + DF L+
Sbjct: 120 KGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 40/165 (24%), Positives = 78/165 (47%), Gaps = 15/165 (9%)
Query: 306 HHFKPIKPLGCGDTGSVHLV-ELQGAGELYAMKAM-----EKSVMLNRNKVHRACIEREI 359
++ + +G G G V +L+ G A+K + E+ + L+ + + R +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS--TIREVAVLRHL 58
Query: 360 MSLLDHPFLPTLYASFQTS-----THICLITDFCPGGELFALLDKQPMKIFREDSARFYA 414
+ +HP + L+ S T + L+ + +L LDK P ++ +
Sbjct: 59 ETF-EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMM 116
Query: 415 AEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459
+++ GL++LH +++RDLKP+NIL+ G + L DF L+ + S
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 161
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 36/109 (33%), Positives = 51/109 (46%), Gaps = 19/109 (17%)
Query: 357 REIM---SLLDHPFLPTLYASF--QTSTHICLI-----TDFCPGGELFALLDKQPMKIFR 406
REIM L DHP + L + I L+ TD L A++ I
Sbjct: 55 REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETD------LHAVIRA---NILE 105
Query: 407 EDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ R+ +++ L+Y+H +I+RDLKP NILL D V L DF L+
Sbjct: 106 DVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLA 154
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 37/155 (23%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD 364
L ++ +KP+G G G V A+K + + N+ RA E +M ++
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN 74
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFR----EDSARFYAAEVVIG 420
H + +L F + +F + L+D ++ + + + +++ G
Sbjct: 75 HKNIISLLNVFTPQK---SLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 131
Query: 421 LEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+++LH GII+RDLKP NI+++ D + + DF L+
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 32/101 (31%), Positives = 45/101 (44%), Gaps = 2/101 (1%)
Query: 356 EREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAA 415
E +IM L H L LYA I ++T++ G L L K R AA
Sbjct: 51 EAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA 110
Query: 416 EVVIGLEYLHCLGIIYRDLKPENILLQKDGHVV-LTDFDLS 455
++ G+ YL I+RDL NIL+ + V + DF L+
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILV-GENLVCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 19/51 (37%), Positives = 33/51 (64%)
Query: 405 FREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
ED ++ +++ GL+Y+H GII+RDLKP N+ + +D + + DF L+
Sbjct: 114 LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA 164
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 21/163 (12%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE--------- 358
++ + P+G G GSV G A+K + + ++ +H RE
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKH 75
Query: 359 --IMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAE 416
++ LLD F P S + + L+T G +L ++ Q + +D +F +
Sbjct: 76 ENVIGLLD-VFTPA--RSLEEFNDVYLVTHLM-GADLNNIVKCQKLT---DDHVQFLIYQ 128
Query: 417 VVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459
++ GL+Y+H II+RDLKP N+ + +D + + DF L+ T
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 17/38 (44%), Positives = 26/38 (68%)
Query: 420 GLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457
+EY+H G+++RDLKP+NILL G VV+ D+ +
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIF 162
|
Length = 932 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 21/52 (40%), Positives = 34/52 (65%)
Query: 407 EDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458
ED +F +++ GL+Y+H GII+RDLKP N+ + +D + + DF L+ T
Sbjct: 117 EDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 29/97 (29%), Positives = 54/97 (55%), Gaps = 7/97 (7%)
Query: 359 IMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVV 418
++ LLD F P S + + L+T+ G +L ++ Q + ++ +F +++
Sbjct: 76 VIGLLD-VFTPA--TSIENFNEVYLVTNLM-GADLNNIVKCQKLS---DEHVQFLIYQLL 128
Query: 419 IGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
GL+Y+H GII+RDLKP N+ + +D + + DF L+
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 8/152 (5%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIE----REIMSLL 363
K +K LG G G+V+ GE + K +LN +A +E IM+ +
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIK--ILNETTGPKANVEFMDEALIMASM 66
Query: 364 DHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEY 423
DHP L L + T I L+T P G L + + I + + ++ G+ Y
Sbjct: 67 DHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN-WCVQIAKGMMY 124
Query: 424 LHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
L +++RDL N+L++ HV +TDF L+
Sbjct: 125 LEERRLVHRDLAARNVLVKSPNHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 37/129 (28%), Positives = 61/129 (47%), Gaps = 5/129 (3%)
Query: 331 GELYAMKAMEKSVMLNRNK-VHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCP 389
G K + K VMLN + A E ++ DH + + F++ + LI ++
Sbjct: 89 GSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148
Query: 390 GGELFALLDKQPMK---IFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGH 446
GG+L + KQ +K F+E ++V+ L+ +H +++RDLK NI L G
Sbjct: 149 GGDLNKQI-KQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI 207
Query: 447 VVLTDFDLS 455
+ L DF S
Sbjct: 208 IKLGDFGFS 216
|
Length = 478 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 41/173 (23%), Positives = 70/173 (40%), Gaps = 31/173 (17%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMK---AMEKSVML-----------NRNKVHRACIEREI 359
LG G G VHL E+ +L ++ + K L N+N + E +I
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 360 MSLLDHPFLPTLYASFQTSTHICLITDFCPGGEL------FALLDKQ-----------PM 402
+S L P + L +C+IT++ G+L L DK+ +
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 403 KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
S A ++ G++YL L ++RDL N L+ ++ + + DF +S
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 27/170 (15%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
+ PIKP+G G G V + E A+K + NR R E +++ LDH
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN-AFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 368 L--------PTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFR------EDSARFY 413
+ P +F + ++ + L+D +I R +D +++
Sbjct: 66 VIAIKDIMPPPHREAFND---VYIVYE---------LMDTDLHQIIRSSQTLSDDHCQYF 113
Query: 414 AAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQ 463
+++ GL+Y+H +++RDLKP N+LL + + + DF L+ TS K
Sbjct: 114 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 49/189 (25%), Positives = 82/189 (43%), Gaps = 35/189 (18%)
Query: 287 NSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELY-AMKAMEKSVML 345
++S I I+K+ G+GE G+ S L +L G E+ A+K ++
Sbjct: 2 DASCIKIEKVIGAGE--------------FGEVCSGRL-KLPGKREIPVAIKTLKAGYT- 45
Query: 346 NRNKVHRACI-EREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKI 404
K R + E IM DHP + L S + ++T++ G L A L
Sbjct: 46 --EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL------- 96
Query: 405 FREDSARFYAAEVV-------IGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457
R+ +F ++V G++YL +G ++RDL NIL+ + ++DF LS +
Sbjct: 97 -RKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155
Query: 458 TSCKPQVFY 466
P+ Y
Sbjct: 156 LEDDPEAAY 164
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 14/148 (9%)
Query: 314 LGCGDTGSVH--LVELQGAGELYAMKAM----EKSVMLNRNKVHRACIEREIMSLLDHPF 367
LG G+ G V + +++ A+K + EKSV R+++ R E EIM LD+P+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSV---RDEMMR---EAEIMHQLDNPY 56
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
+ + + + L+ + GG L L + +I + +V +G++YL
Sbjct: 57 IVRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMH-QVSMGMKYLEGK 114
Query: 428 GIIYRDLKPENILLQKDGHVVLTDFDLS 455
++RDL N+LL + ++DF LS
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLS 142
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 13/50 (26%), Positives = 30/50 (60%), Gaps = 1/50 (2%)
Query: 407 EDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVV-LTDFDLS 455
+ + + +++ G+ + H G+++RDLKP+N+L+ K ++ + D L
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 5/101 (4%)
Query: 357 REIMSLL---DHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFY 413
REI SLL +HP + L + + L+ +F +L +D P+ + Y
Sbjct: 47 REI-SLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSY 104
Query: 414 AAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDL 454
+++ G+ Y H +++RDLKP+N+L+ ++G + L DF L
Sbjct: 105 LYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGL 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 19/149 (12%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
+ IK L G G V + G + +K +K L IE ++ ++HP
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTL---------IEAMLLQNVNHPS 118
Query: 368 LPTLYASFQTSTHICLITDFCP--GGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEY 423
+ + + + C++ P +L+ L K+ P+ I D A +++ GL Y
Sbjct: 119 VIRMKDTLVSGAITCMVL---PHYSSDLYTYLTKRSRPLPI---DQALIIEKQILEGLRY 172
Query: 424 LHCLGIIYRDLKPENILLQKDGHVVLTDF 452
LH II+RD+K ENI + V + D
Sbjct: 173 LHAQRIIHRDVKTENIFINDVDQVCIGDL 201
|
Length = 357 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 4e-05
Identities = 42/151 (27%), Positives = 64/151 (42%), Gaps = 12/151 (7%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL--LDHPFLP 369
K LG G G V+L G A K ++ + +E EI L L H +
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 370 TLYASFQTSTH--ICLITDFCPGGELFALLDKQPMKIF---REDSARFYAAEVVIGLEYL 424
Y + + + ++ PGG + K +K + E R Y +++ G+ YL
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSV-----KDQLKAYGALTESVTRKYTRQILEGMSYL 122
Query: 425 HCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
H I++RD+K NIL G+V L DF S
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGAS 153
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 21/43 (48%), Positives = 28/43 (65%), Gaps = 1/43 (2%)
Query: 414 AAEVVIGLEYL-HCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
A V L YL L II+RD+KP NILL ++G++ L DF +S
Sbjct: 113 AVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 38/146 (26%), Positives = 60/146 (41%), Gaps = 5/146 (3%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYA 373
LG G G V+ + A+K +++ M +V E +M + HP L L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 374 SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRD 433
+IT+F G L L + + + A ++ +EYL I+RD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 434 LKPENILLQKDGHVVLTDFDLS-FMT 458
L N L+ ++ V + DF LS MT
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRLMT 155
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 7e-05
Identities = 28/100 (28%), Positives = 49/100 (49%), Gaps = 1/100 (1%)
Query: 356 EREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAA 415
E ++M L H L LYA + I ++T++ G L L + K R AA
Sbjct: 51 EAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 109
Query: 416 EVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
++ G+ Y+ + ++RDL+ NIL+ ++ + DF L+
Sbjct: 110 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 9e-05
Identities = 30/100 (30%), Positives = 45/100 (45%)
Query: 356 EREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAA 415
E +IM L HP L LYA I ++T+ G L L + + AA
Sbjct: 51 EAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA 110
Query: 416 EVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+V G+ YL I+RDL N+L+ ++ + DF L+
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 18/32 (56%), Positives = 22/32 (68%)
Query: 421 LEYLHCLGIIYRDLKPENILLQKDGHVVLTDF 452
L YLH GII+RD+K ENI L + + VL DF
Sbjct: 198 LAYLHGRGIIHRDVKTENIFLDEPENAVLGDF 229
|
Length = 392 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 37/155 (23%), Positives = 70/155 (45%), Gaps = 8/155 (5%)
Query: 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD 364
L ++ +KP+G G G V A+K + + N+ RA E +M ++
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN 81
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFR----EDSARFYAAEVVIG 420
H + L F + D + L+D ++ + + + +++ G
Sbjct: 82 HKNIIGLLNVFTPQKSLEEFQDVYI---VMELMDANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 421 LEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+++LH GII+RDLKP NI+++ D + + DF L+
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 37/147 (25%), Positives = 62/147 (42%), Gaps = 5/147 (3%)
Query: 309 KPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFL 368
K +K LG G G V + + ++ A+K ++ M V E +M L H L
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTM----SVQAFLEEANLMKTLQHDKL 63
Query: 369 PTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLG 428
LYA I +IT++ G L L ++A++ G+ Y+
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123
Query: 429 IIYRDLKPENILLQKDGHVVLTDFDLS 455
I+RDL+ N+L+ + + DF L+
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE-------IMSLL- 363
K LG G G V VE G + M+ +V + + H + ERE IMS L
Sbjct: 41 KTLGAGAFGKV--VEATAYGLSKSDAVMKVAVKMLKPTAHSS--EREALMSELKIMSHLG 96
Query: 364 DHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEY 423
+H + L + I +IT++C G+L L ++ + ++ +V G+ +
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 424 LHCLGIIYRDLKPENILLQKDGHVV-LTDFDLS 455
L I+RDL N+LL G +V + DF L+
Sbjct: 157 LASKNCIHRDLAARNVLLT-HGKIVKICDFGLA 188
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 30/101 (29%), Positives = 52/101 (51%), Gaps = 4/101 (3%)
Query: 357 REIMSL--LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYA 414
REI L L H + LY + + L+ ++C +L D I E + +
Sbjct: 48 REICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPE-IVKSFM 105
Query: 415 AEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+++ GL + H +++RDLKP+N+L+ K+G + L DF L+
Sbjct: 106 FQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 16/158 (10%)
Query: 312 KPLGCGDTGSVHLVELQ---GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFL 368
K LG G+ GSV +L G+ A+K M K + +++ E M DHP +
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 369 PTLYA-SFQTSTH-----ICLITDFCPGGELFALL-----DKQPMKIFREDSARFYAAEV 417
L F+ S+ +I F G+L + L P K+ + +F ++
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF-MVDI 122
Query: 418 VIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+G+EYL I+RDL N +L++D V + DF LS
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 32/127 (25%), Positives = 60/127 (47%), Gaps = 18/127 (14%)
Query: 356 EREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFRED------- 408
E ++ L H + TL+ T + L+ F LDK +K + +D
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLV---------FEYLDKD-LKQYMDDCGNIMSM 103
Query: 409 -SARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYH 467
+ + + +++ GL Y H +++RDLKP+N+L+ + G + L DF L+ S + + +
Sbjct: 104 HNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN 163
Query: 468 AHVNGFY 474
V +Y
Sbjct: 164 EVVTLWY 170
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 40/147 (27%), Positives = 65/147 (44%), Gaps = 6/147 (4%)
Query: 309 KPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFL 368
K +K LG G G V + G ++ A+K++++ M E +M L HP L
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGHTKV-AIKSLKQGSM----SPEAFLAEANLMKQLQHPRL 63
Query: 369 PTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLG 428
LYA T I +IT++ G L L + AA++ G+ ++
Sbjct: 64 VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN 122
Query: 429 IIYRDLKPENILLQKDGHVVLTDFDLS 455
I+RDL+ NIL+ + + DF L+
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 20/46 (43%), Positives = 30/46 (65%), Gaps = 6/46 (13%)
Query: 420 GLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDL------SFMTS 459
G+++LH GII+RDLKP NI+++ D + + DF L SFM +
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 175
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 39/159 (24%), Positives = 68/159 (42%), Gaps = 21/159 (13%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRA---------CIERE 358
+P +P+G G G V V G+ A+K M V N R
Sbjct: 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPN-VFQNLVSCKRVFRELKMLCFFKHDN 60
Query: 359 IMSLLD--HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAE 416
++S LD P + I ++T+ ++ QP+ D + + +
Sbjct: 61 VLSALDILQPPHIDPF------EEIYVVTELMQSDLHKIIVSPQPLS---SDHVKVFLYQ 111
Query: 417 VVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
++ GL+YLH GI++RD+KP N+L+ + + + DF L+
Sbjct: 112 ILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 16/156 (10%)
Query: 314 LGCGDTGSVHLVELQ---GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPT 370
LG G+ GSV +L+ G+ + A+K M K+ + + + + E M DHP +
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVK-MLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 371 LYA-SFQTSTHICL-----ITDFCPGGELFALL-----DKQPMKIFREDSARFYAAEVVI 419
L S ++ L I F G+L L ++P + + RF ++
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF-MIDIAS 124
Query: 420 GLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
G+EYL I+RDL N +L ++ V + DF LS
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 9/165 (5%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGE----LYAMKAMEKSVMLNRNKVHRACIEREIMSLL 363
K +K LG G G+V+ GE A+K + ++ NK E +M+ +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANK--EILDEAYVMAGV 66
Query: 364 DHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEY 423
P++ L TST + L+T P G L + + +I +D + ++ G+ Y
Sbjct: 67 GSPYVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLN-WCVQIAKGMSY 124
Query: 424 LHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHA 468
L + +++RDL N+L++ HV +TDF L+ + + YHA
Sbjct: 125 LEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID-ETEYHA 168
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 29/100 (29%), Positives = 45/100 (45%)
Query: 356 EREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAA 415
E + + L H L +L+A + +IT+ G L A L ++ S A
Sbjct: 52 EVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMAC 111
Query: 416 EVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+V G+ YL I+RDL NIL+ +D + DF L+
Sbjct: 112 QVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLA 151
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 32/117 (27%), Positives = 50/117 (42%), Gaps = 26/117 (22%)
Query: 364 DHPFLPTLYASFQTSTHIC-----------LITDFCPGGELFALLDKQPMKIFRE----- 407
D P A F+ T +C L + P G LFA+ + P + RE
Sbjct: 14 DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAAD 73
Query: 408 ------DSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG---HVVLTDFDLS 455
++ R +V+ L H GI++RDLKP+NI++ + G H + DF +
Sbjct: 74 GALPAGETGRL-MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIG 129
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 37/155 (23%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD 364
L ++ +KP+G G G V G A+K + + N+ RA E ++ ++
Sbjct: 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVN 78
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFRED----SARFYAAEVVIG 420
H + +L F + +F + L+D ++ + + +++ G
Sbjct: 79 HKNIISLLNVFTPQKSL---EEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCG 135
Query: 421 LEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+++LH GII+RDLKP NI+++ D + + DF L+
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 26/100 (26%), Positives = 48/100 (48%), Gaps = 1/100 (1%)
Query: 356 EREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAA 415
E I+ DHP + L I ++ + PGG+ + L K+ ++ + +F A
Sbjct: 42 EARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF-AL 100
Query: 416 EVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ G+ YL I+RDL N L+ ++ + ++DF +S
Sbjct: 101 DAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 6/145 (4%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPT 370
IK LG G G V + G ++ A+K ++ M + + A +IM L H L
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPESFLEEA----QIMKKLRHDKLVQ 65
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGII 430
LYA + I ++T++ G L L + + + AA+V G+ Y+ + I
Sbjct: 66 LYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 124
Query: 431 YRDLKPENILLQKDGHVVLTDFDLS 455
+RDL+ NIL+ + DF L+
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 22/64 (34%), Positives = 36/64 (56%)
Query: 411 RFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHV 470
R + +++ GL Y+H I++RDLKP+N+L+ G + L DF L+ S Q + V
Sbjct: 106 RLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV 165
Query: 471 NGFY 474
+Y
Sbjct: 166 TLWY 169
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 22/64 (34%), Positives = 35/64 (54%), Gaps = 1/64 (1%)
Query: 392 ELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTD 451
+L LL+ + F ED + + +++ GL Y H ++RD+K NILL G + L D
Sbjct: 101 DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159
Query: 452 FDLS 455
F L+
Sbjct: 160 FGLA 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 32/103 (31%), Positives = 48/103 (46%), Gaps = 15/103 (14%)
Query: 356 EREIMSLLDHPFLPTLYASFQTSTHICLI-----TD-FCPGGELFALLDKQPMKIFREDS 409
E I+ ++HP + L +F + CLI TD +C L K+ + I +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYC------YLAAKRNIAICDILA 186
Query: 410 ARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDF 452
V+ ++YLH II+RD+K ENI + G V L DF
Sbjct: 187 IE---RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDF 226
|
Length = 391 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 32/127 (25%), Positives = 60/127 (47%), Gaps = 18/127 (14%)
Query: 356 EREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFRED------- 408
E ++ L H + TL+ T + L+ F LDK +K + +D
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLV---------FEYLDKD-LKQYLDDCGNSINM 103
Query: 409 -SARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYH 467
+ + + +++ GL Y H +++RDLKP+N+L+ + G + L DF L+ S + + +
Sbjct: 104 HNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN 163
Query: 468 AHVNGFY 474
V +Y
Sbjct: 164 EVVTLWY 170
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 39/142 (27%), Positives = 65/142 (45%), Gaps = 6/142 (4%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYA 373
LG G G V + G ++ A+K ++ M+ + A +IM L H L LYA
Sbjct: 14 LGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMPEAFLQEA----QIMKKLRHDKLVPLYA 68
Query: 374 SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRD 433
+ I ++T+F G L L + K + AA++ G+ Y+ + I+RD
Sbjct: 69 VV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 434 LKPENILLQKDGHVVLTDFDLS 455
L+ NIL+ + + DF L+
Sbjct: 128 LRAANILVGDNLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 42/151 (27%), Positives = 64/151 (42%), Gaps = 12/151 (7%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL--LDHPFLP 369
K LG G G V+L G A+K ++ +E EI L L H +
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 370 TLYASFQTSTH--ICLITDFCPGGELFALLDKQPMKIF---REDSARFYAAEVVIGLEYL 424
Y + + + + PGG + K +K + E+ R Y +++ G+ YL
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSI-----KDQLKSYGALTENVTRKYTRQILEGVSYL 122
Query: 425 HCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
H I++RD+K NIL G+V L DF S
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGAS 153
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 29/103 (28%), Positives = 40/103 (38%), Gaps = 15/103 (14%)
Query: 363 LDHPFLPTLYASFQTSTHICLITDFCPGGELFALL---------DKQPMKIFREDSARFY 413
L+HP + S L+ +FCP G+L L Q + R
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR------M 105
Query: 414 AAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSF 456
A EV GL +LH I+ DL N L D V + D+ L+
Sbjct: 106 ACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLAL 148
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 20/66 (30%), Positives = 38/66 (57%)
Query: 409 SARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHA 468
+ + + +++ GL Y H I++RDLKP+N+L+ + G + L DF L+ S + + +
Sbjct: 104 NVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNE 163
Query: 469 HVNGFY 474
V +Y
Sbjct: 164 VVTLWY 169
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 15/45 (33%), Positives = 30/45 (66%)
Query: 411 RFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ + +++ GL+Y+H +++RDLKP N+L+ D + + DF L+
Sbjct: 108 QSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLA 152
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 8e-04
Identities = 40/149 (26%), Positives = 69/149 (46%), Gaps = 14/149 (9%)
Query: 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD 364
L+ ++ IK +G G G V LV+ + E + KA+ + R K + IE +M L
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREK-SQLVIEVNVMRELK 70
Query: 365 HPFLPTLYASF--QTSTHICLITDFCPGGELFALLDKQPMKIF---REDSARFYAAEVVI 419
H + F + + + ++ +FC G+L + K K+F E + +++
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQK-CYKMFGKIEEHAIVDITRQLLH 129
Query: 420 GLEYLHCLG-------IIYRDLKPENILL 441
L Y H L +++RDLKP+NI L
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFL 158
|
Length = 1021 |
| >gnl|CDD|232884 TIGR00229, sensory_box, PAS domain S-box | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.001
Identities = 31/137 (22%), Positives = 53/137 (38%), Gaps = 42/137 (30%)
Query: 92 IIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYG 151
I++ + +F E+ Y+ EE++GRN L E REE+ R
Sbjct: 25 ILYVNPAFEEIFGYSAEELIGRNVLELIPEED-REEVRER-------------------- 63
Query: 152 VYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKG 211
+ LE R+ V E+R + K G + W + P+R + G
Sbjct: 64 -----IERRLE---------GEREPVSEERRV------RRKDGSEIWVEVSVSPIRTNGG 103
Query: 212 ELQYFIGVQLDGSDHVE 228
EL +G+ D ++ +
Sbjct: 104 EL-GVVGIVRDITERKQ 119
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator [Regulatory functions, Small molecule interactions]. Length = 124 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 17/55 (30%), Positives = 31/55 (56%), Gaps = 1/55 (1%)
Query: 414 AAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS-FMTSCKPQVFYH 467
A +++ ++Y+H GII+RD+K EN+L+ + L DF + F F++
Sbjct: 266 ARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320
|
Length = 461 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 30/107 (28%), Positives = 49/107 (45%), Gaps = 15/107 (14%)
Query: 356 EREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAA 415
E IM DHP + L S + +IT+F G L + L R++ +F
Sbjct: 55 EASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFL--------RQNDGQFTVI 106
Query: 416 EVV-------IGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
++V G++YL + ++RDL NIL+ + ++DF LS
Sbjct: 107 QLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS 153
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|131984 TIGR02938, nifL_nitrog, nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 33/150 (22%), Positives = 58/150 (38%), Gaps = 47/150 (31%)
Query: 92 IIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYG 151
I++A+D+F +T YT+EEI+G+N S L E + ALW
Sbjct: 26 ILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPE--------------VYQALWGS--- 68
Query: 152 VYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKG 211
+ EQ+ +L+N K G+ + + P+ + G
Sbjct: 69 -------------------------LAEQKPWAGKLLNRRKDGELYLAELTVAPVLNEAG 103
Query: 212 ELQYFIGVQLDGSDHVEPLRNRLSEKTEQQ 241
E +F+G+ D ++ +RL + Q
Sbjct: 104 ETTHFLGMHRDITE-----LHRLEQVVANQ 128
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes [Central intermediary metabolism, Nitrogen fixation, Regulatory functions, Protein interactions]. Length = 494 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 42/158 (26%), Positives = 69/158 (43%), Gaps = 17/158 (10%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVML---NRNKVHRACIEREIMSLLDHPFL 368
K LG G+ GSV +E Q + +K K++ + R+++ E M DHP +
Sbjct: 5 KTLGEGEFGSV--MEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62
Query: 369 PTLYA-SFQTSTH-----ICLITDFCPGGEL-----FALLDKQPMKIFREDSARFYAAEV 417
L QT +I F G+L ++ L P + + +F ++
Sbjct: 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF-MTDI 121
Query: 418 VIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
G+EYL I+RDL N +L ++ +V + DF LS
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 37/163 (22%), Positives = 59/163 (36%), Gaps = 21/163 (12%)
Query: 311 IKPLGCGDTGSVHLVEL-----QGAGELYAMKAM-EKSVMLNRNKVHRACIEREIMSLLD 364
+ LG G G V L E + EL A+K + E + R R E E+++
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFER---EAELLTNFQ 66
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGEL------------FALLDKQPMKIFREDSARF 412
H + Y ++ ++ G+L F PM
Sbjct: 67 HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 413 YAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
A ++ G+ YL ++RDL N L+ D V + DF +S
Sbjct: 127 IAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 35/132 (26%), Positives = 60/132 (45%), Gaps = 5/132 (3%)
Query: 321 SVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE-IMS-LLDHPFLPTLYASFQTS 378
SV+L G L ++ + + N + H ++ E ++S HP + T + F T
Sbjct: 15 SVYLARHTPTGTLVTVRITD---LENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG 71
Query: 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPEN 438
+ + +I+ F G +LL + E + GL YLH G I+R++K +
Sbjct: 72 SWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASH 131
Query: 439 ILLQKDGHVVLT 450
IL+ DG V L+
Sbjct: 132 ILISGDGLVSLS 143
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 19/55 (34%), Positives = 32/55 (58%)
Query: 420 GLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFY 474
GL Y H +++RDLKP+N+L+ + G + L DF L+ S + + + V +Y
Sbjct: 115 GLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWY 169
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 32/136 (23%), Positives = 58/136 (42%), Gaps = 1/136 (0%)
Query: 315 GCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYAS 374
G D +V+L + GE ++ + N E + L +HP + A+
Sbjct: 9 GFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQG-ELHVSKLFNHPNIVPYRAT 67
Query: 375 FQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDL 434
F + ++T F G L+ M E + + V+ L+Y+H +G ++R +
Sbjct: 68 FIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSV 127
Query: 435 KPENILLQKDGHVVLT 450
K +IL+ DG V L+
Sbjct: 128 KASHILISVDGKVYLS 143
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|238075 cd00130, PAS, PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Score = 37.2 bits (86), Expect = 0.002
Identities = 25/143 (17%), Positives = 50/143 (34%), Gaps = 45/143 (31%)
Query: 80 FVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFM 139
++ D D I++A+ + +L Y+ EE++G++ L + E
Sbjct: 5 VIVLDL---DGRILYANPAAEQLLGYSPEELIGKS-----LLDLIHPEDR---------- 46
Query: 140 LYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWN 199
+ ++ + + +T+++ K G W
Sbjct: 47 ---------------------------EELRERLENLLSGGEPVTLEVRLRRKDGSVIWV 79
Query: 200 LFHLQPMRDHKGELQYFIGVQLD 222
L L P+RD GE+ +GV D
Sbjct: 80 LVSLTPIRDEGGEVIGLLGVVRD 102
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. Length = 103 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 41/149 (27%), Positives = 64/149 (42%), Gaps = 16/149 (10%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTL 371
K LG G G V + ++ A+K M+ M V E +M L H L L
Sbjct: 12 KKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKL 66
Query: 372 YASFQTSTHICLITDFCPGGELFALL-----DKQPMKIFREDSARFYAAEVVIGLEYLHC 426
+A T I +IT+F G L L KQP+ + ++A++ G+ ++
Sbjct: 67 HAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID-----FSAQIAEGMAFIEQ 120
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDFDLS 455
I+RDL+ NIL+ + DF L+
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 16/45 (35%), Positives = 29/45 (64%)
Query: 411 RFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+F+ +++ L+Y+H + +RDLKP+NIL D + + DF L+
Sbjct: 106 QFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.003
Identities = 15/36 (41%), Positives = 25/36 (69%)
Query: 420 GLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
GL+Y+H +++RDLKP N+LL + + + DF L+
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA 153
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 19/62 (30%), Positives = 35/62 (56%)
Query: 413 YAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNG 472
Y +++ G+ + H +++RDLKP+N+L+ G + L DF L+ +V+ H V
Sbjct: 106 YLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTL 165
Query: 473 FY 474
+Y
Sbjct: 166 WY 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.003
Identities = 37/154 (24%), Positives = 66/154 (42%), Gaps = 25/154 (16%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE--IMSLLDH--P 366
IK L G T V+L+ + Y +K +N ++ A ERE I+ LL
Sbjct: 3 IKLLKGGLTNRVYLLGTKDED--YVLK-------INPSREKGADREREVAILQLLARKGL 53
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
+P + AS ++ L+ ++ G L + +++ I + AE+ L LH
Sbjct: 54 PVPKVLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQ------LAEL---LAKLHQ 104
Query: 427 L---GIIYRDLKPENILLQKDGHVVLTDFDLSFM 457
L + + DL P NIL+ + + D++ +
Sbjct: 105 LPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.004
Identities = 39/174 (22%), Positives = 63/174 (36%), Gaps = 37/174 (21%)
Query: 312 KPLGCGDTGSVHLVELQGAGE----------------LYAMKAMEKSVMLNRNKVHRACI 355
+ LG G G VHL E G + L A+K + + R
Sbjct: 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA----SDNAREDF 66
Query: 356 ERE--IMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFY 413
+E I+S L P + L +C+I ++ G+L L K +
Sbjct: 67 LKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKH---VAETSGLACN 123
Query: 414 ------------AAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
A ++ G+ YL L ++RDL N L+ K+ + + DF +S
Sbjct: 124 SKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 489 | |||
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.98 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.97 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.97 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.97 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.97 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.97 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.97 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.97 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.97 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.96 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.96 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.96 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.96 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.96 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.96 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.96 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.96 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.96 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.96 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.96 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.96 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.96 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.96 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.96 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.96 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.96 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.96 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.96 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.96 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.96 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.96 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.96 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.96 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.95 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.95 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.95 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.95 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.95 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.95 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.95 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.95 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.95 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.95 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.95 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.95 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.95 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.95 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.95 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.95 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.95 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.95 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.95 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.95 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.94 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.94 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.94 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.94 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.94 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.94 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.94 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.94 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.94 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.94 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.94 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.94 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.94 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.94 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.94 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.94 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.94 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.94 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.94 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.94 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.94 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.94 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.94 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.94 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.94 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.94 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.94 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.94 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.94 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.94 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.94 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.94 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.94 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.94 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.94 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.94 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.94 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.94 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.94 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.94 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.94 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.94 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.94 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.94 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.94 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.94 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.94 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.94 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.93 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.93 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.93 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.93 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.93 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.93 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.93 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.93 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.93 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.93 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.93 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.93 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.93 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.93 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.93 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.93 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.93 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.93 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.93 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.93 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.93 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.93 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.93 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.93 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.93 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.93 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.93 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.93 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.93 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.93 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.93 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.93 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.93 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.93 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.93 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.93 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.93 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.93 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.93 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.93 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.93 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.93 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.93 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.93 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.93 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.93 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.93 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.93 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.93 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.93 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.93 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.93 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.93 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.93 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.93 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.93 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.93 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.92 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.92 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.92 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.92 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.92 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.92 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.92 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.92 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.92 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.92 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.92 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.92 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.92 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.92 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.92 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.92 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.92 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.92 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.92 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.92 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.92 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.92 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.92 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.92 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.92 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.92 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.92 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.92 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.92 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.92 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.91 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.91 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.91 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.91 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.91 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.91 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.91 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.91 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.91 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.91 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.91 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.91 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.91 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.91 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.91 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.9 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.9 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.9 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.9 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.89 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.89 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.89 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.88 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.88 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.88 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.87 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.87 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.87 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.86 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.86 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.86 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.86 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.84 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.83 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.72 | |
| PF13426 | 104 | PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_ | 99.72 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.62 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.61 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.52 | |
| PRK13557 | 540 | histidine kinase; Provisional | 99.52 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.51 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| PRK13559 | 361 | hypothetical protein; Provisional | 99.48 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.48 | |
| PF08448 | 110 | PAS_4: PAS fold; InterPro: IPR013656 The PAS fold | 99.47 | |
| PF00989 | 113 | PAS: PAS fold; InterPro: IPR013767 PAS domains are | 99.46 | |
| KOG0501 | 971 | consensus K+-channel KCNQ [Inorganic ion transport | 99.44 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.37 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.36 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.28 | |
| PRK11091 | 779 | aerobic respiration control sensor protein ArcB; P | 99.27 | |
| TIGR02040 | 442 | PpsR-CrtJ transcriptional regulator PpsR. This mod | 99.26 | |
| PRK13558 | 665 | bacterio-opsin activator; Provisional | 99.25 | |
| PRK13560 | 807 | hypothetical protein; Provisional | 99.24 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.24 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.21 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.2 | |
| TIGR02938 | 494 | nifL_nitrog nitrogen fixation negative regulator N | 99.2 | |
| PRK10060 | 663 | RNase II stability modulator; Provisional | 99.19 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.19 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.18 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.16 | |
| PRK11359 | 799 | cyclic-di-GMP phosphodiesterase; Provisional | 99.13 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.1 | |
| PRK09776 | 1092 | putative diguanylate cyclase; Provisional | 99.1 | |
| PRK09776 | 1092 | putative diguanylate cyclase; Provisional | 99.06 | |
| TIGR00229 | 124 | sensory_box PAS domain S-box. The PAS domain was p | 99.06 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.99 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.98 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.96 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.92 | |
| PF08447 | 91 | PAS_3: PAS fold; InterPro: IPR013655 The PAS fold | 98.9 | |
| PRK13560 | 807 | hypothetical protein; Provisional | 98.89 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.88 | |
| cd00130 | 103 | PAS PAS domain; PAS motifs appear in archaea, euba | 98.83 | |
| PRK11073 | 348 | glnL nitrogen regulation protein NR(II); Provision | 98.78 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.78 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.72 | |
| PRK11360 | 607 | sensory histidine kinase AtoS; Provisional | 98.69 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.67 | |
| PRK11359 | 799 | cyclic-di-GMP phosphodiesterase; Provisional | 98.66 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.66 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.63 | |
| TIGR02966 | 333 | phoR_proteo phosphate regulon sensor kinase PhoR. | 98.62 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.59 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.55 | |
| TIGR02040 | 442 | PpsR-CrtJ transcriptional regulator PpsR. This mod | 98.51 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.43 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.38 | |
| KOG1229 | 775 | consensus 3'5'-cyclic nucleotide phosphodiesterase | 98.34 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.3 | |
| PF13596 | 106 | PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D. | 98.27 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.26 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.26 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.25 | |
| TIGR02938 | 494 | nifL_nitrog nitrogen fixation negative regulator N | 98.18 | |
| PF12860 | 115 | PAS_7: PAS fold | 98.18 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.13 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.12 | |
| COG2202 | 232 | AtoS FOG: PAS/PAC domain [Signal transduction mech | 98.06 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.03 | |
| PRK11006 | 430 | phoR phosphate regulon sensor protein; Provisional | 98.02 | |
| COG5002 | 459 | VicK Signal transduction histidine kinase [Signal | 98.0 | |
| PRK10820 | 520 | DNA-binding transcriptional regulator TyrR; Provis | 97.97 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.95 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.93 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 97.87 | |
| PF14598 | 111 | PAS_11: PAS domain; PDB: 1P97_A 3F1O_A 2A24_A 3H7W | 97.78 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.75 | |
| PRK11086 | 542 | sensory histidine kinase DcuS; Provisional | 97.64 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.59 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.58 | |
| PRK11388 | 638 | DNA-binding transcriptional regulator DhaR; Provis | 97.54 |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=304.65 Aligned_cols=184 Identities=41% Similarity=0.714 Sum_probs=167.7
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
...++|++++.||+|+||+|+.++.+.|++.||+|+++|......+.++....|..||..++||+||.++..|++...+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 45678999999999999999999999999999999999998888888999999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC---
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS--- 459 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~--- 459 (489)
+|+||+.||+|+.+|.++ +.++|+.+++++++|+.||.|||++|||||||||+|||||..|+|+|+|||+|+...
T Consensus 102 lVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 999999999999999886 449999999999999999999999999999999999999999999999999996321
Q ss_pred ------CC-Ccee-----------ecccccchHHHHHHHHhCCcccC
Q 042772 460 ------CK-PQVF-----------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ------~~-~~~~-----------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|. +++. ...|-|++|.++|+|++|..||.
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~ 226 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY 226 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc
Confidence 11 2222 23477999999999999999996
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=298.70 Aligned_cols=181 Identities=27% Similarity=0.462 Sum_probs=162.3
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|...+.||+|+||+||+|.++.++..||||.+.+... ..+.++.+..|+.+|+.++|||||.+++++..++.+|+|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4679999999999999999999999999999999987754 566778888999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC------CcEEEEecCCcccc
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD------GHVVLTDFDLSFMT 458 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~------g~vKL~DFGlS~~~ 458 (489)
||||.||+|.+|+.+.. .+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+.+
T Consensus 88 MEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 99999999999999874 59999999999999999999999999999999999999865 46899999999865
Q ss_pred C--------CC------Ccee------ecccccchHHHHHHHHhCCcccC
Q 042772 459 S--------CK------PQVF------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~--------~~------~~~~------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. |. |+++ ..+|.|+.|.+++++++|..||.
T Consensus 166 ~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 166 QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 4 22 2222 34588999999999999999996
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=298.16 Aligned_cols=178 Identities=58% Similarity=1.026 Sum_probs=169.4
Q ss_pred CCCCCCCCCchhHHHHhhc-CCCccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHH
Q 042772 279 FPRPHKRDNSSWIAIQKIT-GSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIER 357 (489)
Q Consensus 279 ~p~p~~~~~~s~~~~~~~~-~~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~ 357 (489)
...|+...+..|.++..+. ..+..+++.+|++++.||.|.-|+||+|+.++++..+|+|++++..+..++.+.++..|.
T Consensus 49 ~~kph~~~d~~w~a~~~~~~~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~ 128 (459)
T KOG0610|consen 49 GNKPHKGNDVRWEAISSIRNSKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTER 128 (459)
T ss_pred cCCCCCCCchhhhhhccccccCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHH
Confidence 4568888888898888776 467788999999999999999999999999999999999999999998899999999999
Q ss_pred HHHHhCCCCCcceeeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 042772 358 EIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPE 437 (489)
Q Consensus 358 ~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~ 437 (489)
+||+.++||++++||..|+++...|++||||+||+|..++++++.+.+++..+++++++|+.||+|||.+|||+|||||+
T Consensus 129 eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPE 208 (459)
T KOG0610|consen 129 EILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPE 208 (459)
T ss_pred HHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CEEEecCCcEEEEecCCcc
Q 042772 438 NILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 438 NILld~~g~vKL~DFGlS~ 456 (489)
||||.++|+|.|+||.+|.
T Consensus 209 NILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 209 NILVREDGHIMLSDFDLSL 227 (459)
T ss_pred eeEEecCCcEEeeeccccc
Confidence 9999999999999999984
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=289.05 Aligned_cols=184 Identities=40% Similarity=0.752 Sum_probs=167.4
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
..+++|+.++.||.|+||+|.+++.+.+|..||+|++++........++...+|..+|+.+.||+++++++.|.+..++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 45678999999999999999999999999999999999988878888899999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC---
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS--- 459 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~--- 459 (489)
+||||++||.|+++|++. +.+++..++++++||+.||+|||+++|++|||||+|||||.+|++||+|||+|....
T Consensus 121 mvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT 198 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRT 198 (355)
T ss_pred EEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCcE
Confidence 999999999999999986 449999999999999999999999999999999999999999999999999996433
Q ss_pred ----CCCceeecc-----------cccchHHHHHHHHhCCcccC
Q 042772 460 ----CKPQVFYHA-----------HVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----~~~~~~~~~-----------~v~s~g~~a~e~~~G~lpY~ 488 (489)
..|+++.++ |-|++|...|||+.|..||-
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~ 242 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFY 242 (355)
T ss_pred EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCc
Confidence 234444333 66888999999999999984
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=304.05 Aligned_cols=155 Identities=41% Similarity=0.746 Sum_probs=149.2
Q ss_pred CccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 300 GEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 300 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
...++.++|.++++||+|+||.||+|+.+.||..+|+|+++++.+...+.+..++.|..+|...++|+||++|.+|++..
T Consensus 135 R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 135 RTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred cccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 33668899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
++||||||+|||++..+|.+. ++|+++.+++++++++.|++.||+.|+|||||||+|+|||..||+||+|||||.
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred eeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccc
Confidence 999999999999999999886 569999999999999999999999999999999999999999999999999984
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=301.50 Aligned_cols=181 Identities=29% Similarity=0.479 Sum_probs=167.3
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
.+|...+.||+|+|++||.+++..+|+.||+|++.+..+......+++.+|++|-+.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 46999999999999999999999999999999999988888888999999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
|+|+.++|..+++++ ++++|.+++.++.||+.||.|||+++|+|||||..|+|++++.+|||+|||||+.+..
T Consensus 98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK 175 (592)
T ss_pred EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence 999999999999965 6699999999999999999999999999999999999999999999999999976541
Q ss_pred -----CCceee-----------cccccchHHHHHHHHhCCcccC
Q 042772 461 -----KPQVFY-----------HAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -----~~~~~~-----------~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.|.++. ..|+|+.|+++|.+++|..||.
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe 219 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE 219 (592)
T ss_pred ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc
Confidence 233332 3389999999999999999996
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=290.45 Aligned_cols=182 Identities=30% Similarity=0.493 Sum_probs=154.9
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccc----hHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN----RNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH 380 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 380 (489)
.+.|-+.+.||+|+||.|.+|..+.||+.||||++++..... ......+.+|++||++|+|||||+++++|.....
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 356889999999999999999999999999999998876543 2234456789999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC---CcEEEEecCCccc
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD---GHVVLTDFDLSFM 457 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~---g~vKL~DFGlS~~ 457 (489)
.|+||||+.||+|++++..+ +.+.++.-..++.|++.|+.|||++||+||||||+|||+..+ ..+||+|||+|..
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred eEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 99999999999999999887 448999999999999999999999999999999999999765 7899999999975
Q ss_pred cC--------C------CCceee---------cccccchHHHHHHHHhCCcccC
Q 042772 458 TS--------C------KPQVFY---------HAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 458 ~~--------~------~~~~~~---------~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.. | +|+++. ..|+|++|++++..++|.+||.
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS 382 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFS 382 (475)
T ss_pred cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcc
Confidence 53 2 233221 2266777777777777777774
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=297.20 Aligned_cols=185 Identities=37% Similarity=0.577 Sum_probs=167.7
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCe
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTH 380 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~ 380 (489)
.....+|.+.+.||.|+|++|++|..+.+++.||||++.+......+.++.+.+|..+|.+| .||.|++|+-.|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 44567899999999999999999999999999999999999888888889999999999999 79999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
+|+|+||+++|+|.++|++. +.|++..++++++||+.||+|||++|||||||||+|||||+++++||+|||.|..+..
T Consensus 149 LYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999999999987 4599999999999999999999999999999999999999999999999999865431
Q ss_pred C----------------------------------CceeecccccchHHHHHHHHhCCcccC
Q 042772 461 K----------------------------------PQVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ~----------------------------------~~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. ......+|+|.+|+++|.|+.|..||-
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFr 288 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFR 288 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCc
Confidence 0 111234488999999999999999984
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=283.16 Aligned_cols=184 Identities=27% Similarity=0.446 Sum_probs=163.4
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC-e
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST-H 380 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-~ 380 (489)
.+.+++.+.++.||+|..|+||+|.++.|++.+|+|++... .+....+++.+|+++++.++||+||.+|++|..+. .
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 45667899999999999999999999999999999999433 35666788999999999999999999999999998 5
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC-LGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
++|+||||.+|+|.++++.. +.++|.....++.+|+.||.|||. ++||||||||+|||++..|.|||||||.|..+.
T Consensus 153 isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred EEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 99999999999999999876 458999999999999999999995 999999999999999999999999999986332
Q ss_pred -------------CCC------ceeecccccchHHHHHHHHhCCcccCC
Q 042772 460 -------------CKP------QVFYHAHVNGFYFIMYKWLTGYFTYVP 489 (489)
Q Consensus 460 -------------~~~------~~~~~~~v~s~g~~a~e~~~G~lpY~~ 489 (489)
-.| .+-..+|+|++|..+.|+++|..||.|
T Consensus 231 nS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~ 279 (364)
T KOG0581|consen 231 NSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPP 279 (364)
T ss_pred hhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCC
Confidence 112 222356999999999999999999985
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=285.93 Aligned_cols=183 Identities=25% Similarity=0.363 Sum_probs=157.8
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC--CeE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS--THI 381 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~ 381 (489)
..+.|+.++.||+|+||.||+|++..||+.||+|.+..... .........+|+.||++|+||||++|.+..... ..+
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 34679999999999999999999999999999999976643 344556677899999999999999999988876 689
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK 461 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~ 461 (489)
|||+|||++ +|.-++... .-.|++.++..++.||+.||+|||++||+|||||.+|||||.+|.+||+|||||++....
T Consensus 194 YlVFeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEEecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 999999965 999888764 344999999999999999999999999999999999999999999999999999987766
Q ss_pred CceeecccccchHHHHHHHHhCCcccCC
Q 042772 462 PQVFYHAHVNGFYFIMYKWLTGYFTYVP 489 (489)
Q Consensus 462 ~~~~~~~~v~s~g~~a~e~~~G~lpY~~ 489 (489)
....+...|.+++|.+||+++|..-|++
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~ 299 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGT 299 (560)
T ss_pred CCcccccceEEeeccChHHhcCCccccc
Confidence 5555666677777777777777766653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=272.50 Aligned_cols=180 Identities=22% Similarity=0.323 Sum_probs=153.8
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
+.|+.+..+|+|+||.||+|+++.||+.||||.+..+. .++.-.+-..+|+.+|++++|||+|.++++|.....++||+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 46888999999999999999999999999999986442 23444456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCCC---
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKP--- 462 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~~--- 462 (489)
|||+. ++.+-|++.+.+ ++++.+..++.|++.|+.|+|+++++||||||+||||+.+|.+||||||+|+.+..+.
T Consensus 81 E~~dh-TvL~eLe~~p~G-~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNG-VPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred eecch-HHHHHHHhccCC-CCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 99965 788888887765 7999999999999999999999999999999999999999999999999999877432
Q ss_pred -------------------ceeecccccchHHHHHHHHhCCcccC
Q 042772 463 -------------------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 463 -------------------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
++-.+.|+|+.|++.-|+++|..+|.
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~P 203 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWP 203 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCC
Confidence 22234466777777777777776664
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=293.21 Aligned_cols=185 Identities=39% Similarity=0.719 Sum_probs=165.4
Q ss_pred ccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCC
Q 042772 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTST 379 (489)
Q Consensus 301 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~ 379 (489)
..+++++|+++++||+|+||+|++++.+.+++.||||+++|.....++.+.....|..|+.... ||+++.++.+|++..
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4788999999999999999999999999999999999999999999999999999999998885 999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
++|+||||+.||++..+.+ .+.|++..+++|+++|+.||.|||++||||||||.+|||+|.+|++||+|||+++...
T Consensus 443 ~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred eEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999999999544433 2559999999999999999999999999999999999999999999999999986321
Q ss_pred ---------CC-Ccee-----------ecccccchHHHHHHHHhCCcccC
Q 042772 460 ---------CK-PQVF-----------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---------~~-~~~~-----------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|. |+++ ...|-|++|+.+|||++|..||.
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~ 569 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP 569 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC
Confidence 22 2222 22266899999999999999996
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=280.09 Aligned_cols=184 Identities=31% Similarity=0.522 Sum_probs=161.1
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeeccccc-ch-HHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCC
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVML-NR-NKVHRACIEREIMSLLD-HPFLPTLYASFQTST 379 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~-~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~ 379 (489)
...+.|.+.+.||+|+||+|++|.+..++..||+|++++.... .. ...+.+.+|+.+++.+. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456899999999999999999999999999999988765322 11 34456678999999998 999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC-CcEEEEecCCcccc
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD-GHVVLTDFDLSFMT 458 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~-g~vKL~DFGlS~~~ 458 (489)
.+|+|||||.||+|++++... +.+.|..++.++.|++.|++|||++||+||||||+|||++.+ +.+||+|||+|...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 999999999999999999984 458999999999999999999999999999999999999999 99999999999855
Q ss_pred -C--------C------C-------C-ceeecccccchHHHHHHHHhCCcccC
Q 042772 459 -S--------C------K-------P-QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 -~--------~------~-------~-~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. + + + -.-..+|+|++|.+++.|++|.+||.
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~ 224 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFD 224 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 1 1 1 1 11245699999999999999999996
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=275.21 Aligned_cols=182 Identities=27% Similarity=0.509 Sum_probs=166.0
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++.+.||.|.||+|-+|.....|+.||||.+.+....+..++-.+++|++||+.|+||||+.+|.+|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 47899999999999999999999999999999999999988888999999999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----- 459 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----- 459 (489)
|||..+|+|++|+.+.. .|++.+++.++.||+.|+.|+|+++++|||||.+|||+|.|+.+||+|||+|....
T Consensus 132 MEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFL 209 (668)
T ss_pred EEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHH
Confidence 99999999999999874 49999999999999999999999999999999999999999999999999995322
Q ss_pred ---CC------Ccee-------ecccccchHHHHHHHHhCCcccC
Q 042772 460 ---CK------PQVF-------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---~~------~~~~-------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|. |+.. ...|.|++|+.+|.+..|.+||+
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFD 254 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFD 254 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccC
Confidence 21 2211 22377999999999999999996
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-33 Score=271.76 Aligned_cols=156 Identities=26% Similarity=0.451 Sum_probs=139.6
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeE-EEEeCCe-
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYA-SFQTSTH- 380 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~-~~~~~~~- 380 (489)
..+.+|++++.||.|+||.||++....+|..+|.|.++-.. .+....+.+..|+.+|++|+|||||++++ .|..++.
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 34568999999999999999999999999999999998544 46677888999999999999999999999 5666555
Q ss_pred EEEEEecCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHH--CC--CeecCCCCCCEEEecCCcEEEEecCC
Q 042772 381 ICLITDFCPGGELFALLDK--QPMKIFREDSARFYAAEVVIGLEYLHC--LG--IIYRDLKPENILLQKDGHVVLTDFDL 454 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~--~~~~~l~e~~~~~i~~qI~~aL~yLH~--~g--IvHrDLKP~NILld~~g~vKL~DFGl 454 (489)
++||||||.+|+|.+.++. ...+.++|..++.++.|+|.||.++|+ .. |+||||||.||||+.+|.+||+|||+
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 9999999999999999875 244569999999999999999999998 45 99999999999999999999999999
Q ss_pred ccccC
Q 042772 455 SFMTS 459 (489)
Q Consensus 455 S~~~~ 459 (489)
+++..
T Consensus 175 ~r~l~ 179 (375)
T KOG0591|consen 175 GRFLS 179 (375)
T ss_pred HhHhc
Confidence 98665
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=272.79 Aligned_cols=181 Identities=35% Similarity=0.623 Sum_probs=159.7
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++++.||+|+||+||+|.++.+++.||+|++.+...........+..|+.++..++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36899999999999999999999999999999998765444555677888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
||++||+|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999999999875 4489999999999999999999999999999999999999999999999999853210
Q ss_pred ---------------------------------------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------------------------------------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------------------------------------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|+++++|++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 111 1234589999999999999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=271.43 Aligned_cols=184 Identities=28% Similarity=0.465 Sum_probs=158.9
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcE-EEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC-
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGEL-YAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST- 379 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~-vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~- 379 (489)
.+....+...+.||+|+||+||+|.+.+ +. ||+|.+......... ...|..|+.+|.+++|||||+++|++....
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWRG--TDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeCC--ceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4455667777889999999999999995 44 999999876544443 789999999999999999999999999887
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CeecCCCCCCEEEecCC-cEEEEecCCccc
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLG-IIYRDLKPENILLQKDG-HVVLTDFDLSFM 457 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~g-IvHrDLKP~NILld~~g-~vKL~DFGlS~~ 457 (489)
..++||||+++|+|.+++.......++...+..++.||+.||.|||+++ ||||||||+|||++.++ ++||+|||+|+.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 7999999999999999998843456999999999999999999999999 99999999999999998 999999999964
Q ss_pred cCC---------------CCcee--------ecccccchHHHHHHHHhCCcccC
Q 042772 458 TSC---------------KPQVF--------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 458 ~~~---------------~~~~~--------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... +|+.+ ..+|++++|.+++|+++|..||.
T Consensus 194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~ 247 (362)
T KOG0192|consen 194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFE 247 (362)
T ss_pred eccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCC
Confidence 331 23322 34489999999999999999996
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=257.05 Aligned_cols=187 Identities=32% Similarity=0.476 Sum_probs=168.5
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
...+++|++.+.||.|-||.||+|+.+.++..||+|++.++........+++.+|++|-+.|+||||+++|++|.++..+
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 34577899999999999999999999999999999999988776666678899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC--
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS-- 459 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~-- 459 (489)
||++||.++|+|+..|..++...+++..+..+..|++.|+.|+|.++++||||||+|+|++..|.+||+|||.|...+
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~ 177 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN 177 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence 999999999999999997777889999999999999999999999999999999999999999999999999985443
Q ss_pred -----CCC------ce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 -----CKP------QV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 -----~~~------~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|.+ +. -...|+|+.|...+|++.|..||.
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFe 223 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFE 223 (281)
T ss_pred CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchh
Confidence 211 11 123388999999999999999996
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=277.38 Aligned_cols=179 Identities=29% Similarity=0.450 Sum_probs=160.4
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
.+|.+.+.||+|+||+||+|+.+.|.+.||+|.++|... ..+.++.+.+|++|++.++||||+.++++|++..++|+|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 478999999999999999999999999999999987643 5567888999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
|||.| +|+.+|.... .++|+.++.++.+++.||.|||+.+|+|||+||.|||++.+|++|+||||+|+..+.
T Consensus 81 e~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred hhhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 99965 9999998864 499999999999999999999999999999999999999999999999999974331
Q ss_pred -----CC-----------ceeecccccchHHHHHHHHhCCcccC
Q 042772 461 -----KP-----------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -----~~-----------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.| .+-..+|.|++|+++||+..|..||-
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~ 201 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY 201 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch
Confidence 11 12234588999999999999999983
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=279.74 Aligned_cols=181 Identities=32% Similarity=0.540 Sum_probs=163.4
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
+.|++.+.||.|+.|.|.+|++..||+.+|||++.+...........+.+|+-||+.+.||||+++|++|....++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 56999999999999999999999999999999998875555556677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccc--------
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM-------- 457 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~-------- 457 (489)
||++||.|+++|-+. +++++..+..++.||+.|+.|+|..+|+||||||+|+|||..+.|||+|||+|.+
T Consensus 92 Eyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLe 169 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLE 169 (786)
T ss_pred EecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcccc
Confidence 999999999999887 4599999999999999999999999999999999999999999999999999963
Q ss_pred cCCC------Cce-------eecccccchHHHHHHHHhCCcccC
Q 042772 458 TSCK------PQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 458 ~~~~------~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
++|+ |++ -.++|||+.|++++-+++|.+||+
T Consensus 170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd 213 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD 213 (786)
T ss_pred ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC
Confidence 2232 222 246699999999999999999996
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=270.53 Aligned_cols=148 Identities=42% Similarity=0.761 Sum_probs=137.0
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|++++.||+|+||.||+|..+.+++.||+|.+.+...........+..|+.+++.++||||++++++|.+...+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 68999999999999999999999999999999976544445566788899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
|+++|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 82 ~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~ 149 (377)
T cd05629 82 FLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLST 149 (377)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccc
Confidence 99999999999765 458999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=268.81 Aligned_cols=181 Identities=38% Similarity=0.675 Sum_probs=159.6
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++++.||+|+||.||+|.+..+++.||+|++.+...........+..|+.++..++||||++++++|.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36999999999999999999999999999999998654444556677888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
||+++|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999999999999875 3489999999999999999999999999999999999999999999999999853210
Q ss_pred ------------------------------------------------CCc------eeecccccchHHHHHHHHhCCcc
Q 042772 461 ------------------------------------------------KPQ------VFYHAHVNGFYFIMYKWLTGYFT 486 (489)
Q Consensus 461 ------------------------------------------------~~~------~~~~~~v~s~g~~a~e~~~G~lp 486 (489)
+|+ ....+|+|++|++++++++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 011 12345999999999999999999
Q ss_pred cC
Q 042772 487 YV 488 (489)
Q Consensus 487 Y~ 488 (489)
|.
T Consensus 239 f~ 240 (364)
T cd05599 239 FC 240 (364)
T ss_pred CC
Confidence 85
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=264.24 Aligned_cols=184 Identities=36% Similarity=0.650 Sum_probs=162.3
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
...++|++.+.||+|+||.||+|.++.+++.||+|.+.+.........+.+..|+.+++.++||||+++++++.....+|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 34578999999999999999999999999999999998764444455677889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC--
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC-- 460 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~-- 460 (489)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 95 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 999999999999999875 3489999999999999999999999999999999999999999999999999864331
Q ss_pred ----------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ----------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ----------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++|..||.
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 216 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216 (329)
T ss_pred ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCC
Confidence 111 1234699999999999999999984
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=269.48 Aligned_cols=148 Identities=42% Similarity=0.705 Sum_probs=137.6
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
.|++++.||+|+||+||+|.+..+++.||+|++.+...........+..|+.+++.++||||+++++++.+...+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 58999999999999999999999999999999987655556667788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
|+++|+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~ 149 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCT 149 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCc
Confidence 99999999999875 348999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=268.88 Aligned_cols=148 Identities=43% Similarity=0.711 Sum_probs=137.1
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|+.++.||+|+||.||+|.+..+++.||+|.+.+...........+..|+.+++.++||||++++++|.+...+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58999999999999999999999999999999987654455567788899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
|+++|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~ 149 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCc
Confidence 99999999999775 348999999999999999999999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=251.71 Aligned_cols=178 Identities=24% Similarity=0.381 Sum_probs=147.3
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
.+|..++.||+|.||.||+|++..||+.||||.++.....+ ..-....+|+.+|+.++||||+.++++|.+.+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 46889999999999999999999999999999998764332 22345678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCCCcee
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVF 465 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~~~~~ 465 (489)
||++ .+|...++... ..++...+..|+.+++.||+|||++.|+||||||.|+|++++|.+||+|||+|+....+...
T Consensus 81 Efm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~- 157 (318)
T KOG0659|consen 81 EFMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI- 157 (318)
T ss_pred Eecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc-
Confidence 9995 59999998753 56899999999999999999999999999999999999999999999999999977643222
Q ss_pred ecccccchHHHHHHHHhCCccc
Q 042772 466 YHAHVNGFYFIMYKWLTGYFTY 487 (489)
Q Consensus 466 ~~~~v~s~g~~a~e~~~G~lpY 487 (489)
....|.+.+|.+||+++|.--|
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Y 179 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQY 179 (318)
T ss_pred cccceeeeeccChHHhccchhc
Confidence 2222444444444444444444
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=269.10 Aligned_cols=148 Identities=42% Similarity=0.721 Sum_probs=136.1
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|++++.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.|...+.+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 69999999999999999999999999999999976544344456778889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
|+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.
T Consensus 82 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 82 YIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 99999999999775 348999999999999999999999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=265.78 Aligned_cols=186 Identities=31% Similarity=0.534 Sum_probs=155.3
Q ss_pred CccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccc-----------hHHHHHHHHHHHHHHhCCCCCc
Q 042772 300 GEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN-----------RNKVHRACIEREIMSLLDHPFL 368 (489)
Q Consensus 300 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~-----------~~~~~~~~~E~~il~~l~HpnI 368 (489)
.....+++|++++.||+|.||.|.+|.+..+++.||||++++..... ....+++.+|+.||+++.||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 34556789999999999999999999999999999999998754321 1124688999999999999999
Q ss_pred ceeeEEEEeC--CeEEEEEecCCCCCHHHHHhhCCCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC
Q 042772 369 PTLYASFQTS--THICLITDFCPGGELFALLDKQPMKI-FREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG 445 (489)
Q Consensus 369 v~l~~~~~~~--~~~~lVmEy~~ggsL~~~L~~~~~~~-l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g 445 (489)
|+|+.+..+. +.+|||+|||..|.+...- ..+. +++.+++.++..++.||+|||.+||+||||||+|+||+++|
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC
Confidence 9999998765 5899999999988875432 2344 89999999999999999999999999999999999999999
Q ss_pred cEEEEecCCccccC--------------------CCCcee----------ecccccchHHHHHHHHhCCcccC
Q 042772 446 HVVLTDFDLSFMTS--------------------CKPQVF----------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 446 ~vKL~DFGlS~~~~--------------------~~~~~~----------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
++||+|||.|.... .+|+.. ..-|+|++|+++|-++.|.+||-
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~ 320 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF 320 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence 99999999986441 112211 22388899999999999999884
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=261.43 Aligned_cols=181 Identities=34% Similarity=0.602 Sum_probs=160.3
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++++.||+|+||.||+|.+..+++.||+|++.+...........+..|+.++..++||||+++++++......|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36999999999999999999999999999999998765444455677888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~ 158 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV 158 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCc
Confidence 999999999999765 3489999999999999999999999999999999999999999999999999864321
Q ss_pred -------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 -------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 199 (333)
T cd05600 159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199 (333)
T ss_pred ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCC
Confidence 1222 234699999999999999999985
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=258.36 Aligned_cols=181 Identities=33% Similarity=0.599 Sum_probs=158.6
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++.+.||+|+||.||+|.++.+++.||+|.+.............+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36899999999999999999999999999999997654333345567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL 158 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCcccc
Confidence 999999999999875 3489999999999999999999999999999999999999999999999999864321
Q ss_pred -------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 -------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++|..||.
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~ 199 (291)
T cd05612 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFF 199 (291)
T ss_pred cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 111 1234599999999999999999985
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=266.97 Aligned_cols=183 Identities=30% Similarity=0.561 Sum_probs=160.5
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
...++|++.+.||+|+||.||+|.++.+++.||+|++.+...........+..|+.+++.++||||+++++++..+..+|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34568999999999999999999999999999999997654444445566788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC---
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS--- 459 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~--- 459 (489)
+||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||+|....
T Consensus 120 lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 999999999999999764 37899999999999999999999999999999999999999999999999986431
Q ss_pred -------------CCCc----------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 -------------CKPQ----------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 -------------~~~~----------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+ ....+|+|++|++++++++|..||.
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~ 248 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCC
Confidence 1122 1235799999999999999999985
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=262.97 Aligned_cols=185 Identities=36% Similarity=0.628 Sum_probs=161.4
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCC-cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAG-ELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH 380 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg-~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 380 (489)
.+..++|++.+.||+|+||.||+|.++.++ ..||+|.+.+...........+..|+.+++.++||||+++++++.+...
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 345678999999999999999999977655 7899999976654445566778899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999999875 3489999999999999999999999999999999999999999999999999864321
Q ss_pred ------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|+++++|++|..||.
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~ 229 (340)
T PTZ00426 184 RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY 229 (340)
T ss_pred CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCC
Confidence 111 1234599999999999999999985
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=254.19 Aligned_cols=181 Identities=31% Similarity=0.526 Sum_probs=157.5
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEec
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDF 387 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 387 (489)
|+..+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 78889999999999999999999999999999765443344445677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-------
Q 042772 388 CPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC------- 460 (489)
Q Consensus 388 ~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~------- 460 (489)
+++|+|.+++.......+++..+..++.|++.||.|||++||+||||||+|||+++++.+||+|||++.....
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR 161 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCC
Confidence 9999999888765444589999999999999999999999999999999999999999999999999864321
Q ss_pred -------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 -------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 162 ~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 202 (285)
T cd05631 162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFR 202 (285)
T ss_pred CCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCC
Confidence 1221 234599999999999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=259.16 Aligned_cols=175 Identities=39% Similarity=0.698 Sum_probs=154.1
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCCCC
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGG 391 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg 391 (489)
+.||+|+||.||+|.++.+|+.||+|++.+...........+..|+.+++.++||||+++++++.....+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998765445556677888999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------------
Q 042772 392 ELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------------ 459 (489)
Q Consensus 392 sL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------------ 459 (489)
+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence 999999875 458999999999999999999999999999999999999999999999999986321
Q ss_pred ---CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ---CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 196 (323)
T cd05571 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred ccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCC
Confidence 11222 234699999999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=293.38 Aligned_cols=185 Identities=34% Similarity=0.567 Sum_probs=167.5
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
.+..++|.++++||+|+||.|.+++++.|++.||+|++++..+..+.....|+.|..+|..-+.+-|+.++-+|+++.++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 44567899999999999999999999999999999999999888888999999999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC--
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS-- 459 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~-- 459 (489)
|+||||++||+|..+|.+.. .++++.+++|++.|+.||.-||+.|+|||||||+|||||..|+|||+|||.+-...
T Consensus 151 YlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 99999999999999998864 59999999999999999999999999999999999999999999999999863222
Q ss_pred ---------CCCceee----------------cccccchHHHHHHHHhCCcccC
Q 042772 460 ---------CKPQVFY----------------HAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---------~~~~~~~----------------~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+.|.+++ ..|-|+.|+++|||+.|.+||-
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 2233332 3367899999999999999983
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=264.87 Aligned_cols=181 Identities=35% Similarity=0.631 Sum_probs=158.9
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++++.||+|+||.||+|..+.+++.||+|++.+...........+..|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36899999999999999999999999999999998654444556678888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
||++||+|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999999999775 3489999999999999999999999999999999999999999999999998753210
Q ss_pred ---------------------------------------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------------------------------------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------------------------------------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|+++++|++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 111 1234589999999999999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=264.37 Aligned_cols=184 Identities=31% Similarity=0.564 Sum_probs=161.4
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
.+..++|++.+.||+|+||.||+|.++.+++.||+|.+.+...........+..|+.+++.++||||+++++++.....+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 45567899999999999999999999999999999999765444445556778899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC--
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS-- 459 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~-- 459 (489)
|+||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 9999999999999999763 37899999999999999999999999999999999999999999999999985322
Q ss_pred --------------CCCc----------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 --------------CKPQ----------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 --------------~~~~----------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+ ....+|+|++|+++++|++|..||.
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 248 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCC
Confidence 1122 1235699999999999999999985
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=268.18 Aligned_cols=185 Identities=26% Similarity=0.384 Sum_probs=160.4
Q ss_pred CCccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 042772 299 SGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS 378 (489)
Q Consensus 299 ~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 378 (489)
....+....+++++.||+|.||.||+|.+++ ...||+|.++...+.. +.|.+|+++|++|+|+|||++++++..+
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~ 273 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQ 273 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence 3445666778999999999999999999996 3468999997654432 4566899999999999999999999998
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
..+||||||++.|+|.++|.......+.......++.|||.||+||+++++|||||..+||||++++.+||+|||+|+..
T Consensus 274 ~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 274 EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccccccc
Confidence 89999999999999999999866667999999999999999999999999999999999999999999999999999953
Q ss_pred CC----------------CCc------eeecccccchHHHHHHH-HhCCcccC
Q 042772 459 SC----------------KPQ------VFYHAHVNGFYFIMYKW-LTGYFTYV 488 (489)
Q Consensus 459 ~~----------------~~~------~~~~~~v~s~g~~a~e~-~~G~lpY~ 488 (489)
.. +|+ ....+|||+||..++|+ ..|..||.
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~ 406 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP 406 (468)
T ss_pred CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC
Confidence 31 111 12456999999999998 58999986
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=264.33 Aligned_cols=184 Identities=32% Similarity=0.549 Sum_probs=161.1
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
.+..++|++.+.||+|+||.||+|.++.+++.||+|.+++...........+..|+.+++.++||||+++++++.+...+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 45567899999999999999999999999999999999765444445556678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
|+||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999999998763 378999999999999999999999999999999999999999999999999854321
Q ss_pred ---------------CCce----------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------------KPQV----------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------------~~~~----------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 248 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcC
Confidence 1221 134699999999999999999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=260.45 Aligned_cols=179 Identities=31% Similarity=0.457 Sum_probs=154.9
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC--eEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST--HICL 383 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~l 383 (489)
.+|...+.||+|+||.||++.+..+|...|+|.+... +....+.+.+|+.+|++++|||||++++...... .+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~---~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE---DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecc---cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 4588899999999999999999999999999998765 1122677889999999999999999999754444 6999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-CCcEEEEecCCccccC---
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK-DGHVVLTDFDLSFMTS--- 459 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~-~g~vKL~DFGlS~~~~--- 459 (489)
+|||+++|+|.+++.+... .+++..++.++.|++.||.|||++|++||||||+|||++. ++.+||+|||++....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999998765 6999999999999999999999999999999999999999 7999999999886332
Q ss_pred ---------------CCCceee-------cccccchHHHHHHHHhCCcccC
Q 042772 460 ---------------CKPQVFY-------HAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---------------~~~~~~~-------~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
-.|+++. .+|+|++|+++-||++|..||.
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~ 223 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWS 223 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcch
Confidence 1233332 5688999999999999998885
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=255.73 Aligned_cols=180 Identities=21% Similarity=0.287 Sum_probs=145.6
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC--CeE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS--THI 381 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~ 381 (489)
+.++|+.++.|++|+||.||+|.++.|++.||+|.++..... ...--...+|+.+|.+++|||||.+-.+.... +.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek-~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK-EGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccccc-CCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 346799999999999999999999999999999999765421 11122356799999999999999999888754 479
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK 461 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~ 461 (489)
|+|||||++ +|.++++..+ .+|...++..++.|++.|++|||.+.|+||||||+|+|++..|.+||+|||+|+....+
T Consensus 153 y~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 999999965 9999999875 56999999999999999999999999999999999999999999999999999977754
Q ss_pred CceeecccccchHHHHHHHHhCCccc
Q 042772 462 PQVFYHAHVNGFYFIMYKWLTGYFTY 487 (489)
Q Consensus 462 ~~~~~~~~v~s~g~~a~e~~~G~lpY 487 (489)
... +.+-|.+++|.+||+++|...|
T Consensus 231 ~k~-~T~lVVTLWYRaPELLLG~~ty 255 (419)
T KOG0663|consen 231 LKP-YTPLVVTLWYRAPELLLGAKTY 255 (419)
T ss_pred ccc-CcceEEEeeecCHHHhcCCccc
Confidence 322 2222334444444444444433
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=254.43 Aligned_cols=185 Identities=39% Similarity=0.718 Sum_probs=167.7
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
.+..++|..++.||+|.||+|-+|+.+.+++.||||++++.....++.+.....|-.+|+..+||++..+-.+|++..++
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 45678999999999999999999999999999999999999988999999999999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccc----
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM---- 457 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~---- 457 (489)
|+||||..||.|+-+|.+. ..++++.++++-.+|+.||.|||+++||+||||.+|+|+|++|+|||+|||++..
T Consensus 244 CFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 9999999999999999875 5599999999999999999999999999999999999999999999999999852
Q ss_pred -----cCC-CCceeec-----------ccccchHHHHHHHHhCCcccC
Q 042772 458 -----TSC-KPQVFYH-----------AHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 458 -----~~~-~~~~~~~-----------~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+.| .|++..+ .+-|+.|+.+|||+||.+||-
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy 369 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY 369 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc
Confidence 112 2333332 356899999999999999984
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=257.11 Aligned_cols=182 Identities=33% Similarity=0.574 Sum_probs=159.1
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++++.||+|+||.||++.+..+++.||+|++.+...........+..|+.++..++||||+++++++....++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36999999999999999999999999999999998654444555677888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
||+++|+|.+++.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 9999999999997642 3489999999999999999999999999999999999999999999999999753211
Q ss_pred -----------CCcee-----------ecccccchHHHHHHHHhCCcccC
Q 042772 461 -----------KPQVF-----------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -----------~~~~~-----------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+.+ ..+|+|++|++++++++|..||.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 12211 24699999999999999999984
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=268.01 Aligned_cols=155 Identities=28% Similarity=0.458 Sum_probs=138.6
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCC-eE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTST-HI 381 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~-~~ 381 (489)
..++|.+++.||.|+||.||+|..+.+|..||||.|++.... -++. .-.+|+..|++|+ ||||+++.+++.+.. .+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 346899999999999999999999999999999999876543 2222 2356999999998 999999999998877 99
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK 461 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~ 461 (489)
|+||||| ..+|+++++.+ .+.|++..++.|+.||+.||+|+|++|+.||||||+|||+..+..|||+|||+||.....
T Consensus 86 ~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence 9999999 56999999988 678999999999999999999999999999999999999998889999999999976654
Q ss_pred C
Q 042772 462 P 462 (489)
Q Consensus 462 ~ 462 (489)
|
T Consensus 164 p 164 (538)
T KOG0661|consen 164 P 164 (538)
T ss_pred C
Confidence 3
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=260.48 Aligned_cols=181 Identities=38% Similarity=0.678 Sum_probs=160.5
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+..|+.++..++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36999999999999999999999999999999998765444456677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCCC---
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKP--- 462 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~~--- 462 (489)
||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 999999999999876 458999999999999999999999999999999999999999999999999986432111
Q ss_pred -----------------------------------------c------eeecccccchHHHHHHHHhCCcccC
Q 042772 463 -----------------------------------------Q------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 463 -----------------------------------------~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+ ....+|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~ 231 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCC
Confidence 1 1234589999999999999999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=256.50 Aligned_cols=188 Identities=26% Similarity=0.359 Sum_probs=165.8
Q ss_pred CCccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 042772 299 SGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS 378 (489)
Q Consensus 299 ~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 378 (489)
.+..+..++|++.+.||.|..++||+|....++..||||+++..... ..++.+.+|++.|+.++||||++++.+|..+
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 34456678899999999999999999999999999999999876543 3488899999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
..+|+||.||.+|++.++++..-...++|..+..++.+++.||.|||++|-||||||+.||||+.+|.|||+|||.+..+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 99999999999999999999875555999999999999999999999999999999999999999999999999987422
Q ss_pred C-------------CCCcee--------------ecccccchHHHHHHHHhCCcccC
Q 042772 459 S-------------CKPQVF--------------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~-------------~~~~~~--------------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. .....| ..+|+|++|.++.|++.|..||.
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~ 233 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFS 233 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcc
Confidence 1 111122 23588999999999999999996
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=269.19 Aligned_cols=186 Identities=24% Similarity=0.345 Sum_probs=163.4
Q ss_pred cCCCccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 042772 297 TGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQ 376 (489)
Q Consensus 297 ~~~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 376 (489)
....+++..+.+.+.+.||+|+||+||+|.+.++ ||||+++..... ...++.|++|+.++++-+|-||+-+.|++.
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt-~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPT-PEQLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCC-HHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 3345667778889999999999999999999974 999999876554 458899999999999999999999999998
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 377 TSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 377 ~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
.+.. .||+-+|+|-+|+.+|+.... .|.......|+.|++.||.|||.++|||||||..|||+.+++.|||+|||++.
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~et-kfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQET-KFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred CCce-eeeehhccCchhhhhccchhh-hhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEeccccee
Confidence 8876 999999999999999987653 48999999999999999999999999999999999999999999999999986
Q ss_pred ccC--------------------------CCCceeecccccchHHHHHHHHhCCcccC
Q 042772 457 MTS--------------------------CKPQVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 457 ~~~--------------------------~~~~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+.. +...+...+||++||..+||+++|++||.
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 432 11223346699999999999999999996
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=255.67 Aligned_cols=175 Identities=39% Similarity=0.697 Sum_probs=154.1
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCCCC
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGG 391 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg 391 (489)
+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.....+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998765545556678888999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------------
Q 042772 392 ELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------------ 459 (489)
Q Consensus 392 sL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------------ 459 (489)
+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence 999998765 348999999999999999999999999999999999999999999999999986321
Q ss_pred ---CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ---CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~ 196 (328)
T cd05593 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (328)
T ss_pred cCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCC
Confidence 11222 234599999999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=255.66 Aligned_cols=175 Identities=38% Similarity=0.697 Sum_probs=153.5
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCCCC
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGG 391 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg 391 (489)
+.||+|+||.||++.++.+|+.||+|.+.+...........+..|+.+++.++||||++++++|.....+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998765444556677788999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------------
Q 042772 392 ELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------------ 459 (489)
Q Consensus 392 sL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------------ 459 (489)
+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence 999998765 348999999999999999999999999999999999999999999999999875321
Q ss_pred ---CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ---CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 196 (323)
T cd05595 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred cCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCC
Confidence 11222 234599999999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=252.94 Aligned_cols=173 Identities=35% Similarity=0.604 Sum_probs=152.7
Q ss_pred cCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCCCCCH
Q 042772 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGEL 393 (489)
Q Consensus 314 LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ggsL 393 (489)
||+|+||.||+|.+..+++.||+|.+.+...........+..|+.+++.++||||+++++++......|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999865544555667788899999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC--------------
Q 042772 394 FALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS-------------- 459 (489)
Q Consensus 394 ~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~-------------- 459 (489)
.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcc
Confidence 9999775 348999999999999999999999999999999999999999999999999986421
Q ss_pred -CCCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 -CKPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 -~~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+ ....+|+|++|++++++++|..||.
T Consensus 159 y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~ 194 (312)
T cd05585 159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194 (312)
T ss_pred cCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcC
Confidence 0111 1234699999999999999999984
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=256.50 Aligned_cols=182 Identities=32% Similarity=0.518 Sum_probs=158.8
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++.+.||+|+||.||++.++.+++.||+|.+.+...........+..|..++..++||||+.+++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36999999999999999999999999999999997654444455666788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------ 459 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------ 459 (489)
||++||+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence 9999999999998642 348999999999999999999999999999999999999999999999999975321
Q ss_pred ----------CCCce-----------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ----------CKPQV-----------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----------~~~~~-----------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 209 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence 11221 124599999999999999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=252.27 Aligned_cols=153 Identities=25% Similarity=0.410 Sum_probs=134.6
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC-cceeeEEEEeCC----
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF-LPTLYASFQTST---- 379 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~---- 379 (489)
...|..++.||+|+||+||+|..+.+|+.||+|.+.-.... ...-....+|+.+++.++|+| |+.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 34688899999999999999999999999999999765331 112245678999999999999 999999998877
Q ss_pred --eEEEEEecCCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCc
Q 042772 380 --HICLITDFCPGGELFALLDKQPM--KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455 (489)
Q Consensus 380 --~~~lVmEy~~ggsL~~~L~~~~~--~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS 455 (489)
.+++|+||+ ..+|..+++..+. ..++...++.++.||+.||+|||+++|+||||||+||||+++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 899999999 5699999998653 24788999999999999999999999999999999999999999999999999
Q ss_pred cccC
Q 042772 456 FMTS 459 (489)
Q Consensus 456 ~~~~ 459 (489)
+...
T Consensus 168 ra~~ 171 (323)
T KOG0594|consen 168 RAFS 171 (323)
T ss_pred HHhc
Confidence 8554
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=256.08 Aligned_cols=182 Identities=34% Similarity=0.614 Sum_probs=159.6
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|.+.+.||+|+||.||+|.++.+++.||+|.+++...........+..|+.+++.++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36899999999999999999999999999999998765444556677888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence 9999999999998753 3489999999999999999999999999999999999999999999999999864321
Q ss_pred -----------CCce------------eecccccchHHHHHHHHhCCcccC
Q 042772 461 -----------KPQV------------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -----------~~~~------------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 210 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCC
Confidence 1221 134699999999999999999984
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=252.32 Aligned_cols=180 Identities=34% Similarity=0.621 Sum_probs=155.8
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC-CcceeeEEEEeCCeEEEEE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP-FLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hp-nIv~l~~~~~~~~~~~lVm 385 (489)
+|++++.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+.|+ +|+.+++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 488999999999999999999999999999999876544455567788899999999764 6888999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------ 459 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------ 459 (489)
||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCce
Confidence 999999999999765 348999999999999999999999999999999999999999999999999875311
Q ss_pred ---------CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ---------CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---------~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~ 202 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202 (324)
T ss_pred eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 11221 134599999999999999999985
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=254.98 Aligned_cols=182 Identities=33% Similarity=0.532 Sum_probs=158.4
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++.+.||+|+||.||++.++.+++.+|+|++.+...........+..|+.++..++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36899999999999999999999999999999997654444445566788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------ 459 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------ 459 (489)
||+++|+|.+++.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 9999999999997642 348999999999999999999999999999999999999999999999999875321
Q ss_pred ----------CCCce-----------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ----------CKPQV-----------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----------~~~~~-----------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~ 209 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence 11222 235699999999999999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=246.44 Aligned_cols=182 Identities=32% Similarity=0.534 Sum_probs=158.1
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
.|+..+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.++||||+++++++.....+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 37889999999999999999999999999999976544334444567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC------ 460 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~------ 460 (489)
|+++|+|.+++.......+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 99999999988765445689999999999999999999999999999999999999999999999999865321
Q ss_pred --------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 --------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 --------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~ 202 (285)
T cd05605 161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202 (285)
T ss_pred ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCC
Confidence 1221 124599999999999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=253.05 Aligned_cols=175 Identities=39% Similarity=0.693 Sum_probs=152.5
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCCCC
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGG 391 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg 391 (489)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|+.++..++||||+++++++.....+|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998765545555677788999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecCCccccC-----------
Q 042772 392 ELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC-LGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----------- 459 (489)
Q Consensus 392 sL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----------- 459 (489)
+|..++... ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence 999998765 348999999999999999999997 799999999999999999999999999875321
Q ss_pred ----CCCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 ----CKPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----~~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+ ....+|+|++|++++++++|..||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~ 197 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 197 (325)
T ss_pred CcccCCHHHHccCCCCCccccccccceeeeeccCCCCCC
Confidence 0111 1234699999999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=251.91 Aligned_cols=175 Identities=31% Similarity=0.606 Sum_probs=153.0
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEecCCC
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHICLITDFCPG 390 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lVmEy~~g 390 (489)
+.||+|+||.||+|.++.+++.||+|++++...........+..|..++..+ +||||++++++|.....+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4689999999999999999999999999876554555567788899999888 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----------
Q 042772 391 GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----------- 459 (489)
Q Consensus 391 gsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----------- 459 (489)
|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccC
Confidence 9999998765 448999999999999999999999999999999999999999999999999985311
Q ss_pred ----CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ----CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcc
Confidence 01111 134699999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=251.00 Aligned_cols=180 Identities=34% Similarity=0.623 Sum_probs=155.6
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lVm 385 (489)
+|++.+.||+|+||.||+|.+..+++.||+|.+.+..............|..++..+ .||+|+.+++++.....+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 488999999999999999999999999999999876544444556677788888877 5899999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------ 459 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------ 459 (489)
||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcc
Confidence 999999999998765 348999999999999999999999999999999999999999999999999986321
Q ss_pred ---------CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ---------CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---------~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~ 202 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCC
Confidence 11211 234599999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=250.31 Aligned_cols=175 Identities=37% Similarity=0.637 Sum_probs=151.9
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEecCCC
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHICLITDFCPG 390 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lVmEy~~g 390 (489)
+.||+|+||.||+|.++.+++.||+|++.+...........+..|..++..+ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4689999999999999999999999999876544455566777899998866 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----------
Q 042772 391 GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----------- 459 (489)
Q Consensus 391 gsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----------- 459 (489)
|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccccc
Confidence 9999998765 348999999999999999999999999999999999999999999999999886321
Q ss_pred ----CCCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 ----CKPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----~~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+ ....+|+|++|++++++++|..||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~ 197 (321)
T cd05591 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197 (321)
T ss_pred CccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCC
Confidence 0111 1234699999999999999999985
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=251.51 Aligned_cols=178 Identities=38% Similarity=0.663 Sum_probs=152.7
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHH---HhCCCCCcceeeEEEEeCCeEEEE
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIM---SLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il---~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
|++++.||+|+||.||+|.+..+++.||+|.+++.........+.+..|+.++ +.++||||+++++++.....+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67889999999999999999999999999999866444444556677777665 456799999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----- 459 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----- 459 (489)
|||+++++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCc
Confidence 999999999988865 348999999999999999999999999999999999999999999999999875321
Q ss_pred ----------CCCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 ----------CKPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----------~~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+ ....+|+|++|++++++++|..||.
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~ 202 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP 202 (324)
T ss_pred ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence 0122 1234699999999999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=249.87 Aligned_cols=175 Identities=39% Similarity=0.708 Sum_probs=150.0
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEecCCC
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHICLITDFCPG 390 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lVmEy~~g 390 (489)
+.||+|+||.||+|.+..+++.||+|.+++..............|..++..+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999999876544444555666777777654 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----------
Q 042772 391 GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----------- 459 (489)
Q Consensus 391 gsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----------- 459 (489)
|+|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccC
Confidence 9999999775 348999999999999999999999999999999999999999999999999986321
Q ss_pred ----CCCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 ----CKPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----~~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+ ....+|+|++|++++++++|..||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~ 197 (316)
T cd05592 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred CccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCC
Confidence 0111 1234699999999999999999985
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=250.69 Aligned_cols=175 Identities=31% Similarity=0.597 Sum_probs=152.7
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEecCCC
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHICLITDFCPG 390 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lVmEy~~g 390 (489)
+.||+|+||.||+|.++.+++.||+|++.+...........+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4689999999999999999999999999876555555667788899888776 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----------
Q 042772 391 GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----------- 459 (489)
Q Consensus 391 gsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----------- 459 (489)
|+|..++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence 9999988765 348999999999999999999999999999999999999999999999999986321
Q ss_pred ----CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ----CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 01111 235699999999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=254.05 Aligned_cols=179 Identities=25% Similarity=0.428 Sum_probs=153.7
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
...+.+|+.++.||+|+||.||+|.+..+++.||+|++.... .......+.+|+++++.++||||+++++++...+.+
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 345678999999999999999999999999999999986542 234456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC--
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS-- 459 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~-- 459 (489)
++||||+++|+|.+. ....+..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||++....
T Consensus 148 ~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 148 QVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred EEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 999999999998643 225678888999999999999999999999999999999999999999999986422
Q ss_pred -------------CCCcee-----------ecccccchHHHHHHHHhCCcccC
Q 042772 460 -------------CKPQVF-----------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 -------------~~~~~~-----------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
..|+.+ ..+|+|++|++++++++|..||.
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 274 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 123322 24699999999999999999984
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=248.14 Aligned_cols=179 Identities=23% Similarity=0.376 Sum_probs=153.2
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++.+.||+|+||.||+|.++.+++.||+|++..... ......+.+|+.+++.++||||+++++++......++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999999875432 222345677999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------ 459 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------ 459 (489)
||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 83 e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 83 EYV-HTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred ECC-CcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence 999 468988887653 348899999999999999999999999999999999999999999999999985321
Q ss_pred ---------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ---------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 205 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFP 205 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 12222 223599999999999999999984
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=250.24 Aligned_cols=180 Identities=33% Similarity=0.616 Sum_probs=155.2
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEEE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lVm 385 (489)
+|+..+.||+|+||.||+|.++.+++.||+|++.+...........+..|..++..+. ||+|+++++++.....+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788899999999999999999999999999998764444455667788999988886 578889999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------ 459 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------ 459 (489)
||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccc
Confidence 999999999999775 348999999999999999999999999999999999999999999999999986321
Q ss_pred ---------CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ---------CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---------~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~ 202 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCC
Confidence 01111 134599999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=246.76 Aligned_cols=180 Identities=24% Similarity=0.351 Sum_probs=154.0
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
+++|++.+.||.|+||.||+|.+..+++.||+|.++.... ......+.+|+.+++.++||||+++++++......++|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 4679999999999999999999999999999999865421 22234567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----- 459 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----- 459 (489)
|||++ ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 82 FEYLD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred EeCCC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 99996 59999987653 347899999999999999999999999999999999999999999999999985321
Q ss_pred ----------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ----------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~ 205 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFP 205 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 11222 224589999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=249.54 Aligned_cols=175 Identities=38% Similarity=0.653 Sum_probs=151.4
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEecCCC
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHICLITDFCPG 390 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lVmEy~~g 390 (489)
+.||+|+||.||+|.++.+++.||+|++.+...........+..|..++..+ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999999876544445566777888888876 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----------
Q 042772 391 GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----------- 459 (489)
Q Consensus 391 gsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----------- 459 (489)
|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence 9999998775 348999999999999999999999999999999999999999999999999876321
Q ss_pred ----CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ----CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (320)
T cd05590 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197 (320)
T ss_pred CccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCC
Confidence 01111 124599999999999999999985
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=251.60 Aligned_cols=185 Identities=22% Similarity=0.307 Sum_probs=152.1
Q ss_pred cccccCcccccccCCCCceEEEEEEEc-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQ-----GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASF 375 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~ 375 (489)
.+..++|++.+.||+|+||.||+|.+. .+++.||+|.+.... .......+..|+.++..+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 345578999999999999999999853 345789999986432 233456788899999999 899999999988
Q ss_pred EeC-CeEEEEEecCCCCCHHHHHhhCC-----------------------------------------------------
Q 042772 376 QTS-THICLITDFCPGGELFALLDKQP----------------------------------------------------- 401 (489)
Q Consensus 376 ~~~-~~~~lVmEy~~ggsL~~~L~~~~----------------------------------------------------- 401 (489)
... ..++++|||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 46899999999999999997532
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC---------------
Q 042772 402 -------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS--------------- 459 (489)
Q Consensus 402 -------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~--------------- 459 (489)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 1247788889999999999999999999999999999999999999999999986421
Q ss_pred --CCCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 460 --CKPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 460 --~~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.+|+. ...+|+|++|++++|+++ |..||.
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~ 278 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 278 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCC
Confidence 11221 234599999999999986 999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=255.57 Aligned_cols=181 Identities=29% Similarity=0.470 Sum_probs=161.2
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~l 383 (489)
...|.+.+.||.|.||.||+|..+.||+.+|+|.+++...........+.+|+++|+++. ||||+.++++|++...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 356999999999999999999999999999999999887766656778899999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC----CcEEEEecCCccccC
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD----GHVVLTDFDLSFMTS 459 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~----g~vKL~DFGlS~~~~ 459 (489)
|||+|.||+|++.+... . +++..+..++.|++.++.|||+.||+||||||+|+|+... +.+|++|||+|....
T Consensus 114 vmEL~~GGeLfd~i~~~--~-~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--H-YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEecCCchHHHHHHHc--c-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 99999999999999887 3 8999999999999999999999999999999999999633 579999999996443
Q ss_pred C--------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 C--------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ~--------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. +|+ +....|+|+.|.++|.+++|..||.
T Consensus 191 ~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~ 239 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFW 239 (382)
T ss_pred CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCc
Confidence 2 122 2234489999999999999999985
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=248.41 Aligned_cols=175 Identities=41% Similarity=0.658 Sum_probs=148.7
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHH-HHHhCCCCCcceeeEEEEeCCeEEEEEecCCC
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE-IMSLLDHPFLPTLYASFQTSTHICLITDFCPG 390 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~g 390 (489)
+.||+|+||+||+|.++.+|+.||+|++.+...........+..|.. +++.++||||+++++++.....+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999999999999999997654433444455555655 46778999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----------
Q 042772 391 GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----------- 459 (489)
Q Consensus 391 gsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----------- 459 (489)
|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccC
Confidence 9999999775 348999999999999999999999999999999999999999999999999885321
Q ss_pred ----CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ----CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 197 (323)
T cd05575 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (323)
T ss_pred ChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCC
Confidence 11221 234699999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=248.09 Aligned_cols=175 Identities=41% Similarity=0.659 Sum_probs=148.2
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHH-HHHhCCCCCcceeeEEEEeCCeEEEEEecCCC
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE-IMSLLDHPFLPTLYASFQTSTHICLITDFCPG 390 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~g 390 (489)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|.. +++.++||||+++++++.....+|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999999999999999997654433334445555554 57889999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----------
Q 042772 391 GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----------- 459 (489)
Q Consensus 391 gsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----------- 459 (489)
|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccC
Confidence 9999988765 448899999999999999999999999999999999999999999999999886321
Q ss_pred ----CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ----CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ....|+|++|++++++++|..||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 197 (321)
T cd05603 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (321)
T ss_pred CcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCC
Confidence 11111 134699999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=242.09 Aligned_cols=175 Identities=32% Similarity=0.531 Sum_probs=151.2
Q ss_pred cCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCCCCCH
Q 042772 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGEL 393 (489)
Q Consensus 314 LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ggsL 393 (489)
||+|+||+||+|.++.+++.||+|.+.+...........+..|+.+++.++||||+++++++.....+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999766544444556778899999999999999999999999999999999999999
Q ss_pred HHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----------
Q 042772 394 FALLDKQ--PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----------- 460 (489)
Q Consensus 394 ~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----------- 460 (489)
.+++... ....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 9887542 234589999999999999999999999999999999999999999999999999864321
Q ss_pred ----CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ----KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ----~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 198 (280)
T cd05608 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFR 198 (280)
T ss_pred cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 1111 235699999999999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=248.02 Aligned_cols=175 Identities=32% Similarity=0.600 Sum_probs=153.1
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEecCCC
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHICLITDFCPG 390 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lVmEy~~g 390 (489)
+.||+|+||.||+|....+++.||+|++.+.........+.+..|..++..+ .||||+.+++++.....+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876555555667788899999887 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----------
Q 042772 391 GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----------- 459 (489)
Q Consensus 391 gsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----------- 459 (489)
|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence 9999988765 348999999999999999999999999999999999999999999999999886321
Q ss_pred ----CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ----CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~ 197 (327)
T cd05617 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197 (327)
T ss_pred CcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCC
Confidence 01111 134699999999999999999994
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=240.73 Aligned_cols=175 Identities=28% Similarity=0.525 Sum_probs=150.7
Q ss_pred cCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCCCCCH
Q 042772 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGEL 393 (489)
Q Consensus 314 LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ggsL 393 (489)
||+|+||.||++..+.+|+.||+|.+.............+..|+++++.++||||+++++++....+.|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765443333344556799999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-------------
Q 042772 394 FALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC------------- 460 (489)
Q Consensus 394 ~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~------------- 460 (489)
.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY 160 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence 9988765555588999999999999999999999999999999999999999999999999864321
Q ss_pred -CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 -KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++|..||.
T Consensus 161 ~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~ 195 (277)
T cd05607 161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK 195 (277)
T ss_pred cCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCC
Confidence 111 1234699999999999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=248.27 Aligned_cols=175 Identities=41% Similarity=0.647 Sum_probs=149.0
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHH-HHHhCCCCCcceeeEEEEeCCeEEEEEecCCC
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE-IMSLLDHPFLPTLYASFQTSTHICLITDFCPG 390 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~g 390 (489)
+.||+|+||+||+|.++.+|+.||+|++.+...........+..|.. +++.++||||+++++++......|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999999999999999997654444444455556655 46778999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----------
Q 042772 391 GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----------- 459 (489)
Q Consensus 391 gsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----------- 459 (489)
|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccC
Confidence 9999998765 448999999999999999999999999999999999999999999999999986321
Q ss_pred ----CCCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 ----CKPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----~~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+ ....+|+|++|++++++++|..||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~ 197 (325)
T cd05604 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFY 197 (325)
T ss_pred ChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCC
Confidence 0111 1234699999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=247.88 Aligned_cols=180 Identities=40% Similarity=0.660 Sum_probs=153.8
Q ss_pred CcccccccCCCCceEEEEEEEc---CCCcEEEEEEeeccccc-chHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQ---GAGELYAMKAMEKSVML-NRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 381 (489)
+|++++.||+|+||.||+|... .+++.||+|++.+.... .......+..|+.+++.+ +||||+++++++.....+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4889999999999999999864 47899999999764332 233456678899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC--
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS-- 459 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~-- 459 (489)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 9999999999999999765 348999999999999999999999999999999999999999999999999986321
Q ss_pred --------------CCCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 --------------CKPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 --------------~~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+ ....+|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~ 208 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT 208 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCC
Confidence 0122 1234699999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=246.86 Aligned_cols=175 Identities=38% Similarity=0.705 Sum_probs=150.0
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEecCCC
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHICLITDFCPG 390 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lVmEy~~g 390 (489)
+.||+|+||.||+|.++.+|+.||+|.+++..............|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999999999999999875433334456667788888754 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----------
Q 042772 391 GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----------- 459 (489)
Q Consensus 391 gsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----------- 459 (489)
|+|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCC
Confidence 9999999775 348999999999999999999999999999999999999999999999999875321
Q ss_pred ----CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ----CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~ 197 (316)
T cd05620 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred CcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 11221 234699999999999999999985
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-28 Score=241.08 Aligned_cols=181 Identities=31% Similarity=0.538 Sum_probs=158.0
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEec
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDF 387 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 387 (489)
|+..+.||+|+||.||+|.+..+++.||+|.+.+...........+..|+.+++.++|+||+.+++.+.....+|+||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 77888999999999999999999999999999765444444456677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-------
Q 042772 388 CPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC------- 460 (489)
Q Consensus 388 ~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~------- 460 (489)
+++++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++.....
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 161 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCC
Confidence 9999999998765545689999999999999999999999999999999999999999999999999864321
Q ss_pred -------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 -------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 162 ~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~ 202 (285)
T cd05630 162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 202 (285)
T ss_pred CCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 1111 124699999999999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=246.51 Aligned_cols=175 Identities=38% Similarity=0.629 Sum_probs=146.8
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHH-HHHhCCCCCcceeeEEEEeCCeEEEEEecCCC
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE-IMSLLDHPFLPTLYASFQTSTHICLITDFCPG 390 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~g 390 (489)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|.. +++.++||||+++++++.....+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999997654332333334444444 56788999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----------
Q 042772 391 GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----------- 459 (489)
Q Consensus 391 gsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----------- 459 (489)
|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccC
Confidence 9999999775 347899999999999999999999999999999999999999999999999986321
Q ss_pred ----CCCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 ----CKPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----~~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+ ....+|+|++|++++++++|..||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 197 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (325)
T ss_pred CccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCC
Confidence 0111 1235699999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=246.40 Aligned_cols=176 Identities=40% Similarity=0.654 Sum_probs=150.2
Q ss_pred ccccCCCCceEEEEEEEc---CCCcEEEEEEeeccccc-chHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 311 IKPLGCGDTGSVHLVELQ---GAGELYAMKAMEKSVML-NRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 311 ~~~LG~G~fG~Vy~a~~~---~tg~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
++.||+|+||.||+|... .+++.||+|++.+.... .......+..|+.+++.++||||++++++|..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999864 46889999999764322 23344567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------- 459 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------- 459 (489)
|+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence 99999999999875 347899999999999999999999999999999999999999999999999975211
Q ss_pred --------CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 --------CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 --------~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~ 201 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT 201 (323)
T ss_pred ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCC
Confidence 11222 134699999999999999999985
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-28 Score=245.30 Aligned_cols=181 Identities=23% Similarity=0.350 Sum_probs=158.0
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 383 (489)
..++|++++.||+|+||.||++.+..++..+|+|.+.... .......+.+|+++++.++||||+++++++...+.+++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4578999999999999999999999999999999987542 23445678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEecCCcEEEEecCCccccCC--
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL-GIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC-- 460 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~-gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~-- 460 (489)
||||+++++|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred EeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 999999999999998753 489999999999999999999986 699999999999999999999999999863321
Q ss_pred -----------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 -----------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -----------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 203 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP 203 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 1221 234599999999999999999985
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=260.25 Aligned_cols=153 Identities=42% Similarity=0.712 Sum_probs=144.9
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
+.+..-|..++.||-|+||.|.++...+|...||+|.+.+.....++.+..++.|..||...+++-||+||-+|++...+
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 34456799999999999999999999999999999999988888899999999999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
|+||+|++||++-++|.+. +.|.|+.++++++++.+|+++.|..|+|||||||+|||||.+|+|||+||||++
T Consensus 705 YFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 777 (1034)
T ss_pred EEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccc
Confidence 9999999999999999886 569999999999999999999999999999999999999999999999999984
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-28 Score=240.31 Aligned_cols=181 Identities=31% Similarity=0.531 Sum_probs=157.4
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEec
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDF 387 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 387 (489)
|+..+.||+|+||+||+|.+..+++.||+|.+.+...........+..|+++++.++|+||+.+++++...+..|++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 67788999999999999999999999999999765444444455677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-------
Q 042772 388 CPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC------- 460 (489)
Q Consensus 388 ~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~------- 460 (489)
+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++.....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR 161 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCC
Confidence 9999999988765445689999999999999999999999999999999999999999999999999854321
Q ss_pred -------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 -------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 162 ~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~ 202 (285)
T cd05632 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR 202 (285)
T ss_pred CCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 1221 123599999999999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-28 Score=245.49 Aligned_cols=175 Identities=37% Similarity=0.672 Sum_probs=149.9
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHh-CCCCCcceeeEEEEeCCeEEEEEecCCC
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL-LDHPFLPTLYASFQTSTHICLITDFCPG 390 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~-l~HpnIv~l~~~~~~~~~~~lVmEy~~g 390 (489)
+.||+|+||.||+|.+..+++.||+|.+++..............|..++.. ++||||+++++++.+...+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 468999999999999999999999999987644333445566778888876 4899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----------
Q 042772 391 GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----------- 459 (489)
Q Consensus 391 gsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----------- 459 (489)
|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecC
Confidence 9999999765 348899999999999999999999999999999999999999999999999975321
Q ss_pred ----CCCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 ----CKPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----~~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+ ....+|+|++|++++++++|..||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~ 197 (316)
T cd05619 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred CccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 1121 1234599999999999999999984
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-28 Score=245.52 Aligned_cols=181 Identities=23% Similarity=0.349 Sum_probs=157.5
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 383 (489)
..++|++.+.||+|+||.||+|.+..++..+|+|.+.... .......+.+|+++++.++||||++++++|...+.+++
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 4568999999999999999999999999999999887542 23345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEecCCcEEEEecCCccccCC--
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL-GIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC-- 460 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~-gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~-- 460 (489)
||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 81 CMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred EEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 99999999999999875 3488999999999999999999975 799999999999999999999999999864321
Q ss_pred -----------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 -----------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -----------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 203 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP 203 (333)
T ss_pred cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 1221 234699999999999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-28 Score=250.16 Aligned_cols=180 Identities=27% Similarity=0.315 Sum_probs=153.2
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC-eEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST-HICL 383 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-~~~l 383 (489)
.++|.....||+|+||.||+|...+ |..||||.++...... ..+|..|+.++.+++|||+|+++|+|.+.. +.+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 3679999999999999999999886 4899999876543211 455999999999999999999999999888 5999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLG---IIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~g---IvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
|+||+++|+|.++|......+++|.....|+.++|.||+|||... |+||||||+|||+|++..+||+|||+|+....
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 999999999999998864326899999999999999999999754 99999999999999999999999999976543
Q ss_pred ----------------CCcee------ecccccchHHHHHHHHhCCcccC
Q 042772 461 ----------------KPQVF------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ----------------~~~~~------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|++. ..+||++||..+-|+++|..+..
T Consensus 230 ~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d 279 (361)
T KOG1187|consen 230 GDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVD 279 (361)
T ss_pred cccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccC
Confidence 12222 24588999999999999986543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-28 Score=240.25 Aligned_cols=179 Identities=20% Similarity=0.278 Sum_probs=152.6
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|++.+.||+|+||.||+|.++.+++.||+|.+..... .......+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 69999999999999999999999999999999976432 23345667889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC------ 460 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~------ 460 (489)
|++++.+..+... . ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 81 YVEKNMLELLEEM-P-NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred cCCCCHHHHHHhc-C-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 9988766554433 2 3489999999999999999999999999999999999999999999999999864321
Q ss_pred ----------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ----------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ----------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~ 202 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFP 202 (287)
T ss_pred cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCC
Confidence 1221 234589999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=244.54 Aligned_cols=179 Identities=24% Similarity=0.391 Sum_probs=156.1
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe-----CCe
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT-----STH 380 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~ 380 (489)
..|..++.||.|+||.|..|.++.+|+.||||.+... ..+....++..+|+.+|+.++|+||+.+.+.+.. -+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 3566689999999999999999999999999998643 3466678899999999999999999999999876 247
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
+|+|+|+| +.+|.+.++.+ +.++++.+..+++|+++||.|+|+.+|+||||||.|+|++.+..+||||||+|+.+..
T Consensus 101 vYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred eEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 99999999 67999999886 3489999999999999999999999999999999999999999999999999997732
Q ss_pred ---C-------Ccee--------------ecccccchHHHHHHHHhCCcccC
Q 042772 461 ---K-------PQVF--------------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---~-------~~~~--------------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. ...| ..-|+||.|+++-||++|...|.
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFp 229 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFP 229 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCC
Confidence 1 1112 23389999999999999998885
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-28 Score=244.23 Aligned_cols=175 Identities=37% Similarity=0.658 Sum_probs=152.3
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEecCCC
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHICLITDFCPG 390 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lVmEy~~g 390 (489)
+.||+|+||.||+|.++.+++.||+|++.+...........+..|..++..+ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999999876554455667778899999887 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----------
Q 042772 391 GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----------- 459 (489)
Q Consensus 391 gsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----------- 459 (489)
|+|..++... ..+++..+..++.|++.||.|||++||+||||||+|||+++++.+||+|||++....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceec
Confidence 9999998775 348999999999999999999999999999999999999999999999999875311
Q ss_pred ----CCCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 ----CKPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----~~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+ ....+|+|++|++++++++|..||.
T Consensus 159 ~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~ 197 (318)
T cd05570 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197 (318)
T ss_pred CccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCC
Confidence 0111 1234599999999999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=257.60 Aligned_cols=188 Identities=26% Similarity=0.362 Sum_probs=157.3
Q ss_pred CccccccCcccccccCCCCceEEEEEEEcCCCc---E-EEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEE
Q 042772 300 GEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGE---L-YAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASF 375 (489)
Q Consensus 300 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~-vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 375 (489)
.+.+..++..+.+.||+|+||.||+|..+..+. . ||+|..+.+....+.....+..|.++|++++|||||++||+.
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345666777788999999999999999875422 3 899998764445677889999999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCc
Q 042772 376 QTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455 (489)
Q Consensus 376 ~~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS 455 (489)
..+..+++|||+|+||+|.++|.+.+. .++..+...++.+.+.||+|||+++++||||..+|+|++.++.+||+|||+|
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 999999999999999999999998754 4899999999999999999999999999999999999999999999999999
Q ss_pred cccC--------C-CCcee------------ecccccchHHHHHHHHh-CCcccC
Q 042772 456 FMTS--------C-KPQVF------------YHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 456 ~~~~--------~-~~~~~------------~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+... + -|-.| ..+|||+||..++|+.. |..||.
T Consensus 310 ~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~ 364 (474)
T KOG0194|consen 310 RAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYP 364 (474)
T ss_pred cCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCC
Confidence 7543 1 12222 33477777777777653 666765
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-29 Score=258.37 Aligned_cols=183 Identities=25% Similarity=0.463 Sum_probs=156.9
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe-EEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH-ICL 383 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~-~~l 383 (489)
.++|..++.+|+|+||.++++.++..++.|++|.+.......+. ......|+.+++++.|||||.+.+.|..++. ++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 35799999999999999999999999999999999876655443 3467889999999999999999999998887 999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCCC-
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKP- 462 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~~- 462 (489)
||+||+||+|.+.++++.+..++++.+..|+.|++.|+.|||+++|+|||||+.|||+++++.|||+|||+|+.....-
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 9999999999999999877779999999999999999999999999999999999999999999999999998765321
Q ss_pred --------ceeecccc---cchHHHHHHHHhCCcccC
Q 042772 463 --------QVFYHAHV---NGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 463 --------~~~~~~~v---~s~g~~a~e~~~G~lpY~ 488 (489)
.++..+.+ -.||+..|+|++||.+|+
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yE 198 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYE 198 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHH
Confidence 11111111 236777778888887774
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=245.42 Aligned_cols=175 Identities=43% Similarity=0.716 Sum_probs=149.8
Q ss_pred ccccCCCCceEEEEEEE---cCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEec
Q 042772 311 IKPLGCGDTGSVHLVEL---QGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDF 387 (489)
Q Consensus 311 ~~~LG~G~fG~Vy~a~~---~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 387 (489)
++.||+|+||.||++.. +.+|+.||+|++.+.... ......+..|++++++++||||+++++++.....+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 36799999999999986 357899999999765432 22345567899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC------
Q 042772 388 CPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK------ 461 (489)
Q Consensus 388 ~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~------ 461 (489)
+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 157 (318)
T cd05582 80 LRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 157 (318)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceec
Confidence 9999999999765 34899999999999999999999999999999999999999999999999998643211
Q ss_pred ---------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 462 ---------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ---------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+ ....+|+|++|++++++++|..||.
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 199 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQ 199 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCC
Confidence 11 1235699999999999999999985
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=256.85 Aligned_cols=177 Identities=28% Similarity=0.441 Sum_probs=156.0
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-C-----CCcceeeEEEEeCCe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-H-----PFLPTLYASFQTSTH 380 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-H-----pnIv~l~~~~~~~~~ 380 (489)
+|.+++.||+|+||+|-+|.+..|++.||||+++.. .....+...|+.+|..|+ | -|+|+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 799999999999999999999999999999999754 445667778999999986 4 389999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC--CcEEEEecCCcccc
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD--GHVVLTDFDLSFMT 458 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~--g~vKL~DFGlS~~~ 458 (489)
+|||+|.+ .-+|+++++.+....++...++.++.||+.||.+||+.||||+||||+||||..- ..|||+|||.|+..
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999999 6699999999988889999999999999999999999999999999999999643 47999999999754
Q ss_pred CC------------CCcee------ecccccchHHHHHHHHhCCcccC
Q 042772 459 SC------------KPQVF------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~~------------~~~~~------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.. +|+++ ..-|+||+|+++-|+.+|..+|.
T Consensus 342 ~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 342 SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 42 12222 33499999999999999988875
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-28 Score=244.44 Aligned_cols=178 Identities=21% Similarity=0.327 Sum_probs=150.6
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC-----CeE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS-----THI 381 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~ 381 (489)
+|++.+.||+|+||.||+|.++.+++.||+|.+.... ........+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5889999999999999999999999999999986432 2233445678899999999999999999987543 358
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC--
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS-- 459 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~-- 459 (489)
|+||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 80 YVVFELM-ESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEEecC-CCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999999 579999987653 48999999999999999999999999999999999999999999999999986421
Q ss_pred ----------------CCCce--------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ----------------CKPQV--------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----------------~~~~~--------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~ 209 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 209 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCC
Confidence 11221 123589999999999999999984
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=246.41 Aligned_cols=173 Identities=38% Similarity=0.622 Sum_probs=147.1
Q ss_pred cCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCCcceeeEEEEeCCeEEEEEecCCC
Q 042772 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL---DHPFLPTLYASFQTSTHICLITDFCPG 390 (489)
Q Consensus 314 LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l---~HpnIv~l~~~~~~~~~~~lVmEy~~g 390 (489)
||+|+||+||+|.++.+++.||+|++.+..............|..++..+ .||||+.+++++.....+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765443344455566677777655 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----------
Q 042772 391 GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----------- 459 (489)
Q Consensus 391 gsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----------- 459 (489)
|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccC
Confidence 9999998765 448999999999999999999999999999999999999999999999999986321
Q ss_pred ----CCCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 ----CKPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----~~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+ ....+|+|++|+++++|++|..||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~ 198 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY 198 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCC
Confidence 1122 1234699999999999999999984
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=253.81 Aligned_cols=178 Identities=26% Similarity=0.387 Sum_probs=158.4
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
...|...+.||+|+.|.||.|....+++.||+|.++.... ....-+.+|+.+|+..+|+|||.+++.|...+.+|+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 3568899999999999999999999999999999987643 3346678999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC---- 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~---- 460 (489)
|||++||+|-+.+... .++|.++..++.+++.||+|||.+||+|||||.+|||++.+|.+||+|||++....+
T Consensus 349 MEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred EeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 9999999999998764 389999999999999999999999999999999999999999999999999865442
Q ss_pred -----CCceeec------------ccccchHHHHHHHHhCCcccC
Q 042772 461 -----KPQVFYH------------AHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -----~~~~~~~------------~~v~s~g~~a~e~~~G~lpY~ 488 (489)
...+|++ .|+|++|.++.||.-|..||.
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYl 470 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYL 470 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCcc
Confidence 2334433 388999999999999999997
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=248.89 Aligned_cols=180 Identities=31% Similarity=0.442 Sum_probs=158.2
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
-|.+.+.||+|.|..|.+|++.-||..||+|++++..+.. .....+..|+..|+.++|||||++|.+..++..+|||+|
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4889999999999999999999999999999999877643 344567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe-cCCcEEEEecCCccccC------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQ-KDGHVVLTDFDLSFMTS------ 459 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld-~~g~vKL~DFGlS~~~~------ 459 (489)
+=.+|+|++|+.++..+ +.|+.+..++.||+.|+.|+|+..+|||||||+||++. +-|.|||+|||+|....
T Consensus 98 LGD~GDl~DyImKHe~G-l~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~ 176 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEG-LNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLT 176 (864)
T ss_pred ecCCchHHHHHHhhhcc-ccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhh
Confidence 99999999999887544 89999999999999999999999999999999998775 56899999999995321
Q ss_pred --------CCCcee-------ecccccchHHHHHHHHhCCcccC
Q 042772 460 --------CKPQVF-------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 --------~~~~~~-------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+.. ...++|++|+++|.+.||..||.
T Consensus 177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFq 220 (864)
T KOG4717|consen 177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQ 220 (864)
T ss_pred cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccc
Confidence 223222 23389999999999999999995
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=236.56 Aligned_cols=182 Identities=24% Similarity=0.328 Sum_probs=149.7
Q ss_pred ccCcccccccCCCCceEEEEEEEcC----------------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCc
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQG----------------AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFL 368 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~----------------tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnI 368 (489)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.++..++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence 4579999999999999999998642 34579999986542 34445678899999999999999
Q ss_pred ceeeEEEEeCCeEEEEEecCCCCCHHHHHhhCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q 042772 369 PTLYASFQTSTHICLITDFCPGGELFALLDKQP-----------------MKIFREDSARFYAAEVVIGLEYLHCLGIIY 431 (489)
Q Consensus 369 v~l~~~~~~~~~~~lVmEy~~ggsL~~~L~~~~-----------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvH 431 (489)
+++++++......++||||+++|+|.+++.... ...+++..+..++.||+.||.|||++||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999986531 123577888999999999999999999999
Q ss_pred cCCCCCCEEEecCCcEEEEecCCccccCC-----------------CCc------eeecccccchHHHHHHHHh--CCcc
Q 042772 432 RDLKPENILLQKDGHVVLTDFDLSFMTSC-----------------KPQ------VFYHAHVNGFYFIMYKWLT--GYFT 486 (489)
Q Consensus 432 rDLKP~NILld~~g~vKL~DFGlS~~~~~-----------------~~~------~~~~~~v~s~g~~a~e~~~--G~lp 486 (489)
|||||+|||++.++.+||+|||+++.... +|+ ....+|+|++|++++++++ |..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999864311 111 1234588999999999876 4566
Q ss_pred cC
Q 042772 487 YV 488 (489)
Q Consensus 487 Y~ 488 (489)
|.
T Consensus 242 ~~ 243 (304)
T cd05096 242 YG 243 (304)
T ss_pred CC
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=232.83 Aligned_cols=183 Identities=16% Similarity=0.225 Sum_probs=154.0
Q ss_pred ccccCcccccccCCCCceEEEEEEEc---CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQ---GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
+...+|++.+.||+|+||.||+|.++ ..+..||+|.++... .......+..|+.+++.++||||+++++++....
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 34567999999999999999999875 446799999987542 2344567888999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.++++|||.+....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999999997653 358999999999999999999999999999999999999999999999999864321
Q ss_pred ----------------CCCc------eeecccccchHHHHHHHH-hCCcccC
Q 042772 460 ----------------CKPQ------VFYHAHVNGFYFIMYKWL-TGYFTYV 488 (489)
Q Consensus 460 ----------------~~~~------~~~~~~v~s~g~~a~e~~-~G~lpY~ 488 (489)
.+|+ ....+|+|++|+++++++ +|..||.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~ 210 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYW 210 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcC
Confidence 0111 113469999999999965 5999984
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=233.83 Aligned_cols=180 Identities=41% Similarity=0.730 Sum_probs=159.8
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|++.+.||+|+||.||++.+..+++.+|+|.+.+...........+..|+++++.++||||+++++++......|+|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 68999999999999999999999999999999977654455566788899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC------ 460 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~------ 460 (489)
|+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++.....
T Consensus 82 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 159 (290)
T cd05580 82 YVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC 159 (290)
T ss_pred cCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCCC
Confidence 99999999999876 4589999999999999999999999999999999999999999999999999864321
Q ss_pred ------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ....|+|++|++++++++|..||.
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 199 (290)
T cd05580 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFF 199 (290)
T ss_pred CCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 1221 124599999999999999999985
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=247.36 Aligned_cols=173 Identities=21% Similarity=0.284 Sum_probs=149.4
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
+...+|++++.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++.++||||++++++|......+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 344679999999999999999999999999999996532 34567999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC---
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS--- 459 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~--- 459 (489)
++||++ +++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 160 lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 160 LILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 999999 57999998765 348899999999999999999999999999999999999999999999999985321
Q ss_pred -------------CCCce------eecccccchHHHHHHHHhCCccc
Q 042772 460 -------------CKPQV------FYHAHVNGFYFIMYKWLTGYFTY 487 (489)
Q Consensus 460 -------------~~~~~------~~~~~v~s~g~~a~e~~~G~lpY 487 (489)
.+|+. ...+|+|++|++++++++|..||
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~ 283 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 12222 22458999999999999998764
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=256.64 Aligned_cols=182 Identities=29% Similarity=0.379 Sum_probs=153.7
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC------
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST------ 379 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~------ 379 (489)
+.|...+.||+|+||.||+++++.+|+.||+|.+++.. ....++...+|+++|++++|||||++++.-.+..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 35778899999999999999999999999999997643 4455678889999999999999999998765433
Q ss_pred eEEEEEecCCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec--CC--cEEEEecCC
Q 042772 380 HICLITDFCPGGELFALLDKQ-PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK--DG--HVVLTDFDL 454 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~-~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~--~g--~vKL~DFGl 454 (489)
...++||||+||+|...|.+- ....|++.+.+.++..++.||.|||++||+||||||.||++.. +| ..||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 468999999999999999863 2234999999999999999999999999999999999999953 34 469999999
Q ss_pred ccccCCCC---------------------ceeecccccchHHHHHHHHhCCcccCC
Q 042772 455 SFMTSCKP---------------------QVFYHAHVNGFYFIMYKWLTGYFTYVP 489 (489)
Q Consensus 455 S~~~~~~~---------------------~~~~~~~v~s~g~~a~e~~~G~lpY~~ 489 (489)
|+.+.... .+....|.|++|+++|+-++|.+||.|
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 98665321 112234889999999999999999986
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-27 Score=233.63 Aligned_cols=181 Identities=22% Similarity=0.328 Sum_probs=147.7
Q ss_pred cCcccccccCCCCceEEEEEEEcC-CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCCcceeeEEEE-----
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQG-AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL---DHPFLPTLYASFQ----- 376 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~-tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l---~HpnIv~l~~~~~----- 376 (489)
++|++++.||+|+||.||+|.+.. +++.||+|.+....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 369999999999999999999854 46889999987543222 2223455677776665 6999999999885
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 377 TSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 377 ~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
....+++||||++ ++|.+++.......+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 2456999999995 699999987655568999999999999999999999999999999999999999999999999986
Q ss_pred ccCC--------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 457 MTSC--------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 457 ~~~~--------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.... +|+ ....+|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 210 (290)
T cd07862 159 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 210 (290)
T ss_pred eccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcC
Confidence 4321 121 1234599999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-27 Score=236.33 Aligned_cols=182 Identities=55% Similarity=0.936 Sum_probs=160.8
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|++.+.||+|+||.||+|....+++.||+|.+.+.........+.+..|+++++.++||||+++++.+......|+|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 68999999999999999999999999999999987655444567788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC------ 460 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~------ 460 (489)
|+.+++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence 99999999999876556789999999999999999999999999999999999999999999999998754321
Q ss_pred --------------------------------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 --------------------------------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 --------------------------------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++|..||.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 011 1124589999999999999999984
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=237.38 Aligned_cols=180 Identities=22% Similarity=0.339 Sum_probs=153.2
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|.+.+.||+|+||.||+|.++.+++.||+|.++.... ......+.+|+.+++.++||||+++++++..+...++|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 3579999999999999999999999999999999875432 22234566799999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----- 459 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----- 459 (489)
|||++ ++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 83 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 83 FEYLD-KDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred EeCCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 99996 58998887653 347899999999999999999999999999999999999999999999999985321
Q ss_pred ----------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ----------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~ 206 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFP 206 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 11221 224589999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=245.92 Aligned_cols=184 Identities=22% Similarity=0.312 Sum_probs=153.5
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGA-----GELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQ 376 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~ 376 (489)
+..++|++.+.||+|+||.||+|.+..+ +..||+|.+.... .......+..|+.+++.+ +||||+++++++.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 3456799999999999999999986544 3589999997543 233456788899999999 8999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhCC-------------------------------------------------------
Q 042772 377 TSTHICLITDFCPGGELFALLDKQP------------------------------------------------------- 401 (489)
Q Consensus 377 ~~~~~~lVmEy~~ggsL~~~L~~~~------------------------------------------------------- 401 (489)
....+++||||+++|+|.+++....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 9999999999999999999986421
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC--------
Q 042772 402 -------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC-------- 460 (489)
Q Consensus 402 -------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~-------- 460 (489)
...+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||+++....
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 12478888999999999999999999999999999999999999999999999864211
Q ss_pred ---------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 461 ---------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 ---------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++ |..||.
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~ 316 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYP 316 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 111 1234599999999999986 999984
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=241.48 Aligned_cols=174 Identities=24% Similarity=0.378 Sum_probs=142.9
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC--C---eE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS--T---HI 381 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~---~~ 381 (489)
.|...+.+|+|+||.||.|....+++.||||.+-.... .--+|.++|+.++|||||++.-+|... . .+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 48889999999999999999999999999998865421 112499999999999999999888643 2 56
Q ss_pred EEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC-CcEEEEecCCcccc
Q 042772 382 CLITDFCPGGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD-GHVVLTDFDLSFMT 458 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~-g~vKL~DFGlS~~~ 458 (489)
.+||||+|. +|.+.++.. .+..++.-.++.+..||++||.|||+.||+||||||.|+|+|.+ |.+||||||.|..+
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 789999975 999999842 22347888899999999999999999999999999999999965 89999999999765
Q ss_pred CC-C--------------------CceeecccccchHHHHHHHHhCCcccC
Q 042772 459 SC-K--------------------PQVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~~-~--------------------~~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.. . .++...-|+||.|+.+-|++.|...|.
T Consensus 177 ~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFp 227 (364)
T KOG0658|consen 177 VKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFP 227 (364)
T ss_pred ccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccC
Confidence 31 1 122223388999999999998888774
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=244.63 Aligned_cols=178 Identities=22% Similarity=0.373 Sum_probs=152.3
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----eE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST-----HI 381 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~~ 381 (489)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... .......++.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4888999999999999999999999999999986432 23334567888999999999999999999998776 79
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 99999995 6898888664 4589999999999999999999999999999999999999999999999999864221
Q ss_pred ---------------CCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------------KPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------------~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ .....|+|++|++++++++|..||.
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 206 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence 111 1234599999999999999999984
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-27 Score=227.42 Aligned_cols=180 Identities=23% Similarity=0.459 Sum_probs=157.5
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|++.+.||.|+||.||++.+..+++.+|+|.+.... .....+.+..|..+++.++||||+++++++.+...+|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4888999999999999999999999999999986432 23456778889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC-----
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK----- 461 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~----- 461 (489)
|+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||++++++.++|+|||++......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence 999999999998765566899999999999999999999999999999999999999999999999998643211
Q ss_pred ----------Cce------eecccccchHHHHHHHHhCCcccC
Q 042772 462 ----------PQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ----------~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+. ...+|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~ 201 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQ 201 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCC
Confidence 111 134589999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=241.89 Aligned_cols=178 Identities=23% Similarity=0.389 Sum_probs=150.7
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST----- 379 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----- 379 (489)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4689999999999999999999999999999999975432 3344567788999999999999999999986543
Q ss_pred -eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 380 -HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 380 -~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
.+|+||||++ ++|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 5799999995 577777643 2788999999999999999999999999999999999999999999999998632
Q ss_pred C--------------CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 459 S--------------CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~--------------~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. .+|+. ...+|+|++|++++++++|..||.
T Consensus 174 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 223 (359)
T cd07876 174 CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223 (359)
T ss_pred ccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 1 12222 234599999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=232.72 Aligned_cols=182 Identities=26% Similarity=0.420 Sum_probs=154.5
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccc-----cchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEe
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVM-----LNRNKVHRACIEREIMSLL-DHPFLPTLYASFQT 377 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~-----~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~ 377 (489)
.+..|...+.||.|..+.|.++.++.+|+.+|+|++..... ...........|+.||+++ .||+|+.+.++|++
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 35679999999999999999999999999999999965322 1223345667799999997 69999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccc
Q 042772 378 STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 378 ~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
+..+++|+|.|+.|.|+++|... -++++..++.++.|+..|++|||.++||||||||+|||++++..+||+|||+|+.
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeec
Confidence 99999999999999999999875 4599999999999999999999999999999999999999999999999999975
Q ss_pred cCC--------------------------CCceeecccccchHHHHHHHHhCCccc
Q 042772 458 TSC--------------------------KPQVFYHAHVNGFYFIMYKWLTGYFTY 487 (489)
Q Consensus 458 ~~~--------------------------~~~~~~~~~v~s~g~~a~e~~~G~lpY 487 (489)
+.. .|-+....|.|+.|++++-++.||.||
T Consensus 173 l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF 228 (411)
T KOG0599|consen 173 LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF 228 (411)
T ss_pred cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch
Confidence 441 122222336677788888888888776
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-27 Score=251.26 Aligned_cols=180 Identities=22% Similarity=0.281 Sum_probs=153.7
Q ss_pred cCcccccccCCCCceEEEEEEEcCC-CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGA-GELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~t-g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
..|.+.+.||+|+||.||+|....+ ++.||+|.+... .......+..|+.+++.++||||+++++++...+.+|+|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 3599999999999999999998877 788999976433 334456677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC--
Q 042772 385 TDFCPGGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC-- 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~-- 460 (489)
|||+++|+|.+++... ...++++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999999988642 234589999999999999999999999999999999999999999999999999864321
Q ss_pred ---------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++|..||.
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~ 272 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK 272 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 111 1123489999999999999999985
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=225.03 Aligned_cols=181 Identities=25% Similarity=0.424 Sum_probs=158.5
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|.+.+.||+|++|.||+|.++.+++.|++|.+..... .......+..|+.+++.++||||+++++++......++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 47888999999999999999999999999999875433 34456778889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC------ 460 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~------ 460 (489)
|+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~ 159 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence 99999999999876555689999999999999999999999999999999999999999999999998764321
Q ss_pred ---------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 202 (256)
T cd08529 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202 (256)
T ss_pred ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 1111 134699999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-27 Score=228.28 Aligned_cols=183 Identities=18% Similarity=0.304 Sum_probs=158.2
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++.+.||+|+||.||+|....+++.||+|.++............+..|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999999999999999887654445556677888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC----
Q 042772 386 DFCPGGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS---- 459 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~---- 459 (489)
||+++++|.+++... ....+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 999999999988642 22447899999999999999999999999999999999999999999999999876422
Q ss_pred -----------CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 -----------CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 -----------~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~ 207 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 11222 123589999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-27 Score=243.67 Aligned_cols=184 Identities=21% Similarity=0.317 Sum_probs=153.0
Q ss_pred ccccCcccccccCCCCceEEEEEEE-----cCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVEL-----QGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQ 376 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~ 376 (489)
+..++|++.+.||+|+||.||+|.+ ..++..||+|+++... .....+.+.+|+.++..+ +||||+++++++.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 4456799999999999999999974 3457789999986542 233456788899999999 8999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhCC-------------------------------------------------------
Q 042772 377 TSTHICLITDFCPGGELFALLDKQP------------------------------------------------------- 401 (489)
Q Consensus 377 ~~~~~~lVmEy~~ggsL~~~L~~~~------------------------------------------------------- 401 (489)
.....++||||+++|+|.+++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 9999999999999999999986532
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC---
Q 042772 402 ------------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC--- 460 (489)
Q Consensus 402 ------------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~--- 460 (489)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 12467888999999999999999999999999999999999999999999999853221
Q ss_pred --------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 461 --------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 --------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++ |..||.
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~ 318 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP 318 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 111 1234589999999999986 888874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=250.07 Aligned_cols=183 Identities=28% Similarity=0.452 Sum_probs=161.4
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
.....|.+.+.||+|.|+.|.+|.+..|+..||||.+++.... ...++.+.+|+++|+.++|||||+++.+...+..+|
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln-~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN-PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC-hHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 3456799999999999999999999999999999999987654 444555899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC---
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS--- 459 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~--- 459 (489)
+||||+.+|.+++++..+.. ..+..++.++.|++.|++|||+++|+|||||++||||+.+..+||+|||+|....
T Consensus 132 lV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred EEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc
Confidence 99999999999999998744 6779999999999999999999999999999999999999999999999996433
Q ss_pred -----CC------C-------ceeecccccchHHHHHHHHhCCcccC
Q 042772 460 -----CK------P-------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 -----~~------~-------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|. | ......|+|++|..+|-+..|.+||+
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD 256 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD 256 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccC
Confidence 11 1 11233488999999999999999986
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=233.10 Aligned_cols=178 Identities=23% Similarity=0.357 Sum_probs=155.7
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|+++++.++||||+++++++..++.++++||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 6999999999999999999999999999999886532 33455678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC-LGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
|+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+|||++.++.+||+|||++.....
T Consensus 80 y~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (308)
T cd06615 80 HMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 157 (308)
T ss_pred ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccccccc
Confidence 99999999999875 448999999999999999999997 5999999999999999999999999998864221
Q ss_pred --------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 --------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 --------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++|..||.
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~ 199 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP 199 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 111 1234689999999999999999984
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=225.00 Aligned_cols=181 Identities=27% Similarity=0.475 Sum_probs=158.5
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|+.++.||.|+||.||.+....+++.+++|.+..... .......+.+|++++++++||||+++++++.....++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 58999999999999999999999999999999875433 23445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC-----
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK----- 461 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~----- 461 (489)
|+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 999999999998765556899999999999999999999999999999999999999999999999988643211
Q ss_pred ----------Cce------eecccccchHHHHHHHHhCCcccC
Q 042772 462 ----------PQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ----------~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+. ...+|+|++|++++++++|..||.
T Consensus 160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~ 202 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD 202 (256)
T ss_pred ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCC
Confidence 111 134699999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-27 Score=262.05 Aligned_cols=183 Identities=24% Similarity=0.305 Sum_probs=156.0
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++.+.||+|+||.||+|.+..+++.||+|.+...........+++.+|+.+++.++||||+++++++.+.+..|++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999999999999999997654434445677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 386 DFCPGGELFALLDKQP---------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~---------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
||++||+|.+++.... ...++...+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 9999999999986421 1224566778899999999999999999999999999999999999999999986
Q ss_pred ccC----------------------------C-----CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 457 MTS----------------------------C-----KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 457 ~~~----------------------------~-----~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... . +|+. ...+|+|++|++++++++|..||.
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~ 232 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 441 0 1111 123489999999999999999984
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-27 Score=228.58 Aligned_cols=183 Identities=20% Similarity=0.334 Sum_probs=158.6
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++.+.||+|+||.||+|....++..+|+|.+.............+..|+.+++.++||||+++++++......+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57999999999999999999999999999999887654445556678889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC---
Q 042772 386 DFCPGGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC--- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~--- 460 (489)
||+++++|.+++... ....+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 999999999998742 234589999999999999999999999999999999999999999999999998754321
Q ss_pred ------------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ------------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ------------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 207 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcc
Confidence 1211 123599999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-27 Score=228.67 Aligned_cols=180 Identities=36% Similarity=0.615 Sum_probs=160.4
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|++.+.||.|+||.||+|.+..+++.||+|.+.+.........+.+..|++++++++||||+++++++......++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 48899999999999999999999999999999987655555567889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC-----
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK----- 461 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~----- 461 (489)
|+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 158 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS 158 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccc
Confidence 99999999999875 35899999999999999999999999999999999999999999999999988643211
Q ss_pred ---------Cce------eecccccchHHHHHHHHhCCcccC
Q 042772 462 ---------PQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ---------~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+. ...+|+|++|.+++++++|..||.
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 200 (258)
T cd05578 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200 (258)
T ss_pred cCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCC
Confidence 111 235699999999999999999986
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=258.30 Aligned_cols=157 Identities=29% Similarity=0.384 Sum_probs=139.5
Q ss_pred cCCCccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEE-
Q 042772 297 TGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYAS- 374 (489)
Q Consensus 297 ~~~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~- 374 (489)
.|....++..++++.+.|.+|||+.||+|.+...|..||+|.+-. .+...+..+++|+++|++|. |+|||.++++
T Consensus 28 ~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~---~de~~L~~v~~EI~~MK~L~gh~nIV~yidss 104 (738)
T KOG1989|consen 28 VGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV---NDEEALNAVKREIDIMKLLSGHKNIVSYIDSS 104 (738)
T ss_pred CceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec---CCHHHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence 344556777899999999999999999999998889999998843 36778899999999999996 9999999993
Q ss_pred EEeC------CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEecCCc
Q 042772 375 FQTS------THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLG--IIYRDLKPENILLQKDGH 446 (489)
Q Consensus 375 ~~~~------~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~g--IvHrDLKP~NILld~~g~ 446 (489)
.... -.++|+||||+||.|-++|..+....|++.+++.|+.|+|+||.+||... |||||||-|||||+.+|+
T Consensus 105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~ 184 (738)
T KOG1989|consen 105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN 184 (738)
T ss_pred cccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC
Confidence 3221 25899999999999999999765566999999999999999999999988 999999999999999999
Q ss_pred EEEEecCCcc
Q 042772 447 VVLTDFDLSF 456 (489)
Q Consensus 447 vKL~DFGlS~ 456 (489)
.||||||.++
T Consensus 185 ~KLCDFGSat 194 (738)
T KOG1989|consen 185 YKLCDFGSAT 194 (738)
T ss_pred EEeCcccccc
Confidence 9999999986
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=227.41 Aligned_cols=179 Identities=22% Similarity=0.323 Sum_probs=155.1
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
..+|++.+.||+|+||.||+|.+..+++.||+|++.... ......+..|+.+++.++||||+++++++.....+++|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 467999999999999999999999999999999986542 22345677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----- 459 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----- 459 (489)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 85 MEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 9999999999998765 348999999999999999999999999999999999999999999999999885321
Q ss_pred ----------CCCcee---------ecccccchHHHHHHHHhCCcccC
Q 042772 460 ----------CKPQVF---------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----------~~~~~~---------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+.. ..+|+|++|++++++++|..||.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~ 210 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 112211 24689999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-27 Score=235.71 Aligned_cols=181 Identities=24% Similarity=0.327 Sum_probs=151.6
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcE----EEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGEL----YAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~----vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
...+|+..+.||+|+||.||+|.+..++.. ||+|.++.. ......+.+..|+.+++.++||||+++++++...
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 346799999999999999999998766654 899988643 2344566788899999999999999999998765
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
..++++||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 5789999999999999998753 347889999999999999999999999999999999999999999999999997432
Q ss_pred C-----------------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 460 C-----------------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 460 ~-----------------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
. .|+. ...+|+|++|++++|+++ |..||.
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~ 213 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 1 1111 123489999999999876 999985
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=232.95 Aligned_cols=180 Identities=35% Similarity=0.657 Sum_probs=157.7
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|++.+.||+|+||.||++.+..+++.|++|.+.+...........+..|+.+++.++||||+++++.+.....+++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999976644444556778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc--------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT-------- 458 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~-------- 458 (489)
|++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++..
T Consensus 82 ~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 82 YVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 99999999999775 34899999999999999999999999999999999999999999999999987531
Q ss_pred ----------------------CCCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 459 ----------------------SCKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ----------------------~~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
..+|+. ...+|+|++|++++++++|..||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~ 217 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 217 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 011221 123588999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=233.64 Aligned_cols=184 Identities=22% Similarity=0.340 Sum_probs=153.5
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcE--EEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCC
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGEL--YAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTST 379 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~--vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~ 379 (489)
+..++|++.+.||+|+||.||+|.++.++.. +|+|.+... ........+..|+.++.++ +||||+++++++...+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 3456899999999999999999999877764 466665432 2344556788899999999 8999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC
Q 042772 380 HICLITDFCPGGELFALLDKQP--------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG 445 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~--------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g 445 (489)
.+|+||||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999997542 12478999999999999999999999999999999999999999
Q ss_pred cEEEEecCCccccC--------------CCCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 446 HVVLTDFDLSFMTS--------------CKPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 446 ~vKL~DFGlS~~~~--------------~~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.+||+|||++.... .+|+ ....+|+|++|++++++++ |..||.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 225 (303)
T cd05088 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 225 (303)
T ss_pred cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcc
Confidence 99999999985221 1111 1235699999999999997 999884
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-26 Score=225.41 Aligned_cols=183 Identities=21% Similarity=0.335 Sum_probs=158.9
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++.+.||+|+||.||+|....+|+.||+|.++.....+....+.+.+|+++++.++|+||+++++++......+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 47999999999999999999999999999999987654445555678889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC---
Q 042772 386 DFCPGGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC--- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~--- 460 (489)
||+++++|.+++... ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 999999999998652 234478999999999999999999999999999999999999999999999998753221
Q ss_pred ------------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ------------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ------------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 207 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcc
Confidence 1221 124599999999999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=231.61 Aligned_cols=173 Identities=15% Similarity=0.170 Sum_probs=148.7
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe----CCeEEEEEec
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT----STHICLITDF 387 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~lVmEy 387 (489)
..||+|++|.||+|.+ +|+.||+|.+.+.........+.+.+|+.++++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6789999999999998 488999999976544444446778899999999999999999999876 3578999999
Q ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecCCccccCC------
Q 042772 388 CPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC-LGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC------ 460 (489)
Q Consensus 388 ~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~------ 460 (489)
+++|+|.+++... ..+++.....++.|++.||.|||+ .+++||||||+|||+++++.+||+|||++.....
T Consensus 104 ~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~~ 181 (283)
T PHA02988 104 CTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNV 181 (283)
T ss_pred CCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccccccc
Confidence 9999999999875 348899999999999999999998 4999999999999999999999999999864221
Q ss_pred ------CCc--------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ------KPQ--------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ------~~~--------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|++++|+++|..||.
T Consensus 182 ~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~ 223 (283)
T PHA02988 182 NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223 (283)
T ss_pred CcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC
Confidence 122 2235699999999999999999995
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=226.95 Aligned_cols=182 Identities=23% Similarity=0.291 Sum_probs=157.4
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
+...+|.+.+.||+|+||.||+|.++.+++.||+|.+... ......+.+|+.+++.++||||+++++++..+..++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 3445789999999999999999999999999999998643 223567888999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC--
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC-- 460 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~-- 460 (489)
++|||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||++.....
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999999999776555689999999999999999999999999999999999999999999999999864321
Q ss_pred --------------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 461 --------------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 --------------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.|+. ...+|+|++|++++++++ |..||.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~ 207 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 207 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 1221 124599999999999997 888874
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-26 Score=224.81 Aligned_cols=181 Identities=25% Similarity=0.333 Sum_probs=156.5
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVML--NRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 383 (489)
++|.+.+.||+|++|.||.|....+++.+|+|.+...... .......+.+|+.++++++||||+++++++.....+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4689999999999999999999999999999998754322 22345678889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC----
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS---- 459 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~---- 459 (489)
+|||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++....
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999999999999875 348899999999999999999999999999999999999999999999999985321
Q ss_pred --------------CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 --------------CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 --------------~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|.+++++++|..||.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 208 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWA 208 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcc
Confidence 11221 134599999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=226.55 Aligned_cols=182 Identities=24% Similarity=0.357 Sum_probs=155.7
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
.+..++|++++.||+|+||.||+|.... +..||+|.+.... ...+.+..|+.+++.++||||+++++++......
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 3556789999999999999999999764 6679999876432 2346788899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
+++|||+++++|.+++.......+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++.....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999999999999876555688999999999999999999999999999999999999999999999999864321
Q ss_pred ---------------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 461 ---------------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 ---------------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+. ....|+|++|++++++++ |..||.
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~ 206 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYP 206 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCC
Confidence 1111 123599999999999997 999984
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-28 Score=244.97 Aligned_cols=186 Identities=32% Similarity=0.547 Sum_probs=163.3
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
.+..+.|+.-++||+|+||.||-++.+.||+.||+|.+.+.....+.......+|..||+++..|+||.+-.+|++.+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 34556799999999999999999999999999999999988777777788889999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK 461 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~ 461 (489)
|+||..|.||+|.-+|.+.....+++..+++++++|+.||++||+.+||+|||||+|||+|+.|+|.|+|+|+|...+..
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999999888877667999999999999999999999999999999999999999999999999999755422
Q ss_pred --------------Cc------eeecccccchHHHHHHHHhCCccc
Q 042772 462 --------------PQ------VFYHAHVNGFYFIMYKWLTGYFTY 487 (489)
Q Consensus 462 --------------~~------~~~~~~v~s~g~~a~e~~~G~lpY 487 (489)
|+ +-..+|-|++|+++|||+-|..||
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPF 386 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPF 386 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCch
Confidence 11 123335566777777777777776
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=232.72 Aligned_cols=180 Identities=23% Similarity=0.336 Sum_probs=154.0
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
+++|++.+.||.|+||.||+|.+..+++.||+|.+..... ......+..|+.+++.++||||+++++++......++|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 4679999999999999999999999999999999865432 22234566799999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----- 459 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----- 459 (489)
|||++ ++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++....
T Consensus 83 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 83 FEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred Eeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 99996 69999887653 347899999999999999999999999999999999999999999999999885322
Q ss_pred ----------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ----------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~ 206 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFP 206 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCC
Confidence 11221 123589999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=224.40 Aligned_cols=174 Identities=20% Similarity=0.340 Sum_probs=148.6
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCCCC
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGG 391 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg 391 (489)
+.||+|+||.||+|.++.+++.+|+|.+.... .......+.+|+++++.++||||+++++++......++||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46899999999999999999999999876432 3344567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------------
Q 042772 392 ELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------------ 459 (489)
Q Consensus 392 sL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------------ 459 (489)
+|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++....
T Consensus 79 ~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 79 DFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred cHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999997643 347899999999999999999999999999999999999999999999999976321
Q ss_pred -----CCCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 460 -----CKPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 460 -----~~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++ |..||.
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~ 198 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYA 198 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 11221 123489999999999986 888874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=250.14 Aligned_cols=184 Identities=26% Similarity=0.342 Sum_probs=155.8
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC----
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST---- 379 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~---- 379 (489)
..++|++.+.||+|+||+||+|.+..+++.||+|.+..... .......+..|+.++..++|+||++++..+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34689999999999999999999999999999999976543 3445667888999999999999999988775432
Q ss_pred ----eEEEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecC
Q 042772 380 ----HICLITDFCPGGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFD 453 (489)
Q Consensus 380 ----~~~lVmEy~~ggsL~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFG 453 (489)
.+++||||+++|+|.+++... ....+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 378999999999999999753 23458999999999999999999999999999999999999999999999999
Q ss_pred CccccCC-----------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 454 LSFMTSC-----------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 454 lS~~~~~-----------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+++.... +|+ ....+|+|++|++++++++|..||.
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~ 246 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 9864321 111 1134589999999999999999985
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.3e-27 Score=238.38 Aligned_cols=178 Identities=22% Similarity=0.395 Sum_probs=151.3
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC------C
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS------T 379 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~ 379 (489)
++|++++.||.|+||.||+|.+..+++.||+|.+.+... .......+.+|+.+++.++||||+++++++... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 579999999999999999999999999999999875432 223445677899999999999999999987543 3
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
..|++|+++ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 579999988 7899988864 348999999999999999999999999999999999999999999999999986432
Q ss_pred ------------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ------------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ------------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 170 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 217 (343)
T cd07878 170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP 217 (343)
T ss_pred CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 12222 234699999999999999999984
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=226.35 Aligned_cols=181 Identities=23% Similarity=0.281 Sum_probs=154.4
Q ss_pred ccCcccccccCCCCceEEEEEEEcCC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGA---GELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
.++|++.+.||+|+||.||+|.++.+ ...||+|.++... .......+..|+.+++.++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 35799999999999999999998644 4589999886542 334456788899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC--
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS-- 459 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~-- 459 (489)
+++|||+++++|.+++..... .+++..+..++.|++.||.|||+++|+|+||||+||++++++.++|+|||++....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 999999999999999977543 58999999999999999999999999999999999999999999999999986542
Q ss_pred ---------------CCCcee------ecccccchHHHHHHHHh-CCcccC
Q 042772 460 ---------------CKPQVF------YHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 460 ---------------~~~~~~------~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.+|+.. ...|+|++|++++++++ |..||.
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~ 210 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW 210 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCC
Confidence 112211 24589999999999886 999984
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=230.12 Aligned_cols=180 Identities=26% Similarity=0.388 Sum_probs=147.8
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCCcceeeEEEEe-----C
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL---DHPFLPTLYASFQT-----S 378 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l---~HpnIv~l~~~~~~-----~ 378 (489)
+|++.+.||+|+||.||+|.++.+++.||+|.+...... ......+..|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 488999999999999999999999999999998754322 11223345577766654 79999999998864 3
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
..++++|||++ ++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 46899999996 59999988765555899999999999999999999999999999999999999999999999998643
Q ss_pred CC--------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 459 SC--------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~~--------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.. +|+ ....+|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~ 208 (288)
T cd07863 159 SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 208 (288)
T ss_pred cCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcC
Confidence 21 122 1234599999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=227.50 Aligned_cols=174 Identities=28% Similarity=0.378 Sum_probs=151.2
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|++++.||+|+||.||+|.+..+++.||+|.+.... .......+..|+.++++++||||+++++++......++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 6889999999999999999999999999999986542 23345678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------- 459 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------- 459 (489)
|+++++|..+. .+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++....
T Consensus 80 ~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 153 (279)
T cd06619 80 FMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY 153 (279)
T ss_pred cCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCC
Confidence 99999996542 26788999999999999999999999999999999999999999999999985321
Q ss_pred ------CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ------CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ------~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 194 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYP 194 (279)
T ss_pred CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCch
Confidence 12222 134599999999999999999984
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-27 Score=227.42 Aligned_cols=178 Identities=31% Similarity=0.530 Sum_probs=153.0
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEec
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDF 387 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 387 (489)
|++++.||+|+||+||++....+++.||+|.+....... ........|+.+++.++||||+++++++......+++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE-EEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH-HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc-cccchhhhhhhccccccccccccccccccccccccccccc
Confidence 678899999999999999999999999999998764322 2223345599999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC--------
Q 042772 388 CPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS-------- 459 (489)
Q Consensus 388 ~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~-------- 459 (489)
+++++|.+++... ..+++..+..++.|++.||.+||++|++|+||||+||++++++.++|+|||.+....
T Consensus 80 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999843 448999999999999999999999999999999999999999999999999985311
Q ss_pred -------CCC-------ceeecccccchHHHHHHHHhCCcccC
Q 042772 460 -------CKP-------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 -------~~~-------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+| ......|+|++|++++++++|..||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~ 200 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFE 200 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSST
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc
Confidence 112 22234488999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=228.87 Aligned_cols=183 Identities=21% Similarity=0.322 Sum_probs=153.5
Q ss_pred cccCcccccccCCCCceEEEEEEEc----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQ----GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~----~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
.+.+|++.+.||+|+||.||+|... .++..+|+|.+... ........+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4567999999999999999999863 35678999998643 23445567888999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC
Q 042772 380 HICLITDFCPGGELFALLDKQP---------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD 444 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~---------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~ 444 (489)
..|++|||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 9999999999999999985431 1247888999999999999999999999999999999999999
Q ss_pred CcEEEEecCCccccC-----------------CCCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 445 GHVVLTDFDLSFMTS-----------------CKPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 445 g~vKL~DFGlS~~~~-----------------~~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+.+||+|||+++... .+|+ ....+|+|++|++++++++ |..||.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~ 228 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY 228 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 999999999986431 1111 1234699999999999997 988873
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=226.31 Aligned_cols=180 Identities=25% Similarity=0.307 Sum_probs=156.4
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
..+|++.+.||.|+||.||+|.+.. +..+|+|.+.... ......+..|+.+++.++||||+++++++......++|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3579999999999999999999988 8899999987542 22345678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC---- 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~---- 460 (489)
|||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999999999876556689999999999999999999999999999999999999999999999999864321
Q ss_pred -----------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 461 -----------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 -----------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++ |..||.
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~ 206 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYP 206 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 1111 124599999999999997 899985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=227.63 Aligned_cols=183 Identities=23% Similarity=0.350 Sum_probs=154.4
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCC-----cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAG-----ELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS 378 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 378 (489)
...+|++.+.||+|+||.||+|.....+ ..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 4567999999999999999999987655 689999886442 334456788999999999999999999999988
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC
Q 042772 379 THICLITDFCPGGELFALLDKQPM--------------KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD 444 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~--------------~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~ 444 (489)
...|++|||+++++|.+++..... ..+++..+..++.|++.||.|||++|++|+||||+||+++++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 899999999999999999976421 347889999999999999999999999999999999999999
Q ss_pred CcEEEEecCCccccC-----------------CCCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 445 GHVVLTDFDLSFMTS-----------------CKPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 445 g~vKL~DFGlS~~~~-----------------~~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+.++|+|||++.... .+|+. ...+|+|++|++++|+++ |..||.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~ 228 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 999999999986421 11221 123589999999999986 998874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=226.32 Aligned_cols=179 Identities=25% Similarity=0.352 Sum_probs=155.5
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++.+.||+|+||.||+|.+..+++.||+|.++... ......+.+|+.+++.++||||+++++++.....+|++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 357999999999999999999999999999999986542 23345677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----- 459 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----- 459 (489)
|||+++++|.+++... +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 85 MEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred EeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 9999999999999765 348999999999999999999999999999999999999999999999999875321
Q ss_pred ----------CCCce---------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ----------CKPQV---------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----------~~~~~---------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~ 210 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence 11222 124699999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=228.31 Aligned_cols=179 Identities=27% Similarity=0.439 Sum_probs=156.7
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
+.|++++.||.|+||.||+|.+..+++.+++|.+... .......+..|+.+++.++||||+++++++..+...|+||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 5699999999999999999999999999999998654 3455677888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------ 459 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------ 459 (489)
||+++++|..++.+.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus 89 e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 167 (292)
T cd06644 89 EFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR 167 (292)
T ss_pred ecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccccc
Confidence 9999999998876543 348999999999999999999999999999999999999999999999999875321
Q ss_pred ---------CCCcee-----------ecccccchHHHHHHHHhCCcccC
Q 042772 460 ---------CKPQVF-----------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---------~~~~~~-----------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+.. ..+|+|++|++++++++|..||.
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 216 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 216 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCc
Confidence 123322 13699999999999999999974
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=238.15 Aligned_cols=179 Identities=22% Similarity=0.367 Sum_probs=150.8
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC-----
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS----- 378 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~----- 378 (489)
..++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35789999999999999999999999999999999865432 334456777899999999999999999988643
Q ss_pred -CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccc
Q 042772 379 -THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 379 -~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
...|+||||++ ++|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 35799999995 578777754 278899999999999999999999999999999999999999999999999864
Q ss_pred cCC--------------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 458 TSC--------------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 458 ~~~--------------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... +|+. ...+|+|++|++++++++|..||.
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 219 (355)
T cd07874 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_pred CCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 321 1211 234599999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=233.13 Aligned_cols=178 Identities=20% Similarity=0.315 Sum_probs=151.8
Q ss_pred cccccCCC--CceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEec
Q 042772 310 PIKPLGCG--DTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDF 387 (489)
Q Consensus 310 ~~~~LG~G--~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 387 (489)
+++.||+| +|++||++..+.+|+.||+|.++.... .......+.+|+.+++.++||||++++++|..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 789999999999999999999975532 233456677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC--------
Q 042772 388 CPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS-------- 459 (489)
Q Consensus 388 ~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~-------- 459 (489)
+++|+|.+++.......+++..+..++.|++.||.|||++||+||||||+|||++.++.++++||+.+....
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999999976544558999999999999999999999999999999999999999999999997532110
Q ss_pred --------------CCCce--------eecccccchHHHHHHHHhCCcccC
Q 042772 460 --------------CKPQV--------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 --------------~~~~~--------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 211 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 11222 234699999999999999999984
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=225.24 Aligned_cols=181 Identities=24% Similarity=0.326 Sum_probs=152.7
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCC---cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAG---ELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg---~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
..+|++.+.||+|+||.||+|.++.++ ..+|+|.++... .......+..|+.+++.++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 457999999999999999999986444 479999886542 233456788899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
|+||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999998754 3478999999999999999999999999999999999999999999999998864321
Q ss_pred -----------------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 461 -----------------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 -----------------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.|+. ....|+|++|++++++++ |..||.
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~ 211 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 211 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcc
Confidence 1111 123588999999999775 999884
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=228.30 Aligned_cols=180 Identities=26% Similarity=0.382 Sum_probs=155.9
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|++++.||+|+||.||+|.+..+++.||+|.+... ........+.+|+.+++.++||||+++++++...+..++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 689999999999999999999999999999988643 233445778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecCCccccC-----
Q 042772 387 FCPGGELFALLDKQP-MKIFREDSARFYAAEVVIGLEYLHC-LGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----- 459 (489)
Q Consensus 387 y~~ggsL~~~L~~~~-~~~l~e~~~~~i~~qI~~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----- 459 (489)
|+++++|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK 159 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccc
Confidence 999999999987631 2358999999999999999999996 599999999999999999999999999885321
Q ss_pred --------CCCce------------eecccccchHHHHHHHHhCCcccC
Q 042772 460 --------CKPQV------------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 --------~~~~~------------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 208 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP 208 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 12322 234699999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=229.39 Aligned_cols=180 Identities=25% Similarity=0.350 Sum_probs=153.5
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
+++|++.+.||+|++|.||+|..+.+++.||+|.+..... ......+.+|+++++.++||||+++++++......++|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 4679999999999999999999998999999999875432 11223456799999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----- 459 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----- 459 (489)
|||++ ++|.+++..... .+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+++...
T Consensus 82 ~e~~~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 82 FEYLD-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred EecCC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 99997 599999876543 58999999999999999999999999999999999999999999999999875321
Q ss_pred ----------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ----------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~ 205 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFP 205 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 11221 123589999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=226.64 Aligned_cols=175 Identities=31% Similarity=0.522 Sum_probs=152.5
Q ss_pred cCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCCCCCH
Q 042772 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGEL 393 (489)
Q Consensus 314 LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ggsL 393 (489)
||+|+||+||+|.+..+|+.||+|.+.+...........+..|+.+++.++||||+++++++......|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999999999999999999765444444556677899999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC--------------
Q 042772 394 FALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS-------------- 459 (489)
Q Consensus 394 ~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~-------------- 459 (489)
.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence 999987654568999999999999999999999999999999999999999999999999885332
Q ss_pred CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 161 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 195 (277)
T cd05577 161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFR 195 (277)
T ss_pred CCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCC
Confidence 11221 234699999999999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=226.67 Aligned_cols=179 Identities=26% Similarity=0.397 Sum_probs=156.7
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++++.||.|+||.||+|.+..++..+|+|.+... .......+..|+.+++.++||||+++++.+......|+||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 5699999999999999999999989999999998643 3445567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------ 459 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------ 459 (489)
||+++++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 82 EFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence 9999999999987643 358999999999999999999999999999999999999999999999999875321
Q ss_pred ---------CCCce-----------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ---------CKPQV-----------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---------~~~~~-----------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|.+++++++|..||.
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~ 209 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH 209 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcc
Confidence 11221 124699999999999999999984
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=245.47 Aligned_cols=176 Identities=21% Similarity=0.269 Sum_probs=144.6
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC------
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS------ 378 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------ 378 (489)
..+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||++++++|...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 457999999999999999999999999999999885431 1234699999999999999999877432
Q ss_pred --CeEEEEEecCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC-cEEEEecC
Q 042772 379 --THICLITDFCPGGELFALLDK--QPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG-HVVLTDFD 453 (489)
Q Consensus 379 --~~~~lVmEy~~ggsL~~~L~~--~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g-~vKL~DFG 453 (489)
..+++||||++ ++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 25789999996 578777753 2234589999999999999999999999999999999999998665 69999999
Q ss_pred CccccCC--------------CCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 454 LSFMTSC--------------KPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 454 lS~~~~~--------------~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+.... +|+. ....|+|++|++++++++|..||.
T Consensus 217 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 272 (440)
T PTZ00036 217 SAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFS 272 (440)
T ss_pred cchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9964321 1222 223589999999999999999984
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=223.44 Aligned_cols=178 Identities=27% Similarity=0.401 Sum_probs=151.4
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
..+|++.+.||+|+||.||++.++. +..+|+|.+..... ....+..|+.+++.++||||+++++++......+++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 4579999999999999999998865 56799998764422 234677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----- 459 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----- 459 (489)
|||+++|+|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++...
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 78 TEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 99999999999997643 347899999999999999999999999999999999999999999999999886321
Q ss_pred -----------CCCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 460 -----------CKPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 460 -----------~~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++ |..||.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~ 203 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFE 203 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCC
Confidence 11221 124589999999999998 898885
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=240.57 Aligned_cols=186 Identities=22% Similarity=0.268 Sum_probs=153.3
Q ss_pred ccccccCcccccccCCCCceEEEEEEEcCC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEE
Q 042772 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGA-----GELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYAS 374 (489)
Q Consensus 301 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~ 374 (489)
..+..++|++.+.||+|+||.||+|.+... +..||+|.+.... .....+.+.+|+.+++++. ||||++++++
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 344567899999999999999999987543 3479999986542 2344567889999999996 9999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhCC-----------------------------------------------------
Q 042772 375 FQTSTHICLITDFCPGGELFALLDKQP----------------------------------------------------- 401 (489)
Q Consensus 375 ~~~~~~~~lVmEy~~ggsL~~~L~~~~----------------------------------------------------- 401 (489)
+.....+|+|||||++|+|.+++..+.
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 999999999999999999999886531
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 042772 402 -----------------------------------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENIL 440 (489)
Q Consensus 402 -----------------------------------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NIL 440 (489)
...+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 123678888999999999999999999999999999999
Q ss_pred EecCCcEEEEecCCccccCC-----------------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 441 LQKDGHVVLTDFDLSFMTSC-----------------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 441 ld~~g~vKL~DFGlS~~~~~-----------------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
++.++.+||+|||+++.... +|+. ...+|+|++|++++++++ |..||.
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~ 341 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYP 341 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCc
Confidence 99999999999999864211 1111 124589999999999985 888874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=237.30 Aligned_cols=179 Identities=22% Similarity=0.367 Sum_probs=151.0
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC-----
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS----- 378 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~----- 378 (489)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 3578999999999999999999999999999999987543 2334456778899999999999999999987543
Q ss_pred -CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccc
Q 042772 379 -THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 379 -~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
..+|+||||++ ++|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 101 FQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred cCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 35899999995 588887754 278899999999999999999999999999999999999999999999999864
Q ss_pred cCC--------------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 458 TSC--------------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 458 ~~~--------------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... +|+. ...+|+|++|++++++++|..||.
T Consensus 176 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 226 (364)
T cd07875 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 226 (364)
T ss_pred cCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCC
Confidence 321 1111 234699999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=227.45 Aligned_cols=180 Identities=23% Similarity=0.331 Sum_probs=153.4
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|++++.||+|++|.||+|.+..+++.||+|.+..... .......+..|+.+++.++||||+++++++..+...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 48889999999999999999999999999999865422 22234567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------
Q 042772 387 FCPGGELFALLDKQP-MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------ 459 (489)
Q Consensus 387 y~~ggsL~~~L~~~~-~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------ 459 (489)
|++ ++|.+++.... ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY 158 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence 996 69999887643 2558999999999999999999999999999999999999999999999999875321
Q ss_pred ---------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ---------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~ 203 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH 203 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 11222 223589999999999999998884
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=243.42 Aligned_cols=149 Identities=25% Similarity=0.376 Sum_probs=133.7
Q ss_pred cccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCC
Q 042772 310 PIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCP 389 (489)
Q Consensus 310 ~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ 389 (489)
..+.||+|.||+||-|.++.+|+.||+|++++-... .+....+++|+.||+.+.||.||.+...|++...+++|||-+
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp-~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl- 645 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFP-TKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL- 645 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCC-CchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-
Confidence 458899999999999999999999999999886653 444578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC---CcEEEEecCCccccCC
Q 042772 390 GGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD---GHVVLTDFDLSFMTSC 460 (489)
Q Consensus 390 ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~---g~vKL~DFGlS~~~~~ 460 (489)
+|+..+.+-....+.+++....+++.||+.||.|||-++|+|+||||+|||+.+. -++||||||+|+.+..
T Consensus 646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE 719 (888)
T KOG4236|consen 646 HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE 719 (888)
T ss_pred cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence 6677777766666779999999999999999999999999999999999999754 4899999999997763
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=223.69 Aligned_cols=181 Identities=24% Similarity=0.308 Sum_probs=153.9
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccc--cchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC--CeE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVM--LNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS--THI 381 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~ 381 (489)
.+|++.+.||+|+||.||.|.+..+++.||+|.+..... ........+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 468999999999999999999999999999998864321 1234567888899999999999999999988763 468
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC--
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS-- 459 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~-- 459 (489)
+++|||+++++|.+++... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 8999999999999999865 347899999999999999999999999999999999999999999999999885321
Q ss_pred ----------------CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ----------------CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----------------~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 210 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA 210 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCC
Confidence 11221 134599999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=225.69 Aligned_cols=179 Identities=23% Similarity=0.379 Sum_probs=153.4
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeC------
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTS------ 378 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~------ 378 (489)
+.|++.+.||+|+||.||+|....+++.||+|.+.... .....+..|+.+++.+ +||||+++++++...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 46899999999999999999999999999999986542 2234677899999988 699999999998753
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
...|++|||+++++|.+++.......+++..+..++.|++.||.|||+++|+|+||||+||++++++.++|+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 46899999999999999998765556899999999999999999999999999999999999999999999999998632
Q ss_pred C---------------CCCcee-----------ecccccchHHHHHHHHhCCcccC
Q 042772 459 S---------------CKPQVF-----------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~---------------~~~~~~-----------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. .+|+.. ..+|+|++|++++++++|..||.
T Consensus 162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~ 217 (272)
T cd06637 162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 217 (272)
T ss_pred ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 1 112222 24799999999999999999984
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-26 Score=224.82 Aligned_cols=177 Identities=27% Similarity=0.410 Sum_probs=154.3
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEec
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDF 387 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 387 (489)
|++.+.||+|+||.||+|.+..++..+++|.+... .......+..|+.+++.++||||+++++++......++||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 78899999999999999999999999999998653 234566788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC--------
Q 042772 388 CPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS-------- 459 (489)
Q Consensus 388 ~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~-------- 459 (489)
+++++|..++.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (282)
T cd06643 84 CAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 162 (282)
T ss_pred cCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence 99999998876532 458999999999999999999999999999999999999999999999999885321
Q ss_pred -------CCCcee-----------ecccccchHHHHHHHHhCCcccC
Q 042772 460 -------CKPQVF-----------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 -------~~~~~~-----------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
..|+.. ..+|+|++|++++++++|..||.
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 209 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHH 209 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcc
Confidence 112221 25799999999999999999984
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-26 Score=220.62 Aligned_cols=179 Identities=24% Similarity=0.367 Sum_probs=156.4
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++.+.||.|+||.||+|....+++.+++|.+.... ....+.+..|+++++.++||||+++++++.....+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 47999999999999999999999999999999997542 235677888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------ 459 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------ 459 (489)
||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||++++++.+||+|||++....
T Consensus 80 e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 158 (262)
T cd06613 80 EYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR 158 (262)
T ss_pred eCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcc
Confidence 9999999999987652 348999999999999999999999999999999999999999999999999875321
Q ss_pred ---------CCCcee---------ecccccchHHHHHHHHhCCcccC
Q 042772 460 ---------CKPQVF---------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---------~~~~~~---------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+.. ..+|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~ 205 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF 205 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 112222 23589999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-26 Score=223.76 Aligned_cols=181 Identities=23% Similarity=0.330 Sum_probs=154.0
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGE---LYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
..+|++.+.||+|+||.||+|.++.++. .||+|.+.... .......+..|+.+++.++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4568999999999999999999887664 69999986542 344567788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 81 MIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999999997653 3488999999999999999999999999999999999999999999999998854221
Q ss_pred -------------------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 461 -------------------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 -------------------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+. ...+|+|++|++++|+++ |..||.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~ 213 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 213 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCC
Confidence 1111 124589999999999775 999884
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=234.56 Aligned_cols=184 Identities=23% Similarity=0.319 Sum_probs=151.5
Q ss_pred ccccCcccccccCCCCceEEEEEEEcC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQG-----AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQ 376 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~ 376 (489)
+..++|++.+.||+|+||.||+|...+ +++.||+|.+.... .....+.+..|+.++.++ +||||+++++++.
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 344689999999999999999997543 45789999886432 234456778899999999 7999999999876
Q ss_pred e-CCeEEEEEecCCCCCHHHHHhhCCC-----------------------------------------------------
Q 042772 377 T-STHICLITDFCPGGELFALLDKQPM----------------------------------------------------- 402 (489)
Q Consensus 377 ~-~~~~~lVmEy~~ggsL~~~L~~~~~----------------------------------------------------- 402 (489)
. ...++++|||+++++|.+++.....
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 5 4578999999999999999865321
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC----------------
Q 042772 403 ------KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC---------------- 460 (489)
Q Consensus 403 ------~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~---------------- 460 (489)
..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 2578899999999999999999999999999999999999999999999999875321
Q ss_pred -CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 461 -KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 -~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++ |..||.
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~ 277 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 277 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCC
Confidence 111 1223599999999999997 999984
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-26 Score=222.96 Aligned_cols=181 Identities=25% Similarity=0.348 Sum_probs=155.0
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
+..++|++.+.||+|++|.||+|.+.. ++.||+|.+..... ..+.+.+|+.+++.++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 445679999999999999999999765 57899999865422 2356778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC---
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS--- 459 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~--- 459 (489)
++|||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||++++++.+||+|||++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999999999987654568999999999999999999999999999999999999999999999999886432
Q ss_pred -------------CCCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 460 -------------CKPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 460 -------------~~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++ |..||.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 206 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYP 206 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 11222 124589999999999998 999884
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-26 Score=224.43 Aligned_cols=180 Identities=23% Similarity=0.320 Sum_probs=153.5
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|+..+.||+|+||.||+|.++.+++.||+|.+..... .....+.+..|+.+++.++||||+++++++......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 368999999999999999999999999999999865421 1223345678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK---- 461 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~---- 461 (489)
||++++.|..++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred eccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 999988887776553 34899999999999999999999999999999999999999999999999998643211
Q ss_pred -----------Cc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 462 -----------PQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 -----------~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+ ....+|+|++|++++++++|..||.
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~ 202 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP 202 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 11 1134689999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=221.95 Aligned_cols=182 Identities=26% Similarity=0.359 Sum_probs=156.6
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
+++.++|++.+.||+|+||.||+|.+.+ ++.+|+|.+..... ..+.+..|+.+++.++||||+++++++......
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 3566789999999999999999999764 57899999875432 235678899999999999999999999988899
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
+++|||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.....
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999999999999876555689999999999999999999999999999999999999999999999999864320
Q ss_pred ---------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 461 ---------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 ---------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.|+ ....+|+|++|++++++++ |..||.
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 206 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYP 206 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 111 1234689999999999998 999884
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=223.24 Aligned_cols=178 Identities=27% Similarity=0.381 Sum_probs=151.1
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
..+|++.+.||+|+||.||+|.++. +..+|+|.+.+.... ...+..|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 3569999999999999999998864 668999988654321 24567799999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC---- 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~---- 460 (489)
|||+++++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 78 TEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred EecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 999999999999976543 589999999999999999999999999999999999999999999999998863211
Q ss_pred ------------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 461 ------------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 ------------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++ |..||.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 203 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCC
Confidence 1111 124689999999999997 888874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=224.26 Aligned_cols=175 Identities=23% Similarity=0.281 Sum_probs=142.7
Q ss_pred cccCCCCceEEEEEEEcC--CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCC
Q 042772 312 KPLGCGDTGSVHLVELQG--AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCP 389 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~--tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ 389 (489)
+.||+|+||.||+|.... ....+++|.+.... .......+.+|+.+++.++||||+++++.+......++||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999997543 34578888765432 23344567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-------
Q 042772 390 GGELFALLDKQPM---KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------- 459 (489)
Q Consensus 390 ggsL~~~L~~~~~---~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------- 459 (489)
+|+|.+++..... ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999999977432 234678888999999999999999999999999999999999999999999985321
Q ss_pred ----------CCCce-------------eecccccchHHHHHHHHh-CCcccC
Q 042772 460 ----------CKPQV-------------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 460 ----------~~~~~-------------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++ |..||.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 211 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP 211 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCC
Confidence 11221 124589999999999988 788874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-28 Score=231.25 Aligned_cols=181 Identities=28% Similarity=0.403 Sum_probs=157.0
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.+.|.+.+.||+|.|+.||++.+..||+.+|+|+++......+ ..+.+.+|+.|.+.|+||||+++.+.+......|+|
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4679999999999999999999999999999999987655443 678889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC---CcEEEEecCCccccCC-
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD---GHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~---g~vKL~DFGlS~~~~~- 460 (489)
+|++.|++|..-+-.+ -.++|..+..++.||+.||.|+|.+||||||+||+|+|+.+. --+||+|||+|.....
T Consensus 89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 9999999998666554 347999999999999999999999999999999999999533 3689999999975441
Q ss_pred --------CCc-----------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 --------KPQ-----------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 --------~~~-----------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.|. +-.+.|+|+.|++++.++.|++||-
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~ 213 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 213 (355)
T ss_pred cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCC
Confidence 122 2245589999999999999999983
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=244.18 Aligned_cols=173 Identities=28% Similarity=0.456 Sum_probs=148.1
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
++.++....++-||+|+.|.||+|+.. ++.||||.++.- -..++..|++|+||||+.|.++|....-+
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCcee
Confidence 344455566788999999999999987 688999976422 12367789999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC--
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS-- 459 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~-- 459 (489)
|||||||+.|.|...|+.. .++.......|..+|+.||.|||.+.|||||||.-||||..+..|||+|||.|+...
T Consensus 188 CIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred EEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 9999999999999999875 458899999999999999999999999999999999999999999999999987543
Q ss_pred ------C------CCceee------cccccchHHHHHHHHhCCcccC
Q 042772 460 ------C------KPQVFY------HAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ------~------~~~~~~------~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+ +|+++. ..|+|+||+.++||++|.+||-
T Consensus 266 STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYk 312 (904)
T KOG4721|consen 266 STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYK 312 (904)
T ss_pred hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcc
Confidence 2 223222 2389999999999999999994
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-26 Score=221.22 Aligned_cols=180 Identities=25% Similarity=0.288 Sum_probs=149.0
Q ss_pred cccccccCCCCceEEEEEEEcC---CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe----
Q 042772 308 FKPIKPLGCGDTGSVHLVELQG---AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH---- 380 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~---tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~---- 380 (489)
|++.+.||+|+||.||+|.... ++..||+|.+..... .......+..|+.+++.++||||+++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 5788999999999999999764 347899999875432 33456778899999999999999999998765443
Q ss_pred --EEEEEecCCCCCHHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCC
Q 042772 381 --ICLITDFCPGGELFALLDKQ----PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDL 454 (489)
Q Consensus 381 --~~lVmEy~~ggsL~~~L~~~----~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGl 454 (489)
.+++|||+++|+|..++... ....+++..+..++.|++.||.|||+++++||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999998543 223589999999999999999999999999999999999999999999999999
Q ss_pred ccccCC-----------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 455 SFMTSC-----------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 455 S~~~~~-----------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
++.... +|+ ....+|+|++|++++|+++ |..||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~ 217 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYP 217 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 864321 111 1134699999999999998 888874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-26 Score=221.44 Aligned_cols=180 Identities=28% Similarity=0.431 Sum_probs=154.7
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccc------hHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN------RNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH 380 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~------~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 380 (489)
+|.+...||.|+||.||+|.+..+++.+|+|.+....... ......+..|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999999889999999886543221 2234678889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
.+++|||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999999999775 3488999999999999999999999999999999999999999999999998764431
Q ss_pred ---------------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 213 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFP 213 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCC
Confidence 111 1134699999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.9e-26 Score=223.39 Aligned_cols=182 Identities=22% Similarity=0.331 Sum_probs=151.9
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGE----LYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS 378 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 378 (489)
+...+|++.+.||+|+||+||+|.+..+++ .||+|.+.... .......+..|..+++.+.||||+++++++...
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence 345689999999999999999999877776 48999886432 334456788899999999999999999988754
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
..+++|||+++|+|.+++.... ..+++..+..++.|++.||.|||+++++||||||+|||++.++.+||+|||+++..
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 5789999999999999997643 34899999999999999999999999999999999999999999999999998643
Q ss_pred CC-----------------CCcee------ecccccchHHHHHHHHh-CCcccC
Q 042772 459 SC-----------------KPQVF------YHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 459 ~~-----------------~~~~~------~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.. +|+.. ..+|+|++|++++|+++ |..||.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 213 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 21 12211 23489999999999887 888885
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=223.77 Aligned_cols=184 Identities=19% Similarity=0.227 Sum_probs=153.7
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGA-----GELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT 377 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 377 (489)
+..++|++.+.||+|+||.||+|.++.. +..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 4567899999999999999999998754 3789999986442 23345667889999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEE
Q 042772 378 STHICLITDFCPGGELFALLDKQP--------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVL 449 (489)
Q Consensus 378 ~~~~~lVmEy~~ggsL~~~L~~~~--------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL 449 (489)
....++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 999999999999999999997532 123678889999999999999999999999999999999999999999
Q ss_pred EecCCccccCC-----------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 450 TDFDLSFMTSC-----------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 450 ~DFGlS~~~~~-----------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|||+++.... +|+ ....+|+|++|++++++++ |..||.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 223 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ 223 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCc
Confidence 99998753210 111 1233589999999999997 888884
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-26 Score=224.17 Aligned_cols=177 Identities=27% Similarity=0.378 Sum_probs=148.8
Q ss_pred Cc-ccccccCCCCceEEEEEEE----cCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC--C
Q 042772 307 HF-KPIKPLGCGDTGSVHLVEL----QGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS--T 379 (489)
Q Consensus 307 ~y-~~~~~LG~G~fG~Vy~a~~----~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~ 379 (489)
+| ++++.||+|+||+||++.. ..++..||+|.+.... .......+.+|+++++.++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 45 8999999999999988753 3567899999986542 233456778899999999999999999987653 4
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
.++++|||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+|||+++++.+||+|||++....
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 689999999999999999764 38999999999999999999999999999999999999999999999999986432
Q ss_pred C------------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 C------------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ~------------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. +|+ ....+|+|++|++++++++|+.||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~ 211 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQ 211 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCC
Confidence 1 111 1234599999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=224.07 Aligned_cols=182 Identities=21% Similarity=0.272 Sum_probs=154.1
Q ss_pred ccCcccccccCCCCceEEEEEEEcC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQG-----AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
..+|.+.+.||+|+||.||+|.... +++.||+|.++... .....+.+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4579999999999999999998753 36789999986542 2334578889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcE
Q 042772 380 HICLITDFCPGGELFALLDKQP------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHV 447 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~v 447 (489)
..+++|||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999997642 2347888999999999999999999999999999999999999999
Q ss_pred EEEecCCccccC-----------------CCCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 448 VLTDFDLSFMTS-----------------CKPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 448 KL~DFGlS~~~~-----------------~~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
||+|||++.... .+|+. ...+|+|++|++++++++ |..||.
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~ 226 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCC
Confidence 999999986321 11221 123599999999999997 999873
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-26 Score=220.05 Aligned_cols=179 Identities=23% Similarity=0.372 Sum_probs=155.3
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 383 (489)
...+|++.+.||.|+||.||+|... |+.||+|.+..... ..+++..|+.+++.++||||+++++++......++
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 4568999999999999999999875 78899999865421 46778889999999999999999999998899999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC----
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS---- 459 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~---- 459 (489)
||||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 9999999999999987654468999999999999999999999999999999999999999999999999886432
Q ss_pred --------CCCcee------ecccccchHHHHHHHHh-CCcccC
Q 042772 460 --------CKPQVF------YHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 460 --------~~~~~~------~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.+|+.. ..+|+|++|++++++++ |..||.
T Consensus 158 ~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 201 (256)
T cd05039 158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCC
Confidence 112221 24589999999999986 999885
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-26 Score=223.15 Aligned_cols=182 Identities=22% Similarity=0.289 Sum_probs=154.0
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGE---LYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH 380 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 380 (489)
..++|+..+.||+|+||.||+|..+.++. .+|+|.+.... .....+.+..|+.+++.++||||+++.+++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 34578999999999999999999876554 79999886542 23345678889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
.++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999999997643 3488999999999999999999999999999999999999999999999999864321
Q ss_pred ------------------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 461 ------------------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 ------------------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++ |..||.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~ 212 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYW 212 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCC
Confidence 1111 123489999999999886 999984
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-26 Score=222.98 Aligned_cols=179 Identities=24% Similarity=0.341 Sum_probs=150.2
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 383 (489)
..++|++.+.||+|+||.||+|.+..+ ..||+|.+.+... ....+.+|+++++.++||||+++++.+. ....++
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI 77 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence 446799999999999999999998765 4599999875322 2246788999999999999999998774 456899
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC---
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC--- 460 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~--- 460 (489)
||||+++|+|.+++.......+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 99999999999999875445578999999999999999999999999999999999999999999999999864321
Q ss_pred -------------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 461 -------------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 -------------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.|+. ...+|+|++|++++++++ |..||.
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~ 205 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 205 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 1111 124689999999999998 888874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.9e-26 Score=225.08 Aligned_cols=185 Identities=22% Similarity=0.360 Sum_probs=155.2
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGA-----GELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASF 375 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~ 375 (489)
.+..++|++.+.||+|+||.||++..... ...+|+|.+.... .......+.+|+.+++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 45567899999999999999999998744 3789999886542 233456688899999999 799999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 042772 376 QTSTHICLITDFCPGGELFALLDKQ--------------PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILL 441 (489)
Q Consensus 376 ~~~~~~~lVmEy~~ggsL~~~L~~~--------------~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILl 441 (489)
.....++++|||+++|+|.+++... ....+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 9999999999999999999999652 23458899999999999999999999999999999999999
Q ss_pred ecCCcEEEEecCCccccC-----------------CCCcee------ecccccchHHHHHHHHh-CCcccC
Q 042772 442 QKDGHVVLTDFDLSFMTS-----------------CKPQVF------YHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 442 d~~g~vKL~DFGlS~~~~-----------------~~~~~~------~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+.++.+||+|||+++... .+|+.. ..+|+|++|++++++++ |..||.
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 236 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCC
Confidence 999999999999986422 112221 23599999999999886 988875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-26 Score=221.71 Aligned_cols=180 Identities=23% Similarity=0.314 Sum_probs=154.4
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccc---hHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN---RNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 383 (489)
+|+..+.||+|+||.||++....+++.||+|.+....... ....+.+..|+.+++.++||||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999999999999999997543221 2345788899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC-cEEEEecCCccccCC--
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG-HVVLTDFDLSFMTSC-- 460 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g-~vKL~DFGlS~~~~~-- 460 (489)
||||+++++|.+++.+. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999999999765 3488999999999999999999999999999999999998776 599999999754321
Q ss_pred -----------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 -----------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -----------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 209 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 111 1134589999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-26 Score=225.83 Aligned_cols=179 Identities=23% Similarity=0.329 Sum_probs=152.0
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
.+|++.+.||+|+||.||+|....++..||+|.+..... ......+.+|+.+++.++|+||+++++++......|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999999865422 222335567999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------ 459 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------ 459 (489)
||+. ++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 9995 78888876543 347888899999999999999999999999999999999999999999999886321
Q ss_pred ---------CCCcee-------ecccccchHHHHHHHHhCCcccC
Q 042772 460 ---------CKPQVF-------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---------~~~~~~-------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+.. ...|+|++|++++++++|..||.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~ 205 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFP 205 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 123322 23599999999999999999984
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.3e-26 Score=226.53 Aligned_cols=177 Identities=23% Similarity=0.346 Sum_probs=154.5
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
.+|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+..|+.+++.+.||||+++++.+......|+||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 579999999999999999999999999999999875432 23466788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------ 459 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------ 459 (489)
||+++++|.+++... .+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus 97 e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 173 (296)
T cd06654 97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (296)
T ss_pred cccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccccc
Confidence 999999999998753 37899999999999999999999999999999999999999999999999875321
Q ss_pred ---------CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ---------CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---------~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~ 217 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 01221 134599999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=224.02 Aligned_cols=174 Identities=34% Similarity=0.553 Sum_probs=144.1
Q ss_pred ccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHH---hCCCCCcceeeEEEEeCCeEEEEEecCC
Q 042772 313 PLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS---LLDHPFLPTLYASFQTSTHICLITDFCP 389 (489)
Q Consensus 313 ~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~---~l~HpnIv~l~~~~~~~~~~~lVmEy~~ 389 (489)
.||+|+||.||++.+..+++.+|+|.+.+..............|..+++ ..+||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999997654433332333344444433 3479999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC----------
Q 042772 390 GGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS---------- 459 (489)
Q Consensus 390 ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~---------- 459 (489)
+++|.+++..+ ..+++..+..++.|++.||.|||+++++||||||+|||+++++.++|+|||++....
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT 158 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCC
Confidence 99999998765 348999999999999999999999999999999999999999999999999985321
Q ss_pred ---CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ---CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 197 (279)
T cd05633 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFR 197 (279)
T ss_pred cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcC
Confidence 11221 234599999999999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=220.00 Aligned_cols=181 Identities=29% Similarity=0.389 Sum_probs=156.8
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++.+.||.|+||+||+|....++..+|+|.+...... ...+.+.+|+.+++.++||||+++++.+......+++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 3689999999999999999999989999999998754332 25677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC----
Q 042772 386 DFCPGGELFALLDKQPM-KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC---- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~-~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~---- 460 (489)
|++++++|.+++..... ..+++..+..++.|++.||.|||++|++|+||||+||++++++.++|+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999976422 4589999999999999999999999999999999999999999999999998753221
Q ss_pred ---------------CCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------------KPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------------~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~ 208 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcc
Confidence 1221 123599999999999999999984
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-26 Score=222.90 Aligned_cols=183 Identities=18% Similarity=0.195 Sum_probs=150.8
Q ss_pred cccCcccccccCCCCceEEEEEEEcC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQG-----AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS 378 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 378 (489)
..++|++.+.||+|+||.||+|.+++ ++..||+|.+.... .......+..|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 44679999999999999999998753 35689999885432 233445678899999999999999999999988
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEE
Q 042772 379 THICLITDFCPGGELFALLDKQPM--------KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLT 450 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~--------~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~ 450 (489)
...++||||+++++|.+++..... ..++...+..++.|++.||.|||+.|++|+||||+||++++++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 999999999999999999875321 235678889999999999999999999999999999999999999999
Q ss_pred ecCCccccC-----------------CCCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 451 DFDLSFMTS-----------------CKPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 451 DFGlS~~~~-----------------~~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
|||++.... .+|+. ...+|+|++|++++++++ |..||.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~ 223 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 223 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 999985321 11221 123589999999999997 788874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-26 Score=223.91 Aligned_cols=181 Identities=20% Similarity=0.311 Sum_probs=148.8
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGE----LYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
..++|++.+.||.|+||.||+|.+..+++ .+++|.+... ........+..|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~ 81 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A 81 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence 44679999999999999999999987776 4666766432 223445667778888999999999999998754 4
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
..++++||+++|+|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 5789999999999999997653 348999999999999999999999999999999999999999999999999986431
Q ss_pred C-----------------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 460 C-----------------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 460 ~-----------------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
. +|+. ...+|+|++|++++|+++ |..||.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~ 213 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 1 1111 123589999999999987 999884
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-26 Score=221.15 Aligned_cols=180 Identities=25% Similarity=0.376 Sum_probs=152.6
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
+..++|++++.||+|+||.||+|..+. ++.||+|.+..... ....+..|+.+++.++||||+++++++. ....+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 445679999999999999999998664 67899999875432 2356778999999999999999998764 55789
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC---
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS--- 459 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~--- 459 (489)
++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999999999987655668999999999999999999999999999999999999999999999999985432
Q ss_pred -------------CCCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 460 -------------CKPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 460 -------------~~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.+|+ .....|+|++|++++++++ |..||.
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 205 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYP 205 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCC
Confidence 0111 1234699999999999998 999984
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-25 Score=217.60 Aligned_cols=181 Identities=24% Similarity=0.463 Sum_probs=157.3
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|++.+.||+|+||.||++....+++.||+|.+..... .......+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 48899999999999999999999999999999875433 23345678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC------ 460 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~------ 460 (489)
|+++++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 99999999999875544578999999999999999999999999999999999999999999999999864321
Q ss_pred ---------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~ 202 (256)
T cd08218 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202 (256)
T ss_pred hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCcc
Confidence 1111 134699999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=219.40 Aligned_cols=173 Identities=36% Similarity=0.675 Sum_probs=152.7
Q ss_pred cCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCCCCCH
Q 042772 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGEL 393 (489)
Q Consensus 314 LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ggsL 393 (489)
||.|+||.||+|.+..+++.+|+|.+.+.........+.+..|+.+++.++||||+++++.+.+....+++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68999999999999999999999999876554455567888999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC------------
Q 042772 394 FALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK------------ 461 (489)
Q Consensus 394 ~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~------------ 461 (489)
.+++.+. ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 158 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEY 158 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCc
Confidence 9999875 34899999999999999999999999999999999999999999999999998654321
Q ss_pred --Cce------eecccccchHHHHHHHHhCCcccC
Q 042772 462 --PQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 --~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+. ...+|+|++|.+++++++|..||.
T Consensus 159 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 193 (262)
T cd05572 159 VAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFG 193 (262)
T ss_pred cChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcC
Confidence 211 123589999999999999999985
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-25 Score=218.62 Aligned_cols=179 Identities=27% Similarity=0.443 Sum_probs=157.5
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|++.+.||+|+||.||+|....+++.|++|.+...... ......+..|+++++.++||||+++++.+......++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 588899999999999999999989999999999765432 4567889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC------ 460 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~------ 460 (489)
|+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 80 YCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred cCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 99999999999775 3478999999999999999999999999999999999999999999999998864321
Q ss_pred -------------CCc---------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 -------------KPQ---------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -------------~~~---------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|.+++++++|..||.
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~ 207 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS 207 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCcc
Confidence 111 2234589999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-26 Score=226.25 Aligned_cols=177 Identities=23% Similarity=0.342 Sum_probs=154.1
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
.+|++++.||+|+||.||+|....+++.||+|.+.... ......+..|+.+++.++||||+++++++......|+||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 67999999999999999999999999999999986542 223456778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
||+++++|.+++... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 96 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 172 (297)
T cd06656 96 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (297)
T ss_pred cccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc
Confidence 999999999998753 378999999999999999999999999999999999999999999999998754321
Q ss_pred ----------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ----------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ----------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.|+. ....|+|++|++++++++|..||.
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~ 216 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 1111 123589999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-25 Score=217.71 Aligned_cols=181 Identities=24% Similarity=0.429 Sum_probs=154.9
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe-CCeEEEEE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT-STHICLIT 385 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lVm 385 (489)
.|++.+.||.|++|.||++.++.+++.||+|.+..... .....+.+..|+.+++.++|||++++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 48899999999999999999999999999999865432 33445678889999999999999999998764 44689999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
||+++++|.+++.......+++.++..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 159 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA 159 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence 999999999999876555689999999999999999999999999999999999999999999999998854321
Q ss_pred ----------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ----------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ----------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~ 203 (257)
T cd08223 160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203 (257)
T ss_pred ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 1221 124599999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-26 Score=221.75 Aligned_cols=178 Identities=25% Similarity=0.361 Sum_probs=151.2
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++.+.||+|+||.||+|.+.. +..+|+|.+..... ....+..|+.+++.++||||+++++++......+++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 3579999999999999999998765 45699998865422 235678899999999999999999999988899999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC---- 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~---- 460 (489)
|||+++|+|.+++..... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.....
T Consensus 78 ~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 78 TEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 999999999999976533 589999999999999999999999999999999999999999999999998763221
Q ss_pred ------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 461 ------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 ------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++ |..||.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~ 203 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcC
Confidence 111 1234689999999999987 999885
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-26 Score=225.56 Aligned_cols=179 Identities=24% Similarity=0.315 Sum_probs=152.9
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVML--NRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
+|++.+.||.|+||.||+|.+..+++.||+|.+...... .......+..|+++++.++||||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478889999999999999999999999999999765432 122345567799999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC---
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK--- 461 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~--- 461 (489)
|||+ +++|.+++.... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence 9999 899999998754 35899999999999999999999999999999999999999999999999998643211
Q ss_pred ------------Cce-------eecccccchHHHHHHHHhCCccc
Q 042772 462 ------------PQV-------FYHAHVNGFYFIMYKWLTGYFTY 487 (489)
Q Consensus 462 ------------~~~-------~~~~~v~s~g~~a~e~~~G~lpY 487 (489)
|+. ....|+|++|++++++++|..+|
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~ 203 (298)
T cd07841 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL 203 (298)
T ss_pred ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccc
Confidence 111 12358899999999999997665
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=223.96 Aligned_cols=182 Identities=25% Similarity=0.365 Sum_probs=153.0
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCC----------------cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCc
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAG----------------ELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFL 368 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg----------------~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnI 368 (489)
..+|++++.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCCE
Confidence 457999999999999999999876543 568999887542 23456778899999999999999
Q ss_pred ceeeEEEEeCCeEEEEEecCCCCCHHHHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 042772 369 PTLYASFQTSTHICLITDFCPGGELFALLDKQP---------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENI 439 (489)
Q Consensus 369 v~l~~~~~~~~~~~lVmEy~~ggsL~~~L~~~~---------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NI 439 (489)
+++++++......+++|||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999997653 12589999999999999999999999999999999999
Q ss_pred EEecCCcEEEEecCCccccC-----------------CCCce------eecccccchHHHHHHHHh--CCcccC
Q 042772 440 LLQKDGHVVLTDFDLSFMTS-----------------CKPQV------FYHAHVNGFYFIMYKWLT--GYFTYV 488 (489)
Q Consensus 440 Lld~~g~vKL~DFGlS~~~~-----------------~~~~~------~~~~~v~s~g~~a~e~~~--G~lpY~ 488 (489)
+++.++.++|+|||++.... .+|+. ...+|+|++|++++++++ |..||.
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 99999999999999986421 01221 234689999999999987 666663
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-27 Score=252.59 Aligned_cols=185 Identities=23% Similarity=0.327 Sum_probs=158.7
Q ss_pred cccccCcccccccCCCCceEEEEEEEcC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQG-----AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQ 376 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 376 (489)
.+...+....+.||+|.||+||+|+..+ ....||||.++.. .+.+..++|.+|++++..++|||||+|+|+|.
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 4566778889999999999999998653 3468999999754 34446789999999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhC--------C----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC
Q 042772 377 TSTHICLITDFCPGGELFALLDKQ--------P----MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD 444 (489)
Q Consensus 377 ~~~~~~lVmEy~~ggsL~~~L~~~--------~----~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~ 444 (489)
..+.+|+|+|||..|+|.++|... . ..+|+..+.+.|+.||+.||.||-++.+|||||..+|+||.++
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 999999999999999999999752 1 2238899999999999999999999999999999999999999
Q ss_pred CcEEEEecCCccccCC-----------------------CCceeecccccchHHHHHHH-HhCCcccC
Q 042772 445 GHVVLTDFDLSFMTSC-----------------------KPQVFYHAHVNGFYFIMYKW-LTGYFTYV 488 (489)
Q Consensus 445 g~vKL~DFGlS~~~~~-----------------------~~~~~~~~~v~s~g~~a~e~-~~G~lpY~ 488 (489)
-.|||+|||+|+.... .......+|||+||+.++|+ ..|..||.
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~ 707 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYY 707 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccc
Confidence 9999999999975431 12223456999999999996 68999984
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-25 Score=222.01 Aligned_cols=178 Identities=26% Similarity=0.401 Sum_probs=148.3
Q ss_pred cCcccccccCCCCceEEEEEEE----cCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe--CC
Q 042772 306 HHFKPIKPLGCGDTGSVHLVEL----QGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT--ST 379 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~----~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~ 379 (489)
.+|++++.||+|+||.||+|.. ..++..||+|.+... .....+.+..|+++++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 4799999999999999999984 456889999998654 34455778899999999999999999997653 34
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
.+++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 6899999999999999997643 347899999999999999999999999999999999999999999999999987532
Q ss_pred CC------------------Cc------eeecccccchHHHHHHHHhCCccc
Q 042772 460 CK------------------PQ------VFYHAHVNGFYFIMYKWLTGYFTY 487 (489)
Q Consensus 460 ~~------------------~~------~~~~~~v~s~g~~a~e~~~G~lpY 487 (489)
.. |+ .....|+|++|++++|+++|..++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~ 211 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKS 211 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcC
Confidence 11 11 112348889999999998876553
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=225.02 Aligned_cols=181 Identities=22% Similarity=0.316 Sum_probs=151.2
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCc--EEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGE--LYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~--~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 382 (489)
++|++.+.||+|+||.||+|..+.++. .+++|.++.. ......+.+..|+.++.++ +||||+++++++.....+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 469999999999999999999887764 4688877532 2334456788899999999 7999999999999989999
Q ss_pred EEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEE
Q 042772 383 LITDFCPGGELFALLDKQP--------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVV 448 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~--------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vK 448 (489)
++|||+++++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999997532 12478899999999999999999999999999999999999999999
Q ss_pred EEecCCccccC--------------CCCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 449 LTDFDLSFMTS--------------CKPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 449 L~DFGlS~~~~--------------~~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
|+|||++.... .+|+. ...+|+|++|++++++++ |..||.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~ 220 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYC 220 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 99999984211 11221 234699999999999996 999984
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=226.57 Aligned_cols=184 Identities=22% Similarity=0.327 Sum_probs=154.7
Q ss_pred ccccCcccccccCCCCceEEEEEEEc-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQ-----GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQ 376 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~ 376 (489)
+..++|.+.+.||+|+||.||+|.+. .++..+|+|.++... .......+..|+.+++++ +||||+++++++.
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 44567999999999999999999853 345689999886542 234456788899999999 7999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 377 TSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 377 ~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
..+..+++|||+++|+|.+++.......+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++|+|||++.
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999999999986544448999999999999999999999999999999999999999999999999986
Q ss_pred ccCCC-----------------Cce------eecccccchHHHHHHHHh-CCcccC
Q 042772 457 MTSCK-----------------PQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 457 ~~~~~-----------------~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
..... |+. ...+|+|++|++++++++ |..||.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~ 245 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYP 245 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcC
Confidence 43211 111 123489999999999987 988874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-25 Score=221.46 Aligned_cols=180 Identities=23% Similarity=0.330 Sum_probs=153.0
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGE----LYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH 380 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 380 (489)
..+|++.+.||+|+||.||+|.++.+|. .+|+|.+.... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 4679999999999999999999877664 68999876543 24455678889999999999999999999887 78
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
.+++|||+++|+|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred eEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999999998753 3489999999999999999999999999999999999999999999999999864321
Q ss_pred -----------------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 461 -----------------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 -----------------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.|+. ...+|+|++|++++++++ |..||.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 213 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCC
Confidence 1111 123588999999999997 999985
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=223.64 Aligned_cols=184 Identities=17% Similarity=0.197 Sum_probs=150.2
Q ss_pred ccccCcccccccCCCCceEEEEEEEcC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQG-----AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT 377 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 377 (489)
+..++|++.+.||+|+||.||+|..+. .+..||+|.++... .......+.+|..+++.++||||+++++++..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 456789999999999999999997653 35689999886442 22334567789999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEE
Q 042772 378 STHICLITDFCPGGELFALLDKQP--------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVL 449 (489)
Q Consensus 378 ~~~~~lVmEy~~ggsL~~~L~~~~--------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL 449 (489)
....|+||||+++|+|.+++.... ...++...+..++.|++.||.|||+++|+||||||+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 899999999999999999997531 123466788899999999999999999999999999999999999999
Q ss_pred EecCCccccCC-----------------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 450 TDFDLSFMTSC-----------------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 450 ~DFGlS~~~~~-----------------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|||+++.... +|+. ...+|+|++|++++++++ |..||.
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~ 223 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ 223 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999863210 1111 123488999999999987 777773
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-25 Score=219.02 Aligned_cols=180 Identities=25% Similarity=0.328 Sum_probs=153.6
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCCcceeeEEEEe--CCeEE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVML--NRNKVHRACIEREIMSLLDHPFLPTLYASFQT--STHIC 382 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ 382 (489)
+|+..+.||+|+||.||+|.+..++..||+|.+...... .......+.+|+.+++.++||||+++++++.. ...++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 689999999999999999999999999999998654321 23345678889999999999999999998875 36789
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC--
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC-- 460 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~-- 460 (489)
++|||+++++|.+++.... .+++.....++.|++.||.|||+++++|+||||+||+++.++.+||+|||++.....
T Consensus 83 l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 9999999999999997653 488999999999999999999999999999999999999999999999999853211
Q ss_pred ----------------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ----------------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ----------------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~ 210 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA 210 (266)
T ss_pred ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcc
Confidence 1111 124589999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-26 Score=236.98 Aligned_cols=173 Identities=21% Similarity=0.346 Sum_probs=147.6
Q ss_pred ccCcccccccCCCCceEEEEEEEcC--CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQG--AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~--tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
..+|.+++.||.|+||.||+|...+ +++.||+|.+... ....+|+.+++.++||||+++++++.....+|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 3579999999999999999998653 5678999988543 12356999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC--
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC-- 460 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~-- 460 (489)
++||++ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 163 lv~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 163 MVMPKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEehhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999999 47999999554 4589999999999999999999999999999999999999999999999999854321
Q ss_pred ---------------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 288 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLF 288 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 1221 234699999999999999999983
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-25 Score=218.81 Aligned_cols=179 Identities=22% Similarity=0.398 Sum_probs=151.3
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEE-eCCeE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQ-TSTHI 381 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~~ 381 (489)
+...+|++.+.||+|+||.||++... |..+|+|.+... ...+.+.+|+.+++.++|||++++++++. .....
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 34568999999999999999999765 778999988543 22456788999999999999999999764 45679
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
+++|||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 9999999999999999876555688999999999999999999999999999999999999999999999999864321
Q ss_pred -----------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 461 -----------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 -----------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++ |..||.
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~ 201 (256)
T cd05082 156 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 121 1224699999999999996 999884
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=222.02 Aligned_cols=182 Identities=22% Similarity=0.303 Sum_probs=153.0
Q ss_pred ccCcccccccCCCCceEEEEEEEcC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQG-----AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+... ........+..|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 3579999999999999999999987 7789999988643 22334456888999999999999999999999888
Q ss_pred eEEEEEecCCCCCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC---cEEEEe
Q 042772 380 HICLITDFCPGGELFALLDKQPM-----KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG---HVVLTD 451 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~-----~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g---~vKL~D 451 (489)
..+++|||+++++|.+++..... ..+++..+..++.||+.||.|||+++++|+||||+||+++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 99999999999999999976521 2488999999999999999999999999999999999998765 599999
Q ss_pred cCCccccCC-----------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 452 FDLSFMTSC-----------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 452 FGlS~~~~~-----------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
||+++.... +|+ ....+|+|++|++++++++ |..||.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~ 223 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYP 223 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 999864321 111 1234689999999999985 999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=220.18 Aligned_cols=179 Identities=21% Similarity=0.323 Sum_probs=153.0
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccc---cchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVM---LNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 383 (489)
+|+..+.||.|+||.||+|.. .+++.+|+|.+..... ........+.+|+++++.++|+||+++++++......++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 478899999999999999986 4688999998864321 123345678889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC----
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS---- 459 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~---- 459 (489)
+|||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+++|+||+|+||++++++.++|+|||++....
T Consensus 80 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999999999775 347899999999999999999999999999999999999999999999999875321
Q ss_pred -----------------CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 -----------------CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 -----------------~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~ 209 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA 209 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccc
Confidence 11222 134689999999999999999985
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-26 Score=223.47 Aligned_cols=183 Identities=17% Similarity=0.293 Sum_probs=151.8
Q ss_pred cccCcccccccCCCCceEEEEEEEcCC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGA-----GELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS 378 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 378 (489)
...+|++.+.||.|+||.||+|.+..+ ++.||+|.++... .......+..|..+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 456799999999999999999987643 5789999987442 233456688899999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC
Q 042772 379 THICLITDFCPGGELFALLDKQP--------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD 444 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~--------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~ 444 (489)
...++++||+++++|.+++.... ...+++..+..++.|++.||.|||++||+||||||+||+++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 99999999999999999986321 2347888899999999999999999999999999999999999
Q ss_pred CcEEEEecCCccccCC-----------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 445 GHVVLTDFDLSFMTSC-----------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 445 g~vKL~DFGlS~~~~~-----------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+.+||+|||+++.... +|+ ....+|+|++|++++|+++ |..||.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 228 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 228 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999998763210 111 1224599999999999986 887874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=223.16 Aligned_cols=181 Identities=26% Similarity=0.379 Sum_probs=157.1
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 383 (489)
..++|++++.||+|+||+||++.+..+++.||+|.+.... .......+.+|+++++.++||||+++++++.....+++
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 3467999999999999999999999999999999886532 23345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecCCccccC---
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC-LGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS--- 459 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~--- 459 (489)
||||+++++|.+++... +.+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++....
T Consensus 81 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 81 CMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred EEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999999999998764 348999999999999999999997 699999999999999999999999999875321
Q ss_pred ----------CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ----------CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----------~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~ 203 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA 203 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCc
Confidence 11221 235689999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-25 Score=222.49 Aligned_cols=181 Identities=20% Similarity=0.296 Sum_probs=152.6
Q ss_pred ccCcccccccCCCCceEEEEEEEc-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQ-----GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
.++|.+.+.||+|+||.||++... .++..+|+|.+... .....+.+..|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 357999999999999999999863 34567999988643 2345667889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEE
Q 042772 380 HICLITDFCPGGELFALLDKQP-----------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVV 448 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~-----------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vK 448 (489)
.++++|||+++++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+||++++++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 9999999999999999997542 12489999999999999999999999999999999999999999999
Q ss_pred EEecCCccccC-----------------CCCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 449 LTDFDLSFMTS-----------------CKPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 449 L~DFGlS~~~~-----------------~~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
|+|||++.... .+|+. ...+|+|++|+++++|++ |..||.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~ 224 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY 224 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999986321 11221 124689999999999998 888873
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=225.84 Aligned_cols=178 Identities=20% Similarity=0.327 Sum_probs=151.6
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|++.+.||+|+||.||+|.++.+|+.||+|.+..... .......+..|+.+++.++||||+++++++.+....++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 48889999999999999999999999999999875422 22233556779999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------- 459 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------- 459 (489)
|++ ++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus 80 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 80 YCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred cCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 996 58988887543 348999999999999999999999999999999999999999999999999886432
Q ss_pred --------CCCce-------eecccccchHHHHHHHHhCCccc
Q 042772 460 --------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTY 487 (489)
Q Consensus 460 --------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY 487 (489)
.+|+. ...+|+|++|++++++++|..|+
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~ 200 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCC
Confidence 11222 22358999999999999998885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=230.59 Aligned_cols=184 Identities=23% Similarity=0.335 Sum_probs=149.9
Q ss_pred ccccCcccccccCCCCceEEEEEEEc-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQ-----GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQ 376 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~ 376 (489)
+..++|++.+.||+|+||.||+|.+. .+++.||+|.++... .......+..|+.++..+ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 34568999999999999999999853 457899999996542 233456788899999999 6899999999876
Q ss_pred eC-CeEEEEEecCCCCCHHHHHhhCC------------------------------------------------------
Q 042772 377 TS-THICLITDFCPGGELFALLDKQP------------------------------------------------------ 401 (489)
Q Consensus 377 ~~-~~~~lVmEy~~ggsL~~~L~~~~------------------------------------------------------ 401 (489)
.. ..++++|||+++|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 54 56899999999999999986531
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC----------
Q 042772 402 -----------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC---------- 460 (489)
Q Consensus 402 -----------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~---------- 460 (489)
...++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 12367788889999999999999999999999999999999999999999999864211
Q ss_pred -------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 461 -------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 -------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++ |..||.
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 283 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 283 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 1211 123489999999999985 998884
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-25 Score=220.69 Aligned_cols=178 Identities=27% Similarity=0.426 Sum_probs=156.4
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++.+.||.|+||.||+|.+..+++.||+|.+.... .......+..|+.+++.++||||+++++++.....+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 36899999999999999999999999999999987542 2344566788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
||+++++|.+++... .+++..+..++.|++.||.|||+++++|+||+|+||++++++.++|+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 79 EYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred EeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 999999999999864 589999999999999999999999999999999999999999999999998854321
Q ss_pred ----------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ----------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ----------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~ 199 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLS 199 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 1221 234699999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-25 Score=219.88 Aligned_cols=180 Identities=25% Similarity=0.309 Sum_probs=146.8
Q ss_pred cccccccCCCCceEEEEEEEcCCCc--EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC------C
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGE--LYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS------T 379 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~--~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~ 379 (489)
|.+.+.||+|+||.||+|.+..++. .+|+|.++... ........+..|..+++.++||||+++++.+... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567889999999999999887765 68999886543 2345567888899999999999999999976432 2
Q ss_pred eEEEEEecCCCCCHHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCc
Q 042772 380 HICLITDFCPGGELFALLDKQ----PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~----~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS 455 (489)
..+++|||+++|+|.+++... ....+++..+..++.|++.||.|||+++|+||||||+|||+++++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 578999999999999987432 2234789999999999999999999999999999999999999999999999998
Q ss_pred cccCCC-----------C-c-----------eeecccccchHHHHHHHHh-CCcccC
Q 042772 456 FMTSCK-----------P-Q-----------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 456 ~~~~~~-----------~-~-----------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
...... + . .....|+|++|++++++++ |..||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 216 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYP 216 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence 643210 0 0 1124589999999999998 788874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-25 Score=220.62 Aligned_cols=177 Identities=24% Similarity=0.362 Sum_probs=154.7
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
.|+.++.||.|+||.||+|.+..++..||+|.+.... .......+..|+.+++.+.||||+++++++.+....|+|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 5888999999999999999999999999999987542 23456788889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC------ 460 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~------ 460 (489)
|+++++|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 83 YLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred cCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence 99999999998753 478999999999999999999999999999999999999999999999999853321
Q ss_pred ---------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCC
Confidence 1211 124589999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=253.50 Aligned_cols=186 Identities=24% Similarity=0.394 Sum_probs=155.4
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC--C
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS--T 379 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~ 379 (489)
...+.+|++++.||.|+||.||+|.+..+++.+|+|.+..... .......+..|+.+++.++||||++++++|... .
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3456789999999999999999999999999999999976533 334557788899999999999999999988653 5
Q ss_pred eEEEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC-------CCeecCCCCCCEEEec-------
Q 042772 380 HICLITDFCPGGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEYLHCL-------GIIYRDLKPENILLQK------- 443 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH~~-------gIvHrDLKP~NILld~------- 443 (489)
.+||||||+++|+|.++|... ....+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 799999999999999999753 224589999999999999999999984 4999999999999964
Q ss_pred ----------CCcEEEEecCCccccC--------------CCCcee--------ecccccchHHHHHHHHhCCcccC
Q 042772 444 ----------DGHVVLTDFDLSFMTS--------------CKPQVF--------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 444 ----------~g~vKL~DFGlS~~~~--------------~~~~~~--------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+.+||+|||++.... .+|+.+ ..+|+|++|++++++++|..||.
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 2358999999986432 122222 24599999999999999999985
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=219.95 Aligned_cols=175 Identities=24% Similarity=0.272 Sum_probs=144.4
Q ss_pred cccCCCCceEEEEEEEc--CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCC
Q 042772 312 KPLGCGDTGSVHLVELQ--GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCP 389 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ 389 (489)
+.||+|+||.||+|... .++..+|+|.+.... .......+.+|+.+++.++||||+++++++.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 36899999999999865 345789999886542 22334567889999999999999999999999889999999999
Q ss_pred CCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-------
Q 042772 390 GGELFALLDKQP---MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------- 459 (489)
Q Consensus 390 ggsL~~~L~~~~---~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------- 459 (489)
+|+|.+++.... ....++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++....
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999999997532 1235677888899999999999999999999999999999999999999999885321
Q ss_pred ----------CCCce-------------eecccccchHHHHHHHHh-CCcccC
Q 042772 460 ----------CKPQV-------------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 460 ----------~~~~~-------------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++ |..||.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~ 211 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYR 211 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 11222 235699999999999985 999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=220.81 Aligned_cols=180 Identities=27% Similarity=0.388 Sum_probs=149.4
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHH-HHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI-MSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~i-l~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
++|++.+.||+|+||.||+|.++.+|+.||+|.++..... .....+..|..+ ++.++||||+++++++.....+|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc--HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 3689999999999999999999999999999998765321 223344556554 6667899999999999999999999
Q ss_pred EecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEecCCcEEEEecCCccccC--
Q 042772 385 TDFCPGGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEYLHCL-GIIYRDLKPENILLQKDGHVVLTDFDLSFMTS-- 459 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH~~-gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~-- 459 (489)
|||++ |+|.+++... ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99995 6888887652 234589999999999999999999997 99999999999999999999999999986321
Q ss_pred ------------CCCce----------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ------------CKPQV----------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ------------~~~~~----------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 208 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCC
Confidence 11222 134699999999999999999984
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=218.85 Aligned_cols=173 Identities=38% Similarity=0.674 Sum_probs=152.3
Q ss_pred cCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCCCCCH
Q 042772 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGEL 393 (489)
Q Consensus 314 LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ggsL 393 (489)
||.|+||.||+|.+..+|+.+++|.+.............+..|+.+++.++||||+++++.+......|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999766544456677888999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC------------
Q 042772 394 FALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK------------ 461 (489)
Q Consensus 394 ~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~------------ 461 (489)
.+++.... .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence 99998753 5899999999999999999999999999999999999999999999999987643221
Q ss_pred -----------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 462 -----------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 -----------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+ .....|+|++|.+++++++|..||.
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~ 202 (265)
T cd05579 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH 202 (265)
T ss_pred cCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 11 1124689999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=226.33 Aligned_cols=172 Identities=30% Similarity=0.399 Sum_probs=149.4
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEEEecCCC
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHICLITDFCPG 390 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lVmEy~~g 390 (489)
+.||+|+|+.|--|....+|..||+|++.+. ......++.+|++++.+++ |+||+.++++|+++...|||||-+.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 6799999999999999999999999999886 3455678899999999885 99999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC---cEEEEecCCccccC--------
Q 042772 391 GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG---HVVLTDFDLSFMTS-------- 459 (489)
Q Consensus 391 gsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g---~vKL~DFGlS~~~~-------- 459 (489)
|+|.+++.++ +.|++.++..++.+|+.||.|||.+||.||||||+|||..+.. -||||||.+..-..
T Consensus 161 GplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 161 GPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred chHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 9999999886 4599999999999999999999999999999999999996554 48999999863111
Q ss_pred --------C-----------------CCceeecccccchHHHHHHHHhCCcccC
Q 042772 460 --------C-----------------KPQVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 --------~-----------------~~~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+ ..-+-...|.|++|.++|+|+.|..||.
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFv 292 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFV 292 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCcc
Confidence 0 0111234478999999999999999985
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=223.95 Aligned_cols=182 Identities=24% Similarity=0.362 Sum_probs=150.4
Q ss_pred ccCcccccccCCCCceEEEEEEEcCC--------------CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcce
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGA--------------GELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPT 370 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~t--------------g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~ 370 (489)
..+|++.+.||+|+||.||+|.+..+ ...||+|.+.... .......+.+|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 45799999999999999999987543 2358999986542 3445567889999999999999999
Q ss_pred eeEEEEeCCeEEEEEecCCCCCHHHHHhhCCC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 042772 371 LYASFQTSTHICLITDFCPGGELFALLDKQPM----------KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENIL 440 (489)
Q Consensus 371 l~~~~~~~~~~~lVmEy~~ggsL~~~L~~~~~----------~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NIL 440 (489)
+++++......++||||+++++|.+++..... ..+++..+..++.|++.||.|||++|++|+||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 99999999999999999999999999865321 13678889999999999999999999999999999999
Q ss_pred EecCCcEEEEecCCccccCC-----------------CCc------eeecccccchHHHHHHHHh--CCcccC
Q 042772 441 LQKDGHVVLTDFDLSFMTSC-----------------KPQ------VFYHAHVNGFYFIMYKWLT--GYFTYV 488 (489)
Q Consensus 441 ld~~g~vKL~DFGlS~~~~~-----------------~~~------~~~~~~v~s~g~~a~e~~~--G~lpY~ 488 (489)
++.++.+||+|||++..... +|+ ....+|+|++|++++++++ |..||.
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~ 234 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence 99999999999999864210 111 1234688999999999987 666664
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=222.76 Aligned_cols=180 Identities=20% Similarity=0.303 Sum_probs=150.2
Q ss_pred CcccccccCCCCceEEEEEEEcC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQG-----AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
+|++.+.||+|+||.||+|.... ....+++|.+.... .......+..|+.+++.+.||||+++++.+......
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 47889999999999999998753 23578888886442 234457788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 042772 382 CLITDFCPGGELFALLDKQP----------------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENI 439 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~----------------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NI 439 (489)
+++|||+++++|.+++.... ...+++..+..++.|++.||.|||+++++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 99999999999999986421 13478899999999999999999999999999999999
Q ss_pred EEecCCcEEEEecCCccccCC-----------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 440 LLQKDGHVVLTDFDLSFMTSC-----------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 440 Lld~~g~vKL~DFGlS~~~~~-----------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
|+++++.+||+|||+++.... +|+ ....+|+|++|++++++++ |..||.
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 999999999999999864311 111 1223589999999999997 999885
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=221.64 Aligned_cols=174 Identities=34% Similarity=0.532 Sum_probs=143.8
Q ss_pred ccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHH---HHHhCCCCCcceeeEEEEeCCeEEEEEecCC
Q 042772 313 PLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE---IMSLLDHPFLPTLYASFQTSTHICLITDFCP 389 (489)
Q Consensus 313 ~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~---il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ 389 (489)
.||+|+||.||+|.+..+++.||+|.+.+...........+..|.. +++...||||+.+++++......++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999999999999997654332222222333433 3445679999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC----------
Q 042772 390 GGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS---------- 459 (489)
Q Consensus 390 ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~---------- 459 (489)
|++|..++... ..+++..+..++.|++.||.|||+++++||||||+||++++++.+||+|||++....
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT 158 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCC
Confidence 99999998764 458999999999999999999999999999999999999999999999999875321
Q ss_pred ---CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ---CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ....|+|++|++++++++|..||.
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~ 197 (278)
T cd05606 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197 (278)
T ss_pred cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 11222 234599999999999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=215.62 Aligned_cols=175 Identities=25% Similarity=0.354 Sum_probs=150.8
Q ss_pred cccCCCCceEEEEEEEcCC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecC
Q 042772 312 KPLGCGDTGSVHLVELQGA---GELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFC 388 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~ 388 (489)
+.||+|+||.||+|..... +..|++|.+...... .....+..|+.+++.++||||+++++++.....++++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE--EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch--hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999866 889999999765332 24678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC
Q 042772 389 PGGELFALLDKQP-------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK 461 (489)
Q Consensus 389 ~ggsL~~~L~~~~-------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~ 461 (489)
++++|.+++.... ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 9999999998752 245899999999999999999999999999999999999999999999999998654321
Q ss_pred -----------------Cce------eecccccchHHHHHHHHh-CCcccC
Q 042772 462 -----------------PQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 462 -----------------~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
|+. ...+|+|++|++++++++ |..||.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 209 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP 209 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCC
Confidence 111 123599999999999988 688885
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=220.78 Aligned_cols=180 Identities=24% Similarity=0.396 Sum_probs=153.4
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEe------
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQT------ 377 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~------ 377 (489)
.+.|++.+.||.|+||.||+|.+..+++.+|+|.+... ......+..|+.+++.+ +||||+++++++..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 35799999999999999999999999999999998653 22345677888999888 79999999998853
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccc
Q 042772 378 STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 378 ~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
....|++|||+++|+|.+++.......+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 45789999999999999999876555688999999999999999999999999999999999999999999999999753
Q ss_pred cC---------------CCCce-----------eecccccchHHHHHHHHhCCcccC
Q 042772 458 TS---------------CKPQV-----------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 458 ~~---------------~~~~~-----------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.. .+|+. ...+|+|++|++++++++|..||.
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~ 227 (282)
T cd06636 171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC 227 (282)
T ss_pred hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcc
Confidence 21 11222 124699999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-27 Score=236.56 Aligned_cols=185 Identities=35% Similarity=0.631 Sum_probs=163.1
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCe
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTH 380 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~ 380 (489)
.+...+|..+.+||.|+||+|.+|+.+++.+.||||++++......+.++-...|..+|... +-|+++.++.+|++-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 45677899999999999999999999999999999999998887777888888899998877 47899999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccc---
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM--- 457 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~--- 457 (489)
+|+||||+.||+|--.+.+- +.+.|..+.+++++|+.||-+||++||++||||.+||++|.+|+|||+|||++..
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 99999999999999888775 3489999999999999999999999999999999999999999999999999852
Q ss_pred ------cCC-CCceee-----------cccccchHHHHHHHHhCCcccC
Q 042772 458 ------TSC-KPQVFY-----------HAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 458 ------~~~-~~~~~~-----------~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+.| .|.++. ..+-|+||+.++||+.|..||+
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd 551 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 551 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC
Confidence 112 222222 2266889999999999999986
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=218.08 Aligned_cols=180 Identities=25% Similarity=0.340 Sum_probs=153.5
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeeccc--ccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC--CeEE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSV--MLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS--THIC 382 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~ 382 (489)
+|++.+.||+|+||.||+|.+..++..||+|.+.... .........+.+|+.++++++||||+++++++.+. ..++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 6899999999999999999999999999999885422 12234567888999999999999999999988764 4689
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC---
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS--- 459 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~--- 459 (489)
++|||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 83 ~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 999999999999999765 347899999999999999999999999999999999999999999999999886321
Q ss_pred ---------------CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ---------------CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---------------~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 210 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA 210 (264)
T ss_pred ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 11221 134599999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=217.36 Aligned_cols=175 Identities=36% Similarity=0.569 Sum_probs=147.4
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHH-hCCCCCcceeeEEEEeCCeEEEEEecCCC
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS-LLDHPFLPTLYASFQTSTHICLITDFCPG 390 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~l~~~~~~~~~~~lVmEy~~g 390 (489)
+.||.|+||.||+|.+..+++.||+|.+.+...........+..|..++. ..+|||++++++++...+..|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999999999999999997654333334444555655544 45899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC----------
Q 042772 391 GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC---------- 460 (489)
Q Consensus 391 gsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~---------- 460 (489)
++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y 159 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDY 159 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccccccCCCCcCc
Confidence 9999999765 3489999999999999999999999999999999999999999999999998864321
Q ss_pred -CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 -KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.|+ ....+|+|++|.+++++++|..||.
T Consensus 160 ~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 194 (260)
T cd05611 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194 (260)
T ss_pred cChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCC
Confidence 111 1234699999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=235.33 Aligned_cols=186 Identities=22% Similarity=0.297 Sum_probs=153.2
Q ss_pred ccccccCcccccccCCCCceEEEEEEEcC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEE
Q 042772 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQG-----AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYAS 374 (489)
Q Consensus 301 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~ 374 (489)
..+..++|.+.+.||+|+||.||+|.+.+ ++..||+|.++... .....+.+..|+.++..+. ||||++++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 34556679999999999999999999653 45689999997542 2334557888999999997 9999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhCCC----------------------------------------------------
Q 042772 375 FQTSTHICLITDFCPGGELFALLDKQPM---------------------------------------------------- 402 (489)
Q Consensus 375 ~~~~~~~~lVmEy~~ggsL~~~L~~~~~---------------------------------------------------- 402 (489)
+.....+++||||+++|+|.+++.+...
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 9999999999999999999999975321
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 042772 403 --------------------------------------------KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPEN 438 (489)
Q Consensus 403 --------------------------------------------~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~N 438 (489)
..+++..+..++.|++.||.|||+++++||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 135677788899999999999999999999999999
Q ss_pred EEEecCCcEEEEecCCccccCC-----------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 439 ILLQKDGHVVLTDFDLSFMTSC-----------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 439 ILld~~g~vKL~DFGlS~~~~~-----------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
||+++++.+||+|||+++.... .|+ ....+|+|++|++++|+++ |..||.
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~ 343 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP 343 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999864311 011 1123589999999999987 888884
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=217.79 Aligned_cols=180 Identities=27% Similarity=0.394 Sum_probs=153.8
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCC----
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTST---- 379 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~---- 379 (489)
.++|++.+.||+|+||.||+|.++.+++.+++|.+.... .....+..|+.+++++ .||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 367999999999999999999999899999999987542 2345678899999998 7999999999997644
Q ss_pred --eEEEEEecCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCc
Q 042772 380 --HICLITDFCPGGELFALLDKQP--MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455 (489)
Q Consensus 380 --~~~lVmEy~~ggsL~~~L~~~~--~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS 455 (489)
.+++||||+++++|.+++.... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 4899999999999999987532 356899999999999999999999999999999999999999999999999987
Q ss_pred cccC---------------CCCce-----------eecccccchHHHHHHHHhCCcccC
Q 042772 456 FMTS---------------CKPQV-----------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 456 ~~~~---------------~~~~~-----------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.... .+|+. ...+|+|++|.+++++++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 219 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219 (275)
T ss_pred eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcc
Confidence 5321 11221 234699999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=217.02 Aligned_cols=174 Identities=29% Similarity=0.371 Sum_probs=148.4
Q ss_pred cccCCCCceEEEEEEEcC-CC--cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecC
Q 042772 312 KPLGCGDTGSVHLVELQG-AG--ELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFC 388 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~-tg--~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~ 388 (489)
+.||+|++|.||+|.+.. .+ ..||+|.+...... ...+.+..|+.++++++||||+++++.+.. ...+++|||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 33 36999999765432 566788899999999999999999999888 8899999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC--------
Q 042772 389 PGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC-------- 460 (489)
Q Consensus 389 ~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~-------- 460 (489)
++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 999999999876434589999999999999999999999999999999999999999999999998864321
Q ss_pred ----------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 461 ----------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 ----------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++ |..||.
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 202 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWA 202 (257)
T ss_pred cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 111 1123699999999999997 999983
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=222.75 Aligned_cols=181 Identities=24% Similarity=0.311 Sum_probs=156.3
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
..|+..+.||+|+||.||+|....+++.||+|.+...........+.+.+|+.+++.++||||+++++++......|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 46999999999999999999999999999999987554444555677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------ 459 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------ 459 (489)
||++ |+|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~~~ 172 (307)
T cd06607 95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV 172 (307)
T ss_pred HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCCCCcc
Confidence 9996 68888776543 348999999999999999999999999999999999999999999999999886432
Q ss_pred -----CCCcee---------ecccccchHHHHHHHHhCCcccC
Q 042772 460 -----CKPQVF---------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 -----~~~~~~---------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+.. ..+|+|++|.+++++++|..||.
T Consensus 173 ~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~ 215 (307)
T cd06607 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (307)
T ss_pred CCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCC
Confidence 123322 24699999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-26 Score=223.54 Aligned_cols=179 Identities=25% Similarity=0.324 Sum_probs=153.4
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|++.+.||+|+||.||+|.++.+++.||+|.+.+.... ....+.+.+|+++++.++||||+++++++......|+|||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 688999999999999999999999999999998654332 2334567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------- 459 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------- 459 (489)
|+++++|..+.... ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++....
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccC
Confidence 99998888776553 338999999999999999999999999999999999999999999999999875421
Q ss_pred --------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 460 --------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 --------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~ 202 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP 202 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCC
Confidence 12222 134689999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=222.70 Aligned_cols=181 Identities=28% Similarity=0.388 Sum_probs=150.3
Q ss_pred cCcccccccCCCCceEEEEEEEcC----------------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcc
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQG----------------AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLP 369 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~----------------tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv 369 (489)
++|++.+.||+|+||.||++.+.. ++..+|+|.+.... .......+..|+.+++.++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 579999999999999999986542 34578999886542 334456788999999999999999
Q ss_pred eeeEEEEeCCeEEEEEecCCCCCHHHHHhhCCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 042772 370 TLYASFQTSTHICLITDFCPGGELFALLDKQPM---------KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENIL 440 (489)
Q Consensus 370 ~l~~~~~~~~~~~lVmEy~~ggsL~~~L~~~~~---------~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NIL 440 (489)
++++++......+++|||+++++|.+++..... ..+++..+..++.|++.||.|||++|++|+||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 999999999999999999999999999976421 23677889999999999999999999999999999999
Q ss_pred EecCCcEEEEecCCccccCC-----------------CC------ceeecccccchHHHHHHHHh--CCcccC
Q 042772 441 LQKDGHVVLTDFDLSFMTSC-----------------KP------QVFYHAHVNGFYFIMYKWLT--GYFTYV 488 (489)
Q Consensus 441 ld~~g~vKL~DFGlS~~~~~-----------------~~------~~~~~~~v~s~g~~a~e~~~--G~lpY~ 488 (489)
++.++.++|+|||++..... .| .....+|+|++|++++|+++ |..||.
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 99999999999999864311 01 11224699999999999987 667774
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=218.79 Aligned_cols=178 Identities=25% Similarity=0.346 Sum_probs=148.9
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++.+.||+|+||.||+|.+..++ .+|+|.+..... ..+.+.+|+.+++.++|||++++++++. ....+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 356999999999999999999987654 589998764321 2356778999999999999999998875 4568999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC---- 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~---- 460 (489)
|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 9999999999999876555578999999999999999999999999999999999999999999999999864321
Q ss_pred ------------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 461 ------------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 ------------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++ |..||.
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 205 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYP 205 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1111 123589999999999998 898884
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=228.73 Aligned_cols=187 Identities=30% Similarity=0.596 Sum_probs=164.1
Q ss_pred CccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeC
Q 042772 300 GEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTS 378 (489)
Q Consensus 300 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~ 378 (489)
...+++++|.++++||+|+|.+|.+++++.|.+.||+|++++...++....+....|..+..+. +||++|.++.+|+++
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 3456789999999999999999999999999999999999998888888889999999998876 799999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
..+++|.||++||+|.-++.++. .++++.++++..+|+.||.|||++||++||||..|||+|..|++||+|+|++..-
T Consensus 324 srlffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC
Confidence 99999999999999988887763 4999999999999999999999999999999999999999999999999998521
Q ss_pred ---------CC-CCceeecc-----------cccchHHHHHHHHhCCcccC
Q 042772 459 ---------SC-KPQVFYHA-----------HVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ---------~~-~~~~~~~~-----------~v~s~g~~a~e~~~G~lpY~ 488 (489)
.| .|.++.++ +-|.+|+.+.||+.|..||+
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 12 23333222 44677888888888888886
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=222.24 Aligned_cols=177 Identities=24% Similarity=0.372 Sum_probs=153.9
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
.|+..+.||+|+||.||+|.+..+++.||+|.+.... .....+.+..|+.+++.++||||+++++++......|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 4888899999999999999999999999999986542 23345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC------ 460 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~------ 460 (489)
|+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++.....
T Consensus 83 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 83 YLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred ccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence 9999999999865 3478999999999999999999999999999999999999999999999999854321
Q ss_pred ---------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCc
Confidence 1111 124589999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=224.85 Aligned_cols=184 Identities=23% Similarity=0.318 Sum_probs=152.1
Q ss_pred ccccCcccccccCCCCceEEEEEEEcC-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQG-------AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYAS 374 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~-------tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~ 374 (489)
+..++|.+.+.||+|+||.||+|.+.. ++..+|+|.+.... .......+..|+.+++.+ +||||++++++
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 334679999999999999999998753 23579999987542 233456788899999999 79999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 042772 375 FQTSTHICLITDFCPGGELFALLDKQP--------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENIL 440 (489)
Q Consensus 375 ~~~~~~~~lVmEy~~ggsL~~~L~~~~--------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NIL 440 (489)
+......|+||||+++|+|.+++.... ...++...+..++.|++.||.|||++|++||||||+||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 172 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence 999999999999999999999997642 124788999999999999999999999999999999999
Q ss_pred EecCCcEEEEecCCccccCC-----------------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 441 LQKDGHVVLTDFDLSFMTSC-----------------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 441 ld~~g~vKL~DFGlS~~~~~-----------------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
++.++.+||+|||++..... +|+. ...+|+|++|+++++|++ |..||.
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~ 244 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 244 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999853210 1111 123588999999999987 888874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=219.99 Aligned_cols=179 Identities=23% Similarity=0.389 Sum_probs=154.9
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|++.+.||+|+||.||+|.+..+|..||+|.+..... .......+..|+.+++.++||||+++++++......++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 48899999999999999999999999999999876532 23345678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC------ 460 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~------ 460 (489)
|+ +++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred cc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 99 999999987654 4589999999999999999999999999999999999999999999999998864321
Q ss_pred ----------CCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ----------KPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ----------~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|.+++++++|..+|.
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 202 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP 202 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcC
Confidence 1222 234689999999999999977763
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=225.44 Aligned_cols=172 Identities=22% Similarity=0.338 Sum_probs=140.1
Q ss_pred ccccCCCCceEEEEEEEc--CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe--CCeEEEEEe
Q 042772 311 IKPLGCGDTGSVHLVELQ--GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT--STHICLITD 386 (489)
Q Consensus 311 ~~~LG~G~fG~Vy~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lVmE 386 (489)
.+.||+|+||.||+|.++ .+++.||+|.+..... ...+.+|+.+++.++||||+++++++.. ...+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999976 4678999999865421 2346679999999999999999998854 457899999
Q ss_pred cCCCCCHHHHHhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE----ecCCcEEEEecCCc
Q 042772 387 FCPGGELFALLDKQ-------PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILL----QKDGHVVLTDFDLS 455 (489)
Q Consensus 387 y~~ggsL~~~L~~~-------~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILl----d~~g~vKL~DFGlS 455 (489)
|+ +++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 99 46998887642 12248999999999999999999999999999999999999 45678999999998
Q ss_pred cccC------------------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 456 FMTS------------------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 456 ~~~~------------------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+... .+|+. ....|+|++|++++++++|..||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 6432 11222 123589999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-27 Score=237.53 Aligned_cols=178 Identities=25% Similarity=0.387 Sum_probs=157.7
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
.|+..+.||+|+||.||+|.+..+++.||+|+++... .......+..|+.+|..++++||.++|++|.....++++||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 5888899999999999999999999999999998653 45567788889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------- 459 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------- 459 (489)
||.||++.++|+.. ..+.+..+..++.+++.|+.|||.++.+|||||+.|||+..+|.+||+|||.+....
T Consensus 92 y~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred HhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 99999999999875 346899999999999999999999999999999999999999999999999985322
Q ss_pred --------CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 --------CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 --------~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|++ -..+|+|++|.+++|++.|..||.
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s 212 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHS 212 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCc
Confidence 12222 234588999999999999999984
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-27 Score=249.65 Aligned_cols=184 Identities=23% Similarity=0.318 Sum_probs=162.3
Q ss_pred ccccccCcccccccCCCCceEEEEEEEcCCC---cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe
Q 042772 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAG---ELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT 377 (489)
Q Consensus 301 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg---~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 377 (489)
.+++.....+.++||.|.||.|++|.++..| ..||||.++... .......|+.|..||.+++||||++|.|+...
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence 3677778899999999999999999998766 489999997653 45566789999999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccc
Q 042772 378 STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 378 ~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
...++||+|||++|+|.++|..+.++ |+.-+...++..|+.||.||-++++|||||..+|||++.+..+|++|||+|+.
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceee
Confidence 99999999999999999999998755 88999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCce------------e------------ecccccchHHHHHHH-HhCCccc
Q 042772 458 TSCKPQV------------F------------YHAHVNGFYFIMYKW-LTGYFTY 487 (489)
Q Consensus 458 ~~~~~~~------------~------------~~~~v~s~g~~a~e~-~~G~lpY 487 (489)
+...++. | ..+|||+||..++|. +.|.-||
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 7654422 1 344888888888874 6888887
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=217.76 Aligned_cols=180 Identities=26% Similarity=0.380 Sum_probs=151.2
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
+..++|++.+.||+|+||.||+|.... +..+|+|.+..... ..+.+.+|+.++++++|||++++++++. ....+
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 344679999999999999999998764 56799999875432 1346788999999999999999999875 45689
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC--
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC-- 460 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~-- 460 (489)
++|||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++.....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999999999876555689999999999999999999999999999999999999999999999999864321
Q ss_pred --------------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 461 --------------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 --------------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+. ...+|+|++|.+++++++ |..||.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~ 205 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYP 205 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCC
Confidence 1211 124689999999999998 888874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=220.53 Aligned_cols=177 Identities=26% Similarity=0.383 Sum_probs=148.6
Q ss_pred CcccccccCCCCceEEEEEEE----cCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC--Ce
Q 042772 307 HFKPIKPLGCGDTGSVHLVEL----QGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS--TH 380 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~----~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~ 380 (489)
.|++++.||+|+||.||+|.. ..++..||+|.++... .......+.+|+.+++.+.||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 478999999999999999985 4568899999986442 334456788999999999999999999988775 57
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
.++||||++|++|.+++.+.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++....
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred eEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 899999999999999997653 3478999999999999999999999999999999999999999999999999864321
Q ss_pred ------------------CCc------eeecccccchHHHHHHHHhCCcc
Q 042772 461 ------------------KPQ------VFYHAHVNGFYFIMYKWLTGYFT 486 (489)
Q Consensus 461 ------------------~~~------~~~~~~v~s~g~~a~e~~~G~lp 486 (489)
+|+ ....+|+|++|++++++++|+.|
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~ 211 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDS 211 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCC
Confidence 111 11346899999999999987654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=223.47 Aligned_cols=184 Identities=22% Similarity=0.309 Sum_probs=151.9
Q ss_pred ccccCcccccccCCCCceEEEEEEEc-------CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQ-------GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYAS 374 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~-------~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~ 374 (489)
+...+|++.+.||+|+||.||+|.+. ..+..||+|.+... ........+..|+.+++.+ +||||++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc--cchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 44568999999999999999999753 23458999988643 2234457788999999999 89999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 042772 375 FQTSTHICLITDFCPGGELFALLDKQP--------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENIL 440 (489)
Q Consensus 375 ~~~~~~~~lVmEy~~ggsL~~~L~~~~--------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NIL 440 (489)
+......+++|||+++|+|.+++.... ...++...+..++.|++.||.|||++|++||||||+||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 999999999999999999999997642 134678889999999999999999999999999999999
Q ss_pred EecCCcEEEEecCCccccCC-----------------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 441 LQKDGHVVLTDFDLSFMTSC-----------------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 441 ld~~g~vKL~DFGlS~~~~~-----------------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
++.++.+||+|||+++.... +|+. ...+|+|++|++++++++ |..||.
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 241 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999863320 1221 124688999999999987 777764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=217.44 Aligned_cols=177 Identities=23% Similarity=0.357 Sum_probs=149.6
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 383 (489)
.+++|++.+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.+++.++||||+++++++... ..++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 346799999999999999999874 57889999886431 235677899999999999999999988665 4799
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC---
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC--- 460 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~--- 460 (489)
+|||+++++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~ 155 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD 155 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccCC
Confidence 99999999999999876555689999999999999999999999999999999999999999999999998864221
Q ss_pred ---------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 461 ---------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 ---------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+ .....|+|++|++++++++ |..||.
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 199 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYP 199 (254)
T ss_pred CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 111 1124589999999999986 999885
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=214.55 Aligned_cols=180 Identities=26% Similarity=0.390 Sum_probs=155.2
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccc--cchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVM--LNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
+|+..+.||+|+||+||+|....++..|++|.+..... ........+..|+.+++.++||||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47788999999999999999998899999999865432 1234567788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC---- 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~---- 460 (489)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccc
Confidence 9999999999999775 3478999999999999999999999999999999999999999999999998753221
Q ss_pred ----------CCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ----------KPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ----------~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.|+ .....|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~ 203 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWS 203 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcc
Confidence 111 2234689999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=223.96 Aligned_cols=184 Identities=24% Similarity=0.310 Sum_probs=152.7
Q ss_pred ccccCcccccccCCCCceEEEEEEEcC-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQG-------AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYAS 374 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~-------tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~ 374 (489)
+..++|.+.+.||+|+||.||+|.... ....+|+|.+.... .......+..|+.+++.+ +||||++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 344679999999999999999998642 34579999886532 234566788899999999 69999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 042772 375 FQTSTHICLITDFCPGGELFALLDKQP--------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENIL 440 (489)
Q Consensus 375 ~~~~~~~~lVmEy~~ggsL~~~L~~~~--------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NIL 440 (489)
+.....+|++|||+++|+|.+++.... ...+++..+..++.|++.||.|||++|++||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 166 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence 999899999999999999999997632 234788899999999999999999999999999999999
Q ss_pred EecCCcEEEEecCCccccCC-----------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 441 LQKDGHVVLTDFDLSFMTSC-----------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 441 ld~~g~vKL~DFGlS~~~~~-----------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
++.++.+||+|||+++.... +|+ ....+|+|++|++++++++ |..||.
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~ 238 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP 238 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCC
Confidence 99999999999999863321 111 1224589999999999988 888874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=224.44 Aligned_cols=181 Identities=21% Similarity=0.301 Sum_probs=151.6
Q ss_pred CcccccccCCCCceEEEEEEEcC--CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC--CeEE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQG--AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS--THIC 382 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~--tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~ 382 (489)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.............+..|+.+++.++||||+++++++... ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48889999999999999999988 8999999999764322333445677899999999999999999999988 7899
Q ss_pred EEEecCCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec----CCcEEEEecCCc
Q 042772 383 LITDFCPGGELFALLDKQP---MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK----DGHVVLTDFDLS 455 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~---~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~----~g~vKL~DFGlS 455 (489)
+||||++ ++|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999996 57887775431 235899999999999999999999999999999999999999 999999999998
Q ss_pred cccCC------------------CCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 456 FMTSC------------------KPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 456 ~~~~~------------------~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
..... +|+. ...+|+|++|++++++++|..||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 217 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 64321 1221 234589999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=214.54 Aligned_cols=181 Identities=24% Similarity=0.429 Sum_probs=156.5
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|+..+.||+|+||.||+|....+++.+|+|.+..... .......+..|+.+++.++||||+++++.+......++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 48899999999999999999999999999999976543 23446778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC-CcEEEEecCCccccCC-----
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD-GHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~-g~vKL~DFGlS~~~~~----- 460 (489)
|+++++|.+++.......+++..+..++.|++.+|.|||++|++|+||||+||+++.+ +.+||+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence 9999999999987655568999999999999999999999999999999999999855 4689999999864321
Q ss_pred ---------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ....|+|++|++++++++|..||.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 202 (256)
T cd08220 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202 (256)
T ss_pred ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcc
Confidence 1221 234689999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=216.88 Aligned_cols=172 Identities=22% Similarity=0.343 Sum_probs=143.5
Q ss_pred ccCCCCceEEEEEEEc--CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCCC
Q 042772 313 PLGCGDTGSVHLVELQ--GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPG 390 (489)
Q Consensus 313 ~LG~G~fG~Vy~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~g 390 (489)
.||+|+||.||+|.+. ..+..||+|.+... ......+.+.+|+.+++.++||||+++++++.. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc--cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 4899999999999875 44567999988654 234445678899999999999999999998764 578999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC----------
Q 042772 391 GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC---------- 460 (489)
Q Consensus 391 gsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~---------- 460 (489)
++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 79 ~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 79 GPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999987543 3589999999999999999999999999999999999999999999999999863221
Q ss_pred --------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 461 --------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 --------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++ |..||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 200 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK 200 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcC
Confidence 1111 124599999999999885 999984
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=216.29 Aligned_cols=180 Identities=24% Similarity=0.323 Sum_probs=152.0
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
+..++|++.+.||+|+||.||++.+.. +..+|+|.+... ....+.+.+|+.+++.++|+||+++++++.. ...+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecC-CccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 345689999999999999999998664 556999988643 2234678889999999999999999998877 7789
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC--
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC-- 460 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~-- 460 (489)
++|||+++++|.+++.......++...+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999999876555578889999999999999999999999999999999999999999999998754321
Q ss_pred --------------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 461 --------------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 --------------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++ |..||.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~ 205 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP 205 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCC
Confidence 1111 124589999999999998 999984
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=218.51 Aligned_cols=177 Identities=25% Similarity=0.426 Sum_probs=153.9
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCCcceeeEEEEeCCeEEE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD---HPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~~~~~l 383 (489)
.|+..+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.+. |||++++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4888999999999999999999999999999986542 3344567788999999886 9999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC---
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC--- 460 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~--- 460 (489)
+|||+++++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 99999999999998653 488999999999999999999999999999999999999999999999998854321
Q ss_pred ------------CCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ------------KPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ------------~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 203 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYS 203 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCC
Confidence 1221 234689999999999999999985
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=219.72 Aligned_cols=181 Identities=25% Similarity=0.342 Sum_probs=151.4
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEE-----e
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQ-----T 377 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~-----~ 377 (489)
..++|++.+.||+|+||.||+|.+..+++.+|+|.+.... .....+..|+.+++.+ +||||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 4468999999999999999999999999999999876432 1224567799999998 7999999999874 3
Q ss_pred CCeEEEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCc
Q 042772 378 STHICLITDFCPGGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455 (489)
Q Consensus 378 ~~~~~lVmEy~~ggsL~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS 455 (489)
....++||||+++++|.+++... ....+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 45799999999999999987642 2345789999999999999999999999999999999999999999999999998
Q ss_pred cccCC---------------CCce-----------eecccccchHHHHHHHHhCCcccC
Q 042772 456 FMTSC---------------KPQV-----------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 456 ~~~~~---------------~~~~-----------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
..... +|+. ...+|+|++|++++++++|..||.
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~ 230 (286)
T cd06638 172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230 (286)
T ss_pred eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCC
Confidence 53221 1221 234699999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=220.85 Aligned_cols=181 Identities=35% Similarity=0.575 Sum_probs=158.8
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV 384 (489)
++|.+.+.||+|+||.||+|....+++.||+|++.+...........+..|..+++++. ||||+++++++......+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36899999999999999999999999999999998755444555677888999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCCC--
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKP-- 462 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~~-- 462 (489)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 99999999999998763 58999999999999999999999999999999999999999999999999986433211
Q ss_pred ---------------------------------c------eeecccccchHHHHHHHHhCCcccC
Q 042772 463 ---------------------------------Q------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 463 ---------------------------------~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+ .....|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 223 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCC
Confidence 1 1123588999999999999999985
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=221.84 Aligned_cols=181 Identities=20% Similarity=0.274 Sum_probs=153.9
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC--CeEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS--THIC 382 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~ 382 (489)
.++|++.+.||.|+||.||+|.++.+++.+|+|.++..... ......+.+|+.+++.++||||+++++++... ...|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 35799999999999999999999999999999999755332 22334567899999999999999999998877 8999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC--
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC-- 460 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~-- 460 (489)
+||||++ ++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.....
T Consensus 83 lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9999996 59999987653 3589999999999999999999999999999999999999999999999998864321
Q ss_pred -------------CCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 461 -------------KPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -------------~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~ 208 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC
Confidence 1221 134589999999999999998874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=238.01 Aligned_cols=179 Identities=25% Similarity=0.346 Sum_probs=145.0
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC------CCCcceeeEEEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD------HPFLPTLYASFQ 376 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~------HpnIv~l~~~~~ 376 (489)
...++|++++.||+|+||+||+|.+..+++.||+|+++... ........|+.+++.+. |++++.++++|.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34578999999999999999999999999999999996431 22234455777776664 456889998887
Q ss_pred eC-CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCC---------
Q 042772 377 TS-THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC-LGIIYRDLKPENILLQKDG--------- 445 (489)
Q Consensus 377 ~~-~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~-~gIvHrDLKP~NILld~~g--------- 445 (489)
.. .++|+|||++ +++|.+++.+. ..+++..+..++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccc
Confidence 65 5799999998 78999998765 348999999999999999999998 5999999999999998765
Q ss_pred -------cEEEEecCCccccC------------CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 446 -------HVVLTDFDLSFMTS------------CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 446 -------~vKL~DFGlS~~~~------------~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+||+|||++.... .+|+. ....|+|++|++++|+++|..||.
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred ccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 49999999875321 12222 223499999999999999999995
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-25 Score=219.32 Aligned_cols=181 Identities=28% Similarity=0.419 Sum_probs=153.4
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC--CeEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS--THICL 383 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~l 383 (489)
++|...+.||.|++|.||+|.+..+++.+|+|.+.... .......+.+|+++++.++||||++++++|... ..+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 36889999999999999999999999999999987542 234567788999999999999999999988653 47899
Q ss_pred EEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 384 ITDFCPGGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
||||+++++|.+++... ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 99999999999887642 234478999999999999999999999999999999999999999999999999753221
Q ss_pred ------------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ------------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ------------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ....|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 204 (287)
T cd06621 159 LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP 204 (287)
T ss_pred ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1211 124589999999999999999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=221.57 Aligned_cols=180 Identities=22% Similarity=0.372 Sum_probs=154.9
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|+.++.||.|++|.||+|.+..+++.||+|.+..... .......+..|++++++++||||+++++++......++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48899999999999999999999999999998865432 22234567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------- 459 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------- 459 (489)
|+. ++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 158 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence 995 689999887655668999999999999999999999999999999999999999999999999875321
Q ss_pred --------CCCcee-------ecccccchHHHHHHHHhCCcccC
Q 042772 460 --------CKPQVF-------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 --------~~~~~~-------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+.. ..+|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~ 202 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 202 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 123322 23589999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-27 Score=229.37 Aligned_cols=176 Identities=24% Similarity=0.387 Sum_probs=156.9
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
-|.+++.||+|+||.||+|.++.+|+.+|||.+... ..++.+..|+.|+++++.|++|++|++|.....+|+|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 488999999999999999999999999999988643 457889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------- 459 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------- 459 (489)
||.-|+..+.+..+ ++++++.++..++...+.||+|||...-+|||||..|||++.+|+.||+|||.|-.+.
T Consensus 109 YCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 109 YCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred hcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence 99999999998765 4679999999999999999999999999999999999999999999999999985433
Q ss_pred --CCCceee------------cccccchHHHHHHHHhCCcccC
Q 042772 460 --CKPQVFY------------HAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 --~~~~~~~------------~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.....|. .+++|++|.++.||+-|..||.
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYs 230 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYS 230 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcc
Confidence 1222332 3478899999999999999985
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-26 Score=216.68 Aligned_cols=185 Identities=22% Similarity=0.284 Sum_probs=159.4
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC---
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS--- 378 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--- 378 (489)
-+...+|++.+.||+|+|+-||+++...+++.||+|.+... +........+|++..++++||||++++++...+
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 45668999999999999999999999999999999999765 345677888999999999999999999876443
Q ss_pred --CeEEEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEecCCcEEEEec
Q 042772 379 --THICLITDFCPGGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEYLHCLG--IIYRDLKPENILLQKDGHVVLTDF 452 (489)
Q Consensus 379 --~~~~lVmEy~~ggsL~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH~~g--IvHrDLKP~NILld~~g~vKL~DF 452 (489)
..+||+++|...|+|.+.+... .+..+++.+++.|+.+||+||++||... +.||||||.|||+.+.+.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 3599999999999999998764 3335899999999999999999999998 999999999999999999999999
Q ss_pred CCccccC------------------------CCCc---------eeecccccchHHHHHHHHhCCcccCC
Q 042772 453 DLSFMTS------------------------CKPQ---------VFYHAHVNGFYFIMYKWLTGYFTYVP 489 (489)
Q Consensus 453 GlS~~~~------------------------~~~~---------~~~~~~v~s~g~~a~e~~~G~lpY~~ 489 (489)
|.++... -+|+ .....|+|++|+++|.|+.|.-||++
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 9985322 1122 22455999999999999999999973
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=219.34 Aligned_cols=180 Identities=26% Similarity=0.342 Sum_probs=152.5
Q ss_pred cCcccccccCCCCceEEEEEEEcC----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe--CC
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQG----AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT--ST 379 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~----tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~ 379 (489)
.+|++.+.||+|+||.||+|.+.. ++..+|+|.+...... .....+..|+.+++.+.||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 468899999999999999999653 4789999999755322 356778899999999999999999998877 55
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
..+++|||+++++|.+++..... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 79999999999999999987643 48999999999999999999999999999999999999999999999999986543
Q ss_pred C------------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 C------------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ~------------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. .|+ ....+|+|++|++++++++|..|+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~ 213 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQ 213 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcc
Confidence 1 111 1124588999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-25 Score=215.37 Aligned_cols=172 Identities=23% Similarity=0.338 Sum_probs=145.7
Q ss_pred cccCCCCceEEEEEEEcCCC---cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecC
Q 042772 312 KPLGCGDTGSVHLVELQGAG---ELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFC 388 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg---~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~ 388 (489)
+.||+|+||.||+|.+..++ ..+|+|.+...... .....+..|+.+++.++||||+++++++. ....+++|||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999876554 78999998765432 34567888999999999999999999876 44689999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC--------
Q 042772 389 PGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC-------- 460 (489)
Q Consensus 389 ~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~-------- 460 (489)
++|+|.+++.... .+++..+..++.|++.||.|||.++++|+||||+|||++.++.+||+|||+++....
T Consensus 78 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 78 PLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 9999999998764 489999999999999999999999999999999999999999999999999863311
Q ss_pred ----------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 461 ----------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 ----------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++ |..||.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~ 200 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYG 200 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcc
Confidence 1111 124699999999999996 999985
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-25 Score=217.11 Aligned_cols=180 Identities=26% Similarity=0.399 Sum_probs=153.7
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeeccccc-------chHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVML-------NRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~-------~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
+|...+.||.|+||.||+|....+++.+|+|.+...... .....+.+..|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 578889999999999999999989999999988642211 1123456778999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 999999999999999999876 458999999999999999999999999999999999999999999999999886321
Q ss_pred C-----------------CCc--------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 C-----------------KPQ--------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ~-----------------~~~--------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. .|+ ....+|+|++|++++++++|..||.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 213 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS 213 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc
Confidence 0 121 1233589999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=222.64 Aligned_cols=174 Identities=28% Similarity=0.470 Sum_probs=146.0
Q ss_pred cCcccc-cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHH-HHhCCCCCcceeeEEEEe----CC
Q 042772 306 HHFKPI-KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI-MSLLDHPFLPTLYASFQT----ST 379 (489)
Q Consensus 306 ~~y~~~-~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~i-l~~l~HpnIv~l~~~~~~----~~ 379 (489)
++|.+. ++||-|-.|.|..|.++.||+.+|+|++..+ ...++|+++ +..-.|||||.++++|.. ..
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 455554 6799999999999999999999999988533 345567776 334479999999998864 35
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---CCcEEEEecCCcc
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK---DGHVVLTDFDLSF 456 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~---~g~vKL~DFGlS~ 456 (489)
.+.+|||.++||+|++.+..+....++|.++..|+.||+.|+.|||+.+|.||||||+|+|... |..+||+|||+|.
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccc
Confidence 6889999999999999999998888999999999999999999999999999999999999964 4579999999997
Q ss_pred ccC--------C------CCcee------ecccccchHHHHHHHHhCCccc
Q 042772 457 MTS--------C------KPQVF------YHAHVNGFYFIMYKWLTGYFTY 487 (489)
Q Consensus 457 ~~~--------~------~~~~~------~~~~v~s~g~~a~e~~~G~lpY 487 (489)
... | +|++. ...+.|++|+++|+++||..||
T Consensus 213 ~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPF 263 (400)
T KOG0604|consen 213 ETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263 (400)
T ss_pred ccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcc
Confidence 544 1 12221 2338899999999999999998
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-25 Score=220.02 Aligned_cols=181 Identities=18% Similarity=0.267 Sum_probs=152.6
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++.+.||.|++|.||+|.++.+++.||+|.+..... .......+..|+.+++.++||||+++++++......|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999998865432 2233456778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-CCcEEEEecCCccccC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK-DGHVVLTDFDLSFMTS----- 459 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~-~g~vKL~DFGlS~~~~----- 459 (489)
||++ ++|.+++.......+++..+..++.||+.||.|||+++++|+||+|+||+++. ++.+||+|||++....
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 9995 68998887665545688899999999999999999999999999999999985 5679999999885321
Q ss_pred ----------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ----------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~ 205 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP 205 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 11221 124588999999999999999984
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=219.37 Aligned_cols=181 Identities=20% Similarity=0.292 Sum_probs=152.1
Q ss_pred ccCcccccccCCCCceEEEEEEEc-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQ-----GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
..+|...+.||+|+||.||++... .++..+|+|.+... .......+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 357888999999999999999753 34678999987643 3445567889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc
Q 042772 380 HICLITDFCPGGELFALLDKQPM-------------KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGH 446 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~-------------~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~ 446 (489)
..+++|||+++++|.+++..... ..+++..+..++.|++.||.|||++|++||||||+|||+++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 99999999999999999976421 24789999999999999999999999999999999999999999
Q ss_pred EEEEecCCccccC-----------------CCCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 447 VVLTDFDLSFMTS-----------------CKPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 447 vKL~DFGlS~~~~-----------------~~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+||+|||++.... .+|+. ...+|+|++|+++++|++ |..||.
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 226 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 9999999985321 11211 123599999999999987 999884
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=220.37 Aligned_cols=180 Identities=41% Similarity=0.664 Sum_probs=152.8
Q ss_pred CcccccccCCCCceEEEEEEEc---CCCcEEEEEEeeccccc-chHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQ---GAGELYAMKAMEKSVML-NRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 381 (489)
+|++.+.||.|+||.||+|... .+|..||+|.+...... .......+..|+.+++.+ +||||+.+++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4788999999999999999875 47899999998754322 223345677899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
|+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 9999999999999999875 3488999999999999999999999999999999999999999999999998864321
Q ss_pred ---------------CCce--------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------------KPQV--------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------------~~~~--------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.|+. ....|+|++|.+++++++|..||.
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 209 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCC
Confidence 1221 124699999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-25 Score=213.82 Aligned_cols=177 Identities=25% Similarity=0.403 Sum_probs=155.5
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++.+.||+|+||.||+|....+++.+++|.+.... ..+.+..|+++++.++||||+++++++......|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 57999999999999999999999889999999986542 1577889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK---- 461 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~---- 461 (489)
||+++++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 78 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 78 EYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred ecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 9999999999997543 45899999999999999999999999999999999999999999999999998643311
Q ss_pred -----------Cce------eecccccchHHHHHHHHhCCcccC
Q 042772 462 -----------PQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 -----------~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+. ...+|+|++|.+++++++|..||.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~ 200 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYS 200 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 111 124689999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=219.44 Aligned_cols=179 Identities=23% Similarity=0.347 Sum_probs=152.7
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|++++.||.|++|.||+|.+..+|+.||+|.+..... ......+..|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 48899999999999999999999999999999875432 2234566789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------
Q 042772 387 FCPGGELFALLDKQP-MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------ 459 (489)
Q Consensus 387 y~~ggsL~~~L~~~~-~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------ 459 (489)
|++ ++|.+++.... ...+++..+..++.|++.||.|||++|++|+||||+||++++++.++|+|||++....
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 79 YMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred cCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence 997 48998887643 2358999999999999999999999999999999999999999999999999885321
Q ss_pred ---------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ---------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
..|+. ...+|+|++|++++++++|..||.
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 202 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP 202 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 11221 224588999999999999999885
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-25 Score=214.71 Aligned_cols=178 Identities=26% Similarity=0.470 Sum_probs=156.9
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|++.+.||.|++|.||+|.+..+++.|++|.+..... ......+..|+.++..++||||+++++++......+++||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 68899999999999999999999999999999876532 2456778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecCCccccCCC----
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC-LGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK---- 461 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~---- 461 (489)
|+++++|.+++... ..+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 80 YMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred ecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence 99999999999875 458999999999999999999999 99999999999999999999999999988643211
Q ss_pred -----------Cce------eecccccchHHHHHHHHhCCcccC
Q 042772 462 -----------PQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 -----------~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+. ....|+|++|.+++++++|..||.
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~ 201 (264)
T cd06623 158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFL 201 (264)
T ss_pred cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 111 124599999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=225.50 Aligned_cols=185 Identities=22% Similarity=0.322 Sum_probs=152.5
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCC-------CcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGA-------GELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYA 373 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~t-------g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~ 373 (489)
++...+|++.+.||+|+||.||+|.+... +..||+|.+... ......+.+..|+.+++++ +||||+++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 44556799999999999999999986432 247899988643 2334567788999999999 7999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 042772 374 SFQTSTHICLITDFCPGGELFALLDKQP--------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENI 439 (489)
Q Consensus 374 ~~~~~~~~~lVmEy~~ggsL~~~L~~~~--------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NI 439 (489)
++.....++++|||+++|+|.+++.... ...++...+..++.|++.||.|||++|++||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 9999999999999999999999997632 23467888899999999999999999999999999999
Q ss_pred EEecCCcEEEEecCCccccCC-----------------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 440 LLQKDGHVVLTDFDLSFMTSC-----------------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 440 Lld~~g~vKL~DFGlS~~~~~-----------------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
|++.++.+||+|||+++.... +|+. ...+|+|++|++++++++ |..||.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 238 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence 999999999999999863221 1111 124589999999999987 888874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=220.66 Aligned_cols=179 Identities=24% Similarity=0.331 Sum_probs=152.5
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|++.+.||+|+||.||+|.++.+++.||+|.++.... .......+..|+++++.++||||+++++++...+..+++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 68999999999999999999999999999998865432 23345678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC-----
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK----- 461 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~----- 461 (489)
|++++.+..+.... ..+++..+..++.|++.||.|||+++++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 81 YVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 99876666555443 34899999999999999999999999999999999999999999999999987643211
Q ss_pred -----------C-------ceeecccccchHHHHHHHHhCCcccC
Q 042772 462 -----------P-------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 -----------~-------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
| .....+|+|++|.+++++++|..||.
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 203 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP 203 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1 11234589999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-25 Score=215.04 Aligned_cols=172 Identities=23% Similarity=0.341 Sum_probs=144.7
Q ss_pred ccCCCCceEEEEEEE--cCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCCC
Q 042772 313 PLGCGDTGSVHLVEL--QGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPG 390 (489)
Q Consensus 313 ~LG~G~fG~Vy~a~~--~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~g 390 (489)
.||+|+||.||+|.+ ..++..+|+|+++... .+....+.+..|+.+++.++||||+++++++.. ...++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 689999999999975 4567899999886442 234456778899999999999999999998754 467999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC----------
Q 042772 391 GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC---------- 460 (489)
Q Consensus 391 gsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~---------- 460 (489)
|+|.+++... ..+++..+..++.|++.||.|||++|++||||||.||+++.++.+||+|||++.....
T Consensus 80 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 80 GPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 9999999765 3489999999999999999999999999999999999999999999999999864321
Q ss_pred --------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 461 --------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 --------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+. ...+|+|++|++++|+++ |..||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 200 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYK 200 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 1111 124689999999999997 999985
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=218.03 Aligned_cols=177 Identities=31% Similarity=0.463 Sum_probs=148.3
Q ss_pred cccccCCCCceEEEEEEEc----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 310 PIKPLGCGDTGSVHLVELQ----GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 310 ~~~~LG~G~fG~Vy~a~~~----~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
+.+.||.|.||.||+|.+. ..+..|++|.++.. ......+.+..|++++++++||||+++++++......++||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccccc
Confidence 5678999999999999998 44678999999543 23445788999999999999999999999999888899999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
||+++|+|.++|.......+++.....++.|++.||.|||+++++|+||+|+|||++.++.+||+|||++.....
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999987445689999999999999999999999999999999999999999999999999876521
Q ss_pred ------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 461 ------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 ------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+ ....+|+|++|.+++|+++ |..||.
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~ 207 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFS 207 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 111 1124489999999999998 778874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=222.05 Aligned_cols=177 Identities=23% Similarity=0.361 Sum_probs=154.6
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
.+|++.+.||.|+||.||+|.+..+++.|++|.+.... ......+.+|+.+++.++||||+++++++......|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 46999999999999999999999999999999986542 223466788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
||+++++|..++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.....
T Consensus 96 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 172 (296)
T cd06655 96 EYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR 172 (296)
T ss_pred EecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccC
Confidence 999999999998753 478999999999999999999999999999999999999999999999998753211
Q ss_pred ----------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ----------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ----------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~ 216 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1221 134689999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=230.36 Aligned_cols=170 Identities=23% Similarity=0.377 Sum_probs=144.5
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
.+|++++.||+|+||.||+|.+..+++.||+|...+. ....|+.+++.++||||+++++++......++||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 4699999999999999999999999999999975432 1245889999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------ 459 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------ 459 (489)
|++ .++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 137 e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 214 (357)
T PHA03209 137 PHY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214 (357)
T ss_pred Ecc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccc
Confidence 999 569999887643 458999999999999999999999999999999999999999999999999986321
Q ss_pred --------CCCcee------ecccccchHHHHHHHHhCCcc
Q 042772 460 --------CKPQVF------YHAHVNGFYFIMYKWLTGYFT 486 (489)
Q Consensus 460 --------~~~~~~------~~~~v~s~g~~a~e~~~G~lp 486 (489)
.+|+.+ ..+|+|++|+++++++++..+
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~ 255 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST 255 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence 112222 345889999999999875433
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-25 Score=218.08 Aligned_cols=177 Identities=24% Similarity=0.377 Sum_probs=153.4
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
-|+..+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++++......++|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 3788899999999999999999899999999886542 23445678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------- 459 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------- 459 (489)
|+++++|.+++... .+++..+..++.|++.|+.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 83 ~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 83 YLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred eCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 99999999998753 47899999999999999999999999999999999999999999999999885321
Q ss_pred --------CCCcee------ecccccchHHHHHHHHhCCcccC
Q 042772 460 --------CKPQVF------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 --------~~~~~~------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+.. ..+|+|++|++++++++|..||.
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 202 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHS 202 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 112221 23589999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-25 Score=213.08 Aligned_cols=173 Identities=21% Similarity=0.374 Sum_probs=146.1
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCCCC
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGG 391 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg 391 (489)
+.||+|+||.||+|... ++..+|+|.+.... .......+..|+.+++.++||||+++++++......++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 46899999999999865 58899999886543 2333456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----------
Q 042772 392 ELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----------- 460 (489)
Q Consensus 392 sL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----------- 460 (489)
+|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.....
T Consensus 78 ~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9999987653 3478999999999999999999999999999999999999999999999999853211
Q ss_pred -----CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 461 -----KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 -----~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+. ....|+|++|++++++++ |..||.
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~ 196 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYP 196 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCC
Confidence 1111 123589999999999987 998884
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=217.68 Aligned_cols=180 Identities=21% Similarity=0.306 Sum_probs=152.0
Q ss_pred cCcccccccCCCCceEEEEEEEcC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQG-----AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH 380 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 380 (489)
.+|++++.||.|+||.||+|..+. +.+.+++|.+.... .......+..|+.++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 579999999999999999999764 35689999886532 23356778899999999999999999999998889
Q ss_pred EEEEEecCCCCCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecC
Q 042772 381 ICLITDFCPGGELFALLDKQPM-------KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFD 453 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~-------~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFG 453 (489)
.|+||||+++|+|.+++..... ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 9999999999999999986541 148999999999999999999999999999999999999999999999999
Q ss_pred CccccC----------------CCCce------eecccccchHHHHHHHHh-CCccc
Q 042772 454 LSFMTS----------------CKPQV------FYHAHVNGFYFIMYKWLT-GYFTY 487 (489)
Q Consensus 454 lS~~~~----------------~~~~~------~~~~~v~s~g~~a~e~~~-G~lpY 487 (489)
++.... .+|+. ...+|+|++|++++++++ |..||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~ 219 (275)
T cd05046 163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF 219 (275)
T ss_pred cccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 975321 11111 223589999999999987 77777
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=216.61 Aligned_cols=179 Identities=26% Similarity=0.410 Sum_probs=156.5
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|+..+.||.|+||.||+|.++.+++.+|+|.+..... ......+.+|+++++.++||||+++++.+......+++||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 68889999999999999999999999999999876532 3455678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecCCccccC------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC-LGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------ 459 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------ 459 (489)
|+++++|.+++.... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+....
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 158 (265)
T cd06605 80 YMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT 158 (265)
T ss_pred ecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc
Confidence 999999999998753 458999999999999999999999 999999999999999999999999999875321
Q ss_pred -------CCCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 -------CKPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 -------~~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+ .....|+|++|.+++++++|..||.
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 200 (265)
T cd06605 159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200 (265)
T ss_pred ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1121 1234599999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=219.86 Aligned_cols=183 Identities=20% Similarity=0.315 Sum_probs=152.4
Q ss_pred cccCcccccccCCCCceEEEEEEEcC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQG-----AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS 378 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 378 (489)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 34679999999999999999999753 57899999886542 234456788899999999999999999999998
Q ss_pred CeEEEEEecCCCCCHHHHHhhCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 042772 379 THICLITDFCPGGELFALLDKQP--------------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPEN 438 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~--------------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~N 438 (489)
...+++|||+++|+|.+++.... ...+++..+..++.|++.||.|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 89999999999999999997531 1236788899999999999999999999999999999
Q ss_pred EEEecCCcEEEEecCCccccCC-----------------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 439 ILLQKDGHVVLTDFDLSFMTSC-----------------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 439 ILld~~g~vKL~DFGlS~~~~~-----------------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
|+++.++.++|+|||++..... +|+. ...+|+|++|++++++++ |..||.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999863210 1111 123589999999999986 877873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-25 Score=219.74 Aligned_cols=181 Identities=21% Similarity=0.279 Sum_probs=151.8
Q ss_pred ccCcccccccCCCCceEEEEEEEcC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQG-----AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
..+|.+.+.||+|+||.||+|.... ++..+++|.+... .....+.+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 4568899999999999999998643 4567889987543 2334466888999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC
Q 042772 380 HICLITDFCPGGELFALLDKQP--------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG 445 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~--------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g 445 (489)
..++||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999997642 13378999999999999999999999999999999999999999
Q ss_pred cEEEEecCCccccC-----------------CCCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 446 HVVLTDFDLSFMTS-----------------CKPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 446 ~vKL~DFGlS~~~~-----------------~~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.++|+|||++.... .+|+. ...+|+|++|++++++++ |..||.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 227 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999985321 11221 124689999999999997 999973
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.5e-25 Score=215.93 Aligned_cols=175 Identities=23% Similarity=0.352 Sum_probs=145.6
Q ss_pred cccCCCCceEEEEEEEcCCCc--EEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEecC
Q 042772 312 KPLGCGDTGSVHLVELQGAGE--LYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHICLITDFC 388 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~--~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lVmEy~ 388 (489)
+.||+|+||.||+|.++.++. .+++|.+... ........+..|+.++.++ +||||+++++++.....++++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999988775 4688877532 2344556788899999999 7999999999999999999999999
Q ss_pred CCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCC
Q 042772 389 PGGELFALLDKQP--------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDL 454 (489)
Q Consensus 389 ~ggsL~~~L~~~~--------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGl 454 (489)
++|+|.+++.... ...+++..+..++.|++.||+|||+.|++||||||+||++++++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999997542 12478999999999999999999999999999999999999999999999999
Q ss_pred ccccC--------------CCCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 455 SFMTS--------------CKPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 455 S~~~~--------------~~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+.... .+|+. ....|+|++|++++++++ |..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~ 213 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 213 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 84211 11211 134589999999999996 999884
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-25 Score=212.91 Aligned_cols=179 Identities=26% Similarity=0.365 Sum_probs=152.5
Q ss_pred cccccccCCCCceEEEEEEEcCCC----cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAG----ELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 383 (489)
+++.+.||.|+||.||++.+..++ ..+|+|.+.... .......+..|+.+++.++||||+++++++...+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 457789999999999999998766 899999986542 22256788889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC--
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK-- 461 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~-- 461 (489)
+|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 999999999999998754333899999999999999999999999999999999999999999999999998643211
Q ss_pred --------------Cc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 462 --------------PQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 462 --------------~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
|+ ....+|+|++|++++++++ |..||.
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~ 206 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYP 206 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 11 1123588999999999987 788874
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-24 Score=220.70 Aligned_cols=180 Identities=24% Similarity=0.312 Sum_probs=154.8
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
.|...+.||+|+||.||+|.+..++..+|+|.+.............+..|+++++.++|||++++++++......++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 48899999999999999999999999999999876544444556678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC------ 460 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~------ 460 (489)
|++ |+|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 106 ~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 183 (317)
T cd06635 106 YCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVG 183 (317)
T ss_pred CCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCcccccC
Confidence 996 58888876543 3489999999999999999999999999999999999999999999999998754321
Q ss_pred -----CCce---------eecccccchHHHHHHHHhCCcccC
Q 042772 461 -----KPQV---------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -----~~~~---------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 184 ~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 225 (317)
T cd06635 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 225 (317)
T ss_pred CccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 1222 234589999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=222.93 Aligned_cols=176 Identities=24% Similarity=0.385 Sum_probs=151.5
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
.|.....||+|+||.||++....++..||+|.+... .......+..|+.+++.++||||+++++.+...+..|+|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 455567899999999999999999999999988653 23345667889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC------ 460 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~------ 460 (489)
|+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+||++++++.++|+|||++.....
T Consensus 100 ~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 100 FLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred CCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence 99999999988653 378999999999999999999999999999999999999999999999998853210
Q ss_pred ---------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++|..||.
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 219 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYF 219 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 111 1234699999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-25 Score=219.43 Aligned_cols=181 Identities=18% Similarity=0.284 Sum_probs=150.6
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCe----
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTH---- 380 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~---- 380 (489)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 368999999999999999999999999999998865422 2223456778999999995 6999999999887655
Q ss_pred -EEEEEecCCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-CCcEEEEecCCc
Q 042772 381 -ICLITDFCPGGELFALLDKQP---MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK-DGHVVLTDFDLS 455 (489)
Q Consensus 381 -~~lVmEy~~ggsL~~~L~~~~---~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~-~g~vKL~DFGlS 455 (489)
.|++|||+++ +|.+++.... ...+++..++.++.||+.||.|||++|++||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999975 8999887542 235899999999999999999999999999999999999998 889999999988
Q ss_pred cccC---------------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 456 FMTS---------------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 456 ~~~~---------------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.... .+|+. ...+|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 213 (295)
T cd07837 159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP 213 (295)
T ss_pred eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC
Confidence 6321 11221 234689999999999999998883
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=236.68 Aligned_cols=170 Identities=19% Similarity=0.249 Sum_probs=145.4
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
..|.+.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.++++++||||+++++++......++||
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 469999999999999999999999999999995421 23457999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
|++ .++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 240 e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 240 PKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred Ecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 999 579999987653 3589999999999999999999999999999999999999999999999999864321
Q ss_pred ------------CCc------eeecccccchHHHHHHHHhCCcc
Q 042772 461 ------------KPQ------VFYHAHVNGFYFIMYKWLTGYFT 486 (489)
Q Consensus 461 ------------~~~------~~~~~~v~s~g~~a~e~~~G~lp 486 (489)
.|+ ....+|+|++|++++|+++|..+
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~ 361 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTAS 361 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCC
Confidence 011 11235899999999999887654
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=250.17 Aligned_cols=182 Identities=23% Similarity=0.305 Sum_probs=156.9
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCC-----cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAG-----ELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
....++.+.||+|.||.||.|...+.. ..||+|.+.+. .+......|..|..+|+.++|||||+++|.+.+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 456788899999999999999987532 24889988654 46778899999999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCC
Q 042772 380 HICLITDFCPGGELFALLDKQ-----PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDL 454 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~-----~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGl 454 (489)
..+|++|||+||+|..+|++. ....++......++.|||.|+.||+++++|||||..+|+||++...+||+|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999999875 123478899999999999999999999999999999999999999999999999
Q ss_pred ccccCCC-----------Ccee------------ecccccchHHHHHHH-HhCCcccC
Q 042772 455 SFMTSCK-----------PQVF------------YHAHVNGFYFIMYKW-LTGYFTYV 488 (489)
Q Consensus 455 S~~~~~~-----------~~~~------------~~~~v~s~g~~a~e~-~~G~lpY~ 488 (489)
|+.+... |-.| ..+|+|+||+.++|+ .+|..||.
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~ 906 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYP 906 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCC
Confidence 9833210 1112 355999999999998 59999996
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-24 Score=210.48 Aligned_cols=179 Identities=30% Similarity=0.390 Sum_probs=157.4
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC--CeEEEE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS--THICLI 384 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lV 384 (489)
+|+..+.||+|++|.||+|.+..+++.+++|.+..... .....+.+.+|+.++++++||||+++++.+... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 47888999999999999999999999999999876532 245677888999999999999999999999888 889999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC---
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK--- 461 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~--- 461 (489)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 99999999999998764 5899999999999999999999999999999999999999999999999988644322
Q ss_pred --------------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 462 --------------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 --------------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+ ....+|+|++|++++++++|..||.
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 204 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWS 204 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 11 1234689999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=214.18 Aligned_cols=181 Identities=24% Similarity=0.292 Sum_probs=152.5
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 383 (489)
..+.+.....||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.+++.++||||+++++++......++
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 344555667899999999999999999999999988654 23345678889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCC--CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-CCcEEEEecCCccccC-
Q 042772 384 ITDFCPGGELFALLDKQPMKIF--REDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK-DGHVVLTDFDLSFMTS- 459 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l--~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~-~g~vKL~DFGlS~~~~- 459 (489)
+|||+++++|.+++.... ..+ ++..+..++.|++.||.|||++||+||||||+||+++. ++.++|+|||++....
T Consensus 83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred EEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 999999999999997642 224 78888999999999999999999999999999999976 6799999999875321
Q ss_pred --------------CCCce--------eecccccchHHHHHHHHhCCcccC
Q 042772 460 --------------CKPQV--------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 --------------~~~~~--------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|.+++++++|..||.
T Consensus 162 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~ 212 (268)
T cd06624 162 INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI 212 (268)
T ss_pred CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCc
Confidence 11222 234689999999999999999984
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-25 Score=212.69 Aligned_cols=181 Identities=22% Similarity=0.390 Sum_probs=154.3
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe--CCeEEEE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT--STHICLI 384 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lV 384 (489)
+|++.+.||.|+||.||+|.+..+++.+|+|.+..... .....+.+..|+++++.++||||+++++.+.. ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 48889999999999999999999999999999876533 34455678889999999999999999997764 4578999
Q ss_pred EecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHH-----HCCCeecCCCCCCEEEecCCcEEEEecCCccc
Q 042772 385 TDFCPGGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEYLH-----CLGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH-----~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
|||+++++|.+++... ....+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 9999999999999763 2345899999999999999999999 89999999999999999999999999999865
Q ss_pred cCCC---------------Cce------eecccccchHHHHHHHHhCCcccC
Q 042772 458 TSCK---------------PQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 458 ~~~~---------------~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.... |+. ....|+|++|.+++++++|..||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 211 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT 211 (265)
T ss_pred ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCccc
Confidence 4311 111 123589999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=216.88 Aligned_cols=180 Identities=26% Similarity=0.353 Sum_probs=152.1
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeC-----
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTS----- 378 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~----- 378 (489)
.++|.+.+.||+|+||.||+|....+++.+|+|.+.... .....+..|+.++..+ +|||++++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 567999999999999999999999999999999986532 1234566788899888 799999999998753
Q ss_pred CeEEEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 379 THICLITDFCPGGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
...++||||+++++|.+++... ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 3689999999999999988642 23458999999999999999999999999999999999999999999999999875
Q ss_pred ccC---------------CCCce-----------eecccccchHHHHHHHHhCCcccC
Q 042772 457 MTS---------------CKPQV-----------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 457 ~~~---------------~~~~~-----------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... .+|+. ...+|+|++|++++++++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~ 234 (291)
T cd06639 177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF 234 (291)
T ss_pred hcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCC
Confidence 321 12322 235699999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-25 Score=220.93 Aligned_cols=181 Identities=24% Similarity=0.326 Sum_probs=149.3
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGE----LYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
...+|+..+.||+|+||.||+|.+..++. .+|+|.+.... .......+..|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 34679999999999999999999887776 56888876442 233345678899999999999999999988654
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
..++++||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++...
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 4789999999999999997653 347899999999999999999999999999999999999999999999999996432
Q ss_pred C-----------------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 460 C-----------------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 460 ~-----------------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
. +|+. ...+|+|++|++++++++ |..||.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~ 213 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1 0111 123488999999999886 888884
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-25 Score=221.17 Aligned_cols=171 Identities=22% Similarity=0.354 Sum_probs=139.3
Q ss_pred cccCCCCceEEEEEEEcC--CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe--CCeEEEEEec
Q 042772 312 KPLGCGDTGSVHLVELQG--AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT--STHICLITDF 387 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~--tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lVmEy 387 (489)
..||+|+||.||+|..+. ++..||+|.+..... ...+.+|+.+++.++||||+++++++.. ...++++|||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 579999999999999764 568999998865421 2346679999999999999999998854 4678999999
Q ss_pred CCCCCHHHHHhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE----ecCCcEEEEecCCcc
Q 042772 388 CPGGELFALLDKQ-------PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILL----QKDGHVVLTDFDLSF 456 (489)
Q Consensus 388 ~~ggsL~~~L~~~-------~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILl----d~~g~vKL~DFGlS~ 456 (489)
++ ++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 95 5888887532 12347899999999999999999999999999999999999 566799999999986
Q ss_pred ccC------------------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 457 MTS------------------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 457 ~~~------------------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... .+|+. ...+|+|++|++++++++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~ 217 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence 432 12222 123599999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=233.37 Aligned_cols=183 Identities=21% Similarity=0.335 Sum_probs=156.1
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
+..+...+.+.||+|-||.|++|+..+ +..||+|.++... ..+....|..|+.+|.+|+||||+.++++|..++.+|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 344567888999999999999999875 7899999997653 4455688999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCCC
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKP 462 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~~ 462 (489)
+||||++.|+|.+++..+....+.......|+.||+.||+||.+.++|||||.++|+|++.++++||+|||+|+-+...+
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999999999988743334566677799999999999999999999999999999999999999999998554322
Q ss_pred -----------------------ceeecccccchHHHHHHHH--hCCcccC
Q 042772 463 -----------------------QVFYHAHVNGFYFIMYKWL--TGYFTYV 488 (489)
Q Consensus 463 -----------------------~~~~~~~v~s~g~~a~e~~--~G~lpY~ 488 (489)
.....+|+|.+|.+++|++ |...||.
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~ 742 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYS 742 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchh
Confidence 1224569999999999974 6777774
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-26 Score=237.09 Aligned_cols=180 Identities=23% Similarity=0.284 Sum_probs=154.4
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
..|.-++.||.|+||.||-|.+..+.+.||||.++.+........+.+..|+..|+++.|||++.+-+||..+...||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 34888999999999999999999999999999998876667777889999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
||| -|+-.+++.-.. +++.+..+..|..+.+.||.|||+.+.||||||..|||+++.|.|||+|||.|.+...
T Consensus 106 EYC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsFv 183 (948)
T KOG0577|consen 106 EYC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSFV 183 (948)
T ss_pred HHH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCchhccc
Confidence 999 568888887653 5689999999999999999999999999999999999999999999999999865431
Q ss_pred CCceee---------------cccccchHHHHHHHHhCCccc
Q 042772 461 KPQVFY---------------HAHVNGFYFIMYKWLTGYFTY 487 (489)
Q Consensus 461 ~~~~~~---------------~~~v~s~g~~a~e~~~G~lpY 487 (489)
+..+|+ ..|||++|.+..|++--..|+
T Consensus 184 GTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl 225 (948)
T KOG0577|consen 184 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 225 (948)
T ss_pred CCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc
Confidence 122332 336677776666666555554
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-24 Score=209.31 Aligned_cols=181 Identities=30% Similarity=0.534 Sum_probs=157.7
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|++.+.||.|+||.||++.+..++..+++|.+..... .......+..|+++++.++|||++++++.+......+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 48889999999999999999999999999999976433 23455678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC---
Q 042772 387 FCPGGELFALLDKQP--MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK--- 461 (489)
Q Consensus 387 y~~ggsL~~~L~~~~--~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~--- 461 (489)
|+++++|.+++.... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 999999999998753 356899999999999999999999999999999999999999999999999998643211
Q ss_pred ------------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 462 ------------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ------------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+ .....|+|++|++++++++|..||.
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~ 204 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFE 204 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCC
Confidence 11 1234689999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=215.54 Aligned_cols=184 Identities=18% Similarity=0.204 Sum_probs=154.2
Q ss_pred ccccCcccccccCCCCceEEEEEEEcC----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe-
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQG----AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT- 377 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~----tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~- 377 (489)
+..++|++.+.||+|+||.||+|.+.. ++..|++|.+... ........+.+|..+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 345689999999999999999999876 3588999988643 244556778889999999999999999998765
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCCC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEe
Q 042772 378 STHICLITDFCPGGELFALLDKQPM------KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTD 451 (489)
Q Consensus 378 ~~~~~lVmEy~~ggsL~~~L~~~~~------~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~D 451 (489)
....+++++|+++++|.+++..... ..+++..+..++.|++.||.|||+++++|+||||+||++++++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 4678999999999999999976422 3588999999999999999999999999999999999999999999999
Q ss_pred cCCccccCC-----------------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 452 FDLSFMTSC-----------------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 452 FGlS~~~~~-----------------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
||+++.... +|+. ...+|+|++|++++++++ |..||.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 221 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYV 221 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcC
Confidence 999974321 1111 134589999999999997 999884
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-25 Score=222.70 Aligned_cols=176 Identities=21% Similarity=0.277 Sum_probs=149.3
Q ss_pred cccCCC--CceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCC
Q 042772 312 KPLGCG--DTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCP 389 (489)
Q Consensus 312 ~~LG~G--~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ 389 (489)
..||.| +||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||++++++|......++||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 999999999999999999999875433 23455788889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc-----------
Q 042772 390 GGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT----------- 458 (489)
Q Consensus 390 ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~----------- 458 (489)
+++|.+++.+.....+++..+..++.|++.||.|||++|++||||||+||+++.++.++++||+.+...
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 999999998764455899999999999999999999999999999999999999999999999743211
Q ss_pred -----------CCCCce--------eecccccchHHHHHHHHhCCcccC
Q 042772 459 -----------SCKPQV--------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 -----------~~~~~~--------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
...|+. ....|+|++|++++++++|..||.
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 211 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 011222 234599999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-24 Score=210.75 Aligned_cols=173 Identities=23% Similarity=0.369 Sum_probs=148.0
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCCCC
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGG 391 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg 391 (489)
+.||.|+||.||+|.+.. ++.||+|.+..... ......+..|+.++++++||||+++++++......++||||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 468999999999999988 99999998865432 235567888999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------------
Q 042772 392 ELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------------ 459 (489)
Q Consensus 392 sL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------------ 459 (489)
+|.+++.... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++....
T Consensus 78 ~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 78 SLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9999997643 347899999999999999999999999999999999999999999999999886332
Q ss_pred -----CCCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 460 -----CKPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 460 -----~~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++ |..||.
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~ 197 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYP 197 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCc
Confidence 11211 124589999999999998 888874
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-27 Score=239.97 Aligned_cols=185 Identities=33% Similarity=0.582 Sum_probs=166.7
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
.+.+.+++.+..||-|+||.|-++..+.....+|+|++++....+......+..|..||..++.|+||++|..|.++.++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 45677899999999999999999999876667999999998888888888899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
|++||-|-||+|+..|..+ +.|++.++++++..++.|++|||++|||+|||||+|++++.+|.+||.|||+|..+..
T Consensus 496 YmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999999999886 4499999999999999999999999999999999999999999999999999975432
Q ss_pred --------CCceeec-----------ccccchHHHHHHHHhCCcccC
Q 042772 461 --------KPQVFYH-----------AHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 --------~~~~~~~-----------~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.|++..+ .|.|++|..++|+++|..||.
T Consensus 574 ~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs 620 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFS 620 (732)
T ss_pred CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCC
Confidence 2333333 377999999999999999995
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=208.21 Aligned_cols=190 Identities=26% Similarity=0.380 Sum_probs=157.7
Q ss_pred hcCCCccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHh-CCCCCcceeeEE
Q 042772 296 ITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL-LDHPFLPTLYAS 374 (489)
Q Consensus 296 ~~~~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~-l~HpnIv~l~~~ 374 (489)
+..++.++.-++...+..||+|++|.|-+.++..+|...|+|.+.... +.+..++..+|+.+..+ .++|++|++|+.
T Consensus 36 I~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa 113 (282)
T KOG0984|consen 36 IGDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGA 113 (282)
T ss_pred EecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehh
Confidence 444445666677888899999999999999999999999999996553 34556778889888665 479999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEecCCcEEEEe
Q 042772 375 FQTSTHICLITDFCPGGELFALLDK--QPMKIFREDSARFYAAEVVIGLEYLHCL-GIIYRDLKPENILLQKDGHVVLTD 451 (489)
Q Consensus 375 ~~~~~~~~lVmEy~~ggsL~~~L~~--~~~~~l~e~~~~~i~~qI~~aL~yLH~~-gIvHrDLKP~NILld~~g~vKL~D 451 (489)
+..+..+++.||.+ ..+|..+-.+ ..++.++|..+-.|+..++.||.|||++ .++|||+||+||||+.+|++|+||
T Consensus 114 ~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCD 192 (282)
T KOG0984|consen 114 LFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICD 192 (282)
T ss_pred hhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcc
Confidence 99999999999999 5588766543 2346689999999999999999999965 799999999999999999999999
Q ss_pred cCCccccC----------CC----C----------ceeecccccchHHHHHHHHhCCcccC
Q 042772 452 FDLSFMTS----------CK----P----------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 452 FGlS~~~~----------~~----~----------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
||+|-.+. |. | .+.-.+|+|++|.++.|++++..||.
T Consensus 193 FGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 193 FGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred cccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 99984221 11 1 23345699999999999999999997
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8e-25 Score=212.70 Aligned_cols=181 Identities=24% Similarity=0.446 Sum_probs=155.4
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|.+.+.||+|+||.||+|..+.+|..+|+|.+..... .......+.+|+.+++.++||||+++++.+......++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 48889999999999999999999999999999876432 22344567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC-cEEEEecCCccccCC-----
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG-HVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g-~vKL~DFGlS~~~~~----- 460 (489)
|+++++|.+++.......+++..+..++.|++.||.|||+.+++|+||||+||++++++ .+||+|||.+.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence 99999999999876555689999999999999999999999999999999999999886 469999998854321
Q ss_pred ----------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ----------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ----------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 203 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203 (257)
T ss_pred cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1221 124589999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=212.01 Aligned_cols=178 Identities=25% Similarity=0.366 Sum_probs=150.9
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
..+|++.+.||+|+||.||+|.+.. +..+|+|.+...... ...+..|+++++.++|||++++++++......+++
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 3478999999999999999998864 678999988654322 24577899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC---- 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~---- 460 (489)
|||+++++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++.....
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 78 FEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999999997653 3478999999999999999999999999999999999999999999999998763211
Q ss_pred ------------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 461 ------------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 ------------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.|+. ...+|+|++|.+++++++ |..||.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 203 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE 203 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence 1221 123689999999999987 999885
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.8e-25 Score=218.79 Aligned_cols=177 Identities=24% Similarity=0.361 Sum_probs=153.8
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|.+.+.||+|+||.||++....+++.||+|.+... .....+.+..|+.+++.++||||+++++.+......|+|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 5799999999999999999999888999999998643 2233466788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------ 459 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------ 459 (489)
||+++++|.+++.+. .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 96 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~ 172 (293)
T cd06647 96 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (293)
T ss_pred ecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence 999999999998763 37899999999999999999999999999999999999999999999999874321
Q ss_pred ---------CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ---------CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---------~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ....|+|++|++++++++|..||.
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~ 216 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 11221 134699999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-25 Score=220.48 Aligned_cols=182 Identities=25% Similarity=0.335 Sum_probs=152.1
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC--CeE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS--THI 381 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~ 381 (489)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 456899999999999999999999999999999998654321 12223456799999999999999999998765 568
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 99999995 58998887643 4589999999999999999999999999999999999999999999999998864321
Q ss_pred --------------CCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 461 --------------KPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 --------------~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~ 210 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCC
Confidence 1221 234589999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-26 Score=235.00 Aligned_cols=179 Identities=27% Similarity=0.418 Sum_probs=152.0
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchH-----HHHHHHHHHHHHHhCC---CCCcceeeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRN-----KVHRACIEREIMSLLD---HPFLPTLYASFQ 376 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~-----~~~~~~~E~~il~~l~---HpnIv~l~~~~~ 376 (489)
..+|..++++|.|+||.|++|.++.....|++|.+.|....-.. .+..+-.|++||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 45699999999999999999999999999999999887653222 2344667999999997 999999999999
Q ss_pred eCCeEEEEEecC-CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCc
Q 042772 377 TSTHICLITDFC-PGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455 (489)
Q Consensus 377 ~~~~~~lVmEy~-~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS 455 (489)
+++++||+||-- +|.+|+++++..+. ++|.++..|+.||+.|+++||++||||||||-+||+++.+|-+||+|||.|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence 999999999975 56799999998865 899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCceeecccccchHHH--------------HHHHHhCCcccC
Q 042772 456 FMTSCKPQVFYHAHVNGFYFI--------------MYKWLTGYFTYV 488 (489)
Q Consensus 456 ~~~~~~~~~~~~~~v~s~g~~--------------a~e~~~G~lpY~ 488 (489)
..+...|-.. -+++.+|. -+.|++|.++|+
T Consensus 718 a~~ksgpfd~---f~gtv~~aapevl~g~~y~gk~qdiwalgillyt 761 (772)
T KOG1152|consen 718 AYTKSGPFDV---FVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYT 761 (772)
T ss_pred hhhcCCCcce---eeeeccccchhhhCCCccCCCcchhhhhhheeeE
Confidence 8776655332 22333344 356777887775
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=214.86 Aligned_cols=181 Identities=25% Similarity=0.417 Sum_probs=153.3
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 382 (489)
..++.+.+..||+|+.|+|+++..+.+|...|+|.+.+. .+....+++...+.++.+. ++|+||+.+|+|.....++
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence 456778889999999999999999999999999999765 4566788888888887765 5899999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecCCccccC--
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC-LGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS-- 459 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~-- 459 (489)
+.||.| ..-+..++++ ..++++|..+-.+...++.||.||-. +||+|||+||+|||+|+.|.|||||||+|-.+.
T Consensus 168 IcMelM-s~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 168 ICMELM-STCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHHH-HHHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc
Confidence 999988 3344455544 44669999999999999999999995 589999999999999999999999999984321
Q ss_pred --------C-------------CCceeecccccchHHHHHHHHhCCcccC
Q 042772 460 --------C-------------KPQVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 --------~-------------~~~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
| .+.+--.+|||++|..+.|+++|..||.
T Consensus 246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~ 295 (391)
T KOG0983|consen 246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYK 295 (391)
T ss_pred cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCC
Confidence 1 2333445699999999999999999996
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=213.31 Aligned_cols=181 Identities=22% Similarity=0.268 Sum_probs=150.4
Q ss_pred cccCcccccccCCCCceEEEEEEEcCC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGA---GELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH 380 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 380 (489)
...+|.+.+.||+|+||.||+|.+... ...||+|...... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 345799999999999999999987644 4578999876442 24455678889999999999999999998875 45
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS- 459 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~- 459 (489)
.++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 789999999999999997653 248999999999999999999999999999999999999999999999999885321
Q ss_pred ---------------CCCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 460 ---------------CKPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 460 ---------------~~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++ |..||.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~ 210 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCC
Confidence 11221 123589999999999874 999984
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=223.95 Aligned_cols=178 Identities=24% Similarity=0.406 Sum_probs=150.6
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC------
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS------ 378 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------ 378 (489)
.++|+..+.||+|+||.||+|.+..+++.||+|.+.+... .......+.+|+.+++.++||||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4679999999999999999999999999999999865422 333456677899999999999999999988644
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
...|+||||+. ++|.+.+... +++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 35799999995 5898888653 789999999999999999999999999999999999999999999999998643
Q ss_pred CC--------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 459 SC--------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~~--------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.. +|+ ....+|+|++|++++++++|..||.
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 218 (353)
T cd07850 169 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFP 218 (353)
T ss_pred CCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCC
Confidence 21 111 1123599999999999999999884
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=206.62 Aligned_cols=178 Identities=30% Similarity=0.478 Sum_probs=156.4
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|+..+.||+|++|.||++.+..+++.+++|.+..... .....+.+|+.+++.++|||++++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 47888999999999999999998999999999976532 355778889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC-----
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK----- 461 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~----- 461 (489)
|+++++|.+++.... ..+++..+..++.|++.||.|||.+|++|+||+|+||+++.++.++|+|||.+......
T Consensus 78 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 156 (253)
T cd05122 78 FCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT 156 (253)
T ss_pred cCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccc
Confidence 999999999998753 35899999999999999999999999999999999999999999999999988654321
Q ss_pred ---------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 462 ---------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ---------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+ .....|+|++|.+++++++|..||.
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 198 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYS 198 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 11 1234699999999999999999885
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=211.70 Aligned_cols=170 Identities=17% Similarity=0.164 Sum_probs=141.5
Q ss_pred cccCCCCceEEEEEEEcCCC----------cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 312 KPLGCGDTGSVHLVELQGAG----------ELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg----------~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
+.||+|+||.||+|.+..++ ..+++|.+.... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999998776 357778765432 115677889999999999999999999887 778
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC-------cEEEEecCC
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG-------HVVLTDFDL 454 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g-------~vKL~DFGl 454 (489)
++||||+++|+|.+++..... .+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999999987643 488999999999999999999999999999999999999888 799999999
Q ss_pred ccccC-----------CCCce--------eecccccchHHHHHHHHh-CCccc
Q 042772 455 SFMTS-----------CKPQV--------FYHAHVNGFYFIMYKWLT-GYFTY 487 (489)
Q Consensus 455 S~~~~-----------~~~~~--------~~~~~v~s~g~~a~e~~~-G~lpY 487 (489)
+.... .+|+. ...+|+|++|++++++++ |..||
T Consensus 155 a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~ 207 (259)
T cd05037 155 PITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL 207 (259)
T ss_pred ccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCc
Confidence 87522 12222 223688999999999988 56665
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=213.14 Aligned_cols=173 Identities=17% Similarity=0.221 Sum_probs=141.0
Q ss_pred cccCCCCceEEEEEEEcCC------------CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 312 KPLGCGDTGSVHLVELQGA------------GELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~t------------g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
+.||+|+||.||+|..... ...+++|.+... .......+..|..+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4689999999999985432 235888887543 2334556778899999999999999999999988
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc-------EEEEec
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGH-------VVLTDF 452 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~-------vKL~DF 452 (489)
..+++|||+++|+|..++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++++||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999999887643 34899999999999999999999999999999999999987664 899999
Q ss_pred CCccccC-----------CCCcee-------ecccccchHHHHHHHH-hCCcccC
Q 042772 453 DLSFMTS-----------CKPQVF-------YHAHVNGFYFIMYKWL-TGYFTYV 488 (489)
Q Consensus 453 GlS~~~~-----------~~~~~~-------~~~~v~s~g~~a~e~~-~G~lpY~ 488 (489)
|++.... .+|+.. ..+|+|++|+++++++ .|..||.
T Consensus 157 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 211 (262)
T cd05077 157 GIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK 211 (262)
T ss_pred CCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9985322 112222 2359999999999997 5888774
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-26 Score=206.98 Aligned_cols=150 Identities=22% Similarity=0.393 Sum_probs=133.2
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
.|...+.||+|.||+|++|+...+++.||+|.+..... +...-....+|+-+++.++|.|||++++....+..+-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 57778999999999999999999999999999865421 12223456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
|| ..+|..+.+... +.++.+.++.++.|++.||.++|+++++||||||.|.||+.+|.+||+|||+|+...
T Consensus 82 ~c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafg 152 (292)
T KOG0662|consen 82 FC-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFG 152 (292)
T ss_pred Hh-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcC
Confidence 99 569999998764 448999999999999999999999999999999999999999999999999998654
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-25 Score=217.10 Aligned_cols=181 Identities=23% Similarity=0.344 Sum_probs=150.1
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~l 383 (489)
.++|+..+.||+|+||.||++.+..+++.+|+|.+.+... ......+..|+.++.++. ||||+++++++..+...++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 3568888999999999999999999999999999875432 244567788999999985 9999999999999999999
Q ss_pred EEecCCCCCHHHHH---hhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 384 ITDFCPGGELFALL---DKQPMKIFREDSARFYAAEVVIGLEYLHCL-GIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 384 VmEy~~ggsL~~~L---~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~-gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
+|||+. ++|.++. .......+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 81 ~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 999985 4665543 222335589999999999999999999974 99999999999999999999999999985321
Q ss_pred --------------CCCc---------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 --------------CKPQ---------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 --------------~~~~---------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
..|+ ....+|+|++|++++++++|..||.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 211 (288)
T cd06616 160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211 (288)
T ss_pred cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCch
Confidence 1121 2234699999999999999999984
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=223.37 Aligned_cols=179 Identities=26% Similarity=0.394 Sum_probs=151.7
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST----- 379 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----- 379 (489)
.++|++++.||+|+||.||+|.+..+++.||+|.+.+.. ........+..|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 357999999999999999999999999999999986532 23334456778999999999999999999987653
Q ss_pred -eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 380 -HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 380 -~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 469999999 7899988865 34899999999999999999999999999999999999999999999999998643
Q ss_pred CC------------CCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 459 SC------------KPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~~------------~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.. .|+ ....+|+|++|++++++++|..||.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 217 (343)
T cd07880 169 DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217 (343)
T ss_pred ccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 31 122 1234589999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=215.61 Aligned_cols=172 Identities=19% Similarity=0.198 Sum_probs=139.4
Q ss_pred ccCCCCceEEEEEEEcCC------------------------CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCc
Q 042772 313 PLGCGDTGSVHLVELQGA------------------------GELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFL 368 (489)
Q Consensus 313 ~LG~G~fG~Vy~a~~~~t------------------------g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnI 368 (489)
.||+|+||.||+|....+ ...|++|.+... .......+..|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence 589999999999985322 236888888643 23344567788999999999999
Q ss_pred ceeeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC---
Q 042772 369 PTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG--- 445 (489)
Q Consensus 369 v~l~~~~~~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g--- 445 (489)
+++++++......++||||+++|+|..++.... ..+++..+..++.|++.||.|||++||+||||||+|||+++.+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 999999999999999999999999999987543 3478999999999999999999999999999999999998654
Q ss_pred ----cEEEEecCCccccC-----------CCCc-------eeecccccchHHHHHHH-HhCCcccC
Q 042772 446 ----HVVLTDFDLSFMTS-----------CKPQ-------VFYHAHVNGFYFIMYKW-LTGYFTYV 488 (489)
Q Consensus 446 ----~vKL~DFGlS~~~~-----------~~~~-------~~~~~~v~s~g~~a~e~-~~G~lpY~ 488 (489)
.+|++|||++.... ..|+ ....+|+|++|++++++ ..|..||.
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 223 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK 223 (274)
T ss_pred CccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcc
Confidence 48999999875321 1122 12345899999999998 46888874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-24 Score=207.30 Aligned_cols=179 Identities=27% Similarity=0.389 Sum_probs=157.0
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|++.+.||+|++|.||++....+++.|++|.+..... .......+..|+++++.++|||++++++++......+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 48889999999999999999999999999999976543 23456788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC-----
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK----- 461 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~----- 461 (489)
|+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred cCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 99999999999875 45899999999999999999999999999999999999999999999999988643321
Q ss_pred ----------Cce------eecccccchHHHHHHHHhCCcccC
Q 042772 462 ----------PQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ----------~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+. ....|+|++|.+++++++|..||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~ 200 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYY 200 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 111 134689999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=212.82 Aligned_cols=175 Identities=17% Similarity=0.231 Sum_probs=141.0
Q ss_pred cccCCCCceEEEEEEEcCC--CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCC
Q 042772 312 KPLGCGDTGSVHLVELQGA--GELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCP 389 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~t--g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ 389 (489)
+.||+|+||.||++..... ...+++|.+.... .......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999986533 2356667665432 23345678889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC--------
Q 042772 390 GGELFALLDKQP--MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS-------- 459 (489)
Q Consensus 390 ggsL~~~L~~~~--~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~-------- 459 (489)
+|+|.+++.+.. ...+++..+..++.||+.||.|||+++++||||||+|||++.++.++|+|||++....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999999997642 2335677788999999999999999999999999999999999999999999875210
Q ss_pred ---------CCCcee-------------ecccccchHHHHHHHHh-CCcccC
Q 042772 460 ---------CKPQVF-------------YHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 460 ---------~~~~~~-------------~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.+|+.. ...|+|++|++++++++ |..||.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 210 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Confidence 113221 24689999999999985 567774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9e-25 Score=219.31 Aligned_cols=176 Identities=25% Similarity=0.383 Sum_probs=150.5
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
.|.....||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++......|++||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 35556689999999999999998999999999865422 234567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------- 459 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------- 459 (489)
|+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++....
T Consensus 99 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 99 FLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred cCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 9999999998765 347899999999999999999999999999999999999999999999999875321
Q ss_pred --------CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 --------CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 --------~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 218 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYF 218 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 11111 234599999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=213.51 Aligned_cols=179 Identities=26% Similarity=0.396 Sum_probs=156.3
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
...|+..+.||+|++|.||+|.+..++..+++|.+..... ....+..|+++++.++||||+++++++......|++
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 3469999999999999999999998899999999975422 456678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC---- 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~---- 460 (489)
+||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 94 MEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred EeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence 99999999999998864 3589999999999999999999999999999999999999999999999998753221
Q ss_pred -----------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 -----------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -----------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. -...|+|++|++++++++|..||.
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~ 217 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYL 217 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 1111 234699999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-25 Score=236.54 Aligned_cols=182 Identities=22% Similarity=0.301 Sum_probs=140.0
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCC-cEEEEEE--------------eecccccchHHHHHHHHHHHHHHhCCCCCc
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAG-ELYAMKA--------------MEKSVMLNRNKVHRACIEREIMSLLDHPFL 368 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg-~~vAiK~--------------i~~~~~~~~~~~~~~~~E~~il~~l~HpnI 368 (489)
..++|++++.||+|+||+||+|..+... ...+.|. +.+...........+.+|+.+++.++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3578999999999999999999865432 2222221 111111222345567889999999999999
Q ss_pred ceeeEEEEeCCeEEEEEecCCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC
Q 042772 369 PTLYASFQTSTHICLITDFCPGGELFALLDKQP---MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG 445 (489)
Q Consensus 369 v~l~~~~~~~~~~~lVmEy~~ggsL~~~L~~~~---~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g 445 (489)
+++++++......|++|+++ +++|..++.... ........+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 99999999999999999999 568888875432 11234667888999999999999999999999999999999999
Q ss_pred cEEEEecCCccccCC----------------CCce------eecccccchHHHHHHHHhCCcc
Q 042772 446 HVVLTDFDLSFMTSC----------------KPQV------FYHAHVNGFYFIMYKWLTGYFT 486 (489)
Q Consensus 446 ~vKL~DFGlS~~~~~----------------~~~~------~~~~~v~s~g~~a~e~~~G~lp 486 (489)
.+||+|||++..... .|+. ....|+|++|++++|+++|..+
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999999964321 1222 1335899999999999988754
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-25 Score=223.52 Aligned_cols=177 Identities=18% Similarity=0.356 Sum_probs=149.4
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC-----Ce
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS-----TH 380 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~ 380 (489)
++|++.+.||+|+||.||+|.+..+|+.||+|.++.. ........+..|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 5799999999999999999999999999999998642 2233456677899999999999999999877544 35
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
+|++|||++ ++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 899999995 589888865 3489999999999999999999999999999999999999999999999999854321
Q ss_pred ------------------CCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ------------------KPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ------------------~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~ 211 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP 211 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 1221 123589999999999999999884
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.4e-25 Score=214.17 Aligned_cols=175 Identities=24% Similarity=0.296 Sum_probs=145.2
Q ss_pred cccCCCCceEEEEEEEcCCC------cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 312 KPLGCGDTGSVHLVELQGAG------ELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg------~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
+.||+|+||.||+|..+... +.+|+|.+.+.. .......+.+|+.+++.++||||+++++++......+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999986544 789999886432 2234567888999999999999999999999989999999
Q ss_pred ecCCCCCHHHHHhhC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC-----cEEEEecCCc
Q 042772 386 DFCPGGELFALLDKQ-----PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG-----HVVLTDFDLS 455 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~-----~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g-----~vKL~DFGlS 455 (489)
||+++++|.+++... ....+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999999753 123378899999999999999999999999999999999999887 8999999998
Q ss_pred cccCC-----------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 456 FMTSC-----------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 456 ~~~~~-----------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
..... +|+ ....+|+|++|+++++|++ |..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~ 215 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP 215 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCc
Confidence 53210 111 1234599999999999997 999884
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-25 Score=214.57 Aligned_cols=172 Identities=19% Similarity=0.235 Sum_probs=142.1
Q ss_pred cccCCCCceEEEEEEEcCCCc-------EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 312 KPLGCGDTGSVHLVELQGAGE-------LYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~-------~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
+.||+|+||.||+|....++. .+|+|.+... .....+.+..|..+++.++||||+++++++......++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 469999999999999865543 4888877543 234456778899999999999999999999998899999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc--------EEEEecCCcc
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGH--------VVLTDFDLSF 456 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~--------vKL~DFGlS~ 456 (489)
|||+++|+|.+++..+.. .+++..+..++.||+.||.|||++||+||||||+||+++.++. ++++|||++.
T Consensus 78 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999999987533 4789999999999999999999999999999999999987764 6999999985
Q ss_pred ccC-----------CCCce-------eecccccchHHHHHHHHhCC-ccc
Q 042772 457 MTS-----------CKPQV-------FYHAHVNGFYFIMYKWLTGY-FTY 487 (489)
Q Consensus 457 ~~~-----------~~~~~-------~~~~~v~s~g~~a~e~~~G~-lpY 487 (489)
... .+|+. ...+|+|++|++++++++|. .||
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~ 206 (258)
T cd05078 157 TVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206 (258)
T ss_pred ccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCCh
Confidence 322 12322 22459999999999999984 554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=217.05 Aligned_cols=181 Identities=25% Similarity=0.305 Sum_probs=149.9
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST----- 379 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----- 379 (489)
.++|++.+.||+|+||.||+|....+++.||+|.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4579999999999999999999999999999998864322 1222334567999999999999999999886643
Q ss_pred ---eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 380 ---HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 380 ---~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 4599999995 58988887643 348999999999999999999999999999999999999999999999999885
Q ss_pred ccC-------------------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 457 MTS-------------------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 457 ~~~-------------------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... .+|+. ...+|+|++|++++++++|..||.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~ 225 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQ 225 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCC
Confidence 331 11221 124689999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=208.09 Aligned_cols=173 Identities=47% Similarity=0.773 Sum_probs=152.5
Q ss_pred cCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCCCCCH
Q 042772 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGEL 393 (489)
Q Consensus 314 LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ggsL 393 (489)
||.|+||.||++.+..+++.+|+|.+.+...........+..|+.+++.++||||+++++.+......|++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999989999999999876555555677888999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-------------
Q 042772 394 FALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC------------- 460 (489)
Q Consensus 394 ~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~------------- 460 (489)
.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcc
Confidence 99998753 489999999999999999999999999999999999999999999999999864322
Q ss_pred --CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 --KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 --~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ....|+|++|.+++++++|..||.
T Consensus 159 ~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~ 194 (250)
T cd05123 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFY 194 (250)
T ss_pred ccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 1111 124688999999999999999985
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=209.89 Aligned_cols=173 Identities=20% Similarity=0.228 Sum_probs=140.0
Q ss_pred cccCCCCceEEEEEEEcC---CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEE-eCCeEEEEEec
Q 042772 312 KPLGCGDTGSVHLVELQG---AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQ-TSTHICLITDF 387 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~---tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~~~lVmEy 387 (489)
+.||+|+||.||+|.+.. ....+|+|.+... ........+..|+.+++.++||||+++++++. .+...+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998753 3467999987532 23445677888999999999999999999765 45568999999
Q ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-------
Q 042772 388 CPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC------- 460 (489)
Q Consensus 388 ~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~------- 460 (489)
+++|+|.+++..... .+++..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||+++....
T Consensus 79 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 79 MKHGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999999976532 357778888999999999999999999999999999999999999999999863211
Q ss_pred ------------CCce------eecccccchHHHHHHHHhC-Cccc
Q 042772 461 ------------KPQV------FYHAHVNGFYFIMYKWLTG-YFTY 487 (489)
Q Consensus 461 ------------~~~~------~~~~~v~s~g~~a~e~~~G-~lpY 487 (489)
+|+. ...+|+|++|++++++++| ..||
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 203 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCC
Confidence 1111 1235899999999999985 5555
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=222.19 Aligned_cols=179 Identities=23% Similarity=0.395 Sum_probs=152.0
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC-----Ce
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS-----TH 380 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~ 380 (489)
.+|.+.+.||.|+||.||+|.+..+++.||+|.+..... .......+..|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 469999999999999999999999999999999875432 233455677899999999999999999987644 35
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
+|++|||+. ++|.+++... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 899999994 7999998765 4489999999999999999999999999999999999999999999999999864321
Q ss_pred C---------------Cc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 K---------------PQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ~---------------~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. |+ ....+|+|++|++++++++|..||.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 210 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFP 210 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCC
Confidence 1 11 1234699999999999999999884
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-24 Score=214.98 Aligned_cols=179 Identities=25% Similarity=0.324 Sum_probs=153.7
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEec
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDF 387 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 387 (489)
|...+.||+|+||.||+|.+..+++.|++|.+.............+..|+.+++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 67778899999999999999999999999999765444445556788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC--------
Q 042772 388 CPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS-------- 459 (489)
Q Consensus 388 ~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~-------- 459 (489)
+. |+|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~~~~ 180 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGT 180 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCCCCcccc
Confidence 95 68888886643 358999999999999999999999999999999999999999999999999875322
Q ss_pred ---CCCcee---------ecccccchHHHHHHHHhCCcccC
Q 042772 460 ---CKPQVF---------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---~~~~~~---------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+.. ..+|+|++|++++++++|..||.
T Consensus 181 ~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~ 221 (313)
T cd06633 181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 221 (313)
T ss_pred ccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 123222 23599999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=213.18 Aligned_cols=178 Identities=26% Similarity=0.377 Sum_probs=152.6
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC--CeEEEEE
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS--THICLIT 385 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lVm 385 (489)
|++.+.||.|+||.||+|....+++.+|+|.+.... ........+..|+++++.+.|||++++++++... ...++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 678899999999999999999999999999998653 2233445677899999999999999999999888 8999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
||++ ++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||++++++.++|+|||++.....
T Consensus 80 e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 80 EYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 9996 59999887653 3589999999999999999999999999999999999999999999999998864321
Q ss_pred -----------CCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 461 -----------KPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -----------~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ....|+|++|++++++++|..||.
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~ 203 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ 203 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 1221 123588999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=212.19 Aligned_cols=173 Identities=26% Similarity=0.363 Sum_probs=143.8
Q ss_pred cCccccccc--CCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEE
Q 042772 306 HHFKPIKPL--GCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 306 ~~y~~~~~L--G~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 382 (489)
+.|.+.+.+ |+|+||.||++..+.++..+|+|.+....... .|......+ +||||++++++|...+..|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 356666666 99999999999999999999999987542211 122222222 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC-cEEEEecCCccccCC-
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG-HVVLTDFDLSFMTSC- 460 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g-~vKL~DFGlS~~~~~- 460 (489)
+||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 86 iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 9999999999999998763 589999999999999999999999999999999999999998 999999998864321
Q ss_pred ----------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ----------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ----------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ....|+|++|.+++++++|..||.
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 207 (267)
T PHA03390 164 SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207 (267)
T ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 1222 233599999999999999999984
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=208.87 Aligned_cols=181 Identities=26% Similarity=0.406 Sum_probs=156.2
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+|++.+.||.|+||.||++.++.+++.+|+|.+...... ......+..|+.+++.++||||+++++++......++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 488899999999999999999999999999999765432 3445677889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC---
Q 042772 387 FCPGGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK--- 461 (489)
Q Consensus 387 y~~ggsL~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~--- 461 (489)
|+++++|.+++.+. ....+++..+..++.|++.||.|||+.|++|+||+|.||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 159 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK 159 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCCcc
Confidence 99999999998762 2245889999999999999999999999999999999999999999999999988644311
Q ss_pred ----------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 462 ----------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ----------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+ ....+|+|++|.+++++++|..||.
T Consensus 160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~ 202 (256)
T cd08530 160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202 (256)
T ss_pred cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 11 1134689999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-26 Score=237.33 Aligned_cols=147 Identities=31% Similarity=0.491 Sum_probs=135.6
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
+.|.++..||.|+||+||+|..+.++...|.|++... ....+..+.-|++||..++||+||++++.|..++.+||+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 4588899999999999999999999999999988643 4567888999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
|||.||.....+-.-. .+|.+.++..+++|++.||.|||++.|||||||..|||+.-+|.|+|+|||.|.
T Consensus 109 EFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSA 178 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSA 178 (1187)
T ss_pred eecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccc
Confidence 9999999998887653 569999999999999999999999999999999999999999999999999984
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=241.42 Aligned_cols=153 Identities=39% Similarity=0.669 Sum_probs=140.6
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
+++|++++.||.|+||.||+|.+..+++.||+|++.+...........+..|+.++..++||||+++++++....++|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 46799999999999999999999999999999999876555566677888999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
|||+.+++|.+++... ..+++..++.++.||+.||.|||.++|+||||||+|||++.++.+||+|||+++...
T Consensus 83 mEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~ 155 (669)
T cd05610 83 MEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155 (669)
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCcccc
Confidence 9999999999999765 348899999999999999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-26 Score=221.66 Aligned_cols=184 Identities=23% Similarity=0.370 Sum_probs=152.7
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCC----cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe-C
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAG----ELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT-S 378 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~ 378 (489)
.+..|+.+..||+|+||.||+|..+.+. +.+|||.++.... ........++|+.+++.++||||+.+..+|.. +
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 3567999999999999999999665443 3789998865422 12234567899999999999999999998877 7
Q ss_pred CeEEEEEecCCCCCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC----CcEEEEe
Q 042772 379 THICLITDFCPGGELFALLDKQ---PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD----GHVVLTD 451 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~---~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~----g~vKL~D 451 (489)
..+++++||.+. +|.+.++.. ..+.++...+..++.||+.|+.|||++-|+||||||.|||+..+ |.|||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 889999999965 999998753 22458999999999999999999999999999999999999877 8999999
Q ss_pred cCCccccCCC--CceeecccccchHHHHHHHHhCCcccCC
Q 042772 452 FDLSFMTSCK--PQVFYHAHVNGFYFIMYKWLTGYFTYVP 489 (489)
Q Consensus 452 FGlS~~~~~~--~~~~~~~~v~s~g~~a~e~~~G~lpY~~ 489 (489)
||+++....+ |-+.....|.++.|.+||+++|.-.|+|
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~ 219 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTK 219 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccc
Confidence 9999987654 3333445678888999999999888874
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=213.77 Aligned_cols=179 Identities=21% Similarity=0.363 Sum_probs=153.6
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEec
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDF 387 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 387 (489)
|++.+.||.|++|.||+|.++.+|..||+|.+..... .......+.+|+++++.++|||++++++++......|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999999999999999875432 222335677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC--------
Q 042772 388 CPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS-------- 459 (489)
Q Consensus 388 ~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~-------- 459 (489)
++ ++|.+++.......+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 94 699999987654468999999999999999999999999999999999999999999999999985321
Q ss_pred -------CCCcee-------ecccccchHHHHHHHHhCCcccC
Q 042772 460 -------CKPQVF-------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 -------~~~~~~-------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+.. ..+|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 201 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP 201 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 123322 23588999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-24 Score=212.26 Aligned_cols=176 Identities=24% Similarity=0.402 Sum_probs=151.3
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
.|...+.||+|++|.||++.+..+++.+++|.+... .......+.+|+.+++.++||||+++++++......++++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 455667999999999999999989999999988543 22334567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC------ 460 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~------ 460 (489)
|+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 97 ~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 97 FLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred ccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 9999999999876 3478999999999999999999999999999999999999999999999998753221
Q ss_pred ---------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++|..||.
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~ 216 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYF 216 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCc
Confidence 111 1234699999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=222.14 Aligned_cols=179 Identities=21% Similarity=0.347 Sum_probs=151.9
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe----CCeE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT----STHI 381 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~ 381 (489)
.+|++.+.||.|+||.||+|..+.+++.||+|.+..... .......+..|+.+++.++||||+++++++.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 579999999999999999999999999999999875432 23345677789999999999999999988763 3578
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC--
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS-- 459 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~-- 459 (489)
++||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++++++.+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 99999995 6999998764 348999999999999999999999999999999999999999999999999985321
Q ss_pred -----------------CCCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 -----------------CKPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 -----------------~~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+ ....+|+|++|++++++++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~ 213 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFP 213 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccC
Confidence 0122 2234689999999999999999984
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-24 Score=210.82 Aligned_cols=176 Identities=21% Similarity=0.330 Sum_probs=147.0
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeC--CeEEEE
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTS--THICLI 384 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~--~~~~lV 384 (489)
|++++.||+|+||.||+|.+..+++.||+|.+++... .... .....|+.++.++. ||||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6788999999999999999999999999999865432 2222 23346888888885 99999999999887 889999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----- 459 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----- 459 (489)
|||++ ++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++. +.+||+|||++....
T Consensus 79 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 79 FELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred EecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 99996 58888887643 35899999999999999999999999999999999999999 999999999986431
Q ss_pred ---------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ---------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~ 200 (282)
T cd07831 156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP 200 (282)
T ss_pred CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCC
Confidence 11221 234689999999999999999884
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=215.55 Aligned_cols=182 Identities=24% Similarity=0.316 Sum_probs=152.0
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC----
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST---- 379 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~---- 379 (489)
..++|++.+.||.|+||.||+|.++.+++.||+|.++.... .......+..|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45689999999999999999999999999999999875432 1222345667999999999999999999887654
Q ss_pred ------eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecC
Q 042772 380 ------HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFD 453 (489)
Q Consensus 380 ------~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFG 453 (489)
.++++|||+++ +|.+++.... ..+++..+..++.|++.||.|||+.||+|+||||+||++++++.+||+|||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 79999999965 8888877642 358999999999999999999999999999999999999999999999999
Q ss_pred CccccC----------------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 454 LSFMTS----------------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 454 lS~~~~----------------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
++.... .+|+. ...+|+|++|++++++++|..||.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~ 219 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ 219 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 886421 11221 134589999999999999998884
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=220.00 Aligned_cols=178 Identities=25% Similarity=0.402 Sum_probs=150.2
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC------C
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS------T 379 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~ 379 (489)
++|.+.+.||+|+||.||+|.+..+++.||+|.+.+... .......+.+|+.+++.++||||+++++++... .
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 679999999999999999999999999999999875422 233345677899999999999999999988643 3
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
..|++++++ +++|.+++... .+++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||++....
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred cEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 478899887 78998888653 38999999999999999999999999999999999999999999999999986432
Q ss_pred C------------CCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 460 C------------KPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ~------------~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. +|+. ....|+|++|++++++++|..||.
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 219 (345)
T cd07877 172 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 219 (345)
T ss_pred ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1 1221 124699999999999999999984
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-24 Score=215.34 Aligned_cols=170 Identities=22% Similarity=0.286 Sum_probs=144.3
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCCCCCHHHHH
Q 042772 318 DTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALL 397 (489)
Q Consensus 318 ~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ggsL~~~L 397 (489)
++|.||.+....+++.||+|.+..... .......+..|+.+++.++||||+++++++......+++|||+++|+|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 445666666677899999999976422 3456678999999999999999999999999999999999999999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------------------
Q 042772 398 DKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------------------ 459 (489)
Q Consensus 398 ~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------------------ 459 (489)
.......+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||.+....
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 87544558999999999999999999999999999999999999999999999999874221
Q ss_pred ----CCCc--------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 ----CKPQ--------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----~~~~--------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+ ....+|+|++|++++++++|..||.
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~ 211 (314)
T cd08216 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211 (314)
T ss_pred cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 1122 1234699999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-25 Score=235.20 Aligned_cols=173 Identities=25% Similarity=0.342 Sum_probs=150.3
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCCCC
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGG 391 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg 391 (489)
-+||.|.||+||-|++..|....|||.+... +...++-+..|+.+-+.|+|.|||+++|++...+++-|.||-+|||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 4699999999999999999999999999643 4456778888999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCC--CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe-cCCcEEEEecCCccccC---------
Q 042772 392 ELFALLDKQPMKIF--REDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQ-KDGHVVLTDFDLSFMTS--------- 459 (489)
Q Consensus 392 sL~~~L~~~~~~~l--~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld-~~g~vKL~DFGlS~~~~--------- 459 (489)
+|.++|... .+++ .|.+..++..||+.||.|||.+.|||||||-+|||++ -.|.+||+|||.|+.+.
T Consensus 658 SLSsLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF 736 (1226)
T KOG4279|consen 658 SLSSLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF 736 (1226)
T ss_pred cHHHHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence 999999875 3456 7899999999999999999999999999999999997 57899999999986332
Q ss_pred ------CCC--------ceeecccccchHHHHHHHHhCCcccC
Q 042772 460 ------CKP--------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ------~~~--------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+| -+-.++|+|++|+++-||++|..||.
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ 779 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFV 779 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCee
Confidence 111 12245688999999999999999884
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-24 Score=209.71 Aligned_cols=182 Identities=26% Similarity=0.381 Sum_probs=151.3
Q ss_pred CcccccccCCCCceEEEEEEEcC-CCcEEEEEEeecccc-------cchHHHHHHHHHHHHHHh-CCCCCcceeeEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQG-AGELYAMKAMEKSVM-------LNRNKVHRACIEREIMSL-LDHPFLPTLYASFQT 377 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~-tg~~vAiK~i~~~~~-------~~~~~~~~~~~E~~il~~-l~HpnIv~l~~~~~~ 377 (489)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+..|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 788999998864321 123345667788888865 799999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecCC
Q 042772 378 STHICLITDFCPGGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEYLHC-LGIIYRDLKPENILLQKDGHVVLTDFDL 454 (489)
Q Consensus 378 ~~~~~lVmEy~~ggsL~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DFGl 454 (489)
....+++|||+++++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999999988542 23458999999999999999999996 7899999999999999999999999999
Q ss_pred ccccCCC--------------Cce------eecccccchHHHHHHHHhCCcccC
Q 042772 455 SFMTSCK--------------PQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 455 S~~~~~~--------------~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+...... |+. -..+|+|++|++++++++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~ 214 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFY 214 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccc
Confidence 8643311 111 123589999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=213.09 Aligned_cols=180 Identities=41% Similarity=0.637 Sum_probs=151.8
Q ss_pred CcccccccCCCCceEEEEEEEc---CCCcEEEEEEeeccccc-chHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQ---GAGELYAMKAMEKSVML-NRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 381 (489)
+|++.+.||+|+||.||++... .++..||+|.+.+.... .......+..|+.++..+ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788999999999999999864 45789999998754322 223445678899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999999998764 3488999999999999999999999999999999999999999999999998754211
Q ss_pred ---------------CCc--------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------------KPQ--------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------------~~~--------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.|+ .....|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 209 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence 111 1234589999999999999999983
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-24 Score=208.89 Aligned_cols=180 Identities=25% Similarity=0.324 Sum_probs=146.2
Q ss_pred cccccccCCCCceEEEEEEEc---CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----
Q 042772 308 FKPIKPLGCGDTGSVHLVELQ---GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST----- 379 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----- 379 (489)
|++.+.||+|+||.||+|.+. .+++.||+|.+..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 677889999999999999865 3578999999965432 3345667888999999999999999999876532
Q ss_pred -eEEEEEecCCCCCHHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCC
Q 042772 380 -HICLITDFCPGGELFALLDKQ----PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDL 454 (489)
Q Consensus 380 -~~~lVmEy~~ggsL~~~L~~~----~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGl 454 (489)
..+++++|+++|+|.+++... ....++...+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 347899999999999887532 112478899999999999999999999999999999999999999999999999
Q ss_pred ccccCCC-----------------Cc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 455 SFMTSCK-----------------PQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 455 S~~~~~~-----------------~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
++..... |+ ....+|+|++|++++++++ |..||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~ 217 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA 217 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCC
Confidence 8743210 11 1224689999999999988 777763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-24 Score=209.30 Aligned_cols=179 Identities=22% Similarity=0.342 Sum_probs=148.6
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCCcceeeEEEEeCCe----
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL---DHPFLPTLYASFQTSTH---- 380 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l---~HpnIv~l~~~~~~~~~---- 380 (489)
|++.+.||+|+||.||+|.++.+++.||+|.+..... .......+..|+.+++++ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6788999999999999999998899999999975432 222234455677777665 69999999999988776
Q ss_pred -EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 381 -ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 381 -~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
++++|||++ ++|.+++.......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999996 589999987654458999999999999999999999999999999999999999999999999986532
Q ss_pred C--------------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 C--------------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ~--------------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. +|+. ...+|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~ 207 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFR 207 (287)
T ss_pred CCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCccc
Confidence 1 1111 224689999999999999988873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-24 Score=213.60 Aligned_cols=186 Identities=25% Similarity=0.381 Sum_probs=153.7
Q ss_pred CCccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEe
Q 042772 299 SGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQT 377 (489)
Q Consensus 299 ~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~ 377 (489)
....+..++|++.+.||+|+||.||+|.+..+++.||+|.+++... ......+..|+.++.++ .||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 85 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFIT 85 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence 3345667889999999999999999999999999999999975432 22345566677766666 59999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 378 STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC-LGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 378 ~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
....|++|||+ +++|.+++.... ..+++..+..++.|++.||.|||+ .||+||||+|+||++++++.+||+|||++.
T Consensus 86 ~~~~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 86 DSDVFICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred CCeEEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccch
Confidence 99999999998 458887776643 358999999999999999999997 599999999999999999999999999985
Q ss_pred ccC--------------CCCce----------eecccccchHHHHHHHHhCCcccC
Q 042772 457 MTS--------------CKPQV----------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 457 ~~~--------------~~~~~----------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... .+|+. ...+|+|++|++++++++|..||.
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 219 (296)
T cd06618 164 RLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK 219 (296)
T ss_pred hccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCC
Confidence 322 11221 234689999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.7e-24 Score=213.16 Aligned_cols=175 Identities=25% Similarity=0.404 Sum_probs=149.8
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEec
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDF 387 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 387 (489)
|.....||+|+||.||++..+.+++.||+|.+... .......+.+|+.+++.++||||+++++.+......+++|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 44457899999999999999999999999987533 233456688899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-------
Q 042772 388 CPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC------- 460 (489)
Q Consensus 388 ~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~------- 460 (489)
+++++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++.....
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 99 LEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 9999999987653 378999999999999999999999999999999999999999999999998753321
Q ss_pred --------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 --------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 --------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ....|+|++|++++++++|..||.
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~ 217 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 217 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1111 124589999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-24 Score=217.86 Aligned_cols=180 Identities=22% Similarity=0.289 Sum_probs=150.2
Q ss_pred cCccc-ccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchH-----------HHHHHHHHHHHHHhCCCCCcceeeE
Q 042772 306 HHFKP-IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRN-----------KVHRACIEREIMSLLDHPFLPTLYA 373 (489)
Q Consensus 306 ~~y~~-~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~-----------~~~~~~~E~~il~~l~HpnIv~l~~ 373 (489)
++|.. .+.||.|+||.||+|.++.+++.||+|.+......... ....+..|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 35654 57799999999999999999999999998654322100 0124678999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecC
Q 042772 374 SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFD 453 (489)
Q Consensus 374 ~~~~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFG 453 (489)
++......+++|||+. |+|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 9999999999999996 6999999765 348999999999999999999999999999999999999999999999999
Q ss_pred CccccC-----------------------------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 454 LSFMTS-----------------------------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 454 lS~~~~-----------------------------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
++.... .+|+. ....|+|++|++++++++|..||.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 235 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 886433 11221 223588999999999999999874
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.6e-24 Score=213.12 Aligned_cols=181 Identities=23% Similarity=0.288 Sum_probs=154.1
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
..|...+.||.|+||.||+|.++.+++.+|+|.+.............+..|+.+++.++|||++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34888899999999999999999999999999987543334445567788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
||+. |+|.+++.... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 172 (308)
T cd06634 95 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV 172 (308)
T ss_pred EccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCccccc
Confidence 9996 68888776543 3488999999999999999999999999999999999999999999999998864221
Q ss_pred ------CCc---------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ------KPQ---------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ------~~~---------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++|..||.
T Consensus 173 ~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 215 (308)
T cd06634 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (308)
T ss_pred CCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCc
Confidence 122 1224699999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-24 Score=217.60 Aligned_cols=179 Identities=26% Similarity=0.382 Sum_probs=151.1
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeC--CeE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTS--THI 381 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~--~~~ 381 (489)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+.+... .......+..|+.+++++ +||||+++++++... ...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4679999999999999999999998999999998865322 233445677899999999 999999999988653 468
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
|+||||++ ++|.+++... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 99999996 5999988764 478899999999999999999999999999999999999999999999998863321
Q ss_pred -------------------CCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 461 -------------------KPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -------------------~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~ 214 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFP 214 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCC
Confidence 1221 134689999999999999999884
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=218.36 Aligned_cols=178 Identities=21% Similarity=0.357 Sum_probs=153.1
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----eE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST-----HI 381 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~~ 381 (489)
+|++.+.||.|+||.||+|....+++.||+|.+.... ......+.+..|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5889999999999999999999999999999987542 22344567888999999999999999999987765 79
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK 461 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~ 461 (489)
|++|||++ ++|.+++.... .+++..+..++.|++.||.|||++||+|+||||.|||++.++.++|+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99999996 58999987653 5899999999999999999999999999999999999999999999999998644321
Q ss_pred ------------------Cc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 462 ------------------PQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ------------------~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+ ....+|+|++|++++++++|..||.
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~ 208 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFP 208 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcC
Confidence 21 1224589999999999999999884
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-25 Score=231.70 Aligned_cols=179 Identities=24% Similarity=0.331 Sum_probs=152.4
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeeccc-ccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe--EEEE
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSV-MLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH--ICLI 384 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~--~~lV 384 (489)
.+....||+|+|-+||+|.+..+|..||--.++-.. ......++++..|+.+|+.|+||||+++|++|.+... +.+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 445678999999999999999999999866554332 2356668999999999999999999999999987755 8899
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEec-CCcEEEEecCCccccC--
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLG--IIYRDLKPENILLQK-DGHVVLTDFDLSFMTS-- 459 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~g--IvHrDLKP~NILld~-~g~vKL~DFGlS~~~~-- 459 (489)
+|.+..|+|..|+++... .+...+..|+.||+.||.|||++. |+|||||.+||||+. .|.|||+|+|||++..
T Consensus 122 TEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred eecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999999998743 789999999999999999999985 999999999999974 5899999999996432
Q ss_pred ------CCCceee----------cccccchHHHHHHHHhCCcccC
Q 042772 460 ------CKPQVFY----------HAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ------~~~~~~~----------~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+.|+.+. ..||++||-++-||++|.+||.
T Consensus 200 ~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYs 244 (632)
T KOG0584|consen 200 HAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYS 244 (632)
T ss_pred ccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChh
Confidence 2233332 2289999999999999999995
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=210.26 Aligned_cols=178 Identities=28% Similarity=0.394 Sum_probs=151.3
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEEEe
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lVmE 386 (489)
|++.+.||+|++|.||+|....+++.|++|.+...... .......+|+..++.+. ||||+++++++......++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 67889999999999999999999999999998654321 12233456888999998 9999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC------ 460 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~------ 460 (489)
|+ +|+|.+++.......+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD 157 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence 99 88999999876544589999999999999999999999999999999999999999999999999864321
Q ss_pred --------CCcee-------ecccccchHHHHHHHHhCCcccC
Q 042772 461 --------KPQVF-------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 --------~~~~~-------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+.. ..+|+|++|.+++++++|..||.
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~ 200 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFP 200 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccC
Confidence 22222 24589999999999999998874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=216.50 Aligned_cols=179 Identities=23% Similarity=0.404 Sum_probs=151.5
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe-CCeEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT-STHICL 383 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~l 383 (489)
.++|++.+.||.|+||.||+|.+..+++.||+|.+.+... .......+..|+++++.++||||++++++|.. ....++
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 4579999999999999999999999999999998865432 23345667789999999999999999999875 457899
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC----
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS---- 459 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~---- 459 (489)
+|||+ +++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++....
T Consensus 88 v~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 163 (328)
T cd07856 88 VTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMT 163 (328)
T ss_pred Eeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCCcC
Confidence 99999 67999888653 37888899999999999999999999999999999999999999999999886332
Q ss_pred --------CCCcee-------ecccccchHHHHHHHHhCCcccC
Q 042772 460 --------CKPQVF-------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 --------~~~~~~-------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+.. ..+|+|++|++++++++|..||.
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~ 207 (328)
T cd07856 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP 207 (328)
T ss_pred CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 123322 23588999999999999998873
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-24 Score=212.43 Aligned_cols=181 Identities=17% Similarity=0.173 Sum_probs=136.3
Q ss_pred ccCcccccccCCCCceEEEEEEEcCC---CcEEEEEEeecccccchHH--------HHHHHHHHHHHHhCCCCCcceeeE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGA---GELYAMKAMEKSVMLNRNK--------VHRACIEREIMSLLDHPFLPTLYA 373 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~--------~~~~~~E~~il~~l~HpnIv~l~~ 373 (489)
-++|++.+.||+|+||.||+|.+..+ +..+|+|............ ......+...+..++|+|++.+++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 35799999999999999999999877 6677877643221110000 011122333455678999999998
Q ss_pred EEEeCC----eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEE
Q 042772 374 SFQTST----HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVL 449 (489)
Q Consensus 374 ~~~~~~----~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL 449 (489)
++.... ..+++|+++ ..++.+.+... ...++..+..++.|++.||.|||+++|+||||||+|||++.++.++|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 765543 457888988 45777777654 23578889999999999999999999999999999999999999999
Q ss_pred EecCCccccC-----------------C-----CC------ceeecccccchHHHHHHHHhCCcccC
Q 042772 450 TDFDLSFMTS-----------------C-----KP------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 450 ~DFGlS~~~~-----------------~-----~~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|||+|+... . +| ......|+|++|+++++|++|..||.
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~ 234 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWK 234 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999986431 0 00 11224489999999999999999994
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-25 Score=229.68 Aligned_cols=186 Identities=22% Similarity=0.265 Sum_probs=163.2
Q ss_pred CCccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 042772 299 SGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS 378 (489)
Q Consensus 299 ~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 378 (489)
+.+++...+......||-|.||.||.|.++.-.-.||+|.++.. .-.++.|..|..+|+-+.|||+|+++++|..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 44555666778889999999999999999998899999999754 44678999999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
..+|||+|||..|+|.+||.+.....++.-..+.++.||..||+||..+++|||||..+|+|+.++..||++|||+|++.
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999999999987777888888999999999999999999999999999999999999999999999865
Q ss_pred CCC----------Ccee------------ecccccchHHHHHHHH-hCCcccC
Q 042772 459 SCK----------PQVF------------YHAHVNGFYFIMYKWL-TGYFTYV 488 (489)
Q Consensus 459 ~~~----------~~~~------------~~~~v~s~g~~a~e~~-~G~lpY~ 488 (489)
... |.-| ..+|||.||+.++|++ .|.-||.
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP 468 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP 468 (1157)
T ss_pred cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC
Confidence 532 1111 3458899999999986 6888885
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.6e-26 Score=252.14 Aligned_cols=180 Identities=27% Similarity=0.424 Sum_probs=156.2
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
-+++-...||.|.||.||-|....+|...|+|.+.-... .......+.+|..++..++|||+|++|++-.+...++|.|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~-~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDS-DHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCcc-ccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 357777889999999999999999999999998865433 2555677888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
|||.+|+|.+++... ...++.....+..|++.|+.|||+.|||||||||+|||++.+|.+|++|||.|.....
T Consensus 1314 EyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 999999999999875 3478899999999999999999999999999999999999999999999999964321
Q ss_pred --------------CCcee---------ecccccchHHHHHHHHhCCcccC
Q 042772 461 --------------KPQVF---------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 --------------~~~~~---------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+.+ ..+|+|++|+..-||++|..||.
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~ 1442 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWA 1442 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchh
Confidence 12222 34488999999999999999985
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-24 Score=209.57 Aligned_cols=178 Identities=24% Similarity=0.385 Sum_probs=152.1
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEec
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDF 387 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 387 (489)
|++.+.||+|++|.||+|....+++.+++|.++.... .......+..|+.+++.++||||+++++++......+++|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 5678899999999999999998999999999875532 223456777899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC------
Q 042772 388 CPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK------ 461 (489)
Q Consensus 388 ~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~------ 461 (489)
++ ++|.+++.... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||.+......
T Consensus 80 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 80 MD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred cC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 96 49998887743 45899999999999999999999999999999999999999999999999987533211
Q ss_pred ---------Cc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 462 ---------PQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ---------~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+ ....+|+|++|++++++++|..||.
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 200 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFP 200 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 11 1234589999999999999998884
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=213.03 Aligned_cols=181 Identities=22% Similarity=0.306 Sum_probs=149.4
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC------
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS------ 378 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------ 378 (489)
.++|++.+.||.|+||.||+|.++.+++.+|+|.+......+ .....+.+|+++++.++||||+++++.+...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 568999999999999999999999999999999986543222 1223456799999999999999999887543
Q ss_pred --CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 379 --THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 379 --~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
..+++||||+. ++|...+.... ..+++..+..++.|++.||.|||++|++|+||||+||++++++.++|+|||++.
T Consensus 86 ~~~~~~lv~~~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 86 KRGSVYMVTPYMD-HDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred cCceEEEEEecCC-cCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 35799999995 57887776542 358999999999999999999999999999999999999999999999999986
Q ss_pred ccCC--------------------------CCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 457 MTSC--------------------------KPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 457 ~~~~--------------------------~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.... +|+. ....|+|++|++++++++|..||.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~ 228 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ 228 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCC
Confidence 4321 1221 123589999999999999998874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-25 Score=231.35 Aligned_cols=184 Identities=23% Similarity=0.293 Sum_probs=159.0
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGA---GELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS 378 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 378 (489)
.|..++.++.+.||+|+||.|+.|.|... ...||+|.+....... ....|++|+.+|.+|+|||+++|||...+
T Consensus 106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~- 182 (1039)
T KOG0199|consen 106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD- 182 (1039)
T ss_pred eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-
Confidence 45566788899999999999999998742 3478999997665432 67899999999999999999999999887
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
..+.+|||+++.|+|.+.|.+.....|.-.....++.||+.||.||.++++|||||..+|+|+...-.|||+|||+.+.+
T Consensus 183 qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceecc
Confidence 56899999999999999999865667889999999999999999999999999999999999999999999999999865
Q ss_pred C------------------CCCcee------ecccccchHHHHHHHH-hCCcccC
Q 042772 459 S------------------CKPQVF------YHAHVNGFYFIMYKWL-TGYFTYV 488 (489)
Q Consensus 459 ~------------------~~~~~~------~~~~v~s~g~~a~e~~-~G~lpY~ 488 (489)
. |.|+.+ ..+|+|.||++++||. .|..||.
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~ 317 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV 317 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCC
Confidence 5 233322 3559999999999995 7888884
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=224.49 Aligned_cols=183 Identities=21% Similarity=0.271 Sum_probs=154.3
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCC----CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGA----GELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT 377 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~t----g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 377 (489)
.+......+.+.||.|.||-||.|.+... .--||+|..+... ..+..+.|..|..+|+.++||||++++|.+..
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 44445567778899999999999987532 3478899887643 34457889999999999999999999999976
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccc
Q 042772 378 STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 378 ~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
. ..|||||.++-|.|..||..+.. .++......++.||+.||.|||+..+|||||..+|||+.+..-|||+|||+|+-
T Consensus 463 ~-P~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 463 Q-PMWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred c-ceeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhh
Confidence 5 59999999999999999998754 489999999999999999999999999999999999999999999999999985
Q ss_pred cCCC----------------Cce------eecccccchHHHHHHH-HhCCcccC
Q 042772 458 TSCK----------------PQV------FYHAHVNGFYFIMYKW-LTGYFTYV 488 (489)
Q Consensus 458 ~~~~----------------~~~------~~~~~v~s~g~~a~e~-~~G~lpY~ 488 (489)
.... |+. ...+|||.||++++|+ ++|.-||-
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfq 594 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQ 594 (974)
T ss_pred ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccc
Confidence 5421 111 2456999999999997 59999983
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-24 Score=208.52 Aligned_cols=178 Identities=26% Similarity=0.400 Sum_probs=152.1
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEec
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDF 387 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 387 (489)
|+..+.||+|++|.||+|....+++.||+|.+.... ........+..|+.+++.++||||+++++++......++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 567788999999999999999999999999997653 1233345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-------
Q 042772 388 CPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC------- 460 (489)
Q Consensus 388 ~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~------- 460 (489)
++ ++|.+++.... ..+++..+..++.|++.||.|||++||+|+||+|+||++++++.++|+|||++.....
T Consensus 80 ~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 80 CD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred cC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 97 59999998753 3489999999999999999999999999999999999999999999999998863321
Q ss_pred --------CCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 461 --------KPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 --------~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ....|+|++|++++++++|..||.
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 200 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFP 200 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 1221 123589999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.1e-24 Score=216.74 Aligned_cols=176 Identities=24% Similarity=0.426 Sum_probs=147.8
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC-------
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS------- 378 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------- 378 (489)
.+|++.+.||.|+||.||+|.+..+++.||+|.+.... ....+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 57999999999999999999999999999999986543 23456677899999999999999999776543
Q ss_pred -------CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe-cCCcEEEE
Q 042772 379 -------THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQ-KDGHVVLT 450 (489)
Q Consensus 379 -------~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld-~~g~vKL~ 450 (489)
...|+||||++ ++|.+++... .+++..++.++.||+.||.|||++|++||||||+||+++ +++.+||+
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35899999996 5999888653 488999999999999999999999999999999999997 45678999
Q ss_pred ecCCccccC------------------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 451 DFDLSFMTS------------------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 451 DFGlS~~~~------------------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|||++.... .+|+. ...+|+|++|++++++++|..||.
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 220 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA 220 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999985321 11221 124689999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-24 Score=216.93 Aligned_cols=179 Identities=25% Similarity=0.421 Sum_probs=152.3
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe----
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH---- 380 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~---- 380 (489)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+..|+.+++.++||||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 357999999999999999999999999999999886542 223345667789999999999999999988766544
Q ss_pred --EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 381 --ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 381 --~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 6799999876 34899999999999999999999999999999999999999999999999998643
Q ss_pred CC------------CCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 459 SC------------KPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~~------------~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.. +|+. ...+|+|++|++++++++|..||.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~ 217 (343)
T cd07851 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP 217 (343)
T ss_pred cccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 21 1211 134699999999999999999984
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=212.83 Aligned_cols=178 Identities=21% Similarity=0.312 Sum_probs=146.7
Q ss_pred CcccccccCCCCceEEEEEEEcCC--CcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEe----CC
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGA--GELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQT----ST 379 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~t--g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~----~~ 379 (489)
+|++.+.||+|+||.||++.+..+ +..||+|.+.... ......+.+..|+.+++.+ +||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488899999999999999999988 8999999986432 2233356677899999998 59999999987543 24
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
.++++|+|+. ++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 6889999984 6999998764 448999999999999999999999999999999999999999999999999986321
Q ss_pred -------------------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 460 -------------------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 -------------------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~ 211 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFK 211 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCC
Confidence 11221 123488999999999999998874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-25 Score=210.98 Aligned_cols=181 Identities=24% Similarity=0.373 Sum_probs=148.0
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHh-CCCCCcceeeEEEEeCCeEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL-LDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~-l~HpnIv~l~~~~~~~~~~~l 383 (489)
.++.+-+..||.|+||+|++..++.+|+..|+|.+.... .....++++.|.+...+ -+.||||++||+...++..|+
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n--~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWi 140 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN--IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWI 140 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc--chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceee
Confidence 456677889999999999999999999999999997653 34556778888887554 579999999999999999999
Q ss_pred EEecCCCCCHHHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 384 ITDFCPGGELFALLDK---QPMKIFREDSARFYAAEVVIGLEYLHC-LGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~---~~~~~l~e~~~~~i~~qI~~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
.||.| ..+|..+-+. -....++|..+..+....+.||.||-. ..|+|||+||+|||++..|.|||||||++-.+.
T Consensus 141 CMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 141 CMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred eHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 99999 5677655432 233458999999999999999999985 589999999999999999999999999974211
Q ss_pred ----------C----CCcee--------ecccccchHHHHHHHHhCCcccC
Q 042772 460 ----------C----KPQVF--------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----------~----~~~~~--------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
| +|+.+ -.+++||+|.+++|.++|..||.
T Consensus 220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr 270 (361)
T KOG1006|consen 220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR 270 (361)
T ss_pred HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc
Confidence 1 22222 34588999999999999999984
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=218.19 Aligned_cols=179 Identities=21% Similarity=0.298 Sum_probs=149.3
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~l 383 (489)
-..|++++.||+|+.+.||++...+ .+.||+|.+... ..+...+.-++.|+.+|.+|+ |.+|+.+|++-..++.+|+
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 3579999999999999999998765 455666655332 235667889999999999995 9999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC---
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC--- 460 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~--- 460 (489)
||||= ..+|...|.+.... .+...+++++.||+.|+.++|+.||||.||||.|+|+- .|.+||+|||+|.....
T Consensus 438 vmE~G-d~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred Eeecc-cccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence 99965 67999999886443 45568999999999999999999999999999999984 78999999999853221
Q ss_pred -------------------------------CCceeecccccchHHHHHHHHhCCcccC
Q 042772 461 -------------------------------KPQVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -------------------------------~~~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.-..-.++|+|++|+++|+|+.|..||.
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~ 573 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG 573 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH
Confidence 0113356799999999999999999995
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=202.85 Aligned_cols=162 Identities=28% Similarity=0.368 Sum_probs=136.1
Q ss_pred CCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCCCCCHHHH
Q 042772 317 GDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFAL 396 (489)
Q Consensus 317 G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ggsL~~~ 396 (489)
|.+|.||+|.++.+++.||+|.+.+... ...|...+....||||+++++++......+++|||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999975421 22344445556799999999999999999999999999999999
Q ss_pred HhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------------CCCce
Q 042772 397 LDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------------CKPQV 464 (489)
Q Consensus 397 L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------------~~~~~ 464 (489)
+.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++++|||++.... ..|+.
T Consensus 76 l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~ 153 (237)
T cd05576 76 ISKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEV 153 (237)
T ss_pred HHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcc
Confidence 97753 38999999999999999999999999999999999999999999999999764221 12222
Q ss_pred ------eecccccchHHHHHHHHhCCcccC
Q 042772 465 ------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 465 ------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
...+|+|++|++++++++|..|+.
T Consensus 154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 154 GGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 234699999999999999987653
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=213.98 Aligned_cols=177 Identities=25% Similarity=0.405 Sum_probs=148.1
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC------
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST------ 379 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~------ 379 (489)
.+|.+.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+..|+.+++.++||||+++++++....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 579999999999999999999999999999999865422 2223456778999999999999999999887542
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
..++||||+. .+|..++. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 4699999995 47777653 237899999999999999999999999999999999999999999999999986432
Q ss_pred ------------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ------------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ------------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~ 216 (342)
T cd07879 169 AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216 (342)
T ss_pred CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC
Confidence 12222 224689999999999999999984
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=203.73 Aligned_cols=181 Identities=26% Similarity=0.404 Sum_probs=148.8
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVML--NRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
+|.+.+.||+|+||.||++.+..++..+++|+++..... .......+..|..+++.++||||+++++++......+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 588899999999999999999887777777776543221 222344566789999999999999999999988899999
Q ss_pred EecCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC--
Q 042772 385 TDFCPGGELFALLDK--QPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC-- 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~--~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~-- 460 (489)
|||+++++|.+++.. .....+++..+..++.|++.||.|||++|++|+||||+||+++. +.++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999998864 22345899999999999999999999999999999999999975 6799999998864321
Q ss_pred -------------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 -------------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -------------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ....|+|++|.+++++++|..||.
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~ 206 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE 206 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1111 123689999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-24 Score=238.07 Aligned_cols=178 Identities=25% Similarity=0.374 Sum_probs=143.2
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe-------
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT------- 377 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------- 377 (489)
..+|+.++.||+|+||.||+++.+-+|+.||||.|.-.. ......++.+|+.+|.+|+|||||++|.+|..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 567999999999999999999999999999999997543 45566788899999999999999999987700
Q ss_pred --------------------------------------------------------------------------------
Q 042772 378 -------------------------------------------------------------------------------- 377 (489)
Q Consensus 378 -------------------------------------------------------------------------------- 377 (489)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 042772 378 ------------------------S--------THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425 (489)
Q Consensus 378 ------------------------~--------~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH 425 (489)
+ ..+||-||||+...|.++++++... -....++.++.||+.||.|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHH
Confidence 0 2368999999987788887775321 147889999999999999999
Q ss_pred HCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----------------CCCceeecccccchHHHHHHHHhCCc
Q 042772 426 CLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS-----------------CKPQVFYHAHVNGFYFIMYKWLTGYF 485 (489)
Q Consensus 426 ~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~-----------------~~~~~~~~~~v~s~g~~a~e~~~G~l 485 (489)
++|||||||||.|||+++++.|||+|||+|+... ..+..-....+++.-|.+||++-+..
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 9999999999999999999999999999997511 11111233355666677777665544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=214.03 Aligned_cols=143 Identities=22% Similarity=0.194 Sum_probs=115.6
Q ss_pred cccCcccccccCCCCceEEEEEEEcC-CCcEEEEEEeecccc--cchHHHHHHHHHHHHHHhCCCCCcce-eeEEEEeCC
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQG-AGELYAMKAMEKSVM--LNRNKVHRACIEREIMSLLDHPFLPT-LYASFQTST 379 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~-tg~~vAiK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~-l~~~~~~~~ 379 (489)
..++|.+.+.||+|+||+||+|.++. +++.+|+|.+..... ........+.+|+++|+.++|+|++. +++. .
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 34679999999999999999999876 678889998753311 12334567889999999999999985 5432 4
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC-CCCCEEEecCCcEEEEecCCcccc
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDL-KPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDL-KP~NILld~~g~vKL~DFGlS~~~ 458 (489)
..|+||||++|++|.. +. .. . ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+..
T Consensus 92 ~~~LVmE~~~G~~L~~-~~--~~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-AR--PH---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred CcEEEEEccCCCCHHH-hC--cc---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 5899999999999963 21 11 1 1457889999999999999999999 999999999999999999999865
Q ss_pred C
Q 042772 459 S 459 (489)
Q Consensus 459 ~ 459 (489)
.
T Consensus 163 ~ 163 (365)
T PRK09188 163 R 163 (365)
T ss_pred c
Confidence 4
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-23 Score=226.41 Aligned_cols=178 Identities=25% Similarity=0.294 Sum_probs=152.8
Q ss_pred CcccccccCCCCceEEEEEEEcCCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGE----LYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
..+..++||+|+||+||+|.+-..|+ +||+|++... ........+..|+-+|..++|||++++++++..+. +.
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 36677899999999999999876665 6788877544 34555678889999999999999999999998776 89
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC-
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK- 461 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~- 461 (489)
||++|+++|+|.++++.+.. .+-....+.|..||+.||.|||.+++|||||..+|||+.+-.++||+|||+|+.+...
T Consensus 774 lvtq~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999999999998754 4778888999999999999999999999999999999999999999999999866522
Q ss_pred ----------------------CceeecccccchHHHHHHHH-hCCcccC
Q 042772 462 ----------------------PQVFYHAHVNGFYFIMYKWL-TGYFTYV 488 (489)
Q Consensus 462 ----------------------~~~~~~~~v~s~g~~a~e~~-~G~lpY~ 488 (489)
+.+...+|||+||++.+|++ +|.-||.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~ 902 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYD 902 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccC
Confidence 22234569999999999975 8999986
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.7e-25 Score=210.70 Aligned_cols=178 Identities=23% Similarity=0.395 Sum_probs=142.6
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----e
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST-----H 380 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~ 380 (489)
.+.+..+.||-|+||.||.+.+..+|+.||+|.+..- ..+-...+++.+|..+|..++|.|++..++..+... .
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 3577789999999999999999999999999988543 233345678889999999999999999998776543 4
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
+|+++|.+ ..+|...+-.- ..++.+.+..+++||++||.|||+.+|+||||||.|.|+++|..+||||||+++....
T Consensus 132 iYV~TELm-QSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 132 LYVLTELM-QSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHH-HhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch
Confidence 78889988 55888777553 5589999999999999999999999999999999999999999999999999986653
Q ss_pred CCceeecccccchHHHHHHHHhCCccc
Q 042772 461 KPQVFYHAHVNGFYFIMYKWLTGYFTY 487 (489)
Q Consensus 461 ~~~~~~~~~v~s~g~~a~e~~~G~lpY 487 (489)
.....+.-.|.+-+|.+||++.|...|
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhY 235 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRY 235 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhh
Confidence 333333334445555555555555444
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.4e-23 Score=212.03 Aligned_cols=172 Identities=27% Similarity=0.353 Sum_probs=146.3
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHh--CCCCCcceeeEEEEeCC---
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL--LDHPFLPTLYASFQTST--- 379 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~~~~~~~~--- 379 (489)
+...++.+.||+|.||.||+|.+. ++.||||++.. ...+.+..|..|.+. +.|+||+.+++.-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 567888999999999999999987 58999999853 345778889999875 58999999998765444
Q ss_pred -eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---------CCCeecCCCCCCEEEecCCcEEE
Q 042772 380 -HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC---------LGIIYRDLKPENILLQKDGHVVL 449 (489)
Q Consensus 380 -~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~---------~gIvHrDLKP~NILld~~g~vKL 449 (489)
.++||++|.+.|+|.+||+.+ ++++.....++..|++||+|||+ ..|+|||||.+|||+.+|+++.|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 799999999999999999984 47999999999999999999995 36999999999999999999999
Q ss_pred EecCCccccC-CCCceeecccccchHHHHHHHHhCCccc
Q 042772 450 TDFDLSFMTS-CKPQVFYHAHVNGFYFIMYKWLTGYFTY 487 (489)
Q Consensus 450 ~DFGlS~~~~-~~~~~~~~~~v~s~g~~a~e~~~G~lpY 487 (489)
+|||+|.... ..++--....|++..|++||++-|.+=|
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl 396 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINL 396 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhccc
Confidence 9999997665 2333334457888889999998887643
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-22 Score=188.78 Aligned_cols=178 Identities=38% Similarity=0.606 Sum_probs=154.3
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEec
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDF 387 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 387 (489)
|.+.+.||.|++|.||++....+++.+++|.+...... ...+.+..|++.++.++|+|++++++++......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 56778999999999999999988999999999765322 2567888899999999999999999999988999999999
Q ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC------
Q 042772 388 CPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK------ 461 (489)
Q Consensus 388 ~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~------ 461 (489)
+++++|.+++...... +++..+..++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||++......
T Consensus 79 ~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred cCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9999999999875321 789999999999999999999999999999999999999999999999988654321
Q ss_pred ----------Ccee-------ecccccchHHHHHHHHhCCcccC
Q 042772 462 ----------PQVF-------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ----------~~~~-------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+.. ...|+|++|++++++++|..||.
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 2211 35688999999999999999994
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.1e-23 Score=216.14 Aligned_cols=174 Identities=28% Similarity=0.375 Sum_probs=147.6
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~l 383 (489)
...|.+...+|.|+|+.|..+.+..+++.+++|++.+.... ...|+.++... +||||+++.+.+.+..+.|+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceeee
Confidence 56799999999999999999999999999999999876221 22366565554 79999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE-ecCCcEEEEecCCccccC---
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILL-QKDGHVVLTDFDLSFMTS--- 459 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILl-d~~g~vKL~DFGlS~~~~--- 459 (489)
|||.+.|+.|.+.+...+. ....+..|+++|+.|+.|||++|+|||||||+|||+ +..|+++|+|||.++...
T Consensus 394 v~e~l~g~ell~ri~~~~~---~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~ 470 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPE---FCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSC 470 (612)
T ss_pred eehhccccHHHHHHHhcch---hHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchhh
Confidence 9999999999988877533 337788899999999999999999999999999999 699999999999986443
Q ss_pred ---------CCCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 ---------CKPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---------~~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
++|+ +....|.||+|..+|+|++|..||.
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~ 514 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFA 514 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccc
Confidence 2222 2244599999999999999999985
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-23 Score=209.37 Aligned_cols=183 Identities=28% Similarity=0.379 Sum_probs=153.8
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccc----cchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC-
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVM----LNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS- 378 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~- 378 (489)
..++|-++..||+|+|+.||+|.+....+.||+|+-....- ...+..+..++|..|-+.|+||.||++|++|.-+
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 34679999999999999999999998899999997643221 1344567788999999999999999999999754
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CCeecCCCCCCEEEe---cCCcEEEEecC
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL--GIIYRDLKPENILLQ---KDGHVVLTDFD 453 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~--gIvHrDLKP~NILld---~~g~vKL~DFG 453 (489)
..+|-|+|||+|-+|.-||+.+ +..++.+++.|+.||+.||.||... -|||-||||.|||+- .-|.|||+|||
T Consensus 541 dsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 5789999999999999999987 4489999999999999999999976 599999999999995 34789999999
Q ss_pred CccccC---------------CCCcee-----------------ecccccchHHHHHHHHhCCcccC
Q 042772 454 LSFMTS---------------CKPQVF-----------------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 454 lS~~~~---------------~~~~~~-----------------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|.... .+..+| ...|||+.|++.|.-+.|.-||.
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFG 685 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFG 685 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCC
Confidence 996432 112222 33489999999999999999986
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-23 Score=206.72 Aligned_cols=179 Identities=23% Similarity=0.332 Sum_probs=152.3
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-C-C----CcceeeEEEEeC
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-H-P----FLPTLYASFQTS 378 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-H-p----nIv~l~~~~~~~ 378 (489)
..+|.++..+|+|+||+|-.+.+..++..||+|+++.. ....+....|+.+|.++. + | -++.+.++|...
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 57899999999999999999999999999999998643 334455677999999984 2 3 367888889999
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---------------
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK--------------- 443 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~--------------- 443 (489)
++.|||+|.+ |.+++++|..+...+++..+++.++.|++.++++||+.+++|-||||+|||+-+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999988 779999999988888999999999999999999999999999999999999842
Q ss_pred -----CCcEEEEecCCccccCCC------------Ccee------ecccccchHHHHHHHHhCCcccC
Q 042772 444 -----DGHVVLTDFDLSFMTSCK------------PQVF------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 444 -----~g~vKL~DFGlS~~~~~~------------~~~~------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+..|+|+|||.|+..... |+++ .+.|+||+|+++.|+.+|..+|-
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred eccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 236899999999754422 2222 45699999999999999998874
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=217.46 Aligned_cols=178 Identities=24% Similarity=0.382 Sum_probs=151.6
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEe-----CC
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQT-----ST 379 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~-----~~ 379 (489)
+-|.+.+.||.|.+|.||++..+.+++.+|+|++..... .-..+..|..+++.+ +|||++.+|++|.. .+
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 358999999999999999999999999999999876532 224566788888876 69999999999864 46
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
.+|||||||.||+.-++++.-.+..+.|..+..|++.++.|+.|||...++|||+|=.|||++.+|.|||+|||.|..+.
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 89999999999999999998767779999999999999999999999999999999999999999999999999985322
Q ss_pred ---------C-----------------CCceeecccccchHHHHHHHHhCCccc
Q 042772 460 ---------C-----------------KPQVFYHAHVNGFYFIMYKWLTGYFTY 487 (489)
Q Consensus 460 ---------~-----------------~~~~~~~~~v~s~g~~a~e~~~G~lpY 487 (489)
. .+.+-..+|+|++|.++-|+.-|..|+
T Consensus 175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl 228 (953)
T KOG0587|consen 175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPL 228 (953)
T ss_pred cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCc
Confidence 1 122234558888888888888888775
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=189.79 Aligned_cols=143 Identities=20% Similarity=0.177 Sum_probs=111.4
Q ss_pred ccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHH-----------------------HHHHHHHHHHHHhCCCCC
Q 042772 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNK-----------------------VHRACIEREIMSLLDHPF 367 (489)
Q Consensus 311 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~-----------------------~~~~~~E~~il~~l~Hpn 367 (489)
...||+|+||.||+|.+. +|+.||+|+++......... ......|..++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 89999999997653221110 122345889999998887
Q ss_pred cceeeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeecCCCCCCEEEecCCc
Q 042772 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYL-HCLGIIYRDLKPENILLQKDGH 446 (489)
Q Consensus 368 Iv~l~~~~~~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yL-H~~gIvHrDLKP~NILld~~g~ 446 (489)
+......... ..++||||++|+++...+... ..+++..+..++.|++.+|.|+ |+.||+||||||+|||++ ++.
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 7554433222 238999999888776553332 3488999999999999999999 799999999999999998 578
Q ss_pred EEEEecCCccccC
Q 042772 447 VVLTDFDLSFMTS 459 (489)
Q Consensus 447 vKL~DFGlS~~~~ 459 (489)
++|+|||+|....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-23 Score=198.66 Aligned_cols=176 Identities=26% Similarity=0.363 Sum_probs=144.7
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeE-EEEeCCeEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYA-SFQTSTHICL 383 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~-~~~~~~~~~l 383 (489)
+.|.+.+.||+|.||.+.+|+++.+...+++|.+.+... ....|.+|..---.| .|.||+.-|+ .|++.+.+++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 569999999999999999999999999999999976533 345566665543333 5899997766 5788889999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe--cCCcEEEEecCCccccC--
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQ--KDGHVVLTDFDLSFMTS-- 459 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld--~~g~vKL~DFGlS~~~~-- 459 (489)
+|||+|.|+|.+-+... .+-|.....++.|++.|+.|||++++||||||.+||||- +...|||||||+++...
T Consensus 100 ~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred eeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 99999999999887653 267889999999999999999999999999999999994 34589999999997433
Q ss_pred ----------CCC-----------ceeecccccchHHHHHHHHhCCcccC
Q 042772 460 ----------CKP-----------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----------~~~-----------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+.| ......|+|.+|.+.+..++|++||-
T Consensus 177 V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ 226 (378)
T KOG1345|consen 177 VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ 226 (378)
T ss_pred ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence 111 11234589999999999999999984
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-24 Score=204.01 Aligned_cols=180 Identities=26% Similarity=0.358 Sum_probs=139.2
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe--------
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT-------- 377 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-------- 377 (489)
+.|.-+..||+|.||.||+|+.+.+|+.||+|.+--... ....-....+|+.+|..+.|+|++.+++.|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 458888999999999999999999999999886532110 11122345679999999999999999887743
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccc
Q 042772 378 STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 378 ~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
...+|+||.+|+. +|.-+|.... ..++..++..++.++..||.|+|+..|+|||+||+|+||+.+|.+||+|||+++.
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 2359999999965 9999887643 4489999999999999999999999999999999999999999999999999975
Q ss_pred cCCCCce---eecccccchHHHHHHHHhCCcccC
Q 042772 458 TSCKPQV---FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 458 ~~~~~~~---~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+-.... .+...|.++.|..||+++|.--|+
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg 207 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYG 207 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccC
Confidence 5421111 123344555555555555555544
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=225.97 Aligned_cols=169 Identities=20% Similarity=0.291 Sum_probs=140.9
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
.|...+.||+|+||.||+|.+..++..||+|.+...... ...|++++++++||||+++++++.+....|+|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 466677899999999999999989999999988643211 1235788999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCCCCEEEecCCcEEEEecCCcccc-----
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH---CLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT----- 458 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH---~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~----- 458 (489)
|+++|+|.++++. +++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+...
T Consensus 764 y~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~ 837 (968)
T PLN00113 764 YIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTK 837 (968)
T ss_pred CCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCCC
Confidence 9999999999963 688999999999999999999 6799999999999999988887765 5544211
Q ss_pred ------CCCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 459 ------SCKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ------~~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
..+|+. ...+|+|++|++++|+++|..||.
T Consensus 838 ~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~ 879 (968)
T PLN00113 838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879 (968)
T ss_pred ccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence 112322 234699999999999999999974
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-21 Score=182.91 Aligned_cols=143 Identities=20% Similarity=0.161 Sum_probs=113.2
Q ss_pred ccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchH-----------------------HHHHHHHHHHHHHhCCCCC
Q 042772 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRN-----------------------KVHRACIEREIMSLLDHPF 367 (489)
Q Consensus 311 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~-----------------------~~~~~~~E~~il~~l~Hpn 367 (489)
.+.||+|+||+||+|.+. +|+.||+|++++....... ....+..|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999987 8999999999865321100 0123457889999999998
Q ss_pred cceeeEEEEeCCeEEEEEecCCCCCHHHH-HhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCC
Q 042772 368 LPTLYASFQTSTHICLITDFCPGGELFAL-LDKQPMKIFREDSARFYAAEVVIGLEYLHC-LGIIYRDLKPENILLQKDG 445 (489)
Q Consensus 368 Iv~l~~~~~~~~~~~lVmEy~~ggsL~~~-L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~-~gIvHrDLKP~NILld~~g 445 (489)
+.....+.... .++||||++|+++... +.. ..+++..+..++.|++.++.++|+ +||+||||||+||+++ ++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 86554443332 4899999988765443 332 336788999999999999999999 9999999999999999 88
Q ss_pred cEEEEecCCccccCC
Q 042772 446 HVVLTDFDLSFMTSC 460 (489)
Q Consensus 446 ~vKL~DFGlS~~~~~ 460 (489)
.++|+|||+|.....
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.2e-22 Score=202.07 Aligned_cols=143 Identities=27% Similarity=0.374 Sum_probs=123.5
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHH--hCCCCCcceeeEEEEeC----C
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS--LLDHPFLPTLYASFQTS----T 379 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~--~l~HpnIv~l~~~~~~~----~ 379 (489)
.+.++.+.||+|.||.||+|.++ |+.||+|++... +...+.+|.+|.+ .|+|+||+.++++=..+ .
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred heeEEEEEecCccccceeecccc--CCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 46888999999999999999999 789999999543 2345667888876 46999999999875433 3
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-----C---CCeecCCCCCCEEEecCCcEEEEe
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC-----L---GIIYRDLKPENILLQKDGHVVLTD 451 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~-----~---gIvHrDLKP~NILld~~g~vKL~D 451 (489)
++|||++|.+.|||++||.+ .+++.+....++..++.||+|||. + .|.|||||..|||+.++|.+.|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 79999999999999999988 448899999999999999999994 2 499999999999999999999999
Q ss_pred cCCccccC
Q 042772 452 FDLSFMTS 459 (489)
Q Consensus 452 FGlS~~~~ 459 (489)
+|+|....
T Consensus 360 LGLAv~h~ 367 (513)
T KOG2052|consen 360 LGLAVRHD 367 (513)
T ss_pred ceeeEEec
Confidence 99997554
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=214.00 Aligned_cols=178 Identities=17% Similarity=0.173 Sum_probs=126.6
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCC----CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEE----
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGA----GELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYAS---- 374 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~t----g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~---- 374 (489)
...++|.+.+.||+|+||.||+|.+..+ +..||+|.+..... ......+ .+....+.++..+...
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 3457899999999999999999999988 89999998754211 1111111 1112222222222211
Q ss_pred --EEeCCeEEEEEecCCCCCHHHHHhhCCCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 042772 375 --FQTSTHICLITDFCPGGELFALLDKQPMK------------------IFREDSARFYAAEVVIGLEYLHCLGIIYRDL 434 (489)
Q Consensus 375 --~~~~~~~~lVmEy~~ggsL~~~L~~~~~~------------------~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDL 434 (489)
.......++||||+++++|.+++...... ...+..+..++.||+.||.|||+++|+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 23456799999999999999998754210 1123456679999999999999999999999
Q ss_pred CCCCEEEec-CCcEEEEecCCccccCC----------------CCcee----------------------------eccc
Q 042772 435 KPENILLQK-DGHVVLTDFDLSFMTSC----------------KPQVF----------------------------YHAH 469 (489)
Q Consensus 435 KP~NILld~-~g~vKL~DFGlS~~~~~----------------~~~~~----------------------------~~~~ 469 (489)
||+|||++. ++.+||+|||+|+.... +|+.+ ...|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999985 68999999999964211 11111 1129
Q ss_pred ccchHHHHHHHHhCCccc
Q 042772 470 VNGFYFIMYKWLTGYFTY 487 (489)
Q Consensus 470 v~s~g~~a~e~~~G~lpY 487 (489)
+|++|++++|+++|.+++
T Consensus 362 VwSlGviL~el~~~~~~~ 379 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRS 379 (566)
T ss_pred cHHHHHHHHHHHhCcCCC
Confidence 999999999999887664
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=206.39 Aligned_cols=156 Identities=21% Similarity=0.252 Sum_probs=118.7
Q ss_pred cccccCcccccccCCCCceEEEEEEEc----------------CCCcEEEEEEeecccccchH-----------HHHHHH
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQ----------------GAGELYAMKAMEKSVMLNRN-----------KVHRAC 354 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~----------------~tg~~vAiK~i~~~~~~~~~-----------~~~~~~ 354 (489)
.+..++|.+.+.||+|+||.||+|.+. ..++.||+|.+......... ..+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 456789999999999999999999752 23567999998643211100 112233
Q ss_pred HHHHHHHhCCCCCc-----ceeeEEEEe--------CCeEEEEEecCCCCCHHHHHhhCC--------------------
Q 042772 355 IEREIMSLLDHPFL-----PTLYASFQT--------STHICLITDFCPGGELFALLDKQP-------------------- 401 (489)
Q Consensus 355 ~E~~il~~l~HpnI-----v~l~~~~~~--------~~~~~lVmEy~~ggsL~~~L~~~~-------------------- 401 (489)
.|+.++.++.|.++ +.++++|.. ....++||||+++++|.++++...
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 46667777766544 566666643 346899999999999999987421
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccc
Q 042772 402 --MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 402 --~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
...+++..+..++.|++.+|.|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~ 358 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVD 358 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccc
Confidence 11245677888999999999999999999999999999999999999999999853
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.2e-21 Score=181.69 Aligned_cols=167 Identities=40% Similarity=0.631 Sum_probs=145.0
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCCCCCHHHHH
Q 042772 318 DTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALL 397 (489)
Q Consensus 318 ~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ggsL~~~L 397 (489)
+||.||+|....+++.+|+|.+........ .+.+..|++.++.++|+||+++++++......+++|||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999999999999999976533221 578888999999999999999999999989999999999999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC--------------Cc
Q 042772 398 DKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK--------------PQ 463 (489)
Q Consensus 398 ~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~--------------~~ 463 (489)
..... ++...+..++.+++.++.|||+.+++|+||+|.||+++.++.++|+|||.+...... |+
T Consensus 79 ~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE 156 (244)
T smart00220 79 KKRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE 156 (244)
T ss_pred HhccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHH
Confidence 87543 789999999999999999999999999999999999999999999999998754321 11
Q ss_pred ------eeecccccchHHHHHHHHhCCcccC
Q 042772 464 ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 464 ------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.....|+|++|.+++++++|..||.
T Consensus 157 ~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~ 187 (244)
T smart00220 157 VLLGKGYGKAVDVWSLGVILYELLTGKPPFP 187 (244)
T ss_pred HHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1234688999999999999999984
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.7e-22 Score=187.61 Aligned_cols=144 Identities=21% Similarity=0.339 Sum_probs=126.8
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeC--CeE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTS--THI 381 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~--~~~ 381 (489)
.++|++++.+|+|-|+.|+.|....+.+.++||++++. ..+.+.+|+.||..|. ||||+++++...++ ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 46799999999999999999999888999999999654 3467889999999997 99999999988765 457
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-CCcEEEEecCCccccC
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK-DGHVVLTDFDLSFMTS 459 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~-~g~vKL~DFGlS~~~~ 459 (489)
.||+||+.+.+...+... ++.-.++.++.|++.||.|+|++||+|||+||.|++||. .-.++|+|+|+|.+..
T Consensus 111 aLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 899999998888776533 788889999999999999999999999999999999984 4579999999997654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-21 Score=211.43 Aligned_cols=186 Identities=22% Similarity=0.312 Sum_probs=155.6
Q ss_pred ccccccCcccccccCCCCceEEEEEEEcC-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceee
Q 042772 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQG-------AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLY 372 (489)
Q Consensus 301 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~-------tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~ 372 (489)
.++...+..+.+.||+|.||+|++|.... ....||+|.++... .....+.+..|+.+|+.+ .||||+.++
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~--~~~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA--SSSEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc--CcHHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 34455566777799999999999998652 14589999986553 236678899999999988 599999999
Q ss_pred EEEEeCCeEEEEEecCCCCCHHHHHhhCC------------C--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 042772 373 ASFQTSTHICLITDFCPGGELFALLDKQP------------M--KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPEN 438 (489)
Q Consensus 373 ~~~~~~~~~~lVmEy~~ggsL~~~L~~~~------------~--~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~N 438 (489)
+++...+.+++|+||+..|+|..+|.... . ..++......++.||+.|++||+++.+|||||..+|
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 99999999999999999999999998764 0 137888999999999999999999999999999999
Q ss_pred EEEecCCcEEEEecCCccccCC---------C---C------------ceeecccccchHHHHHHH-HhCCcccC
Q 042772 439 ILLQKDGHVVLTDFDLSFMTSC---------K---P------------QVFYHAHVNGFYFIMYKW-LTGYFTYV 488 (489)
Q Consensus 439 ILld~~g~vKL~DFGlS~~~~~---------~---~------------~~~~~~~v~s~g~~a~e~-~~G~lpY~ 488 (489)
||+.++..+||+|||+|+.... . | .....+|||+||..++|+ .+|..||.
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp 523 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP 523 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence 9999999999999999973221 1 1 122345999999999998 59999996
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.1e-20 Score=169.02 Aligned_cols=143 Identities=38% Similarity=0.603 Sum_probs=127.7
Q ss_pred cCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCCCCCH
Q 042772 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGEL 393 (489)
Q Consensus 314 LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ggsL 393 (489)
||+|.+|.||++....+++.+++|.+....... ....+.+|+.+++.+.|++|+++++++......+++|||+++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999999889999999987553211 356788899999999999999999999998999999999998999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-CCcEEEEecCCccccC
Q 042772 394 FALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK-DGHVVLTDFDLSFMTS 459 (489)
Q Consensus 394 ~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~-~g~vKL~DFGlS~~~~ 459 (489)
.+++.... ..++...+..++.+++.++.+||++|++|+||+|.||+++. ++.++|+|||.+....
T Consensus 79 ~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~ 144 (215)
T cd00180 79 KDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLT 144 (215)
T ss_pred HHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEcc
Confidence 99998752 24789999999999999999999999999999999999998 8999999999987543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4e-21 Score=188.92 Aligned_cols=177 Identities=23% Similarity=0.368 Sum_probs=149.3
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC------
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS------ 378 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------ 378 (489)
..+|.-+.++|.|.- .|..|.+.-+++.||+|.+.... .+....++..+|..++..+.|+||++++.+|...
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc-ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 457899999999998 88889999999999999887653 3455567888999999999999999999999754
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
..+|+|||++ ..+|.+.+... ++-.++..++.|+++|+.|||+.||+||||||+||++..++.+||.|||+|+.-
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~~e----lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVILME----LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHHHh----cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 3589999999 66999988743 678899999999999999999999999999999999999999999999999632
Q ss_pred CC--------------CC------ceeecccccchHHHHHHHHhCCcccC
Q 042772 459 SC--------------KP------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~~--------------~~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.. .| ..-...++|+.|+++-|+++|.+.|.
T Consensus 169 ~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 169 DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 20 11 12234488999999999999988774
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-19 Score=185.73 Aligned_cols=178 Identities=24% Similarity=0.340 Sum_probs=145.4
Q ss_pred CcccccccCCCCceEEEEEEEcCCC-cEEEEEEeecccccchHHHHHHHHHHHHHHhCCC----CCcceeeEEE-EeCCe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAG-ELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDH----PFLPTLYASF-QTSTH 380 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg-~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H----pnIv~l~~~~-~~~~~ 380 (489)
+|.+.+.||+|+||.||+|.+..++ ..+|+|+......... ..+..|..++..+.. +++..+++.. .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 7999999999999999999988764 6889998765422211 156678888888762 6899999998 47788
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC-----CcEEEEecCCc
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD-----GHVVLTDFDLS 455 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~-----g~vKL~DFGlS 455 (489)
.|+||+.+ |.+|.++....+.+.++..++..++.|++.+|++||+.|++||||||.|+++... -.+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999988 8899999877776779999999999999999999999999999999999999765 36999999999
Q ss_pred c--ccC-CC--------C--------------------ceeecccccchHHHHHHHHhCCcccC
Q 042772 456 F--MTS-CK--------P--------------------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 456 ~--~~~-~~--------~--------------------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+ ... .. + +.-...|.++++|++.+|..|.+||.
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~ 238 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWE 238 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCc
Confidence 8 311 00 0 00122377889999999999999994
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=173.79 Aligned_cols=139 Identities=23% Similarity=0.266 Sum_probs=108.2
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-----CCCCcceeeEEEEeCC---
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-----DHPFLPTLYASFQTST--- 379 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~~~~~~~~--- 379 (489)
+.-.+.||+|+||.||. ++.++.. +||++.... ....+.+.+|+.+++.+ +||||+++++++.++.
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 34457899999999995 6666555 688886532 22346788999999999 6799999999998873
Q ss_pred eEE-EEEec--CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHH-HHHHHCCCeecCCCCCCEEEecC----CcEEEEe
Q 042772 380 HIC-LITDF--CPGGELFALLDKQPMKIFREDSARFYAAEVVIGL-EYLHCLGIIYRDLKPENILLQKD----GHVVLTD 451 (489)
Q Consensus 380 ~~~-lVmEy--~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL-~yLH~~gIvHrDLKP~NILld~~----g~vKL~D 451 (489)
.++ +|||| +++|+|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+|
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 444 78999 5579999999763 25555 35577888777 99999999999999999999743 3799999
Q ss_pred -cCCccc
Q 042772 452 -FDLSFM 457 (489)
Q Consensus 452 -FGlS~~ 457 (489)
||.+..
T Consensus 153 g~G~~~~ 159 (210)
T PRK10345 153 NIGESTF 159 (210)
T ss_pred CCCCcce
Confidence 554433
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-20 Score=195.01 Aligned_cols=180 Identities=22% Similarity=0.306 Sum_probs=149.4
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC------CCcceeeEEEEe
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDH------PFLPTLYASFQT 377 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H------pnIv~l~~~~~~ 377 (489)
.-.+|.+....|+|-|+.|..|.+...|+.||||+|..... ..+.-..|++||++|+. -++++++..|..
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 34678888899999999999999999999999999976533 23344569999999852 378999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC-CcEEEEecCCc
Q 042772 378 STHICLITDFCPGGELFALLDKQPM-KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD-GHVVLTDFDLS 455 (489)
Q Consensus 378 ~~~~~lVmEy~~ggsL~~~L~~~~~-~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~-g~vKL~DFGlS 455 (489)
.+++|||+|.+ ..+|.+.|+.-+. -.|....++.++.|+..||.+|-..||+|.||||.|||+++. ..+||||||.|
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence 99999999998 5699999987532 237889999999999999999999999999999999999865 56899999998
Q ss_pred cccCC-------------CCcee------ecccccchHHHHHHHHhCCcccC
Q 042772 456 FMTSC-------------KPQVF------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 456 ~~~~~-------------~~~~~------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
...+. +|+++ .+-+.|+.|+++||+.+|.++|.
T Consensus 585 ~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp 636 (752)
T KOG0670|consen 585 SFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP 636 (752)
T ss_pred cccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence 64431 23222 34488999999999999998885
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.4e-20 Score=178.26 Aligned_cols=143 Identities=19% Similarity=0.195 Sum_probs=117.6
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHH------HHHHHHHHHhCCCCCcceeeEEEEe
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHR------ACIEREIMSLLDHPFLPTLYASFQT 377 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~------~~~E~~il~~l~HpnIv~l~~~~~~ 377 (489)
..++|+.++.||.|+||.||++.. ++..+|+|.+............. +.+|+..+.++.||+|+.+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 346899999999999999999765 36689999997665444444444 5688889999999999999988664
Q ss_pred C--------CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEE
Q 042772 378 S--------THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVL 449 (489)
Q Consensus 378 ~--------~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL 449 (489)
. +..+++|||++|.+|.++.. +++. ...+++.+|..+|+.|++|||+||+||+++.+| ++|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEE
Confidence 3 35899999999999988732 3332 355899999999999999999999999999988 999
Q ss_pred EecCCccccC
Q 042772 450 TDFDLSFMTS 459 (489)
Q Consensus 450 ~DFGlS~~~~ 459 (489)
+|||.+....
T Consensus 176 iDfg~~~~~~ 185 (232)
T PRK10359 176 IDLSGKRCTA 185 (232)
T ss_pred EECCCccccc
Confidence 9999887554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.4e-20 Score=175.51 Aligned_cols=179 Identities=20% Similarity=0.264 Sum_probs=146.0
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CCcceeeEEEEeCCeE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDH-PFLPTLYASFQTSTHI 381 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~ 381 (489)
+-.+.|++++.||+|+||-+|+|....+|..||||+=+... . -..+..|..+.+.|++ ..|+.+..++....+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-K----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-C----CcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 34467999999999999999999999999999999764332 1 2346678999999974 7888888888888899
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC---CcEEEEecCCcccc
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD---GHVVLTDFDLSFMT 458 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~---g~vKL~DFGlS~~~ 458 (489)
.+||+.+ |.+|.+++.-.. ..++..+++-.+-|++.-++|+|.++++||||||+|+|+.-+ ..+.|+|||+|...
T Consensus 87 vlVMdLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeeecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 9999999 899999987653 348999999999999999999999999999999999999643 46889999999632
Q ss_pred CC----------------------------CCceeecccccchHHHHHHHHhCCcccC
Q 042772 459 SC----------------------------KPQVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~~----------------------------~~~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
-. ..+.....|..+.||.+-.+..|.+||-
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQ 222 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQ 222 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccc
Confidence 11 0111233366788999988899999984
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.2e-21 Score=203.88 Aligned_cols=175 Identities=25% Similarity=0.421 Sum_probs=147.7
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|.++..+|+|+||-||+++++.+++..|+|+++... .....-+..|+-+++-.+||||+.+++.+.....+++.|
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 57999999999999999999999999999999997543 334555667888999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------ 459 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------ 459 (489)
|||.||+|.+.-.- .+++++.++.++..+.+.|++|||++|-+|||||=.|||+++.|.+|++|||.+..+.
T Consensus 92 EycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Kr 169 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKR 169 (829)
T ss_pred EecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhh
Confidence 99999999887654 3669999999999999999999999999999999999999999999999999985332
Q ss_pred ---CCCceeecccc------cchHHHHHHHHhCCc
Q 042772 460 ---CKPQVFYHAHV------NGFYFIMYKWLTGYF 485 (489)
Q Consensus 460 ---~~~~~~~~~~v------~s~g~~a~e~~~G~l 485 (489)
....+|+.++| ++|+-..+.|++|..
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~git 204 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGIT 204 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccc
Confidence 23445555544 345556666666643
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.8e-19 Score=171.17 Aligned_cols=147 Identities=21% Similarity=0.146 Sum_probs=114.7
Q ss_pred CcccccccCCCCceEEEEEE-EcCCCcEEEEEEeecccccch--------------------H-HHHHHHHHHHHHHhCC
Q 042772 307 HFKPIKPLGCGDTGSVHLVE-LQGAGELYAMKAMEKSVMLNR--------------------N-KVHRACIEREIMSLLD 364 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~-~~~tg~~vAiK~i~~~~~~~~--------------------~-~~~~~~~E~~il~~l~ 364 (489)
.|.+.+.||+|+||.||+|. +..+|+.||+|.+........ . ....+..|..++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48889999999999999998 667899999999975431100 0 1123567999999987
Q ss_pred CC--CcceeeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CeecCCCCCCEEE
Q 042772 365 HP--FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLG-IIYRDLKPENILL 441 (489)
Q Consensus 365 Hp--nIv~l~~~~~~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~g-IvHrDLKP~NILl 441 (489)
+. .++.+++. ...++||||++|.+|...+... ..+....+..++.|++.+|.+||++| ++||||||+||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 53 34455542 2358999999988887665333 23566677889999999999999999 9999999999999
Q ss_pred ecCCcEEEEecCCccccCC
Q 042772 442 QKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 442 d~~g~vKL~DFGlS~~~~~ 460 (489)
+ ++.++|+|||+|.....
T Consensus 183 ~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 183 H-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred E-CCCEEEEEChhhhccCC
Confidence 9 88999999999986554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=172.62 Aligned_cols=176 Identities=22% Similarity=0.306 Sum_probs=145.1
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV 384 (489)
-+|++.+.||+|+||.+++|...-+++.||||.=... ....++..|-...+.|. .++|+..|-+.+...+..||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 4799999999999999999999989999999965432 12345566888888874 79999999877888899999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC-----CcEEEEecCCccccC
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD-----GHVVLTDFDLSFMTS 459 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~-----g~vKL~DFGlS~~~~ 459 (489)
||.+ |.+|.++++-.+ ..|+..++..++.|++.-++|+|++.+|+|||||+|+||..- ..|.|+|||+|...-
T Consensus 103 idLL-GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hhhh-CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 9999 899999998875 459999999999999999999999999999999999999643 368999999996432
Q ss_pred CC----------------------------CceeecccccchHHHHHHHHhCCcccC
Q 042772 460 CK----------------------------PQVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ~~----------------------------~~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+ .+.....|..++|-+.-.++-|.+||-
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQ 237 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 237 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccc
Confidence 11 111223366778888888999999994
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.4e-18 Score=162.80 Aligned_cols=140 Identities=21% Similarity=0.239 Sum_probs=115.5
Q ss_pred ccccCCCCceEEEEEEEcCCCcEEEEEEeecccccch-----HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNR-----NKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 311 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++.||+|++|.||+|.+ .|..+++|.......... ....++.+|..++..+.|++|+....++......+++|
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 36799999999999987 467889997654322111 12345778999999999999988777777777899999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
||++|++|.+++... .. ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||++....
T Consensus 79 e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 79 EYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred EEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 999999999998653 12 7788899999999999999999999999999999 7899999999987543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-18 Score=188.58 Aligned_cols=167 Identities=25% Similarity=0.322 Sum_probs=130.9
Q ss_pred CcccccccCCCCce-EEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEE
Q 042772 307 HFKPIKPLGCGDTG-SVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 307 ~y~~~~~LG~G~fG-~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV 384 (489)
-|...+.+|.|+.| .||+|... |+.||+|.+-.. ....+.+|+.+|+.- +|||||++|+.-.++..+||.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIa 581 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIA 581 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEE
Confidence 35666788899886 57889887 789999987433 345667899999988 499999999988899999999
Q ss_pred EecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---C--CcEEEEecCCccc
Q 042772 385 TDFCPGGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK---D--GHVVLTDFDLSFM 457 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~---~--g~vKL~DFGlS~~ 457 (489)
.|.| ..+|.++++.. .......-..+..+.|++.||+|||+.+||||||||.||||+. + ..++|+|||+|..
T Consensus 582 lELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 582 LELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred ehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 9999 45999999874 1110111335778899999999999999999999999999976 3 4789999999988
Q ss_pred cCCCCceeec--ccccchHHHHHHHHh
Q 042772 458 TSCKPQVFYH--AHVNGFYFIMYKWLT 482 (489)
Q Consensus 458 ~~~~~~~~~~--~~v~s~g~~a~e~~~ 482 (489)
+......... ...++.|+++||++.
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~ 687 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLR 687 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHh
Confidence 8766555443 345677888877653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-17 Score=158.59 Aligned_cols=137 Identities=23% Similarity=0.233 Sum_probs=106.9
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccch-HHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEEE
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNR-NKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lVm 385 (489)
+.+...|++|+||+||++.. .+..++.+.++-.....+ -....+.+|+++|++|. |+++++++++ ...+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 45678899999999998775 467777776654322111 12235788999999995 5889999885 3479999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC-CCCCEEEecCCcEEEEecCCccccC
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDL-KPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDL-KP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
||+.|.+|.+.+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|....
T Consensus 78 eyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 78 SYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred eeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 99999998754321 1 1346789999999999999999999 7999999999999999999997544
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-17 Score=157.58 Aligned_cols=135 Identities=19% Similarity=0.211 Sum_probs=108.7
Q ss_pred ccCCCCceEEEEEEEcCCCcEEEEEEeecccccc-----hHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEec
Q 042772 313 PLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN-----RNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDF 387 (489)
Q Consensus 313 ~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 387 (489)
.||+|+||.||+|.+ ++..+++|......... .....++.+|..++..+.|+++.....++......+++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 389999999999985 46789999865432211 11246677899999999988766655556666778999999
Q ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 388 CPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 388 ~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
++|++|.+++.... . .++.|++.+|.+||+.|++|+|++|.||+++ ++.++++|||++....
T Consensus 79 ~~g~~l~~~~~~~~-----~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 79 IEGKPLKDVIEEGN-----D----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred ECCccHHHHHhhcH-----H----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 99999999876531 1 6788999999999999999999999999999 8899999999987643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=171.73 Aligned_cols=137 Identities=26% Similarity=0.417 Sum_probs=119.9
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-----CC---CcceeeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-----HP---FLPTLYAS 374 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----Hp---nIv~l~~~ 374 (489)
+..++|.+.+.||-|.|++||+|.+..+.+.||+|+++.. ....+....|+.+|++++ |+ +||+|++.
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 3447899999999999999999999999999999998643 445566778999999873 33 69999999
Q ss_pred EEeC----CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecC
Q 042772 375 FQTS----THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC-LGIIYRDLKPENILLQKD 444 (489)
Q Consensus 375 ~~~~----~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~-~gIvHrDLKP~NILld~~ 444 (489)
|... .++|+|+|++ |-+|..++.....+.++...+..|+.||+.||.|||. .||||-||||+|||+..+
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST 224 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence 9754 5899999999 7899999999888889999999999999999999995 599999999999999654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=157.55 Aligned_cols=140 Identities=19% Similarity=0.155 Sum_probs=108.6
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccc------hH-------------HHHHHHHHHHHHHhCCCC--
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN------RN-------------KVHRACIEREIMSLLDHP-- 366 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~------~~-------------~~~~~~~E~~il~~l~Hp-- 366 (489)
|.+.+.||+|+||.||++... +|+.||+|++....... .. .......|..++..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 788899999999999999875 79999999876532100 00 112356688888888777
Q ss_pred CcceeeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc
Q 042772 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGH 446 (489)
Q Consensus 367 nIv~l~~~~~~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~ 446 (489)
.++..++ ....+++|||++|++|...... .....++.+++.++.++|+.|++|+||||+||++++++.
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence 4455543 2356899999999998765321 234567889999999999999999999999999999999
Q ss_pred EEEEecCCccccCC
Q 042772 447 VVLTDFDLSFMTSC 460 (489)
Q Consensus 447 vKL~DFGlS~~~~~ 460 (489)
++|+|||++.....
T Consensus 164 ~~liDfg~~~~~~~ 177 (198)
T cd05144 164 IYIIDWPQMVSTDH 177 (198)
T ss_pred EEEEECCccccCCC
Confidence 99999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1e-16 Score=155.99 Aligned_cols=148 Identities=38% Similarity=0.586 Sum_probs=129.5
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC-CcceeeEEEEeCCeEEEEEe
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP-FLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hp-nIv~l~~~~~~~~~~~lVmE 386 (489)
|.+.+.||.|+||.||++.+. ..+++|.+.............+.+|..++..+.|+ +++++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 678889999999999999988 78899999876544434577888999999999988 79999999988778899999
Q ss_pred cCCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC-cEEEEecCCcccc
Q 042772 387 FCPGGELFALLDKQPM-KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG-HVVLTDFDLSFMT 458 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~-~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g-~vKL~DFGlS~~~ 458 (489)
++.++++.+++..... ..+++.....++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||++...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence 9999999977776532 1488999999999999999999999999999999999999988 7999999998633
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.5e-17 Score=178.25 Aligned_cols=141 Identities=20% Similarity=0.234 Sum_probs=112.9
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeeccccc-----chHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVML-----NRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH 380 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 380 (489)
..|...+.||+|+||.||++.+.... +++|........ ......++.+|..+++.++|++++....++.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34567889999999999999876543 344432221111 11234568889999999999999988777777777
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
.++||||++|++|.+++. ....++.|++.+|.|||+.|++||||||+|||+ .++.++|+|||+|+...
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 899999999999999885 245688899999999999999999999999999 67899999999997643
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.6e-17 Score=167.02 Aligned_cols=184 Identities=16% Similarity=0.151 Sum_probs=148.4
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGA-----GELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT 377 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 377 (489)
+...+++....+-+|.||.||.|.+... .+.|-+|.++.. .++-.+..+..|.-++..+.|||+..+.+.+..
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 3456788889999999999999977643 234455655432 245567788888888888999999999987754
Q ss_pred C-CeEEEEEecCCCCCHHHHHhh------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEE
Q 042772 378 S-THICLITDFCPGGELFALLDK------QPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLT 450 (489)
Q Consensus 378 ~-~~~~lVmEy~~ggsL~~~L~~------~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~ 450 (489)
+ ...++++.+..-|+|..+|.. ...+.++..+...++.|++.|++|||++|+||.||..+|++||+..++||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 4 568889999999999999973 233457788889999999999999999999999999999999999999999
Q ss_pred ecCCccccCC-----------C------------CceeecccccchHHHHHHH-HhCCcccC
Q 042772 451 DFDLSFMTSC-----------K------------PQVFYHAHVNGFYFIMYKW-LTGYFTYV 488 (489)
Q Consensus 451 DFGlS~~~~~-----------~------------~~~~~~~~v~s~g~~a~e~-~~G~lpY~ 488 (489)
|=.+|+.+.. . .++...+|+|++|+.++|+ .+|..||-
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya 500 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA 500 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc
Confidence 9999985431 1 2233567999999999998 58999984
|
|
| >PF13426 PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_B 3P7N_B 1LL8_A 3MJQ_A 3BWL_A 4EET_B 4EEP_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.7e-17 Score=136.04 Aligned_cols=104 Identities=28% Similarity=0.461 Sum_probs=95.2
Q ss_pred cCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhcccccccc
Q 042772 77 EKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFT 156 (489)
Q Consensus 77 ~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (489)
++++++.|+ ++.|+++|++|++++||+++|++|+++..+..+.
T Consensus 1 p~~i~i~d~---~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~---------------------------------- 43 (104)
T PF13426_consen 1 PDGIFILDP---DGRILYVNPAFERLFGYSREELIGKSISDFFPEE---------------------------------- 43 (104)
T ss_dssp -SEEEEEET---TSBEEEE-HHHHHHHTS-HHHHTTSBGGGGCSTT----------------------------------
T ss_pred CEEEEEECC---cCcEEehhHHHHHHHCcCHHHHcCCCcccccCcc----------------------------------
Confidence 578999999 9999999999999999999999999998777654
Q ss_pred cCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCc
Q 042772 157 LGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSD 225 (489)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te 225 (489)
......+.+.+++..++.++.++..++++|+.+|+.++++|++|.+|++.+++++.+||||
T Consensus 44 --------~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~~~~~~~~i~~~~g~~~~~i~~~~DiTe 104 (104)
T PF13426_consen 44 --------DRPEFEEQIERALEEGGSWSGEVRLRRKDGETFWVEVSASPIRDEDGEITGIIGIFRDITE 104 (104)
T ss_dssp --------SCHHHHHHHHHHHHHTSSEEEEEEEEETTSEEEEEEEEEEEEEETTSSEEEEEEEEEEEHH
T ss_pred --------cchhhHHHHHHHHhcCCceeEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEECCC
Confidence 5778889999999999999999999999999999999999999999999999999999986
|
... |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-17 Score=169.86 Aligned_cols=141 Identities=23% Similarity=0.350 Sum_probs=125.8
Q ss_pred cCcccccccCCCCceEEEEEEEcC---CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQG---AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~---tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 381 (489)
..|..+++||.|+|++||++.+.. .++.||+|.+... ....++.+|+++|..+ .+.||+++.+++...+++
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-----SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-----cCchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 469999999999999999999877 7889999998643 2235688899999988 489999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe-cCCcEEEEecCCcc
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQ-KDGHVVLTDFDLSF 456 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld-~~g~vKL~DFGlS~ 456 (489)
.+||||+++-+..++... ++...++.++..++.||.++|.+|||||||||.|+|.+ ..+.-.|+|||+|-
T Consensus 111 ~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence 999999999998888765 67888999999999999999999999999999999997 45678899999984
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-16 Score=148.44 Aligned_cols=140 Identities=21% Similarity=0.206 Sum_probs=100.6
Q ss_pred ccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHH---------------------HHHHHHHHHhCCCC--C
Q 042772 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHR---------------------ACIEREIMSLLDHP--F 367 (489)
Q Consensus 311 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~---------------------~~~E~~il~~l~Hp--n 367 (489)
.+.||+|+||+||+|.+. +++.||+|++............. ...|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999987 78999999987643221111111 13455566665443 3
Q ss_pred cceeeEEEEeCCeEEEEEecCCCCCHHH-HHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCC
Q 042772 368 LPTLYASFQTSTHICLITDFCPGGELFA-LLDKQPMKIFREDSARFYAAEVVIGLEYLHC-LGIIYRDLKPENILLQKDG 445 (489)
Q Consensus 368 Iv~l~~~~~~~~~~~lVmEy~~ggsL~~-~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~-~gIvHrDLKP~NILld~~g 445 (489)
+++++++ ...+++|||++++.+.. .+.... . ...+..++.+++.++.++|. +||+|+||||+||+++ ++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 4555543 23699999999854432 122111 1 15678889999999999999 9999999999999999 89
Q ss_pred cEEEEecCCccccCC
Q 042772 446 HVVLTDFDLSFMTSC 460 (489)
Q Consensus 446 ~vKL~DFGlS~~~~~ 460 (489)
.++|+|||.+.....
T Consensus 152 ~~~liDfg~a~~~~~ 166 (187)
T cd05119 152 KVYIIDVPQAVEIDH 166 (187)
T ss_pred cEEEEECcccccccC
Confidence 999999999976554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.6e-15 Score=148.61 Aligned_cols=139 Identities=22% Similarity=0.315 Sum_probs=105.9
Q ss_pred cccC-CCCceEEEEEEEcCCCcEEEEEEeecccc----------cchHHHHHHHHHHHHHHhCCCCCc--ceeeEEEEeC
Q 042772 312 KPLG-CGDTGSVHLVELQGAGELYAMKAMEKSVM----------LNRNKVHRACIEREIMSLLDHPFL--PTLYASFQTS 378 (489)
Q Consensus 312 ~~LG-~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~----------~~~~~~~~~~~E~~il~~l~HpnI--v~l~~~~~~~ 378 (489)
..|| .|+.|+||.+... +..+++|.+..... .......++.+|..++..+.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3466 7888888888765 67889998854211 011234567889999999998775 6677654432
Q ss_pred -C---eEEEEEecCCC-CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecC
Q 042772 379 -T---HICLITDFCPG-GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFD 453 (489)
Q Consensus 379 -~---~~~lVmEy~~g-gsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFG 453 (489)
. ..++|||+++| .+|.+++... .+++.. +.|++.+|.+||++||+||||||.|||++.++.++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 2 23599999997 6999888653 355543 5689999999999999999999999999999999999999
Q ss_pred CccccC
Q 042772 454 LSFMTS 459 (489)
Q Consensus 454 lS~~~~ 459 (489)
.+....
T Consensus 188 ~~~~~~ 193 (239)
T PRK01723 188 RGELRT 193 (239)
T ss_pred CcccCC
Confidence 998755
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.5e-15 Score=132.80 Aligned_cols=133 Identities=25% Similarity=0.242 Sum_probs=110.8
Q ss_pred cccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC--CCcceeeEEEEeCCeEEEEEec
Q 042772 310 PIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDH--PFLPTLYASFQTSTHICLITDF 387 (489)
Q Consensus 310 ~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~~~~~~~~~~~lVmEy 387 (489)
+++.||.|.++.||++...+ ..+++|....... ...+..|..+++.+.| +++++++.++...+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 45789999999999999864 6789998865421 3567789999999876 5899999888887889999999
Q ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 388 CPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL---GIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 388 ~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~---gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
++++++..+ +......++.+++.++.+||.. +++|+|++|+||++++.+.++++|||.+...
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 988777543 3455666788999999999984 7999999999999999899999999998643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.2e-15 Score=171.72 Aligned_cols=149 Identities=27% Similarity=0.410 Sum_probs=118.6
Q ss_pred CccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCCcceeeEEEE
Q 042772 300 GEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD---HPFLPTLYASFQ 376 (489)
Q Consensus 300 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~ 376 (489)
..+++...|.+.+.||+|+||+||+|.... |+.||+|+-++..... |..=.+++.+|+ -+.|..+..++.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHc
Confidence 345667789999999999999999999887 9999999876654322 112223333443 244556666666
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-------CCcEEE
Q 042772 377 TSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK-------DGHVVL 449 (489)
Q Consensus 377 ~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~-------~g~vKL 449 (489)
-.+.-++|+||.+.|+|.+++.. .+..++..+.++..|++..|++||..+|||+||||+|+||.. +-.++|
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred cCCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEE
Confidence 66778999999999999999974 456899999999999999999999999999999999999942 236999
Q ss_pred EecCCccc
Q 042772 450 TDFDLSFM 457 (489)
Q Consensus 450 ~DFGlS~~ 457 (489)
+|||.|..
T Consensus 843 IDfG~siD 850 (974)
T KOG1166|consen 843 IDFGRSID 850 (974)
T ss_pred Eeccccee
Confidence 99999953
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=9.7e-17 Score=170.28 Aligned_cols=173 Identities=42% Similarity=0.655 Sum_probs=146.7
Q ss_pred ccCCCCceEEEEEEE---cCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEEEecC
Q 042772 313 PLGCGDTGSVHLVEL---QGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHICLITDFC 388 (489)
Q Consensus 313 ~LG~G~fG~Vy~a~~---~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lVmEy~ 388 (489)
.+|+|+||.|+++.- ...|+.||+|+..+.....+... ....|..++...+ ||++++++.+|+.+..++++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 379999999998763 35678999999987655444433 5667889999887 999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----C---
Q 042772 389 PGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS-----C--- 460 (489)
Q Consensus 389 ~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~-----~--- 460 (489)
.||+|...+..... +.+.....+.+.++.+++++|+.+|+|||+|++||+++.+|++++.|||+++..- |
T Consensus 80 rgg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cgt~ 157 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACGTY 157 (612)
T ss_pred ccchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhcccch
Confidence 99999999987644 7889999999999999999999999999999999999999999999999996432 1
Q ss_pred ---CCc----eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ---KPQ----VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---~~~----~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.|+ .....|-|++|..+.++++|..||.
T Consensus 158 eymApEI~~gh~~a~D~ws~gvl~felltg~~pf~ 192 (612)
T KOG0603|consen 158 EYRAPEIINGHLSAADWWSFGVLAFELLTGTLPFG 192 (612)
T ss_pred hhhhhHhhhccCCcccchhhhhhHHHHhhCCCCCc
Confidence 111 2234577999999999999999986
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.7e-15 Score=172.41 Aligned_cols=123 Identities=13% Similarity=0.151 Sum_probs=93.5
Q ss_pred CC-CCcceeeEEE-------EeCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 042772 364 DH-PFLPTLYASF-------QTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLK 435 (489)
Q Consensus 364 ~H-pnIv~l~~~~-------~~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLK 435 (489)
.| +||..++++| .....++.+|||+ +++|.++|... ...+++..+..++.||+.||.|||++||+|||||
T Consensus 30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 45 5777777777 2234578888988 67999999754 3458999999999999999999999999999999
Q ss_pred CCCEEEec-------------------CCcEEEEecCCccccC-------------------------------CCCce-
Q 042772 436 PENILLQK-------------------DGHVVLTDFDLSFMTS-------------------------------CKPQV- 464 (489)
Q Consensus 436 P~NILld~-------------------~g~vKL~DFGlS~~~~-------------------------------~~~~~- 464 (489)
|+||||+. ++.+|++|||+++... .+|+.
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 99999954 4556777777775311 11221
Q ss_pred -----eecccccchHHHHHHHHhCCcccC
Q 042772 465 -----FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 465 -----~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
....|+|++|++++|+++|..|+.
T Consensus 188 ~~~~~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 188 NGSSSNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred ccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence 123488999999999998877753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.8e-14 Score=149.81 Aligned_cols=148 Identities=22% Similarity=0.240 Sum_probs=100.2
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccch---------------------------HHHH-------
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNR---------------------------NKVH------- 351 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~---------------------------~~~~------- 351 (489)
..|. .++||+|++|+||+|..+ +|+.||||+..+.....- ..++
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~ 195 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLR 195 (437)
T ss_pred hhCC-CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHH
Confidence 3444 378999999999999986 589999999876421100 0000
Q ss_pred ---HHHHHHHHHHhC----C-CCCcceeeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHH-HHH
Q 042772 352 ---RACIEREIMSLL----D-HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVI-GLE 422 (489)
Q Consensus 352 ---~~~~E~~il~~l----~-HpnIv~l~~~~~~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~-aL~ 422 (489)
.+.+|...+.++ . +++|.-..-++...+..+|||||++|++|.++....... .+ ...++.+++. .+.
T Consensus 196 ~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~~---~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 196 RELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG-LD---RKALAENLARSFLN 271 (437)
T ss_pred HHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC-CC---HHHHHHHHHHHHHH
Confidence 133455544444 2 344332222223344579999999999998876542211 22 2334555555 477
Q ss_pred HHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 423 yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
.+|..|++|+|+||.||+++.+|.++++|||++...+
T Consensus 272 ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 272 QVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8999999999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK13557 histidine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=9.3e-14 Score=149.57 Aligned_cols=126 Identities=42% Similarity=0.777 Sum_probs=113.7
Q ss_pred hhhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHH
Q 042772 66 GIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLAL 145 (489)
Q Consensus 66 ~~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (489)
...+..+++.+.++|+++|+..++++|+|+|++|++++||+++|++|+++.++..+.
T Consensus 29 ~~~~~~~~~~~~~~i~v~d~~~~~g~i~~~N~a~~~~~G~~~~e~~g~~~~~l~~~~----------------------- 85 (540)
T PRK13557 29 SDIFFAAVETTRMPMIVTDPNQPDNPIVFANRAFLEMTGYAAEEIIGNNCRFLQGPE----------------------- 85 (540)
T ss_pred hHHHHHHHHhCcCcEEEEcCCCCCCCEEEEcHHHHHHhCCCHHHhcCCChHhhcCCC-----------------------
Confidence 445789999999999999987679999999999999999999999999998887664
Q ss_pred hhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCc
Q 042772 146 WKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSD 225 (489)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te 225 (489)
.+......++..+..++.+..++.+++|+|+.+|...++.|++|.+|.+++++++.+|+|+
T Consensus 86 -------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G~~~~~~~~~~~i~~~~g~~~~~~~~~~dit~ 146 (540)
T PRK13557 86 -------------------TDRATVAEVRDAIAERREIATEILNYRKDGSSFWNALFVSPVYNDAGDLVYFFGSQLDVSR 146 (540)
T ss_pred -------------------CCHHHHHHHHHHHHcCCCceEEEEEEeCCCCEEEEEEEEEEeECCCCCEEEEEEEecChHH
Confidence 5677778889999999999999999999999999999999999999999999999999999
Q ss_pred cccccccc
Q 042772 226 HVEPLRNR 233 (489)
Q Consensus 226 ~ke~e~~~ 233 (489)
+++.+++.
T Consensus 147 ~~~~e~~l 154 (540)
T PRK13557 147 RRDAEDAL 154 (540)
T ss_pred HHHHHHHH
Confidence 98776543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.2e-14 Score=156.88 Aligned_cols=148 Identities=17% Similarity=0.244 Sum_probs=96.9
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccc---------------------------h----HHHHH
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN---------------------------R----NKVHR 352 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~---------------------------~----~~~~~ 352 (489)
-...|.. ++||+|++|+||+|..+.+|+.||+|++.+..... . ...+.
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456777 89999999999999999889999999997652110 0 01111
Q ss_pred ------HHHHHHHHHhC----CCCCcceeeEEE-EeCCeEEEEEecCCCCCHHHH--HhhCCC--CCCCHHHHHHHHHHH
Q 042772 353 ------ACIEREIMSLL----DHPFLPTLYASF-QTSTHICLITDFCPGGELFAL--LDKQPM--KIFREDSARFYAAEV 417 (489)
Q Consensus 353 ------~~~E~~il~~l----~HpnIv~l~~~~-~~~~~~~lVmEy~~ggsL~~~--L~~~~~--~~l~e~~~~~i~~qI 417 (489)
+.+|...+.++ .+.+.+.+-..+ ...+..+|||||+.|+++.++ +...+. ..+.+..+..++.|
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q- 275 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ- 275 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-
Confidence 22333333333 233222222222 234567899999999999874 332211 01333333334444
Q ss_pred HHHHHHHHHCCCeecCCCCCCEEEecCC----cEEEEecCCccccC
Q 042772 418 VIGLEYLHCLGIIYRDLKPENILLQKDG----HVVLTDFDLSFMTS 459 (489)
Q Consensus 418 ~~aL~yLH~~gIvHrDLKP~NILld~~g----~vKL~DFGlS~~~~ 459 (489)
++..|++|+|+||.||+++.+| .++++|||++...+
T Consensus 276 ------if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 ------VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 4469999999999999999888 99999999986554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1e-14 Score=160.00 Aligned_cols=177 Identities=25% Similarity=0.362 Sum_probs=130.9
Q ss_pred ccccccCCCCceEEEEEEEcCCCcEEEEEEeec---ccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 309 KPIKPLGCGDTGSVHLVELQGAGELYAMKAMEK---SVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 309 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~---~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
.....+|.|++|.|+.+........++.|.... ...........+..|.-+-..+.|||++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 466789999999888888776666666665431 11122223333555666677889999887776666555455559
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK---- 461 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~---- 461 (489)
|||++ +|+.++... ..+....+..++.|++.||.|||.+||.||||||+|+++..+|.+||+|||.+.....+
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 99999 999999875 23788889999999999999999999999999999999999999999999998532211
Q ss_pred ---------------Ccee-------ecccccchHHHHHHHHhCCcccC
Q 042772 462 ---------------PQVF-------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ---------------~~~~-------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+.. ...++|+.|.+...|.+|..||-
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk 526 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWK 526 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccc
Confidence 1111 12266777777777777777774
|
|
| >PRK13559 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.1e-13 Score=138.27 Aligned_cols=125 Identities=42% Similarity=0.757 Sum_probs=110.7
Q ss_pred hhhhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHH
Q 042772 65 QGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLA 144 (489)
Q Consensus 65 ~~~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (489)
.+..+..+++.++++++++|+.-++++|+++|++|++++||+.+|++|+++.++..+.
T Consensus 41 ~~~~~~~~~e~~~~~i~i~D~~~~~g~i~~~N~a~~~l~G~~~~e~iG~~~~~l~~~~---------------------- 98 (361)
T PRK13559 41 SGRLFEQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFLQGAA---------------------- 98 (361)
T ss_pred hhhHHHHHHHhCCCcEEEecCCCCCCcEEEEchHHHHHhCCCHHHHcCCChhhhcCCC----------------------
Confidence 3455778899999999999986667889999999999999999999999988776543
Q ss_pred HhhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCC
Q 042772 145 LWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGS 224 (489)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~T 224 (489)
........+++++..+..+..+...+++||+.+|+.+++.|++|.+|.+.+++++.+|||
T Consensus 99 --------------------~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~i~d~~G~~~~~v~~~~DIT 158 (361)
T PRK13559 99 --------------------TDPIAVAKIRAAIAAEREIVVELLNYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQWDVT 158 (361)
T ss_pred --------------------CCHHHHHHHHHHhccCCceEEEEEEEcCCCCEEEEEEEEEEEEcCCCCEEEeeeeeeehh
Confidence 456667778889999999999999999999999999999999999999999999999999
Q ss_pred ccccccc
Q 042772 225 DHVEPLR 231 (489)
Q Consensus 225 e~ke~e~ 231 (489)
++++.++
T Consensus 159 erk~~e~ 165 (361)
T PRK13559 159 DIRAVRA 165 (361)
T ss_pred cchhhHH
Confidence 9987653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.4e-13 Score=137.54 Aligned_cols=181 Identities=19% Similarity=0.242 Sum_probs=117.3
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC----------CCcceeeEEEE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDH----------PFLPTLYASFQ 376 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H----------pnIv~l~~~~~ 376 (489)
.+...+.||.|+++.||.+++..|++.+|+|+............+.+.+|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 35677899999999999999999999999999865543444556677666655444322 12332223221
Q ss_pred ---------eC---C-----eEEEEEecCCCCCHHHHHhh---CCCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 042772 377 ---------TS---T-----HICLITDFCPGGELFALLDK---QPMK--IFREDSARFYAAEVVIGLEYLHCLGIIYRDL 434 (489)
Q Consensus 377 ---------~~---~-----~~~lVmEy~~ggsL~~~L~~---~~~~--~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDL 434 (489)
.. + ..+++|+-+ .++|.+++.. .... .+.......+..|++..+++||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 1 247788877 5699888653 1111 1112223445589999999999999999999
Q ss_pred CCCCEEEecCCcEEEEecCCccccC------------CCCc--------------eeecccccchHHHHHHHHhCCcccC
Q 042772 435 KPENILLQKDGHVVLTDFDLSFMTS------------CKPQ--------------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 435 KP~NILld~~g~vKL~DFGlS~~~~------------~~~~--------------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
||+|+|++.+|.++|+||+...... .+|+ .....|.|.+|.+++.|.||.+||+
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~ 251 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFG 251 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STC
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCC
Confidence 9999999999999999998653211 1111 1122288999999999999999996
|
|
| >PF08448 PAS_4: PAS fold; InterPro: IPR013656 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.6e-13 Score=114.03 Aligned_cols=110 Identities=22% Similarity=0.332 Sum_probs=95.9
Q ss_pred HHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhcccc
Q 042772 73 LERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGV 152 (489)
Q Consensus 73 ~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (489)
||++++++++.|+ ++.|+++|+++.++.|++.++++|+++.-+..++
T Consensus 1 l~~~p~~i~v~D~---~~~i~~~N~~~~~~~~~~~~~~~G~~~~~~~~~~------------------------------ 47 (110)
T PF08448_consen 1 LDSSPDGIFVIDP---DGRIVYANQAAAELFGVSPEELIGRSLFDLLPPE------------------------------ 47 (110)
T ss_dssp HHHCSSEEEEEET---TSBEEEE-HHHHHHHTSTHHHHTTSBHHHHSCCG------------------------------
T ss_pred CCCCCceeEEECC---CCEEEEEHHHHHHHhCCCHHHHhhccchhccccc------------------------------
Confidence 6889999999999 9999999999999999999999999987554442
Q ss_pred cccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCcccc
Q 042772 153 YNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVE 228 (489)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~ke 228 (489)
..+.....+.+++..+.....+..... +|...|..++++|++|.+|++.+++.+.+|||++++
T Consensus 48 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~Pi~~~~g~~~g~~~~~~DiT~~rr 110 (110)
T PF08448_consen 48 ------------DREEFQAALRRALAGGEPVFFEEILLR-DGEERWFEVSISPIFDEDGEVVGVLVIIRDITERRR 110 (110)
T ss_dssp ------------CHHHHHHHHHHHHHHTSEEEEEEEECT-TSCEEEEEEEEEEEECTTTCEEEEEEEEEEECCHHH
T ss_pred ------------hhhhhHHHHHHhhccCceEEEEEEEee-cCCcEEEEEEEEEeEcCCCCEEEEEEEEEECchhhC
Confidence 455667788899998888877766655 999999999999999999999999999999999874
|
The PAS fold appears in archaea, eubacteria and eukarya. ; PDB: 3K3D_A 3K3C_B 3KX0_X 3FC7_B 3LUQ_D 3MXQ_A 3BWL_C 3FG8_A. |
| >PF00989 PAS: PAS fold; InterPro: IPR013767 PAS domains are involved in many signalling proteins where they are used as a signal sensor domain [] | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.9e-13 Score=112.96 Aligned_cols=111 Identities=21% Similarity=0.355 Sum_probs=93.0
Q ss_pred hHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhh
Q 042772 68 DLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWK 147 (489)
Q Consensus 68 ~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (489)
.+.++++.+++++++.|. +|.|+|+|++|++++||+++|++|+++..+..+.
T Consensus 2 ~~~~i~~~~~~~i~~~d~---~g~I~~~N~a~~~l~g~~~~~~~g~~~~~~~~~~------------------------- 53 (113)
T PF00989_consen 2 RYRAILENSPDGIFVIDE---DGRILYVNQAAEELLGYSREELIGKSLFDLIHPE------------------------- 53 (113)
T ss_dssp HHHHHHHCSSSEEEEEET---TSBEEEECHHHHHHHSS-HHHHTTSBGGGGCSGG-------------------------
T ss_pred HHHHHHhcCCceEEEEeC---cCeEEEECHHHHHHHccCHHHHcCCcHHHhcCch-------------------------
Confidence 367899999999999998 9999999999999999999999999987665443
Q ss_pred hcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeee-cCCCeeeEEEeecccccCCCCeeEEeeeeccC
Q 042772 148 KNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYT-KSGKKFWNLFHLQPMRDHKGELQYFIGVQLDG 223 (489)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~ 223 (489)
......+.+.+.+..++.....-.... ++|+.+|+.++.+|++|..|++.+++++.+||
T Consensus 54 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~DI 113 (113)
T PF00989_consen 54 -----------------DRRELRERLRQALSQGESGESFEVRFRLRDGRPRWVEVRASPVRDEDGQIIGILVIFRDI 113 (113)
T ss_dssp -----------------GHHHHHHHHHHHHHHCCHECEEEEEEEETTSCEEEEEEEEEEEEETTEEEEEEEEEEEE-
T ss_pred -----------------hhHHHHHHHHHHHHcCCCceeEEEEEEecCCcEEEEEEEEEEEEeCCCCEEEEEEEEEeC
Confidence 233577788888888877655444444 59999999999999999999999999999997
|
PAS domains appear in archaea, bacteria and eukaryotes. Several PAS-domain proteins are known to detect their signal by way of an associated cofactor. Haeme, flavin, and a 4-hydroxycinnamyl chromophore are used in different proteins. The PAS domain was named after three proteins that it occurs in: Per- period circadian protein Arnt- Ah receptor nuclear translocator protein Sim- single-minded protein. PAS domains are often associated with PAC domains IPR001610 from INTERPRO. It appears that these domains are directly linked, and that together they form the conserved 3D PAS fold. The division between the PAS and PAC domains is caused by major differences in sequences in the region connecting these two motifs []. In human PAS kinase, this region has been shown to be very flexible, and adopts different conformations depending on the bound ligand []. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels [].; GO: 0006355 regulation of transcription, DNA-dependent; PDB: 2GJ3_A 4F3L_B 1XFN_A 1OTD_A 2PYR_A 1KOU_A 1XFQ_A 2ZOI_A 2ZOH_A 1OTA_A .... |
| >KOG0501 consensus K+-channel KCNQ [Inorganic ion transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.8e-13 Score=141.20 Aligned_cols=124 Identities=27% Similarity=0.615 Sum_probs=109.5
Q ss_pred HHHHHHhc---cCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHH
Q 042772 69 LATTLERI---EKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLAL 145 (489)
Q Consensus 69 ~~~~~~~~---~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (489)
|+.++.+. ..+|++.++.+-|-||+|+|++|+++.||.|.|++.+.| +|.||
T Consensus 16 LENiiRRsn~~dtsFlL~NAQiVD~PiVY~NdgFcKlsGY~RAevMQKs~-------------------tc~FM------ 70 (971)
T KOG0501|consen 16 LENIIRRSNNADTSFLLANAQIVDWPIVYCNDGFCKLSGYHRAEVMQKSC-------------------TCSFM------ 70 (971)
T ss_pred HHHHHhhccCCCcceeeccceeeccceEEecCcchhccCccHHHHhcccc-------------------eeeee------
Confidence 44444444 368999999999999999999999999999999999985 24444
Q ss_pred hhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCc
Q 042772 146 WKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSD 225 (489)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te 225 (489)
||| -+|..+++++++++.+.+.-++|+..|+|+-+|.|..+.+.|++|++..++-|+..++|||.
T Consensus 71 ----yGE-----------ltdk~ti~k~~~t~eN~~~~qfEillyKKN~TPvW~~vqiAPIrNe~d~VVLfLctFkDIT~ 135 (971)
T KOG0501|consen 71 ----YGE-----------LTDKGTIEKVRQTLENYETNQFEILLYKKNRTPVWLLVQIAPIRNEKDKVVLFLCTFKDITA 135 (971)
T ss_pred ----ecc-----------ccchhhHHHHHHHHHhhhhcceeeEeeecCCCceEEEEEeecccCCCceEEEEEeecccchh
Confidence 444 48999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccc
Q 042772 226 HVEPLRN 232 (489)
Q Consensus 226 ~ke~e~~ 232 (489)
.|++...
T Consensus 136 ~KQPidd 142 (971)
T KOG0501|consen 136 LKQPIDD 142 (971)
T ss_pred hcCCCcc
Confidence 9987743
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.9e-13 Score=138.33 Aligned_cols=89 Identities=26% Similarity=0.383 Sum_probs=75.7
Q ss_pred CCCCcceeeEEEEe---------------------------CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHH
Q 042772 364 DHPFLPTLYASFQT---------------------------STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAE 416 (489)
Q Consensus 364 ~HpnIv~l~~~~~~---------------------------~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~q 416 (489)
+|||||.+.++|.+ ...+|+||.-++ .+|.+++..+. .+......++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHH
Confidence 69999999998843 235899999885 49999998753 578888899999
Q ss_pred HHHHHHHHHHCCCeecCCCCCCEEEe--cCC--cEEEEecCCcc
Q 042772 417 VVIGLEYLHCLGIIYRDLKPENILLQ--KDG--HVVLTDFDLSF 456 (489)
Q Consensus 417 I~~aL~yLH~~gIvHrDLKP~NILld--~~g--~vKL~DFGlS~ 456 (489)
+++|+.|||++||.|||||.+|||+. +++ .+.|+|||++-
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 99999999999999999999999993 444 57899999874
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.4e-12 Score=116.88 Aligned_cols=128 Identities=29% Similarity=0.302 Sum_probs=95.1
Q ss_pred ccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC-cceeeEEEEeCCeEEEEEecCC
Q 042772 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF-LPTLYASFQTSTHICLITDFCP 389 (489)
Q Consensus 311 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~lVmEy~~ 389 (489)
++.|+.|.++.||++... +..|++|....... ....+..|..+++.+.+.+ +++++.+.. ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999999865 77899998754421 1123456888888876544 445555432 33589999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-----eecCCCCCCEEEecCCcEEEEecCCccc
Q 042772 390 GGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGI-----IYRDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 390 ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gI-----vHrDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
|.++.+. . . .....+.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 75 G~~l~~~--~-----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE--D-----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc--c-----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9887543 0 1 112356789999999999885 9999999999999 67899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.4e-11 Score=113.02 Aligned_cols=141 Identities=16% Similarity=0.120 Sum_probs=101.7
Q ss_pred ccccCCCCceEEEEEEEcC------CCcEEEEEEeecccccc-------------------hHHHHH----HHHHHHHHH
Q 042772 311 IKPLGCGDTGSVHLVELQG------AGELYAMKAMEKSVMLN-------------------RNKVHR----ACIEREIMS 361 (489)
Q Consensus 311 ~~~LG~G~fG~Vy~a~~~~------tg~~vAiK~i~~~~~~~-------------------~~~~~~----~~~E~~il~ 361 (489)
...||.|--+.||.|.... .+..+|+|+...+.... .+..+. ...|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998553 35789999885432110 011222 337888888
Q ss_pred hCC--CCCcceeeEEEEeCCeEEEEEecCCCCCHHH-HHhhCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeecCCCCC
Q 042772 362 LLD--HPFLPTLYASFQTSTHICLITDFCPGGELFA-LLDKQPMKIFREDSARFYAAEVVIGLEYL-HCLGIIYRDLKPE 437 (489)
Q Consensus 362 ~l~--HpnIv~l~~~~~~~~~~~lVmEy~~ggsL~~-~L~~~~~~~l~e~~~~~i~~qI~~aL~yL-H~~gIvHrDLKP~ 437 (489)
++. .-+++.++++ ...+|||||+.+..+.. .++. ..+++.....+..+++.+|..| |+.||+|+||+|.
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 885 3567777764 45789999996654432 2322 2255566777788999999998 8999999999999
Q ss_pred CEEEecCCcEEEEecCCccccC
Q 042772 438 NILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 438 NILld~~g~vKL~DFGlS~~~~ 459 (489)
||+++ ++.+.|+|||.|....
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCC
Confidence 99997 5789999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK11091 aerobic respiration control sensor protein ArcB; Provisional | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.1e-11 Score=137.15 Aligned_cols=122 Identities=13% Similarity=0.081 Sum_probs=105.5
Q ss_pred hhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHh
Q 042772 67 IDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALW 146 (489)
Q Consensus 67 ~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (489)
..+..+++.+++++++.|+ +|.|+++|++|++++||+++|++|+++..+..++
T Consensus 155 ~~l~~il~~~~~~i~~~D~---~g~i~~~N~a~~~l~G~~~~eliG~~~~~l~~~~------------------------ 207 (779)
T PRK11091 155 SLLRSFLDASPDLVYYRNE---DGEFSGCNRAMELLTGKSEKQLIGLTPKDVYSPE------------------------ 207 (779)
T ss_pred HHHHHHHhcCcceEEEECC---CCcEEeEcHHHHHHhCcCHHHHcCCChHHhCCHH------------------------
Confidence 4478899999999999999 9999999999999999999999999976555443
Q ss_pred hhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCcc
Q 042772 147 KKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDH 226 (489)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~ 226 (489)
............+..+..++.+....+++|+.+|..++..|++|.+|...+++++.+|||++
T Consensus 208 ------------------~~~~~~~~~~~~~~~~~~~~~e~~~~~~~G~~~~~~~~~~pi~~~~g~~~g~v~~~~DITe~ 269 (779)
T PRK11091 208 ------------------AAEKVIETDEKVFRHNVSLTYEQWLDYPDGRKACFELRKVPFYDRVGKRHGLMGFGRDITER 269 (779)
T ss_pred ------------------HHHHHHHHHHHHHhcCCCeEEEEEEEcCCCCEEEEEEEeeeEEcCCCCEEEEEEEEeehhHH
Confidence 23334455666777888899999999999999999999999999999999999999999999
Q ss_pred ccccccc
Q 042772 227 VEPLRNR 233 (489)
Q Consensus 227 ke~e~~~ 233 (489)
++++++.
T Consensus 270 k~~e~~l 276 (779)
T PRK11091 270 KRYQDAL 276 (779)
T ss_pred HHHHHHH
Confidence 9877553
|
|
| >TIGR02040 PpsR-CrtJ transcriptional regulator PpsR | Back alignment and domain information |
|---|
Probab=99.26 E-value=3e-11 Score=128.44 Aligned_cols=128 Identities=17% Similarity=0.077 Sum_probs=93.1
Q ss_pred hHHHHHHHHHhhh-hHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCC-hhhhcCCCccccccccchhhhhhccc
Q 042772 55 DRAERERDIRQGI-DLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYT-REEILGRNCSFLELTEYTREEILGRN 132 (489)
Q Consensus 55 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~-~~e~~g~~~~~l~~~~~~~~~~~~~~ 132 (489)
|++++.+.+++.. .+..+++.++++|+++|+ +|.|+++|++|++++||+ .++++|+++..+..+.
T Consensus 239 dit~~~~~e~~~~~~~~~l~e~~~d~I~v~D~---~G~I~~~N~a~~~l~G~~~~~~l~G~~~~~~~~~~---------- 305 (442)
T TIGR02040 239 PAGATQPVGDELSENLARLYHEAPDAIVFSDA---DGTIRGANEAFLELTDSSSLEAVRGRTLDRWLGRG---------- 305 (442)
T ss_pred ccchhhhhhHHHHHHHHHHHHhCCceEEEEcC---CCcEEehhHHHHHHhCCCChHHHcCCCHHHHhCCC----------
Confidence 3455544443333 588999999999999999 999999999999999997 5789999975332221
Q ss_pred cccchhHHHHHHHhhhcccccccccCcccccCCCHHHHHHHHHHHHcCCc-EEEEEEeeecCCCeeeEEEeecccccCCC
Q 042772 133 CSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQRE-ITVQLINYTKSGKKFWNLFHLQPMRDHKG 211 (489)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~k~g~~~~~~~~~~p~~~~~g 211 (489)
..+ ...+.+.+...+. ...+....++||+.+|+.++++|+.+..+
T Consensus 306 -------------------------------~~~---~~~~~~~~~~~g~~~~~~~~~~~~~G~~~~ve~s~~~i~~~~~ 351 (442)
T TIGR02040 306 -------------------------------GVD---LRVLLSNVRRTGQVRLYATTLTGEFGAQTEVEISAAWVDQGER 351 (442)
T ss_pred -------------------------------ccc---HHHHHHHHhhcCceEEEEEEEEcCCCCEEEEEEEEEEeccCCc
Confidence 011 2223333433333 33444557999999999999999987654
Q ss_pred CeeEEeeeeccCCccccccc
Q 042772 212 ELQYFIGVQLDGSDHVEPLR 231 (489)
Q Consensus 212 ~~~~~~~~~~d~Te~ke~e~ 231 (489)
..++++.+|||++++++.
T Consensus 352 --~~~~~v~rDITeR~~~~~ 369 (442)
T TIGR02040 352 --PLIVLVIRDISRRLTMRD 369 (442)
T ss_pred --eEEEEEEecchhhccCCC
Confidence 568899999999998753
|
This model represents the transcriptional regulator PpsR which is strictly associated with photosynthetic proteobacteria and found in photosynthetic operons. PpsR has been reported to be a repressor. These proteins contain a Helix-Turn_Helix motif of the "fis" type (pfam02954). |
| >PRK13558 bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Probab=99.25 E-value=4e-11 Score=133.91 Aligned_cols=125 Identities=33% Similarity=0.684 Sum_probs=110.6
Q ss_pred HHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhh
Q 042772 69 LATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKK 148 (489)
Q Consensus 69 ~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (489)
+..+++..+.++++.|...+++.|+|+|++|++++||+++|++|+++.++..+.
T Consensus 150 ~~~~~~~~~~gi~~~d~~~~dg~i~~~N~~~~~l~G~~~eel~g~~~~~l~~~~-------------------------- 203 (665)
T PRK13558 150 KERALDEAPVGITIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGED-------------------------- 203 (665)
T ss_pred HHHHHhcCCccEEEEcCCCCCCcEEEEcHHHHHHhCcCHHHHcCCCHHHhcCCC--------------------------
Confidence 467889999999999876678999999999999999999999999987776553
Q ss_pred cccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCcccc
Q 042772 149 NYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVE 228 (489)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~ke 228 (489)
........++.++..++.+..++..++++|..+|+.++..|++|..|.+.+++++.+|||++|+
T Consensus 204 ----------------~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~pi~d~~G~~~~~vgi~~DITerk~ 267 (665)
T PRK13558 204 ----------------TNEERVAELREAIDEERPTSVELRNYRKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTERKE 267 (665)
T ss_pred ----------------ccHHHHHHHHHHHhcCCCeEEEEEEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEeCcHHHH
Confidence 4555667788888889999999999999999999999999999999999999999999999998
Q ss_pred ccccccc
Q 042772 229 PLRNRLS 235 (489)
Q Consensus 229 ~e~~~l~ 235 (489)
.+++...
T Consensus 268 ~E~~L~~ 274 (665)
T PRK13558 268 AELALQR 274 (665)
T ss_pred HHHHHHH
Confidence 8766543
|
|
| >PRK13560 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.1e-11 Score=135.45 Aligned_cols=135 Identities=17% Similarity=0.106 Sum_probs=108.6
Q ss_pred hhHHHHHHHHHhh----hhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhh
Q 042772 54 WDRAERERDIRQG----IDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEIL 129 (489)
Q Consensus 54 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~ 129 (489)
.|+++|++.+++. ..+..+++.+++++++.|+ ++.|+++|++|++++||+++|++|++...+..+.
T Consensus 187 ~DIT~rk~ae~~l~~~~~~l~~l~e~~~~~i~~~d~---~g~i~~~N~~~~~~~G~~~~e~~g~~~~~~~~~~------- 256 (807)
T PRK13560 187 EDITERKRAEERIDEALHFLQQLLDNIADPAFWKDE---DAKVFGCNDAACLACGFRREEIIGMSIHDFAPAQ------- 256 (807)
T ss_pred EccchHHHHHHHHHHHHHHHHHHHhhCCCeEEEEcC---CCCEEEEhHHHHHHhCCCHHHHcCCcchhcCCcc-------
Confidence 4888888766643 4478899999999999999 9999999999999999999999999987665432
Q ss_pred ccccccchhHHHHHHHhhhcccccccccCcccccCCCHHHH-HHHHHHHHcCCcEEEEEEeeecCCCeeeEEEee--ccc
Q 042772 130 GRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATV-SKIRDAVREQREITVQLINYTKSGKKFWNLFHL--QPM 206 (489)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~--~p~ 206 (489)
....+ ...+..+..++....+....++||+.+|+.+.+ .|+
T Consensus 257 ------------------------------------~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~~~~ 300 (807)
T PRK13560 257 ------------------------------------PADDYQEADAAKFDADGSQIIEAEFQNKDGRTRPVDVIFNHAEF 300 (807)
T ss_pred ------------------------------------hhHHHHHHHHHHhccCCceEEEEEEEcCCCCEEEEEEEecceEE
Confidence 22222 334455566777788888899999999766554 567
Q ss_pred ccCCCCeeEEeeeeccCCcccccccccc
Q 042772 207 RDHKGELQYFIGVQLDGSDHVEPLRNRL 234 (489)
Q Consensus 207 ~~~~g~~~~~~~~~~d~Te~ke~e~~~l 234 (489)
.|..|.+++++++.+|||++++++++..
T Consensus 301 ~~~~g~~~g~~~~~~DITerk~~e~~L~ 328 (807)
T PRK13560 301 DDKENHCAGLVGAITDISGRRAAERELL 328 (807)
T ss_pred EcCCCCEEEEEEEEEechHHHHHHHHHH
Confidence 8999999999999999999998876653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.6e-12 Score=141.20 Aligned_cols=109 Identities=39% Similarity=0.667 Sum_probs=83.5
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
.+|..++.|..|+||.||++.++.+.+++|+| +++....-++ ++.....|++|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn----------ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN----------ILTFAGNPFVV---------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc----------cccccCCccee----------------
Confidence 46999999999999999999999999999995 4443221111 33333455554
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
|+-..+++.-+ +++-+ ++.+++|+|+.||+|||+||+|.+|..-|++|++|||++.
T Consensus 136 -----gDc~tllk~~g--~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk 191 (1205)
T KOG0606|consen 136 -----GDCATLLKNIG--PLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSK 191 (1205)
T ss_pred -----chhhhhcccCC--CCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhh
Confidence 56666665532 23322 3788999999999999999999999999999999999985
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.2e-10 Score=106.52 Aligned_cols=136 Identities=19% Similarity=0.193 Sum_probs=102.6
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchH-----HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRN-----KVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
..+++|+-+.+|.+.+. |..+++|.-.+..+..+. ...+..+|..++.++.--.|...+-++.+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 45789999999999775 444666755443332222 34567789999998876666666556667777899999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
|++|-.|.+.+... . ..++..+-.-+.-||..||+|+||.++||++..++ +.++|||++....
T Consensus 80 ~I~G~~lkd~l~~~-----~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 80 YIEGELLKDALEEA-----R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred EeCChhHHHHHHhc-----c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 99998888888764 1 33556677778889999999999999999997554 9999999997554
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=6.7e-12 Score=121.76 Aligned_cols=183 Identities=17% Similarity=0.280 Sum_probs=144.8
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
++.....++..|.....|..|+|++.++ .++.|+++...... .....|..|.-.|+.+.||||+.+++.|....++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 4456677888999999999999999854 45667776544332 23355777888899999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEecCCcEEE--EecCCcccc
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLG--IIYRDLKPENILLQKDGHVVL--TDFDLSFMT 458 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~g--IvHrDLKP~NILld~~g~vKL--~DFGlS~~~ 458 (489)
++..|++.|+|+..|+.+.+-..+..++..++.++++|+.|||+.. |..--|....+++|++.+.+| +|--+|+..
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe 343 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE 343 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec
Confidence 9999999999999999987777889999999999999999999875 445568899999999886654 554444321
Q ss_pred C-----------------CCCceeecccccchHHHHHHHHhCCcccC
Q 042772 459 S-----------------CKPQVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~-----------------~~~~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. .....+..++.|++...++|+.+..+||.
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfa 390 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFA 390 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccc
Confidence 1 01112345688999999999999999984
|
|
| >TIGR02938 nifL_nitrog nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.5e-11 Score=127.45 Aligned_cols=121 Identities=25% Similarity=0.389 Sum_probs=106.4
Q ss_pred hHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhh
Q 042772 68 DLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWK 147 (489)
Q Consensus 68 ~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (489)
.+..+++.++.++++.|. ++.|+|+|++|++++||+++|++|++...+..+.
T Consensus 5 ~~~~i~~~~~~~i~~~d~---~g~~~~~N~~~~~~~G~~~~~~~g~~~~~~~~~~------------------------- 56 (494)
T TIGR02938 5 AYRQTVDQAPLAISITDL---KANILYANDAFTRITGYTKEEIIGKNESVLSNHT------------------------- 56 (494)
T ss_pred HHHHHHHhCCceEEEECC---CCcEEEEchhheeecCCCHHHHhCCCchhhcCCC-------------------------
Confidence 467899999999999999 9999999999999999999999999977665443
Q ss_pred hcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCccc
Q 042772 148 KNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHV 227 (489)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~k 227 (489)
........+++++..++.+..++...+++|+.+|....+.|++|.+|.+.+++++.+|||+++
T Consensus 57 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIt~~k 119 (494)
T TIGR02938 57 -----------------TPPEVYQALWGSLAEQKPWAGKLLNRRKDGELYLAELTVAPVLNEAGETTHFLGMHRDITELH 119 (494)
T ss_pred -----------------CCHHHHHHHHHHHHhCCcccceeeccCCCccchhhheeeEEEECCCCCEEEEEEehhhhhHHH
Confidence 445566777888888889989988899999999999999999999999999999999999998
Q ss_pred cccccc
Q 042772 228 EPLRNR 233 (489)
Q Consensus 228 e~e~~~ 233 (489)
+++++.
T Consensus 120 ~~e~~l 125 (494)
T TIGR02938 120 RLEQVV 125 (494)
T ss_pred HHHHHH
Confidence 766543
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes. |
| >PRK10060 RNase II stability modulator; Provisional | Back alignment and domain information |
|---|
Probab=99.19 E-value=1e-10 Score=130.74 Aligned_cols=131 Identities=15% Similarity=0.144 Sum_probs=100.9
Q ss_pred HHHHHHHHHh-hhhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCcccc-ccccchhhhhhcccc
Q 042772 56 RAERERDIRQ-GIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFL-ELTEYTREEILGRNC 133 (489)
Q Consensus 56 ~~~~~~~~~~-~~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l-~~~~~~~~~~~~~~~ 133 (489)
.++..++..+ ...+..+++.+.++|+++|. +|.|+++|++|+++|||+.+|++|+++..+ ..+.
T Consensus 99 ~~~~~~~~~~~~~~~~~v~~~~~~gI~i~D~---~g~I~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~~----------- 164 (663)
T PRK10060 99 TPSVARDLSHGLSFAEQVVSEANSVIVILDS---RGNIQRFNRLCEEYTGLKEHDVIGQSVFKLFMSRR----------- 164 (663)
T ss_pred HHHHHHHHHHHHHHHHHHHhhCCceEEEEeC---CCCEEEEcHHHHHHHCcCHHHHcCCCHHHHhCChh-----------
Confidence 3344444333 34466789999999999999 999999999999999999999999997433 3332
Q ss_pred ccchhHHHHHHHhhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCC-C
Q 042772 134 STYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKG-E 212 (489)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g-~ 212 (489)
........++..+..+..+.++..+.+|+|+.+|...... +.+..| .
T Consensus 165 -------------------------------~~~~~~~~~~~~~~~~~~~~~e~~~~~~~G~~~~~~~~~~-~~~~~g~~ 212 (663)
T PRK10060 165 -------------------------------EAAASRRNIRGFFRSGNAYEVERWIKTRKGQRLFLFRNKF-VHSGSGKN 212 (663)
T ss_pred -------------------------------hHHHHHHHHHHHHhcCCceEEEEEEEeCCCCEEEEEeeeE-EEcCCCCc
Confidence 2334456677888889999999999999999999876544 444445 4
Q ss_pred eeEEeeeeccCCcccccccc
Q 042772 213 LQYFIGVQLDGSDHVEPLRN 232 (489)
Q Consensus 213 ~~~~~~~~~d~Te~ke~e~~ 232 (489)
..+++++.+|||++++.+++
T Consensus 213 ~~~~i~~~~DITe~k~~e~~ 232 (663)
T PRK10060 213 EIFLICSGTDITEERRAQER 232 (663)
T ss_pred eEEEEEEEEechHHHHHHHH
Confidence 56788999999998876654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=7e-12 Score=139.97 Aligned_cols=142 Identities=20% Similarity=0.257 Sum_probs=116.4
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccc-cchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVM-LNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++...+.||++.|=+|.+|++.. |. |++|++-+... .+-....+...|++ ...++|||.+.+.-+..+....|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 68888999999999999999875 65 88998865431 11112223333444 66678999999988877888899999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCC
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDL 454 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGl 454 (489)
+|+. -+|++.|..++. +..-+...|+.|++.||..+|..||+|+|||.+||||+.=+-+.|+||..
T Consensus 101 qyvk-hnLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAs 166 (1431)
T KOG1240|consen 101 QYVK-HNLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFAS 166 (1431)
T ss_pred HHHh-hhhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccc
Confidence 9995 499999988765 77888889999999999999999999999999999999988899999964
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=7e-11 Score=108.75 Aligned_cols=89 Identities=21% Similarity=0.216 Sum_probs=74.8
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC----------
Q 042772 391 GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC---------- 460 (489)
Q Consensus 391 gsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~---------- 460 (489)
|+|.+++.... ..+++..++.++.|++.||.|||+++ ||+|||++.++.+|+ ||++.....
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~~g~~~y~ 71 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQSRVDPYFM 71 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccccCCCccccc
Confidence 68999998643 45899999999999999999999999 999999999999999 999864321
Q ss_pred CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|.+++|+++|..||.
T Consensus 72 aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~ 105 (176)
T smart00750 72 APEVIQGQSYTEKADIYSLGITLYEALDYELPYN 105 (176)
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 122 1234699999999999999999985
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.6e-10 Score=104.17 Aligned_cols=147 Identities=20% Similarity=0.179 Sum_probs=110.1
Q ss_pred cccccCCCCceEEEEEEEcCCCcEEEEEEeecccccc-----hHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 310 PIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN-----RNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 310 ~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.+..|-+|+-+.|+.+.+. |+.+.||.-....+.. +-..++..+|..+|.++.--.|....-+|.+...-+|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 6778899999999999877 6777777543332222 22356788899999888655665555556677778999
Q ss_pred EecCCC-CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC---cEEEEecCCcccc
Q 042772 385 TDFCPG-GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG---HVVLTDFDLSFMT 458 (489)
Q Consensus 385 mEy~~g-gsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g---~vKL~DFGlS~~~ 458 (489)
|||++| .++.+++...-...........++.++-..+.-||..+|+|+||..+||++..+| .+.++|||+|...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999966 4788888765333333344467788899999999999999999999999997665 3589999998654
|
|
| >PRK11359 cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.1e-10 Score=130.13 Aligned_cols=133 Identities=17% Similarity=0.258 Sum_probs=110.9
Q ss_pred hhHHHHHHHHHhhhhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccc-cccchhhhhhccc
Q 042772 54 WDRAERERDIRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLE-LTEYTREEILGRN 132 (489)
Q Consensus 54 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~-~~~~~~~~~~~~~ 132 (489)
.|++++.+.+++...+..+++.++.+++++|+ ++.|+++|++|++++||+.+|++|+++..+. .+.
T Consensus 123 ~DiT~~~~~~~~~~~~~~~~~~~~~~i~~~d~---~g~i~~~N~~~~~l~G~~~~e~~g~~~~~~~~~~~---------- 189 (799)
T PRK11359 123 RDASVEMAQKEQTRQLIIAVDHLDRPVIVLDP---ERRIVQCNRAFTEMFGYCISEASGMQPDTLLNIPE---------- 189 (799)
T ss_pred eeccchhhhHHHHHHHHHHHhcCCCcEEEEcC---CCcEEEEChhhHhhhCCCHHHHCCCChHHhcCCCC----------
Confidence 46666666666666677789999999999999 9999999999999999999999999976443 222
Q ss_pred cccchhHHHHHHHhhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCC
Q 042772 133 CSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGE 212 (489)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~ 212 (489)
........+...+.....+..+....+++|..+|......|+.|.+|.
T Consensus 190 --------------------------------~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~v~d~~g~ 237 (799)
T PRK11359 190 --------------------------------FPADNRIRLQQLLWKTARDQDEFLLLTRTGEKIWIKASISPVYDVLAH 237 (799)
T ss_pred --------------------------------CcHHHHHHHHHhhccCCCCcceeEEeCCCCCEEEEEeeeeeeecCCCc
Confidence 344455566777777777888888899999999999999999999999
Q ss_pred eeEEeeeeccCCccccccc
Q 042772 213 LQYFIGVQLDGSDHVEPLR 231 (489)
Q Consensus 213 ~~~~~~~~~d~Te~ke~e~ 231 (489)
+.+++++.+|||++++.++
T Consensus 238 ~~~~~~~~~DITerk~~e~ 256 (799)
T PRK11359 238 LQNLVMTFSDITEERQIRQ 256 (799)
T ss_pred eeEEEEEeehhhhHHHHHH
Confidence 9999999999999887653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.5e-10 Score=106.26 Aligned_cols=142 Identities=18% Similarity=0.264 Sum_probs=104.9
Q ss_pred ccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC--CCcceeeEEEEeC---CeEEEEE
Q 042772 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDH--PFLPTLYASFQTS---THICLIT 385 (489)
Q Consensus 311 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~~~~~~~---~~~~lVm 385 (489)
.+.|+.|.++.||++.... |..+++|........ .....+..|.++++.+.+ .++++++.+.... +..++||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 3678999999999998754 678999987654221 123456789999999865 4567777766543 2578999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC--------------------------------------- 426 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~--------------------------------------- 426 (489)
||++|.++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 80 e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 80 ERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99999888765532 125666666677777777777773
Q ss_pred -----------------CCCeecCCCCCCEEEec--CCcEEEEecCCcccc
Q 042772 427 -----------------LGIIYRDLKPENILLQK--DGHVVLTDFDLSFMT 458 (489)
Q Consensus 427 -----------------~gIvHrDLKP~NILld~--~g~vKL~DFGlS~~~ 458 (489)
..++|+|++|.||+++. ++.+.|+||+.+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 23699999999999998 667899999988643
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK09776 putative diguanylate cyclase; Provisional | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.6e-10 Score=132.65 Aligned_cols=138 Identities=19% Similarity=0.195 Sum_probs=107.9
Q ss_pred chhHHHHHHHHHhh----hhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhh
Q 042772 53 SWDRAERERDIRQG----IDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEI 128 (489)
Q Consensus 53 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~ 128 (489)
..|+++|++.+++. ..+..+++.++++++++|. ++.|+++|++|++++||+.+|++|+++..+.....
T Consensus 518 ~~DITerk~~e~~L~~~~~~l~~~l~~~~~~i~~~D~---~g~i~~~N~a~~~l~G~~~~e~iG~~~~~~~~~~~----- 589 (1092)
T PRK09776 518 NMDMTEVRQLNEALFQEKERLHITLDSIGEAVVCTDM---AMKVTFMNPVAEKMTGWTQEEALGVPLLTVLHITF----- 589 (1092)
T ss_pred eeehhHHHHHHHHHHHHHHHHHHHHhccccEEEEECC---CCeEEEEcHHHHHHhCCCHHHHcCCCHHHHccccc-----
Confidence 35788887766543 3477889999999999999 99999999999999999999999998754432110
Q ss_pred hccccccchhHHHHHHHhhhcccccccccCcccccCCCHHHHHHHHHHHHcCCc--EEEEEEeeecCCCeeeEEEeeccc
Q 042772 129 LGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQRE--ITVQLINYTKSGKKFWNLFHLQPM 206 (489)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~k~g~~~~~~~~~~p~ 206 (489)
..+......+.......+. +..+....++||..+|...+++|+
T Consensus 590 -----------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G~~~~~~~~~~pi 634 (1092)
T PRK09776 590 -----------------------------------GDNGPLMENIYSCLTSRSAAYLEQDVVLHCRSGGSYDVHYSITPL 634 (1092)
T ss_pred -----------------------------------CCcchhhHHHHHHHhcCCCccccceEEEEeCCCcEEEEEEEeeee
Confidence 0122222335555555544 556667789999999999999999
Q ss_pred ccCCCCeeEEeeeeccCCccccccccc
Q 042772 207 RDHKGELQYFIGVQLDGSDHVEPLRNR 233 (489)
Q Consensus 207 ~~~~g~~~~~~~~~~d~Te~ke~e~~~ 233 (489)
+|.+|++.+++++.+|||++++.+++.
T Consensus 635 ~~~~g~~~g~v~~~~DITe~k~~e~~L 661 (1092)
T PRK09776 635 STLDGENIGSVLVIQDVTESRKMLRQL 661 (1092)
T ss_pred ecCCCCEEEEEEEEEecchHHHHHHHH
Confidence 999999999999999999999877553
|
|
| >PRK09776 putative diguanylate cyclase; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=5.1e-10 Score=131.36 Aligned_cols=125 Identities=14% Similarity=0.273 Sum_probs=101.1
Q ss_pred hhhhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHH
Q 042772 65 QGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLA 144 (489)
Q Consensus 65 ~~~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (489)
....+..+++.++.+++++|+ +|.|+++|++|++++||+++|++|++...+..++
T Consensus 281 ~e~r~~~l~e~~~~~i~~~d~---dG~i~~~N~~~~~l~G~~~~el~g~~~~~~~~~~---------------------- 335 (1092)
T PRK09776 281 SETRFRNAMEYSAIGMALVGT---EGQWLQVNKALCQFLGYSQEELRGLTFQQLTWPE---------------------- 335 (1092)
T ss_pred HHHHHHHHHHhCCceEEEEcC---CCcEEehhHHHHHHhCCCHHHHccCCceeccCcc----------------------
Confidence 345578899999999999999 9999999999999999999999999877665543
Q ss_pred HhhhcccccccccCcccccCCCHHHHHHHHHHHHcC-CcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccC
Q 042772 145 LWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQ-REITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDG 223 (489)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~ 223 (489)
........+....... ..+..+....+|||+.+|..++.+|++|.+|.+.+++++.+||
T Consensus 336 --------------------d~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~~~~~~g~~~~~i~~~~DI 395 (1092)
T PRK09776 336 --------------------DLNKDLQQVEKLLSGEINSYSMEKRYYRRDGEVVWALLAVSLVRDTDGTPLYFIAQIEDI 395 (1092)
T ss_pred --------------------hhHhHHHHHHHHHcCCccceeeeeEEEcCCCCEEEEEEEEEEEECCCCCEeeehhhHHhh
Confidence 1122223333333322 3467888889999999999999999999999999999999999
Q ss_pred Ccccccccccc
Q 042772 224 SDHVEPLRNRL 234 (489)
Q Consensus 224 Te~ke~e~~~l 234 (489)
|++++++++..
T Consensus 396 Terk~~e~~l~ 406 (1092)
T PRK09776 396 NELKRTEQVNE 406 (1092)
T ss_pred HHHHHHHHHHH
Confidence 99998776543
|
|
| >TIGR00229 sensory_box PAS domain S-box | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.4e-09 Score=87.18 Aligned_cols=117 Identities=19% Similarity=0.345 Sum_probs=89.5
Q ss_pred HHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhh
Q 042772 69 LATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKK 148 (489)
Q Consensus 69 ~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (489)
+..+++.++.+++++|+ ++.|+++|++|.+++|++.++++|+++..+..+.
T Consensus 5 ~~~~~~~~~~~~~~~d~---~~~i~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~-------------------------- 55 (124)
T TIGR00229 5 YRAIFESSPDAIIVIDL---EGNILYVNPAFEEIFGYSAEELIGRNVLELIPEE-------------------------- 55 (124)
T ss_pred HHHHHhhCCceEEEEcC---CCcEEEEchHHHHHhCCChHHhcCcchhhhcChh--------------------------
Confidence 56788999999999999 9999999999999999999999998876543332
Q ss_pred cccccccccCcccccCCCHHHHHHHHHHHHcC-CcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCccc
Q 042772 149 NYGVYNFTLGCCLEISSDQATVSKIRDAVREQ-REITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHV 227 (489)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~k 227 (489)
........+..++... .....+.....++|...|......|+. ..|...+++++..|+|+++
T Consensus 56 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~dit~~~ 118 (124)
T TIGR00229 56 ----------------DREEVRERIERLLEGEREPVSEERRVRRKDGSEIWVEVSVSPIR-TNGGELGVVGIVRDITERK 118 (124)
T ss_pred ----------------hhHHHHHHHHHHHcCCCCCcceEeeeEcCCCCEEEEEEEEeehh-hCCCeeEEEEEeeehhHHH
Confidence 1222233344555423 223334444589999999999999998 7889999999999999987
Q ss_pred cccc
Q 042772 228 EPLR 231 (489)
Q Consensus 228 e~e~ 231 (489)
+.++
T Consensus 119 ~~~~ 122 (124)
T TIGR00229 119 QAEE 122 (124)
T ss_pred HHHh
Confidence 6543
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=1e-08 Score=102.31 Aligned_cols=135 Identities=19% Similarity=0.062 Sum_probs=93.6
Q ss_pred EEEEEEEcCCCcEEEEEEeecccccc--------hHHHHHHHHHHHHHHhCCCCCc--ceeeEEEEe-----CCeEEEEE
Q 042772 321 SVHLVELQGAGELYAMKAMEKSVMLN--------RNKVHRACIEREIMSLLDHPFL--PTLYASFQT-----STHICLIT 385 (489)
Q Consensus 321 ~Vy~a~~~~tg~~vAiK~i~~~~~~~--------~~~~~~~~~E~~il~~l~HpnI--v~l~~~~~~-----~~~~~lVm 385 (489)
.|..++.. |+.|.+|......... ......+.+|...+..|..-+| +.++++... ....++||
T Consensus 37 rvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 45566553 6788999664321100 0011136678888877743333 233444432 23578999
Q ss_pred ecCCCC-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-------CCcEEEEecCCccc
Q 042772 386 DFCPGG-ELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK-------DGHVVLTDFDLSFM 457 (489)
Q Consensus 386 Ey~~gg-sL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~-------~g~vKL~DFGlS~~ 457 (489)
|++++. +|.+++........+......++.+++..+.-||..||+|+|+++.|||++. ++.+.|+||+.+..
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999875 8999886432233566777889999999999999999999999999999985 46899999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.9e-11 Score=131.99 Aligned_cols=152 Identities=24% Similarity=0.331 Sum_probs=122.8
Q ss_pred cCcccccccCCCCceEEEEEEEcC-CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQG-AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~-tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~l 383 (489)
..|.+.+.||+|+|+.|-+..... +...+|.|.+.... ...........|..+-+.+. |+|++++++........++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 358888899999999999988743 34566666665432 22333444555777777776 9999999999999999999
Q ss_pred EEecCCCCCHHHHH-hhCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCCEEEecCC-cEEEEecCCccccC
Q 042772 384 ITDFCPGGELFALL-DKQPMKIFREDSARFYAAEVVIGLEYLH-CLGIIYRDLKPENILLQKDG-HVVLTDFDLSFMTS 459 (489)
Q Consensus 384 VmEy~~ggsL~~~L-~~~~~~~l~e~~~~~i~~qI~~aL~yLH-~~gIvHrDLKP~NILld~~g-~vKL~DFGlS~~~~ 459 (489)
+++|..|++++..+ .... ...+...+..++.|+..++.|+| ..++.|||+||+|.+++..+ .+++.|||+|....
T Consensus 99 ~~~~s~g~~~f~~i~~~~~-~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDS-TGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccCcccccccccccccCCc-cCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999999988 4432 13677888899999999999999 99999999999999999999 99999999996443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.3e-09 Score=115.57 Aligned_cols=165 Identities=12% Similarity=0.142 Sum_probs=127.0
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEec
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDF 387 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 387 (489)
|.+ ....-++.+....|..+.++..|.+...+.+.. .......+-.+-|+.++||||+++++.+..++.+|||+|-
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTEr 90 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTER 90 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeec
Confidence 555 444445554443567777888999998876532 3345566677789999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC-----
Q 042772 388 CPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH-CLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK----- 461 (489)
Q Consensus 388 ~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH-~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~----- 461 (489)
+ ..|..++++. ....+..-+.||+.||.||| +.+++|++|.-.-|+++..|..||++|-++......
T Consensus 91 V--~Pl~~~lk~l-----~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~ 163 (690)
T KOG1243|consen 91 V--RPLETVLKEL-----GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAK 163 (690)
T ss_pred c--ccHHHHHHHh-----HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccc
Confidence 8 4888888874 46777788899999999998 668999999999999999999999999887543321
Q ss_pred ----------Cceeecc----cccchHHHHHHHHhC
Q 042772 462 ----------PQVFYHA----HVNGFYFIMYKWLTG 483 (489)
Q Consensus 462 ----------~~~~~~~----~v~s~g~~a~e~~~G 483 (489)
|....++ |.|++|....+...|
T Consensus 164 ~~~~~~s~~~P~~~~~s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 164 SLYLIESFDDPEEIDPSEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhcccChhhcCccccchhhhhHHHHHHHHhCc
Confidence 2222223 677778888877777
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.92 E-value=8e-09 Score=97.65 Aligned_cols=128 Identities=22% Similarity=0.178 Sum_probs=82.5
Q ss_pred EEEEEEcCCCcEEEEEEeecccccc-----------------------hHHHHHHHHHHHHHHhCCCC--CcceeeEEEE
Q 042772 322 VHLVELQGAGELYAMKAMEKSVMLN-----------------------RNKVHRACIEREIMSLLDHP--FLPTLYASFQ 376 (489)
Q Consensus 322 Vy~a~~~~tg~~vAiK~i~~~~~~~-----------------------~~~~~~~~~E~~il~~l~Hp--nIv~l~~~~~ 376 (489)
||.|... .|..+|+|......... .........|...|.++..- ++++++++.
T Consensus 2 Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 2 VYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred EEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 7888875 47899999885422111 01134567799999999755 577777542
Q ss_pred eCCeEEEEEecCC--CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHH-HHHCCCeecCCCCCCEEEecCCcEEEEecC
Q 042772 377 TSTHICLITDFCP--GGELFALLDKQPMKIFREDSARFYAAEVVIGLEY-LHCLGIIYRDLKPENILLQKDGHVVLTDFD 453 (489)
Q Consensus 377 ~~~~~~lVmEy~~--ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~y-LH~~gIvHrDLKP~NILld~~g~vKL~DFG 453 (489)
..+|||||++ |..+..+.... ++......++.+++..+.. +|+.||+|+||.+.|||++++ .+.|+|||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~ 151 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFG 151 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GT
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecC
Confidence 2479999998 65565544322 1234455667778875555 579999999999999999877 89999999
Q ss_pred CccccC
Q 042772 454 LSFMTS 459 (489)
Q Consensus 454 lS~~~~ 459 (489)
.|....
T Consensus 152 qav~~~ 157 (188)
T PF01163_consen 152 QAVDSS 157 (188)
T ss_dssp TEEETT
T ss_pred cceecC
Confidence 987655
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF08447 PAS_3: PAS fold; InterPro: IPR013655 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=98.90 E-value=6e-09 Score=85.30 Aligned_cols=85 Identities=26% Similarity=0.379 Sum_probs=65.7
Q ss_pred EEEecHhhHHhcCCChhhhcCCC----ccccccccchhhhhhccccccchhHHHHHHHhhhcccccccccCcccccCCCH
Q 042772 92 IIFASDSFLELTEYTREEILGRN----CSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQ 167 (489)
Q Consensus 92 i~~~n~~~~~~~gy~~~e~~g~~----~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (489)
|+|+|++|++++||+++|+ |.. ..-+..|+ ...
T Consensus 1 ~i~~s~~~~~i~G~~~~~~-~~~~~~~~~~~ihpd------------------------------------------D~~ 37 (91)
T PF08447_consen 1 IIYWSDNFYEIFGYSPEEI-GKPDFEEWLERIHPD------------------------------------------DRE 37 (91)
T ss_dssp -EEE-THHHHHHTS-HHHH-TCBEHHHHHHHB-TT------------------------------------------THH
T ss_pred CEEEeHHHHHHhCCCHHHh-ccCCHHHHHhhcCHH------------------------------------------HHH
Confidence 7899999999999999999 655 22122232 344
Q ss_pred HHHHHHHH-HHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeee
Q 042772 168 ATVSKIRD-AVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGV 219 (489)
Q Consensus 168 ~~~~~~~~-~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~ 219 (489)
...+.+++ +...+..++.++...++||+..|+.....|++|.+|+++.++|+
T Consensus 38 ~~~~~~~~~~~~~~~~~~~e~R~~~~~G~~~wi~~~~~~~~d~~g~~~~~~Gv 90 (91)
T PF08447_consen 38 RVRQAIQQAALQNGEPFEIEYRIRRKDGEYRWIEVRGRPIFDENGKPIRIIGV 90 (91)
T ss_dssp HHHHHHHHHHHHTT-EEEEEEEEEGTTSTEEEEEEEEEEEETTTS-EEEEEEE
T ss_pred HHHHHHHHHhhccCcceEEEEEEECCCCCEEEEEEEEEEEECCCCCEEEEEEE
Confidence 45566777 67888899999999999999999999999999999999999987
|
The PAS fold appears in archaea, eubacteria and eukarya. The PAS domain contains a sensory box, or S-box domain that occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include haem in the oxygen sensor FixL [], FAD in the redox potential sensor NifL [], and a 4-hydroxycinnamyl chromophore in photoactive yellow protein []. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. This domain has been found in the gene product of the madA gene of the filamentous zygomycete fungus Phycomyces blakesleeanus. It has been shown that MadA encodes a blue-light photoreceptor for phototropism and other light responses. The gene is involved in the phototropic responses associated with sporangiophore growth; they exhibit phototropism by bending toward near-UV and blue wavelengths and away from far-UV wavelengths in a manner that is physiologically similar to plant phototropic responses [].; GO: 0005515 protein binding; PDB: 3NJA_D 3H9W_A 3GDI_B 3ICY_A 3EEH_A 3MR0_B. |
| >PRK13560 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=5.7e-09 Score=118.02 Aligned_cols=152 Identities=12% Similarity=0.148 Sum_probs=107.6
Q ss_pred chhHHHHHHHHHhhh----hHHHHHHhccCcEEEECCCCCCCCEEEe-cHhhHHhcCCChhhhcCCCccccccccchhhh
Q 042772 53 SWDRAERERDIRQGI----DLATTLERIEKNFVITDPRIPDNPIIFA-SDSFLELTEYTREEILGRNCSFLELTEYTREE 127 (489)
Q Consensus 53 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~i~d~~~~~~~i~~~-n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~ 127 (489)
..|+++|++.+++.. .+..+++.++.+++++|+ ++.|+++ |+++++++||+.+|++|++...+....
T Consensus 314 ~~DITerk~~e~~L~~se~~l~~l~~~~~~~i~~~d~---~g~i~~~nn~~~~~~~G~~~~e~~g~~~~~~~~~~----- 385 (807)
T PRK13560 314 ITDISGRRAAERELLEKEDMLRAIIEAAPIAAIGLDA---DGNICFVNNNAAERMLGWSAAEVMGKPLPGMDPEL----- 385 (807)
T ss_pred EEechHHHHHHHHHHHHHHHHHHHHHhCcccEEEEcC---CCCEEEecCHHHHHHhCCCHHHHcCCCccccChhh-----
Confidence 358888887766543 477889999999999999 9999987 678888999999999999865433221
Q ss_pred hhccccccchhHHHHHHHhhhcccccccccCcccccCCCHH--HHHHHHHHHHcCCcEE-EEEEeeecCCCeeeEEEeec
Q 042772 128 ILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQA--TVSKIRDAVREQREIT-VQLINYTKSGKKFWNLFHLQ 204 (489)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~k~g~~~~~~~~~~ 204 (489)
...+|...+..|. +..... ....+...+..++.+. .++...+++|..+|+.....
T Consensus 386 --------------~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~~~~~~~ 443 (807)
T PRK13560 386 --------------NEEFWCGDFQEWY--------PDGRPMAFDACPMAKTIKGGKIFDGQEVLIEREDDGPADCSAYAE 443 (807)
T ss_pred --------------hhhhhhchhhhcC--------CcCCcchhhhhhHHHHHhcCCcccCceEEEEcCCCCeEEEEEEEe
Confidence 0011211111110 000000 1112344455565543 46677899999999999999
Q ss_pred ccccCCCCeeEEeeeeccCCcccccccccc
Q 042772 205 PMRDHKGELQYFIGVQLDGSDHVEPLRNRL 234 (489)
Q Consensus 205 p~~~~~g~~~~~~~~~~d~Te~ke~e~~~l 234 (489)
|++|.+|.+.+++++..|||++|+++++..
T Consensus 444 p~~d~~g~~~~~~~~~~DITerk~~E~~L~ 473 (807)
T PRK13560 444 PLHDADGNIIGAIALLVDITERKQVEEQLL 473 (807)
T ss_pred eeECCCCCEEEEEEEeehhhhHHHHHHHHH
Confidence 999999999999999999999998876654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=4.6e-09 Score=111.67 Aligned_cols=128 Identities=23% Similarity=0.347 Sum_probs=108.2
Q ss_pred HHhCCCCCcceeeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-eecCCCCCC
Q 042772 360 MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGI-IYRDLKPEN 438 (489)
Q Consensus 360 l~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gI-vHrDLKP~N 438 (489)
|+.+.|.|+.++++.+..+...++|.+||+.|+|.+.+..... .++..-...++.+++.||.|+|.--| .|+.|++.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~-~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI-KLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc-CccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 3567899999999999999999999999999999999987533 37788888899999999999997655 999999999
Q ss_pred EEEecCCcEEEEecCCccccC-----------------CCCc-------------eeecccccchHHHHHHHHhCCcccC
Q 042772 439 ILLQKDGHVVLTDFDLSFMTS-----------------CKPQ-------------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 439 ILld~~g~vKL~DFGlS~~~~-----------------~~~~-------------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+++|....+||+|||+..... .+|+ .....|++++|.+++|+++-.-||.
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 999999999999999986652 1111 1233588999999999999888885
|
|
| >cd00130 PAS PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Probab=98.83 E-value=8.8e-08 Score=72.75 Aligned_cols=102 Identities=25% Similarity=0.417 Sum_probs=82.1
Q ss_pred cCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhcccccccc
Q 042772 77 EKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFT 156 (489)
Q Consensus 77 ~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (489)
+.++++.|. ++.++++|++|.+++||+.++++|++...+..+.
T Consensus 2 ~~~i~~~d~---~~~~~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~---------------------------------- 44 (103)
T cd00130 2 PDGVIVLDL---DGRILYANPAAEQLLGYSPEELIGKSLLDLIHPE---------------------------------- 44 (103)
T ss_pred CceEEEECC---CCcEEEECHHHHHHhCCCHHHHcCccHHHhcCCc----------------------------------
Confidence 467899999 9999999999999999999999998865443332
Q ss_pred cCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccC
Q 042772 157 LGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDG 223 (489)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~ 223 (489)
........+..+.........++....++|...|......|+.+..|....++++..||
T Consensus 45 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~di 103 (103)
T cd00130 45 --------DREELRERLENLLSGGEPVTLEVRLRRKDGSVIWVLVSLTPIRDEGGEVIGLLGVVRDI 103 (103)
T ss_pred --------cchHHHHHHHHHHhcCcCeEEEEEEEccCCCEEEEEEEEEEEecCCCCEEEEEEEEecC
Confidence 22234445566666566677788888889999999999999999989999999888875
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. |
| >PRK11073 glnL nitrogen regulation protein NR(II); Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.7e-08 Score=101.66 Aligned_cols=115 Identities=11% Similarity=0.132 Sum_probs=90.6
Q ss_pred hhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHh
Q 042772 67 IDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALW 146 (489)
Q Consensus 67 ~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (489)
..+.++++.+++++++.|+ ++.|+++|++|++++||+.++++|+++..+....
T Consensus 7 ~~~~~il~~~~~gi~~~d~---~~~i~~~N~a~~~~~g~~~~~~~g~~~~~~~~~~------------------------ 59 (348)
T PRK11073 7 PDAGQILNSLINSILLLDD---DLAIHYANPAAQQLLAQSSRKLFGTPLPELLSYF------------------------ 59 (348)
T ss_pred chHHHHHhcCcCeEEEECC---CCeEeeEcHHHHHHhCCCHHHHcCCCHHHHcCcc------------------------
Confidence 3578899999999999999 9999999999999999999999999987664221
Q ss_pred hhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCcc
Q 042772 147 KKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDH 226 (489)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~ 226 (489)
......+.+++..++.++..-..+.++|+++|..++.+|+.+ .+++...+|+|++
T Consensus 60 --------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~-----~~~~~~~~dit~~ 114 (348)
T PRK11073 60 --------------------SLNIELMRESLQAGQGFTDNEVTLVIDGRSHILSLTAQRLPE-----GMILLEMAPMDNQ 114 (348)
T ss_pred --------------------hhhHHHHHHHHHcCCcccccceEEEECCceEEEEEEEEEccC-----ceeEEEEechhHH
Confidence 112234556676766666556667889999999999999972 3466778999988
Q ss_pred ccccccc
Q 042772 227 VEPLRNR 233 (489)
Q Consensus 227 ke~e~~~ 233 (489)
++.+++.
T Consensus 115 ~~~~~~~ 121 (348)
T PRK11073 115 RRLSQEQ 121 (348)
T ss_pred HHHHHHH
Confidence 7765544
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.78 E-value=5.3e-09 Score=111.53 Aligned_cols=153 Identities=21% Similarity=0.244 Sum_probs=124.5
Q ss_pred ccccccCcccccccCCCCceEEEEEEEc-CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeC
Q 042772 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQ-GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTS 378 (489)
Q Consensus 301 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~-~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~ 378 (489)
....+.+|..+..||.|.|+.|+.+... .++..|++|.+.+.......++.. ..|+.+...+ .|.+++.++..|..-
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-l~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-LGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-hhhhhHhhHhhcccccCCCCCCcccc
Confidence 4556788999999999999999998866 678899999887765554443322 3355555555 589999988888888
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC-CcEEEEecCCcc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD-GHVVLTDFDLSF 456 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~-g~vKL~DFGlS~ 456 (489)
.+.|+-.|||.++++.....-. ..+++...+.+..|++.++.++|++.++|+|+||+||++..+ +..++.|||+..
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred ccccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccc
Confidence 8889999999999887666332 337888899999999999999999999999999999999876 778999999874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.5e-07 Score=99.19 Aligned_cols=164 Identities=15% Similarity=0.180 Sum_probs=124.3
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe----CCeEEEEEecCCC-CC
Q 042772 318 DTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT----STHICLITDFCPG-GE 392 (489)
Q Consensus 318 ~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~lVmEy~~g-gs 392 (489)
.-.+.|++....+|..|++|.++-......+ ....-.++++++.|+|||.+.++|.+ +..+++|++|.|+ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 4468999999999999999999433222221 12234668999999999999999873 4579999999975 57
Q ss_pred HHHHHhhC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 393 LFALLDKQ-------------PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 393 L~~~L~~~-------------~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
|.++--.. .+...+|..+|.++.|+..||.++|+.|+..+-|.|.+||++.+.+++|.--|+.-++.
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 77664221 12236789999999999999999999999999999999999988889998888776665
Q ss_pred CCC-ce---eecccccchHHHHHHHHhCC
Q 042772 460 CKP-QV---FYHAHVNGFYFIMYKWLTGY 484 (489)
Q Consensus 460 ~~~-~~---~~~~~v~s~g~~a~e~~~G~ 484 (489)
..+ .. ....|..-+|..+--+++|+
T Consensus 445 ~d~~~~le~~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 445 EDPTEPLESQQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred CCCCcchhHHhhhhHHHHHHHHHHHhhcc
Confidence 554 11 12335556788877777774
|
|
| >PRK11360 sensory histidine kinase AtoS; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.7e-07 Score=101.61 Aligned_cols=119 Identities=15% Similarity=0.089 Sum_probs=93.6
Q ss_pred hHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhh
Q 042772 68 DLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWK 147 (489)
Q Consensus 68 ~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (489)
.+..+++.++++++++|. ++.|+++|++|++++||++++++|+++..+..+.
T Consensus 263 ~~~~i~~~~~~~i~~~d~---~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~------------------------- 314 (607)
T PRK11360 263 LNELILESIADGVIAIDR---QGKITTMNPAAEVITGLQRHELVGKPYSELFPPN------------------------- 314 (607)
T ss_pred HHHHHHHhccCeEEEEcC---CCCEEEECHHHHHHhCCChHHhcCCcHHHHcCCc-------------------------
Confidence 456788999999999999 9999999999999999999999999977654321
Q ss_pred hcccccccccCcccccCCCHHHHHHHHHHHHcCCcEE-EEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCcc
Q 042772 148 KNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREIT-VQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDH 226 (489)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~ 226 (489)
......+.+.+..+.... .++...+++|..+ +.++..|++|.+|++.+++++..|+|++
T Consensus 315 -------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~i~~~~g~~~~~i~~~~Dite~ 374 (607)
T PRK11360 315 -------------------TPFASPLLDTLEHGTEHVDLEISFPGRDRTIE-LSVSTSLLHNTHGEMIGALVIFSDLTER 374 (607)
T ss_pred -------------------hhHHHHHHHHHhcCCCccceEEEEEcCCCcEE-EEEEEeeEEcCCCCEEEEEEEEeechHH
Confidence 222334555555555443 3444556677665 8999999999999999999999999999
Q ss_pred cccccccc
Q 042772 227 VEPLRNRL 234 (489)
Q Consensus 227 ke~e~~~l 234 (489)
++.+++..
T Consensus 375 ~~~e~~l~ 382 (607)
T PRK11360 375 KRLQRRVA 382 (607)
T ss_pred HHHHHHHH
Confidence 98776543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.3e-07 Score=88.84 Aligned_cols=108 Identities=27% Similarity=0.260 Sum_probs=83.2
Q ss_pred HHHHHHHHHHHHhCCCC--CcceeeEEEEeC----CeEEEEEecCCCC-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHH
Q 042772 350 VHRACIEREIMSLLDHP--FLPTLYASFQTS----THICLITDFCPGG-ELFALLDKQPMKIFREDSARFYAAEVVIGLE 422 (489)
Q Consensus 350 ~~~~~~E~~il~~l~Hp--nIv~l~~~~~~~----~~~~lVmEy~~gg-sL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~ 422 (489)
..+..+|...+..|..- .++.++++.... ...++|||++++. +|.+++..... .+......++.+++..+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 34566787777766432 344555554432 2468999999874 89999887432 566777888999999999
Q ss_pred HHHHCCCeecCCCCCCEEEecCC---cEEEEecCCccccC
Q 042772 423 YLHCLGIIYRDLKPENILLQKDG---HVVLTDFDLSFMTS 459 (489)
Q Consensus 423 yLH~~gIvHrDLKP~NILld~~g---~vKL~DFGlS~~~~ 459 (489)
-||..||+|+|++|.|||++.++ .+.++||+-++...
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99999999999999999999887 89999999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK11359 cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Probab=98.66 E-value=7.3e-08 Score=109.52 Aligned_cols=116 Identities=22% Similarity=0.357 Sum_probs=87.1
Q ss_pred HHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhh
Q 042772 69 LATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKK 148 (489)
Q Consensus 69 ~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (489)
+..+++..+.+++++|. ++.|+++|++|++++||+++|++|++...+..+.
T Consensus 14 ~~~~le~~~~~i~~~d~---~g~i~~~N~~~~~l~G~s~eeliG~~~~~~~~~~-------------------------- 64 (799)
T PRK11359 14 FFPALEQNMMGAVLINE---NDEVLFFNPAAEKLWGYKREEVIGNNIDMLIPRD-------------------------- 64 (799)
T ss_pred HHHHHHhhcCcEEEEcC---CCeEEEEcHHHHHHhCCCHHHHcCCCHHHhcCcc--------------------------
Confidence 46788999999999999 9999999999999999999999999987665443
Q ss_pred cccccccccCcccccCCCHHHHHHHHHHHHc----CCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCC
Q 042772 149 NYGVYNFTLGCCLEISSDQATVSKIRDAVRE----QREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGS 224 (489)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~T 224 (489)
........++..... ...+..++..+++||+.+|..+.+.|+. ..|. .+++++.+|+|
T Consensus 65 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~v~~~~~~~~-~~g~-~~~~~~~~DiT 126 (799)
T PRK11359 65 ----------------LRPAHPEYIRHNREGGKARVEGMSRELQLEKKDGSKIWTRFALSKVS-AEGK-VYYLALVRDAS 126 (799)
T ss_pred ----------------ccccchHHHhhhhccCCccccccceeeEEecCCcCEEEEEEEeeeec-cCCc-eEEEEEEeecc
Confidence 111111222222222 2234557888999999999999999874 4455 56889999999
Q ss_pred ccccccc
Q 042772 225 DHVEPLR 231 (489)
Q Consensus 225 e~ke~e~ 231 (489)
++++.++
T Consensus 127 ~~~~~~~ 133 (799)
T PRK11359 127 VEMAQKE 133 (799)
T ss_pred chhhhHH
Confidence 9776543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=6.7e-08 Score=104.29 Aligned_cols=149 Identities=22% Similarity=0.273 Sum_probs=97.6
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccc---------------------------hHHH----HH-
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN---------------------------RNKV----HR- 352 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~---------------------------~~~~----~~- 352 (489)
...|.. ++|+.++-|+||.|..+. |+.||||+..+..... ...+ +.
T Consensus 125 F~eF~~-~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l 202 (517)
T COG0661 125 FSEFEP-EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRL 202 (517)
T ss_pred HHHcCC-CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHH
Confidence 444544 789999999999999986 9999999986643210 0001 11
Q ss_pred -----HHHHHHHHHhC-----CCCCcceeeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHH-H
Q 042772 353 -----ACIEREIMSLL-----DHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIG-L 421 (489)
Q Consensus 353 -----~~~E~~il~~l-----~HpnIv~l~~~~~~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~a-L 421 (489)
+.+|..-+.++ +.|++.-..=+++..+.-.|+|||++|..+.+...-.. ..++...+... ++.+ +
T Consensus 203 ~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~---~~~~f~ 278 (517)
T COG0661 203 REELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAEL---LVRAFL 278 (517)
T ss_pred HHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHH---HHHHHH
Confidence 22333333333 24554433334454566789999999999988743221 22443333322 2222 3
Q ss_pred HHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 422 ~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
..+-..|++|.|..|.||+++.+|.+.+.|||+....+
T Consensus 279 ~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 279 RQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHHhcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 34445899999999999999999999999999986554
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.63 E-value=5.8e-07 Score=86.19 Aligned_cols=141 Identities=13% Similarity=0.146 Sum_probs=102.3
Q ss_pred CCCCceEEEEEEEcCCCcEEEEEEeecccc---cchHHHHHHHHHHHHHHhCCCC--CcceeeEEEEe----CCeEEEEE
Q 042772 315 GCGDTGSVHLVELQGAGELYAMKAMEKSVM---LNRNKVHRACIEREIMSLLDHP--FLPTLYASFQT----STHICLIT 385 (489)
Q Consensus 315 G~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~~~~E~~il~~l~Hp--nIv~l~~~~~~----~~~~~lVm 385 (489)
|+|+-+.|+.....+ +.+=+|....... ..+.....+.+|...+..|..- .++.+...-.. .-..+||+
T Consensus 27 ~rgG~SgV~r~~~~g--~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERNG--KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeCC--cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 568888899877664 3577776642111 1133557788999999888532 24555422111 12578999
Q ss_pred ecCCC-CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc--EEEEecCCccc
Q 042772 386 DFCPG-GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGH--VVLTDFDLSFM 457 (489)
Q Consensus 386 Ey~~g-gsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~--vKL~DFGlS~~ 457 (489)
|-++| -+|.+++........++.....++.+++..+.-||+.|+.|+|+-+.||+++.+|. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98853 58988887654444577777889999999999999999999999999999987777 99999988763
|
|
| >TIGR02966 phoR_proteo phosphate regulon sensor kinase PhoR | Back alignment and domain information |
|---|
Probab=98.62 E-value=8.7e-08 Score=96.09 Aligned_cols=106 Identities=11% Similarity=0.035 Sum_probs=80.4
Q ss_pred hhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHh
Q 042772 67 IDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALW 146 (489)
Q Consensus 67 ~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (489)
..+..+++.+++++++.|+ ++.|+|+|++|++++||+++|++|+++..+..+
T Consensus 6 ~~l~~~~~~~~~~i~~~d~---~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~------------------------- 57 (333)
T TIGR02966 6 SRFRAAAQALPDAVVVLDE---EGQIEWCNPAAERLLGLRWPDDLGQRITNLIRH------------------------- 57 (333)
T ss_pred HHHHHHHHhCcCcEEEECC---CCcEEEEcHHHHHHhCCChHHHcCCcHHHHccC-------------------------
Confidence 4478999999999999999 999999999999999999999999987644322
Q ss_pred hhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCcc
Q 042772 147 KKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDH 226 (489)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~ 226 (489)
......+..... ..+ +....++|...|+.+.++|+.+.. ++++..|+|+.
T Consensus 58 --------------------~~~~~~l~~~~~-~~~----~~~~~~~~~~~~~~~~~~p~~~~~-----~~~~~~dit~~ 107 (333)
T TIGR02966 58 --------------------PEFVEYLAAGRF-SEP----LELPSPINSERVLEIRIAPYGEEQ-----KLLVARDVTRL 107 (333)
T ss_pred --------------------HHHHHHHHhccc-CCC----eEeecCCCCceEEEEEEEEcCCCc-----eEEEEeCchHH
Confidence 222222222221 222 333358999999999999998753 77889999987
Q ss_pred cccc
Q 042772 227 VEPL 230 (489)
Q Consensus 227 ke~e 230 (489)
++.+
T Consensus 108 ~~~~ 111 (333)
T TIGR02966 108 RRLE 111 (333)
T ss_pred HHHH
Confidence 7654
|
Members of this protein family are the regulatory histidine kinase PhoR associated with the phosphate ABC transporter in most Proteobacteria. Related proteins from Gram-positive organisms are not included in this model. The phoR gene usually is adjacent to the response regulator phoB gene (TIGR02154). |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.1e-07 Score=89.62 Aligned_cols=139 Identities=21% Similarity=0.204 Sum_probs=99.1
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeeccccc------chH-------------HHHHHHHHHHHHHhCCCC--
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVML------NRN-------------KVHRACIEREIMSLLDHP-- 366 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~------~~~-------------~~~~~~~E~~il~~l~Hp-- 366 (489)
..+...||-|--+.||.|.+. .|..+|+|.-...... .+. ......+|.++|.+|..-
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456688999999999999987 4889999954321110 011 123456788899988643
Q ss_pred CcceeeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc
Q 042772 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGH 446 (489)
Q Consensus 367 nIv~l~~~~~~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~ 446 (489)
.|++.+++ +...+||||++|-.|...- ++......++..|+.-+.-+-..|+||+|+.+-||+++++|.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 78888764 4678999999887765432 122333344445555555555899999999999999999999
Q ss_pred EEEEecCCcccc
Q 042772 447 VVLTDFDLSFMT 458 (489)
Q Consensus 447 vKL~DFGlS~~~ 458 (489)
+.++||--+...
T Consensus 241 ~~vIDwPQ~v~~ 252 (304)
T COG0478 241 IVVIDWPQAVPI 252 (304)
T ss_pred EEEEeCcccccC
Confidence 999999766543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.55 E-value=4.2e-08 Score=104.78 Aligned_cols=151 Identities=23% Similarity=0.240 Sum_probs=120.7
Q ss_pred cCcccccccCC--CCceEEEEEEE--cCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCe
Q 042772 306 HHFKPIKPLGC--GDTGSVHLVEL--QGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTH 380 (489)
Q Consensus 306 ~~y~~~~~LG~--G~fG~Vy~a~~--~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~ 380 (489)
..|.+...+|. |.+|.||.+.. ..++..+|+|.-+... .....-.+-.+|...-++++ |+|.++.+..+...+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCcccccCCc
Confidence 45778889999 99999999998 8889999999743221 11122222334555555554 9999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHH----HHHHHHHCCCeecCCCCCCEEEecC-CcEEEEecCCc
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVI----GLEYLHCLGIIYRDLKPENILLQKD-GHVVLTDFDLS 455 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~----aL~yLH~~gIvHrDLKP~NILld~~-g~vKL~DFGlS 455 (489)
+|+-+|+| +.+|.++...- ..-+++..++..+.+... ||.++|+.+++|-|+||.||++..+ ..++++|||+.
T Consensus 193 lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred ceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 99999999 57888887654 233788889999999998 9999999999999999999999999 88999999998
Q ss_pred cccC
Q 042772 456 FMTS 459 (489)
Q Consensus 456 ~~~~ 459 (489)
....
T Consensus 271 ~~i~ 274 (524)
T KOG0601|consen 271 SKIS 274 (524)
T ss_pred EEcc
Confidence 6544
|
|
| >TIGR02040 PpsR-CrtJ transcriptional regulator PpsR | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.6e-07 Score=99.88 Aligned_cols=112 Identities=15% Similarity=0.080 Sum_probs=83.3
Q ss_pred HHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhcccc
Q 042772 73 LERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGV 152 (489)
Q Consensus 73 ~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (489)
++.+.+++++.|. +|.|++||++|.+++||+++|++|++...+..++
T Consensus 2 ~~~~~d~~~~~d~---~g~i~~~n~~~~~~~g~~~~el~G~~~~~~~~~~------------------------------ 48 (442)
T TIGR02040 2 LATAADVTLLLDA---EGVVREVAANPHHPSFEQLSEWEGRRWEEIVTAE------------------------------ 48 (442)
T ss_pred CcccCcEEEEECC---CCcEEEEEECCCcccccccccCCCCcHhHhhCcc------------------------------
Confidence 5678899999999 9999999999999999999999999987666553
Q ss_pred cccccCcccccCCCHHHHHHHHHHHHcCC-cEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCccccccc
Q 042772 153 YNFTLGCCLEISSDQATVSKIRDAVREQR-EITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLR 231 (489)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~ke~e~ 231 (489)
........+..+...+. .+.+++....++|..+|+.++..|+.+.. +++++.+|+|+.++.++
T Consensus 49 ------------~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~~~~~~~~~~~~~----~~~~i~rDi~~~~~~~~ 112 (442)
T TIGR02040 49 ------------SVEKFELRLSEALRTGRGAVRVELNHIDPSSFELPMRFILVRLGADR----GVLALGRDLRAVAELQQ 112 (442)
T ss_pred ------------hHHHHHHHHHHHhccCCCcceEeeccCCCCCCccCeEEEEEEeCCCC----eEEEEecccHHHHHHHH
Confidence 22333445556565554 45566555567777788888777765532 56788999999887544
Q ss_pred cc
Q 042772 232 NR 233 (489)
Q Consensus 232 ~~ 233 (489)
+.
T Consensus 113 ~l 114 (442)
T TIGR02040 113 QL 114 (442)
T ss_pred HH
Confidence 43
|
This model represents the transcriptional regulator PpsR which is strictly associated with photosynthetic proteobacteria and found in photosynthetic operons. PpsR has been reported to be a repressor. These proteins contain a Helix-Turn_Helix motif of the "fis" type (pfam02954). |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.43 E-value=4.3e-08 Score=103.26 Aligned_cols=78 Identities=23% Similarity=0.337 Sum_probs=68.4
Q ss_pred CeEEEEEecCCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccc
Q 042772 379 THICLITDFCPGGELFALLDKQ-PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~-~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
.++|+.|++|...+|.++|.+. .....+......++.|++.|++| +|.+|||+||.||+...+..+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 3689999999999999999754 33346778889999999999999 9999999999999999999999999999865
Q ss_pred cC
Q 042772 458 TS 459 (489)
Q Consensus 458 ~~ 459 (489)
..
T Consensus 406 ~~ 407 (516)
T KOG1033|consen 406 QD 407 (516)
T ss_pred cc
Confidence 44
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.38 E-value=6e-06 Score=79.63 Aligned_cols=143 Identities=21% Similarity=0.267 Sum_probs=90.5
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHH------HHHHHHHHhC---CCCCcceeeE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRA------CIEREIMSLL---DHPFLPTLYA 373 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~------~~E~~il~~l---~HpnIv~l~~ 373 (489)
+...+|...+.+-.....-|.+.... |..+++|...............+ .+.+..+..+ .--....++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 34467888888888877777776654 68899997754322111111111 1122222222 1122223222
Q ss_pred EEE-----eCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEE
Q 042772 374 SFQ-----TSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVV 448 (489)
Q Consensus 374 ~~~-----~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vK 448 (489)
+.. -....+++|||++|..|.++.. +++. +...+..++.-||+.|++|+|..|.|+++++++ ++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~ 174 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IR 174 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh------cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EE
Confidence 222 2234678999999988876542 2332 345577889999999999999999999998554 99
Q ss_pred EEecCCcccc
Q 042772 449 LTDFDLSFMT 458 (489)
Q Consensus 449 L~DFGlS~~~ 458 (489)
++||+..+.+
T Consensus 175 iID~~~k~~~ 184 (229)
T PF06176_consen 175 IIDTQGKRMS 184 (229)
T ss_pred EEECcccccc
Confidence 9999887654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1229 consensus 3'5'-cyclic nucleotide phosphodiesterases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=2.3e-07 Score=94.93 Aligned_cols=110 Identities=17% Similarity=0.309 Sum_probs=94.6
Q ss_pred hhhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHH
Q 042772 66 GIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLAL 145 (489)
Q Consensus 66 ~~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (489)
...+-++||....+|-|+|. |..|.|||+||+.++||-+.|++|+....|.-...
T Consensus 156 cnalFaaLD~c~eAiEI~~d---dhViQYVNpAfE~mmG~hkgEliGke~adlpkkdk---------------------- 210 (775)
T KOG1229|consen 156 CNALFAALDECDEAIEICDD---DHVIQYVNPAFENMMGCHKGELIGKEEADLPKKDK---------------------- 210 (775)
T ss_pred hHHHHHHHhhhhhhheeccc---hhHHHHhcHHHHhhhcchhhhhcCCchhhcccccc----------------------
Confidence 44578899999999999999 99999999999999999999999999877754431
Q ss_pred hhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeee
Q 042772 146 WKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGV 219 (489)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~ 219 (489)
.......-|-..+..+.+++++-..+||+|..---.+.++|+-+..|++.+|+..
T Consensus 211 -------------------nradlldtintcikkgke~qG~~~aRRksgdS~dqh~~itP~~gqggkirhfvsl 265 (775)
T KOG1229|consen 211 -------------------NRADLLDTINTCIKKGKEAQGEEEARRKSGDSCDQHFIITPFAGQGGKIRHFVSL 265 (775)
T ss_pred -------------------chhhhhhhhhHhhhcCccccchHHHhhccCCcccceEEEeeecCCCCceeeehhh
Confidence 2334456678888999999999999999999887789999999999999999764
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.30 E-value=9.9e-06 Score=79.13 Aligned_cols=139 Identities=22% Similarity=0.169 Sum_probs=97.3
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchH-------------------H--HHHHHHHHHHHHhCC--CCCc
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRN-------------------K--VHRACIEREIMSLLD--HPFL 368 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~-------------------~--~~~~~~E~~il~~l~--HpnI 368 (489)
..|.+|--+.||+|.. ..+..+|+|++.......+. . ......|..-|+++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3788899999999986 45889999998654332211 1 122344666677663 5567
Q ss_pred ceeeEEEEeCCeEEEEEecCCCC-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCc
Q 042772 369 PTLYASFQTSTHICLITDFCPGG-ELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC-LGIIYRDLKPENILLQKDGH 446 (489)
Q Consensus 369 v~l~~~~~~~~~~~lVmEy~~gg-sL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~-~gIvHrDLKP~NILld~~g~ 446 (489)
++.+.+. ...|||||+... .-.-.|+.- .+....+..+..+++..+.-|-+ .++||+||+.-|||+. ++.
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe
Confidence 7777654 357999999542 111112221 12333677788889999998887 8999999999999999 889
Q ss_pred EEEEecCCccccC
Q 042772 447 VVLTDFDLSFMTS 459 (489)
Q Consensus 447 vKL~DFGlS~~~~ 459 (489)
+.|+|||-|....
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999986554
|
|
| >PF13596 PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D | Back alignment and domain information |
|---|
Probab=98.27 E-value=5.2e-06 Score=70.47 Aligned_cols=106 Identities=20% Similarity=0.279 Sum_probs=74.3
Q ss_pred HHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhh
Q 042772 69 LATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKK 148 (489)
Q Consensus 69 ~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (489)
|...|+.++.++++.|. ++.|.|.|++..++++.+. ..+||+..-+..+.
T Consensus 1 L~~il~s~~~~i~~vD~---~~~I~~~n~~a~~~f~~~~-~~iGr~l~~~~~~~-------------------------- 50 (106)
T PF13596_consen 1 LNNILDSMPIGIIFVDR---NLRIRYFNPAAARLFNLSP-SDIGRPLFDIHPPL-------------------------- 50 (106)
T ss_dssp HHHHHHHSSSEEEEEET---TSBEEEE-SCGC-SS---G-GGTTSBCCCSS-HH--------------------------
T ss_pred ChHHHhcCCCCEEEEcC---CCeEEEeChhHhhhcCCCh-HHCCCCHHHcCCcc--------------------------
Confidence 46789999999999999 9999999999999999764 55799987665442
Q ss_pred cccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCC
Q 042772 149 NYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGS 224 (489)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~T 224 (489)
....+..+.+.+..++.-..+... .++| .|....+.|++|.+|+..+++.+..|||
T Consensus 51 -----------------~~~~l~~~i~~~~~~~~~~~~~~~-~~~~--~~~~~~~~P~~~~~g~~~G~v~~~~DIT 106 (106)
T PF13596_consen 51 -----------------SYPNLKKIIEQVRSGKEEEFEIVI-PNGG--RWYLVRYRPYRDEDGEYAGAVITFQDIT 106 (106)
T ss_dssp -----------------HHHHHHHHHHHHHTTSBSEEEEEE-EETT--EEEEEEEEEEE-TTS-EEEEEEEEEE-G
T ss_pred -----------------chHHHHHHHHHHHcCCCceEEEEe-cCCC--EEEEEEEEEEECCCCCEEEEEEEEEecC
Confidence 334455555666667654444333 3555 4667899999999999999999999997
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.1e-07 Score=106.83 Aligned_cols=150 Identities=26% Similarity=0.321 Sum_probs=122.6
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
...+.+.+.+.+-+|.++.++.+.-..+|...++|......+...+.......+..++....||.++...-.+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34567888999999999999999988888877877766554444444555555555555556788877766666667899
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCC
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDL 454 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGl 454 (489)
|+|+|+.+++|...|+..+ +.+++.++.+...+..+.+|||...+.|||++|.|.++..+|+.+++|||.
T Consensus 881 L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t 950 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGT 950 (1205)
T ss_pred hhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccc
Confidence 9999999999999998764 467888888888999999999999999999999999999999999999983
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=5.5e-06 Score=89.54 Aligned_cols=140 Identities=23% Similarity=0.287 Sum_probs=92.6
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccc--hH--------------------------HHHH------HHHHH
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN--RN--------------------------KVHR------ACIER 357 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~--~~--------------------------~~~~------~~~E~ 357 (489)
++||.-+.|+||+|+.+. |+.||+|+.++..... .+ .... |..|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 789999999999999998 9999999887643211 00 0001 12222
Q ss_pred H----HHHhCCCCC------cceeeEEEEeCCeEEEEEecCCCCCHHHH--HhhCCCCCCCHHHHHHHHHHHHHH-HHHH
Q 042772 358 E----IMSLLDHPF------LPTLYASFQTSTHICLITDFCPGGELFAL--LDKQPMKIFREDSARFYAAEVVIG-LEYL 424 (489)
Q Consensus 358 ~----il~~l~Hpn------Iv~l~~~~~~~~~~~lVmEy~~ggsL~~~--L~~~~~~~l~e~~~~~i~~qI~~a-L~yL 424 (489)
+ +.+.+.|-+ |+++|..+. ..-.|+||||+|..+.+. |++.+ ++...+... +.++ ..-|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~~---l~~~~~~qI 317 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILNK---LVEAYLEQI 317 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcC---CCHHHHHHH---HHHHHHHHH
Confidence 2 233344555 666665443 346899999999877654 44432 455543333 3332 2334
Q ss_pred HHCCCeecCCCCCCEEEec----CCcEEEEecCCccccCC
Q 042772 425 HCLGIIYRDLKPENILLQK----DGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 425 H~~gIvHrDLKP~NILld~----~g~vKL~DFGlS~~~~~ 460 (489)
-..|++|.|=.|.||++.. ++.+.+.|||+....+.
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 4689999999999999984 67899999999876653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.5e-05 Score=77.65 Aligned_cols=136 Identities=10% Similarity=0.043 Sum_probs=83.0
Q ss_pred cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--CcceeeEEEEeCCeEEEEEecCC
Q 042772 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP--FLPTLYASFQTSTHICLITDFCP 389 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hp--nIv~l~~~~~~~~~~~lVmEy~~ 389 (489)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..- .+++.+.+....+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999984 24467788775432 123457799999887533 35677777777777899999998
Q ss_pred CCC-HH--------------HHH-------hhCCCCCCCHHH-HHHHHHH----------HHH-HHHHHH----HCCCee
Q 042772 390 GGE-LF--------------ALL-------DKQPMKIFREDS-ARFYAAE----------VVI-GLEYLH----CLGIIY 431 (489)
Q Consensus 390 ggs-L~--------------~~L-------~~~~~~~l~e~~-~~~i~~q----------I~~-aL~yLH----~~gIvH 431 (489)
|.+ +. ..+ +..+........ ...+..+ +.. ...+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 11 111 111000011010 0111000 111 122222 124789
Q ss_pred cCCCCCCEEEecCCcEEEEecCCccc
Q 042772 432 RDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 432 rDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
+|+.|.||++++++ +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >TIGR02938 nifL_nitrog nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.9e-06 Score=91.26 Aligned_cols=130 Identities=14% Similarity=0.097 Sum_probs=85.6
Q ss_pred hhHHHHHHHHHhh----hhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhh
Q 042772 54 WDRAERERDIRQG----IDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEIL 129 (489)
Q Consensus 54 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~ 129 (489)
.|++++++.+++. ..+..+++.++.++++.|+ ++.|+++|++|++++|+...+..+.....+..+.
T Consensus 113 ~DIt~~k~~e~~l~~~~~~~~~~~~~~~~~i~~~d~---~~~i~~~N~~~~~~~g~~~~~~~~~~~~~~~~~~------- 182 (494)
T TIGR02938 113 RDITELHRLEQVVANQKLLIESVVDAAPVAFVLLDP---TGRVILDNQEYKKLATDLRVKEPAHTVLDLLREA------- 182 (494)
T ss_pred hhhhHHHHHHHHHHHHHHHHHHHHhcccceEEEEcC---CCCEEEechhHHHhhchhhhhHHHHHHHHHhhHH-------
Confidence 5888877766543 3467888999999999999 9999999999999999999887765432111111
Q ss_pred ccccccchhHHHHHHHhhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEE-EEEeeecCCC-eeeEEEeecccc
Q 042772 130 GRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITV-QLINYTKSGK-KFWNLFHLQPMR 207 (489)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~k~g~-~~~~~~~~~p~~ 207 (489)
.... +.+....+..+.. +....+++|. ..|......|+.
T Consensus 183 ------------------------------------~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (494)
T TIGR02938 183 ------------------------------------WREA---LAENWPQQLAFSNREARFDRGGGRPARWLSCTGSVIG 223 (494)
T ss_pred ------------------------------------hhhh---hhhcchhhhccccceeeeccCCCceeeEEEecCceEE
Confidence 0000 1111111111222 2222344545 789999999988
Q ss_pred cCCCCee---------EEeeeeccCCcccccccc
Q 042772 208 DHKGELQ---------YFIGVQLDGSDHVEPLRN 232 (489)
Q Consensus 208 ~~~g~~~---------~~~~~~~d~Te~ke~e~~ 232 (489)
+..|.+. +++++.+|||++++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~DITe~k~~ee~ 257 (494)
T TIGR02938 224 MESDCADSFFCAAEQPYLLLTIADISNLREEQER 257 (494)
T ss_pred eecchhhheeccCCCchheehHHHHHHHHHHHHH
Confidence 7776653 456688999999987764
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes. |
| >PF12860 PAS_7: PAS fold | Back alignment and domain information |
|---|
Probab=98.18 E-value=5.1e-06 Score=71.55 Aligned_cols=114 Identities=19% Similarity=0.270 Sum_probs=78.4
Q ss_pred HHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhh-cCCCccccccccchhhhhhccccccchhHHHHHHHhhhccc
Q 042772 73 LERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEI-LGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYG 151 (489)
Q Consensus 73 ~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~-~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (489)
||+++.||++-|+ ++.++++|++|.+++|++.+.+ .|.+..-+... ....+.+.
T Consensus 1 Ld~l~~Gv~v~D~---~~rl~~~N~~~~~l~~~~~~~~~~G~~~~~l~~~----------------------~~~~g~~~ 55 (115)
T PF12860_consen 1 LDSLPQGVAVFDS---DGRLVFWNQRFRELFGLPPEMLRPGASFRDLLRR----------------------LAERGEFP 55 (115)
T ss_pred CCCcCceEEEEcC---CCeEEeEcHHHHHHhCCCHHHhcCCCCHHHHHHH----------------------HHHcCCCC
Confidence 5788999999999 9999999999999999999998 78886533211 00111111
Q ss_pred ccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCccccccc
Q 042772 152 VYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLR 231 (489)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~ke~e~ 231 (489)
+....+.+...............++ ...||. |+.+..+|+-| | ++|.+..|||+.+++|+
T Consensus 56 -----------~~~~~~~~~~~~~~~~~~~~~~~~~--~~~dgr--~l~~~~~~~~~--G---g~v~~~~DVT~~~~~E~ 115 (115)
T PF12860_consen 56 -----------PGDPEAWVRQRLARLRRRQPRSFEL--RLPDGR--WLEVRAQPLPD--G---GFVLTFTDVTERRRAEE 115 (115)
T ss_pred -----------CCCHHHHHHHHHHHHhcCCCceeEE--ECCCCE--EEEEEeEECCC--C---CEEEEEEeCCHHHHhcC
Confidence 0123344444444455555555553 357886 67788888844 4 58899999999998764
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.13 E-value=4.5e-05 Score=72.53 Aligned_cols=141 Identities=24% Similarity=0.304 Sum_probs=82.5
Q ss_pred ccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--CcceeeEEEEe---CCeEEEEE
Q 042772 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP--FLPTLYASFQT---STHICLIT 385 (489)
Q Consensus 311 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hp--nIv~l~~~~~~---~~~~~lVm 385 (489)
++.|+.|..+.||++.... ..+++|..... .....+..|..+++.+... .+++++..... ....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4678999999999999775 47889986433 3345666788888877422 35667664432 34579999
Q ss_pred ecCCCCCHHH----------------HHh---hC--CCCCCCHHH---HH---H---H------------HHHHHH-HHH
Q 042772 386 DFCPGGELFA----------------LLD---KQ--PMKIFREDS---AR---F---Y------------AAEVVI-GLE 422 (489)
Q Consensus 386 Ey~~ggsL~~----------------~L~---~~--~~~~l~e~~---~~---~---i------------~~qI~~-aL~ 422 (489)
++++|.++.. .+. .. ....+.... .. . . ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988877 111 11 111111110 00 0 0 011111 233
Q ss_pred HHH-------HCCCeecCCCCCCEEEe-cCCcEEEEecCCcccc
Q 042772 423 YLH-------CLGIIYRDLKPENILLQ-KDGHVVLTDFDLSFMT 458 (489)
Q Consensus 423 yLH-------~~gIvHrDLKP~NILld-~~g~vKL~DFGlS~~~ 458 (489)
.++ ...++|+|+.|.||+++ +++.+.|+||+.+...
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 333 24599999999999999 6677789999988543
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.4e-05 Score=73.60 Aligned_cols=128 Identities=25% Similarity=0.308 Sum_probs=90.9
Q ss_pred cCcccccccCCCCc-eEEEEEEEcCCCcEEEEEEeecccccc------------------hHHHHHHHHHHHHHHhCC--
Q 042772 306 HHFKPIKPLGCGDT-GSVHLVELQGAGELYAMKAMEKSVMLN------------------RNKVHRACIEREIMSLLD-- 364 (489)
Q Consensus 306 ~~y~~~~~LG~G~f-G~Vy~a~~~~tg~~vAiK~i~~~~~~~------------------~~~~~~~~~E~~il~~l~-- 364 (489)
.+++.++.||.|.- |.||+++.. |+.||+|+........ ......|..|-....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 57999999999999 999999987 6799999932211111 023445777888777664
Q ss_pred -CCCc--ceeeEEEEeC------------------CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHH
Q 042772 365 -HPFL--PTLYASFQTS------------------THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEY 423 (489)
Q Consensus 365 -HpnI--v~l~~~~~~~------------------~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~y 423 (489)
+.++ ++++|+..-. ....||.||++... .++.. -+.+|.+-|..
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~----~~~~~~~dl~~ 179 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIR----DIPQMLRDLKI 179 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchh----HHHHHHHHHHH
Confidence 4456 8888887311 12467888776533 12222 34567788899
Q ss_pred HHHCCCeecCCCCCCEEEecCCcEEEEecCCc
Q 042772 424 LHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455 (489)
Q Consensus 424 LH~~gIvHrDLKP~NILld~~g~vKL~DFGlS 455 (489)
+|+.||+-+|+++.|.. .=||+|||.+
T Consensus 180 ~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999999975 3589999875
|
|
| >COG2202 AtoS FOG: PAS/PAC domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=5.7e-05 Score=65.99 Aligned_cols=116 Identities=26% Similarity=0.339 Sum_probs=88.5
Q ss_pred HHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhh
Q 042772 69 LATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKK 148 (489)
Q Consensus 69 ~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (489)
+..+++....++++.|. ++.|+++|+++.+++||+..+.++++...+.....
T Consensus 114 ~~~~~~~~~~~~~~~d~---~~~~~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~------------------------- 165 (232)
T COG2202 114 LRALLEASPDGIWVLDE---DGRILYANPAAEELLGYSPEEELGRGLSDLIHPED------------------------- 165 (232)
T ss_pred HHHHHhhCCceEEEEeC---CCCEEEeCHHHHHHhCCChHHhcCCChhheEecCC-------------------------
Confidence 78899999999999999 99999999999999999999888888655543320
Q ss_pred cccccccccCcccccCCCH-HHHHHHHHHHHcCCcEEEEEEeeecCCCe-eeEEEeecccccCCCCeeEEeeeeccCCcc
Q 042772 149 NYGVYNFTLGCCLEISSDQ-ATVSKIRDAVREQREITVQLINYTKSGKK-FWNLFHLQPMRDHKGELQYFIGVQLDGSDH 226 (489)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~k~g~~-~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~ 226 (489)
.+. ..................+.....++|.. .|....+.+..+ .|.+..+.....|+++.
T Consensus 166 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~~~ 228 (232)
T COG2202 166 ----------------EERRELELARALAEGRGGPLEIEYRVRRKDGERVRWILSRISPVRD-DGEIVGVVGIARDITER 228 (232)
T ss_pred ----------------CchhhHHHHHHhhccCCCCcceEEEEEecCCCEEEEEEeeeeEecC-CCceEEEEEEEechHHH
Confidence 111 01111222223334577888889999996 999888888776 78999999999999987
Q ss_pred ccc
Q 042772 227 VEP 229 (489)
Q Consensus 227 ke~ 229 (489)
++.
T Consensus 229 ~~~ 231 (232)
T COG2202 229 KQA 231 (232)
T ss_pred hhc
Confidence 753
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.03 E-value=6.9e-05 Score=73.12 Aligned_cols=137 Identities=16% Similarity=0.039 Sum_probs=82.7
Q ss_pred ccCCCCc-eEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEEEecCCC
Q 042772 313 PLGCGDT-GSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHICLITDFCPG 390 (489)
Q Consensus 313 ~LG~G~f-G~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lVmEy~~g 390 (489)
.|..|.. ..||++... +..+.+|...... ...+..|.++++.+. +--+++++.+....+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3444555 789998754 3577888765431 234556888888773 44567788777666678999999998
Q ss_pred CCHHHHH-------------------hhCC--CCCCCHH---HHHHHHH-------------------HHHHHHHHHH--
Q 042772 391 GELFALL-------------------DKQP--MKIFRED---SARFYAA-------------------EVVIGLEYLH-- 425 (489)
Q Consensus 391 gsL~~~L-------------------~~~~--~~~l~e~---~~~~i~~-------------------qI~~aL~yLH-- 425 (489)
.+|.... +..+ ..++... ....... .+...+..|-
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 7776432 1111 0011100 0000000 0111112221
Q ss_pred -----HCCCeecCCCCCCEEEecCCcEEEEecCCccc
Q 042772 426 -----CLGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 426 -----~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
...++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 23489999999999999887788999998853
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PRK11006 phoR phosphate regulon sensor protein; Provisional | Back alignment and domain information |
|---|
Probab=98.02 E-value=1.3e-05 Score=84.77 Aligned_cols=51 Identities=18% Similarity=0.168 Sum_probs=46.0
Q ss_pred hhhhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCcccc
Q 042772 65 QGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFL 118 (489)
Q Consensus 65 ~~~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l 118 (489)
....+.++++.+++++++.|+ +|.|+++|++|++++||+.+|++|+++..+
T Consensus 96 ~~~~~~~~~~~~~~~i~~~d~---~g~i~~~N~~a~~l~g~~~~~~~g~~~~~~ 146 (430)
T PRK11006 96 LIKRFRSGAESLPDAVVLTTE---EGNIFWCNGLAQQLLGFRWPEDNGQNILNL 146 (430)
T ss_pred HHHHHHHHHHhCCCeEEEEcC---CCceeHHHHHHHHHhCCCChHhCCCcHHHH
Confidence 345678899999999999999 999999999999999999999999987544
|
|
| >COG5002 VicK Signal transduction histidine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.00 E-value=2.7e-05 Score=78.62 Aligned_cols=120 Identities=17% Similarity=0.274 Sum_probs=95.9
Q ss_pred HHHhhhhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCcc-ccccccchhhhhhccccccchhHH
Q 042772 62 DIRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCS-FLELTEYTREEILGRNCSTYTFML 140 (489)
Q Consensus 62 ~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ 140 (489)
.+.+.+.|..+|-...++++-||. .|.|+.+|+..+++.|.+.|+++|++.- .|...+
T Consensus 106 ~e~Er~kL~SvlayMtDGViATdR---rG~iI~iN~~A~k~L~~~~E~~~~~~i~elL~i~d------------------ 164 (459)
T COG5002 106 TEQERRKLDSVLAYMTDGVIATDR---RGKIILINKPALKMLGVSKEDALGRSILELLKIED------------------ 164 (459)
T ss_pred HHHHHHHHHHHHHHHcCceEeecC---CCcEEEeccHHHHHhCcCHHHHhcccHHHHhCCcc------------------
Confidence 444667799999999999999999 9999999999999999999999999954 444332
Q ss_pred HHHHHhhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeee
Q 042772 141 YFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQ 220 (489)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~ 220 (489)
.- .+++.+......+... +..|+.+-..+..+-++-+.|-+.++|+|.
T Consensus 165 --------------------------~y---~~~dL~e~~~s~lld~---~~~~E~~~lrv~Fs~i~rEsGfisGlIaVl 212 (459)
T COG5002 165 --------------------------TY---TFEDLVEKNDSLLLDS---SDEEEGYVLRVNFSVIQRESGFISGLIAVL 212 (459)
T ss_pred --------------------------ce---eHHHHHhcCCcEEEee---cCCCccEEEEEEEEEEeecccccceeEEEE
Confidence 11 1344454555555543 348888999999999999999999999999
Q ss_pred ccCCcccccccccc
Q 042772 221 LDGSDHVEPLRNRL 234 (489)
Q Consensus 221 ~d~Te~ke~e~~~l 234 (489)
.|+||+.+.++++.
T Consensus 213 hDvTEqek~e~ErR 226 (459)
T COG5002 213 HDVTEQEKVERERR 226 (459)
T ss_pred ecccHHHHHHHHHH
Confidence 99999887666554
|
|
| >PRK10820 DNA-binding transcriptional regulator TyrR; Provisional | Back alignment and domain information |
|---|
Probab=97.97 E-value=2e-05 Score=85.98 Aligned_cols=105 Identities=11% Similarity=0.091 Sum_probs=76.4
Q ss_pred hhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHh
Q 042772 67 IDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALW 146 (489)
Q Consensus 67 ~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (489)
..+..+|+.++++|+++|. +|.|+++|+++++++|++.++++|+++.-+-...
T Consensus 80 ~~L~aIL~sm~eGVi~vD~---~G~I~~iN~aA~~Llg~~~eel~Gk~i~eli~~~------------------------ 132 (520)
T PRK10820 80 RALSALLEALPEPVLSIDM---KGKVELANPASCQLFGQSEEKLRNHTAAQLINGF------------------------ 132 (520)
T ss_pred HHHHHHHHhCCCcEEEECC---CCeeeHhHHHHHHHHCcCHHHHCCCcHHHHcCcc------------------------
Confidence 3478999999999999999 9999999999999999999999999987543221
Q ss_pred hhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccc--cCCCCe--eEEeeeecc
Q 042772 147 KKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMR--DHKGEL--QYFIGVQLD 222 (489)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~--~~~g~~--~~~~~~~~d 222 (489)
. +.+.+..++.. ........+|..|+ +.+.|+. |++|.. .++|.+.+|
T Consensus 133 ---------------------~----l~~~le~~~~~-~~~~~v~~~g~~~~--v~~~PI~~~d~~g~~~~~GaVivlrd 184 (520)
T PRK10820 133 ---------------------N----FLRWLESEPQD-SHNEHVVINGQDFL--MEITPVYLQDENDQHVLVGAVVMLRS 184 (520)
T ss_pred ---------------------h----HHHHHHcCCCc-cceEEEEECCEEEE--EEEEeeeecCCCCceeEEEEEEEecc
Confidence 1 12223333321 01122355688776 5568887 767664 789999999
Q ss_pred CCcc
Q 042772 223 GSDH 226 (489)
Q Consensus 223 ~Te~ 226 (489)
+++.
T Consensus 185 ~~~l 188 (520)
T PRK10820 185 TARM 188 (520)
T ss_pred HHHH
Confidence 9874
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00038 Score=66.50 Aligned_cols=137 Identities=18% Similarity=0.204 Sum_probs=93.2
Q ss_pred ccccCCCCceEEEEEEEcCCCcEEEEEEeeccccc-------------chHHHHHHHHHHHHHHhCC------CCCccee
Q 042772 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVML-------------NRNKVHRACIEREIMSLLD------HPFLPTL 371 (489)
Q Consensus 311 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~-------------~~~~~~~~~~E~~il~~l~------HpnIv~l 371 (489)
...||+|+.-.||.- .......||++.+.... .........+|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 467999999988863 33445678988765410 0112344455555444433 8899999
Q ss_pred eEEEEeCCeEEEEEecCC------CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC
Q 042772 372 YASFQTSTHICLITDFCP------GGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG 445 (489)
Q Consensus 372 ~~~~~~~~~~~lVmEy~~------ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g 445 (489)
+|+.++..-+.+|+|.+. ..+|.+++... .+++ .. ...+-.-..||-+.+|+.+||+|.||++....
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence 999999988999999763 24688888653 2444 22 22334456688899999999999999996432
Q ss_pred ----cEEEEe-cCCccc
Q 042772 446 ----HVVLTD-FDLSFM 457 (489)
Q Consensus 446 ----~vKL~D-FGlS~~ 457 (489)
.+.|+| ||....
T Consensus 156 ~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 156 SGEFRLVLIDGLGEKEL 172 (199)
T ss_pred CCceEEEEEeCCCCccc
Confidence 588888 666544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.93 E-value=9.4e-05 Score=85.11 Aligned_cols=80 Identities=19% Similarity=0.394 Sum_probs=56.4
Q ss_pred ccccCCCCceEEEEEEEcCCC--cEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCc--ceeeEEEEeC---CeEE
Q 042772 311 IKPLGCGDTGSVHLVELQGAG--ELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFL--PTLYASFQTS---THIC 382 (489)
Q Consensus 311 ~~~LG~G~fG~Vy~a~~~~tg--~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnI--v~l~~~~~~~---~~~~ 382 (489)
++.++.|.+..+|+......+ ..+++|........ .....+.+|..+++.+. |+++ ++++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 577899999999998876432 46777766443211 12245678999999985 6665 7777777654 4679
Q ss_pred EEEecCCCCC
Q 042772 383 LITDFCPGGE 392 (489)
Q Consensus 383 lVmEy~~ggs 392 (489)
+||||++|..
T Consensus 121 lVME~v~G~~ 130 (822)
T PLN02876 121 YIMEYLEGRI 130 (822)
T ss_pred EEEEecCCcc
Confidence 9999998754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=1.9e-05 Score=79.46 Aligned_cols=92 Identities=21% Similarity=0.378 Sum_probs=78.1
Q ss_pred HHhCCCCCcceeeEEEEeCC-----eEEEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC--CCe
Q 042772 360 MSLLDHPFLPTLYASFQTST-----HICLITDFCPGGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEYLHCL--GII 430 (489)
Q Consensus 360 l~~l~HpnIv~l~~~~~~~~-----~~~lVmEy~~ggsL~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH~~--gIv 430 (489)
|-++.|.||++++.+|.+.. .+.+++||+..|+|.++|++. ....+.......|+.||+.||.|||+- -|+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 34457999999999987643 588999999999999999873 234577888899999999999999976 499
Q ss_pred ecCCCCCCEEEecCCcEEEEe
Q 042772 431 YRDLKPENILLQKDGHVVLTD 451 (489)
Q Consensus 431 HrDLKP~NILld~~g~vKL~D 451 (489)
|+++..+-|++..+|.||+.-
T Consensus 201 hgnlTc~tifiq~ngLIkig~ 221 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGS 221 (458)
T ss_pred cCCcchhheeecCCceEEecc
Confidence 999999999999999988753
|
|
| >PF14598 PAS_11: PAS domain; PDB: 1P97_A 3F1O_A 2A24_A 3H7W_A 3F1P_A 3H82_A 3F1N_A 4F3L_B 4DJ3_A 2KDK_A | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.0002 Score=61.83 Aligned_cols=94 Identities=16% Similarity=0.215 Sum_probs=75.4
Q ss_pred CCCEEEecHh-hHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhcccccccccCcccccCCCH
Q 042772 89 DNPIIFASDS-FLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQ 167 (489)
Q Consensus 89 ~~~i~~~n~~-~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (489)
|+.|+++... ...++||.++|++|+.+-.|..++ |.
T Consensus 11 dgki~~~d~~~v~~~lgy~~~eLvG~s~y~~~H~~-------------------------------------------D~ 47 (111)
T PF14598_consen 11 DGKITYVDSRAVSSLLGYLPEELVGRSIYDFVHPD-------------------------------------------DL 47 (111)
T ss_dssp TSBEEEEETTHHHHHHSS-HHHHTTSBGGGGBSCC-------------------------------------------TH
T ss_pred CcEEEEEcCccChhhcCCCcHHHcCCchHHhCCHh-------------------------------------------hh
Confidence 9999999999 799999999999999988777774 44
Q ss_pred H--HHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCC-CCeeEEeeeeccCCc
Q 042772 168 A--TVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHK-GELQYFIGVQLDGSD 225 (489)
Q Consensus 168 ~--~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~-g~~~~~~~~~~d~Te 225 (489)
. ..+..++.+..++..+.-.....|+|...|+.....++.|.. ++..+++++..=++|
T Consensus 48 ~~~~~~~~~~~~~~g~~~~~~yR~~~k~g~~vwvqt~~~~~~n~~~~~~~~Iv~~n~vlse 108 (111)
T PF14598_consen 48 QRVLKQHHREVLQKGQSVSPYYRFRTKNGGYVWVQTKATLFYNPWTSKPEFIVCTNTVLSE 108 (111)
T ss_dssp HHHHHHHHHHHHHHSSEEEEEEEEE-TTSSEEEEEEEEEEEEETTTTCEEEEEEEEEEESC
T ss_pred hhHHHHHHHHHhhCCCcCcceEEEEecCCcEEEEEEEEEEEECCCCCCccEEEEEEEEecc
Confidence 4 334688888899988888888999999999999999999755 566777777655554
|
... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.0003 Score=65.60 Aligned_cols=134 Identities=23% Similarity=0.216 Sum_probs=94.2
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCc-ceeeEEEEeCCeEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFL-PTLYASFQTSTHICLI 384 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~lV 384 (489)
...+..+.|+.|++|.||+|.+. |..+|+|+-... .....+..|.++|..+.--++ +.+|.+-. .++.
T Consensus 22 ~~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d-----s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~ 90 (201)
T COG2112 22 YELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD-----SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIR 90 (201)
T ss_pred hhhhhhhhhhcccccEEEEeecc--CceEEEEEecCC-----cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhh
Confidence 34667789999999999999988 558899976433 334567779999999876555 34544322 3455
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC-CCCEEEecCCcEEEEecCCccccC
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLK-PENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLK-P~NILld~~g~vKL~DFGlS~~~~ 459 (489)
|||+.|-+|.+.-... +..++ ..++.+-.-|-..||-|..|. |...+|-.++.+.|+||.-|++..
T Consensus 91 me~i~G~~L~~~~~~~-----~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 91 MEYIDGRPLGKLEIGG-----DRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred hhhhcCcchhhhhhcc-----cHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 9999888887765431 22333 235555455667899998885 566666666699999999997443
|
|
| >PRK11086 sensory histidine kinase DcuS; Provisional | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00019 Score=77.69 Aligned_cols=108 Identities=18% Similarity=0.272 Sum_probs=75.8
Q ss_pred hHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCCh---hhhcCCCccccccccchhhhhhccccccchhHHHHHH
Q 042772 68 DLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTR---EEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLA 144 (489)
Q Consensus 68 ~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~---~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (489)
.+..+++.+.++++++|. ++.|+++|+++++++|++. ++.+|+.+..+...
T Consensus 222 ~~~~il~~~~~gIi~~D~---~g~I~~~N~~a~~llg~~~~~~~~~~~~~~~~~~~~----------------------- 275 (542)
T PRK11086 222 QRQAMLQSIKEGVIAVDD---RGEVTLINDEAKRLFNYKKGLEDDPLGTDVESWMPV----------------------- 275 (542)
T ss_pred HHHHHHHHhcCcEEEECC---CCeEEEEhHHHHHHhCCCcCCcccccCCcHHHhCCc-----------------------
Confidence 356889999999999999 9999999999999998763 45566554322211
Q ss_pred HhhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCC
Q 042772 145 LWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGS 224 (489)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~T 224 (489)
..+...+..+++...+.. +.+|..+ .....|+.+ +|++.+++.+.+|+|
T Consensus 276 --------------------------~~~~~~~~~~~~~~~~~~--~~~g~~~--~~~~~pi~~-~g~~~g~v~~~rDit 324 (542)
T PRK11086 276 --------------------------SRLKEVLRTGTPRRDEEI--NINGRLL--LTNTVPVRV-NGEIIGAIATFRDKT 324 (542)
T ss_pred --------------------------hhHHHHHhcCCCccceEE--EECCEEE--EEEEEEEeE-CCEEEEEEEEEEEch
Confidence 123444555554433222 3356544 456789998 899999999999999
Q ss_pred cccccccc
Q 042772 225 DHVEPLRN 232 (489)
Q Consensus 225 e~ke~e~~ 232 (489)
+.++.+++
T Consensus 325 e~~~l~~~ 332 (542)
T PRK11086 325 EVRQLAQR 332 (542)
T ss_pred HHHHHHHH
Confidence 97765443
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00048 Score=66.97 Aligned_cols=74 Identities=11% Similarity=0.114 Sum_probs=44.8
Q ss_pred ccccCCCCce-EEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC---CcceeeEEEEeC---CeEEE
Q 042772 311 IKPLGCGDTG-SVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP---FLPTLYASFQTS---THICL 383 (489)
Q Consensus 311 ~~~LG~G~fG-~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hp---nIv~l~~~~~~~---~~~~l 383 (489)
++.|+.|+.. .||+.. ..+++|..... .....+..|.+++..+... -++.+++..... ...++
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 4567766665 588752 34677865432 1234677899998877521 344555433322 23588
Q ss_pred EEecCCCCCHH
Q 042772 384 ITDFCPGGELF 394 (489)
Q Consensus 384 VmEy~~ggsL~ 394 (489)
+|++++|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999886653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00063 Score=65.80 Aligned_cols=75 Identities=28% Similarity=0.365 Sum_probs=47.6
Q ss_pred ccccCCCCceEEEEEEEcC-CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEEEecC
Q 042772 311 IKPLGCGDTGSVHLVELQG-AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHICLITDFC 388 (489)
Q Consensus 311 ~~~LG~G~fG~Vy~a~~~~-tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lVmEy~ 388 (489)
++.|..|-...+|++.... .++.|++|....... ..-....|..+++.+. +...++++..+. . .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEee
Confidence 4567788889999987553 356788997654311 1112235888888774 333455554432 1 4799999
Q ss_pred CCCCH
Q 042772 389 PGGEL 393 (489)
Q Consensus 389 ~ggsL 393 (489)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 88665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK11388 DNA-binding transcriptional regulator DhaR; Provisional | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00048 Score=77.11 Aligned_cols=106 Identities=15% Similarity=0.233 Sum_probs=76.9
Q ss_pred hHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhh
Q 042772 68 DLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWK 147 (489)
Q Consensus 68 ~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (489)
.+...++.+.++|++.|+ +|.|+++|+++++++|++.++++|+++..+...
T Consensus 204 ~~~~il~~~~~gVl~vD~---~G~I~~~N~aa~~llg~s~~~l~G~~i~~l~~~-------------------------- 254 (638)
T PRK11388 204 QLNALLESMDDGVIAWDE---QGNLQFLNAQAARLLRLDATASQGRAITELLTL-------------------------- 254 (638)
T ss_pred HHHHHHhccCCcEEEECC---CCeEehhhHHHHHHhCcCHHHHCCCcHHHHhcc--------------------------
Confidence 345688999999999999 999999999999999999999999987544311
Q ss_pred hcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCcc
Q 042772 148 KNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDH 226 (489)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~ 226 (489)
. ..+.+.+..++.+...-.....+|..+|+.+++.|+.+..|.. ++.+..|++..
T Consensus 255 ------------------~----~~l~~vl~~~~~~~~~~~~l~~~g~~~~~~v~~~Pi~~~~g~~--~v~~l~~~~~~ 309 (638)
T PRK11388 255 ------------------P----AVLQQAIKQAHPLKHVEVTFESQGQFIDAVITLKPIIEGQGTS--FILLLHPVEQM 309 (638)
T ss_pred ------------------c----hHHHHHHhcCCceeeEEEEEecCCceEEEEEEEEeecccCceE--EEEEehhhHHH
Confidence 0 1234455556655443344455788889999999997655542 55555676653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 489 | ||||
| 2v1a_A | 144 | N- And C-Terminal Helices Of Oat Lov2 (404-546) Are | 4e-50 | ||
| 2v0u_A | 146 | N- And C-terminal Helices Of Oat Lov2 (404-546) Are | 4e-50 | ||
| 2wkp_A | 332 | Structure Of A Photoactivatable Rac1 Containing Lov | 7e-50 | ||
| 2wkq_A | 332 | Structure Of A Photoactivatable Rac1 Containing The | 7e-49 | ||
| 2wkr_A | 332 | Structure Of A Photoactivatable Rac1 Containing The | 9e-49 | ||
| 4eep_A | 115 | Crystal Structure Of Lov2 Domain Of Arabidopsis Tha | 2e-45 | ||
| 4eer_A | 115 | Crystal Structure Of Lov2 Domain Of Arabidopsis Tha | 1e-44 | ||
| 4ees_A | 115 | Crystal Structure Of Ilov Length = 115 | 8e-43 | ||
| 4eeu_A | 118 | Crystal Structure Of Philov2.1 Length = 118 | 4e-39 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-34 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-33 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-32 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-32 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-32 | ||
| 1g28_A | 104 | Structure Of A Flavin-Binding Domain, Lov2, From Th | 7e-32 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-31 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-30 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-30 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-30 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-30 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-30 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-30 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-30 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-30 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-30 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-30 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-30 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-30 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-28 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-28 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-28 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-28 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-28 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-28 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-28 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-28 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-28 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-28 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-28 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-28 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-28 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-28 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-28 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-28 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-28 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-28 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-28 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-28 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-27 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-27 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-27 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-27 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-27 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-27 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-27 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-27 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-27 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-27 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-27 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-27 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-27 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-27 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-27 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-27 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-27 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-27 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-27 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-27 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-27 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-27 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-27 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-27 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-27 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-27 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-27 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-27 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-27 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-27 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-27 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-27 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-26 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-26 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-26 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-26 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-26 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-26 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-26 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-25 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-25 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-25 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-25 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-25 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-25 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-25 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-25 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-25 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-25 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-25 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-25 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-25 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-25 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-25 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-25 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-25 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-25 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-25 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-24 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-24 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-24 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-23 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-23 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-23 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-23 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-23 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-23 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-23 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-23 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-23 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-22 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-21 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-21 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-21 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-21 | ||
| 3ulf_A | 170 | The Light State Structure Of The Blue-light Photore | 4e-20 | ||
| 3ue6_A | 166 | The Dark Structure Of The Blue-light Photoreceptor | 4e-20 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-20 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-20 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-20 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-20 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-19 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-19 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-19 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-19 | ||
| 2z6d_A | 130 | Crystal Structure Of Lov1 Domain Of Phototropin2 Fr | 7e-18 | ||
| 3t50_A | 128 | X-Ray Structure Of The Lov Domain From The Lov-Hk S | 4e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-16 | ||
| 1n9l_A | 109 | Crystal Structure Of The Phot-lov1 Domain From Chla | 9e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-15 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-15 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-15 | ||
| 2pr5_A | 132 | Structural Basis For Light-dependent Signaling In T | 6e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-14 | ||
| 2z6c_A | 129 | Crystal Structure Of Lov1 Domain Of Phototropin1 Fr | 2e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-14 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-14 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-13 | ||
| 3rh8_B | 148 | Crystal Structure Of The Light-State Dimer Of Funga | 2e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3hjk_A | 154 | 2.0 Angstrom Structure Of The Ile74val Variant Of V | 2e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-13 | ||
| 3p7n_A | 258 | Crystal Structure Of Light Activated Transcription | 2e-13 | ||
| 3hji_A | 154 | 1.8 Angstrom Crystal Structure Of The I74v:i85v Var | 2e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-13 | ||
| 3is2_B | 154 | 2.3 Angstrom Crystal Structure Of A Cys71 Sulfenic | 3e-13 | ||
| 3d72_A | 149 | 1.65 Angstrom Crystal Structure Of The Cys71val Var | 3e-13 | ||
| 3is2_A | 154 | 2.3 Angstrom Crystal Structure Of A Cys71 Sulfenic | 3e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-13 | ||
| 2pd7_A | 149 | 2.0 Angstrom Crystal Structure Of The Fungal Blue-L | 3e-13 | ||
| 2pd8_A | 149 | 1.8 Angstrom Crystal Structure Of The Cys71ser Muta | 3e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-12 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-12 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-12 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-12 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-12 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 3sw1_A | 162 | Structure Of A Full-Length Bacterial Lov Protein Le | 1e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-07 | ||
| 4hia_A | 176 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 4e-07 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-07 | ||
| 4hj3_A | 176 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 5e-07 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-07 | ||
| 4hj6_A | 178 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 5e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-07 | ||
| 4hj4_A | 177 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 6e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-06 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-06 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-06 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-06 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-06 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-06 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 5e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 6e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-05 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-05 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-05 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-05 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-05 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-05 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-05 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-05 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-05 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-05 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-05 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-05 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-05 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-05 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-05 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-05 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-05 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-05 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-05 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-05 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-05 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-05 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-05 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-05 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-05 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-05 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-04 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-04 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-04 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-04 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-04 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-04 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-04 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-04 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-04 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-04 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-04 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-04 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-04 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-04 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-04 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-04 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-04 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-04 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-04 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 7e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 8e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-04 |
| >pdb|2V1A|A Chain A, N- And C-Terminal Helices Of Oat Lov2 (404-546) Are Involved In Light-Induced Signal Transduction (Room Temperature (293k) Dark Structure Of Lov2 (404-546)) Length = 144 | Back alignment and structure |
|
| >pdb|2V0U|A Chain A, N- And C-terminal Helices Of Oat Lov2 (404-546) Are Involved In Light-induced Signal Transduction (cryo Dark Structure Of Lov2 (404-546)) Length = 146 | Back alignment and structure |
|
| >pdb|2WKP|A Chain A, Structure Of A Photoactivatable Rac1 Containing Lov2 Wildtype Length = 332 | Back alignment and structure |
|
| >pdb|2WKQ|A Chain A, Structure Of A Photoactivatable Rac1 Containing The Lov2 C450a Mutant Length = 332 | Back alignment and structure |
|
| >pdb|2WKR|A Chain A, Structure Of A Photoactivatable Rac1 Containing The Lov2 C450m Mutant Length = 332 | Back alignment and structure |
|
| >pdb|4EEP|A Chain A, Crystal Structure Of Lov2 Domain Of Arabidopsis Thaliana Phototropin 2 Length = 115 | Back alignment and structure |
|
| >pdb|4EER|A Chain A, Crystal Structure Of Lov2 Domain Of Arabidopsis Thaliana Phototropin 2 C426a Mutant Length = 115 | Back alignment and structure |
|
| >pdb|4EES|A Chain A, Crystal Structure Of Ilov Length = 115 | Back alignment and structure |
|
| >pdb|4EEU|A Chain A, Crystal Structure Of Philov2.1 Length = 118 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1G28|A Chain A, Structure Of A Flavin-Binding Domain, Lov2, From The Chimeric PhytochromePHOTOTROPIN PHOTORECEPTOR PHY3 Length = 104 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3ULF|A Chain A, The Light State Structure Of The Blue-light Photoreceptor Aureochrome1 Lov Length = 170 | Back alignment and structure |
|
| >pdb|3UE6|A Chain A, The Dark Structure Of The Blue-light Photoreceptor Aureochrome1 Lov Length = 166 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2Z6D|A Chain A, Crystal Structure Of Lov1 Domain Of Phototropin2 From Arabidopsis Thaliana Length = 130 | Back alignment and structure |
|
| >pdb|3T50|A Chain A, X-Ray Structure Of The Lov Domain From The Lov-Hk Sensory Protein From Brucella Abortus (Dark State). Length = 128 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1N9L|A Chain A, Crystal Structure Of The Phot-lov1 Domain From Chlamydomonas Reinhardtii In The Dark State. Length = 109 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2PR5|A Chain A, Structural Basis For Light-dependent Signaling In The Dimeric Lov Photosensor Ytva (dark Structure) Length = 132 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2Z6C|A Chain A, Crystal Structure Of Lov1 Domain Of Phototropin1 From Arabidopsis Thaliana Length = 129 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3RH8|B Chain B, Crystal Structure Of The Light-State Dimer Of Fungal Blue-Light Photoreceptor Vivid Length = 148 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3HJK|A Chain A, 2.0 Angstrom Structure Of The Ile74val Variant Of Vivid (Vvd). Length = 154 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3P7N|A Chain A, Crystal Structure Of Light Activated Transcription Factor El222 From Erythrobacter Litoralis Length = 258 | Back alignment and structure |
|
| >pdb|3HJI|A Chain A, 1.8 Angstrom Crystal Structure Of The I74v:i85v Variant Of Vivid (Vvd). Length = 154 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3IS2|B Chain B, 2.3 Angstrom Crystal Structure Of A Cys71 Sulfenic Acid Form Of Vivid Length = 154 | Back alignment and structure |
|
| >pdb|3D72|A Chain A, 1.65 Angstrom Crystal Structure Of The Cys71val Variant In The Fungal Photoreceptor Vvd Length = 149 | Back alignment and structure |
|
| >pdb|3IS2|A Chain A, 2.3 Angstrom Crystal Structure Of A Cys71 Sulfenic Acid Form Of Vivid Length = 154 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2PD7|A Chain A, 2.0 Angstrom Crystal Structure Of The Fungal Blue-Light Photoreceptor Vivid Length = 149 | Back alignment and structure |
|
| >pdb|2PD8|A Chain A, 1.8 Angstrom Crystal Structure Of The Cys71ser Mutant Of Vivid Length = 149 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3SW1|A Chain A, Structure Of A Full-Length Bacterial Lov Protein Length = 162 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4HIA|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 176 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4HJ3|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 176 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4HJ6|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 178 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HJ4|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 177 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 489 | |||
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 4e-65 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-62 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-62 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 5e-62 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-61 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-61 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 5e-61 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 9e-61 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-60 | |
| 2wkq_A | 332 | NPH1-1, RAS-related C3 botulinum toxin substrate 1 | 3e-60 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 3e-60 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 6e-60 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-59 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-59 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 2e-59 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 4e-59 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-58 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 5e-58 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 8e-58 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 7e-56 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 8e-56 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-55 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 4e-54 | |
| 2v0u_A | 146 | NPH1-1, LOV2; kinase, transferase, ATP-binding, se | 2e-52 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-49 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 3e-49 | |
| 3ue6_A | 166 | Aureochrome1; PAS/LOV domain, FMN-binding blue-lig | 5e-47 | |
| 3p7n_A | 258 | Sensor histidine kinase; LOV domain, light-activat | 6e-47 | |
| 4eet_B | 115 | Phototropin-2; LOV, blue light photoreceptor, sign | 9e-47 | |
| 2z6d_A | 130 | Phototropin-2; PAS-fold, LOV-fold, alternative spl | 5e-45 | |
| 3d72_A | 149 | Vivid PAS protein VVD; circadian, photoreceptor, b | 1e-43 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 3e-43 | |
| 2l0w_A | 138 | Potassium voltage-gated channel, subfamily H (EAG | 8e-43 | |
| 1n9l_A | 109 | PHOT-LOV1, putative blue light receptor; phototrop | 5e-42 | |
| 3sw1_A | 162 | Sensory box protein; light-oxygen-voltage, LOV, PA | 6e-42 | |
| 3t50_A | 128 | Blue-light-activated histidine kinase; PAS superfa | 1e-41 | |
| 2pr5_A | 132 | Blue-light photoreceptor; light-oxygen-voltage, LO | 2e-40 | |
| 1byw_A | 110 | Protein (human ERG potassium channel); PAS domain, | 1e-39 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-39 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-38 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-37 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 8e-36 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 8e-36 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-35 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-34 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 3e-34 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-33 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-33 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-32 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 5e-32 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 6e-32 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 6e-32 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 7e-32 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-31 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 5e-31 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 6e-31 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 6e-31 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 6e-31 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 8e-31 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-30 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-30 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-30 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-30 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-30 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-30 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-30 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-30 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-30 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-30 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 3e-30 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 3e-30 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 4e-30 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 6e-30 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 6e-30 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 7e-30 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 7e-30 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 9e-30 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 9e-30 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 1e-29 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-29 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-29 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-29 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-29 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-29 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 4e-29 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 5e-29 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 6e-29 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 1e-28 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 4e-28 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 4e-28 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 5e-28 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 8e-28 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-27 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-27 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-27 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 7e-27 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 7e-27 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 5e-26 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 6e-26 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 8e-26 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 9e-26 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-25 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 3e-25 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 9e-25 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-24 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-24 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-23 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 3e-23 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 7e-23 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 1e-22 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-22 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-22 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 3e-22 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 4e-22 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 9e-22 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-21 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-21 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-21 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 3e-21 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-21 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 5e-21 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 9e-21 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-20 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-20 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 4e-20 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-19 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-19 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 3e-19 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-19 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 4e-19 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 4e-19 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-18 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 4e-18 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 5e-18 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-17 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-17 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-17 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 6e-17 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-16 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-16 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-15 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-15 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 7e-14 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-13 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-13 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-13 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 6e-13 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 1e-12 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 7e-10 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-12 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 3e-12 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 4e-12 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 4e-12 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 6e-12 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 6e-12 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-11 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-11 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-11 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 3e-11 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 6e-11 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 7e-11 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 8e-11 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 9e-11 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-10 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-10 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 1e-10 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-10 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-10 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-10 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 3e-10 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 3e-10 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 3e-10 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 3e-10 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 3e-10 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 4e-10 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 5e-10 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 6e-10 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 9e-10 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 9e-10 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-09 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-09 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-09 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-09 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-09 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 2e-09 | |
| 3lyx_A | 124 | Sensory BOX/ggdef domain protein; structural genom | 2e-09 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 3e-09 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 3e-09 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 3e-09 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-09 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 3e-09 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 4e-09 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 4e-09 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 4e-09 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 5e-09 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 5e-09 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 5e-09 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 5e-09 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 5e-09 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 6e-09 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 8e-09 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 8e-09 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-08 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-08 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-08 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 1e-08 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-08 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-08 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-08 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-08 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 3e-08 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 3e-08 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 3e-08 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 4e-08 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 4e-08 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 5e-08 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 5e-08 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 5e-08 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 5e-08 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 6e-08 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 6e-08 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 6e-08 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 7e-08 | |
| 2gj3_A | 120 | Nitrogen fixation regulatory protein; PAS domain, | 8e-08 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 9e-08 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 1e-07 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-07 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-07 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-07 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-07 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 3e-07 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 4e-07 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 5e-07 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 7e-07 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-06 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-06 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 3e-06 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 4e-06 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 5e-06 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 7e-06 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 8e-06 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-05 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-05 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-05 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-05 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 3e-05 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-04 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-04 | |
| 3mqq_A | 120 | Transcriptional regulator, LUXR family; PAS domain | 2e-04 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-04 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-04 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-04 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 4e-04 |
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 4e-65
Identities = 66/174 (37%), Positives = 86/174 (49%), Gaps = 2/174 (1%)
Query: 282 PHKRDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEK 341
R + + + K FK K LG G +V L YA+K +EK
Sbjct: 6 AEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEK 65
Query: 342 SVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQP 401
++ NKV ER++MS LDHPF LY +FQ + + GEL + K
Sbjct: 66 RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 124
Query: 402 MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
F E RFY AE+V LEYLH GII+RDLKPENILL +D H+ +TDF +
Sbjct: 125 -GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA 177
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 1e-62
Identities = 53/154 (34%), Positives = 89/154 (57%), Gaps = 3/154 (1%)
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS 361
++ ++ +K +G G G V LV + ++YAMK + K M+ R+ ER+IM+
Sbjct: 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 124
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
+ P++ L+ +FQ ++ ++ ++ PGG+L L+ E ARFY AEVV+ L
Sbjct: 125 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLAL 181
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ +H +G I+RD+KP+N+LL K GH+ L DF
Sbjct: 182 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 215
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 1e-62
Identities = 53/154 (34%), Positives = 91/154 (59%), Gaps = 1/154 (0%)
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS 361
++ F+ +K +G G V +V+++ G++YAMK M K ML R +V ER+++
Sbjct: 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLV 116
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
D ++ L+ +FQ ++ L+ ++ GG+L LL K + + ARFY AE+V+ +
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAI 175
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ +H LG ++RD+KP+NILL + GH+ L DF
Sbjct: 176 DSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC 209
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 5e-62
Identities = 72/165 (43%), Positives = 104/165 (63%), Gaps = 6/165 (3%)
Query: 294 QKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVE---LQGAGELYAMKAMEKSVMLNRNKV 350
+ EK F+ +K LG G G V LV+ A +LYAMK ++K+ + R++V
Sbjct: 12 HHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV 71
Query: 351 HRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSA 410
+ER+I+ ++HPF+ L+ +FQT + LI DF GG+LF L K+ +F E+
Sbjct: 72 R-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDV 128
Query: 411 RFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+FY AE+ + L++LH LGIIYRDLKPENILL ++GH+ LTDF LS
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 1e-61
Identities = 68/154 (44%), Positives = 98/154 (63%), Gaps = 2/154 (1%)
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS 361
K L F+ ++ LG G G VHL+ + G YAMK ++K +++ +V ER ++S
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
++ HPF+ ++ +FQ + I +I D+ GGELF+LL K + F A+FYAAEV + L
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLAL 119
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
EYLH IIYRDLKPENILL K+GH+ +TDF +
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 153
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 3e-61
Identities = 54/155 (34%), Positives = 91/155 (58%), Gaps = 1/155 (0%)
Query: 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIM 360
++ F+ +K +G G G V +V+L+ A +++AMK + K ML R + ER+++
Sbjct: 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL 128
Query: 361 SLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIG 420
D ++ TL+ +FQ ++ L+ D+ GG+L LL K E+ ARFY AE+VI
Sbjct: 129 VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIA 187
Query: 421 LEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
++ +H L ++RD+KP+NIL+ +GH+ L DF
Sbjct: 188 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC 222
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 5e-61
Identities = 68/167 (40%), Positives = 96/167 (57%), Gaps = 8/167 (4%)
Query: 294 QKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVE---LQGAGELYAMKAMEKSVMLNRNKV 350
+ EKI F+ ++ LG G G V V G+++AMK ++K++++ K
Sbjct: 5 TSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAK- 63
Query: 351 HRACI--EREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFRED 408
A ER I+ + HPF+ L +FQT + LI ++ GGELF L+++ IF ED
Sbjct: 64 DTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMED 121
Query: 409 SARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+A FY AE+ + L +LH GIIYRDLKPENI+L GHV LTDF L
Sbjct: 122 TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 9e-61
Identities = 67/172 (38%), Positives = 100/172 (58%), Gaps = 7/172 (4%)
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS 361
K+ ++ F +K LG G G V LV + G YAMK + K V++ +++V E ++
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
HPFL L +FQT +C + ++ GGELF L ++ ++F E+ ARFY AE+V L
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSAL 118
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGF 473
EYLH ++YRD+K EN++L KDGH+ +TDF L CK + A + F
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL-----CKEGISDGATMKTF 165
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 1e-60
Identities = 57/157 (36%), Positives = 92/157 (58%), Gaps = 2/157 (1%)
Query: 299 SGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE 358
E + HF+ ++ +G G G V +V+ ++YAMK M K + RN+V E +
Sbjct: 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQ 67
Query: 359 IMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVV 418
IM L+HPFL L+ SFQ + ++ D GG+L L + F+E++ + + E+V
Sbjct: 68 IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELV 125
Query: 419 IGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ L+YL II+RD+KP+NILL + GHV +TDF+++
Sbjct: 126 MALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA 162
|
| >2wkq_A NPH1-1, RAS-related C3 botulinum toxin substrate 1; transferase, cell adhesion, nucleotide-binding, protein engineering, RAS superfamily LOV2; HET: GTP FMN; 1.60A {Avena sativa} PDB: 2wkr_A* 2wkp_A* Length = 332 | Back alignment and structure |
|---|
Score = 200 bits (509), Expect = 3e-60
Identities = 110/269 (40%), Positives = 142/269 (52%), Gaps = 50/269 (18%)
Query: 58 ERERDIRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSF 117
LATTLERIEKNFVITDPR+PDNPIIFASDSFL+LTEY+REEILGRN F
Sbjct: 2 RGSHHHHHHGSLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNARF 61
Query: 118 LELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAV 177
L+ E +D+ATV KIRDA+
Sbjct: 62 LQGPE------------------------------------------TDRATVRKIRDAI 79
Query: 178 REQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNRLSEK 237
Q E+TVQLINYTKSGKKFWNLFHLQPMRD KG++QYFIGVQLDG++HV R
Sbjct: 80 DNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVRDAAEREGVM 139
Query: 238 TEQQSAKIVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNS-SWIAIQKI 296
+++A+ + A+ + + + D + L ++ FP + ++ A +
Sbjct: 140 LIKKTAENIDEAAKELIK-CVVVGDGAVGKTCLLISYTTNAFPGEYIPTVFDNYSANVMV 198
Query: 297 TGSGEKIGL------HHFKPIKPLGCGDT 319
G +GL + ++PL T
Sbjct: 199 DGKPVNLGLWDTAGLEDYDRLRPLSYPQT 227
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 3e-60
Identities = 72/197 (36%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 275 SQPVFPRPH----KRDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGA 330
SQP P + I S F +K +G G G V L +
Sbjct: 3 SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAE 62
Query: 331 GELYAMKAMEKSVMLNRNKVHRACIEREIMSL-LDHPFLPTLYASFQTSTHICLITDFCP 389
YA+K ++K +L + + ER ++ + HPFL L+ SFQT+ + + D+
Sbjct: 63 EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 122
Query: 390 GGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVL 449
GGELF L ++ + F E ARFYAAE+ L YLH L I+YRDLKPENILL GH+VL
Sbjct: 123 GGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVL 180
Query: 450 TDFDLSFMTSCKPQVFY 466
TDF L CK + +
Sbjct: 181 TDFGL-----CKENIEH 192
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 6e-60
Identities = 55/159 (34%), Positives = 93/159 (58%), Gaps = 3/159 (1%)
Query: 298 GSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIER 357
G+ + +GL F ++ +G G V LV L+ +YAMK ++K ++ + + E+
Sbjct: 1 GAMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEK 60
Query: 358 EIMSL-LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAE 416
+ +HPFL L++ FQT + + + ++ GG+L + +Q + E+ ARFY+AE
Sbjct: 61 HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAE 118
Query: 417 VVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ + L YLH GIIYRDLK +N+LL +GH+ LTD+ +
Sbjct: 119 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 1e-59
Identities = 74/170 (43%), Positives = 105/170 (61%), Gaps = 7/170 (4%)
Query: 291 IAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVE---LQGAGELYAMKAMEKSVMLNR 347
+ +TG EK+G+ +F+ +K LG G G V LV G+LYAMK ++K+ ++ +
Sbjct: 39 LRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK 98
Query: 348 NK-VHRACIEREIMSLLDH-PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIF 405
K ER+++ + PFL TL+ +FQT T + LI D+ GGELF L ++ + F
Sbjct: 99 AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERF 156
Query: 406 REDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
E + Y E+V+ LE+LH LGIIYRD+K ENILL +GHVVLTDF LS
Sbjct: 157 TEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-59
Identities = 59/180 (32%), Positives = 101/180 (56%), Gaps = 8/180 (4%)
Query: 288 SSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNR 347
++ ++ G+ +++ L F + LG G G V L E +G ELYA+K ++K V++
Sbjct: 2 TNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD 61
Query: 348 NKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFR 406
+ V +E+ +++L PFL L++ FQT + + ++ GG+L + + F+
Sbjct: 62 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFK 119
Query: 407 EDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFY 466
E A FYAAE+ IGL +L GIIYRDLK +N++L +GH+ + DF + CK ++
Sbjct: 120 EPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM-----CKENIWD 174
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-59
Identities = 61/174 (35%), Positives = 99/174 (56%), Gaps = 8/174 (4%)
Query: 294 QKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRA 353
++ K+ + F K LG G G V L E + + +A+KA++K V+L + V
Sbjct: 5 KERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT 64
Query: 354 CIEREIMSL-LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARF 412
+E+ ++SL +HPFL ++ +FQT ++ + ++ GG+L + Q F A F
Sbjct: 65 MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATF 122
Query: 413 YAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFY 466
YAAE+++GL++LH GI+YRDLK +NILL KDGH+ + DF + CK +
Sbjct: 123 YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGM-----CKENMLG 171
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 4e-59
Identities = 59/157 (37%), Positives = 95/157 (60%), Gaps = 2/157 (1%)
Query: 299 SGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE 358
S L F IK LG G G V LV+ + +G YAMK ++K ++ ++ E+
Sbjct: 34 SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 359 IMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVV 418
I+ ++ PFL L SF+ ++++ ++ ++ GGE+F+ L + F E ARFYAA++V
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIV 151
Query: 419 IGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ EYLH L +IYRDLKPEN+L+ + G++ +TDF +
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-58
Identities = 66/171 (38%), Positives = 98/171 (57%), Gaps = 8/171 (4%)
Query: 297 TGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIE 356
S ++G+ +F+ I+ LG G G V L ++ G+LYA+K ++K V+L + V E
Sbjct: 14 VNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE 73
Query: 357 REIMSL-LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAA 415
+ I+SL +HPFL L+ FQT + + +F GG+L + K + F E ARFYAA
Sbjct: 74 KRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAA 131
Query: 416 EVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFY 466
E++ L +LH GIIYRDLK +N+LL +GH L DF + CK +
Sbjct: 132 EIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM-----CKEGICN 177
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 5e-58
Identities = 53/177 (29%), Positives = 95/177 (53%), Gaps = 3/177 (1%)
Query: 280 PRPHKRDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAM 339
+ + ++ + +GL F ++ +G G V LV L+ +YAM+ +
Sbjct: 26 MGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV 85
Query: 340 EKSVMLNRNKVHRACIEREIMSL-LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLD 398
+K ++ + + E+ + +HPFL L++ FQT + + + ++ GG+L +
Sbjct: 86 KKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ 145
Query: 399 KQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+Q + E+ ARFY+AE+ + L YLH GIIYRDLK +N+LL +GH+ LTD+ +
Sbjct: 146 RQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 8e-58
Identities = 73/226 (32%), Positives = 114/226 (50%), Gaps = 9/226 (3%)
Query: 249 TAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNSSWIAIQKITGSGEKIGLHHF 308
T E E + + A P + + + + ++ ++ F
Sbjct: 92 TPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEV-SLAKPKHRVTMNEF 150
Query: 309 KPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFL 368
+ +K LG G G V LV+ + G YAMK ++K V++ +++V E ++ HPFL
Sbjct: 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210
Query: 369 PTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC-L 427
L SFQT +C + ++ GGELF L ++ ++F ED ARFY AE+V L+YLH
Sbjct: 211 TALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK 268
Query: 428 GIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGF 473
++YRDLK EN++L KDGH+ +TDF L CK + A + F
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGL-----CKEGIKDGATMKTF 309
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 7e-56
Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 2/228 (0%)
Query: 230 LRNRLSEKTEQQSAKIVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNSS 289
+N LS ++ + N + + + P +L E H +S
Sbjct: 106 TQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSI 165
Query: 290 WIA--IQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNR 347
+ +Q + + + F+ + LG G G V +++ G++YA K +EK + R
Sbjct: 166 YFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR 225
Query: 348 NKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFRE 407
A E++I+ ++ F+ +L +++T +CL+ GG+L + F E
Sbjct: 226 KGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE 285
Query: 408 DSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
A FYAAE+ GLE LH I+YRDLKPENILL GH+ ++D L+
Sbjct: 286 ARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA 333
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 8e-56
Identities = 56/175 (32%), Positives = 90/175 (51%), Gaps = 7/175 (4%)
Query: 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIM 360
+ +G F + LG G G V +++ G+LYA K + K + R A +E++I+
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL 239
Query: 361 SLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDK--QPMKIFREDSARFYAAEVV 418
+ + F+ +L +F+T T +CL+ GG++ + + F+E A FY A++V
Sbjct: 240 AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 419 IGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGF 473
GLE+LH IIYRDLKPEN+LL DG+V ++D L G+
Sbjct: 300 SGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL-----AVELKAGQTKTKGY 349
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 2e-55
Identities = 68/250 (27%), Positives = 117/250 (46%), Gaps = 13/250 (5%)
Query: 230 LRNRLSEKTEQQSAKIVKATAENVNEAV-----RELPDANLRPEDLWAIHSQPVFPRPHK 284
L +SE + K ++ E E + N + + +
Sbjct: 260 LSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPE 319
Query: 285 RDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVM 344
++ I+ G+ +++ L F + LG G G V L E +G ELYA+K ++K V+
Sbjct: 320 EKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV 379
Query: 345 LNRNKVHRACIEREIMSL-LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMK 403
+ + V +E+ +++L PFL L++ FQT + + ++ GG+L + +
Sbjct: 380 IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--G 437
Query: 404 IFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQ 463
F+E A FYAAE+ IGL +L GIIYRDLK +N++L +GH+ + DF + CK
Sbjct: 438 RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM-----CKEN 492
Query: 464 VFYHAHVNGF 473
++ F
Sbjct: 493 IWDGVTTKTF 502
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 4e-54
Identities = 65/235 (27%), Positives = 110/235 (46%), Gaps = 9/235 (3%)
Query: 228 EPLRNRLSEKTEQQSAKIVKATAENVNEAVREL-PDANLRPEDLWAIH---SQPVFPRPH 283
E + ++ S K+ E+V + + +L + I VF +
Sbjct: 107 EIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFI 166
Query: 284 KRDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSV 343
+ D + K + ++ F + +G G G V+ G++YAMK ++K
Sbjct: 167 ESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR 226
Query: 344 MLNRNKVHRACIEREIMSLL---DHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQ 400
+ + A ER ++SL+ D PF+ + +F T + I D GG+L L +
Sbjct: 227 IKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ- 285
Query: 401 PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+F E RFYAAE+++GLE++H ++YRDLKP NILL + GHV ++D L+
Sbjct: 286 -HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 339
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* Length = 146 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-52
Identities = 107/194 (55%), Positives = 125/194 (64%), Gaps = 53/194 (27%)
Query: 69 LATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFL--ELTEYTRE 126
LATTLERIEKNFVITDPR+PDNPIIFASDSFL+LTEY+REEILGRNC FL T
Sbjct: 4 LATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPET----- 58
Query: 127 EILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQ 186
D+ATV KIRDA+ Q E+TVQ
Sbjct: 59 ---------------------------------------DRATVRKIRDAIDNQTEVTVQ 79
Query: 187 LINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNRLSEKTEQQSAKIV 246
LINYTKSGKKFWNLFHLQPMRD KG++QYFIGVQLDG++HV + E++ ++
Sbjct: 80 LINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVR-------DAAEREGVMLI 132
Query: 247 KATAENVNEAVREL 260
K TAEN++EA +EL
Sbjct: 133 KKTAENIDEAAKEL 146
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-49
Identities = 50/157 (31%), Positives = 75/157 (47%), Gaps = 2/157 (1%)
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS 361
K + F +PLG G G+V+L + + A+K + KS + H+ E EI S
Sbjct: 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
L HP + +Y F I L+ +F P GEL+ L K F E + + E+ L
Sbjct: 70 HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADAL 127
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458
Y H +I+RD+KPEN+L+ G + + DF S
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA 164
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-49
Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 2/157 (1%)
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS 361
+ L F+ +PLG G G+V+L + + + A+K + K+ + H+ E EI S
Sbjct: 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
L HP + LY F +T + LI ++ P G ++ L K F E Y E+ L
Sbjct: 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANAL 122
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458
Y H +I+RD+KPEN+LL G + + DF S
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* Length = 166 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-47
Identities = 61/208 (29%), Positives = 90/208 (43%), Gaps = 48/208 (23%)
Query: 36 PSIAPEVFMTKDLKWTDSWDRAERERDIRQGIDLATTLERIEKNFVITDPRIPDNPIIFA 95
S+ + D TD+ +A R + L L+ ++NFVITD +PDNPI++A
Sbjct: 5 DSLIAQCSPEADTLLTDNPSKANRILE-DPDYSLVKALQMAQQNFVITDASLPDNPIVYA 63
Query: 96 SDSFLELTEYTREEILGRNCSFL--ELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVY 153
S FL LT Y+ ++ILGRNC FL T
Sbjct: 64 SRGFLTLTGYSLDQILGRNCRFLQGPET-------------------------------- 91
Query: 154 NFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGEL 213
D V KIR+A+ + + +V L+NY + G FWNLF + +RD KG +
Sbjct: 92 ------------DPRAVDKIRNAITKGVDTSVCLLNYRQDGTTFWNLFFVAGLRDSKGNI 139
Query: 214 QYFIGVQLDGSDHVEPLRNRLSEKTEQQ 241
++GVQ S+ L + E +
Sbjct: 140 VNYVGVQSKVSEDYAKLL-VNEQNIEYK 166
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} Length = 258 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 6e-47
Identities = 62/299 (20%), Positives = 104/299 (34%), Gaps = 69/299 (23%)
Query: 10 SRKSGRNSLMGLKVRSPSLAGKHEPQPSIAPEVFMTKDLKWTDSWDRAERERDIRQGIDL 69
++ GR+ P G+ P R E + + +
Sbjct: 18 GQQMGRDLYDDDDKDHPFTMGQDRPIDGSGAP---------GADDTRVEVQPPAQW---V 65
Query: 70 ATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEIL 129
+E V++DPR+ DNP+I + +F +LT Y+ EE +GRNC FL
Sbjct: 66 LDLIEASPIASVVSDPRLADNPLIAINQAFTDLTGYSEEECVGRNCRFLA---------- 115
Query: 130 GRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLIN 189
G ++ KIR VRE + + V+++N
Sbjct: 116 GSG--------------------------------TEPWLTDKIRQGVREHKPVLVEILN 143
Query: 190 YTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNRLSEKTEQQSAKIVKAT 249
Y K G F N + P+ D EL YF+G Q++ D ++ A + T
Sbjct: 144 YKKDGTPFRNAVLVAPIYDDDDELLYFLGSQVEVDDDQPN-----MGMARRERAAEMLKT 198
Query: 250 AENVNEAVRELPDANLRPEDLWAI----------HSQPVFPRPHKRDNSSWIAIQKITG 298
V L + LR +++ A H V + + + ++ + I G
Sbjct: 199 LSPRQLEVTTLVASGLRNKEVAARLGLSEKTVKMHRGLVMEKLNLKTSADLVRIAVEAG 257
|
| >4eet_B Phototropin-2; LOV, blue light photoreceptor, signaling protein, flavoprote; HET: FMN; 1.20A {Arabidopsis thaliana} PDB: 4ees_A* 4eer_A* 4eep_A* 4eeu_A* 1jnu_A* 1g28_A* Length = 115 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 9e-47
Identities = 95/157 (60%), Positives = 100/157 (63%), Gaps = 46/157 (29%)
Query: 73 LERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFL--ELTEYTREEILG 130
E IEKNFVITDPR+PDNPIIFASD FLELTEY+REEILGRN FL T
Sbjct: 3 PEFIEKNFVITDPRLPDNPIIFASDGFLELTEYSREEILGRNARFLQGPET--------- 53
Query: 131 RNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINY 190
DQATV KIRDA+R+QRE TVQLINY
Sbjct: 54 -----------------------------------DQATVQKIRDAIRDQRETTVQLINY 78
Query: 191 TKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHV 227
TKSGKKFWNL HLQP+RD KGELQYFIGVQLDGSDHV
Sbjct: 79 TKSGKKFWNLLHLQPVRDQKGELQYFIGVQLDGSDHV 115
|
| >2z6d_A Phototropin-2; PAS-fold, LOV-fold, alternative splicing, ATP-binding, chromophore, flavoprotein, FMN, kinase, membrane, nucleotide-binding; HET: FMN; 2.00A {Arabidopsis thaliana} PDB: 2z6c_A* Length = 130 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-45
Identities = 49/172 (28%), Positives = 78/172 (45%), Gaps = 46/172 (26%)
Query: 64 RQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFL--ELT 121
R +L T L +++ FV++D P PI++AS F +T Y+ +EI+GRNC FL T
Sbjct: 3 RVSQELKTALSTLQQTFVVSDATQPHCPIVYASSGFFTMTGYSSKEIVGRNCRFLQGPDT 62
Query: 122 EYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQR 181
D+ V+KIRD V+ +
Sbjct: 63 --------------------------------------------DKNEVAKIRDCVKNGK 78
Query: 182 EITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNR 233
+L+NY K G FWNL + P++D +G FIG+Q++ S + E + ++
Sbjct: 79 SYCGRLLNYKKDGTPFWNLLTVTPIKDDQGNTIKFIGMQVEVSKYTEGVNDK 130
|
| >3d72_A Vivid PAS protein VVD; circadian, photoreceptor, blue-light, LOV, signaling protein; HET: FAD; 1.65A {Neurospora crassa} PDB: 3is2_A* 2pd8_A* 3hjk_A* 2pdr_A* 2pd7_A* 2pdt_A* 3hji_A* 3rh8_B* Length = 149 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-43
Identities = 42/172 (24%), Positives = 71/172 (41%), Gaps = 46/172 (26%)
Query: 66 GIDLATTLERI--EKN-------------FVITDPRIPDNPIIFASDSFLELTEYTREEI 110
G D+ L +I N ++ D + D PI++AS++FL +T Y+ E+
Sbjct: 9 GYDIMGYLIQIMNRPNPQVELGPVDTSVALILCDLKQKDTPIVYASEAFLYMTGYSNAEV 68
Query: 111 LGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATV 170
LGRNC FL D T+
Sbjct: 69 LGRNCRFL-------------------------------QSPDGMVKPKSTRKYVDSNTI 97
Query: 171 SKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLD 222
+ +R A+ E+ V+++N+ K+G++F N + P+RD GE +Y +G Q +
Sbjct: 98 NTMRKAIDRNAEVQVEVVNFKKNGQRFVNFLTMIPVRDETGEYRYSMGFQCE 149
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-43
Identities = 37/202 (18%), Positives = 72/202 (35%), Gaps = 30/202 (14%)
Query: 287 NSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN 346
N S + + ++ ++ I+ L G + L E + YA+K EKS++
Sbjct: 12 NYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDN--KFYALKKYEKSLLEK 69
Query: 347 RNKVHRAC------------IEREI--MSLLDHPFLPTLYASFQTSTHICLITDFCPGGE 392
+ ++ + E+ ++ + + + T + +I ++
Sbjct: 70 KRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDS 129
Query: 393 LFALL------DKQPMKIFREDSARFYAAEVVIGLEYLHC-LGIIYRDLKPENILLQKDG 445
+ DK + V+ Y+H I +RD+KP NIL+ K+G
Sbjct: 130 ILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG 189
Query: 446 HVVLTDFDLS-------FMTSC 460
V L+DF S S
Sbjct: 190 RVKLSDFGESEYMVDKKIKGSR 211
|
| >2l0w_A Potassium voltage-gated channel, subfamily H (EAG member 2, isoform CRA_B; HERG, PAS domain, voltage-gated potassium channel, membrane; NMR {Homo sapiens} PDB: 2l1m_A 2l4r_A Length = 138 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 8e-43
Identities = 34/175 (19%), Positives = 58/175 (33%), Gaps = 51/175 (29%)
Query: 58 ERERDIRQGIDLATTLERIEK---NFVITDPRIPDNPIIFASDSFLELTEYTREEILGR- 113
R Q L T + + E F+I + R+ + +I+ +D F EL Y+R E++ R
Sbjct: 7 RRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRP 66
Query: 114 -NCSFL--ELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATV 170
C FL T +
Sbjct: 67 CTCDFLHGPRT--------------------------------------------QRRAA 82
Query: 171 SKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSD 225
++I A+ E V++ Y K G F L + P+++ G + FI +
Sbjct: 83 AQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVME 137
|
| >1n9l_A PHOT-LOV1, putative blue light receptor; phototropin, flavin, electron transport; HET: FMN; 1.90A {Chlamydomonas reinhardtii} SCOP: d.110.3.6 PDB: 1n9n_A* 1n9o_A* Length = 109 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-42
Identities = 44/146 (30%), Positives = 65/146 (44%), Gaps = 46/146 (31%)
Query: 79 NFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFL--ELTEYTREEILGRNCSTY 136
FV+ D +PD P+++AS+ F +T Y +E+LG NC FL E T
Sbjct: 5 TFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGT--------------- 49
Query: 137 TFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKK 196
D V KIRDA+++ +V+L+NY K G
Sbjct: 50 -----------------------------DPKEVQKIRDAIKKGEACSVRLLNYRKDGTP 80
Query: 197 FWNLFHLQPMRDHKGELQYFIGVQLD 222
FWNL + P++ G + F+GVQ+D
Sbjct: 81 FWNLLTVTPIKTPDGRVSKFVGVQVD 106
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} Length = 162 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-42
Identities = 44/189 (23%), Positives = 69/189 (36%), Gaps = 43/189 (22%)
Query: 55 DRAERERDIRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRN 114
R + L + ++ V+ + D +I+ + +F LT Y+R+EIL ++
Sbjct: 13 GLVPRGSHMINAQLLQSMVDASNDGIVVAEKEGDDTILIYVNAAFEYLTGYSRDEILYQD 72
Query: 115 CSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIR 174
C FL+ DQ ++IR
Sbjct: 73 CRFLQ--------------GDDR----------------------------DQLGRARIR 90
Query: 175 DAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNRL 234
A+ E R L NY K G FWN + P++ + YFIG+Q D S VE L L
Sbjct: 91 KAMAEGRPCREVLRNYRKDGSAFWNELSITPVKSDFDQRTYFIGIQKDVSRQVE-LEREL 149
Query: 235 SEKTEQQSA 243
+E +
Sbjct: 150 AELRARPKP 158
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} Length = 128 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-41
Identities = 48/158 (30%), Positives = 72/158 (45%), Gaps = 46/158 (29%)
Query: 73 LERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFL--ELTEYTREEILG 130
E +IT+P +PDNPI+FA+ +FL+LT Y +E++GRNC FL T
Sbjct: 3 SEFTLMPMLITNPHLPDNPIVFANPAFLKLTGYEADEVMGRNCRFLQGHGT--------- 53
Query: 131 RNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINY 190
D A V I+ A+ ++ I + +INY
Sbjct: 54 -----------------------------------DPAHVRAIKSAIAAEKPIDIDIINY 78
Query: 191 TKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVE 228
KSG+ FWN H+ P+ + G LQ+F+ QLD + +
Sbjct: 79 KKSGEAFWNRLHISPVHNANGRLQHFVSSQLDVTLELV 116
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* Length = 132 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-40
Identities = 49/167 (29%), Positives = 75/167 (44%), Gaps = 47/167 (28%)
Query: 73 LERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRN 132
L+ + VITDP + DNPI++ + F+++T Y EEILG+NC FL+
Sbjct: 5 LDHVRVGVVITDPALEDNPIVYVNQGFVQMTGYETEEILGKNCRFLQ------------- 51
Query: 133 CSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTK 192
+T D A V IR A++ + +TVQ+ NY K
Sbjct: 52 -GKHT----------------------------DPAEVDNIRTALQNKEPVTVQIQNYKK 82
Query: 193 SGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHV---EPLRNRLSE 236
G FWN ++ PM + YF+G+Q D + + L + L+E
Sbjct: 83 DGTMFWNELNIDPMEI--EDKTYFVGIQNDITKQKEYEKLLEDSLTE 127
|
| >1byw_A Protein (human ERG potassium channel); PAS domain, potassium channel domain, membrane protein; 2.60A {Homo sapiens} SCOP: d.110.3.6 Length = 110 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-39
Identities = 29/151 (19%), Positives = 51/151 (33%), Gaps = 48/151 (31%)
Query: 79 NFVITDPRIPDNPIIFASDSFLELTEYTREEILGR--NCSFL--ELTEYTREEILGRNCS 134
F+I + R+ + +I+ +D F EL Y+R E++ R C FL T
Sbjct: 3 KFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCT------------- 49
Query: 135 TYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSG 194
+ ++I A+ E V++ Y K G
Sbjct: 50 -------------------------------QRRAAAQIAQALLGAEERKVEIAFYRKDG 78
Query: 195 KKFWNLFHLQPMRDHKGELQYFIGVQLDGSD 225
F L + P+++ G + FI +
Sbjct: 79 SCFLCLVDVVPVKNEDGAVIMFILNFEVVME 109
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 43/197 (21%), Positives = 72/197 (36%), Gaps = 4/197 (2%)
Query: 259 ELPDANLRPEDLWAIHSQPVFPRPHKRDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGD 318
+L NL + + + + V R + E F+ + LG G
Sbjct: 12 DLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPS--RPESFFQQSFQRLSRLGHGS 69
Query: 319 TGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS 378
G V V + G LYA+K +++ + + HP L +++
Sbjct: 70 YGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129
Query: 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPEN 438
+ L T+ C G L + E Y + ++ L +LH G+++ D+KP N
Sbjct: 130 GILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPAN 187
Query: 439 ILLQKDGHVVLTDFDLS 455
I L G L DF L
Sbjct: 188 IFLGPRGRCKLGDFGLL 204
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 54/175 (30%), Positives = 84/175 (48%), Gaps = 16/175 (9%)
Query: 297 TGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIE 356
T GEKI FK LG G V+ E G A+K ++K M V R ++
Sbjct: 4 TCIGEKIE--DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR--VQ 59
Query: 357 REI--MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYA 414
E+ L HP + LY F+ S ++ L+ + C GE+ L + K F E+ AR +
Sbjct: 60 NEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFM 118
Query: 415 AEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS---------FMTSC 460
+++ G+ YLH GI++RDL N+LL ++ ++ + DF L+ T C
Sbjct: 119 HQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC 173
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 38/164 (23%), Positives = 71/164 (43%), Gaps = 18/164 (10%)
Query: 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD 364
F+ I LG G G V YA+K + + K+ E +++ L+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLN 60
Query: 365 HPFLPTLYASFQ-------------TSTHICLITDFCPGGELFALLDKQPMKIFREDSAR 411
H ++ YA++ + + + ++C G L+ L+ + + + D
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN-QQRDEYW 119
Query: 412 FYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+++ L Y+H GII+RDLKP NI + + +V + DF L+
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA 163
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 8e-36
Identities = 39/153 (25%), Positives = 72/153 (47%), Gaps = 6/153 (3%)
Query: 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI--MSL 362
+ + LG G + E++A K + KS++L ++ + + EI
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRS 71
Query: 363 LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLE 422
L H + + F+ + + ++ + C L L ++ K E AR+Y ++V+G +
Sbjct: 72 LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQ 129
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
YLH +I+RDLK N+ L +D V + DF L+
Sbjct: 130 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-36
Identities = 39/157 (24%), Positives = 73/157 (46%), Gaps = 6/157 (3%)
Query: 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI- 359
+ + + LG G + E++A K + KS++L ++ + + EI
Sbjct: 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEIS 93
Query: 360 -MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVV 418
L H + + F+ + + ++ + C L L ++ K E AR+Y ++V
Sbjct: 94 IHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIV 151
Query: 419 IGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+G +YLH +I+RDLK N+ L +D V + DF L+
Sbjct: 152 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 42/159 (26%), Positives = 84/159 (52%), Gaps = 1/159 (0%)
Query: 297 TGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIE 356
T + + + ++ +G G G LV+ G Y +K + S M ++ + + E
Sbjct: 15 TENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER-EESRRE 73
Query: 357 REIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAE 416
+++ + HP + SF+ + + ++ D+C GG+LF ++ Q +F+ED + +
Sbjct: 74 VAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ 133
Query: 417 VVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ + L+++H I++RD+K +NI L KDG V L DF ++
Sbjct: 134 ICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIA 172
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 49/199 (24%), Positives = 84/199 (42%), Gaps = 37/199 (18%)
Query: 296 ITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRAC- 354
SG+ + L+ + +G G G V L + YAMK + K ++ + R
Sbjct: 3 SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62
Query: 355 --------------------IEREI--MSLLDHPFLPTLY--ASFQTSTHICLITDFCPG 390
+ +EI + LDHP + L H+ ++ +
Sbjct: 63 PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ 122
Query: 391 GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLT 450
G + + +P+ ED ARFY +++ G+EYLH II+RD+KP N+L+ +DGH+ +
Sbjct: 123 GPVMEVPTLKPLS---EDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIA 179
Query: 451 DFDLSFM---------TSC 460
DF +S +
Sbjct: 180 DFGVSNEFKGSDALLSNTV 198
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 47/157 (29%), Positives = 66/157 (42%), Gaps = 9/157 (5%)
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS 361
I H+ I+ LG G V LVE G YA+K + +R + R E ++
Sbjct: 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQR---EADMHR 81
Query: 362 LLDHPFLPTLYASFQTST----HICLITDFCPGGELFALLD--KQPMKIFREDSARFYAA 415
L +HP + L A L+ F G L+ ++ K ED +
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 416 EVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDF 452
+ GLE +H G +RDLKP NILL +G VL D
Sbjct: 142 GICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDL 178
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 45/175 (25%), Positives = 73/175 (41%), Gaps = 17/175 (9%)
Query: 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIM 360
+ H + LG G T +V + G+L+A+K L V E E++
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVL 61
Query: 361 SLLDHPFLPTLYASFQTST--HICLITDFCPGGELF-ALLDKQPMKIFREDSARFYAAEV 417
L+H + L+A + +T H LI +FCP G L+ L + E +V
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 418 VIGLEYLHCLGIIYRDLKPENILLQ----KDGHVVLTDFDLS--------FMTSC 460
V G+ +L GI++R++KP NI+ LTDF + F++
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 45/177 (25%), Positives = 74/177 (41%), Gaps = 17/177 (9%)
Query: 299 SGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE 358
+ H + LG G T +V + G+L+A+K L V E E
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFE 59
Query: 359 IMSLLDHPFLPTLYASFQTST--HICLITDFCPGGELFALL-DKQPMKIFREDSARFYAA 415
++ L+H + L+A + +T H LI +FCP G L+ +L + E
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 416 EVVIGLEYLHCLGIIYRDLKPENILLQ----KDGHVVLTDFDLS--------FMTSC 460
+VV G+ +L GI++R++KP NI+ LTDF + F++
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 52/176 (29%), Positives = 83/176 (47%), Gaps = 18/176 (10%)
Query: 298 GSGEKIGLH--HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACI 355
GS + H+ LG G G V + E Q G A+K + + + + + V + I
Sbjct: 1 GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK--I 58
Query: 356 EREI--MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFA-LLDKQPMKIFREDSARF 412
+REI + L HP + LY T T ++ ++ GGELF + ++ E AR
Sbjct: 59 KREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVE---EMEARR 115
Query: 413 YAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM--------TSC 460
+++ ++Y H +++RDLKPEN+LL + + DF LS M TSC
Sbjct: 116 LFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC 171
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-32
Identities = 39/164 (23%), Positives = 68/164 (41%), Gaps = 23/164 (14%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
FK I+ +G G G V + + G+ Y +K ++ N K R E + ++ LDH
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY----NNEKAER---EVKALAKLDHVN 65
Query: 368 LPTLYASFQ----------------TSTHICLITDFCPGGELFALLDKQPMKIFREDSAR 411
+ + + + + +FC G L ++K+ + + A
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 412 FYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
++ G++Y+H +I RDLKP NI L V + DF L
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLV 169
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-32
Identities = 35/153 (22%), Positives = 71/153 (46%), Gaps = 2/153 (1%)
Query: 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD 364
L +F+ K +G G V+ G A+K ++ +++ E +++ L+
Sbjct: 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALL--DKQPMKIFREDSARFYAAEVVIGLE 422
HP + YASF + ++ + G+L ++ K+ ++ E + Y ++ LE
Sbjct: 91 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
++H +++RD+KP N+ + G V L D L
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 28/181 (15%), Positives = 58/181 (32%), Gaps = 22/181 (12%)
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQG-----AGELYAMKAMEKSVMLNRNKVHRACIE 356
++G LG G V+ + + +K + + N + +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQL 117
Query: 357 REIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDK---QPMKIFREDSARFY 413
E + Y++ L+ + G L ++ P K+ + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 414 AAEVVIGLEYLHCLGIIYRDLKPENILLQ-----------KDGHVVLTDFDLSFMTSCKP 462
A ++ +E +H II+ D+KP+N +L + L D S P
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237
Query: 463 Q 463
+
Sbjct: 238 K 238
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-32
Identities = 33/160 (20%), Positives = 69/160 (43%), Gaps = 10/160 (6%)
Query: 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD 364
++ + +G G G + + G++ K ++ M K E ++ L
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELK 63
Query: 365 HPFLPTLYASFQ--TSTHICLITDFCPGGELFALLD--KQPMKIFREDSARFYAAEVVIG 420
HP + Y T+T + ++ ++C GG+L +++ + + E+ ++ +
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 421 LEYLH-----CLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
L+ H +++RDLKP N+ L +V L DF L+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 34/168 (20%), Positives = 72/168 (42%), Gaps = 7/168 (4%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE--IMSLL 363
++ + +G G V + G+ +A+K ++ + + + ++RE I +L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 364 DHPFLPTLYASFQTSTHICLITDFCPGGELF-ALLDK-QPMKIFREDSARFYAAEVVIGL 421
HP + L ++ + + ++ +F G +L ++ + ++ E A Y +++ L
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 422 EYLHCLGIIYRDLKPENILLQ---KDGHVVLTDFDLSFMTSCKPQVFY 466
Y H II+RD+KP +LL V L F ++ V
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG 191
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-31
Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 19/170 (11%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVH----RACIEREI--- 359
+++P + LG G + V + + YA+K ++ + + + R +E+
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 360 MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELF-ALLDKQPMKIFREDSARFYAAEVV 418
+ HP + L +++T+T L+ D GELF L +K E R ++
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALL 134
Query: 419 IGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS--------FMTSC 460
+ LH L I++RDLKPENILL D ++ LTDF S C
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 184
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-31
Identities = 54/237 (22%), Positives = 98/237 (41%), Gaps = 19/237 (8%)
Query: 223 GSDHVEPLRNRLSEKTEQQSAKIVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRP 282
G++++ + S + +S + + +P + R L P P
Sbjct: 15 GTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFD 74
Query: 283 HKRDNSSWIAIQKITGSGEKIGLH-HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEK 341
H+ +T + + LG G G VH E G A K ++
Sbjct: 75 HR----------IVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT 124
Query: 342 SVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELF-ALLDKQ 400
M ++ +V E +M+ LDH L LY +F++ I L+ ++ GGELF ++D+
Sbjct: 125 RGMKDKEEVKN---EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE- 180
Query: 401 PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILL--QKDGHVVLTDFDLS 455
E + ++ G+ ++H + I++ DLKPENIL + + + DF L+
Sbjct: 181 -SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLA 236
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 44/147 (29%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTL 371
+ LG G G VH + G ++ K + L++ V E IM+ L HP L L
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLHHPKLINL 113
Query: 372 YASFQTSTHICLITDFCPGGELF-ALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGII 430
+ +F+ + LI +F GGELF + + E Y + GL+++H I+
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHSIV 171
Query: 431 YRDLKPENILLQ--KDGHVVLTDFDLS 455
+ D+KPENI+ + K V + DF L+
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLA 198
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 8e-31
Identities = 42/181 (23%), Positives = 76/181 (41%), Gaps = 16/181 (8%)
Query: 294 QKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRA 353
+ + E + + PLG G G V + + +K ++K +L +
Sbjct: 12 LEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDP 71
Query: 354 C---IEREI--MSLLDHPFLPTLYASFQTSTHICLITDF-CPGGELFALLDKQPMKIFRE 407
+ EI +S ++H + + F+ L+ + G +LFA +D+ P E
Sbjct: 72 KLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR--LDE 129
Query: 408 DSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS--------FMTS 459
A + ++V + YL II+RD+K ENI++ +D + L DF + F T
Sbjct: 130 PLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF 189
Query: 460 C 460
C
Sbjct: 190 C 190
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 49/154 (31%), Positives = 77/154 (50%), Gaps = 10/154 (6%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDH 365
++ +G G G V + +G A K + K + + ++ + E EIM LDH
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ---EIEIMKSLDH 65
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDK-QPMKIFREDSARFYAAEVVIGLEYL 424
P + LY +F+ +T I L+ + C GGELF ++ ++FRE A +V+ + Y
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELF---ERVVHKRVFRESDAARIMKDVLSAVAYC 122
Query: 425 HCLGIIYRDLKPENILLQ---KDGHVVLTDFDLS 455
H L + +RDLKPEN L D + L DF L+
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 7/173 (4%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
+K + LG G G V L + + G+ A+K + K + + E +++ LDHP
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
+ LY F+ + L+ + GGELF + + K F E A +V+ G+ Y+H
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHK 144
Query: 427 LGIIYRDLKPENILLQ---KDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFYFI 476
I++RDLKPEN+LL+ KD ++ + DF LS T + + Y+I
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDKIGTAYYI 195
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 52/260 (20%), Positives = 92/260 (35%), Gaps = 26/260 (10%)
Query: 224 SDHVEPLRNRLSEKTEQQSAKIVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPH 283
H + K +++ + ++ E R + A
Sbjct: 4 HHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLND 63
Query: 284 KRDNSSWIAIQKITGSGEKIGLH--------HFKPIKPLGCGDTGSVHLVELQGAGELYA 335
+ + + G +++ + P +G G + V + G +A
Sbjct: 64 AQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFA 123
Query: 336 MKAMEKSVMLNRNKVH---RACIEREI---MSLLDHPFLPTLYASFQTSTHICLITDFCP 389
+K ME + + R RE + HP + TL S+++S+ + L+ D
Sbjct: 124 VKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMR 183
Query: 390 GGELF-ALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVV 448
GELF L +K E R ++ + +LH I++RDLKPENILL + +
Sbjct: 184 KGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIR 240
Query: 449 LTDFDLS--------FMTSC 460
L+DF S C
Sbjct: 241 LSDFGFSCHLEPGEKLRELC 260
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 48/160 (30%), Positives = 86/160 (53%), Gaps = 17/160 (10%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTL 371
+ LG G V LV+ + G+L+A+K ++KS + + E ++ + H + TL
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKHENIVTL 71
Query: 372 YASFQTSTHICLITDFCPGGELF-ALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGII 430
++++TH L+ GGELF +L++ ++ E A +V+ ++YLH GI+
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENGIV 128
Query: 431 YRDLKPENILL---QKDGHVVLTDFDLS-------FMTSC 460
+RDLKPEN+L +++ +++TDF LS T+C
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC 168
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 52/152 (34%), Positives = 79/152 (51%), Gaps = 11/152 (7%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN-RNKVHRACIERE--IMSLLDHPFL 368
+ LG G V +G G+ YA K ++K + + R V R IERE I+ + HP +
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 369 PTLYASFQTSTHICLITDFCPGGELF-ALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
TL+ F+ T + LI + GGELF L +K + ED A + +++ G+ YLH
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSK 127
Query: 428 GIIYRDLKPENILLQ----KDGHVVLTDFDLS 455
I + DLKPENI+L + + L DF ++
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-30
Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 12/166 (7%)
Query: 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI- 359
+ + ++ LG G G V L + E A+K ++ ++ I++EI
Sbjct: 4 PFVE--DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD----CPENIKKEIC 57
Query: 360 -MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFA-LLDKQPMKIFREDSARFYAAEV 417
+L+H + Y + L ++C GGELF + M E A+ + ++
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP---EPDAQRFFHQL 114
Query: 418 VIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQ 463
+ G+ YLH +GI +RD+KPEN+LL + ++ ++DF L+ + +
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 51/170 (30%), Positives = 83/170 (48%), Gaps = 18/170 (10%)
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI-- 359
KIG H+ LG G G V + + + G A+K + + + + + V + I REI
Sbjct: 14 KIG--HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK--IRREIQN 69
Query: 360 MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFA-LLDKQPMKIFREDSARFYAAEVV 418
+ L HP + LY T + I ++ ++ GGELF + + E +R +++
Sbjct: 70 LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLD---EKESRRLFQQIL 126
Query: 419 IGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM--------TSC 460
G++Y H +++RDLKPEN+LL + + DF LS M TSC
Sbjct: 127 SGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC 176
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 51/157 (32%), Positives = 75/157 (47%), Gaps = 11/157 (7%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN-RNKVHRACIERE--IMSLL 363
+ + LG G V + G YA K ++K R V R IERE I+ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 364 DHPFLPTLYASFQTSTHICLITDFCPGGELF-ALLDKQPMKIFREDSARFYAAEVVIGLE 422
HP + TL+ ++ T + LI + GGELF L K+ E+ A + +++ G+
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVN 129
Query: 423 YLHCLGIIYRDLKPENILLQ----KDGHVVLTDFDLS 455
YLH I + DLKPENI+L H+ L DF L+
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 47/182 (25%), Positives = 83/182 (45%), Gaps = 10/182 (5%)
Query: 281 RPHKRDNSSWIAIQKITG-SGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAM 339
H + + + + S E + K LG G V + G+ YA K +
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFL 62
Query: 340 EKSVMLNRNKVHRACIERE--IMSLLDH-PFLPTLYASFQTSTHICLITDFCPGGELFAL 396
+K R + RA I E ++ L P + L+ ++ ++ I LI ++ GGE+F+L
Sbjct: 63 KKR---RRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSL 119
Query: 397 LDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQ---KDGHVVLTDFD 453
+ ++ E+ +++ G+ YLH I++ DLKP+NILL G + + DF
Sbjct: 120 CLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179
Query: 454 LS 455
+S
Sbjct: 180 MS 181
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 48/217 (22%), Positives = 75/217 (34%), Gaps = 43/217 (19%)
Query: 283 HKRDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKS 342
H +S + GS ++ + +G G G V + + A+K M K+
Sbjct: 4 HHHHSSGRENLYFQGGSLLELQ-KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62
Query: 343 VMLNRNKVHRACIERE--IMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELF------ 394
+ N I+ E +M L HP + LY ++ +ICL+ + C GG L
Sbjct: 63 KIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVF 122
Query: 395 --------------------------------ALLDKQPMKIFREDSARFYAAEVVIGLE 422
+ + RE ++ L
Sbjct: 123 IDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182
Query: 423 YLHCLGIIYRDLKPENILLQKDG--HVVLTDFDLSFM 457
YLH GI +RD+KPEN L + + L DF LS
Sbjct: 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKE 219
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 46/162 (28%), Positives = 84/162 (51%), Gaps = 9/162 (5%)
Query: 297 TGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIE 356
+ + E+ + +++ +K +G G+ V L G A+K ++K+ + + +
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK---LF 62
Query: 357 REI--MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFA-LLDKQPMKIFREDSARFY 413
RE+ M +L+HP + L+ +T + LI ++ GGE+F L+ MK E AR
Sbjct: 63 REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMK---EKEARSK 119
Query: 414 AAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
++V ++Y H I++RDLK EN+LL D ++ + DF S
Sbjct: 120 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFS 161
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 10/168 (5%)
Query: 294 QKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKS-VMLNRNKVHR 352
++ I F + LG G G VHLVE + +G +K + K + ++
Sbjct: 11 RENLYFQGTID-DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEA 69
Query: 353 ACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELF-ALLDKQP-MKIFREDSA 410
E E++ LDHP + ++ F+ ++ ++ + C GGEL ++ Q K E
Sbjct: 70 ---EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYV 126
Query: 411 RFYAAEVVIGLEYLHCLGIIYRDLKPENILLQ---KDGHVVLTDFDLS 455
+++ L Y H ++++DLKPENIL Q + + DF L+
Sbjct: 127 AELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI- 359
+ +K +G G+ G L+ + EL A+K +E+ ++ N ++REI
Sbjct: 17 HDSD--RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN------VQREII 68
Query: 360 -MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVV 418
L HP + T TH+ +I ++ GGEL+ + F ED ARF+ +++
Sbjct: 69 NHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLL 126
Query: 419 IGLEYLHCLGIIYRDLKPENILL--QKDGHVVLTDFDLS 455
G+ Y H + I +RDLK EN LL + + DF S
Sbjct: 127 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS 165
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-30
Identities = 32/149 (21%), Positives = 67/149 (44%), Gaps = 13/149 (8%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE--IMSLLDHPFLP 369
+ LG G+ G VH + + Y K ++ + +++E I+++ H +
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRNIL 64
Query: 370 TLYASFQTSTHICLITDFCPGGELF-ALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLG 428
L+ SF++ + +I +F G ++F + E Y +V L++LH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHN 122
Query: 429 IIYRDLKPENILLQ--KDGHVVLTDFDLS 455
I + D++PENI+ Q + + + +F +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQA 151
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-30
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 13/208 (6%)
Query: 274 HSQPVFPRPHKRDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGEL 333
H + + + IT + ++ +K LG G G V L +
Sbjct: 6 HHSSGRENLYFQGDLQATPGMFITSKKGHLS-EMYQRVKKLGSGAYGEVLLCRDKVTHVE 64
Query: 334 YAMKAMEKSVMLNRNKVHRACIERE--IMSLLDHPFLPTLYASFQTSTHICLITDFCPGG 391
A+K + K+ + + + + E ++ LLDHP + LY F+ + L+ + GG
Sbjct: 65 RAIKIIRKTSVSTSSN---SKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121
Query: 392 ELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQ---KDGHVV 448
ELF + + F E A +V+ G+ YLH I++RDLKPEN+LL+ KD +
Sbjct: 122 ELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIK 179
Query: 449 LTDFDLSFMTSCKPQVFYHAHVNGFYFI 476
+ DF LS + Q + Y+I
Sbjct: 180 IVDFGLS--AVFENQKKMKERLGTAYYI 205
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-30
Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 12/166 (7%)
Query: 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI- 359
+ + ++ LG G G V L + E A+K ++ ++ I++EI
Sbjct: 4 PFVE--DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD----CPENIKKEIC 57
Query: 360 -MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFA-LLDKQPMKIFREDSARFYAAEV 417
+L+H + Y + L ++C GGELF + M E A+ + ++
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP---EPDAQRFFHQL 114
Query: 418 VIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQ 463
+ G+ YLH +GI +RD+KPEN+LL + ++ ++DF L+ + +
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-30
Identities = 47/156 (30%), Positives = 74/156 (47%), Gaps = 9/156 (5%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVH-RACIERE--IMSLL 363
+ + LG G V + G YA K ++K + R IERE I+ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 364 DHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEY 423
H + TL+ ++ T + LI + GGELF L ++ + E+ A + +++ G+ Y
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNY 130
Query: 424 LHCLGIIYRDLKPENILLQ----KDGHVVLTDFDLS 455
LH I + DLKPENI+L H+ L DF L+
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 9e-30
Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 12/155 (7%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE--IMSLLD 364
++ + LG G V + G +A K + + R+ +ERE I L
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKLQ 63
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELF-ALLDKQPMKIFREDSARFYAAEVVIGLEY 423
HP + L+ S Q + L+ D GGELF ++ + + + E A +++ + Y
Sbjct: 64 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAY 120
Query: 424 LHCLGIIYRDLKPENILL---QKDGHVVLTDFDLS 455
H GI++R+LKPEN+LL K V L DF L+
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-30
Identities = 56/176 (31%), Positives = 89/176 (50%), Gaps = 19/176 (10%)
Query: 296 ITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACI 355
+ S IG + + LG G G V L + A+K + + ++ + R +
Sbjct: 1 MAISKRHIG--PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR--V 56
Query: 356 EREI--MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFA-LLDKQPMKIFREDSARF 412
EREI + LL HP + LY T T I ++ ++ GGELF +++K+ M ED R
Sbjct: 57 EREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMT---EDEGRR 112
Query: 413 YAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM--------TSC 460
+ +++ +EY H I++RDLKPEN+LL + +V + DF LS + TSC
Sbjct: 113 FFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC 168
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 49/151 (32%), Positives = 76/151 (50%), Gaps = 9/151 (5%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN-RNKVHRACIERE--IMSLLDHPFL 368
+ LG G V + G YA K ++K + R V R IERE I+ + HP +
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 369 PTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLG 428
TL+ ++ T + LI + GGELF L ++ + E+ A + +++ G+ YLH L
Sbjct: 77 ITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 429 IIYRDLKPENILLQ----KDGHVVLTDFDLS 455
I + DLKPENI+L + + DF L+
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 53/215 (24%), Positives = 86/215 (40%), Gaps = 24/215 (11%)
Query: 282 PHKRDNSSWIAIQKITGSGEKIGLHHFKPI-------KPLGCGDTGSVHLVELQGAGELY 334
H + Q I + I + LG G G V L + +
Sbjct: 5 HHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEK 64
Query: 335 AMKAMEKSVMLNR--------NKVHRACIERE--IMSLLDHPFLPTLYASFQTSTHICLI 384
A+K ++KS + I E ++ LDHP + L+ F+ + L+
Sbjct: 65 AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLV 124
Query: 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQ-- 442
T+F GGELF + + F E A +++ G+ YLH I++RD+KPENILL+
Sbjct: 125 TEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENK 182
Query: 443 -KDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFYFI 476
++ + DF LS + + Y+I
Sbjct: 183 NSLLNIKIVDFGLS--SFFSKDYKLRDRLGTAYYI 215
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 50/155 (32%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE--IMSLLD 364
+ + LG G G V + + + YA+K + K+ N++ + I RE ++ LD
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT---STILREVELLKKLD 79
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALLDK-QPMKIFREDSARFYAAEVVIGLEY 423
HP + L+ + S+ ++ + GGELF D+ K F E A +V G+ Y
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELF---DEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 424 LHCLGIIYRDLKPENILLQ---KDGHVVLTDFDLS 455
+H I++RDLKPENILL+ KD + + DF LS
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-29
Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 11/218 (5%)
Query: 241 QSAKIVKATAENVNEAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNSSWIAIQKITGSG 300
+ V + D + + + D Q +
Sbjct: 95 EPTAPVLIPGDERKRRRGYDVDEQGKIVR--GKGTVSSNYDNYVFDIWKQYYPQPVEIKH 152
Query: 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIM 360
+ + H+ + LG G G VH V + G +A K + ++ V + E + M
Sbjct: 153 DHVL-DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTM 208
Query: 361 SLLDHPFLPTLYASFQTSTHICLITDFCPGGELF-ALLDKQPMKIFREDSARFYAAEVVI 419
S+L HP L L+ +F+ + +I +F GGELF + D+ ED A Y +V
Sbjct: 209 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCK 266
Query: 420 GLEYLHCLGIIYRDLKPENILLQ--KDGHVVLTDFDLS 455
GL ++H ++ DLKPENI+ + + L DF L+
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 304
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 52/178 (29%), Positives = 85/178 (47%), Gaps = 15/178 (8%)
Query: 283 HKRDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKS 342
H +S ++ + + LG G G V + + + YA+K + K+
Sbjct: 4 HHHHSSG----RENLYFQGTFA-ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA 58
Query: 343 VMLNRN--KVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQ 400
N++ + R E E++ LDHP + L+ + S+ ++ + GGELF + K+
Sbjct: 59 SAKNKDTSTILR---EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR 115
Query: 401 PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQ---KDGHVVLTDFDLS 455
K F E A +V G+ Y+H I++RDLKPENILL+ KD + + DF LS
Sbjct: 116 --KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 38/150 (25%), Positives = 67/150 (44%), Gaps = 10/150 (6%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI--MSLLDHPFLP 369
LG G G V V A+K ++K + +++EI + L H +
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEAN-VKKEIQLLRRLRHKNVI 69
Query: 370 TLY--ASFQTSTHICLITDFCPGG--ELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
L + + ++ ++C G E+ D P K F A Y +++ GLEYLH
Sbjct: 70 QLVDVLYNEEKQKMYMVMEYCVCGMQEML---DSVPEKRFPVCQAHGYFCQLIDGLEYLH 126
Query: 426 CLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
GI+++D+KP N+LL G + ++ ++
Sbjct: 127 SQGIVHKDIKPGNLLLTTGGTLKISALGVA 156
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 39/179 (21%), Positives = 74/179 (41%), Gaps = 14/179 (7%)
Query: 283 HKRDNSSWIAI--QKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAME 340
H +SS + + + + + + +K +G G + V V L ++YA+K +
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVN 61
Query: 341 KSVMLNRNKVHRACIEREI--MSLLDHPFLP--TLYASFQTSTHICLITDFCPGGELFAL 396
+ EI ++ L LY T +I ++ + C +L +
Sbjct: 62 LE---EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSW 117
Query: 397 LDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
L K+ K + Y ++ + +H GI++ DLKP N L+ DG + L DF ++
Sbjct: 118 LKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIA 173
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 21/171 (12%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRAC---IERE--IMS 361
+ K LG G G V L + + A+K + K + +E E I+
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELF-ALLDKQPMKIFREDSARFYAAEVVIG 420
L+HP + + F ++ + GGELF ++ + +E + + Y ++++
Sbjct: 71 KLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKR---LKEATCKLYFYQMLLA 126
Query: 421 LEYLHCLGIIYRDLKPENILLQ---KDGHVVLTDFDLS--------FMTSC 460
++YLH GII+RDLKPEN+LL +D + +TDF S T C
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 177
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE--IMSLLD 364
++ + LG G V + G +A K + + + +ERE I L
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRKLQ 86
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELF-ALLDKQPMKIFREDSARFYAAEVVIGLEY 423
HP + L+ S Q + L+ D GGELF ++ + + + E A +++ + Y
Sbjct: 87 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAY 143
Query: 424 LHCLGIIYRDLKPENILL---QKDGHVVLTDFDLS 455
H GI++R+LKPEN+LL K V L DF L+
Sbjct: 144 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 36/158 (22%), Positives = 66/158 (41%), Gaps = 12/158 (7%)
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI-- 359
+ + +K +G G + V V L ++YA+K + + EI
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLE---EADNQTLDSYRNEIAY 60
Query: 360 MSLLDHPFLP--TLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEV 417
++ L LY T +I ++ + C +L + L K+ K + Y +
Sbjct: 61 LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNM 117
Query: 418 VIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ + +H GI++ DLKP N L+ DG + L DF ++
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIA 154
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 54/186 (29%), Positives = 86/186 (46%), Gaps = 12/186 (6%)
Query: 274 HSQPVFPRPHKRDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGEL 333
S +S + I GS F+ LG G T V+ + +G +
Sbjct: 21 QSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKP 80
Query: 334 YAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGEL 393
YA+K ++K+V ++ V E ++ L HP + L F+T T I L+ + GGEL
Sbjct: 81 YALKVLKKTV--DKKIVRT---EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135
Query: 394 F-ALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQ---KDGHVVL 449
F +++K + E A +++ + YLH GI++RDLKPEN+L D + +
Sbjct: 136 FDRIVEK---GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKI 192
Query: 450 TDFDLS 455
DF LS
Sbjct: 193 ADFGLS 198
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 46/166 (27%), Positives = 76/166 (45%), Gaps = 12/166 (7%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE--IMSLLD 364
++ + LG G V AG+ YA + + + +ERE I LL
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL---SARDHQKLEREARICRLLK 68
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELF-ALLDKQPMKIFREDSARFYAAEVVIGLEY 423
HP + L+ S H LI D GGELF ++ ++ + E A +++ + +
Sbjct: 69 HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLH 125
Query: 424 LHCLGIIYRDLKPENILL---QKDGHVVLTDFDLSFMTSCKPQVFY 466
H +G+++R+LKPEN+LL K V L DF L+ + Q ++
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF 171
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 45/171 (26%), Positives = 77/171 (45%), Gaps = 21/171 (12%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRAC---IERE--IMS 361
+ K LG G G V L + + A++ + K + +E E I+
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELF-ALLDKQPMKIFREDSARFYAAEVVIG 420
L+HP + + F ++ + GGELF ++ + +E + + Y ++++
Sbjct: 196 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKR---LKEATCKLYFYQMLLA 251
Query: 421 LEYLHCLGIIYRDLKPENILLQ---KDGHVVLTDFDLS--------FMTSC 460
++YLH GII+RDLKPEN+LL +D + +TDF S T C
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 302
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-28
Identities = 42/165 (25%), Positives = 70/165 (42%), Gaps = 17/165 (10%)
Query: 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVM-LNRNKVHRACIEREIMSLL 363
L F+PI+ LG G G V + + YA+K + L R KV R E + ++ L
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMR---EVKALAKL 60
Query: 364 DHPFLPTLYASF------------QTSTHICLITDFCPGGELFALLDKQPMKIFREDS-A 410
+HP + + ++ ++ + C L ++ + RE S
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 411 RFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
++ +E+LH G+++RDLKP NI D V + DF L
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 165
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 36/158 (22%), Positives = 66/158 (41%), Gaps = 12/158 (7%)
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI-- 359
+ + +K +G G + V V L ++YA+K + + EI
Sbjct: 52 SVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLE---EADNQTLDSYRNEIAY 107
Query: 360 MSLLDHPFLP--TLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEV 417
++ L LY T +I ++ + C +L + L K+ K + Y +
Sbjct: 108 LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNM 164
Query: 418 VIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ + +H GI++ DLKP N L+ DG + L DF ++
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIA 201
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 43/149 (28%), Positives = 63/149 (42%), Gaps = 11/149 (7%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIM-SLLDHPFLPT 370
LG G V + YA+K +EK R++V R E E++ H +
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR---EVEMLYQCQGHRNVLE 75
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDK-QPMKIFREDSARFYAAEVVIGLEYLHCLGI 429
L F+ L+ + GG + + F E A +V L++LH GI
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSIL---SHIHKRRHFNELEASVVVQDVASALDFLHNKGI 132
Query: 430 IYRDLKPENILLQ---KDGHVVLTDFDLS 455
+RDLKPENIL + + V + DFDL
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLG 161
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 40/163 (24%), Positives = 70/163 (42%), Gaps = 23/163 (14%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPT 370
KPLG G + + + +A+K + K E + L + HP +
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVK 70
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDK-QPMKIFREDSARFYAAEVVIGLEYLHCLGI 429
L+ F H L+ + GGELF ++ + K F E A + ++V + ++H +G+
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELF---ERIKKKKHFSETEASYIMRKLVSAVSHMHDVGV 127
Query: 430 IYRDLKPENILL---QKDGHVVLTDFDLS---------FMTSC 460
++RDLKPEN+L + + + DF + T C
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-27
Identities = 44/172 (25%), Positives = 70/172 (40%), Gaps = 20/172 (11%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
++ + LG G G V Q GE A+K + L+ R C+E +IM L+HP
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHP 72
Query: 367 FLPTLYASFQTSTHI------CLITDFCPGGELFALLDK-QPMKIFREDSARFYAAEVVI 419
+ + + L ++C GG+L L++ + +E R +++
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 420 GLEYLHCLGIIYRDLKPENILLQKDGH---VVLTDFDLS--------FMTSC 460
L YLH II+RDLKPENI+LQ + D +
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV 184
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 7e-27
Identities = 35/165 (21%), Positives = 70/165 (42%), Gaps = 8/165 (4%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI---MSLL 363
F ++ +G G+ GSV + G +YA+K +S V RE+ L
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIK---RSKKPLAGSVDEQNALREVYAHAVLG 68
Query: 364 DHPFLPTLYASFQTSTHICLITDFCPGGELFALLDK--QPMKIFREDSARFYAAEVVIGL 421
H + ++++ H+ + ++C GG L + + + M F+E + +V GL
Sbjct: 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFY 466
Y+H + +++ D+KP NI + + + +V +
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF 173
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 36/167 (21%), Positives = 64/167 (38%), Gaps = 14/167 (8%)
Query: 297 TGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIE 356
G ++G + + L G V+ + G+G YA+K + + + + E
Sbjct: 19 VGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ---E 75
Query: 357 REIM-SLLDHPFLPTLYASFQTSTH--------ICLITDFCPGGELFALLDKQPMKIFRE 407
M L HP + ++ L+T+ C G + L +
Sbjct: 76 VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC 135
Query: 408 DSARFYAAEVVIGLEYLHCLG--IIYRDLKPENILLQKDGHVVLTDF 452
D+ + ++++H II+RDLK EN+LL G + L DF
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDF 182
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 39/164 (23%), Positives = 68/164 (41%), Gaps = 23/164 (14%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIM-SLLDHPFLPT 370
+ LG G G V + G+ A+K + S + E + P +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ--------EVDHHWQASGGPHIVC 86
Query: 371 LYASFQTSTH----ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
+ ++ H + +I + GGELF+ + ++ + F E A ++ +++LH
Sbjct: 87 ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 427 LGIIYRDLKPENILLQ---KDGHVVLTDFDLS-------FMTSC 460
I +RD+KPEN+L KD + LTDF + T C
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC 190
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 42/204 (20%), Positives = 83/204 (40%), Gaps = 21/204 (10%)
Query: 274 HSQPVFPRPHKRDNSSWIAIQKIT-GSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGE 332
HS + PR + + K+ G ++ ++ LG G GSV+
Sbjct: 10 HSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 69
Query: 333 LYAMKAMEKSVMLNRNKV-HRACIEREI--MSLLDHPFLP---TLYASFQTSTHICLITD 386
A+K +EK + + ++ + + E+ + + F L F+ LI +
Sbjct: 70 PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF-SGVIRLLDWFERPDSFVLILE 128
Query: 387 FC-PGGELFA-LLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILL-QK 443
P +LF + ++ ++ E+ AR + +V+ + + H G+++RD+K ENIL+
Sbjct: 129 RPEPVQDLFDFITERGALQ---EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN 185
Query: 444 DGHVVLTDFDLS-------FMTSC 460
G + L DF +
Sbjct: 186 RGELKLIDFGSGALLKDTVYTDFD 209
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 9e-26
Identities = 41/169 (24%), Positives = 71/169 (42%), Gaps = 25/169 (14%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIM-SLLDH 365
++ + +G G + +A+K ++KS E EI+ H
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-------EIEILLRYGQH 75
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELF-ALLDKQPMKIFREDSARFYAAEVVIGLEYL 424
P + TL + ++ ++T+ GGEL +L ++ F E A + +EYL
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF---FSEREASAVLFTITKTVEYL 132
Query: 425 HCLGIIYRDLKPENILLQ-KDGH---VVLTDFDLS---------FMTSC 460
H G+++RDLKP NIL + G+ + + DF + MT C
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 44/188 (23%), Positives = 73/188 (38%), Gaps = 11/188 (5%)
Query: 266 RPEDLWAIHSQPVFPRPHKRDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLV 325
+ + Q + P + K + +H +G G G VH +
Sbjct: 18 KTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRM 77
Query: 326 ELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385
+ + G A+K + V E + L P + LY + + + +
Sbjct: 78 KDKQTGFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGAVREGPWVNIFM 129
Query: 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG 445
+ GG L L+ + M ED A +Y + + GLEYLH I++ D+K +N+LL DG
Sbjct: 130 ELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDG 187
Query: 446 HVV-LTDF 452
L DF
Sbjct: 188 SRAALCDF 195
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 35/151 (23%), Positives = 64/151 (42%), Gaps = 16/151 (10%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIM-SLLDHPFLPT 370
+ LG G G V + + E +A+K ++ R E E+ P +
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCPHIVR 75
Query: 371 LYASFQTS----THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
+ ++ + ++ + GGELF+ + + + F E A + ++YLH
Sbjct: 76 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135
Query: 427 LGIIYRDLKPENILLQ---KDGHVVLTDFDL 454
+ I +RD+KPEN+L + + LTDF
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 40/206 (19%), Positives = 82/206 (39%), Gaps = 24/206 (11%)
Query: 272 AIHSQPVFPRPHKRDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAG 331
++ ++P+ P + G + ++ LG G G+V
Sbjct: 1 SMLTKPLQGPPAPPGTPT----PPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDR 56
Query: 332 ELYAMKAMEKSVMLNRNKVHRAC-IEREI--MSLLD----HPFLPTLYASFQTSTHICLI 384
A+K + ++ +L + + + E+ + + HP + L F+T L+
Sbjct: 57 LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLV 116
Query: 385 TDF-CPGGELFALL-DKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILL- 441
+ P +LF + +K P+ E +R + +VV +++ H G+++RD+K ENIL+
Sbjct: 117 LERPLPAQDLFDYITEKGPLG---EGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID 173
Query: 442 QKDGHVVLTDFDLS-------FMTSC 460
+ G L DF +
Sbjct: 174 LRRGCAKLIDFGSGALLHDEPYTDFD 199
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 37/165 (22%), Positives = 67/165 (40%), Gaps = 24/165 (14%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIM-SLLDHPFLPT 370
+ LG G G V + + E +A+K ++ R E E+ P +
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCPHIVR 119
Query: 371 LYASFQTS----THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
+ ++ + ++ + GGELF+ + + + F E A + ++YLH
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 179
Query: 427 LGIIYRDLKPENILLQ---KDGHVVLTDFDLS--------FMTSC 460
+ I +RD+KPEN+L + + LTDF + T C
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 224
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 34/231 (14%), Positives = 70/231 (30%), Gaps = 40/231 (17%)
Query: 255 EAVRELPDANLRPEDLWAIHSQPVFPRPHKRDNSSWIAIQKITGSGEKIGLHHFKPIKPL 314
+A P + + V+P+ ++ + + GE+ K ++PL
Sbjct: 21 LIGYCREEALKEPAAMVEAVTATVWPQ------NAETTVDSLLSQGER----KLKLVEPL 70
Query: 315 GCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYAS 374
GD V LV E +A+K +R+++ R + L
Sbjct: 71 RVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDR 130
Query: 375 FQ--------------------------TSTHICLITDFCPG--GELFALLDKQPMK--I 404
+ + L+ LF+ LD +
Sbjct: 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGD 190
Query: 405 FREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ A+++ L G+++ P+N+ + DG ++L D
Sbjct: 191 EGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 25/177 (14%), Positives = 49/177 (27%), Gaps = 35/177 (19%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVH-------------------- 351
LG D + Q GE + + + N +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 352 -----RACIEREIMSLLDHPFLPTLYASFQT--STHICLITDFC------PGGELFALLD 398
R +++ + + + + G L +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 399 KQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
K + +V+ L LH G+++ L+P +I+L + G V LT F+
Sbjct: 199 TH--KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-23
Identities = 39/162 (24%), Positives = 68/162 (41%), Gaps = 10/162 (6%)
Query: 295 KITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRAC 354
I G + ++ + + +G G G V + + G + A+K M + NK
Sbjct: 14 TIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR----RSGNKEENKR 69
Query: 355 IEREI---MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSAR 411
I ++ + D P++ + +F T+T + + + L K+ E
Sbjct: 70 ILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAE--KLKKRMQGPIPERILG 127
Query: 412 FYAAEVVIGLEYLHC-LGIIYRDLKPENILLQKDGHVVLTDF 452
+V L YL G+I+RD+KP NILL + G + L DF
Sbjct: 128 KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDF 169
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 7e-23
Identities = 35/179 (19%), Positives = 62/179 (34%), Gaps = 19/179 (10%)
Query: 299 SGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE 358
S +G F P LG G G++ + A+K + + +RE
Sbjct: 17 SVVIVGKISFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILPECF--------SFADRE 67
Query: 359 I---MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAA 415
+ +HP + + + + + + C L + +Q
Sbjct: 68 VQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYV-EQKDFAHLGLEPITLLQ 125
Query: 416 EVVIGLEYLHCLGIIYRDLKPENILLQKDGH-----VVLTDFDLSFMTSCKPQVFYHAH 469
+ GL +LH L I++RDLKP NIL+ +++DF L + F
Sbjct: 126 QTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS 184
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-22
Identities = 31/140 (22%), Positives = 61/140 (43%), Gaps = 5/140 (3%)
Query: 315 GCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI--MSLLDHPFLPTLY 372
G D +V+L + GE ++ + + + ++ E+ L +HP +
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRIN---LEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 373 ASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYR 432
A+F + ++T F G L+ M E + + V+ L+Y+H +G ++R
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHR 152
Query: 433 DLKPENILLQKDGHVVLTDF 452
+K +IL+ DG V L+
Sbjct: 153 SVKASHILISVDGKVYLSGL 172
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 99.0 bits (246), Expect = 1e-22
Identities = 28/175 (16%), Positives = 52/175 (29%), Gaps = 31/175 (17%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-------- 363
LG D + Q GE + + + N + + E + LL
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 364 --------------DHPFLPTLYASFQTSTHICLITDF-------CPGGELFALLDKQPM 402
P + + +++ F +L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 403 --KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
K + +V+ L LH G+++ L+P +I+L + G V LT F+
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 258
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 9/148 (6%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI--MSLLD 364
F ++ +G G G V ++ A+K ++ L + I++EI +S D
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID----LEEAEDEIEDIQQEITVLSQCD 78
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYL 424
P++ Y S+ T + +I ++ GG LL+ P E E++ GL+YL
Sbjct: 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYL 135
Query: 425 HCLGIIYRDLKPENILLQKDGHVVLTDF 452
H I+RD+K N+LL + G V L DF
Sbjct: 136 HSEKKIHRDIKAANVLLSEHGEVKLADF 163
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 12/154 (7%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI--MSLLD 364
++ + +G G T V E A+K + L + + + +EI MS
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN----LEKCQTSMDELLKEIQAMSQCH 71
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALL------DKQPMKIFREDSARFYAAEVV 418
HP + + Y SF + L+ GG + ++ + + E + EV+
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 419 IGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDF 452
GLEYLH G I+RD+K NILL +DG V + DF
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADF 165
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 9e-22
Identities = 32/157 (20%), Positives = 64/157 (40%), Gaps = 10/157 (6%)
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI-- 359
K + +G G GSV+ + + +G++ A+K + ++ + + ++
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR----STVDEKEQKQLLMDLDV 73
Query: 360 -MSLLDHPFLPTLYASFQTSTHICLITDFCPGG--ELFALLDKQPMKIFREDSARFYAAE 416
M D P++ Y + + + + + + + E+
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 417 VVIGLEYLHC-LGIIYRDLKPENILLQKDGHVVLTDF 452
V L +L L II+RD+KP NILL + G++ L DF
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDF 170
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 44/164 (26%), Positives = 69/164 (42%), Gaps = 9/164 (5%)
Query: 292 AIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVH 351
A ++ F+ I LG G+ G V V + +G + A K + L
Sbjct: 19 AFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH----LEIKPAI 74
Query: 352 RACIERE--IMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDS 409
R I RE ++ + P++ Y +F + I + + GG L +L K E
Sbjct: 75 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQI 132
Query: 410 ARFYAAEVVIGLEYLHC-LGIIYRDLKPENILLQKDGHVVLTDF 452
+ V+ GL YL I++RD+KP NIL+ G + L DF
Sbjct: 133 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF 176
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 9/146 (6%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI--MSLLDHPFLPTL 371
LG G G V+ A+K + + R+ + + EI L H +
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPE-----RDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 372 YASFQTSTHICLITDFCPGGELFALLDKQPMKI-FREDSARFYAAEVVIGLEYLHCLGII 430
SF + I + + PGG L ALL + + E + FY +++ GL+YLH I+
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 431 YRDLKPENILL-QKDGHVVLTDFDLS 455
+RD+K +N+L+ G + ++DF S
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTS 170
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 39/146 (26%), Positives = 75/146 (51%), Gaps = 4/146 (2%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
++ + LG G G V+ + + G L A K +E + ++ +E EI++ DHP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATCDHP 76
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
++ L ++ + ++ +FCPGG + A++ + + E + +++ L +LH
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHS 135
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDF 452
II+RDLK N+L+ +G + L DF
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADF 161
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-21
Identities = 42/182 (23%), Positives = 77/182 (42%), Gaps = 28/182 (15%)
Query: 293 IQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHR 352
I I + + + K LG G +G+V G A+K M
Sbjct: 3 IANIPNFEQSLK-NLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLID------FCDI 54
Query: 353 ACIEREIMS-LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDK-----QPMKIFR 406
A +E ++++ DHP + Y S T + + + C L L++ + +K+ +
Sbjct: 55 ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQK 113
Query: 407 EDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILL-------------QKDGHVVLTDFD 453
E + ++ G+ +LH L II+RDLKP+NIL+ ++ ++++DF
Sbjct: 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 454 LS 455
L
Sbjct: 174 LC 175
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 41/147 (27%), Positives = 68/147 (46%), Gaps = 10/147 (6%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI--MSLLDH 365
+G G TG V L + +G A+K +M R + R + E+ M H
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVK-----MMDLRKQQRRELLFNEVVIMRDYQH 101
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
+ +Y S+ + ++ +F GG L ++ + + E+ V+ L YLH
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLN---EEQIATVCEAVLQALAYLH 158
Query: 426 CLGIIYRDLKPENILLQKDGHVVLTDF 452
G+I+RD+K ++ILL DG V L+DF
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDF 185
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 5e-21
Identities = 38/156 (24%), Positives = 66/156 (42%), Gaps = 9/156 (5%)
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI-- 359
++ +PI LG G G V + +G++ A+K + N + + ++
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR----ATVNSQEQKRLLMDLDI 58
Query: 360 -MSLLDHPFLPTLYASFQTSTHICLITDFCPGG-ELFALLDKQPMKIFREDSARFYAAEV 417
M +D PF T Y + + + + + F + ED A +
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 418 VIGLEYLHC-LGIIYRDLKPENILLQKDGHVVLTDF 452
V LE+LH L +I+RD+KP N+L+ G V + DF
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDF 154
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 9e-21
Identities = 38/151 (25%), Positives = 69/151 (45%), Gaps = 18/151 (11%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAM------EKSVMLNRNKVHRACIEREIMS 361
+ + +G G +G+V+ G+ A++ M +K +++N E +M
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---------EILVMR 72
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
+P + S+ + ++ ++ GG L ++ + M E E + L
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQAL 129
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDF 452
E+LH +I+RD+K +NILL DG V LTDF
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDF 160
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 37/142 (26%), Positives = 65/142 (45%), Gaps = 4/142 (2%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYA 373
LG G G V + GE+ MK + + + + E ++M L+HP +
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK---EVKVMRCLEHPNVLKFIG 74
Query: 374 SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRD 433
+ IT++ GG L ++ + F A ++ G+ YLH + II+RD
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSF-AKDIASGMAYLHSMNIIHRD 133
Query: 434 LKPENILLQKDGHVVLTDFDLS 455
L N L++++ +VV+ DF L+
Sbjct: 134 LNSHNCLVRENKNVVVADFGLA 155
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 44/147 (29%), Positives = 70/147 (47%), Gaps = 10/147 (6%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI--MSLLDH 365
F ++ LG G GSV+ + G++ A+K + L I +EI M D
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-------IIKEISIMQQCDS 83
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
P + Y S+ +T + ++ ++C G + ++ + K ED + GLEYLH
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLH 142
Query: 426 CLGIIYRDLKPENILLQKDGHVVLTDF 452
+ I+RD+K NILL +GH L DF
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADF 169
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 45/188 (23%), Positives = 84/188 (44%), Gaps = 30/188 (15%)
Query: 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE--IM 360
I + + +G G G V + + + A+K + ++ R E +
Sbjct: 5 IDYKEIEVEEVVGRGAFGVVCKAKWRA--KDVAIKQI-------ESESERKAFIVELRQL 55
Query: 361 SLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALL-DKQPMKIFREDSARFYAAEVVI 419
S ++HP + LY + +CL+ ++ GG L+ +L +P+ + A + +
Sbjct: 56 SRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113
Query: 420 GLEYLHCL---GIIYRDLKPENILLQKDGHVV-LTDFDLS-----FMTSCK-------PQ 463
G+ YLH + +I+RDLKP N+LL G V+ + DF + MT+ K P+
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPE 173
Query: 464 VFYHAHVN 471
VF ++ +
Sbjct: 174 VFEGSNYS 181
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 28/186 (15%), Positives = 63/186 (33%), Gaps = 14/186 (7%)
Query: 283 HKRDNSSW----IAIQKITGSGEKI--------GLHHFKPIKPLGCGDTGSVHLVELQGA 330
+K D+ ++ I + + EK+ L H ++ + +
Sbjct: 27 NKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD 86
Query: 331 GELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCPG 390
++ + + + + + ++ M ++ + C
Sbjct: 87 EIWLKDESTDWPLS-SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRK 145
Query: 391 GELFALLDKQPMKIFRE-DSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVL 449
L ++++ RE ++ +E+LH G+++RDLKP NI D V +
Sbjct: 146 ENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV 205
Query: 450 TDFDLS 455
DF L
Sbjct: 206 GDFGLV 211
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 42/164 (25%), Positives = 69/164 (42%), Gaps = 14/164 (8%)
Query: 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIE--RE-- 358
+ + + K +G G G VH L + A+K++ ++ E RE
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 359 IMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVV 418
IMS L+HP + LY ++ +F P G+L+ L + I R ++
Sbjct: 76 IMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRL-MLDIA 132
Query: 419 IGLEYLHCLG--IIYRDLKPENILLQKDG-----HVVLTDFDLS 455
+G+EY+ I++RDL+ NI LQ + DF LS
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 40/158 (25%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI---MSLL 363
F+ ++ +G G G V+ G+L A+K M+ + ++ I++EI
Sbjct: 25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEE--IKQEINMLKKYS 78
Query: 364 DHPFLPTLYASF------QTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEV 417
H + T Y +F + L+ +FC G + L+ +E+ + E+
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138
Query: 418 VIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ GL +LH +I+RD+K +N+LL ++ V L DF +S
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 38/148 (25%), Positives = 62/148 (41%), Gaps = 6/148 (4%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI--MSLLD 364
F ++ +G G G+V+ E+ A+K M ++ I +E+ + L
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYL 424
HP + L+ ++C G + L + K +E + GL YL
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 425 HCLGIIYRDLKPENILLQKDGHVVLTDF 452
H +I+RD+K NILL + G V L DF
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDF 198
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 4e-19
Identities = 23/110 (20%), Positives = 49/110 (44%), Gaps = 4/110 (3%)
Query: 356 EREIMSLLDHPFLPTLYASFQT--STHICLITDFCPGGELFALLDKQPMKIFREDSARFY 413
E + + HP + + + Q+ + H LIT + P G L+ +L + + + A +
Sbjct: 57 ECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF 116
Query: 414 AAEVVIGLEYLHCLG--IIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK 461
A ++ G+ +LH L I L ++++ +D ++ D+ F
Sbjct: 117 ALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP 166
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 28/100 (28%), Positives = 45/100 (45%), Gaps = 2/100 (2%)
Query: 356 EREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAA 415
E ++ H + T+ + ++T +C G L+ L K + A
Sbjct: 70 EVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDI-AR 127
Query: 416 EVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ G++YLH II+RDLK NI L +D V + DF L+
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 28/100 (28%), Positives = 50/100 (50%), Gaps = 2/100 (2%)
Query: 356 EREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAA 415
E H + + + H+ +IT C G L++++ + + + + A
Sbjct: 79 EVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQI-AQ 137
Query: 416 EVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
E+V G+ YLH GI+++DLK +N+ +G VV+TDF L
Sbjct: 138 EIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLF 176
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 30/103 (29%), Positives = 48/103 (46%), Gaps = 3/103 (2%)
Query: 356 EREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALL-DKQPMKIFREDSARFYA 414
E IM L HP + + ++ ++T++ G L+ LL + E A
Sbjct: 84 EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 415 AEVVIGLEYLHCLG--IIYRDLKPENILLQKDGHVVLTDFDLS 455
+V G+ YLH I++R+LK N+L+ K V + DF LS
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-18
Identities = 36/151 (23%), Positives = 64/151 (42%), Gaps = 14/151 (9%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI--MSLLDHPFLPTL 371
+G G +V+ A ++ K R + E + L HP +
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDR---KLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 372 YASFQTST----HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
Y S++++ I L+T+ G L L + K+ + R + +++ GL++LH
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 428 G--IIYRDLKPENILLQ-KDGHVVLTDFDLS 455
II+RDLK +NI + G V + D L+
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 32/116 (27%), Positives = 49/116 (42%), Gaps = 17/116 (14%)
Query: 356 EREIMSL--LDHPFLPTLYAS----FQTSTHICLITDFCPGGELFALLDKQPMKIFREDS 409
E E+ + L H + AS +ST + LIT + G L+ L +
Sbjct: 50 ETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDT--VSC 107
Query: 410 ARFYAAEVVIGLEYLHCL--------GIIYRDLKPENILLQKDGHVVLTDFDLSFM 457
R + GL +LH I +RDLK +NIL++K+G + D L+ M
Sbjct: 108 LRI-VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM 162
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 32/114 (28%), Positives = 52/114 (45%), Gaps = 17/114 (14%)
Query: 356 EREI--MSLLDHPFLPTLYAS----FQTSTHICLITDFCPGGELFALLDKQPMKIFREDS 409
E EI +L H + A+ T T + L++D+ G LF L++ + + E
Sbjct: 84 EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV--EGM 141
Query: 410 ARFYAAEVVIGLEYLHC--------LGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ A GL +LH I +RDLK +NIL++K+G + D L+
Sbjct: 142 IKL-ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 32/114 (28%), Positives = 50/114 (43%), Gaps = 17/114 (14%)
Query: 356 EREI--MSLLDHPFLPTLYAS----FQTSTHICLITDFCPGGELFALLDKQPMKIFREDS 409
E EI L+ H + A+ + T + LITD+ G L+ L + +
Sbjct: 79 ETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDA--KSM 136
Query: 410 ARFYAAEVVIGLEYLHCL--------GIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ A V GL +LH I +RDLK +NIL++K+G + D L+
Sbjct: 137 LKL-AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 38/154 (24%), Positives = 66/154 (42%), Gaps = 17/154 (11%)
Query: 314 LGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRA-CIEREIMSLLDHPFLPTLY 372
+G G G V+ G + A+KA + ++ E ++ ++L HP + L
Sbjct: 15 IGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 373 ASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLG---I 429
++CL+ +F GG L +L + + +A ++ G+ YLH I
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDI---LVNWAVQIARGMNYLHDEAIVPI 129
Query: 430 IYRDLKPENILLQKDGHVV--------LTDFDLS 455
I+RDLK NIL+ + +TDF L+
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 40/169 (23%), Positives = 65/169 (38%), Gaps = 27/169 (15%)
Query: 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL 362
+ L + K ++ +G G G+V+ L A+K + NR E+ I +
Sbjct: 10 LDLDNLKLLELIGRGRYGAVYKGSLDE--RPVAVKVFSFA---NRQNFIN---EKNIYRV 61
Query: 363 --LDHPFLPTLYA-----SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAA 415
++H + + L+ ++ P G L L S+ A
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDW---VSSCRLAH 118
Query: 416 EVVIGLEYLH---------CLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
V GL YLH I +RDL N+L++ DG V++DF LS
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 37/175 (21%), Positives = 60/175 (34%), Gaps = 39/175 (22%)
Query: 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAM---EKSVMLNRNKVHRACIEREI 359
+ ++ G G V +L E A+K +K N +V+
Sbjct: 21 FQSMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQNEYEVY-------S 71
Query: 360 MSLLDHPFLPTLYASFQTSTHI----CLITDFCPGGELFALLDKQPMKIFR-----EDSA 410
+ + H + + + T + LIT F G L L + E A
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMA 131
Query: 411 RFYAAEVVIGLEYLHC----------LGIIYRDLKPENILLQKDGHVVLTDFDLS 455
R GL YLH I +RD+K +N+LL+ + + DF L+
Sbjct: 132 R--------GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 7e-14
Identities = 38/182 (20%), Positives = 66/182 (36%), Gaps = 24/182 (13%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHR--ACIEREIMSLL 363
+ I+ LG G +V L + AMK ++ + + A E ++ +
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK------VVKSAEHYTETALDEIRLLKSV 90
Query: 364 -----DHP---FLPTLYASFQTS----THICLITDFCPGGE-LFALLDKQPMKIFREDSA 410
+ P + L F+ S THIC++ + G L + K +
Sbjct: 91 RNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE--VLGHHLLKWIIKSNYQGLPLPCV 148
Query: 411 RFYAAEVVIGLEYLH-CLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAH 469
+ +V+ GL+YLH II+ D+KPENILL + + +
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 470 VN 471
Sbjct: 209 AV 210
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQG----AGELYAMKAMEKSVMLNRNKVHRACIEREIMS 361
H K ++ LG G+ GSV + GE+ A+K ++ S + R E EI+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER---EIEILK 66
Query: 362 LLDHPFLPTLYA--SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARF--YAAEV 417
L H + ++ LI ++ P G L L K +I D + Y +++
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI---DHIKLLQYTSQI 123
Query: 418 VIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
G+EYL I+RDL NIL++ + V + DF L+
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQG----AGELYAMKAMEKSVMLNRNKVHRACIEREIMS 361
H K ++ LG G+ GSV + GE+ A+K ++ S + R E EI+
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER---EIEILK 97
Query: 362 LLDHPFLPTLYA--SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARF--YAAEV 417
L H + ++ LI ++ P G L L K +I D + Y +++
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI---DHIKLLQYTSQI 154
Query: 418 VIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
G+EYL I+RDL NIL++ + V + DF L+
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 21/140 (15%), Positives = 41/140 (29%), Gaps = 4/140 (2%)
Query: 313 PLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLY 372
G A+ ++ +L + + +S +D P + +
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 373 ASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYR 432
T ++ ++ GG L + D P A + + H G+
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADTSPS----PVGAIRAMQSLAAAADAAHRAGVALS 153
Query: 433 DLKPENILLQKDGHVVLTDF 452
P + + DG VVL
Sbjct: 154 IDHPSRVRVSIDGDVVLAYP 173
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 6e-13
Identities = 27/108 (25%), Positives = 51/108 (47%), Gaps = 10/108 (9%)
Query: 350 VHRACIEREIMSLLDHPFLPTLYASFQTSTHIC-----LITDFCPGGELFALLDKQPMKI 404
A ER+ ++ + HP + ++ + + ++ ++ G L Q + +
Sbjct: 123 QAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-GQKLPV 181
Query: 405 FREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDF 452
A Y E++ L YLH +G++Y DLKPENI+L ++ + L D
Sbjct: 182 ---AEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDL 225
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 22/142 (15%), Positives = 48/142 (33%), Gaps = 45/142 (31%)
Query: 81 VITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFML 140
ITD I++A+D+F ++ Y REE++G++ + + +
Sbjct: 3 SITDL---QGRILYANDNFCAVSRYGREELVGQDHRIVNSGYHGKAY------------- 46
Query: 141 YFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNL 200
+W + + N K G ++W
Sbjct: 47 -IRDMW----------------------------RTISRGNIWQGEFCNRRKDGTRYWVD 77
Query: 201 FHLQPMRDHKGELQYFIGVQLD 222
+ P+ D+ G+ + +I ++ D
Sbjct: 78 STIVPLMDNAGKPRQYISIRRD 99
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 7e-10
Identities = 23/171 (13%), Positives = 52/171 (30%), Gaps = 51/171 (29%)
Query: 58 ERERDIRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSF 117
++ Q L ++ + ++TD II+A+ + + E+LG++ S
Sbjct: 102 AQKEAEAQLARLKQAMDANSEMILLTDR---AGRIIYANPALCRFSGMAEGELLGQSPSI 158
Query: 118 LELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAV 177
L S A+ +A+
Sbjct: 159 L--------------DSPLADQETLAAMQ----------------------------EAL 176
Query: 178 REQREITVQLINYTKSGKK------FWNLFHLQPMRDHKGELQYFIGVQLD 222
+ + + +L+N ++G +W P+ L ++ +Q D
Sbjct: 177 QAGQPWSGRLLNRRRTGPAPHDAEDYWAEISTTPIHTDGNGLVGYVQIQHD 227
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 2e-12
Identities = 29/101 (28%), Positives = 51/101 (50%), Gaps = 3/101 (2%)
Query: 357 REIMSL--LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYA 414
REI L L+HP + L T + L+ +F +L +D + + Y
Sbjct: 51 REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYL 109
Query: 415 AEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+++ GL + H +++RDLKP+N+L+ +G + L DF L+
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 150
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 30/149 (20%), Positives = 61/149 (40%), Gaps = 3/149 (2%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
+ +G G+ G V L+ L A+K+ +++ + + E I+ HP
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP--PDLKAKFLQEARILKQYSHP 172
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
+ L I ++ + GG+ L + ++ + + + G+EYL
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQM-VGDAAAGMEYLES 231
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDFDLS 455
I+RDL N L+ + + ++DF +S
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 37/154 (24%), Positives = 65/154 (42%), Gaps = 7/154 (4%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE--IMSLL 363
+ K I+ LG G G V L + K++ + HR+ ++E I+ L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 364 DHPFLPTLYA--SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
H + + + L+ ++ P G L L + + + + +A ++ G+
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQ---LLLFAQQICEGM 147
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
YLH I+RDL N+LL D V + DF L+
Sbjct: 148 AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 4e-12
Identities = 39/162 (24%), Positives = 72/162 (44%), Gaps = 11/162 (6%)
Query: 298 GSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIER 357
GS E + ++ + +G G G ++L AGE A+K +E + K + IE
Sbjct: 1 GSMELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LEC----VKTKHPQLHIES 55
Query: 358 EIMSLLDH-PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAE 416
+I ++ +PT+ + ++ + G L L + K F + A +
Sbjct: 56 KIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRK-FSLKTVLLLADQ 113
Query: 417 VVIGLEYLHCLGIIYRDLKPENILLQKDGH---VVLTDFDLS 455
++ +EY+H I+RD+KP+N L+ V + DF L+
Sbjct: 114 MISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 14/158 (8%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQGAGELY----AMKAMEKSVMLNRNKVHRACIEREIMS 361
H K I LG G+ GSV L G+ A+K ++ S + R E +I+
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR---EIQILK 79
Query: 362 LLDHPFLPTLYA-SFQTSTH-ICLITDFCPGGELFALLDKQPMKIFREDSARF--YAAEV 417
L F+ S+ + L+ ++ P G L L + ++ D++R Y++++
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL---DASRLLLYSSQI 136
Query: 418 VIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
G+EYL ++RDL NIL++ + HV + DF L+
Sbjct: 137 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 6e-12
Identities = 39/149 (26%), Positives = 66/149 (44%), Gaps = 7/149 (4%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL--LDH 365
++ I +G G G V + G++ A+K K + + V + REI L L H
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
P L L F+ + L+ ++C + LD+ + E + + + + + H
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCH 119
Query: 426 CLGIIYRDLKPENILLQKDGHVVLTDFDL 454
I+RD+KPENIL+ K + L DF
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGF 148
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 36/155 (23%), Positives = 66/155 (42%), Gaps = 13/155 (8%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDH- 365
H+K + +G G G + + A+K E R+ + E LL
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-FEP----RRSDAPQLRDEYRTYKLLAGC 65
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
+P +Y Q H L+ D G L LLD + F + A +++ ++ +H
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH 123
Query: 426 CLGIIYRDLKPENILL----QKDGHVV-LTDFDLS 455
++YRD+KP+N L+ K+ +++ + DF +
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 42/156 (26%), Positives = 67/156 (42%), Gaps = 9/156 (5%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE--IMSLL 363
K I+ LG G G V L G+ + KS+ H A +++E I+ L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 364 DHPFLPTLYA--SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARF--YAAEVVI 419
H + + I LI +F P G L L K KI + + YA ++
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI---NLKQQLKYAVQICK 137
Query: 420 GLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
G++YL ++RDL N+L++ + V + DF L+
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 24/184 (13%)
Query: 282 PHKRDNSSWIAIQKITGSG-EKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAME 340
+D S + G G ++ + K +G G G V+ +L +GEL A+K
Sbjct: 29 SRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--- 85
Query: 341 KSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST------HICLITDFCPGGELF 394
V+ ++ +R E +IM LDH + L F +S ++ L+ D+ P ++
Sbjct: 86 -KVLQDKRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVY 140
Query: 395 ALLD-----KQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVV- 448
+ KQ + + Y ++ L Y+H GI +RD+KP+N+LL D V+
Sbjct: 141 RVARHYSRAKQTLP---VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLK 197
Query: 449 LTDF 452
L DF
Sbjct: 198 LCDF 201
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 3e-11
Identities = 29/101 (28%), Positives = 52/101 (51%), Gaps = 4/101 (3%)
Query: 357 REIMSL--LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYA 414
REI L L H + LY T + L+ + +L LLD +A+ +
Sbjct: 49 REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKSFL 106
Query: 415 AEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+++ G+ Y H +++RDLKP+N+L+ ++G + + DF L+
Sbjct: 107 LQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA 147
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 38/155 (24%), Positives = 70/155 (45%), Gaps = 13/155 (8%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDH- 365
+F+ K +GCG+ G + L + E A+K +E +++ + +E L
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEP----MKSRAPQLHLEYRFYKQLGSG 64
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
+P +Y + ++ + G L L D + F + A +++ +EY+H
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVH 122
Query: 426 CLGIIYRDLKPENILL----QKDGHVV-LTDFDLS 455
+IYRD+KPEN L+ K V+ + DF L+
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 7e-11
Identities = 30/101 (29%), Positives = 54/101 (53%), Gaps = 4/101 (3%)
Query: 357 REIMSL--LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYA 414
REI L L HP + +L + + L+ +F +L +LD+ ++ + Y
Sbjct: 68 REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENK-TGLQDSQIKIYL 125
Query: 415 AEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+++ G+ + H I++RDLKP+N+L+ DG + L DF L+
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA 166
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 8e-11
Identities = 37/150 (24%), Positives = 70/150 (46%), Gaps = 8/150 (5%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL--LDH 365
+ + LG G +V+ + + L A+K + + + I RE+ L L H
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALK---EIRLEHEEGAPCTAI-REVSLLKDLKH 59
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
+ TL+ T + L+ ++ +L LD I + + + +++ GL Y H
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCH 117
Query: 426 CLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+++RDLKP+N+L+ + G + L DF L+
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLA 147
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 9e-11
Identities = 30/101 (29%), Positives = 46/101 (45%), Gaps = 4/101 (3%)
Query: 357 REIMSL--LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYA 414
REI L L H L L + L+ +F + L+ P + Y
Sbjct: 73 REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFP-NGLDYQVVQKYL 130
Query: 415 AEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+++ G+ + H II+RD+KPENIL+ + G V L DF +
Sbjct: 131 FQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 35/100 (35%), Positives = 52/100 (52%), Gaps = 4/100 (4%)
Query: 357 REIMSL--LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYA 414
REI L L HP + L +F ++I L+ DF +L ++ + + Y
Sbjct: 61 REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLV-LTPSHIKAYM 118
Query: 415 AEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDL 454
+ GLEYLH I++RDLKP N+LL ++G + L DF L
Sbjct: 119 LMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGL 158
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 1e-10
Identities = 26/101 (25%), Positives = 51/101 (50%), Gaps = 4/101 (3%)
Query: 357 REIMSL--LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYA 414
REI L L H + L+ + + L+ +FC +L D + + +
Sbjct: 50 REICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD-LDPEIVKSFL 107
Query: 415 AEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+++ GL + H +++RDLKP+N+L+ ++G + L +F L+
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA 148
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 33/153 (21%), Positives = 63/153 (41%), Gaps = 11/153 (7%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DH 365
F+ + +G G G ++L E A+K +E + K + E +I +L
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LEN----VKTKHPQLLYESKIYRILQGG 62
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
+P + + L+ D G L L + K + A +++ +E++H
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVH 120
Query: 426 CLGIIYRDLKPENILLQKDGH---VVLTDFDLS 455
++RD+KP+N L+ V + DF L+
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 36/155 (23%), Positives = 55/155 (35%), Gaps = 14/155 (9%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMK-----AMEKSVMLNRNKVHRACIEREIM 360
LG G G V+ + A+K ME L E +M
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---------EAAVM 270
Query: 361 SLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIG 420
+ HP L L +IT+F G L L + + + A ++
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 330
Query: 421 LEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+EYL I+R+L N L+ ++ V + DF LS
Sbjct: 331 MEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLS 365
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 29/105 (27%), Positives = 53/105 (50%), Gaps = 7/105 (6%)
Query: 357 REIMSL--LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKI----FREDSA 410
REI + L H + LY T + L+ +F +L +D + + +
Sbjct: 52 REISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLV 110
Query: 411 RFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+++ +++ GL + H I++RDLKP+N+L+ K G + L DF L+
Sbjct: 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 33/109 (30%), Positives = 52/109 (47%), Gaps = 13/109 (11%)
Query: 357 REIMSLL------DHPFLPTLY-----ASFQTSTHICLITDFCPGGELFALLDKQPMKIF 405
RE+ +LL +HP + L + + L+ + +L LDK P
Sbjct: 60 REV-ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGL 117
Query: 406 REDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDL 454
++ + + + GL++LH I++RDLKPENIL+ G V L DF L
Sbjct: 118 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 40/152 (26%), Positives = 60/152 (39%), Gaps = 5/152 (3%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELY---AMKAMEKSVMLNRNKVHRACIEREIMSLL 363
+ ++ LG G G V E A+K ++ V+ + E M L
Sbjct: 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 364 DHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEY 423
DH L LY + + ++T+ P G L L K +R+ A +V G+ Y
Sbjct: 79 DHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY-AVQVAEGMGY 136
Query: 424 LHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
L I+RDL N+LL V + DF L
Sbjct: 137 LESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 43/167 (25%), Positives = 74/167 (44%), Gaps = 24/167 (14%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL--LD 364
++ + P+G G GSV G A+K K ++ +H RE+ L +
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 365 HP--------FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAE 416
H F P S + + L+T G +L ++ Q + +D +F +
Sbjct: 87 HENVIGLLDVFTPA--RSLEEFNDVYLVTHLM-GADLNNIVKCQKLT---DDHVQFLIYQ 140
Query: 417 VVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS-----FMT 458
++ GL+Y+H II+RDLKP N+ + +D + + DF L+ MT
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT 187
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 40/155 (25%), Positives = 72/155 (46%), Gaps = 10/155 (6%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQGAGELY----AMKAMEKSVMLNRNKVHRACI-EREIM 360
FK IK LG G G+V+ GE A+K + ++ K ++ + E +M
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS---PKANKEILDEAYVM 71
Query: 361 SLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIG 420
+ +D+P + L ++ + LIT P G L + + I + + ++ G
Sbjct: 72 ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW-CVQIAKG 129
Query: 421 LEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ YL +++RDL N+L++ HV +TDF L+
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 36/154 (23%), Positives = 65/154 (42%), Gaps = 19/154 (12%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIM---SLL 363
++ ++ LG G V E +K + V + I+REI +L
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL--------KPVKKKKIKREIKILENLR 88
Query: 364 DHPFLPTLYASFQ--TSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
P + TL + S L+ + + KQ + + RFY E++ L
Sbjct: 89 GGPNIITLADIVKDPVSRTPALVFEHVNNTDF-----KQLYQTLTDYDIRFYMYEILKAL 143
Query: 422 EYLHCLGIIYRDLKPENILL-QKDGHVVLTDFDL 454
+Y H +GI++RD+KP N+++ + + L D+ L
Sbjct: 144 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 38/150 (25%), Positives = 60/150 (40%), Gaps = 6/150 (4%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDH 365
K K LG G G V + ++ A+K M+ M + E +M L H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAFLA----EANVMKTLQH 242
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
L L+A T I +IT+F G L L ++A++ G+ ++
Sbjct: 243 DKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 426 CLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
I+RDL+ NIL+ + DF L+
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLA 331
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 32/148 (21%), Positives = 64/148 (43%), Gaps = 10/148 (6%)
Query: 312 KPLGCGDTGSVHLVELQGAGELY--AMKAMEKSVMLNRNKVHRACIERE--IMSLLDHPF 367
K LG G+ G+V Q + A+K ++ + + + E +M LD+P+
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN---DPALKDELLAEANVMQQLDNPY 79
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
+ + + L+ + G L L + + ++ + +V +G++YL
Sbjct: 80 IVRMIG-ICEAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES 136
Query: 428 GIIYRDLKPENILLQKDGHVVLTDFDLS 455
++RDL N+LL + ++DF LS
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 5e-10
Identities = 37/155 (23%), Positives = 55/155 (35%), Gaps = 14/155 (9%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMK-----AMEKSVMLNRNKVHRACIEREIM 360
LG G G V+ + A+K ME L E +M
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---------EAAVM 63
Query: 361 SLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIG 420
+ HP L L +IT+F G L L + + + A ++
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 421 LEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+EYL I+RDL N L+ ++ V + DF LS
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 158
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 35/176 (19%), Positives = 67/176 (38%), Gaps = 29/176 (16%)
Query: 300 GEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHR-ACIERE 358
GE + ++ LG G +V L + AMK ++ A E +
Sbjct: 13 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMK-----IVRGDKVYTEAAEDEIK 67
Query: 359 IMSLL--------DHPFLP---TLYASFQ----TSTHICLITDFCPGGELFALLDKQPMK 403
++ + D L F H+ ++ + G L AL+ K +
Sbjct: 68 LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR 126
Query: 404 IFREDSARFYAAEVVIGLEYLH-CLGIIYRDLKPENILL------QKDGHVVLTDF 452
+ + ++++GL+Y+H GII+ D+KPEN+L+ + + + D
Sbjct: 127 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADL 182
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 9e-10
Identities = 30/109 (27%), Positives = 55/109 (50%), Gaps = 13/109 (11%)
Query: 357 REIMSLL------DHPFLPTLY-----ASFQTSTHICLITDFCPGGELFALLDKQPMKIF 405
RE+ ++L +HP + L+ + T + L+ + +L LDK P
Sbjct: 60 REV-AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV 117
Query: 406 REDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDL 454
++ + +++ GL++LH +++RDLKP+NIL+ G + L DF L
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 9e-10
Identities = 27/100 (27%), Positives = 44/100 (44%), Gaps = 6/100 (6%)
Query: 356 ERE--IMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQ-PMKIFREDSARF 412
+RE L P + ++ + + + G +L A+L +Q P+ R A
Sbjct: 82 QREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPR---AVA 138
Query: 413 YAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDF 452
++ L+ H G +RD+KPENIL+ D L DF
Sbjct: 139 IVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDF 178
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 33/145 (22%), Positives = 69/145 (47%), Gaps = 8/145 (5%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS--LLDHPFL 368
+ LG G +V+L E A+KA+ + R ERE+ + L H +
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKR--FEREVHNSSQLSHQNI 73
Query: 369 PTLYASFQTSTHICLITDFCPGGELFALLDKQ-PMKIFREDSARFYAAEVVIGLEYLHCL 427
++ + L+ ++ G L ++ P+ + D+A + +++ G+++ H +
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSV---DTAINFTNQILDGIKHAHDM 130
Query: 428 GIIYRDLKPENILLQKDGHVVLTDF 452
I++RD+KP+NIL+ + + + DF
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDF 155
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 36/146 (24%), Positives = 66/146 (45%), Gaps = 6/146 (4%)
Query: 312 KPLGCGDTGSVHLVELQGAGELY--AMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLP 369
LGCG+ GSV + + A+K +++ + E +IM LD+P++
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR--EAQIMHQLDNPYIV 399
Query: 370 TLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGI 429
L + + L+ + GG L L + +I + A +V +G++YL
Sbjct: 400 RLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL-LHQVSMGMKYLEEKNF 457
Query: 430 IYRDLKPENILLQKDGHVVLTDFDLS 455
++R+L N+LL + ++DF LS
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLS 483
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 37/150 (24%), Positives = 64/150 (42%), Gaps = 6/150 (4%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDH 365
+ LG G G V + G + A+K ++ M E ++M L H
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRH 238
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
L LYA + I ++T++ G L L + K R AA++ G+ Y+
Sbjct: 239 EKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 426 CLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ ++RDL+ NIL+ ++ + DF L+
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLA 327
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 38/155 (24%), Positives = 60/155 (38%), Gaps = 10/155 (6%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQGAGELY---AMKAMEKSVMLNRNKVHRACIERE--IM 360
K +G GD+G V L+ G+ A+KA++ + R E IM
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT----ERQRRDFLSEASIM 104
Query: 361 SLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIG 420
DHP + L ++T++ G L L + V G
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM-LRGVGAG 163
Query: 421 LEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ YL LG ++RDL N+L+ + ++DF LS
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 37/150 (24%), Positives = 64/150 (42%), Gaps = 6/150 (4%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDH 365
+ LG G G V + G + A+K ++ M E ++M L H
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRH 321
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
L LYA + I ++T++ G L L + K R AA++ G+ Y+
Sbjct: 322 EKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 426 CLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ ++RDL+ NIL+ ++ + DF L+
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLA 410
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 34/162 (20%), Positives = 59/162 (36%), Gaps = 27/162 (16%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMK---AMEKSVMLNRNKVHRACIEREIMSL- 362
+ + +G G G V A+K E R REI L
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR-------TLREIKILL 80
Query: 363 -LDHP--------FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFY 413
H + + ++ D +L+ LL Q + D ++
Sbjct: 81 RFRHENIIGINDIIRAPTIEQMK---DVYIVQDLM-ETDLYKLLKTQHLS---NDHICYF 133
Query: 414 AAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+++ GL+Y+H +++RDLKP N+LL + + DF L+
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} Length = 124 | Back alignment and structure |
|---|
Score = 54.4 bits (132), Expect = 2e-09
Identities = 21/142 (14%), Positives = 39/142 (27%), Gaps = 45/142 (31%)
Query: 81 VITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFML 140
V+TD II + L Y++E+ +G+ + L + T
Sbjct: 21 VVTDL---QGFIIDWNKGSETLYGYSKEQAIGQPVNMLHVPGDTEHI------------- 64
Query: 141 YFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNL 200
+ AV Q + T ++ K G W
Sbjct: 65 -TSEVI----------------------------SAVENQGKWTGEIRMLHKDGHIGWIE 95
Query: 201 FHLQPMRDHKGELQYFIGVQLD 222
P+ ++ +G+ D
Sbjct: 96 SMCVPIYGENYQMVGALGINRD 117
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 24/167 (14%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL--LD 364
++ ++P+G G G+V G A+K K ++++ RE+ L +
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHMR 82
Query: 365 HP--------FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAE 416
H F P + T L+ F G +L L+ + + ED +F +
Sbjct: 83 HENVIGLLDVFTPD--ETLDDFTDFYLVMPFM-GTDLGKLMKHEKLG---EDRIQFLVYQ 136
Query: 417 VVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDL-----SFMT 458
++ GL Y+H GII+RDLKP N+ + +D + + DF L S MT
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 183
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 15/40 (37%), Positives = 22/40 (55%)
Query: 413 YAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDF 452
A+ L + H GII+RD+KP NI++ V + DF
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDF 160
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 3e-09
Identities = 40/145 (27%), Positives = 64/145 (44%), Gaps = 6/145 (4%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPT 370
++ +G G G VHL ++ A+K + + M + E E+M L HP L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAM-SEEDFIE---EAEVMMKLSHPKLVQ 67
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGII 430
LY ICL+T+F G L L Q E +V G+ YL +I
Sbjct: 68 LYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM-CLDVCEGMAYLEEACVI 126
Query: 431 YRDLKPENILLQKDGHVVLTDFDLS 455
+RDL N L+ ++ + ++DF ++
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMT 151
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 39/145 (26%), Positives = 69/145 (47%), Gaps = 8/145 (5%)
Query: 314 LGCGDTGSVHLVELQGAGELY--AMKAM-EKSVMLNRNKVHRACIEREIMSLLDHPFLPT 370
LGCG+ GSV + + A+K + + + + ++ R E +IM LD+P++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR---EAQIMHQLDNPYIVR 74
Query: 371 LYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGII 430
L Q + L+ + GG L L + +I + A +V +G++YL +
Sbjct: 75 LIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL-LHQVSMGMKYLEEKNFV 132
Query: 431 YRDLKPENILLQKDGHVVLTDFDLS 455
+RDL N+LL + ++DF LS
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLS 157
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 37/167 (22%), Positives = 73/167 (43%), Gaps = 23/167 (13%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI--MSLLD 364
++ +KP+G G G V A+K K +N+ H RE+ M ++
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK---KLSRPFQNQTHAKRAYRELVLMKCVN 119
Query: 365 HPFLPTLY------ASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVV 418
H + +L + + + L+ + L ++ + + + + +++
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-QMELD---HERMSYLLYQML 174
Query: 419 IGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS-------FMT 458
G+++LH GII+RDLKP NI+++ D + + DF L+ MT
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 221
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 27/169 (15%), Positives = 57/169 (33%), Gaps = 21/169 (12%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAG--------ELYAMK--------AMEKSVMLNRNKV 350
+K + G ++ + +++K E++ K
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 351 HRACIEREIMSLLDHPFLPTLYAS-FQTSTHICLITDFCPGGELFALLDKQPMKIFREDS 409
+ +++ S +PT + L+ G L + LD P + E S
Sbjct: 103 LQVNKWKKLYST-PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERS 160
Query: 410 ARFYAAEVVIGLEYLHCLGIIYRDLKPENILL--QKDGHVVLTDFDLSF 456
A ++ LE+LH ++ ++ ENI + + V L + +F
Sbjct: 161 VLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 38/150 (25%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELY----AMKAMEKSVMLNRNKVHRACI-EREIMSLLDH 365
IK LG G G+V+ GE A+K + ++ K ++ + E +M+ +D+
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS---PKANKEILDEAYVMASVDN 76
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
P + L ++ + LIT P G L + + I + + ++ G+ YL
Sbjct: 77 PHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW-CVQIAKGMNYLE 134
Query: 426 CLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+++RDL N+L++ HV +TDF L+
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 36/191 (18%), Positives = 70/191 (36%), Gaps = 33/191 (17%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMK---AMEKSVMLNRNKVHRACIEREIMSL- 362
F+ LG G G V + GE+ A+K +K + R REI L
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR-------TLREIKILK 64
Query: 363 -LDHP--------FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFY 413
H P + +F + +I + +L ++ Q + +D +++
Sbjct: 65 HFKHENIITIFNIQRPDSFENFN---EVYIIQELM-QTDLHRVISTQMLS---DDHIQYF 117
Query: 414 AAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGF 473
+ + ++ LH +I+RDLKP N+L+ + + + DF L+ +
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 474 YFIMYKWLTGY 484
+ +
Sbjct: 178 G------MVEF 182
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 5e-09
Identities = 29/109 (26%), Positives = 44/109 (40%), Gaps = 19/109 (17%)
Query: 356 EREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGG----ELFALLDKQP------MKIF 405
E ++M+ H L L +CL+ + P G L L P KI
Sbjct: 80 EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIA 139
Query: 406 REDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDL 454
+ +A G+ +LH I+RD+K NILL + ++DF L
Sbjct: 140 -QGAAN--------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGL 179
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 5e-09
Identities = 33/111 (29%), Positives = 46/111 (41%), Gaps = 20/111 (18%)
Query: 356 EREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGEL-FALLDKQP----------MKI 404
E E +S HP L +L + LI + G L L ++I
Sbjct: 85 EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 405 FREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+AR GL YLH II+RD+K NILL ++ +TDF +S
Sbjct: 145 C-IGAAR--------GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 32/155 (20%), Positives = 58/155 (37%), Gaps = 9/155 (5%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQGAGELY----AMKAMEKSVMLN-RNKVHRACIEREIM 360
K +G G+ G V+ L+ + A+K ++ R E IM
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG---EAGIM 100
Query: 361 SLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIG 420
H + L + +IT++ G L L ++ + + G
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM-LRGIAAG 159
Query: 421 LEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
++YL + ++RDL NIL+ + ++DF LS
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 24/105 (22%), Positives = 47/105 (44%), Gaps = 10/105 (9%)
Query: 357 REIMSL--LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYA 414
RE+ L L H + L + + + LI ++ +L +DK + +
Sbjct: 82 REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDK--NPDVSMRVIKSFL 138
Query: 415 AEVVIGLEYLHCLGIIYRDLKPENILL-----QKDGHVVLTDFDL 454
+++ G+ + H ++RDLKP+N+LL + + + DF L
Sbjct: 139 YQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 44/180 (24%), Positives = 80/180 (44%), Gaps = 24/180 (13%)
Query: 285 RDNSSWIAIQKITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVM 344
D + I + G + + K +G G G V +L + E+ A+ K V+
Sbjct: 19 DDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEV----AI-KKVL 73
Query: 345 LNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH------ICLITDFCPGGELFALLD 398
++ +R E +IM ++ HP + L A F ++ + L+ ++ P ++
Sbjct: 74 QDKRFKNR---ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASR 129
Query: 399 -----KQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVV-LTDF 452
KQ M + Y +++ L Y+H +GI +RD+KP+N+LL V+ L DF
Sbjct: 130 HYAKLKQTMP---MLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 41/160 (25%), Positives = 67/160 (41%), Gaps = 14/160 (8%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHR-ACIEREIMSLL------ 363
I+ +G G G V L + + YA+K V+ N K R A IE +I+ +
Sbjct: 40 IRKMGDGTFGRVLLCQHIDNKKYYAVK-----VVRNIKKYTRSAKIEADILKKIQNDDIN 94
Query: 364 DHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEY 423
++ + + F H+CLI + G L+ ++ + F + + Y E++ L Y
Sbjct: 95 NNNIV-KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 424 LHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQ 463
L + + + DLKPENILL K Q
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 8e-09
Identities = 33/147 (22%), Positives = 66/147 (44%), Gaps = 10/147 (6%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACI-EREIMSLLDHPFLP 369
++ +G G+ G V L + +G A+K + + +A + E +M+ L H L
Sbjct: 26 LQTIGKGEFGDVMLGDYRG--NKVAVK------CIKNDATAQAFLAEASVMTQLRHSNLV 77
Query: 370 TLYAS-FQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLG 428
L + + ++T++ G L L + + D ++ +V +EYL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137
Query: 429 IIYRDLKPENILLQKDGHVVLTDFDLS 455
++RDL N+L+ +D ++DF L+
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 8e-09
Identities = 34/175 (19%), Positives = 67/175 (38%), Gaps = 29/175 (16%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN------RNKVHRACIEREIM 360
+ + + G G+V + G A+K + +V + + REI
Sbjct: 23 PYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 361 SL--LDHP--------FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSA 410
L HP F+ + + L+T+ +L ++ +
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMH---KLYLVTELM-RTDLAQVI-HDQRIVISPQHI 136
Query: 411 RFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS-------FMT 458
+++ +++GL LH G+++RDL P NILL + + + DF+L+ T
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT 191
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 35/154 (22%), Positives = 61/154 (39%), Gaps = 8/154 (5%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQGAGELY---AMKAMEKSVML-NRNKVHRACIEREIMS 361
+ K +G G+ G V L+ + A+K ++ R E IM
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EASIMG 101
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
DHP + L S + ++T++ G L + L K + + G+
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM-LRGIASGM 160
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+YL +G ++RDL NIL+ + ++DF L
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 35/159 (22%), Positives = 72/159 (45%), Gaps = 20/159 (12%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL--LD 364
+ +G G GSV + +GE A+K + + ++++ RE++ L +
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---QSEIFAKRAYRELLLLKHMQ 81
Query: 365 HP--------FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAE 416
H F P +S + L+ F +L ++ E+ ++ +
Sbjct: 82 HENVIGLLDVFTPA--SSLRNFYDFYLVMPFM-QTDLQKIM-GLKFS---EEKIQYLVYQ 134
Query: 417 VVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
++ GL+Y+H G+++RDLKP N+ + +D + + DF L+
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 173
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 36/155 (23%), Positives = 60/155 (38%), Gaps = 16/155 (10%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMK-----AMEKSVMLNRNKVHRACIEREIM 360
+K LG G G V L + +G ++ A+K +M + E + M
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSMSEDEFFQ---------EAQTM 57
Query: 361 SLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIG 420
L HP L Y I ++T++ G L L + +V G
Sbjct: 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM-CYDVCEG 116
Query: 421 LEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ +L I+RDL N L+ +D V ++DF ++
Sbjct: 117 MAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 36/149 (24%), Positives = 57/149 (38%), Gaps = 9/149 (6%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELY---AMKAMEKSVML-NRNKVHRACIEREIMSLLDHP 366
+ +G G G VH A+K + R K + E M DHP
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ---EALTMRQFDHP 76
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
+ L T + +I + C GEL + L + + + A ++ L YL
Sbjct: 77 HIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY-AYQLSTALAYLES 134
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDFDLS 455
++RD+ N+L+ + V L DF LS
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 34/155 (21%), Positives = 64/155 (41%), Gaps = 10/155 (6%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQGAGELY----AMKAM-EKSVMLNRNKVHRACIEREIM 360
+ +K LG G G+VH GE +K + +KS + V +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD---HMLAI 69
Query: 361 SLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIG 420
LDH + L + + L+T + P G L + + + + + ++ G
Sbjct: 70 GSLDHAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW-GVQIAKG 127
Query: 421 LEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ YL G+++R+L N+LL+ V + DF ++
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 43/159 (27%), Positives = 62/159 (38%), Gaps = 22/159 (13%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRA----CIEREIMSLL 363
F LG G G V+ L G L A+K L + E E++S+
Sbjct: 32 FSNKNILGRGGFGKVYKGRLAD-GTLVAVK------RLKEERTQGGELQFQTEVEMISMA 84
Query: 364 DHPFLPTLYASFQTSTHICLITDFCPGGEL-FALLDKQPMKIFREDSARFY----AAEVV 418
H L L T T L+ + G + L ++ + + R +A
Sbjct: 85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR-- 142
Query: 419 IGLEYLHC---LGIIYRDLKPENILLQKDGHVVLTDFDL 454
GL YLH II+RD+K NILL ++ V+ DF L
Sbjct: 143 -GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 33/155 (21%), Positives = 65/155 (41%), Gaps = 16/155 (10%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSV---MLNRNKVHRACI-EREIMS 361
K ++ +G G+ G V L + +G V + + +A + E +M+
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRG-----------NKVAVKCIKNDATAQAFLAEASVMT 241
Query: 362 LLDHPFLPTLYA-SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIG 420
L H L L + + ++T++ G L L + + D ++ +V
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 301
Query: 421 LEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+EYL ++RDL N+L+ +D ++DF L+
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 2e-08
Identities = 39/155 (25%), Positives = 61/155 (39%), Gaps = 16/155 (10%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMK-----AMEKSVMLNRNKVHRACIEREIM 360
K ++ LG G G V + G ++ A+K +M L E +M
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLA---------EANLM 62
Query: 361 SLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIG 420
L H L LYA T I +IT++ G L L + AA++ G
Sbjct: 63 KQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 421 LEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ ++ I+RDL+ NIL+ + DF L+
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 33/108 (30%), Positives = 49/108 (45%), Gaps = 12/108 (11%)
Query: 357 REIMSL--LDHPFLPTLY--------ASFQTSTHICLITDFCPGGELFALLDKQPMKIFR 406
REI L L H + L + I L+ DFC +L LL +K F
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVK-FT 122
Query: 407 EDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDL 454
+ ++ GL Y+H I++RD+K N+L+ +DG + L DF L
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 32/153 (20%), Positives = 56/153 (36%), Gaps = 15/153 (9%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSV---MLNRNKVHRACI----EREIMSLL 363
+ +G G G V+ G L + LNR E IM
Sbjct: 30 NEVIGRGHFGCVYH------GTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 83
Query: 364 DHPFLPTLYA-SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLE 422
HP + +L ++ ++ + G+L + + +D F +V G++
Sbjct: 84 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAKGMK 142
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
YL ++RDL N +L + V + DF L+
Sbjct: 143 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 3e-08
Identities = 38/149 (25%), Positives = 59/149 (39%), Gaps = 9/149 (6%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELY---AMKAMEKSVML-NRNKVHRACIEREIMSLLDHP 366
+ LG G G V+ A+K +K L N+ K E IM LDHP
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS---EAVIMKNLDHP 73
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
+ L +I + P GEL L++ + + + ++ + YL
Sbjct: 74 HIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY-SLQICKAMAYLES 131
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ ++RD+ NIL+ V L DF LS
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 38/150 (25%), Positives = 65/150 (43%), Gaps = 6/150 (4%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDH 365
+K LG G G V + +G ++ A+K +++ M + ++ E ++M L H
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSM-SEDEFIE---EAKVMMNLSH 78
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
L LY I +IT++ G L L + + + +V +EYL
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYLE 137
Query: 426 CLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
++RDL N L+ G V ++DF LS
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 18/164 (10%)
Query: 300 GEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHR-ACIERE 358
GEK ++ +G G G V + E A+K ++ N+ A IE
Sbjct: 49 GEKWM-DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK-----IIKNKKAFLNQAQIEVR 102
Query: 359 IMSLL------DHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARF 412
++ L+ ++ L F H+CL+ + L+ LL + + R
Sbjct: 103 LLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRK 161
Query: 413 YAAEVVIGLEYLHC--LGIIYRDLKPENILLQKDGH--VVLTDF 452
+A ++ L +L L II+ DLKPENILL + + DF
Sbjct: 162 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 41/151 (27%), Positives = 66/151 (43%), Gaps = 15/151 (9%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHR-ACIEREIMSLL------ 363
+K +G G G V + A+K ++ N + HR A E I+ L
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALK-----MVRNEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 364 DHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEY 423
+ + + +F HIC+ + L+ L+ K + F R +A ++ L+
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215
Query: 424 LHCLGIIYRDLKPENILLQKDGHVV--LTDF 452
LH II+ DLKPENILL++ G + DF
Sbjct: 216 LHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 35/160 (21%), Positives = 66/160 (41%), Gaps = 21/160 (13%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL--LD 364
++ +G G G V + + A+K K + + + + I REI L L+
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK---KILRVFEDLIDCKRILREIAILNRLN 110
Query: 365 HP--------FLPTLYASFQTSTHICLITDFCPGGELFALLDK-QPMKIFREDSARFYAA 415
H +P F + ++ + + L + E +
Sbjct: 111 HDHVVKVLDIVIPKDVEKFD---ELYVVLEIA-DSDFKKLFRTPVYLT---ELHIKTLLY 163
Query: 416 EVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+++G++Y+H GI++RDLKP N L+ +D V + DF L+
Sbjct: 164 NLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 34/152 (22%), Positives = 62/152 (40%), Gaps = 20/152 (13%)
Query: 311 IKPLGCGDTGSVHLVE---LQGAGELYAMKAMEKSVMLNRNKVHR-ACIEREIMSLL--- 363
+ LG G G V VE + G A+K ++ N ++ A E +++ L
Sbjct: 19 VDTLGEGAFGKV--VECIDHKAGGRHVAVK-----IVKNVDRYCEAARSEIQVLEHLNTT 71
Query: 364 ----DHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVI 419
+ + F+ HIC++ + G + + + FR D R A ++
Sbjct: 72 DPNSTFRCV-QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICK 129
Query: 420 GLEYLHCLGIIYRDLKPENILLQKDGHVVLTD 451
+ +LH + + DLKPENIL + + +
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYN 161
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 40/166 (24%), Positives = 73/166 (43%), Gaps = 26/166 (15%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL--LD 364
+ +KPLGCG G V + A+K K V+ + REI + LD
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVL--TDPQSVKHALREIKIIRRLD 66
Query: 365 HP--------FLP------TLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSA 410
H P S + ++ ++ +L +L++ P+ E+ A
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLL---EEHA 122
Query: 411 RFYAAEVVIGLEYLHCLGIIYRDLKPENILL-QKDGHVVLTDFDLS 455
R + +++ GL+Y+H +++RDLKP N+ + +D + + DF L+
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA 168
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 31/153 (20%), Positives = 56/153 (36%), Gaps = 15/153 (9%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSV---MLNRNKVHRACI----EREIMSLL 363
+ +G G G V+ G L + LNR E IM
Sbjct: 94 NEVIGRGHFGCVYH------GTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 147
Query: 364 DHPFLPTLYA-SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLE 422
HP + +L ++ ++ + G+L + + +D F +V G++
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAKGMK 206
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+L ++RDL N +L + V + DF L+
Sbjct: 207 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 31/169 (18%), Positives = 63/169 (37%), Gaps = 21/169 (12%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQ-----GAGELYAMKAMEKSV--------MLNRNKVHRA 353
+K P+G G G ++L ++ G+ +K R
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 354 CIEREIMSLLDHPFLPTLYAS----FQTSTHICLITDFCPGGELFALLDKQPMKIFREDS 409
+ L + +P + S ++ +I D G +L + + + F +
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKR-FSRKT 153
Query: 410 ARFYAAEVVIGLEYLHCLGIIYRDLKPENILL-QKDGHVV-LTDFDLSF 456
+ ++ LEY+H ++ D+K N+LL K+ V L D+ L++
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 29/160 (18%), Positives = 54/160 (33%), Gaps = 19/160 (11%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELY-------AMKAMEKSVMLNRNKVHRACIEREIMSLL 363
+ LG G + + G+ +K ++K+ +MS L
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE---AASMMSKL 69
Query: 364 DHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEY 423
H L Y L+ +F G L L K I A ++ + +
Sbjct: 70 SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV-AKQLAAAMHF 128
Query: 424 LHCLGIIYRDLKPENILLQK-------DGHVV-LTDFDLS 455
L +I+ ++ +NILL + + + L+D +S
Sbjct: 129 LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 36/167 (21%), Positives = 73/167 (43%), Gaps = 23/167 (13%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL--LD 364
++ +KP+G G G V A+K K +N+ H RE++ + ++
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIK---KLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 365 HPFLPTLY------ASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVV 418
H + L S + + ++ + L ++ + + + + +++
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-QMELD---HERMSYLLYQML 137
Query: 419 IGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS-------FMT 458
G+++LH GII+RDLKP NI+++ D + + DF L+ MT
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 184
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} Length = 120 | Back alignment and structure |
|---|
Score = 49.8 bits (120), Expect = 8e-08
Identities = 30/154 (19%), Positives = 52/154 (33%), Gaps = 45/154 (29%)
Query: 69 LATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEI 128
T+E ITD I++A+ +F +T Y EE+LG+N S L
Sbjct: 7 FRQTVEHAPIAISITDL---KANILYANRAFRTITGYGSEEVLGKNESILS--------- 54
Query: 129 LGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLI 188
+ T L + ALW ++ + + +
Sbjct: 55 -----NGTTPRLVYQALWG--------------RLAQKK----------PWSGVL----V 81
Query: 189 NYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLD 222
N K + + P+ + GE Y++G+ D
Sbjct: 82 NRRKDKTLYLAELTVAPVLNEAGETIYYLGMHRD 115
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 9e-08
Identities = 38/200 (19%), Positives = 65/200 (32%), Gaps = 54/200 (27%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
+ K LG G G V V +G+ +A+K K V+ + +R E +IM +LDH
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALK---K-VLQDPRYKNR---ELDIMKVLDHV 60
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVI------- 419
+ L F T+ P + + + +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 420 --------------------------------GLEYLHCLGIIYRDLKPENILL-QKDGH 446
+ ++H LGI +RD+KP+N+L+ KD
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 447 VVLTDFDLS-------FMTS 459
+ L DF + +
Sbjct: 181 LKLCDFGSAKKLIPSEPSVA 200
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 35/148 (23%), Positives = 56/148 (37%), Gaps = 7/148 (4%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELY---AMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
+ +G G G VH A+K + + + E M DHP
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ--EALTMRQFDHPH 452
Query: 368 LPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL 427
+ L T + +I + C GEL + L + + YA ++ L YL
Sbjct: 453 IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLIL-YAYQLSTALAYLESK 510
Query: 428 GIIYRDLKPENILLQKDGHVVLTDFDLS 455
++RD+ N+L+ + V L DF LS
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLS 538
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 36/160 (22%), Positives = 66/160 (41%), Gaps = 21/160 (13%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL--LD 364
++ +G G G V+L + + A+K + + + + + I REI L L
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR---MFEDLIDCKRILREITILNRLK 83
Query: 365 HP--------FLPTLYASFQTSTHICLITDFCPGGELFALL-DKQPMKIFREDSARFYAA 415
+P F + ++ + +L L + E+ +
Sbjct: 84 SDYIIRLYDLIIPDDLLKFD---ELYIVLEIA-DSDLKKLFKTPIFLT---EEHIKTILY 136
Query: 416 EVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+++G ++H GII+RDLKP N LL +D V + DF L+
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 33/152 (21%), Positives = 55/152 (36%), Gaps = 20/152 (13%)
Query: 311 IKPLGCGDTGSVHLVE---LQGAGELYAMKAMEKSVMLNRNKVHR-ACIEREIMSLL--- 363
+ LG G G V VE A+K ++ N K A +E ++ +
Sbjct: 24 VGNLGEGTFGKV--VECLDHARGKSQVALK-----IIRNVGKYREAARLEINVLKKIKEK 76
Query: 364 ----DHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVI 419
+ + F H+C+ + G F L + + + R A ++
Sbjct: 77 DKENKFLCV-LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134
Query: 420 GLEYLHCLGIIYRDLKPENILLQKDGHVVLTD 451
L +LH + + DLKPENIL L +
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYN 166
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 16/159 (10%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELY---AMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
+ LG G+ GSV +L+ + A+K ++ ++ + + E M DHP
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR-EAACMKEFDHPH 86
Query: 368 LPTLYA------SFQTSTHICLITDFCPGGELFALL-----DKQPMKIFREDSARFYAAE 416
+ L + +I F G+L A L + P + + RF +
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF-MVD 145
Query: 417 VVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ G+EYL I+RDL N +L +D V + DF LS
Sbjct: 146 IACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 33/153 (21%), Positives = 57/153 (37%), Gaps = 15/153 (9%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELY---AMKAMEKSVMLNRNKVHRACI----EREIMSLL 363
+ +G G G V+ E + A+K L+R + E +M L
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIK------SLSRITEMQQVEAFLREGLLMRGL 79
Query: 364 DHPFLPTLYA-SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLE 422
+HP + L ++ + G+L + +D F +V G+E
Sbjct: 80 NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF-GLQVARGME 138
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
YL ++RDL N +L + V + DF L+
Sbjct: 139 YLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 35/167 (20%), Positives = 67/167 (40%), Gaps = 20/167 (11%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAM-----EKSVMLNRNKV-HRACIEREI- 359
+ K +G G G ++L E A + E + + K R + I
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 360 ----MSLLDHPFLPTLYAS----FQTSTHICLITDFCPGGELFALLDKQPMKIFREDSAR 411
LD+ +P Y S F+ ++ ++ + G +L + + F++ +
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVL 154
Query: 412 FYAAEVVIGLEYLHCLGIIYRDLKPENILL-QKDGHVV-LTDFDLSF 456
++ LEY+H ++ D+K N+LL K+ V L D+ LS+
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 31/137 (22%), Positives = 58/137 (42%), Gaps = 19/137 (13%)
Query: 331 GELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH--ICLITDFC 388
+ YA+K +E + + AC E ++ L HP + +L F + + L+ D+
Sbjct: 48 DKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 102
Query: 389 PGGELFALLDKQPMKIFREDSARFYAAEV-------VIGLEYLHCLGIIYRDLKPENILL 441
+L+ ++ + + V + G+ YLH +++RDLKP NIL+
Sbjct: 103 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILV 161
Query: 442 QKD----GHVVLTDFDL 454
+ G V + D
Sbjct: 162 MGEGPERGRVKIADMGF 178
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 12/154 (7%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIM---SLL 363
++ +K LG G G V + GE+ A+K K +N REIM L
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVK---KIFDAFQNSTDAQRTFREIMILTELS 66
Query: 364 DHPFLPTLYASFQTST--HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
H + L + + L+ D+ +L A++ ++ ++ +++ +
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANILE---PVHKQYVVYQLIKVI 122
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+YLH G+++RD+KP NILL + HV + DF LS
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLS 156
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 32/162 (19%), Positives = 55/162 (33%), Gaps = 23/162 (14%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSV-----MLNRNKVHRACI----EREIMS 361
+ LG G G V+ G + E +N R I E +M
Sbjct: 30 SRELGQGSFGMVYE------GVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMK 83
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFA-LLDKQPMKIFREDSARF-------Y 413
+ + L +I + G+L + L +P A
Sbjct: 84 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143
Query: 414 AAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
A E+ G+ YL+ ++RDL N ++ +D V + DF ++
Sbjct: 144 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 33/161 (20%), Positives = 68/161 (42%), Gaps = 23/161 (14%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
F+ + G G G+V L + + G A+K K V+ + +R + +++L HP
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIK---K-VIQDPRFRNRELQIMQDLAVLHHP 79
Query: 367 FLPTLYASFQTSTH-------ICLITDFCPGGELFALLD-----KQPMKIFREDSARFYA 414
+ L + F T + ++ ++ P L + + +
Sbjct: 80 NIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPP---ILIKVFL 135
Query: 415 AEVVIGLEYLHC--LGIIYRDLKPENILL-QKDGHVVLTDF 452
+++ + LH + + +RD+KP N+L+ + DG + L DF
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 36/164 (21%), Positives = 63/164 (38%), Gaps = 23/164 (14%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELY-----AMKAMEKSVMLNRNKVHRACIEREIMSLLDH 365
LG G G V L E A+KA++++ R R E E++++L H
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTMLQH 102
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALL--------------DKQPMKIFREDSAR 411
+ + + ++ ++ G+L L D P +
Sbjct: 103 QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 412 FYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
A++V G+ YL L ++RDL N L+ + V + DF +S
Sbjct: 163 V-ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 32/168 (19%), Positives = 58/168 (34%), Gaps = 29/168 (17%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSV-----MLNRNKVHRACI----EREIMS 361
++ LG G V+ G L+ E++ L E + +
Sbjct: 14 MEELGEDRFGKVYK------GHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRA 67
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALL-------DKQPMKIFREDSARF-- 412
L HP + L + +I +C G+L L D R +
Sbjct: 68 RLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 127
Query: 413 -----YAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
A++ G+EYL ++++DL N+L+ +V ++D L
Sbjct: 128 PDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 4e-06
Identities = 34/164 (20%), Positives = 60/164 (36%), Gaps = 22/164 (13%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELY-----AMKAMEKSVMLNRNKVHRACIEREIMSLLDH 365
+ LG G G V L E A+KA++ + R R E E+++ L H
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLTNLQH 76
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALL-------DKQPMKIFREDSARFY----- 413
+ Y + ++ ++ G+L L R+
Sbjct: 77 EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 414 --AAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
A+++ G+ YL ++RDL N L+ + V + DF +S
Sbjct: 137 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 29/116 (25%), Positives = 49/116 (42%), Gaps = 16/116 (13%)
Query: 356 EREIMSLLD-HPFLPTLY-ASFQTSTHICLITDFCPGGELFA-LLDKQPMKIFREDSARF 412
E +I+ + H + L A + + +I +FC G L L K+ + + +
Sbjct: 80 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 413 -------------YAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
Y+ +V G+E+L I+RDL NILL + V + DF L+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 42/158 (26%), Positives = 64/158 (40%), Gaps = 15/158 (9%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELY---AMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
K LG G+ GSV L+ A+K M K ++ ++ E M HP
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 368 LPTLYA-----SFQTSTHICLITDFCPGGELFALL-----DKQPMKIFREDSARFYAAEV 417
+ L S Q +I F G+L L + P I + +F ++
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF-MVDI 156
Query: 418 VIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+G+EYL ++RDL N +L+ D V + DF LS
Sbjct: 157 ALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 8e-06
Identities = 25/122 (20%), Positives = 51/122 (41%), Gaps = 22/122 (18%)
Query: 356 EREIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFA-LLDKQPMKIFREDSARF-- 412
E ++ ++HP + LY + + LI ++ G L L + + + S
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 413 -------------------YAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFD 453
+A ++ G++YL + +++RDL NIL+ + + ++DF
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 454 LS 455
LS
Sbjct: 196 LS 197
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 35/163 (21%), Positives = 59/163 (36%), Gaps = 25/163 (15%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSV-----MLNRNKVHRACI----EREIMS 361
I+ LG G G V+ G++ M + L + + E I+S
Sbjct: 35 IRGLGHGAFGEVYE------GQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIIS 88
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALL------DKQPMKIFREDSARFYAA 415
+H + S ++ + GG+L + L QP + D A
Sbjct: 89 KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV-AR 147
Query: 416 EVVIGLEYLHCLGIIYRDLKPENILL--QKDGHVV-LTDFDLS 455
++ G +YL I+RD+ N LL G V + DF ++
Sbjct: 148 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 35/163 (21%), Positives = 59/163 (36%), Gaps = 25/163 (15%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSV-----MLNRNKVHRACI----EREIMS 361
I+ LG G G V+ G++ M + L + + E I+S
Sbjct: 76 IRGLGHGAFGEVYE------GQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIIS 129
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALL------DKQPMKIFREDSARFYAA 415
+H + S ++ + GG+L + L QP + D A
Sbjct: 130 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV-AR 188
Query: 416 EVVIGLEYLHCLGIIYRDLKPENILL--QKDGHVV-LTDFDLS 455
++ G +YL I+RD+ N LL G V + DF ++
Sbjct: 189 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 28/117 (23%), Positives = 47/117 (40%), Gaps = 17/117 (14%)
Query: 356 EREIMSLL-DHPFLPTLYASFQTSTHICLITDFCPGGELFALL---------DKQPMKIF 405
E +++S L +H + L + +IT++C G+L L K I
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 406 REDSARF-------YAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+D ++ +V G+ +L I+RDL NILL + DF L+
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 38/166 (22%), Positives = 66/166 (39%), Gaps = 22/166 (13%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSV-MLNRNKVHRACI----EREIMSLL-D 364
KPLG G G V L E G + + + +V ML + + E E+M ++
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGEL---------------FALLDKQPMKIFREDS 409
H + L + + +I ++ G L + ++ +D
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 410 ARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
A +V G+EYL I+RDL N+L+ +D + + DF L+
Sbjct: 194 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 34/177 (19%), Positives = 57/177 (32%), Gaps = 39/177 (22%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSV-----MLNRNKVHRACI----EREIMS 361
++ +G G G V + E ML E +M+
Sbjct: 52 VRDIGEGAFGRVFQ------ARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 105
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGEL--FALLDKQPMKIFREDSARF------- 412
D+P + L +CL+ ++ G+L F L P + +
Sbjct: 106 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEF-LRSMSPHTVCSLSHSDLSTRARVS 164
Query: 413 --------------YAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
A +V G+ YL ++RDL N L+ ++ V + DF LS
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 36/165 (21%), Positives = 66/165 (40%), Gaps = 20/165 (12%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSV-MLNRNKVHRACI----EREIMSLL-D 364
KPLG G G V + E G + +A+ +V ML + + E E+M ++
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFA-LLDKQPMKIFREDSARF----------- 412
H + L + + +I ++ G L L ++P +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 413 --YAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
++ G+EYL I+RDL N+L+ ++ + + DF L+
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 28/114 (24%), Positives = 48/114 (42%), Gaps = 15/114 (13%)
Query: 356 EREIMSLLD-HPFLPTLYASFQTSTHICLITDFCPGGEL--FALLDKQPMKIFREDSARF 412
E +IMS L H + L + + +IT++C G+L F L K + A
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNF-LRRKSRVLETDPAFAIA 157
Query: 413 -----------YAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
++++V G+ +L I+RD+ N+LL + DF L+
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A Length = 120 | Back alignment and structure |
|---|
Score = 40.2 bits (95), Expect = 2e-04
Identities = 18/136 (13%), Positives = 30/136 (22%), Gaps = 42/136 (30%)
Query: 87 IPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALW 146
D I +D + R +++GR+ L + E I R
Sbjct: 19 SRDRVIEDCNDELAAIFRCARADLIGRSFEVLYPSSDEFERIGER--------------- 63
Query: 147 KKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPM 206
I + I G+ FW + +
Sbjct: 64 --------------------------ISPVMIAHGSYADDRIMKRAGGELFWCHVTGRAL 97
Query: 207 RDHKGELQYFIGVQLD 222
D L + D
Sbjct: 98 -DRTAPLAAGVWTFED 112
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 23/115 (20%), Positives = 46/115 (40%), Gaps = 15/115 (13%)
Query: 356 EREIMSLL-DHPFLPTLYASFQTSTHICLITDFCPGGELFA-LLDKQPMKIFREDSARF- 412
E E+M ++ H + L + + +I ++ G L L ++P +
Sbjct: 136 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195
Query: 413 ------------YAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
++ G+EYL I+RDL N+L+ ++ + + DF L+
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 38/163 (23%), Positives = 65/163 (39%), Gaps = 21/163 (12%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELY--AMKAMEKSVMLN-RNKVHRACIEREIMS-LLDHP 366
+G G+ G V ++ G A+K M++ + E E++ L HP
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG---ELEVLCKLGHHP 86
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARF-------------- 412
+ L + + ++ L ++ P G L L K + A
Sbjct: 87 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 413 YAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+AA+V G++YL I+RDL NIL+ ++ + DF LS
Sbjct: 147 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 3e-04
Identities = 71/410 (17%), Positives = 124/410 (30%), Gaps = 126/410 (30%)
Query: 52 DSWDRAERER-DIRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLE-LTEYTREE 109
+ + ++ I L TT + +TD + D LT +
Sbjct: 252 NVQNAKAWNAFNLSCKI-LLTT-----RFKQVTDFLSAATTTHISLDHHSMTLTPDEVKS 305
Query: 110 ILGR--NCSFLELTEYTREEILGRN---CSTYTFMLY-FLALWKKNYGVYNF-TLGCCLE 162
+L + +C +L E+L N S + LA W N+ N L +E
Sbjct: 306 LLLKYLDCRPQDL----PREVLTTNPRRLSIIAESIRDGLATWD-NWKHVNCDKLTTIIE 360
Query: 163 ISSDQATVSKIRD-----AV-REQREITVQLINYTKSGKKFW------------NLFHLQ 204
S + ++ R +V I L+ W N H
Sbjct: 361 SSLNVLEPAEYRKMFDRLSVFPPSAHIPTILL------SLIWFDVIKSDVMVVVNKLHKY 414
Query: 205 PM--RDHKGELQYFI-GVQLDGSDHVEPLRNRLSEKTEQQSA---KIVKATAENVNEAVR 258
+ + K E I + L+ L K E + A IV ++ N +
Sbjct: 415 SLVEKQPK-ESTISIPSIYLE-----------LKVKLENEYALHRSIV----DHYN-IPK 457
Query: 259 ELPDANLRPEDL---WAIH------------SQPVFPRPHKRDNSSWIAIQKITGSGEKI 303
+L P L + H +F + ++ QKI
Sbjct: 458 TFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFL--DFRFLE-QKIRHDS--- 511
Query: 304 GLHHFKPIKPLGCGDTGSVH--LVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS 361
+GS+ L +L + Y + + N K ER + +
Sbjct: 512 ----------TAWNASGSILNTLQQL----KFY-----KPYICDNDPK-----YERLVNA 547
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSAR 411
+LD FLP + + S + L+ AL+ + IF E++ +
Sbjct: 548 ILD--FLPKIEENLICSKYTDLLR--------IALMAEDE-AIF-EEAHK 585
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 4e-04
Identities = 17/83 (20%), Positives = 31/83 (37%), Gaps = 4/83 (4%)
Query: 374 SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH-CLGIIYR 432
F + ++ +F GG L++ K+ +A+ ++ L L +R
Sbjct: 130 DFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHR 186
Query: 433 DLKPENILLQKDGHVVLTDFDLS 455
DL N+LL+K L
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNG 209
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 489 | |||
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.98 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.98 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.98 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.98 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.98 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.98 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.97 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.97 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.97 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.97 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.97 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.97 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.97 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.97 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.97 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.97 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.97 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.97 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.97 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.97 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.97 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.97 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.97 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.97 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.97 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.97 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.97 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.97 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.97 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.97 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.97 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.97 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.97 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.97 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.97 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.97 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.97 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.97 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.97 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.97 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.97 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.97 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.97 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.97 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.97 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.97 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.97 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.97 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.97 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.97 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.97 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.97 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.97 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.96 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.96 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.96 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.96 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.96 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.96 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.96 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.96 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.96 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.96 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.96 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.96 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.96 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.96 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.96 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.96 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.96 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.96 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.96 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.96 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.96 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.96 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.96 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.96 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.96 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.96 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.96 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.96 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.96 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.96 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.96 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.96 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.96 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.96 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.96 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.96 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.96 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.96 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.96 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.96 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.96 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.96 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.96 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.96 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.96 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.96 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.96 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.96 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.96 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.96 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.96 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.96 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.96 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.96 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.96 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.96 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.96 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.96 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.96 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.96 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.96 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.96 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.96 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.96 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.96 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.96 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.96 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.96 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.96 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.96 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.96 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.96 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.96 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.96 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.96 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.96 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.96 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.96 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.96 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.96 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.96 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.96 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.96 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.96 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.96 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.96 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.96 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.96 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.96 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.96 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.96 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.96 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.96 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.96 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.96 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.96 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.96 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.96 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.96 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.96 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.96 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.96 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.96 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.96 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.96 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.96 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.96 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.96 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.96 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.96 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.96 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.96 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.96 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.95 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.95 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.95 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.95 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.95 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.95 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.95 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.95 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.95 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.95 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.95 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.95 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.95 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.95 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.95 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.95 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.95 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.95 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.95 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.95 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.95 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.95 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.95 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.95 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.95 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.95 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.95 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.95 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.95 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.95 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.95 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.95 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.95 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.95 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.95 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.94 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.94 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.94 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.94 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.94 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.93 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.93 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1n9l_A | 109 | PHOT-LOV1, putative blue light receptor; phototrop | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 2gj3_A | 120 | Nitrogen fixation regulatory protein; PAS domain, | 99.82 | |
| 2pr5_A | 132 | Blue-light photoreceptor; light-oxygen-voltage, LO | 99.79 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 99.78 | |
| 4hia_A | 176 | LOV protein; PAS, HTH, signaling protein; HET: FMN | 99.77 | |
| 4eet_B | 115 | Phototropin-2; LOV, blue light photoreceptor, sign | 99.72 | |
| 3ue6_A | 166 | Aureochrome1; PAS/LOV domain, FMN-binding blue-lig | 99.72 | |
| 3p7n_A | 258 | Sensor histidine kinase; LOV domain, light-activat | 99.71 | |
| 3t50_A | 128 | Blue-light-activated histidine kinase; PAS superfa | 99.71 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 99.68 | |
| 2wkq_A | 332 | NPH1-1, RAS-related C3 botulinum toxin substrate 1 | 99.67 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 3f1p_A | 117 | Endothelial PAS domain-containing protein 1; PAS d | 99.64 | |
| 3f1p_B | 121 | ARYL hydrocarbon receptor nuclear translocator; PA | 99.64 | |
| 3mqq_A | 120 | Transcriptional regulator, LUXR family; PAS domain | 99.63 | |
| 2z6d_A | 130 | Phototropin-2; PAS-fold, LOV-fold, alternative spl | 99.61 | |
| 2vv6_A | 119 | FIXL, sensor protein FIXL; signaling protein, tran | 99.61 | |
| 2r78_A | 117 | Sensor protein; sensory box sensor histidine kinas | 99.61 | |
| 2v0u_A | 146 | NPH1-1, LOV2; kinase, transferase, ATP-binding, se | 99.6 | |
| 1d06_A | 130 | Nitrogen fixation regulatory protein FIXL; oxygen | 99.59 | |
| 3lyx_A | 124 | Sensory BOX/ggdef domain protein; structural genom | 99.59 | |
| 1byw_A | 110 | Protein (human ERG potassium channel); PAS domain, | 99.58 | |
| 3sw1_A | 162 | Sensory box protein; light-oxygen-voltage, LOV, PA | 99.57 | |
| 4eho_A | 635 | Bacteriophytochrome, PAS/PAC sensor; photoreceptor | 99.55 | |
| 3d72_A | 149 | Vivid PAS protein VVD; circadian, photoreceptor, b | 99.53 | |
| 3mxq_A | 152 | Sensor protein; PSI2, MCSG, structural genomics, p | 99.52 | |
| 2l0w_A | 138 | Potassium voltage-gated channel, subfamily H (EAG | 99.52 | |
| 2kdk_A | 121 | ARYL hydrocarbon receptor nuclear translocator-LI | 99.48 | |
| 3luq_A | 114 | Sensor protein; PAS, histidine, kinase, PSI, MCSG, | 99.48 | |
| 3nja_A | 125 | Probable ggdef family protein; structural genomics | 99.48 | |
| 3k3c_A | 158 | Protein RV1364C/MT1410; sensor, PAS, signal transd | 99.47 | |
| 3olo_A | 118 | Two-component sensor histidine kinase; structural | 99.47 | |
| 3bwl_A | 126 | Sensor protein; structural genomics, APC87707.1, P | 99.46 | |
| 3h9w_A | 115 | Diguanylate cyclase with PAS/PAC sensor; alpha-bet | 99.45 | |
| 3mr0_A | 142 | Sensory box histidine kinase/response regulator; P | 99.45 | |
| 3kx0_X | 185 | Uncharacterized protein RV1364C/MT1410; PAS domain | 99.41 | |
| 3eeh_A | 125 | Putative light and redox sensing histidine kinase; | 99.4 | |
| 3mjq_A | 126 | Uncharacterized protein; NESG, structural genomics | 99.39 | |
| 3vol_A | 233 | Aerotaxis transducer AER2; heme, oxygen sensor pro | 99.37 | |
| 3icy_A | 118 | Sensor protein; sensory box histidine kinase/respo | 99.36 | |
| 3mfx_A | 129 | Sensory BOX/ggdef family protein; alpha-beta prote | 99.34 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.34 | |
| 4hi4_A | 121 | Aerotaxis transducer AER2; PAS domain, diatomic GA | 99.33 | |
| 1v9y_A | 167 | Heme PAS sensor protein; signaling protein; HET: H | 99.31 | |
| 2qkp_A | 151 | Uncharacterized protein; structural genomics, unkn | 99.22 | |
| 3b33_A | 115 | Sensor protein; structural genomics, PAS domain, n | 99.19 | |
| 1ll8_A | 114 | PAS kinase; PAS domain, ligand binding, ligand scr | 99.18 | |
| 3fc7_A | 125 | HTR-like protein, sensor protein; APC87712.1, HTR- | 99.17 | |
| 3fg8_A | 118 | Uncharacterized protein RHA05790; PAS domain, stru | 99.17 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.15 | |
| 4f3l_A | 361 | Mclock, circadian locomoter output cycles protein | 99.14 | |
| 2vlg_A | 111 | Sporulation kinase A; histidine kinase, two-compon | 99.14 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.08 | |
| 3a0s_A | 96 | Sensor protein; PAS-fold, kinase, phosphoprotein, | 99.06 | |
| 3a0r_A | 349 | Sensor protein; four helix bundle, PAS fold, kinas | 99.03 | |
| 4f3l_B | 387 | BMAL1B; BHLH, PAS, circadian rhythm proteins, tran | 98.99 | |
| 3cax_A | 369 | Uncharacterized protein PF0695; structural genomic | 98.97 | |
| 2w0n_A | 118 | Sensor protein DCUS; signal transduction, two-comp | 98.93 | |
| 1nwz_A | 125 | PYP, photoactive yellow protein; PAS, LOV, GAF, do | 98.87 | |
| 1mzu_A | 129 | PPR; photoactive yellow protein, PAS, PYP, signali | 98.82 | |
| 2jhe_A | 190 | Transcription regulator TYRR; aromatic hydrocarbon | 98.75 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.71 | |
| 3rty_A | 339 | Period circadian protein; PAS domain, signalling, | 98.65 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.56 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.52 | |
| 4dj3_A | 317 | Period circadian protein homolog 3; PAS domain, ci | 98.51 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.46 | |
| 3gdi_A | 309 | Period circadian protein homolog 2; tandem PAS dom | 98.29 | |
| 4dj2_A | 320 | Period circadian protein homolog 1; PAS domains, c | 98.26 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.25 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.1 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.0 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.98 | |
| 2ykf_A | 305 | Pdtas, probable sensor histidine kinase pdtas; tra | 97.17 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.9 | |
| 3rty_A | 339 | Period circadian protein; PAS domain, signalling, | 97.75 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.55 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.5 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.41 | |
| 4f3l_A | 361 | Mclock, circadian locomoter output cycles protein | 97.29 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.06 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.03 | |
| 4f3l_B | 387 | BMAL1B; BHLH, PAS, circadian rhythm proteins, tran | 96.95 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.86 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.74 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.69 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.64 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.63 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.43 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.35 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.81 | |
| 1oj5_A | 132 | Steroid receptor coactivator 1A; transcriptional c | 95.12 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.65 | |
| 2ool_A | 337 | Sensor protein; bacteriophytochrome, photoconversi | 93.06 | |
| 4dj2_A | 320 | Period circadian protein homolog 1; PAS domains, c | 92.72 | |
| 3gdi_A | 309 | Period circadian protein homolog 2; tandem PAS dom | 92.46 | |
| 4dj3_A | 317 | Period circadian protein homolog 3; PAS domain, ci | 91.3 |
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=422.77 Aligned_cols=351 Identities=25% Similarity=0.367 Sum_probs=235.1
Q ss_pred CCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhcccccccccCcccccCCCHHH
Q 042772 90 NPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQAT 169 (489)
Q Consensus 90 ~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (489)
-.-|+||.+|++.++|++++..||++++|++|+ ...
T Consensus 4 l~~i~a~~~~l~a~~~~~~~~~~~~~~~~~~p~--------------------------------------------~~~ 39 (689)
T 3v5w_A 4 LEAVLADVSYLMAMEKSKATPAARASKKILLPE--------------------------------------------PSI 39 (689)
T ss_dssp --------------------------CCCCCCC--------------------------------------------TTH
T ss_pred cchhHhhHHHHHHhccCCCCcchhhhhhhhCCC--------------------------------------------chH
Confidence 346889999999999999999999999999885 235
Q ss_pred HHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCccccccccccchhhhhHHHHHHHHh
Q 042772 170 VSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNRLSEKTEQQSAKIVKAT 249 (489)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~ke~e~~~l~~~~e~qsa~ivkat 249 (489)
++.|+.++......+++.+++.+-|+.+|.+|..+++.+..+.+.+|.+++. -|..+..+++...........+.+..
T Consensus 40 ~~~~~~~~~~~~~~~~~~i~~q~ig~~~f~~f~~~~~~~~~~~~~~~~~v~~--~~~~~~~~~r~~~~~~i~~~~~~~~~ 117 (689)
T 3v5w_A 40 RSVMQKYLEDRGEVTFEKIFSQKLGYLLFRDFCLNHLEEARPLVEFYEEIKK--YEKLETEEERVARSREIFDSYIMKEL 117 (689)
T ss_dssp HHHHHHHHHHTTCCSHHHHHTSHHHHHHHHHHHHHHCGGGHHHHHHHHHHHH--HHTCCSHHHHHHHHHHHHTSHHHHHH
T ss_pred HHHHHHHHhhccccccceecCccHHHHHHHHHhcCcchhhhHHHHHHHHHHh--hhccCchhhHHHHHHHHHHHhcchhh
Confidence 6669999999999999999999999999999999999999998888876642 01112222222222121111222211
Q ss_pred -------hhhhhHHhhccCCCCCCccchhhccC--------CCCCCCCCCCCCchhHHHHhhcCCCccccccCccccccc
Q 042772 250 -------AENVNEAVRELPDANLRPEDLWAIHS--------QPVFPRPHKRDNSSWIAIQKITGSGEKIGLHHFKPIKPL 314 (489)
Q Consensus 250 -------~e~vdeavreLp~a~~~p~~l~a~~s--------~~~~p~p~~~~~~s~~~~~~~~~~~~~i~~~~y~~~~~L 314 (489)
.....+.+++.+.++..+.+++.... +.++..........+....+.......+.+++|++++.|
T Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lf~~~~~~~~~~l~~~~f~~~~~s~~~~r~~q~k~~e~~~~~slddf~i~k~L 197 (689)
T 3v5w_A 118 LACSHPFSKSATEHVQGHLGKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRII 197 (689)
T ss_dssp HSSSSCCCHHHHHHHHHHHHTTCCCTTTTHHHHHHHHHHHTTHHHHHHHHSHHHHHHHHHHHHHTTCCCCGGGEEEEEEE
T ss_pred hhccCccchHHHHHHHHhhhhccCChHHHHHHHHHHHHHhccCcccccccChhHHHHHhccccccCCCCchHHeEEEEEE
Confidence 22333444444333333444443322 222221111111112222233334456778999999999
Q ss_pred CCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHH---HHHHHhCCCCCcceeeEEEEeCCeEEEEEecCCCC
Q 042772 315 GCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIE---REIMSLLDHPFLPTLYASFQTSTHICLITDFCPGG 391 (489)
Q Consensus 315 G~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E---~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg 391 (489)
|+|+||+||+|.++.+|+.||||++++...........+..| +.+++.++|||||+++++|++...+|+|||||+||
T Consensus 198 G~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GG 277 (689)
T 3v5w_A 198 GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277 (689)
T ss_dssp EECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred ecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCC
Confidence 999999999999999999999999987655433333444444 55666779999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----------
Q 042772 392 ELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----------- 460 (489)
Q Consensus 392 sL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----------- 460 (489)
+|.++|.+. +.+++..+++++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 278 dL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~~~t~~GTp~ 355 (689)
T 3v5w_A 278 DLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG 355 (689)
T ss_dssp BHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCCCCSCCSCGG
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCCCCCccCCcC
Confidence 999999876 4599999999999999999999999999999999999999999999999999964321
Q ss_pred --CCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 461 --KPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 --~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. -..+|+|++|+++|||++|..||.
T Consensus 356 YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~ 392 (689)
T 3v5w_A 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 392 (689)
T ss_dssp GCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 1221 233488999999999999999994
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=336.99 Aligned_cols=182 Identities=38% Similarity=0.554 Sum_probs=163.7
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++++.||+|+||+||+|.++.+|+.||+|++++.........+.+.+|+++|+.++|||||+++++|++++.+|+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46799999999999999999999999999999999887655556678899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC---- 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~---- 460 (489)
||||+||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 111 mEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 9999999999999875 3499999999999999999999999999999999999999999999999999975421
Q ss_pred -------C-Cce-----------eecccccchHHHHHHHHhCCcccC
Q 042772 461 -------K-PQV-----------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -------~-~~~-----------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. +.+ -..+|+|++|+++++|++|..||.
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 235 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 235 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 1 111 123488999999999999999995
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=337.00 Aligned_cols=184 Identities=24% Similarity=0.444 Sum_probs=159.0
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 383 (489)
.+++|++++.||+|+||+||+|.++.+|+.||||++++... .....+.+.+|+.+++.++|||||+++++|.+++.+||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 35789999999999999999999999999999999987654 34457789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC----
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS---- 459 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~---- 459 (489)
|||||+||+|.++|..+....+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+...
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 9999999999999987766668999999999999999999999999999999999999999999999999997433
Q ss_pred ------C-----CC------ceeecccccchHHHHHHHHhCCcccC
Q 042772 460 ------C-----KP------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ------~-----~~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. +| .+-..+|+|++|++++||++|..||.
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~ 226 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE 226 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 1 11 12234599999999999999999995
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=320.03 Aligned_cols=181 Identities=29% Similarity=0.464 Sum_probs=152.7
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
+++|++++.||+|+||+||+|.++.+|+.||+|++++...........+.+|+.+++.++||||++++++|.+++.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 35899999999999999999999999999999999887665556677899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC---- 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~---- 460 (489)
|||| +|+|.+++.++ +.+++..++.++.||+.||.|||++||+||||||+|||++++|.+||+|||+|+....
T Consensus 92 mEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~ 168 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL 168 (275)
T ss_dssp EECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCcc
Confidence 9999 78999999876 4499999999999999999999999999999999999999999999999999964321
Q ss_pred ----------CCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ----------KPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ----------~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|+++++|++|..||.
T Consensus 169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~ 213 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213 (275)
T ss_dssp ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCC
Confidence 1111 124599999999999999999995
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=329.84 Aligned_cols=178 Identities=24% Similarity=0.361 Sum_probs=157.7
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
...|++++.||+|+||+||+|.++.+|+.||||++++..... .+.+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 356999999999999999999999999999999998654332 34577899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC---- 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~---- 460 (489)
||||+||+|.+++... .+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+....
T Consensus 150 mEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 150 MEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp ECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred EeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 9999999999999863 489999999999999999999999999999999999999999999999999975421
Q ss_pred -----C------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 461 -----K------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -----~------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. | .+-...|+|++|++++||++|..||.
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 271 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 271 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 1 1 11233489999999999999999995
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=329.83 Aligned_cols=178 Identities=24% Similarity=0.365 Sum_probs=158.0
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
...|++++.||+|+||.||+|.++.+|+.||||+++...... .+.+.+|+.+|+.++|||||+++++|.+.+.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 357999999999999999999999999999999998654332 35577899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC---
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK--- 461 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~--- 461 (489)
||||+||+|.+++... .+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.....
T Consensus 227 mEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 227 MEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp EECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred EeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 9999999999999764 4899999999999999999999999999999999999999999999999999754311
Q ss_pred ------------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 462 ------------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ------------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
| .+-...|+|++|++++||++|..||.
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 348 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 348 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 1 12234489999999999999999995
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=322.01 Aligned_cols=183 Identities=43% Similarity=0.704 Sum_probs=153.0
Q ss_pred ccccCcccccccCCCCceEEEEEEEc---CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQ---GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
...++|++++.||+|+||+||+|++. .+++.||+|++++...... ...++.+|+.+++.++|||||+++++|.+++
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 34468999999999999999999974 4688999999987654322 2345778999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
.+|+|||||+||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999999999875 349999999999999999999999999999999999999999999999999996432
Q ss_pred ---------CC------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 ---------CK------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---------~~------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+. |+ +...+|+|++|++++||++|..||.
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~ 227 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCC
Confidence 11 11 1133489999999999999999995
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=309.96 Aligned_cols=178 Identities=24% Similarity=0.355 Sum_probs=154.7
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe----CCeEEE
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT----STHICL 383 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~l 383 (489)
|++.+.||+|+||+||+|.++.+++.||+|.+.+... .....+.+.+|+.+++.++|||||+++++|.+ +..+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 3677889999999999999999999999999976543 34556789999999999999999999999875 356899
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEe-cCCcEEEEecCCccccCC
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLG--IIYRDLKPENILLQ-KDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~g--IvHrDLKP~NILld-~~g~vKL~DFGlS~~~~~ 460 (489)
|||||+||+|.+++.+. ..+++..+..++.||+.||.|||++| |+||||||+||||+ .+|.+||+|||+|+....
T Consensus 107 vmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999999875 45899999999999999999999998 99999999999997 489999999999974321
Q ss_pred -------------CCce-----eecccccchHHHHHHHHhCCcccC
Q 042772 461 -------------KPQV-----FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -------------~~~~-----~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. -..+|+|++|++++||++|..||.
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~ 230 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 1221 123489999999999999999994
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=313.31 Aligned_cols=184 Identities=21% Similarity=0.319 Sum_probs=156.8
Q ss_pred cccccCcccccccCCCCceEEEEEEEc-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQ-----GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQ 376 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 376 (489)
.+..++|.+.+.||+|+||+||+|.+. .++..||+|.++.. .....+.+.+|+++|++++|||||+++++|.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 456678999999999999999999975 35789999999754 3455678999999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC
Q 042772 377 TSTHICLITDFCPGGELFALLDKQ-----------PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG 445 (489)
Q Consensus 377 ~~~~~~lVmEy~~ggsL~~~L~~~-----------~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g 445 (489)
+.+.+|||||||++|+|.++|... ....+++..+..++.||+.||.|||+++|+||||||+|||+++++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 999999999999999999999763 234589999999999999999999999999999999999999999
Q ss_pred cEEEEecCCccccCC-----------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 446 HVVLTDFDLSFMTSC-----------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 446 ~vKL~DFGlS~~~~~-----------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.+||+|||+|+.... +|+ +...+|+|++|.+++|+++ |..||.
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~ 232 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY 232 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 999999999964321 111 1123489999999999997 999995
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=318.59 Aligned_cols=175 Identities=25% Similarity=0.392 Sum_probs=153.9
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 383 (489)
..+.|++.+.||+|+||+||+|.++.+|+.||||++++.... .+|+.+++.++|||||+++++|.+.+.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 346799999999999999999999999999999999865332 359999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC-cEEEEecCCccccCC--
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG-HVVLTDFDLSFMTSC-- 460 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g-~vKL~DFGlS~~~~~-- 460 (489)
|||||+||+|.++|.+. +.+++..+..++.||+.||.|||++||+||||||+||||+.+| ++||+|||+|+....
T Consensus 128 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp EECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999999999875 4599999999999999999999999999999999999999987 699999999974321
Q ss_pred ------------C------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ------------K------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ------------~------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. |+ +-..+|+|++|++++||++|..||.
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~ 257 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT 257 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSST
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCC
Confidence 1 11 1123489999999999999999995
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=310.66 Aligned_cols=183 Identities=23% Similarity=0.352 Sum_probs=157.1
Q ss_pred CccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 300 GEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 300 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
.+++..+++++.+.||+|+||+||+|.++. .||||+++... ......+.+.+|+.++++++|||||++++++.. +
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D 104 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence 456778899999999999999999998764 58999986543 345567889999999999999999999998754 5
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
.+|||||||+||+|.++|.... ..+++..+..++.||+.||.|||+++||||||||+||||++++.+||+|||+|+...
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred eEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 6899999999999999997653 358999999999999999999999999999999999999999999999999996432
Q ss_pred -----------------CCCce---------eecccccchHHHHHHHHhCCcccC
Q 042772 460 -----------------CKPQV---------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 -----------------~~~~~---------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|.+++|+++|..||.
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~ 238 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS 238 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCC
Confidence 11222 124589999999999999999995
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=311.92 Aligned_cols=184 Identities=21% Similarity=0.289 Sum_probs=155.0
Q ss_pred cccccCcccccccCCCCceEEEEEEEcC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQG-----AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQ 376 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 376 (489)
.+...+|.+.+.||+|+||+||+|.++. +++.||||.++.. .....+.|.+|+++|++++|||||+++++|.
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 4556789999999999999999999753 5889999999754 4455678999999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec
Q 042772 377 TSTHICLITDFCPGGELFALLDKQP-------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK 443 (489)
Q Consensus 377 ~~~~~~lVmEy~~ggsL~~~L~~~~-------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~ 443 (489)
+...+|||||||++|+|.+++.... ..++++..+..++.||+.||.|||+++|+||||||+||||++
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 9999999999999999999997642 235899999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCccccCC-----------CCcee------------ecccccchHHHHHHHHh-CCcccC
Q 042772 444 DGHVVLTDFDLSFMTSC-----------KPQVF------------YHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 444 ~g~vKL~DFGlS~~~~~-----------~~~~~------------~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
++.+||+|||+|+.... .+..| ..+|+|++|.+++|+++ |..||.
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~ 262 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 262 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCC
Confidence 99999999999974321 11111 23489999999999997 999995
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=308.71 Aligned_cols=185 Identities=18% Similarity=0.300 Sum_probs=156.1
Q ss_pred cccccCcccccccCCCCceEEEEEEEc-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQ-----GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQ 376 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 376 (489)
++...++++.+.||+|+||+||+|.+. .+++.||||.++... .....+.|.+|+.++++++|||||++++++.
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 456678999999999999999999974 357899999997542 3334577899999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe
Q 042772 377 TSTHICLITDFCPGGELFALLDKQP--------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQ 442 (489)
Q Consensus 377 ~~~~~~lVmEy~~ggsL~~~L~~~~--------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld 442 (489)
+...++||||||++|+|.++|..+. ...+++..+..++.||+.||.|||+++||||||||+||||+
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 9999999999999999999996532 23489999999999999999999999999999999999999
Q ss_pred cCCcEEEEecCCccccCC-----------CCcee------------ecccccchHHHHHHHHh-CCcccC
Q 042772 443 KDGHVVLTDFDLSFMTSC-----------KPQVF------------YHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 443 ~~g~vKL~DFGlS~~~~~-----------~~~~~------------~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+++.+||+|||+|+.... .+..| ..+|+|++|.+++|+++ |..||.
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~ 249 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 249 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCC
Confidence 999999999999974321 11112 23489999999999997 899995
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=302.10 Aligned_cols=151 Identities=22% Similarity=0.335 Sum_probs=129.9
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC------
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST------ 379 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~------ 379 (489)
.+|++++.||+|+||+||+|.++.+|+.||+|.++... .....+.+.+|+.+|+.++|||||+++++|...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 46999999999999999999999999999999997542 3445677889999999999999999999987543
Q ss_pred ------eEEEEEecCCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEec
Q 042772 380 ------HICLITDFCPGGELFALLDKQPM-KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDF 452 (489)
Q Consensus 380 ------~~~lVmEy~~ggsL~~~L~~~~~-~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DF 452 (489)
++|+|||||+||+|.+++..... ...++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 47999999999999999987532 22456778899999999999999999999999999999999999999999
Q ss_pred CCcccc
Q 042772 453 DLSFMT 458 (489)
Q Consensus 453 GlS~~~ 458 (489)
|+|+..
T Consensus 163 Gla~~~ 168 (299)
T 4g31_A 163 GLVTAM 168 (299)
T ss_dssp CCC---
T ss_pred ccceec
Confidence 999753
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=311.89 Aligned_cols=179 Identities=18% Similarity=0.331 Sum_probs=155.3
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC------C
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS------T 379 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~ 379 (489)
++|++++.||+|+||+||+|.++.+|+.||||++++... .....+++.+|+.+|+.++|||||++++++... .
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 579999999999999999999999999999999976532 344567788999999999999999999987643 5
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
.+|||||||+ |+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 7999999995 7899999775 459999999999999999999999999999999999999999999999999996431
Q ss_pred -------------C------CCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 460 -------------C------KPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 -------------~------~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+ +|+. ....|+|++|++++||++|..||.
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~ 264 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFP 264 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCC
Confidence 0 1111 123489999999999999999984
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=301.46 Aligned_cols=186 Identities=23% Similarity=0.329 Sum_probs=157.0
Q ss_pred ccccccCcccccccCCCCceEEEEEEEcCCC-----cEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CCcceeeEE
Q 042772 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAG-----ELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDH-PFLPTLYAS 374 (489)
Q Consensus 301 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~ 374 (489)
+++..++|++.+.||+|+||+||+|.+..++ +.||+|.++... .....+.+.+|+.+|.++.| ||||+++++
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 3566788999999999999999999987643 689999997543 34456778999999999965 999999999
Q ss_pred EEeC-CeEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 042772 375 FQTS-THICLITDFCPGGELFALLDKQP--------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENI 439 (489)
Q Consensus 375 ~~~~-~~~~lVmEy~~ggsL~~~L~~~~--------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NI 439 (489)
|... ..+|||||||++|+|.++|.... ...+++..+..++.||+.||.|||+++||||||||+||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 8764 57999999999999999997632 23488999999999999999999999999999999999
Q ss_pred EEecCCcEEEEecCCccccCCCC-----------cee------------ecccccchHHHHHHHHh-CCcccC
Q 042772 440 LLQKDGHVVLTDFDLSFMTSCKP-----------QVF------------YHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 440 Lld~~g~vKL~DFGlS~~~~~~~-----------~~~------------~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
|+++++.+||+|||+|+...... ..| ..+|+|++|++++|+++ |..||.
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 99999999999999997543211 111 23499999999999986 999995
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=296.71 Aligned_cols=173 Identities=22% Similarity=0.327 Sum_probs=149.7
Q ss_pred cCcccccccCCCCceEEEEEEEc---CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQ---GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 381 (489)
++|++.+.||+|+||+||+|.++ .+++.||+|.+.+.. ...++.+|+++|+.+ .||||++++++|.+.+++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 57999999999999999999875 467899999986542 234577899999988 699999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC-CcEEEEecCCccccC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD-GHVVLTDFDLSFMTS- 459 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~-g~vKL~DFGlS~~~~- 459 (489)
|+|||||+||+|.+++.. +++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 96 ~lvmE~~~g~~L~~~~~~-----l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILNS-----LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEEECCCCCCHHHHHTT-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEEeCCCcccHHHHHcC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 999999999999999842 8999999999999999999999999999999999999876 899999999995321
Q ss_pred ------------------------------------------CCCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 ------------------------------------------CKPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ------------------------------------------~~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+ +....|+|++|++++||++|..||.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 0111 1223489999999999999999984
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=311.35 Aligned_cols=180 Identities=30% Similarity=0.437 Sum_probs=158.5
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
+++|++++.||+|+||+||+|.++.+|+.||+|.+.+.. ....+.+.+|+.+|+.++||||++++++|.+...+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 568999999999999999999999999999999997653 33456788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC--CcEEEEecCCccccCCC-
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD--GHVVLTDFDLSFMTSCK- 461 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~--g~vKL~DFGlS~~~~~~- 461 (489)
||||+||+|.++|.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 233 ~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 233 YEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp EECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred EeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999999997543 358999999999999999999999999999999999999854 89999999999754321
Q ss_pred -------------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 462 -------------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 -------------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+ +-...|+|++|+++++|++|..||.
T Consensus 312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~ 357 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 357 (573)
T ss_dssp EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 11 1224488999999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=287.89 Aligned_cols=173 Identities=22% Similarity=0.296 Sum_probs=142.1
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC----eE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST----HI 381 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~~ 381 (489)
.+|.+.+.||+|+||+||+|.+. |+.||||+++... ........|+..+.+++|||||++++++..++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 35888899999999999999884 8899999996542 11122234555566789999999999998653 68
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeecCCCCCCEEEecCCcEEEEecC
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL--------GIIYRDLKPENILLQKDGHVVLTDFD 453 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~--------gIvHrDLKP~NILld~~g~vKL~DFG 453 (489)
|||||||++|+|.++|... .+++..+..++.|++.||.|||++ +|+||||||+||||+.++.+||+|||
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 9999999999999999874 378999999999999999999987 99999999999999999999999999
Q ss_pred CccccCC-------------------CCcee------------ecccccchHHHHHHHHhCCccc
Q 042772 454 LSFMTSC-------------------KPQVF------------YHAHVNGFYFIMYKWLTGYFTY 487 (489)
Q Consensus 454 lS~~~~~-------------------~~~~~------------~~~~v~s~g~~a~e~~~G~lpY 487 (489)
+|+.... +|+.. ..+|+|++|.+++|+++|..||
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~ 218 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCC
Confidence 9864321 12211 2358999999999999997665
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=280.95 Aligned_cols=184 Identities=37% Similarity=0.687 Sum_probs=162.7
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
+..++|++++.||+|+||+||+|.++.+|+.||+|++++...........+..|+.+++.++||||+++++++.+...+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 45678999999999999999999999999999999998765444555677889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC---
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS--- 459 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~--- 459 (489)
+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|....
T Consensus 82 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 999999999999999875 348999999999999999999999999999999999999999999999999986421
Q ss_pred ------------CCCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ------------CKPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ------------~~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ....|+|++|++++++++|..||.
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 206 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCC
Confidence 11221 234588999999999999999985
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=282.80 Aligned_cols=186 Identities=37% Similarity=0.682 Sum_probs=161.0
Q ss_pred ccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCC
Q 042772 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTST 379 (489)
Q Consensus 301 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~ 379 (489)
..+..++|++++.||+|+||.||+|.++.+++.||+|++.+...........+..|..+++.+ +||||+++++++.+..
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 346678999999999999999999999999999999999876555555677788999999988 7999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
.+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 999999999999999999875 348999999999999999999999999999999999999999999999999987422
Q ss_pred C---------------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 C---------------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ~---------------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. +|+. ....|+|++|+++++|++|..||.
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~ 225 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCC
Confidence 1 1111 123489999999999999999995
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-32 Score=278.56 Aligned_cols=185 Identities=31% Similarity=0.596 Sum_probs=164.6
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCe
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTH 380 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~ 380 (489)
.+..++|++++.||+|+||.||+|.++.+++.||+|++.+...........+..|..+++.+ +||||+++++++.+...
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 45678899999999999999999999999999999999887666667778889999999987 89999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999999999875 3489999999999999999999999999999999999999999999999999874211
Q ss_pred ---------------CC------ceeecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------------KP------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------------~~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+| ......|+|++|++++++++|..||.
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 211 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcC
Confidence 01 11234589999999999999999984
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=284.68 Aligned_cols=186 Identities=34% Similarity=0.609 Sum_probs=165.9
Q ss_pred ccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 042772 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH 380 (489)
Q Consensus 301 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 380 (489)
..+..++|++++.||+|+||.||+|.++.+++.||+|.+.+...........+.+|+.+++.++||||++++++|.+...
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 45677899999999999999999999999999999999987655555567788899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS- 459 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~- 459 (489)
+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|....
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999999999875 348999999999999999999999999999999999999999999999999996432
Q ss_pred -------------CCCce---------eecccccchHHHHHHHHhCCcccC
Q 042772 460 -------------CKPQV---------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 -------------~~~~~---------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ....|+|++|++++++++|..||.
T Consensus 168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~ 218 (384)
T 4fr4_A 168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH 218 (384)
T ss_dssp TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCC
Confidence 12222 224589999999999999999995
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=276.29 Aligned_cols=184 Identities=40% Similarity=0.717 Sum_probs=162.6
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
+.+++|++++.||+|+||.||+|.++.+|+.||+|++++...........+..|..+++.++||||+++++++.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 34678999999999999999999999999999999998765444445677888999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC-
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK- 461 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~- 461 (489)
+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|......
T Consensus 83 lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~ 160 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 160 (318)
T ss_dssp EEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred EEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCcc
Confidence 999999999999999875 34899999999999999999999999999999999999999999999999999643311
Q ss_pred -----------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 462 -----------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 -----------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
| ......|+|++|++++++++|..||.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 204 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY 204 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 1 11234589999999999999999984
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-32 Score=284.92 Aligned_cols=185 Identities=30% Similarity=0.597 Sum_probs=160.4
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCe
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTH 380 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~ 380 (489)
.+.+++|++++.||+|+||+||+|.++.+++.||+|++++...........+..|..++.++ +||||++++++|.+...
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 45678899999999999999999999999999999999887665555667788899999876 89999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
+|+||||++||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 99999999999999999875 3489999999999999999999999999999999999999999999999999974211
Q ss_pred ---------------CC------ceeecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------------KP------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------------~~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+| .+....|+|++|+++++|++|..||.
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~ 254 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSST
T ss_pred CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence 11 11234589999999999999999994
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=288.85 Aligned_cols=184 Identities=31% Similarity=0.561 Sum_probs=161.4
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
.+..++|++++.||+|+||+||+|.++.+++.||+|++.+...........+..|+.+++.++||||++++++|.+...+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 34567899999999999999999999999999999999765443333445577899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 145 ~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 9999999999999999864 389999999999999999999999999999999999999999999999999864321
Q ss_pred ---------------CCc----------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------------KPQ----------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------------~~~----------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ .....|+|++|+++++|++|..||.
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 274 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCC
Confidence 111 2235689999999999999999985
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.98 E-value=5.2e-32 Score=274.79 Aligned_cols=183 Identities=27% Similarity=0.454 Sum_probs=162.2
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
...++|++++.||+|+||.||+|.+..+|+.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 346789999999999999999999999999999999976543 4455678889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC--
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC-- 460 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~-- 460 (489)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp EEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 999999999999999775 3489999999999999999999999999999999999999999999999999964321
Q ss_pred ------------CCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ------------KPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ------------~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 215 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 1111 134699999999999999999995
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=286.48 Aligned_cols=186 Identities=30% Similarity=0.509 Sum_probs=162.9
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
.+..++|++++.||+|+||.||+|.++.+|+.||+|++++...........+..|+.++..++||||++++++|.+...+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 45668899999999999999999999999999999999875444444556688899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
|+||||++||+|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 99999999999999998743 3489999999999999999999999999999999999999999999999999864321
Q ss_pred ---------------CCc-------------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------------KPQ-------------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------------~~~-------------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ +....|+|++|++++|+++|..||.
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 271 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY 271 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCC
Confidence 111 1234589999999999999999985
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.5e-32 Score=277.45 Aligned_cols=185 Identities=34% Similarity=0.640 Sum_probs=159.9
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCe
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTH 380 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~ 380 (489)
.+..++|++.+.||+|+||.||+|.++.+++.||+|++++...........+..|..++..+ +||||+++++++.+...
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 34567899999999999999999999999999999999876543444566778899999876 89999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 99999999999999999875 3489999999999999999999999999999999999999999999999999864311
Q ss_pred ---------------CC------ceeecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------------KP------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------------~~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+| ......|+|++|++++++++|..||.
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 219 (345)
T 1xjd_A 171 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH 219 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCC
Confidence 01 11234489999999999999999985
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=277.02 Aligned_cols=184 Identities=34% Similarity=0.631 Sum_probs=163.1
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
..+++|++++.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34578999999999999999999999999999999998765444455678889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC-
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK- 461 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~- 461 (489)
+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 118 lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~ 195 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp EEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred EEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCCc
Confidence 999999999999999875 34899999999999999999999999999999999999999999999999999754321
Q ss_pred -----------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 462 -----------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 -----------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
| ......|+|++|++++++++|..||.
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 239 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCC
Confidence 1 11234589999999999999999985
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-32 Score=286.91 Aligned_cols=186 Identities=32% Similarity=0.515 Sum_probs=162.0
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
.+..++|++++.||+|+||+||+|.++.+++.||+|++++...........+..|+.++..++||||++++++|.+...+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 45567899999999999999999999999999999999865443333445578899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
|+||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 99999999999999998742 4489999999999999999999999999999999999999999999999999854321
Q ss_pred ---------------CCce-----------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------------KPQV-----------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------------~~~~-----------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ....|+|++|++++||++|..||.
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~ 282 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY 282 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCC
Confidence 1221 224589999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=280.92 Aligned_cols=185 Identities=37% Similarity=0.594 Sum_probs=152.4
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHH-HHhCCCCCcceeeEEEEeCCe
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI-MSLLDHPFLPTLYASFQTSTH 380 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~i-l~~l~HpnIv~l~~~~~~~~~ 380 (489)
.+..++|++++.||+|+||.||+|.++.+++.||+|++.+...........+..|..+ ++.++||||++++++|.+...
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 4556789999999999999999999999999999999988765555556667777776 567899999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 99999999999999999875 3489999999999999999999999999999999999999999999999999874211
Q ss_pred ----------CCc-----------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ----------KPQ-----------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ----------~~~-----------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+. +....|+|++|++++|+++|..||.
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~ 240 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 240 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 111 1234589999999999999999985
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-32 Score=277.33 Aligned_cols=185 Identities=33% Similarity=0.599 Sum_probs=160.7
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCe
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTH 380 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~ 380 (489)
.+..++|++++.||+|+||.||+|.++.+++.||+|++++...........+..|..++..+ .||||+++++++.+...
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 45678999999999999999999999999999999999876544445567788899999887 79999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999999999875 3489999999999999999999999999999999999999999999999999874211
Q ss_pred ---------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ .....|+|++|++++++++|..||.
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~ 222 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCC
Confidence 011 1224489999999999999999985
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=265.62 Aligned_cols=184 Identities=21% Similarity=0.269 Sum_probs=162.9
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
+..++|++++.||+|+||.||+|.+..+++.||+|.+...........+.+.+|+.+++.++||||+++++++......|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 34568999999999999999999999999999999997665556667788999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC-
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK- 461 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~- 461 (489)
+||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 88 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 999999999999999875 34899999999999999999999999999999999999999999999999998643211
Q ss_pred ---------------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 462 ---------------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ---------------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+ ....+|+|++|++++++++|..||.
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~ 213 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 11 1123589999999999999999995
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=263.64 Aligned_cols=178 Identities=22% Similarity=0.328 Sum_probs=157.2
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++++......|+|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 46899999999999999999999999999999999765322 245678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC---
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK--- 461 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~--- 461 (489)
|||+++|+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 96 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp EECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 9999999999999874 3899999999999999999999999999999999999999999999999998643311
Q ss_pred ------------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 462 ------------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ------------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+ ....+|+|++|++++++++|..||.
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 217 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 11 1234489999999999999999985
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=260.08 Aligned_cols=182 Identities=21% Similarity=0.328 Sum_probs=160.1
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
+..++|++.+.||+|+||.||+|.+..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+....+
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 3457899999999999999999999999999999988543 4556678899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC--
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC-- 460 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~-- 460 (489)
+||||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 9999999999999998753 3489999999999999999999999999999999999999999999999999964321
Q ss_pred ---------------------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------------------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------------------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++|..||.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~ 223 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP 223 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSST
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCc
Confidence 111 1234589999999999999998875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=287.71 Aligned_cols=187 Identities=30% Similarity=0.509 Sum_probs=165.3
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
.+..++|++.+.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+...+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 35667899999999999999999999999999999999876544445567788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK 461 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~ 461 (489)
|+||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|......
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999999998765556999999999999999999999999999999999999999999999999999754311
Q ss_pred --------------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 462 --------------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 --------------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
| .+....|+|++|++++++++|..||.
T Consensus 340 ~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~ 386 (576)
T 2acx_A 340 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 386 (576)
T ss_dssp CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSS
T ss_pred ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCc
Confidence 1 11233489999999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-31 Score=261.56 Aligned_cols=176 Identities=14% Similarity=0.106 Sum_probs=158.2
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
+..++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|..++..++||||+++++++...+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 44478999999999999999999999999999999998765555666788899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCCC
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKP 462 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~~ 462 (489)
+||||++|++|.+++... .....+..++.|++.||.|||++||+||||||+|||++.+|.+||+++|...
T Consensus 108 lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~~------ 177 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMP------ 177 (286)
T ss_dssp EEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCCT------
T ss_pred EEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccccC------
Confidence 999999999999999653 3566788899999999999999999999999999999999999999877652
Q ss_pred ceeecccccchHHHHHHHHhCCcccC
Q 042772 463 QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 463 ~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.....+|+|++|++++++++|..||.
T Consensus 178 ~~~~~~Di~slG~il~elltg~~Pf~ 203 (286)
T 3uqc_A 178 DANPQDDIRGIGASLYALLVNRWPLP 203 (286)
T ss_dssp TCCHHHHHHHHHHHHHHHHHSEECSC
T ss_pred CCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 24467799999999999999999985
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=263.68 Aligned_cols=179 Identities=21% Similarity=0.312 Sum_probs=157.4
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++.+.||+|+||.||+|.+..+++.||+|.+... ......+.+|+.+++.++||||+++++++.+...+++|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 36799999999999999999999999999999998643 23445678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec--CCcEEEEecCCccccCCC-
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK--DGHVVLTDFDLSFMTSCK- 461 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~--~g~vKL~DFGlS~~~~~~- 461 (489)
|||++||+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 80 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 80 FEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp ECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999999997653 35899999999999999999999999999999999999987 789999999999754321
Q ss_pred -------------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 462 -------------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 -------------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+ ....+|+|++|++++++++|..||.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 204 (321)
T 1tki_A 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL 204 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 11 1234589999999999999999985
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-31 Score=270.08 Aligned_cols=182 Identities=27% Similarity=0.389 Sum_probs=158.4
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNR---NKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
.++|++.+.||+|+||.||+|.++.+|+.||+|.+++...... ...+.+.+|+.+++.++||||++++++|.+...+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 3579999999999999999999999999999999987543221 1346788899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC----cEEEEecCCccc
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG----HVVLTDFDLSFM 457 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g----~vKL~DFGlS~~ 457 (489)
|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 9999999999999999765 4589999999999999999999999999999999999998777 799999999965
Q ss_pred cCCC--------------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 458 TSCK--------------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 458 ~~~~--------------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.... | ......|+|++|++++++++|..||.
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~ 219 (361)
T 2yab_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219 (361)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred cCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 4321 1 11224589999999999999999985
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=270.35 Aligned_cols=182 Identities=29% Similarity=0.459 Sum_probs=159.3
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 383 (489)
..++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.....+++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 35689999999999999999999999999999999976544333344678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC---
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC--- 460 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~--- 460 (489)
||||+ +|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 87 v~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp EECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred EEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 99999 78999998775 3489999999999999999999999999999999999999999999999999864321
Q ss_pred -----------CCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 461 -----------KPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -----------~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~ 209 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSB
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCC
Confidence 1222 124589999999999999999985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-31 Score=284.31 Aligned_cols=187 Identities=30% Similarity=0.524 Sum_probs=164.1
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
.+..++|++.+.||+|+||+||+|.++.+|+.||+|++.+...........+..|+.+++.++||||++++++|.+...+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 45668899999999999999999999999999999999876554445567888999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 382 CLITDFCPGGELFALLDKQP--MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~--~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
|+||||++||+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999999997643 3458999999999999999999999999999999999999999999999999996432
Q ss_pred CC---------------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 CK---------------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ~~---------------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.. |+ +....|+|++|++++||++|..||.
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~ 390 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCC
Confidence 11 11 1223488999999999999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=269.09 Aligned_cols=184 Identities=19% Similarity=0.295 Sum_probs=162.4
Q ss_pred cccCcccccccCCC--CceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 304 GLHHFKPIKPLGCG--DTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 304 ~~~~y~~~~~LG~G--~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
..++|++++.||+| +||.||+|.++.+++.||+|.+..... .......+.+|+.+++.++||||+++++++...+.+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 34689999999999 999999999999999999999986543 345667888899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC--
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS-- 459 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~-- 459 (489)
|+||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 999999999999999988755669999999999999999999999999999999999999999999999999874210
Q ss_pred --------------------CCCc--------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 --------------------CKPQ--------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 --------------------~~~~--------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+ ....+|+|++|++++++++|..||.
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 238 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 1121 2234589999999999999999985
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-31 Score=264.86 Aligned_cols=184 Identities=25% Similarity=0.328 Sum_probs=158.7
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGE---LYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS 378 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 378 (489)
.+..++|++.+.||+|+||.||+|.+..+++ .||+|.+.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 4567889999999999999999999986554 59999997542 344567788999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
...|+||||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999997653 34899999999999999999999999999999999999999999999999999754
Q ss_pred CCC------------------Cc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 459 SCK------------------PQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 459 ~~~------------------~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
... |+ ....+|+|++|++++++++ |..||.
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 256 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW 256 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 321 11 1123489999999999998 999984
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=279.94 Aligned_cols=185 Identities=37% Similarity=0.684 Sum_probs=153.2
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
.+..++|++++.||+|+||.||+|.+..+|+.||+|++.+...........+..|+.+++.++||||+++++++.....+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 45567899999999999999999999999999999999876554555667788899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC-LGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 9999999999999999875 348999999999999999999998 9999999999999999999999999999864221
Q ss_pred ---------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ .....|+|++|++++++++|..||.
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 350 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 350 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCC
Confidence 111 1234489999999999999999985
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=264.11 Aligned_cols=185 Identities=39% Similarity=0.621 Sum_probs=151.3
Q ss_pred cccccCcccccccCCCCceEEEEEEEc---CCCcEEEEEEeeccccc-chHHHHHHHHHHHHHHhCCCCCcceeeEEEEe
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQ---GAGELYAMKAMEKSVML-NRNKVHRACIEREIMSLLDHPFLPTLYASFQT 377 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 377 (489)
.+..++|++.+.||+|+||.||+|... .+++.||+|++++.... .......+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 455678999999999999999999985 68999999999765432 23345667889999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccc
Q 042772 378 STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 378 ~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
...+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred CCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999999999875 3489999999999999999999999999999999999999999999999999864
Q ss_pred cCC---------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 458 TSC---------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 458 ~~~---------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... +|+ .....|+|++|++++++++|..||.
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 222 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT 222 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCC
Confidence 211 111 1224489999999999999999985
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=266.92 Aligned_cols=181 Identities=26% Similarity=0.394 Sum_probs=158.6
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++.+.||+|+||.||+|.++.+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4579999999999999999999999999999999976543 344567788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC---CcEEEEecCCccccCCC
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD---GHVVLTDFDLSFMTSCK 461 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~---g~vKL~DFGlS~~~~~~ 461 (489)
|||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 107 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp ECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999999999999765 448999999999999999999999999999999999999865 45999999999654311
Q ss_pred --------------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 462 --------------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 --------------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
| ......|+|++|++++++++|..||.
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~ 231 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 231 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 1 12234589999999999999999984
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=266.49 Aligned_cols=184 Identities=21% Similarity=0.336 Sum_probs=156.5
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccc--hHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN--RNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
.++|++.+.||+|+||.||+|.++.+++.||+|++....... ....+.+.+|+.+++.++||||+++++++.....+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999999999999999997543221 113567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc---EEEEecCCccc
Q 042772 383 LITDFCPGGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGH---VVLTDFDLSFM 457 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~---vKL~DFGlS~~ 457 (489)
+|||||+|++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999999888653 2335899999999999999999999999999999999999986654 99999999965
Q ss_pred cCCC---------------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 458 TSCK---------------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 458 ~~~~---------------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.... | ......|+|++|++++++++|..||.
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCC
Confidence 3311 1 11234589999999999999999984
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=264.35 Aligned_cols=182 Identities=22% Similarity=0.297 Sum_probs=157.6
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC----e
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST----H 380 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~ 380 (489)
.++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 468999999999999999999999999999999998765556666778899999999999999999999987654 3
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
.|+||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred cEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 59999999999999999875 3489999999999999999999999999999999999999999999999999864321
Q ss_pred ------------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ------------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ------------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++|..||.
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~ 220 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 111 1224589999999999999999985
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-31 Score=259.92 Aligned_cols=184 Identities=28% Similarity=0.499 Sum_probs=152.6
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccc-----------------------hHHHHHHHHHHH
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN-----------------------RNKVHRACIERE 358 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~-----------------------~~~~~~~~~E~~ 358 (489)
.+..++|++.+.||+|+||.||+|.+..+++.||+|++.+..... ....+.+.+|+.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 455678999999999999999999999999999999997653221 122456888999
Q ss_pred HHHhCCCCCcceeeEEEEe--CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 042772 359 IMSLLDHPFLPTLYASFQT--STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKP 436 (489)
Q Consensus 359 il~~l~HpnIv~l~~~~~~--~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP 436 (489)
+++.++||||+++++++.. ...+|+||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 165 (298)
T 2zv2_A 89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP 165 (298)
T ss_dssp HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 9999999999999999986 5689999999999999886543 4589999999999999999999999999999999
Q ss_pred CCEEEecCCcEEEEecCCccccCC---------------CCcee---------ecccccchHHHHHHHHhCCcccC
Q 042772 437 ENILLQKDGHVVLTDFDLSFMTSC---------------KPQVF---------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 437 ~NILld~~g~vKL~DFGlS~~~~~---------------~~~~~---------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|||++.++.+||+|||++..... +|+.. ..+|+|++|++++++++|..||.
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred HHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999999999999864321 12221 23489999999999999999985
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=260.96 Aligned_cols=183 Identities=26% Similarity=0.348 Sum_probs=157.0
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC--eE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST--HI 381 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~ 381 (489)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.... ..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 44689999999999999999999999999999999975432 223566778999999999999999999988765 78
Q ss_pred EEEEecCCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE----ecCCcEEEEecCCcc
Q 042772 382 CLITDFCPGGELFALLDKQPM-KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILL----QKDGHVVLTDFDLSF 456 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~-~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILl----d~~g~vKL~DFGlS~ 456 (489)
++||||+++++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999999987532 238999999999999999999999999999999999999 777889999999996
Q ss_pred ccCC--------------CCc--------------eeecccccchHHHHHHHHhCCcccC
Q 042772 457 MTSC--------------KPQ--------------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 457 ~~~~--------------~~~--------------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.... +|+ ....+|+|++|++++++++|..||.
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 224 (319)
T 4euu_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224 (319)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEE
T ss_pred ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 5321 111 1234599999999999999999995
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-31 Score=265.21 Aligned_cols=180 Identities=24% Similarity=0.399 Sum_probs=155.0
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++......|+|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4689999999999999999999999999999999975432 22335677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----- 459 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----- 459 (489)
|||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 84 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999999999999765 348999999999999999999999999999999999999999999999999996421
Q ss_pred ------------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ------------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ------------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ....|+|++|++++++++|..||.
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 209 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCC
Confidence 01111 124589999999999999999985
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=261.78 Aligned_cols=181 Identities=27% Similarity=0.414 Sum_probs=157.8
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNR---NKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
++|++.+.||+|+||.||+|.++.+++.||+|.+.+...... .....+.+|+.+++.++||||+++++++.....++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 569999999999999999999999999999999976543211 13567888999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC----cEEEEecCCcccc
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG----HVVLTDFDLSFMT 458 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g----~vKL~DFGlS~~~ 458 (489)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999999999765 4589999999999999999999999999999999999999887 8999999999654
Q ss_pred CCC--------------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 459 SCK--------------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~~~--------------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... |+ ....+|+|++|++++++++|..||.
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 218 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCC
Confidence 311 11 1234589999999999999999984
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-30 Score=255.81 Aligned_cols=179 Identities=18% Similarity=0.299 Sum_probs=154.5
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++++.||+|+||+||+|.++.+++.||+|.+..... .......+.+|+.+++.++||||+++++++.+...+++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 579999999999999999999999999999999976542 3444567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
||+++ +|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 81 e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp ECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred ecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 99964 7777776543 4489999999999999999999999999999999999999999999999999964321
Q ss_pred ----------CCc-------eeecccccchHHHHHHHHhCCccc
Q 042772 461 ----------KPQ-------VFYHAHVNGFYFIMYKWLTGYFTY 487 (489)
Q Consensus 461 ----------~~~-------~~~~~~v~s~g~~a~e~~~G~lpY 487 (489)
+|+ ....+|+|++|++++++++|..||
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~ 202 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence 111 223448999999999999888885
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=256.00 Aligned_cols=185 Identities=29% Similarity=0.447 Sum_probs=161.7
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
....++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 34567899999999999999999999999999999999765444444456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 9999999999999999875 3489999999999999999999999999999999999999999999999998854321
Q ss_pred ------------CC------ceeecccccchHHHHHHHHhCCcccC
Q 042772 461 ------------KP------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ------------~~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+| .....+|+|++|++++++++|..||.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 208 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCC
Confidence 11 11234589999999999999999985
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=271.76 Aligned_cols=176 Identities=26% Similarity=0.414 Sum_probs=148.6
Q ss_pred ccCcccc-cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHH-HhCCCCCcceeeEEEEe----C
Q 042772 305 LHHFKPI-KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIM-SLLDHPFLPTLYASFQT----S 378 (489)
Q Consensus 305 ~~~y~~~-~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il-~~l~HpnIv~l~~~~~~----~ 378 (489)
.++|.+. +.||+|+||+||+|.++.+++.||+|++... ..+.+|+.++ +..+||||++++++|.. .
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 4678877 7899999999999999999999999998643 2455688876 45589999999999876 5
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---CCcEEEEecCCc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK---DGHVVLTDFDLS 455 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~---~g~vKL~DFGlS 455 (489)
..+|+||||++||+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 67999999999999999998865556999999999999999999999999999999999999997 789999999998
Q ss_pred cccCC--------------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 456 FMTSC--------------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 456 ~~~~~--------------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+.... .|+. ....|+|++|++++++++|..||.
T Consensus 212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 264 (400)
T 1nxk_A 212 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_dssp EECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Confidence 64321 1221 224489999999999999999984
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=259.39 Aligned_cols=181 Identities=20% Similarity=0.328 Sum_probs=151.4
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST----- 379 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----- 379 (489)
.++|++++.||+|+||.||+|.++.+++.||+|++.... .....+.+.+|+.+++.++||||++++++|....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 457999999999999999999999999999999997543 3345677889999999999999999999986543
Q ss_pred ----------------------------------------------------eEEEEEecCCCCCHHHHHhhCCC-CCCC
Q 042772 380 ----------------------------------------------------HICLITDFCPGGELFALLDKQPM-KIFR 406 (489)
Q Consensus 380 ----------------------------------------------------~~~lVmEy~~ggsL~~~L~~~~~-~~l~ 406 (489)
.+++|||||++++|.+++..... ...+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 38999999999999999987532 2246
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC-------------------------
Q 042772 407 EDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK------------------------- 461 (489)
Q Consensus 407 e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~------------------------- 461 (489)
+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 6678999999999999999999999999999999999999999999998754321
Q ss_pred --C------ceeecccccchHHHHHHHHhCCccc
Q 042772 462 --P------QVFYHAHVNGFYFIMYKWLTGYFTY 487 (489)
Q Consensus 462 --~------~~~~~~~v~s~g~~a~e~~~G~lpY 487 (489)
| .....+|+|++|++++++++|..|+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 1 1122348899999999999887664
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=278.45 Aligned_cols=185 Identities=27% Similarity=0.438 Sum_probs=163.3
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
.+..++|.+.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+...+
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 45567899999999999999999999999999999999876444444567888999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK 461 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~ 461 (489)
|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 92 ~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999999999765 44899999999999999999999999999999999999999999999999999754311
Q ss_pred --------------Cce-------eecccccchHHHHHHHHhCCcccC
Q 042772 462 --------------PQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 --------------~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+. ...+|+|++|++++++++|..||.
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~ 217 (476)
T 2y94_A 170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217 (476)
T ss_dssp CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCC
Confidence 111 134589999999999999999985
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-30 Score=272.47 Aligned_cols=181 Identities=27% Similarity=0.381 Sum_probs=157.3
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++.+.||+|+||.||+|.++.+|+.||+|.+.+... .....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3579999999999999999999999999999999986543 334567788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe---cCCcEEEEecCCccccCCC
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQ---KDGHVVLTDFDLSFMTSCK 461 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld---~~g~vKL~DFGlS~~~~~~ 461 (489)
|||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|......
T Consensus 89 ~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp ECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 99999999999998763 489999999999999999999999999999999999998 4678999999999654321
Q ss_pred ---------------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 462 ---------------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ---------------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
| .....+|+|++|++++++++|..||.
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~ 214 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW 214 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 1 12234489999999999999999984
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-30 Score=264.85 Aligned_cols=185 Identities=22% Similarity=0.316 Sum_probs=158.1
Q ss_pred cccccCcccccccCCCCceEEEEEEEcC-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQG-------AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYA 373 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~-------tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~ 373 (489)
.+..++|++.+.||+|+||.||+|.+.. ++..||+|+++.. ........+.+|+.+++.+ +||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 3456789999999999999999999753 4568999999754 2445677899999999999 8999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 042772 374 SFQTSTHICLITDFCPGGELFALLDKQP--------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENI 439 (489)
Q Consensus 374 ~~~~~~~~~lVmEy~~ggsL~~~L~~~~--------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NI 439 (489)
++.....+|+||||+++|+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 9999999999999999999999998753 23478999999999999999999999999999999999
Q ss_pred EEecCCcEEEEecCCccccCC-----------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 440 LLQKDGHVVLTDFDLSFMTSC-----------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 440 Lld~~g~vKL~DFGlS~~~~~-----------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
|++.++.+||+|||+|+.... +|+ ....+|+|++|++++|+++ |..||.
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~ 307 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 307 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999974321 111 1123488999999999998 999985
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-30 Score=264.05 Aligned_cols=179 Identities=28% Similarity=0.412 Sum_probs=154.1
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 383 (489)
..++|++++.||+|+||.||+|.++.+++.||+|.+.+.... ...+.+|+.+++.++||||+++++++.+...+++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 346899999999999999999999999999999999765322 2456789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc--EEEEecCCccccC--
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGH--VVLTDFDLSFMTS-- 459 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~--vKL~DFGlS~~~~-- 459 (489)
||||+++|+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+|+...
T Consensus 94 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 94 IMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999999999997753 4899999999999999999999999999999999999987765 9999999986321
Q ss_pred ------------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ------------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ------------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 219 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCC
Confidence 11111 122599999999999999999995
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-30 Score=257.30 Aligned_cols=183 Identities=23% Similarity=0.298 Sum_probs=158.7
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 383 (489)
.+++|++.+.||+|+||.||+|.+..+++.||+|.+...........+.+.+|+.+++.++||||+++++++......|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 45789999999999999999999999999999999977655555566888999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC---
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC--- 460 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~--- 460 (489)
||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 112 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 99999999999999875 3489999999999999999999999999999999999999999999999999854321
Q ss_pred -------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 -------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++|..||.
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQ 236 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCC
Confidence 111 1234699999999999999999985
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-30 Score=260.64 Aligned_cols=182 Identities=24% Similarity=0.387 Sum_probs=158.6
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-----CCCcceeeEEEE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-----HPFLPTLYASFQ 376 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----HpnIv~l~~~~~ 376 (489)
.+..++|++++.||+|+||.||+|.+..+++.||+|++... ......+..|..+++.+. ||||+++++++.
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 34557899999999999999999999999999999998643 334456677999999886 999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-------------
Q 042772 377 TSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK------------- 443 (489)
Q Consensus 377 ~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~------------- 443 (489)
.....|+||||+ +++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence 999999999999 999999999876666999999999999999999999999999999999999975
Q ss_pred ------------CCcEEEEecCCccccCCC------------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 444 ------------DGHVVLTDFDLSFMTSCK------------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 444 ------------~g~vKL~DFGlS~~~~~~------------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
++.+||+|||+|...... | .....+|+|++|++++++++|..||.
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 789999999999743311 1 12234599999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-30 Score=251.64 Aligned_cols=183 Identities=29% Similarity=0.460 Sum_probs=159.4
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.+.........+.+.+|+.+++.++||||+++++++......++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35799999999999999999999999999999999765433334457788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC---- 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~---- 460 (489)
|||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 168 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168 (278)
T ss_dssp EECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence 99999999999998653 4589999999999999999999999999999999999999999999999999864321
Q ss_pred -----------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 -----------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -----------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|.+++++++|..||.
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 213 (278)
T 3cok_A 169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213 (278)
T ss_dssp -----------------------CTHHHHHHHHHHHHHHSSCSSC
T ss_pred ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1221 235699999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=287.28 Aligned_cols=186 Identities=33% Similarity=0.602 Sum_probs=160.9
Q ss_pred ccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCC
Q 042772 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTST 379 (489)
Q Consensus 301 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~ 379 (489)
..+.+++|++++.||+|+||.||+|.++.+++.||+|++++...........+..|..++..+ .||||+.++++|++..
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 345678999999999999999999999999999999999876544455567788899999887 7999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
.+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999999999875 348999999999999999999999999999999999999999999999999987421
Q ss_pred C----------C-----Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 C----------K-----PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ~----------~-----~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. . |+ +....|+|++|++++||++|..||.
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~ 543 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCC
Confidence 1 1 11 1223489999999999999999995
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-30 Score=254.60 Aligned_cols=181 Identities=23% Similarity=0.314 Sum_probs=157.8
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++++.||+|+||.||+|.+..+|+.||+|.+.... ......+.+.+|+.+++.++||||+++++++......++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 357999999999999999999999999999999986543 2344456788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC---- 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~---- 460 (489)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp EECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 9999999999988765 3489999999999999999999999999999999999999999999999999864331
Q ss_pred -----------CC-------ceeecccccchHHHHHHHHhCCcccC
Q 042772 461 -----------KP-------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -----------~~-------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+| .....+|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 204 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWP 204 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 11 12234589999999999999999985
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-30 Score=257.42 Aligned_cols=190 Identities=25% Similarity=0.380 Sum_probs=156.7
Q ss_pred hcCCCccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEE
Q 042772 296 ITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASF 375 (489)
Q Consensus 296 ~~~~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 375 (489)
..+....+...+|++.+.||+|+||.||+|.+ ++..||+|++..... .......+.+|+.++++++||||+++++++
T Consensus 27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 103 (309)
T 3p86_A 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAV 103 (309)
T ss_dssp -----CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34445567778999999999999999999987 478999999976533 445567889999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEecCCcEEEEec
Q 042772 376 QTSTHICLITDFCPGGELFALLDKQPM-KIFREDSARFYAAEVVIGLEYLHCLG--IIYRDLKPENILLQKDGHVVLTDF 452 (489)
Q Consensus 376 ~~~~~~~lVmEy~~ggsL~~~L~~~~~-~~l~e~~~~~i~~qI~~aL~yLH~~g--IvHrDLKP~NILld~~g~vKL~DF 452 (489)
.....+++||||+++|+|.+++..... ..+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+||
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence 999999999999999999999987531 23889999999999999999999999 999999999999999999999999
Q ss_pred CCccccCC---------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 453 DLSFMTSC---------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 453 GlS~~~~~---------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+|+.... +|+ ....+|+|++|++++++++|..||.
T Consensus 184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~ 240 (309)
T 3p86_A 184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240 (309)
T ss_dssp C-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTT
T ss_pred CCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99863221 111 1234599999999999999999985
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-30 Score=252.68 Aligned_cols=184 Identities=22% Similarity=0.271 Sum_probs=162.6
Q ss_pred ccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 042772 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH 380 (489)
Q Consensus 301 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 380 (489)
..+...+|++.+.||+|+||.||+|.+..+++.||+|.+... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 455667899999999999999999999999999999999653 3345678889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
.++||||+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999999999999999887666799999999999999999999999999999999999999999999999999975432
Q ss_pred CC----------------c------eeecccccchHHHHHHHHh-CCcccC
Q 042772 461 KP----------------Q------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 ~~----------------~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.. + ....+|+|++|++++++++ |..||.
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~ 214 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 214 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 11 1 1124489999999999998 999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-30 Score=252.01 Aligned_cols=182 Identities=25% Similarity=0.403 Sum_probs=162.1
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.+.........+.+.+|+.+++.+.||||+++++++......++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 46799999999999999999999999999999999877655666778889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC---
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK--- 461 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~--- 461 (489)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 171 (294)
T 2rku_A 94 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171 (294)
T ss_dssp EECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence 9999999999998875 34899999999999999999999999999999999999999999999999998653211
Q ss_pred ------------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 462 ------------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ------------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
| .....+|+|++|.+++++++|..||.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 216 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216 (294)
T ss_dssp BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1 11224589999999999999999985
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=268.16 Aligned_cols=185 Identities=20% Similarity=0.314 Sum_probs=160.2
Q ss_pred ccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 042772 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH 380 (489)
Q Consensus 301 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 380 (489)
..+..++|++.+.||+|+||.||+|.++.+++.||+|.+... ........+.+|+.+++.++||||+++++++.....
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 355667899999999999999999999999999999998754 234455678889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
+|+||||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999999999999999998643 3489999999999999999999999999999999999999999999999999864321
Q ss_pred -----------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 461 -----------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 -----------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+ ....+|+|++|++++|+++ |..||.
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~ 317 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYP 317 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 111 1124589999999999997 999985
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-30 Score=259.25 Aligned_cols=181 Identities=23% Similarity=0.344 Sum_probs=142.1
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++++.||+|+||.||+|.++.+++.||+|.+.... .......+.+|+.+++.++||||+++++++...+.+++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 457999999999999999999999999999999997543 222345677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 385 TDFCPGGELFALLDKQP----MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~----~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
|||++ |+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99997 69999987531 23489999999999999999999999999999999999999999999999999864321
Q ss_pred ---------------CCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------------KPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------------~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++|..||.
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 210 (317)
T 2pmi_A 161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFP 210 (317)
T ss_dssp CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 111 2234589999999999999999985
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-30 Score=255.14 Aligned_cols=187 Identities=20% Similarity=0.285 Sum_probs=160.2
Q ss_pred CccccccCcccccccCCCCceEEEEEEEc-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEE
Q 042772 300 GEKIGLHHFKPIKPLGCGDTGSVHLVELQ-----GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYAS 374 (489)
Q Consensus 300 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~ 374 (489)
...+..++|++.+.||+|+||.||+|.+. .+++.||+|.+... ......+.+.+|+.+++.++||||++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 34566788999999999999999999984 45689999999754 245566788999999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 042772 375 FQTSTHICLITDFCPGGELFALLDKQPM----------------------KIFREDSARFYAAEVVIGLEYLHCLGIIYR 432 (489)
Q Consensus 375 ~~~~~~~~lVmEy~~ggsL~~~L~~~~~----------------------~~l~e~~~~~i~~qI~~aL~yLH~~gIvHr 432 (489)
+......++||||+++++|.+++..... ..+++..+..++.||+.||.|||++||+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 9999999999999999999999987532 237899999999999999999999999999
Q ss_pred CCCCCCEEEecCCcEEEEecCCccccCCC-----------------Cc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 433 DLKPENILLQKDGHVVLTDFDLSFMTSCK-----------------PQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 433 DLKP~NILld~~g~vKL~DFGlS~~~~~~-----------------~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
||||+|||++.++.+||+|||++...... |+ ....+|+|++|++++++++ |..||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998643211 11 1224589999999999998 999985
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-30 Score=255.13 Aligned_cols=183 Identities=25% Similarity=0.369 Sum_probs=155.3
Q ss_pred cccccCcccccccCCCCceEEEEEE----EcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVE----LQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT 377 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~----~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 377 (489)
.+..++|++++.||+|+||.||+|. ...+++.||+|.+... .....+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4556789999999999999999999 4568999999998654 44556788899999999999999999999865
Q ss_pred C--CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCc
Q 042772 378 S--THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455 (489)
Q Consensus 378 ~--~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS 455 (489)
. ..+++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 3 56899999999999999998764 34899999999999999999999999999999999999999999999999999
Q ss_pred cccCCC------------------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 456 FMTSCK------------------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 456 ~~~~~~------------------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
...... |+ ....+|+|++|++++++++|..||.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 218 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 218 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTC
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccC
Confidence 754211 11 1123489999999999999988874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-30 Score=261.37 Aligned_cols=181 Identities=23% Similarity=0.288 Sum_probs=158.5
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
..|+.++.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++++......++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 46999999999999999999999999999999998654445556678899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
||+. |+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~ 211 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV 211 (348)
T ss_dssp ECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCC
T ss_pred ecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCCCccc
Confidence 9996 68988886542 4589999999999999999999999999999999999999999999999999864331
Q ss_pred ------CCc---------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ------KPQ---------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ------~~~---------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++|..||.
T Consensus 212 gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 254 (348)
T 1u5q_A 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 254 (348)
T ss_dssp SCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 122 2234599999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-30 Score=252.50 Aligned_cols=184 Identities=29% Similarity=0.431 Sum_probs=161.0
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
+..++|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++++......+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 45678999999999999999999999999999999997654333334567888999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC--
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC-- 460 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~-- 460 (489)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp EEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 9999999999999998753 489999999999999999999999999999999999999999999999999854321
Q ss_pred -----------CC------ceeecccccchHHHHHHHHhCCcccC
Q 042772 461 -----------KP------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -----------~~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+| .....+|+|++|.+++++++|..||.
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 213 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCC
Confidence 11 12234589999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-30 Score=263.58 Aligned_cols=180 Identities=25% Similarity=0.364 Sum_probs=147.7
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCC--e
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTST--H 380 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~--~ 380 (489)
..++|++++.||+|+||.||+|.+..+|+.||+|.+.+.. ........+.+|+.+++.+. ||||+++++++...+ .
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3568999999999999999999999999999999986543 34556677889999999997 999999999997654 7
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
+|+||||++ ++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred EEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 999999996 6999999873 489999999999999999999999999999999999999999999999999964311
Q ss_pred ------------------------------------CCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ------------------------------------KPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ------------------------------------~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ .....|+|++|++++++++|..||.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 232 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence 111 2233589999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-30 Score=270.69 Aligned_cols=149 Identities=20% Similarity=0.317 Sum_probs=125.6
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC-----Ce
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS-----TH 380 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~ 380 (489)
++|++++.||+|+||+||+|.++.+++.||+|.+.+.. ......+++.+|+.+++.++||||+++++++... ..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 67999999999999999999999999999999996542 3455677889999999999999999999998443 57
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
+|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 99999998 67999999875 44899999999999999999999999999999999999999999999999999753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-30 Score=255.67 Aligned_cols=182 Identities=21% Similarity=0.338 Sum_probs=153.9
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
...++|++++.||+|+||.||+|.+. +++.||+|.+..... .......+.+|+.+++.++||||+++++++.+...++
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 34578999999999999999999986 489999999965432 3334567888999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC--
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC-- 460 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~-- 460 (489)
+||||++ ++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 96 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 96 LVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9999996 58998887754 3489999999999999999999999999999999999999999999999999864321
Q ss_pred -------------CCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 -------------KPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -------------~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ .....|+|++|++++++++|..||.
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 221 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFP 221 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCC
Confidence 111 2234489999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-29 Score=257.37 Aligned_cols=182 Identities=25% Similarity=0.408 Sum_probs=162.4
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
..+|.+.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 46799999999999999999999999999999999877655666778889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC---
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK--- 461 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~--- 461 (489)
|||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence 9999999999998875 34899999999999999999999999999999999999999999999999999654211
Q ss_pred ------------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 462 ------------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ------------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+ .....|+|++|++++++++|..||.
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 242 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCC
Confidence 11 1124589999999999999999985
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=9.5e-30 Score=264.24 Aligned_cols=180 Identities=26% Similarity=0.384 Sum_probs=156.9
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++++.||+|+||.||+|.++.+++.||+|.+.... ......+.+|+.+++.++||||+++++++.....+++|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 367999999999999999999999999999999997642 23345788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec--CCcEEEEecCCccccCCC-
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK--DGHVVLTDFDLSFMTSCK- 461 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~--~g~vKL~DFGlS~~~~~~- 461 (489)
|||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|......
T Consensus 127 ~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 127 LEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp EECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999999997653 34899999999999999999999999999999999999974 578999999999754321
Q ss_pred -------------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 462 -------------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 -------------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+ ....+|+|++|++++++++|..||.
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 251 (387)
T 1kob_A 206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 251 (387)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCC
Confidence 11 1234589999999999999999985
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-30 Score=253.39 Aligned_cols=175 Identities=25% Similarity=0.389 Sum_probs=155.3
Q ss_pred ccCcccc-cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHH-HhCCCCCcceeeEEEEe----C
Q 042772 305 LHHFKPI-KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIM-SLLDHPFLPTLYASFQT----S 378 (489)
Q Consensus 305 ~~~y~~~-~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il-~~l~HpnIv~l~~~~~~----~ 378 (489)
.++|.+. +.||+|+||.||+|.+..+++.||+|.+... ..+.+|+.++ +.++||||+++++++.. .
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 4578887 7899999999999999999999999998643 2455688887 56689999999999987 6
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---CCcEEEEecCCc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK---DGHVVLTDFDLS 455 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~---~g~vKL~DFGlS 455 (489)
..+++||||+++|+|.+++.......+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 78999999999999999999876567999999999999999999999999999999999999998 789999999999
Q ss_pred cccCCCCceeecccccchHHHHHHHHhCCcccC
Q 042772 456 FMTSCKPQVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 456 ~~~~~~~~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
..... ......+|+|++|++++++++|..||.
T Consensus 168 ~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~ 199 (299)
T 3m2w_A 168 KETTG-EKYDKSCDMWSLGVIMYILLCGYPPFY 199 (299)
T ss_dssp EECTT-CGGGGHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccc-ccCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 87654 334567799999999999999999984
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-30 Score=257.06 Aligned_cols=178 Identities=21% Similarity=0.323 Sum_probs=154.0
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 382 (489)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+..|+.+++.+ +||||+++++++......+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 34679999999999999999999999999999999875422 23467899999999 8999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc-----EEEEecCCccc
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGH-----VVLTDFDLSFM 457 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~-----vKL~DFGlS~~ 457 (489)
+||||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+|..
T Consensus 82 lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEEeC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 999999 999999998752 45899999999999999999999999999999999999998887 99999999974
Q ss_pred cCCC-----------------Cc-----------eeecccccchHHHHHHHHhCCcccC
Q 042772 458 TSCK-----------------PQ-----------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 458 ~~~~-----------------~~-----------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.... +. ....+|+|++|++++++++|..||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~ 218 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQ 218 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcc
Confidence 3211 11 1224489999999999999999995
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-30 Score=250.09 Aligned_cols=185 Identities=28% Similarity=0.429 Sum_probs=162.7
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
.+..++|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++++......
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 45567899999999999999999999999999999999765433444567788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999999998753 489999999999999999999999999999999999999999999999999865431
Q ss_pred -------------CCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 461 -------------KPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -------------~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 212 (276)
T 2h6d_A 165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 1222 134589999999999999999985
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.9e-30 Score=260.84 Aligned_cols=179 Identities=29% Similarity=0.425 Sum_probs=147.1
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|+.+++.++||||+++++++......+
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 34567999999999999999999999999999999997542 2355778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---CCcEEEEecCCccccC
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK---DGHVVLTDFDLSFMTS 459 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~---~g~vKL~DFGlS~~~~ 459 (489)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 125 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999999999999775 34899999999999999999999999999999999999975 8899999999986432
Q ss_pred CC--------------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 460 CK--------------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ~~--------------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.. | .....+|+|++|++++++++|..||.
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 251 (349)
T 2w4o_A 203 HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY 251 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 11 1 12234589999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=272.91 Aligned_cols=184 Identities=30% Similarity=0.426 Sum_probs=161.7
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
...++|++.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.....+|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34467999999999999999999999999999999998765544555678889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE---ecCCcEEEEecCCccccC
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILL---QKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILl---d~~g~vKL~DFGlS~~~~ 459 (489)
+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|....
T Consensus 103 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 999999999999999875 348999999999999999999999999999999999999 567899999999986433
Q ss_pred CC--------------Cc-----eeecccccchHHHHHHHHhCCcccC
Q 042772 460 CK--------------PQ-----VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ~~--------------~~-----~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.. |+ ....+|+|++|++++++++|..||.
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 228 (484)
T 3nyv_A 181 ASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFN 228 (484)
T ss_dssp CCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCC
Confidence 21 11 1234599999999999999999995
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=248.56 Aligned_cols=181 Identities=25% Similarity=0.382 Sum_probs=158.4
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++.+.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.+++.++||||+++++++......++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4689999999999999999999999999999999976543 444567788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc---EEEEecCCccccCCC
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGH---VVLTDFDLSFMTSCK 461 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~---vKL~DFGlS~~~~~~ 461 (489)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||++......
T Consensus 84 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999999999998775 34899999999999999999999999999999999999986655 999999998643321
Q ss_pred C--------------------ceeecccccchHHHHHHHHhCCcccC
Q 042772 462 P--------------------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ~--------------------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. .....+|+|++|++++++++|..||.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 208 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 208 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCC
Confidence 1 11234589999999999999999984
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-30 Score=253.93 Aligned_cols=179 Identities=21% Similarity=0.332 Sum_probs=153.6
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++++.||+|+||.||+|.+ .+++.||+|.+..... .......+.+|+.+++.++||||+++++++......++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 5799999999999999999998 5789999999965432 2223456778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------ 459 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------ 459 (489)
||+++ +|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 80 e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp ECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 99965 9999998653 348999999999999999999999999999999999999999999999999985322
Q ss_pred ---------CCCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 ---------CKPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---------~~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+ ....+|+|++|.+++++++|..||.
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 202 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 1111 2234589999999999999999985
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-30 Score=257.90 Aligned_cols=185 Identities=19% Similarity=0.298 Sum_probs=158.8
Q ss_pred cccccCcccccccCCCCceEEEEEEEcC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQG-----AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQ 376 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 376 (489)
.+..++|++.+.||+|+||.||+|.+.. +++.||+|.++... .......+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 3456789999999999999999999973 45899999997542 3445678899999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 042772 377 TSTHICLITDFCPGGELFALLDKQP----------------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDL 434 (489)
Q Consensus 377 ~~~~~~lVmEy~~ggsL~~~L~~~~----------------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDL 434 (489)
.....++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 9999999999999999999998742 145899999999999999999999999999999
Q ss_pred CCCCEEEecCCcEEEEecCCccccC-----------------CCCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 435 KPENILLQKDGHVVLTDFDLSFMTS-----------------CKPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 435 KP~NILld~~g~vKL~DFGlS~~~~-----------------~~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
||+|||++.++.+||+|||++.... .+|+ ....+|+|++|++++++++ |..||.
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999985321 0111 1234589999999999998 999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-30 Score=262.22 Aligned_cols=181 Identities=19% Similarity=0.241 Sum_probs=151.3
Q ss_pred cccccCcccccccCCCCceEEEEE-----EEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCCcceeeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLV-----ELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD---HPFLPTLYA 373 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a-----~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~~ 373 (489)
.+..++|++.+.||+|+||.||+| ....+++.||+|.+.... ...+..|..+++.+. |+||+.+++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 455678999999999999999999 466789999999986542 245667888888876 999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-------
Q 042772 374 SFQTSTHICLITDFCPGGELFALLDKQ---PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK------- 443 (489)
Q Consensus 374 ~~~~~~~~~lVmEy~~ggsL~~~L~~~---~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~------- 443 (489)
++...+..|+||||+++|+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 999999999999999999999999752 2355999999999999999999999999999999999999998
Q ss_pred ----CCcEEEEecCCccccC-----------------CCCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 444 ----DGHVVLTDFDLSFMTS-----------------CKPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 444 ----~g~vKL~DFGlS~~~~-----------------~~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
++.+||+|||+|+... .+|+ ....+|+|++|++++++++|..||.
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence 8999999999995321 0111 1234489999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=247.25 Aligned_cols=181 Identities=25% Similarity=0.375 Sum_probs=156.5
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
.+..++|++.+.||+|+||.||+|.+.. ++.||+|.+...... .+.+.+|+.++++++||||+++++++.+....
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred EeChhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 4566789999999999999999999874 778999999765322 24678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999999999997653 3589999999999999999999999999999999999999999999999999864321
Q ss_pred ---------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 461 ---------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 ---------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++ |..||.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~ 209 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 209 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCC
Confidence 111 1224589999999999998 999985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-30 Score=263.31 Aligned_cols=186 Identities=21% Similarity=0.303 Sum_probs=153.3
Q ss_pred CccccccCcccccccCCCCceEEEEEEEc---CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 042772 300 GEKIGLHHFKPIKPLGCGDTGSVHLVELQ---GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQ 376 (489)
Q Consensus 300 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 376 (489)
...+...+|++.+.||+|+||.||+|.++ .++..||+|.++... .......+.+|+.++++++||||+++++++.
T Consensus 39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 116 (373)
T 2qol_A 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVT 116 (373)
T ss_dssp SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 34566788999999999999999999987 457789999997542 3445678899999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 377 TSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 377 ~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
....+++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 117 ~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 117 KSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred eCCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 9999999999999999999998653 358999999999999999999999999999999999999999999999999987
Q ss_pred ccCCC------------------Cc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 457 MTSCK------------------PQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 457 ~~~~~------------------~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
..... |+ ....+|+|++|++++++++ |..||.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~ 252 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTT
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCC
Confidence 54311 11 1123489999999999886 999984
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=248.25 Aligned_cols=179 Identities=32% Similarity=0.470 Sum_probs=157.4
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++.+.||+|+||.||+|.+..++..+|+|.+.+.... ..+.+.+|+.+++.++||||+++++++......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 35799999999999999999999999999999999765332 346788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE---ecCCcEEEEecCCccccCCC
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILL---QKDGHVVLTDFDLSFMTSCK 461 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILl---d~~g~vKL~DFGlS~~~~~~ 461 (489)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 85 MELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred EeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999999999999875 348999999999999999999999999999999999999 78899999999998643211
Q ss_pred --------------Cc-----eeecccccchHHHHHHHHhCCcccC
Q 042772 462 --------------PQ-----VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 --------------~~-----~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+ ....+|+|++|++++++++|..||.
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 208 (277)
T 3f3z_A 163 KMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFS 208 (277)
T ss_dssp SCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCC
Confidence 11 1234589999999999999999985
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=249.61 Aligned_cols=183 Identities=24% Similarity=0.339 Sum_probs=154.6
Q ss_pred CccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 300 GEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 300 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
...+..++|++++.||+|+||.||+|.+. ++..||+|.+...... .+.+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 34567789999999999999999999887 4778999999765322 256788999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
..++||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 9999999999999999997642 348999999999999999999999999999999999999999999999999996432
Q ss_pred ----------------CCCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 460 ----------------CKPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 460 ----------------~~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.+|+ ....+|+|++|++++++++ |..||.
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~ 223 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 1111 1124589999999999997 999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=254.95 Aligned_cols=182 Identities=27% Similarity=0.376 Sum_probs=158.3
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNR---NKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
.++|++.+.||+|+||.||+|.++.+|+.||+|.+.+...... ...+.+.+|+.+++.++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 3579999999999999999999999999999999976543221 1356788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC----cEEEEecCCccc
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG----HVVLTDFDLSFM 457 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g----~vKL~DFGlS~~ 457 (489)
++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 9999999999999999875 3489999999999999999999999999999999999999888 799999999865
Q ss_pred cCCC--------------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 458 TSCK--------------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 458 ~~~~--------------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.... | .....+|+|++|++++++++|..||.
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 219 (321)
T 2a2a_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219 (321)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred cCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCC
Confidence 4321 1 11234589999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=250.99 Aligned_cols=185 Identities=21% Similarity=0.342 Sum_probs=155.1
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 383 (489)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++.++||||+++++++......++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 35689999999999999999999999999999999986554556667888999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC
Q 042772 384 ITDFCPGGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK 461 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~ 461 (489)
||||+++++|.+++... ....+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 99999999999998752 2345899999999999999999999999999999999999999999999999998643211
Q ss_pred ---------------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 462 ---------------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ---------------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+ ....+|+|++|++++++++|..||.
T Consensus 190 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 237 (310)
T 2wqm_A 190 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 237 (310)
T ss_dssp ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 11 1234589999999999999999984
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=246.99 Aligned_cols=181 Identities=24% Similarity=0.342 Sum_probs=156.3
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
.+..++|++.+.||+|+||.||+|.++. +..||+|.+...... ...+.+|+.+++.++||||+++++++......
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 4556789999999999999999998774 778999999764322 25678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK 461 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~ 461 (489)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999999999998753 34899999999999999999999999999999999999999999999999998643211
Q ss_pred ----------------C------ceeecccccchHHHHHHHHh-CCcccC
Q 042772 462 ----------------P------QVFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 462 ----------------~------~~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
| .....+|+|++|++++++++ |..||.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 207 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD 207 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTT
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcc
Confidence 1 11234589999999999998 999985
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.7e-30 Score=258.42 Aligned_cols=185 Identities=23% Similarity=0.324 Sum_probs=156.1
Q ss_pred cccccCcccccccCCCCceEEEEEEE-----cCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVEL-----QGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASF 375 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~ 375 (489)
.+..++|++.+.||+|+||.||+|.+ ..+++.||+|.++.. ........+.+|+.++..+ +||||+++++++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc--CCHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 44567899999999999999999994 456789999999754 2344567789999999999 799999999998
Q ss_pred EeCC-eEEEEEecCCCCCHHHHHhhCCC----------------------------------------------------
Q 042772 376 QTST-HICLITDFCPGGELFALLDKQPM---------------------------------------------------- 402 (489)
Q Consensus 376 ~~~~-~~~lVmEy~~ggsL~~~L~~~~~---------------------------------------------------- 402 (489)
.... .+++||||+++|+|.+++.....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 8754 59999999999999999987532
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC---------
Q 042772 403 ------------KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK--------- 461 (489)
Q Consensus 403 ------------~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~--------- 461 (489)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence 12889999999999999999999999999999999999999999999999999744211
Q ss_pred --------Cc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 462 --------PQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 462 --------~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
|+ ....+|+|++|++++++++ |..||.
T Consensus 256 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 297 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 297 (359)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCC
Confidence 11 1124489999999999997 999985
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9.5e-30 Score=272.15 Aligned_cols=185 Identities=22% Similarity=0.289 Sum_probs=162.2
Q ss_pred CccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 300 GEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 300 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
...+...+|++.+.||+|+||.||+|.++.++..||+|.++.... ..+.+.+|+.+++.++||||+++++++....
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 345667789999999999999999999999999999999975432 3567889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
.+|+||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 99999999999999999987655668999999999999999999999999999999999999999999999999997543
Q ss_pred CC----------------Cc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 460 CK----------------PQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 460 ~~----------------~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.. |+ ....+|+|++|++++|+++ |..||.
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~ 421 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 421 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCC
Confidence 11 11 1123489999999999998 999985
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=254.56 Aligned_cols=174 Identities=26% Similarity=0.456 Sum_probs=148.8
Q ss_pred Ccccc---cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEE
Q 042772 307 HFKPI---KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 307 ~y~~~---~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~ 382 (489)
+|.+. +.||+|+||.||+|.++.+++.||+|++.+. ....+.+|+.+++.+. ||||+++++++.+....|
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 45543 7899999999999999999999999999653 2345667999999997 999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC---cEEEEecCCccccC
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG---HVVLTDFDLSFMTS 459 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g---~vKL~DFGlS~~~~ 459 (489)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp EEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred EEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 999999999999999886 4489999999999999999999999999999999999998766 89999999996432
Q ss_pred C---------------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 C---------------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ~---------------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. +|+. ....|+|++|++++++++|..||.
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 210 (325)
T 3kn6_A 161 PDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210 (325)
T ss_dssp C----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 1 1222 123489999999999999999985
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=254.49 Aligned_cols=176 Identities=25% Similarity=0.377 Sum_probs=154.4
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
.|...+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4777789999999999999999999999999997543 2334667889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC-----
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK----- 461 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~----- 461 (489)
|+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 123 ~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 123 FLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp CCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred cCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence 99999999998753 4899999999999999999999999999999999999999999999999998643311
Q ss_pred ----------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 462 ----------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ----------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
| ......|+|++|++++++++|..||.
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~ 242 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYF 242 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1 11234589999999999999999985
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=261.77 Aligned_cols=177 Identities=27% Similarity=0.410 Sum_probs=148.0
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEec
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDF 387 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 387 (489)
+...+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++.....+++||||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 167 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 444678999999999999999999999999997642 24456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE--ecCCcEEEEecCCccccCCC----
Q 042772 388 CPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILL--QKDGHVVLTDFDLSFMTSCK---- 461 (489)
Q Consensus 388 ~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILl--d~~g~vKL~DFGlS~~~~~~---- 461 (489)
+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 168 ~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~ 246 (373)
T 2x4f_A 168 VDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246 (373)
T ss_dssp CTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC
T ss_pred CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc
Confidence 99999999987653 348999999999999999999999999999999999999 45679999999999754311
Q ss_pred ----------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 462 ----------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ----------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+ .....|+|++|++++++++|..||.
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 289 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFL 289 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 11 1124589999999999999999985
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-29 Score=250.55 Aligned_cols=178 Identities=28% Similarity=0.389 Sum_probs=152.6
Q ss_pred cCcccc-cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEE
Q 042772 306 HHFKPI-KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 306 ~~y~~~-~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~l 383 (489)
+.|++. +.||+|+||.||+|.+..+++.||+|++.+.. ......+.+|+.++.++ +||||+++++++.....+|+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 568885 78999999999999999999999999997652 23346778899999885 79999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc---EEEEecCCccccC-
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGH---VVLTDFDLSFMTS- 459 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~---vKL~DFGlS~~~~- 459 (489)
||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 99999999999999875 34899999999999999999999999999999999999988776 9999999986432
Q ss_pred ---------------------CCCce-----------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ---------------------CKPQV-----------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---------------------~~~~~-----------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 227 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCc
Confidence 11221 123589999999999999999985
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=251.37 Aligned_cols=185 Identities=24% Similarity=0.344 Sum_probs=151.0
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccc--hHHHHHHHHHHHHHHhC---CCCCcceeeEEEEe
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN--RNKVHRACIEREIMSLL---DHPFLPTLYASFQT 377 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~~~~E~~il~~l---~HpnIv~l~~~~~~ 377 (489)
+..++|++++.||+|+||+||+|.+..+++.||+|.+....... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 34568999999999999999999999999999999997543211 11123445677766655 59999999999987
Q ss_pred CC-----eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEec
Q 042772 378 ST-----HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDF 452 (489)
Q Consensus 378 ~~-----~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DF 452 (489)
.. .+++||||+. ++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 54 5899999996 69999999876666999999999999999999999999999999999999999999999999
Q ss_pred CCccccCCC--------------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 453 DLSFMTSCK--------------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 453 GlS~~~~~~--------------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+|...... |+ ....+|+|++|++++++++|..||.
T Consensus 165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 220 (308)
T 3g33_A 165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 220 (308)
T ss_dssp SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCC
T ss_pred ccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCC
Confidence 999643311 11 1234589999999999999999984
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-30 Score=259.97 Aligned_cols=182 Identities=23% Similarity=0.352 Sum_probs=157.1
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccch-----HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNR-----NKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
.++|++.+.||+|+||.||+|.++.+++.||+|.+.+...... .....+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 3579999999999999999999999999999999986543221 13345667999999999999999999999999
Q ss_pred eEEEEEecCCCC-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 380 HICLITDFCPGG-ELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 380 ~~~lVmEy~~gg-sL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
..++||||+.+| +|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 999999999766 9999998763 4899999999999999999999999999999999999999999999999999744
Q ss_pred CCC--------------Cce-------eecccccchHHHHHHHHhCCcccC
Q 042772 459 SCK--------------PQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~~~--------------~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... |+. ....|+|++|++++++++|..||.
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 231 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchh
Confidence 321 111 223489999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=269.60 Aligned_cols=182 Identities=30% Similarity=0.444 Sum_probs=154.6
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccch----------HHHHHHHHHHHHHHhCCCCCcceeeEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNR----------NKVHRACIEREIMSLLDHPFLPTLYAS 374 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~----------~~~~~~~~E~~il~~l~HpnIv~l~~~ 374 (489)
.++|++++.||+|+||+||+|.++.+++.||+|++.+...... ...+.+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4679999999999999999999999999999999986543211 235678899999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC---cEEEEe
Q 042772 375 FQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG---HVVLTD 451 (489)
Q Consensus 375 ~~~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g---~vKL~D 451 (489)
+.+...+|+|||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 99999999999999999999999775 3489999999999999999999999999999999999998776 699999
Q ss_pred cCCccccCCC--------------Cc-----eeecccccchHHHHHHHHhCCcccC
Q 042772 452 FDLSFMTSCK--------------PQ-----VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 452 FGlS~~~~~~--------------~~-----~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
||+|...... |+ ....+|+|++|++++++++|..||.
T Consensus 193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 248 (504)
T 3q5i_A 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFG 248 (504)
T ss_dssp CTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCC
Confidence 9999644321 11 1234589999999999999999995
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=250.10 Aligned_cols=181 Identities=27% Similarity=0.463 Sum_probs=155.5
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|.+.+.||+|+||.||+|.+..++..+|+|.+.... .......+.+|+.+++.++||||+++++++......++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 57999999999999999999999999999999997653 2233567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE---ecCCcEEEEecCCccccCC
Q 042772 386 DFCPGGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILL---QKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILl---d~~g~vKL~DFGlS~~~~~ 460 (489)
||+++|+|.+++... ....+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 999999999998643 22458999999999999999999999999999999999999 4567899999999964321
Q ss_pred C--------------C-----ceeecccccchHHHHHHHHhCCcccC
Q 042772 461 K--------------P-----QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ~--------------~-----~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. | .....+|+|++|++++++++|..||.
T Consensus 180 ~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~ 226 (285)
T 3is5_A 180 DEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFT 226 (285)
T ss_dssp -------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCC
Confidence 1 1 11234589999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=258.22 Aligned_cols=183 Identities=23% Similarity=0.357 Sum_probs=160.7
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
.+..++|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++++......
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence 345678999999999999999999999999999999997652 345567888999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEecCCcEEEEecCCccccC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL-GIIYRDLKPENILLQKDGHVVLTDFDLSFMTS- 459 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~-gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~- 459 (489)
++||||+++++|.+++.... .+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999999998753 489999999999999999999996 99999999999999999999999999985221
Q ss_pred ------------CCCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 ------------CKPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ------------~~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+ ....+|+|++|++++++++|..||.
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 231 (360)
T 3eqc_A 185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 231 (360)
T ss_dssp HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSS
T ss_pred ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1111 2234589999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=264.81 Aligned_cols=180 Identities=21% Similarity=0.288 Sum_probs=154.5
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC-----C
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS-----T 379 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~ 379 (489)
.++|++.+.||+|+||.||+|.++.+++.||+|.+.+.. ......+++.+|+.+++.++||||+++++++... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 357999999999999999999999999999999997542 3455667889999999999999999999999766 5
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred eEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 7999999995 6999999875 448999999999999999999999999999999999999999999999999997532
Q ss_pred C-------------------------------------CCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 C-------------------------------------KPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ~-------------------------------------~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. +|+ .....|+|++|++++|+++|..||.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 1 111 1123488999999999998766653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=253.72 Aligned_cols=183 Identities=24% Similarity=0.271 Sum_probs=157.2
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
....++|++.+.||+|+||.||+|.+. +++.||+|.+... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE---SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC---CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 345578999999999999999999965 5899999988654 234467788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 382 CLITDFCPGGELFALLDKQP--MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~--~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
++||||+++|+|.+++.... ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 99999999999999997643 2348999999999999999999999999999999999999999999999999986432
Q ss_pred C-----------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 C-----------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ~-----------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. +|+ ....+|+|++|++++++++|..||.
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~ 242 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCS
T ss_pred cccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccc
Confidence 1 111 1234589999999999999999884
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=249.15 Aligned_cols=181 Identities=19% Similarity=0.187 Sum_probs=155.2
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCC-------cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAG-------ELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASF 375 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg-------~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 375 (489)
+..++|++.+.||+|+||.||+|.+..++ ..||+|.+... .....+.+.+|+.+++.++||||+++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 45678999999999999999999998877 47999998654 334457788999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc--------E
Q 042772 376 QTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGH--------V 447 (489)
Q Consensus 376 ~~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~--------v 447 (489)
......++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999999998763 33899999999999999999999999999999999999999887 9
Q ss_pred EEEecCCccccC-----------CCCc-------eeecccccchHHHHHHHHhCC-ccc
Q 042772 448 VLTDFDLSFMTS-----------CKPQ-------VFYHAHVNGFYFIMYKWLTGY-FTY 487 (489)
Q Consensus 448 KL~DFGlS~~~~-----------~~~~-------~~~~~~v~s~g~~a~e~~~G~-lpY 487 (489)
||+|||++.... .+|+ ....+|+|++|.+++++++|. .||
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~ 219 (289)
T 4fvq_A 161 KLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219 (289)
T ss_dssp EECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eeccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCc
Confidence 999999986432 1222 223458999999999999954 444
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-30 Score=265.67 Aligned_cols=183 Identities=26% Similarity=0.372 Sum_probs=156.5
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC--eE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST--HI 381 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~ 381 (489)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+++++.++||||+++++++.... ..
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 34689999999999999999999999999999999975432 233566778999999999999999999998765 78
Q ss_pred EEEEecCCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE----ecCCcEEEEecCCcc
Q 042772 382 CLITDFCPGGELFALLDKQPM-KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILL----QKDGHVVLTDFDLSF 456 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~-~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILl----d~~g~vKL~DFGlS~ 456 (489)
++||||+++|+|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999999976422 238999999999999999999999999999999999999 777889999999996
Q ss_pred ccCC--------------CCcee--------------ecccccchHHHHHHHHhCCcccC
Q 042772 457 MTSC--------------KPQVF--------------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 457 ~~~~--------------~~~~~--------------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.... +|+.+ ..+|+|++|++++++++|..||.
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~ 224 (396)
T 4eut_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224 (396)
T ss_dssp ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEE
T ss_pred EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 4321 12221 23589999999999999999985
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-29 Score=248.75 Aligned_cols=183 Identities=25% Similarity=0.322 Sum_probs=153.1
Q ss_pred ccccCcccccccCCCCceEEEEEE----EcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVE----LQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS 378 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~----~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 378 (489)
+...+|++++.||+|+||.||+|. ...+++.||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 344679999999999999999999 45689999999997543 233457788999999999999999999999876
Q ss_pred --CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 379 --THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 379 --~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
..+++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence 67999999999999999996543 348999999999999999999999999999999999999999999999999996
Q ss_pred ccCCCC------------------c------eeecccccchHHHHHHHHhCCcccC
Q 042772 457 MTSCKP------------------Q------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 457 ~~~~~~------------------~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
...... + ....+|+|++|++++++++|..|+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 543211 1 1123489999999999999988763
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=267.30 Aligned_cols=178 Identities=22% Similarity=0.370 Sum_probs=151.8
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC------
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS------ 378 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------ 378 (489)
.++|++++.||+|+||+||+|.+..+++.||+|++.+.. ......+++.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 578999999999999999999999999999999997653 3455667888999999999999999999999654
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
..+|+||||+++ +|.+.+... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~~----l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTSC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred CeEEEEEeCCCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 468999999965 677777542 889999999999999999999999999999999999999999999999999643
Q ss_pred CCC--------------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 459 SCK--------------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~~~--------------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... | .+....|+|++|++++++++|..||.
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~ 264 (464)
T 3ttj_A 215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 264 (464)
T ss_dssp --CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCC
Confidence 311 1 11234599999999999999999985
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=249.86 Aligned_cols=185 Identities=21% Similarity=0.298 Sum_probs=158.9
Q ss_pred cccccCcccccccCCCCceEEEEEEE-----cCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVEL-----QGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASF 375 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~ 375 (489)
.+..++|++.+.||+|+||.||+|.+ ..+++.||+|.+.... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 45567899999999999999999996 3567899999997552 334567788999999999 899999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhCCC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 042772 376 QTSTHICLITDFCPGGELFALLDKQPM----------------KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENI 439 (489)
Q Consensus 376 ~~~~~~~lVmEy~~ggsL~~~L~~~~~----------------~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NI 439 (489)
......++||||+++|+|.+++..... ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 999999999999999999999987542 2489999999999999999999999999999999999
Q ss_pred EEecCCcEEEEecCCccccCCCC-----------------c------eeecccccchHHHHHHHHh-CCcccC
Q 042772 440 LLQKDGHVVLTDFDLSFMTSCKP-----------------Q------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 440 Lld~~g~vKL~DFGlS~~~~~~~-----------------~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+++.++.+||+|||++....... + ....+|+|++|.+++++++ |..||.
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999987543221 1 1123488999999999998 999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=267.93 Aligned_cols=180 Identities=31% Similarity=0.441 Sum_probs=156.5
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++++.||+|+||+||+|.++.+++.||+|++.+.... ......+.+|+.+++.++||||+++++++.....+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 5799999999999999999999999999999999765432 223567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe---cCCcEEEEecCCccccCC--
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQ---KDGHVVLTDFDLSFMTSC-- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld---~~g~vKL~DFGlS~~~~~-- 460 (489)
|||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|.....
T Consensus 101 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 999999999998775 3489999999999999999999999999999999999995 456899999999964321
Q ss_pred ------------CCce-----eecccccchHHHHHHHHhCCcccC
Q 042772 461 ------------KPQV-----FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ------------~~~~-----~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 179 ~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 223 (486)
T 3mwu_A 179 KMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFY 223 (486)
T ss_dssp ---CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1221 123489999999999999999984
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=257.28 Aligned_cols=181 Identities=26% Similarity=0.401 Sum_probs=157.2
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeeccccc-----chHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCC
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVML-----NRNKVHRACIEREIMSLL-DHPFLPTLYASFQTST 379 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~-----~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~ 379 (489)
++|++.+.||+|+||.||+|.++.+|+.||+|++...... .......+.+|+.+++.+ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5699999999999999999999999999999999764311 122346678899999998 7999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
..|+||||++|++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 999999999999999999865 348999999999999999999999999999999999999999999999999986432
Q ss_pred C--------------CCc------------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 C--------------KPQ------------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ~--------------~~~------------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. +|+ ....+|+|++|++++++++|..||.
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 306 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW 306 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCC
Confidence 1 111 1224699999999999999999984
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.6e-30 Score=261.54 Aligned_cols=185 Identities=19% Similarity=0.254 Sum_probs=154.6
Q ss_pred cccccCcccccccCCCCceEEEEEEE-----cCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVEL-----QGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQ 376 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 376 (489)
.+..++|++++.||+|+||.||+|.+ ..+++.||+|.++.. ........+.+|+.+++.++||||+++++++.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 45567899999999999999999994 456789999998643 23445567888999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC---cEE
Q 042772 377 TSTHICLITDFCPGGELFALLDKQP-----MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG---HVV 448 (489)
Q Consensus 377 ~~~~~~lVmEy~~ggsL~~~L~~~~-----~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g---~vK 448 (489)
.....++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+| .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999999998642 23489999999999999999999999999999999999999555 599
Q ss_pred EEecCCccccC-----------------CCCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 449 LTDFDLSFMTS-----------------CKPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 449 L~DFGlS~~~~-----------------~~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
|+|||+|+... .+|+ .....|+|++|++++++++ |..||.
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~ 288 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 288 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999986321 1111 1234489999999999997 999985
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=246.54 Aligned_cols=180 Identities=24% Similarity=0.399 Sum_probs=157.7
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++......++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 3579999999999999999999999999999999975432 33456788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----- 459 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----- 459 (489)
|||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 84 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 9999999999998764 348999999999999999999999999999999999999999999999999986321
Q ss_pred ------------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ------------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ------------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|++++++++|..||.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 209 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCS
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCC
Confidence 11221 124589999999999999999985
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-29 Score=257.39 Aligned_cols=185 Identities=23% Similarity=0.329 Sum_probs=158.8
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCC-------CcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGA-------GELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYA 373 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~t-------g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~ 373 (489)
.+..++|++.+.||+|+||.||+|.+..+ +..||+|++... ........+.+|+++++.+ +||||+++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 45567899999999999999999997643 358999999754 2445567888999999999 8999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 042772 374 SFQTSTHICLITDFCPGGELFALLDKQP--------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENI 439 (489)
Q Consensus 374 ~~~~~~~~~lVmEy~~ggsL~~~L~~~~--------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NI 439 (489)
++......++||||+++|+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence 9999999999999999999999998753 23589999999999999999999999999999999999
Q ss_pred EEecCCcEEEEecCCccccCC-----------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 440 LLQKDGHVVLTDFDLSFMTSC-----------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 440 Lld~~g~vKL~DFGlS~~~~~-----------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
|++.++.+||+|||+|+.... +|+ ....+|+|++|++++++++ |..||.
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999974321 111 1124589999999999998 999985
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=246.12 Aligned_cols=183 Identities=25% Similarity=0.360 Sum_probs=155.4
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHH----HHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNK----VHRACIEREIMSLLDHPFLPTLYASFQTS 378 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~----~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 378 (489)
+..++|++.+.||+|+||.||+|.+..+++.||+|.+.......... .+.+.+|+.+++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 44578999999999999999999999999999999987544322222 26788999999999999999999998766
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEecCCc-----EEEEe
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLG--IIYRDLKPENILLQKDGH-----VVLTD 451 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~g--IvHrDLKP~NILld~~g~-----vKL~D 451 (489)
. ++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++| |+||||||+|||++.++. +||+|
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred C--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 5 79999999999999987653 45899999999999999999999999 999999999999988776 99999
Q ss_pred cCCccccC------------CCCcee--------ecccccchHHHHHHHHhCCcccC
Q 042772 452 FDLSFMTS------------CKPQVF--------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 452 FGlS~~~~------------~~~~~~--------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
||+|.... .+|+.. ..+|+|++|++++++++|..||.
T Consensus 173 fg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 229 (287)
T 4f0f_A 173 FGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229 (287)
T ss_dssp CTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCc
Confidence 99986322 123322 24589999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=250.49 Aligned_cols=184 Identities=27% Similarity=0.361 Sum_probs=156.4
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe----
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT---- 377 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~---- 377 (489)
.+..++|++.+.||+|+||.||+|.+..+++.||+|.+... .......+.+|+.+++.++||||+++++++..
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 34567899999999999999999999999999999998653 34556778899999999999999999999873
Q ss_pred CCeEEEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCc
Q 042772 378 STHICLITDFCPGGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455 (489)
Q Consensus 378 ~~~~~lVmEy~~ggsL~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS 455 (489)
....++||||+++|+|.+++... ....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 34789999999999999999762 2345899999999999999999999999999999999999999999999999986
Q ss_pred ccc------------------------CCCCce---------eecccccchHHHHHHHHhCCcccC
Q 042772 456 FMT------------------------SCKPQV---------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 456 ~~~------------------------~~~~~~---------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... ..+|+. ...+|+|++|++++++++|..||.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 247 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence 532 123332 235599999999999999999983
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=266.01 Aligned_cols=184 Identities=22% Similarity=0.392 Sum_probs=158.9
Q ss_pred CCCccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe
Q 042772 298 GSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT 377 (489)
Q Consensus 298 ~~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 377 (489)
..+..+..++|++.+.||+|+||.||+|.+. ++.||+|.++... ..+.+.+|+.++++++||||+++++++..
T Consensus 185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 257 (450)
T 1k9a_A 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVE 257 (450)
T ss_dssp HTTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEc
Confidence 4456778889999999999999999999986 6799999997542 34678889999999999999999999876
Q ss_pred CC-eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 378 ST-HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 378 ~~-~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
.. .+|+||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 258 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 337 (450)
T 1k9a_A 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337 (450)
T ss_dssp TTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence 54 79999999999999999988655557999999999999999999999999999999999999999999999999986
Q ss_pred ccCCC------------Cc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 457 MTSCK------------PQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 457 ~~~~~------------~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
..... |+ ....+|+|++|.+++|+++ |..||.
T Consensus 338 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~ 388 (450)
T 1k9a_A 338 EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 388 (450)
T ss_dssp ECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 43211 11 1234589999999999997 999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-29 Score=249.63 Aligned_cols=174 Identities=20% Similarity=0.296 Sum_probs=151.8
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEe--CCe
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQT--STH 380 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~--~~~ 380 (489)
..++|++++.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+.+++.+. ||||+++++++.. ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 3578999999999999999999999999999999986431 356788999999997 9999999999987 568
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC-cEEEEecCCccccC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG-HVVLTDFDLSFMTS 459 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g-~vKL~DFGlS~~~~ 459 (489)
.++||||+++++|.+++.. +++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|....
T Consensus 108 ~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999999999854 78999999999999999999999999999999999999777 89999999996432
Q ss_pred C--------------CC-------ceeecccccchHHHHHHHHhCCcccC
Q 042772 460 C--------------KP-------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ~--------------~~-------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. +| .....+|+|++|++++++++|..||.
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 232 (330)
T 3nsz_A 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232 (330)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 1 11 12234589999999999999999983
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-29 Score=252.34 Aligned_cols=182 Identities=21% Similarity=0.265 Sum_probs=156.7
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 383 (489)
..++|++++.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++||||+++++++......++
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 4678999999999999999999999999999999986553 234445667889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC---
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC--- 460 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~--- 460 (489)
||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 102 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999998888877654 3489999999999999999999999999999999999999999999999999864321
Q ss_pred ------------CC-------ceeecccccchHHHHHHHHhCCcccC
Q 042772 461 ------------KP-------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ------------~~-------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+| ......|+|++|++++++++|..||.
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFP 226 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCC
Confidence 11 12234589999999999999999985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=245.96 Aligned_cols=181 Identities=29% Similarity=0.453 Sum_probs=157.2
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNR---NKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
++|++.+.||+|+||.||+|.+..+++.||+|.+........ ...+.+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 579999999999999999999999999999999976543221 13567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC----cEEEEecCCcccc
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG----HVVLTDFDLSFMT 458 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g----~vKL~DFGlS~~~ 458 (489)
+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++...
T Consensus 85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999999999999765 3489999999999999999999999999999999999998877 8999999998653
Q ss_pred CCC--------------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 459 SCK--------------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~~~--------------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... | .....+|+|++|.+++++++|..||.
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 212 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 212 (283)
T ss_dssp C--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCC
Confidence 211 1 11234589999999999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-30 Score=260.69 Aligned_cols=186 Identities=41% Similarity=0.670 Sum_probs=157.5
Q ss_pred ccccccCcccccccCCCCceEEEEEEEc---CCCcEEEEEEeeccccc-chHHHHHHHHHHHHHHhC-CCCCcceeeEEE
Q 042772 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQ---GAGELYAMKAMEKSVML-NRNKVHRACIEREIMSLL-DHPFLPTLYASF 375 (489)
Q Consensus 301 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~ 375 (489)
..+..++|++.+.||+|+||.||+|.+. .+++.||+|++++.... .......+..|+.+++.+ .||||+++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 3456678999999999999999999984 57999999999754321 122234566799999999 699999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCc
Q 042772 376 QTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455 (489)
Q Consensus 376 ~~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS 455 (489)
.....+++||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999999999875 34899999999999999999999999999999999999999999999999998
Q ss_pred cccC----------------CCCce--------eecccccchHHHHHHHHhCCcccC
Q 042772 456 FMTS----------------CKPQV--------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 456 ~~~~----------------~~~~~--------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+... .+|+. ....|+|++|++++++++|..||.
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 263 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence 6321 11111 134599999999999999999985
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=255.34 Aligned_cols=182 Identities=20% Similarity=0.260 Sum_probs=151.9
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
...++|++++.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++.....++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 446789999999999999999999999999999999975432 3334566778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe-----cCCcEEEEecCCccc
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQ-----KDGHVVLTDFDLSFM 457 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld-----~~g~vKL~DFGlS~~ 457 (489)
+||||++ |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.
T Consensus 110 lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999996 59999998864 389999999999999999999999999999999999994 455699999999853
Q ss_pred cC---------------CCCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 458 TS---------------CKPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 458 ~~---------------~~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.. .+|+ ....+|+|++|++++++++|..||.
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 239 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239 (329)
T ss_dssp HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 22 1111 2334589999999999999999985
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=256.88 Aligned_cols=175 Identities=26% Similarity=0.413 Sum_probs=149.8
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~l 383 (489)
.++|++.+.||+|+||.||+|.++.+++.||+|++++.... ...|++++.++ +||||+++++++.+...+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 45799999999999999999999999999999999765322 23577788777 79999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC----CcEEEEecCCccccC
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD----GHVVLTDFDLSFMTS 459 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~----g~vKL~DFGlS~~~~ 459 (489)
||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+..+ +.+||+|||++....
T Consensus 94 v~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999999999875 348999999999999999999999999999999999998533 359999999997432
Q ss_pred CC---------------Cce------eecccccchHHHHHHHHhCCcccC
Q 042772 460 CK---------------PQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ~~---------------~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.. |+. ....|+|++|++++++++|..||.
T Consensus 172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 221 (342)
T 2qr7_A 172 AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFA 221 (342)
T ss_dssp CTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCC
Confidence 11 111 123489999999999999999985
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=252.87 Aligned_cols=180 Identities=19% Similarity=0.256 Sum_probs=151.8
Q ss_pred CccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 300 GEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 300 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
...+..++|++.+.||+|+||.||+|.+. ++.||+|++... .........|+.+++.++||||+++++++....
T Consensus 18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91 (322)
T ss_dssp CEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred ccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence 34566788999999999999999999876 789999999654 223344556888899999999999999998743
Q ss_pred ----eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----------CCeecCCCCCCEEEecCC
Q 042772 380 ----HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL----------GIIYRDLKPENILLQKDG 445 (489)
Q Consensus 380 ----~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~----------gIvHrDLKP~NILld~~g 445 (489)
.+++||||+++|+|.+++... .+++..+..++.|++.||.|||++ ||+||||||+|||++.++
T Consensus 92 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 92 SVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred CCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence 479999999999999999874 389999999999999999999999 999999999999999999
Q ss_pred cEEEEecCCccccCC-----------------CCcee-----------ecccccchHHHHHHHHhCCcccC
Q 042772 446 HVVLTDFDLSFMTSC-----------------KPQVF-----------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 446 ~vKL~DFGlS~~~~~-----------------~~~~~-----------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+||+|||+|+.... +|+.. ..+|+|++|++++++++|..||.
T Consensus 169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~ 239 (322)
T 3soc_A 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239 (322)
T ss_dssp CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSS
T ss_pred eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCC
Confidence 999999999954321 12211 12389999999999999998884
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=256.83 Aligned_cols=184 Identities=27% Similarity=0.404 Sum_probs=155.4
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVML--NRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
.++|++.+.||+|+||.||+|.+..+++.||+|++.+.... .......+.+|+.+++.++||||+++++++.+....+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 46799999999999999999999999999999999765322 3445678899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhC--------------------------------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 042772 383 LITDFCPGGELFALLDKQ--------------------------------------PMKIFREDSARFYAAEVVIGLEYL 424 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~--------------------------------------~~~~l~e~~~~~i~~qI~~aL~yL 424 (489)
+||||+++|+|.+++... ....+++..++.++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999998521 011246788889999999999999
Q ss_pred HHCCCeecCCCCCCEEEecCC--cEEEEecCCccccC-------------------CCCce--------eecccccchHH
Q 042772 425 HCLGIIYRDLKPENILLQKDG--HVVLTDFDLSFMTS-------------------CKPQV--------FYHAHVNGFYF 475 (489)
Q Consensus 425 H~~gIvHrDLKP~NILld~~g--~vKL~DFGlS~~~~-------------------~~~~~--------~~~~~v~s~g~ 475 (489)
|++||+||||||+|||++.++ .+||+|||++.... .+|+. ...+|+|++|+
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 999999999999999998776 89999999986421 11221 12458999999
Q ss_pred HHHHHHhCCcccC
Q 042772 476 IMYKWLTGYFTYV 488 (489)
Q Consensus 476 ~a~e~~~G~lpY~ 488 (489)
+++++++|..||.
T Consensus 265 il~el~~g~~pf~ 277 (345)
T 3hko_A 265 LLHLLLMGAVPFP 277 (345)
T ss_dssp HHHHHHHSSCSSC
T ss_pred HHHHHHHCCCCCC
Confidence 9999999999985
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=254.32 Aligned_cols=185 Identities=22% Similarity=0.331 Sum_probs=154.8
Q ss_pred cccccCcccccccCCCCceEEEEEEEc-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQ-----GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASF 375 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~ 375 (489)
.+..++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.+ .||||+++++++
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 456678999999999999999999973 456789999997542 233456788999999999 899999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 042772 376 QTSTHICLITDFCPGGELFALLDKQPM---------------------KIFREDSARFYAAEVVIGLEYLHCLGIIYRDL 434 (489)
Q Consensus 376 ~~~~~~~lVmEy~~ggsL~~~L~~~~~---------------------~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDL 434 (489)
......++||||+++|+|.+++..... ..+++..+..++.||+.||.|||++||+||||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 999999999999999999999987532 23789999999999999999999999999999
Q ss_pred CCCCEEEecCCcEEEEecCCccccCCC-----------------Cc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 435 KPENILLQKDGHVVLTDFDLSFMTSCK-----------------PQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 435 KP~NILld~~g~vKL~DFGlS~~~~~~-----------------~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
||+|||++.++.+||+|||++...... |+ ....+|+|++|++++++++ |..||.
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 999999999999999999999643211 11 1123489999999999997 999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=268.48 Aligned_cols=181 Identities=30% Similarity=0.449 Sum_probs=151.8
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++++.||+|+||+||+|.++.++..||+|++.+.... ......+.+|+.+++.++||||++++++|.....+|+|
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35799999999999999999999999999999999765432 22346678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---CCcEEEEecCCccccCCC
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK---DGHVVLTDFDLSFMTSCK 461 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~---~g~vKL~DFGlS~~~~~~ 461 (489)
||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|......
T Consensus 115 ~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 115 MECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred EecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 9999999999998775 34899999999999999999999999999999999999976 455999999998653311
Q ss_pred --------------Cc-----eeecccccchHHHHHHHHhCCcccC
Q 042772 462 --------------PQ-----VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 --------------~~-----~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+ ....+|+|++|++++++++|..||.
T Consensus 193 ~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~ 238 (494)
T 3lij_A 193 KKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFG 238 (494)
T ss_dssp BCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCC
Confidence 11 1234589999999999999999985
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=246.41 Aligned_cols=184 Identities=23% Similarity=0.298 Sum_probs=149.3
Q ss_pred ccccccCcccccccCCCCceEEEEEEEcCC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe
Q 042772 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGA---GELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT 377 (489)
Q Consensus 301 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 377 (489)
..+..++|++.+.||+|+||.||+|.+..+ +..||+|.+... ........+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 345667899999999999999999998653 567999988653 23445677889999999999999999999884
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccc
Q 042772 378 STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 378 ~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
.+..|+||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 567899999999999999998753 3489999999999999999999999999999999999999999999999999864
Q ss_pred cCC----------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 458 TSC----------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 458 ~~~----------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
... +|+ .....|+|++|++++++++ |..||.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~ 219 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 219 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCC
Confidence 321 111 1123489999999999986 999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.9e-29 Score=245.39 Aligned_cols=182 Identities=27% Similarity=0.357 Sum_probs=157.9
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccc------cchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEe
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVM------LNRNKVHRACIEREIMSLLD-HPFLPTLYASFQT 377 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~------~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~ 377 (489)
.++|++.+.||+|+||.||+|.++.+++.||+|.++.... ........+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 4689999999999999999999999999999999975431 11233567788999999995 9999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccc
Q 042772 378 STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 378 ~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
....++||||+++++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++..
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999999999875 3489999999999999999999999999999999999999999999999999864
Q ss_pred cCC--------------CCc------------eeecccccchHHHHHHHHhCCcccC
Q 042772 458 TSC--------------KPQ------------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 458 ~~~--------------~~~------------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... +|+ ....+|+|++|.+++++++|..||.
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 230 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 230 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCc
Confidence 321 111 1224589999999999999999984
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.1e-30 Score=256.58 Aligned_cols=179 Identities=23% Similarity=0.338 Sum_probs=151.5
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++++.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++......++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 579999999999999999999999999999999865421 111123446999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
||++ |+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp ECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 9996 69999998764 3589999999999999999999999999999999999999999999999999864321
Q ss_pred ----------CC-------ceeecccccchHHHHHHHHhCCcccC
Q 042772 461 ----------KP-------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ----------~~-------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+| .....+|+|++|++++++++|..||.
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 202 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFP 202 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 11 12234589999999999999999985
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=263.34 Aligned_cols=181 Identities=27% Similarity=0.451 Sum_probs=152.3
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeeccccc-----chHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVML-----NRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.+.... .......+.+|+.++++++||||+++++++.. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 35799999999999999999999999999999999865432 12223357789999999999999999998854 4
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC---cEEEEecCCcc
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG---HVVLTDFDLSF 456 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g---~vKL~DFGlS~ 456 (489)
..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred ceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 689999999999999998765 4489999999999999999999999999999999999997544 59999999996
Q ss_pred ccC--------------CCCcee---------ecccccchHHHHHHHHhCCcccC
Q 042772 457 MTS--------------CKPQVF---------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 457 ~~~--------------~~~~~~---------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... .+|+.. ...|+|++|++++++++|..||.
T Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~ 345 (419)
T 3i6u_A 291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345 (419)
T ss_dssp SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 432 223332 24589999999999999999985
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=249.99 Aligned_cols=180 Identities=23% Similarity=0.285 Sum_probs=148.9
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHh-CCCCCcceeeEEEEeCCeEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL-LDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~-l~HpnIv~l~~~~~~~~~~~l 383 (489)
.++|++++.||+|+||+||+|.+..+++.||+|++....... ........|+..+.. ..||||++++++|.....+|+
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccCh-HHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 467999999999999999999999999999999986543332 333444455555544 589999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC---
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC--- 460 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~--- 460 (489)
||||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 135 v~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp EEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred EEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence 99999 779999987753 4589999999999999999999999999999999999999999999999999864321
Q ss_pred -----------CCce-----eecccccchHHHHHHHHhCCccc
Q 042772 461 -----------KPQV-----FYHAHVNGFYFIMYKWLTGYFTY 487 (489)
Q Consensus 461 -----------~~~~-----~~~~~v~s~g~~a~e~~~G~lpY 487 (489)
+|+. ...+|+|++|++++++++|..|+
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~ 255 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELP 255 (311)
T ss_dssp --CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCC
T ss_pred CcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 1221 12348999999999999995543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-29 Score=247.74 Aligned_cols=183 Identities=23% Similarity=0.346 Sum_probs=154.8
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeeccccc-chHHHHHHHHHHHHHHhCCCCCcceeeEEEE--eCCeE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVML-NRNKVHRACIEREIMSLLDHPFLPTLYASFQ--TSTHI 381 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~ 381 (489)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+++.++||||+++++++. .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 36899999999999999999999999999999999765322 1344677889999999999999999999984 45689
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
++||||++++ |.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999765 88888876666799999999999999999999999999999999999999999999999999865321
Q ss_pred ----------------CCce--------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ----------------KPQV--------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ----------------~~~~--------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|.+++++++|..||.
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 214 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 1111 124599999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=257.68 Aligned_cols=179 Identities=25% Similarity=0.391 Sum_probs=150.0
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST----- 379 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----- 379 (489)
.++|++++.||+|+||.||+|.+..+|+.||+|.+.... ......+++.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 467999999999999999999999999999999986543 34455678889999999999999999999997653
Q ss_pred -eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 380 -HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 380 -~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
.+|+||||+ +++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 469999999 88999999873 4899999999999999999999999999999999999999999999999999753
Q ss_pred CC------------CCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 459 SC------------KPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~~------------~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.. +|+ .....|+|++|++++++++|..||.
T Consensus 179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 227 (367)
T 1cm8_A 179 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227 (367)
T ss_dssp CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCC
Confidence 21 122 2234589999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=250.51 Aligned_cols=182 Identities=22% Similarity=0.341 Sum_probs=156.1
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEe----
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQT---- 377 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~---- 377 (489)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 34578999999999999999999999999999999997542 2235677899999998 79999999999987
Q ss_pred --CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCc
Q 042772 378 --STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455 (489)
Q Consensus 378 --~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS 455 (489)
...+++||||+++|+|.+++.......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 468999999999999999998765556899999999999999999999999999999999999999999999999998
Q ss_pred cccCC---------------CCc-----------eeecccccchHHHHHHHHhCCcccC
Q 042772 456 FMTSC---------------KPQ-----------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 456 ~~~~~---------------~~~-----------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
..... +|+ .....|+|++|++++++++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 235 (326)
T 2x7f_A 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235 (326)
T ss_dssp C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 64321 111 1223589999999999999999985
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=253.00 Aligned_cols=182 Identities=25% Similarity=0.338 Sum_probs=148.2
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEE----EEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELY----AMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS 378 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~v----AiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 378 (489)
+..++|++.+.||+|+||.||+|.+..+++.+ |+|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 44578999999999999999999998877755 66666432 2334457788999999999999999999999876
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
. .++|+||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred C-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 4 789999999999999998754 34899999999999999999999999999999999999999999999999998643
Q ss_pred CCC-----------------Cc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 459 SCK-----------------PQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 459 ~~~-----------------~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
... |+ ....+|+|++|++++++++ |..||.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 221 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCcc
Confidence 211 11 1123489999999999998 999985
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=255.07 Aligned_cols=183 Identities=20% Similarity=0.313 Sum_probs=151.9
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcE----EEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGEL----YAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT 377 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~----vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 377 (489)
.+..++|++++.||+|+||.||+|.+..+++. ||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 34567899999999999999999999888876 6666664321 2222345667999999999999999999886
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccc
Q 042772 378 STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 378 ~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
....++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 456999999999999999998652 3588999999999999999999999999999999999999999999999999975
Q ss_pred cCCC-----------------C------ceeecccccchHHHHHHHHh-CCcccC
Q 042772 458 TSCK-----------------P------QVFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 458 ~~~~-----------------~------~~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.... | .....+|+|++|++++++++ |..||.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 219 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA 219 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcc
Confidence 4211 1 11124489999999999999 999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-29 Score=244.17 Aligned_cols=182 Identities=20% Similarity=0.321 Sum_probs=153.3
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~l 383 (489)
.++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.++..+ +||||+++++++......++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3579999999999999999999999999999999976533 233456778899999988 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC-----------------
Q 042772 384 ITDFCPGGELFALLDKQP--MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD----------------- 444 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~--~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~----------------- 444 (489)
||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 999999999999997641 1448999999999999999999999999999999999999844
Q ss_pred --CcEEEEecCCccccCCC-----------Cc-------eeecccccchHHHHHHHHhCCccc
Q 042772 445 --GHVVLTDFDLSFMTSCK-----------PQ-------VFYHAHVNGFYFIMYKWLTGYFTY 487 (489)
Q Consensus 445 --g~vKL~DFGlS~~~~~~-----------~~-------~~~~~~v~s~g~~a~e~~~G~lpY 487 (489)
..+||+|||++...... |+ ....+|+|++|.+++++++|..++
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 231 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231 (289)
T ss_dssp -CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred CceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence 47999999998754321 11 113458899999999998887654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9.4e-29 Score=244.06 Aligned_cols=181 Identities=24% Similarity=0.342 Sum_probs=156.6
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe----CCe
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT----STH 380 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~ 380 (489)
...|++.+.||+|+||.||+|.+..++..||+|.+..... .....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 3468999999999999999999999999999999976543 34557788999999999999999999999875 356
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEe-cCCcEEEEecCCccc
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLG--IIYRDLKPENILLQ-KDGHVVLTDFDLSFM 457 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~g--IvHrDLKP~NILld-~~g~vKL~DFGlS~~ 457 (489)
+++||||+++++|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999999875 34899999999999999999999999 99999999999997 789999999999864
Q ss_pred cCC-------------CCce-----eecccccchHHHHHHHHhCCcccC
Q 042772 458 TSC-------------KPQV-----FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 458 ~~~-------------~~~~-----~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... +|+. ...+|+|++|++++++++|..||.
T Consensus 182 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 230 (290)
T 1t4h_A 182 KRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp CCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccccccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCC
Confidence 321 1111 124489999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=250.90 Aligned_cols=185 Identities=26% Similarity=0.394 Sum_probs=141.4
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
.+..++|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++++......
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh--cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 345678999999999999999999999899999999886542 223456778899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhh------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCc
Q 042772 382 CLITDFCPGGELFALLDK------QPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~------~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS 455 (489)
++||||+++++|.+++.. .....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999999974 12345899999999999999999999999999999999999999999999999988
Q ss_pred cccCC--------------------CCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 456 FMTSC--------------------KPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 456 ~~~~~--------------------~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
..... +|+ ....+|+|++|++++++++|..||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 228 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH 228 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 53321 111 1234589999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=265.02 Aligned_cols=183 Identities=24% Similarity=0.311 Sum_probs=156.5
Q ss_pred CccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 300 GEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 300 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
...+..++|++.+.||+|+||.||+|.+.. +..||+|.++... ...+.+.+|+.+++.++||||+++++++. ..
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 346677889999999999999999999874 6789999997643 23567889999999999999999999886 56
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
.+|+||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 79999999999999999986433347899999999999999999999999999999999999999999999999997532
Q ss_pred C----------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 460 C----------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 460 ~----------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
. +|+ ....+|+|++|++++|+++ |..||.
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~ 387 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP 387 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCC
Confidence 1 111 1124489999999999998 999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=250.53 Aligned_cols=180 Identities=28% Similarity=0.450 Sum_probs=150.5
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeeccccc-----chHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVML-----NRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH 380 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 380 (489)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5799999999999999999999999999999999764321 1223345778999999999999999999987655
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc---EEEEecCCccc
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGH---VVLTDFDLSFM 457 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~---vKL~DFGlS~~ 457 (489)
.|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 89999999999999999765 45899999999999999999999999999999999999987664 99999999865
Q ss_pred cCC--------------CCce---------eecccccchHHHHHHHHhCCcccC
Q 042772 458 TSC--------------KPQV---------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 458 ~~~--------------~~~~---------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... +|+. ....|+|++|++++++++|..||.
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 220 (322)
T 2ycf_A 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220 (322)
T ss_dssp CCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 321 1222 234599999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=251.55 Aligned_cols=186 Identities=25% Similarity=0.324 Sum_probs=144.0
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGE---LYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS 378 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 378 (489)
.+..++|++.+.||+|+||.||+|.+..++. .||+|.+..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 4456789999999999999999999887665 899999976533 334567889999999999999999999999876
Q ss_pred CeE------EEEEecCCCCCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEE
Q 042772 379 THI------CLITDFCPGGELFALLDKQP----MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVV 448 (489)
Q Consensus 379 ~~~------~lVmEy~~ggsL~~~L~~~~----~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vK 448 (489)
... ++||||+++|+|.+++.... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence 654 99999999999999996532 12489999999999999999999999999999999999999999999
Q ss_pred EEecCCccccCC-----------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 449 LTDFDLSFMTSC-----------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 449 L~DFGlS~~~~~-----------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
|+|||+|+.... +|+ ....+|+|++|++++++++ |..||.
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 241 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA 241 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 999999964321 111 1224489999999999999 999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-30 Score=265.78 Aligned_cols=183 Identities=14% Similarity=0.103 Sum_probs=148.7
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHH---HHhCCCCCcceee-------EE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI---MSLLDHPFLPTLY-------AS 374 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~i---l~~l~HpnIv~l~-------~~ 374 (489)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.+.........+.+.+|+.+ ++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4679999999999999999999999999999999986555555667888899954 5555899999998 66
Q ss_pred EEeCC-----------------eEEEEEecCCCCCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 042772 375 FQTST-----------------HICLITDFCPGGELFALLDKQPM-----KIFREDSARFYAAEVVIGLEYLHCLGIIYR 432 (489)
Q Consensus 375 ~~~~~-----------------~~~lVmEy~~ggsL~~~L~~~~~-----~~l~e~~~~~i~~qI~~aL~yLH~~gIvHr 432 (489)
+...+ ..|+||||+ +|+|.+++..... ..+++..+..++.||+.||.|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 65543 389999999 6899999986421 112347788899999999999999999999
Q ss_pred CCCCCCEEEecCCcEEEEecCCccccCC-----------CC-----------------ceeecccccchHHHHHHHHhCC
Q 042772 433 DLKPENILLQKDGHVVLTDFDLSFMTSC-----------KP-----------------QVFYHAHVNGFYFIMYKWLTGY 484 (489)
Q Consensus 433 DLKP~NILld~~g~vKL~DFGlS~~~~~-----------~~-----------------~~~~~~~v~s~g~~a~e~~~G~ 484 (489)
||||+|||++.++.+||+|||+|+.... +| .....+|+|++|++++++++|.
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~ 310 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTCEEECCCCTTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCCcccCCCCcCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCC
Confidence 9999999999999999999999974321 11 1223459999999999999999
Q ss_pred cccC
Q 042772 485 FTYV 488 (489)
Q Consensus 485 lpY~ 488 (489)
.||.
T Consensus 311 ~Pf~ 314 (377)
T 3byv_A 311 LPIT 314 (377)
T ss_dssp CCC-
T ss_pred CCCc
Confidence 9985
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=255.85 Aligned_cols=182 Identities=19% Similarity=0.243 Sum_probs=146.9
Q ss_pred ccCcccccccCCCCceEEEEEEEcCC-----CcEEEEEEeecccccchHHH--------HHHHHHHHHHHhCCCCCccee
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGA-----GELYAMKAMEKSVMLNRNKV--------HRACIEREIMSLLDHPFLPTL 371 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAiK~i~~~~~~~~~~~--------~~~~~E~~il~~l~HpnIv~l 371 (489)
.++|++.+.||+|+||.||+|.+..+ ++.||+|++........... .....|...++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 45899999999999999999998764 58899999876432111111 123345556777889999999
Q ss_pred eEEEEeC----CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe--cCC
Q 042772 372 YASFQTS----THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQ--KDG 445 (489)
Q Consensus 372 ~~~~~~~----~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld--~~g 445 (489)
++++... ...|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 9998764 5689999999 999999998753 4589999999999999999999999999999999999999 889
Q ss_pred cEEEEecCCccccCC----------------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 446 HVVLTDFDLSFMTSC----------------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 446 ~vKL~DFGlS~~~~~----------------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+||+|||+|+.... +|+ ....+|+|++|++++++++|..||.
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 999999999954210 111 1123489999999999999999995
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=9.1e-29 Score=249.85 Aligned_cols=185 Identities=21% Similarity=0.306 Sum_probs=156.3
Q ss_pred cccccCcccccccCCCCceEEEEEEEc-------CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQ-------GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYA 373 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~-------~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~ 373 (489)
.+..++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.+ +||||+++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 345578999999999999999999986 356789999997542 345567888999999999 8999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 042772 374 SFQTSTHICLITDFCPGGELFALLDKQPM--------------KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENI 439 (489)
Q Consensus 374 ~~~~~~~~~lVmEy~~ggsL~~~L~~~~~--------------~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NI 439 (489)
++.....+++||||+++|+|.+++..... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 99999999999999999999999987531 2488999999999999999999999999999999999
Q ss_pred EEecCCcEEEEecCCccccCCC-----------------Cc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 440 LLQKDGHVVLTDFDLSFMTSCK-----------------PQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 440 Lld~~g~vKL~DFGlS~~~~~~-----------------~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
|++.++.+||+|||++...... |+ ....+|+|++|++++++++ |..||.
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 261 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcC
Confidence 9999999999999998643211 11 1123489999999999998 999985
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-29 Score=242.32 Aligned_cols=184 Identities=18% Similarity=0.317 Sum_probs=159.2
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC--C
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS--T 379 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~ 379 (489)
.+..++|++.+.||+|+||.||+|.+. ++.||+|++..... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 456678999999999999999999986 88999999976532 344567788999999999999999999999877 7
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEecCCcEEEEecCCccc
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLG--IIYRDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~g--IvHrDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
..++||||+++|+|.+++.......+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 8999999999999999999876556899999999999999999999999 99999999999999999999998888753
Q ss_pred cCC----------CCcee------e---cccccchHHHHHHHHhCCcccC
Q 042772 458 TSC----------KPQVF------Y---HAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 458 ~~~----------~~~~~------~---~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... +|+.. . .+|+|++|.+++++++|..||.
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 212 (271)
T 3kmu_A 163 FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA 212 (271)
T ss_dssp TSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTT
T ss_pred ecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 321 12211 1 3699999999999999999985
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-29 Score=252.28 Aligned_cols=181 Identities=25% Similarity=0.301 Sum_probs=153.0
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe-------
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT------- 377 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------- 377 (489)
.++|++++.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 4689999999999999999999999999999999865532 22234566789999999999999999999987
Q ss_pred -CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 378 -STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 378 -~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
.+.+|+||||++ ++|.+.+.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.
T Consensus 95 ~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 95 CKGSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp --CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 346899999996 58888887653 348999999999999999999999999999999999999999999999999986
Q ss_pred ccC-------------------CCCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 457 MTS-------------------CKPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 457 ~~~-------------------~~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... .+|+ ....+|+|++|++++++++|..||.
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 230 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 230 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCC
Confidence 432 0111 1234589999999999999999985
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=244.18 Aligned_cols=184 Identities=20% Similarity=0.287 Sum_probs=154.8
Q ss_pred ccccccCccccc-ccCCCCceEEEEEEE--cCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe
Q 042772 301 EKIGLHHFKPIK-PLGCGDTGSVHLVEL--QGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT 377 (489)
Q Consensus 301 ~~i~~~~y~~~~-~LG~G~fG~Vy~a~~--~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 377 (489)
..+..++|++.+ .||+|+||.||+|.+ ..+++.||+|.+.... ......+.+.+|+.+++.++||||+++++++ .
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 345567899998 999999999999955 5667899999997543 2344467888999999999999999999998 5
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccc
Q 042772 378 STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 378 ~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
....++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 667899999999999999998753 489999999999999999999999999999999999999999999999999865
Q ss_pred cCCC------------------Cc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 458 TSCK------------------PQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 458 ~~~~------------------~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.... |+ ....+|+|++|++++++++ |..||.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 222 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 222 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCC
Confidence 4321 11 1124589999999999998 999985
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=245.03 Aligned_cols=178 Identities=23% Similarity=0.348 Sum_probs=157.1
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
..|++++.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++......++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 569999999999999999999999999999999976532 334677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK---- 461 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~---- 461 (489)
||+++++|.+++.. ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++......
T Consensus 100 e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 100 EYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp ECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred EeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 99999999999975 34899999999999999999999999999999999999999999999999998643211
Q ss_pred -----------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 462 -----------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 -----------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
| .....+|+|++|++++++++|..||.
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 220 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS 220 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCC
Confidence 1 11234589999999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-29 Score=246.99 Aligned_cols=179 Identities=30% Similarity=0.482 Sum_probs=154.5
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .....+.+|+.+++.++||||+++++++......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 3579999999999999999999999999999999975432 2235677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE---ecCCcEEEEecCCccccCC-
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILL---QKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILl---d~~g~vKL~DFGlS~~~~~- 460 (489)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 85 MQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp ECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred EEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 9999999999999765 348999999999999999999999999999999999999 7889999999999864321
Q ss_pred ------------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ------------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ------------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ....|+|++|++++++++|..||.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 208 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY 208 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 2222 234589999999999999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.9e-29 Score=241.27 Aligned_cols=181 Identities=26% Similarity=0.382 Sum_probs=156.5
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
.+..++|++.+.||+|+||.||+|.+. +++.||+|.+...... .+.+.+|+.+++.++||||+++++++......
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 455678999999999999999999987 5788999999765322 25678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.....
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999999999998753 3489999999999999999999999999999999999999999999999999864321
Q ss_pred ---------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 461 ---------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 ---------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+ ....+|+|++|.+++++++ |..||.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 207 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 207 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCC
Confidence 111 1124589999999999999 899985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-29 Score=243.70 Aligned_cols=176 Identities=23% Similarity=0.326 Sum_probs=151.9
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe-------
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT------- 377 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------- 377 (489)
..+|++++.||+|+||.||+|.+..+++.||+|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 357999999999999999999999999999999997542 235579999999999999999998864
Q ss_pred ---------CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEE
Q 042772 378 ---------STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVV 448 (489)
Q Consensus 378 ---------~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vK 448 (489)
...+++||||+++++|.+++.......+++..+..++.|++.||.|||++||+|+||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence 44589999999999999999876445689999999999999999999999999999999999999999999
Q ss_pred EEecCCccccCCC--------------Cc------eeecccccchHHHHHHHHhCCccc
Q 042772 449 LTDFDLSFMTSCK--------------PQ------VFYHAHVNGFYFIMYKWLTGYFTY 487 (489)
Q Consensus 449 L~DFGlS~~~~~~--------------~~------~~~~~~v~s~g~~a~e~~~G~lpY 487 (489)
|+|||++...... |+ ....+|+|++|++++++++|..||
T Consensus 163 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 221 (284)
T 2a19_B 163 IGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221 (284)
T ss_dssp ECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred ECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcc
Confidence 9999998654321 11 123458899999999999998876
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-29 Score=251.10 Aligned_cols=184 Identities=22% Similarity=0.345 Sum_probs=155.5
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEE--EEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCC
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELY--AMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTST 379 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~v--AiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~ 379 (489)
+..++|++.+.||+|+||.||+|.+..++..+ |+|.+... ........+.+|+.+++.+ +||||+++++++....
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 45678999999999999999999999888865 99988643 2334456788899999999 8999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC
Q 042772 380 HICLITDFCPGGELFALLDKQP--------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG 445 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~--------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g 445 (489)
.+|+||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999998653 23589999999999999999999999999999999999999999
Q ss_pred cEEEEecCCccccC--------------CCCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 446 HVVLTDFDLSFMTS--------------CKPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 446 ~vKL~DFGlS~~~~--------------~~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.+||+|||++.... .+|+ ....+|+|++|++++++++ |..||.
T Consensus 180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~ 243 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243 (327)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCC
Confidence 99999999986321 1111 1234589999999999997 999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.9e-29 Score=256.01 Aligned_cols=178 Identities=23% Similarity=0.321 Sum_probs=146.8
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe-----
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT----- 377 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----- 377 (489)
...++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ..+|+.+++.++||||++++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 3456899999999999999999999999999999998654221 2259999999999999999999844
Q ss_pred ---------------------------------CCeEEEEEecCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHH
Q 042772 378 ---------------------------------STHICLITDFCPGGELFALLDK--QPMKIFREDSARFYAAEVVIGLE 422 (489)
Q Consensus 378 ---------------------------------~~~~~lVmEy~~ggsL~~~L~~--~~~~~l~e~~~~~i~~qI~~aL~ 422 (489)
...+++||||++ |+|.+.+.. .....+++..+..++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 335899999997 588877764 22355899999999999999999
Q ss_pred HHHHCCCeecCCCCCCEEEe-cCCcEEEEecCCccccCC--------------CCc-------eeecccccchHHHHHHH
Q 042772 423 YLHCLGIIYRDLKPENILLQ-KDGHVVLTDFDLSFMTSC--------------KPQ-------VFYHAHVNGFYFIMYKW 480 (489)
Q Consensus 423 yLH~~gIvHrDLKP~NILld-~~g~vKL~DFGlS~~~~~--------------~~~-------~~~~~~v~s~g~~a~e~ 480 (489)
|||++||+||||||+|||++ .++.+||+|||+|..... +|+ .....|+|++|++++++
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 99999999999999999998 689999999999964321 111 22344899999999999
Q ss_pred HhCCcccC
Q 042772 481 LTGYFTYV 488 (489)
Q Consensus 481 ~~G~lpY~ 488 (489)
++|..||.
T Consensus 236 l~g~~pf~ 243 (383)
T 3eb0_A 236 ILGKPLFS 243 (383)
T ss_dssp HHSSCSSC
T ss_pred HhCCCCCC
Confidence 99999985
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-29 Score=248.88 Aligned_cols=181 Identities=25% Similarity=0.370 Sum_probs=154.0
Q ss_pred ccccCcccccccCCCCceEEEEEEEc----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQ----GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS 378 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~----~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 378 (489)
+....|++++.||+|+||.||++.+. .+++.||+|++... ........+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 33334599999999999999888653 47899999999765 2445567889999999999999999999999874
Q ss_pred --CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 379 --THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 379 --~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
..+++||||+++|+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred CCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 6899999999999999999874 38999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCC------------------c------eeecccccchHHHHHHHHhCCcccC
Q 042772 457 MTSCKP------------------Q------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 457 ~~~~~~------------------~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
...... + ....+|+|++|++++++++|..||.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 238 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ 238 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccc
Confidence 543211 1 1123489999999999999999884
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=253.14 Aligned_cols=179 Identities=22% Similarity=0.359 Sum_probs=152.2
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC----
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST---- 379 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~---- 379 (489)
..++|++++.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 3578999999999999999999999999999999997643 24455677889999999999999999999997654
Q ss_pred --eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccc
Q 042772 380 --HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 380 --~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
.+|+||||++ ++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 102 ~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 102 FQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp CCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 7899999996 589988864 278999999999999999999999999999999999999999999999999864
Q ss_pred cCC--------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 458 TSC--------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 458 ~~~--------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... +|+ ....+|+|++|++++++++|..||.
T Consensus 177 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 227 (371)
T 2xrw_A 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 227 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 321 111 1234599999999999999999985
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=250.09 Aligned_cols=180 Identities=21% Similarity=0.285 Sum_probs=154.0
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC--CCcceeeEEEEeCCe
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDH--PFLPTLYASFQTSTH 380 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~~~~~~~~~ 380 (489)
+...+|++++.||+|+||.||+|.+. +++.||+|.+..... .......+.+|+.+++.+.| |||+++++++.....
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 34567999999999999999999885 589999999976532 44556788899999999976 999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
+|+|||+ .+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+....
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 9999995 588999999886 3489999999999999999999999999999999999997 68899999999964321
Q ss_pred -----------------CCcee-----------------ecccccchHHHHHHHHhCCcccC
Q 042772 461 -----------------KPQVF-----------------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -----------------~~~~~-----------------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+.. ..+|+|++|++++++++|..||.
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 221 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcch
Confidence 12211 23589999999999999999985
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.1e-29 Score=248.85 Aligned_cols=183 Identities=24% Similarity=0.377 Sum_probs=156.8
Q ss_pred cccccCcccccccCCCCceEEEEEEE----cCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEE-
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVEL----QGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQ- 376 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~----~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~- 376 (489)
-+..++|++++.||+|+||.||+|.+ ..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 95 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYG 95 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence 34567899999999999999999994 567899999999754 3455677889999999999999999999886
Q ss_pred -eCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCc
Q 042772 377 -TSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455 (489)
Q Consensus 377 -~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS 455 (489)
....+++||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 96 PGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp SSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred CCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccc
Confidence 4567999999999999999998743 24899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCC------------------c------eeecccccchHHHHHHHHhCCcccC
Q 042772 456 FMTSCKP------------------Q------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 456 ~~~~~~~------------------~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
....... + .....|+|++|++++++++|..||.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 231 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 231 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 7543211 1 1224489999999999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-29 Score=242.73 Aligned_cols=181 Identities=25% Similarity=0.384 Sum_probs=146.8
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccc-hHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN-RNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
+..++|++.+.||+|+||.||+|.+. ++.||+|++....... ....+.+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 45678999999999999999999975 7899999987543222 23356788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCCCCEEEec--------CCcEEEE
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLG---IIYRDLKPENILLQK--------DGHVVLT 450 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~g---IvHrDLKP~NILld~--------~g~vKL~ 450 (489)
++||||+++++|.+++.. ..+++..+..++.|++.||.|||++| |+||||||+|||++. ++.+||+
T Consensus 82 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999999999864 34899999999999999999999999 899999999999986 7789999
Q ss_pred ecCCccccCC-------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 451 DFDLSFMTSC-------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 451 DFGlS~~~~~-------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|||++..... +|+ ....+|+|++|++++++++|..||.
T Consensus 159 Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 215 (271)
T 3dtc_A 159 DFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215 (271)
T ss_dssp CCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTT
T ss_pred cCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999864321 111 1234589999999999999999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=251.16 Aligned_cols=185 Identities=21% Similarity=0.342 Sum_probs=157.8
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCc-----EEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGE-----LYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASF 375 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~-----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~ 375 (489)
.+..++|++.+.||+|+||.||+|.+..+++ .||+|.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4556789999999999999999999987664 79999997542 344567788999999999 899999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhCC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec
Q 042772 376 QTSTHICLITDFCPGGELFALLDKQP------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK 443 (489)
Q Consensus 376 ~~~~~~~lVmEy~~ggsL~~~L~~~~------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~ 443 (489)
.....+++||||+++|+|.+++.... ...+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence 99999999999999999999997531 235799999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCccccCCC-----------------Cc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 444 DGHVVLTDFDLSFMTSCK-----------------PQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 444 ~g~vKL~DFGlS~~~~~~-----------------~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
++.+||+|||++...... |+ ....+|+|++|++++++++ |..||.
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 268 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 268 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCc
Confidence 999999999999743211 11 1123488999999999997 988885
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-28 Score=241.35 Aligned_cols=183 Identities=22% Similarity=0.342 Sum_probs=155.2
Q ss_pred cccccCccccc-ccCCCCceEEEEEEEc--CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 042772 302 KIGLHHFKPIK-PLGCGDTGSVHLVELQ--GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS 378 (489)
Q Consensus 302 ~i~~~~y~~~~-~LG~G~fG~Vy~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 378 (489)
.+..++|.+.+ .||+|+||.||+|.+. .++..||+|.+... ......+.+.+|+.+++.++||||+++++++ ..
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 44567788887 9999999999999864 46889999999764 2445677889999999999999999999998 45
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
...++||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 57999999999999999997543 45899999999999999999999999999999999999999999999999998754
Q ss_pred CCC------------------Cc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 459 SCK------------------PQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 459 ~~~------------------~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
... |+ ....+|+|++|++++++++ |..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 215 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 215 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 311 11 1123588999999999998 999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-29 Score=249.81 Aligned_cols=186 Identities=23% Similarity=0.302 Sum_probs=154.7
Q ss_pred CCccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEE-
Q 042772 299 SGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQ- 376 (489)
Q Consensus 299 ~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~- 376 (489)
....+...+|++.+.||+|+||.||+|.+..+++.||+|.+... .......+.+|+.+++.+. ||||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 97 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence 33455567899999999999999999999999999999998554 3445567888999999995 999999999984
Q ss_pred -------eCCeEEEEEecCCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEecCCc
Q 042772 377 -------TSTHICLITDFCPGGELFALLDKQ-PMKIFREDSARFYAAEVVIGLEYLHCLG--IIYRDLKPENILLQKDGH 446 (489)
Q Consensus 377 -------~~~~~~lVmEy~~ggsL~~~L~~~-~~~~l~e~~~~~i~~qI~~aL~yLH~~g--IvHrDLKP~NILld~~g~ 446 (489)
....++++|||+. |+|.+++... ....+++..+..++.||+.||.|||++| |+||||||+|||++.++.
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC
T ss_pred cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC
Confidence 3446899999995 7999988752 2345899999999999999999999999 999999999999999999
Q ss_pred EEEEecCCccccC---------------------------CCCcee---------ecccccchHHHHHHHHhCCcccC
Q 042772 447 VVLTDFDLSFMTS---------------------------CKPQVF---------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 447 vKL~DFGlS~~~~---------------------------~~~~~~---------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+||+|||++.... .+|+.. ..+|+|++|++++++++|..||.
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 9999999986432 123222 24589999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-29 Score=249.62 Aligned_cols=184 Identities=26% Similarity=0.319 Sum_probs=154.6
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
....++|++.+.||+|+||.||+|.+. +++.||+|.+...... .....+.+|+.+++.++||||+++++++......
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 344578999999999999999999854 5899999999764321 1223578899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 382 CLITDFCPGGELFALLDKQP--MKIFREDSARFYAAEVVIGLEYLHCL---GIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~--~~~l~e~~~~~i~~qI~~aL~yLH~~---gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
++||||+++|+|.+++.... ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++.
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 99999999999999998753 23489999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCC----------------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 457 MTSCK----------------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 457 ~~~~~----------------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
..... |+ ....+|+|++|++++++++|..||.
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp ECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred ccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 54211 11 1123489999999999999999984
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-29 Score=249.78 Aligned_cols=187 Identities=17% Similarity=0.186 Sum_probs=158.2
Q ss_pred CccccccCcccccccCCCCceEEEEEEEc-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEE
Q 042772 300 GEKIGLHHFKPIKPLGCGDTGSVHLVELQ-----GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYAS 374 (489)
Q Consensus 300 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~ 374 (489)
...+..++|++.+.||+|+||.||+|.+. .+++.||+|.+.... .......+.+|+.+++.++||||++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 34556678999999999999999999887 357899999997542 34455678899999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc
Q 042772 375 FQTSTHICLITDFCPGGELFALLDKQP--------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGH 446 (489)
Q Consensus 375 ~~~~~~~~lVmEy~~ggsL~~~L~~~~--------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~ 446 (489)
+......++||||+++|+|.+++.... ...+++..+..++.|++.||.|||++||+||||||+||+++.++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence 999999999999999999999997531 134689999999999999999999999999999999999999999
Q ss_pred EEEEecCCccccCC-----------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 447 VVLTDFDLSFMTSC-----------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 447 vKL~DFGlS~~~~~-----------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+||+|||++..... +|+ ....+|+|++|++++++++ |..||.
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 242 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 242 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccc
Confidence 99999999864321 111 1223589999999999998 888884
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-28 Score=241.90 Aligned_cols=179 Identities=20% Similarity=0.255 Sum_probs=154.3
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 381 (489)
+..++|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+|+.+++.+ .|||++.+++++......
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 345689999999999999999999999999999999865422 23466799999998 799999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc-----EEEEecCCcc
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGH-----VVLTDFDLSF 456 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~-----vKL~DFGlS~ 456 (489)
++||||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+|.
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 9999999 999999998753 34899999999999999999999999999999999999987776 9999999986
Q ss_pred ccCCC----------------------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 457 MTSCK----------------------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 457 ~~~~~----------------------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
..... |+ ....+|+|++|++++++++|..||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 219 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 219 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcc
Confidence 43211 11 1223589999999999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=6.9e-29 Score=245.43 Aligned_cols=182 Identities=25% Similarity=0.387 Sum_probs=150.2
Q ss_pred ccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 042772 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH 380 (489)
Q Consensus 301 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 380 (489)
.++..++|++.+.||+|+||.||+|.+.. .||+|+++... ......+.+.+|+.+++.++||||+++++++ ....
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 35677899999999999999999998654 49999997543 2455667889999999999999999999954 5567
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS- 459 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~- 459 (489)
.++||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred cEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 899999999999999997653 458999999999999999999999999999999999999999999999999986322
Q ss_pred ----------------CCCce---------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ----------------CKPQV---------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----------------~~~~~---------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ....|+|++|++++++++|..||.
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 226 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcc
Confidence 11211 124599999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-28 Score=244.16 Aligned_cols=177 Identities=23% Similarity=0.403 Sum_probs=147.2
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEE--------
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQ-------- 376 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-------- 376 (489)
.++|++++.||+|+||.||+|.+..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 46899999999999999999999999999999998654 4456678889999999999999999999873
Q ss_pred ------eCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe-cCCcEEE
Q 042772 377 ------TSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQ-KDGHVVL 449 (489)
Q Consensus 377 ------~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld-~~g~vKL 449 (489)
.....|+||||++ |+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 3468999999996 699999975 3489999999999999999999999999999999999998 5679999
Q ss_pred EecCCccccCC------------------CCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 450 TDFDLSFMTSC------------------KPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 450 ~DFGlS~~~~~------------------~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|||++..... +|+ ....+|+|++|++++++++|..||.
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 226 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA 226 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCC
Confidence 99999874321 111 1223489999999999999999985
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=249.38 Aligned_cols=185 Identities=22% Similarity=0.262 Sum_probs=154.2
Q ss_pred ccccccCcccccccCCCCceEEEEEEEcCCC----cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 042772 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAG----ELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQ 376 (489)
Q Consensus 301 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 376 (489)
.++...+|++.+.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 3566678999999999999999999987653 469999997542 3445567889999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 377 TSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 377 ~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
.....++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 9999999999999999999998753 358999999999999999999999999999999999999999999999999986
Q ss_pred ccCCC------------------Cc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 457 MTSCK------------------PQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 457 ~~~~~------------------~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
..... |+ ....+|+|++|++++++++ |..||.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~ 252 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 252 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcc
Confidence 53211 11 1123589999999999998 999984
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-28 Score=241.14 Aligned_cols=183 Identities=23% Similarity=0.259 Sum_probs=155.3
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
....+|.....||+|+||.||+|.+..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++......+
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER---DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC---CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC---chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence 4455677777999999999999999999999999999754 2334567888999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-CCcEEEEecCCccccCC
Q 042772 383 LITDFCPGGELFALLDKQP-MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK-DGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~-~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~-~g~vKL~DFGlS~~~~~ 460 (489)
+||||+++++|.+++.... ...+++..+..++.|++.||.|||++||+|+||||+||+++. ++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999999999998753 234678999999999999999999999999999999999997 89999999999864321
Q ss_pred ---------------CCc--------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------------KPQ--------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------------~~~--------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ .....|+|++|++++++++|..||.
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (295)
T 2clq_A 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 111 1234589999999999999999984
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-29 Score=246.61 Aligned_cols=180 Identities=24% Similarity=0.401 Sum_probs=154.4
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++++.||+|+||.||+|.+..+++.||+|.+... .......+..|+.+++.++||||+++++++......++|
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC---CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 46799999999999999999999999999999998654 233456788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc------
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT------ 458 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~------ 458 (489)
|||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus 95 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173 (302)
T ss_dssp EECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC
T ss_pred EEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccc
Confidence 99999999999987643 34899999999999999999999999999999999999999999999999986321
Q ss_pred ---------CCCCce-----------eecccccchHHHHHHHHhCCcccC
Q 042772 459 ---------SCKPQV-----------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ---------~~~~~~-----------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
..+|+. ...+|+|++|.+++++++|..||.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 223 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 223 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCc
Confidence 012222 124699999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.9e-29 Score=242.30 Aligned_cols=183 Identities=19% Similarity=0.375 Sum_probs=156.6
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe--CCeEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT--STHIC 382 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ 382 (489)
.++|++.+.||+|+||.||+|.++.+++.||+|.+..... .....+.+..|+.+++.++||||+++++++.. ...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 4689999999999999999999999999999999976543 34456788899999999999999999998854 56899
Q ss_pred EEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeecCCCCCCEEEecCCcEEEEecCCc
Q 042772 383 LITDFCPGGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEYLHCLG-----IIYRDLKPENILLQKDGHVVLTDFDLS 455 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH~~g-----IvHrDLKP~NILld~~g~vKL~DFGlS 455 (489)
+||||+++++|.+++... ....+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999999763 2234899999999999999999999999 999999999999999999999999998
Q ss_pred cccCC---------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 456 FMTSC---------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 456 ~~~~~---------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
..... +|+ ....+|+|++|.+++++++|..||.
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 217 (279)
T 2w5a_A 164 RILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 217 (279)
T ss_dssp HHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence 64321 111 1234589999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-29 Score=243.51 Aligned_cols=185 Identities=23% Similarity=0.309 Sum_probs=147.5
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
++..++|++++.||+|+||.||+|.+..+++.||+|.+..... .......+..+..+++.++||||+++++++......
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 3456789999999999999999999999999999999975432 223333444455557888999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 382 CLITDFCPGGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEYLHCL-GIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH~~-gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
++||||++ |+|.+++... ....+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999996 5988877641 234589999999999999999999998 9999999999999999999999999998532
Q ss_pred C--------------CCCce----------eecccccchHHHHHHHHhCCcccC
Q 042772 459 S--------------CKPQV----------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~--------------~~~~~----------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. .+|+. ....|+|++|++++++++|..||.
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 214 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSC
T ss_pred cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 2 11222 124589999999999999999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=241.69 Aligned_cols=183 Identities=23% Similarity=0.293 Sum_probs=153.8
Q ss_pred cccccCcccccccCCCCceEEEEEEEcC---CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQG---AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS 378 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~---tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 378 (489)
.+..++|++.+.||+|+||.||+|.+.. ++..||+|.+.+.. .....+.+.+|+.+++.++||||+++++++...
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 4556789999999999999999999764 34579999987642 344567888999999999999999999988654
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
..++||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred -CCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 5789999999999999997753 34899999999999999999999999999999999999999999999999998643
Q ss_pred CCC----------------Cc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 459 SCK----------------PQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 459 ~~~----------------~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
... |+ ....+|+|++|.+++++++ |..||.
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~ 216 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFF 216 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcc
Confidence 211 11 1123489999999999998 999984
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-29 Score=252.62 Aligned_cols=185 Identities=21% Similarity=0.319 Sum_probs=159.2
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchH--------------HHHHHHHHHHHHHhCCCCC
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRN--------------KVHRACIEREIMSLLDHPF 367 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~--------------~~~~~~~E~~il~~l~Hpn 367 (489)
....++|++.+.||+|+||.||+|.+ +++.||+|.+......... ....+.+|+.+++.++|||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 34567899999999999999999998 7999999999765432211 1267889999999999999
Q ss_pred cceeeEEEEeCCeEEEEEecCCCCCHHHH------HhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEE
Q 042772 368 LPTLYASFQTSTHICLITDFCPGGELFAL------LDKQPMKIFREDSARFYAAEVVIGLEYLHC-LGIIYRDLKPENIL 440 (489)
Q Consensus 368 Iv~l~~~~~~~~~~~lVmEy~~ggsL~~~------L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~-~gIvHrDLKP~NIL 440 (489)
|+++++++......++||||+++|+|.++ +.......+++..+..++.|++.||.|||+ +||+||||||+||+
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999999999999999999999999998 665445669999999999999999999999 99999999999999
Q ss_pred EecCCcEEEEecCCccccCC-------------CCc-------eee-cccccchHHHHHHHHhCCcccC
Q 042772 441 LQKDGHVVLTDFDLSFMTSC-------------KPQ-------VFY-HAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 441 ld~~g~vKL~DFGlS~~~~~-------------~~~-------~~~-~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
++.++.+||+|||++..... +|+ ... .+|+|++|++++++++|..||.
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 253 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999865321 122 112 5699999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-28 Score=244.13 Aligned_cols=179 Identities=26% Similarity=0.397 Sum_probs=151.2
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 383 (489)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+.+|+.+++.++||||+++++++......|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 3467999999999999999999999999999999997542 23567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC--
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK-- 461 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~-- 461 (489)
||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus 102 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp EEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred EeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 999999999999997432 44899999999999999999999999999999999999999999999999998643211
Q ss_pred -------------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 462 -------------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 -------------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+ ....+|+|++|++++++++|..||.
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 226 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA 226 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 11 1234589999999999999999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-28 Score=250.61 Aligned_cols=177 Identities=19% Similarity=0.307 Sum_probs=153.9
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC-----Ce
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS-----TH 380 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~ 380 (489)
.+|++++.||+|+||.||+|.+..+++.||+|.+... ........+.+|+.+++.++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 5799999999999999999999999999999999753 2345567888999999999999999999998765 36
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS- 459 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~- 459 (489)
.|+||||+. |+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 999999996 6999999874 38999999999999999999999999999999999999999999999999986432
Q ss_pred -----------------CCCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 -----------------CKPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 -----------------~~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+ .....|+|++|++++++++|..||.
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 233 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 233 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCC
Confidence 1111 1223489999999999999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=253.06 Aligned_cols=179 Identities=23% Similarity=0.328 Sum_probs=153.0
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC--------CCCcceeeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD--------HPFLPTLYASFQ 376 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~--------HpnIv~l~~~~~ 376 (489)
.++|++.+.||+|+||+||+|.+..+++.||+|++... ......+.+|+.+++.+. ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 46899999999999999999999999999999999643 344567788999998885 788999999987
Q ss_pred ----eCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEecCC------
Q 042772 377 ----TSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL-GIIYRDLKPENILLQKDG------ 445 (489)
Q Consensus 377 ----~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~-gIvHrDLKP~NILld~~g------ 445 (489)
....+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhh
Confidence 456899999999 77888888776555699999999999999999999999 999999999999998775
Q ss_pred -------------------------------------------cEEEEecCCccccCC------------CCc------e
Q 042772 446 -------------------------------------------HVVLTDFDLSFMTSC------------KPQ------V 464 (489)
Q Consensus 446 -------------------------------------------~vKL~DFGlS~~~~~------------~~~------~ 464 (489)
.+||+|||+|+.... +|+ .
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~ 270 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGY 270 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCC
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCC
Confidence 799999999864321 111 2
Q ss_pred eecccccchHHHHHHHHhCCcccC
Q 042772 465 FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 465 ~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
...+|+|++|++++++++|..||.
T Consensus 271 ~~~~DiwslG~il~elltg~~pf~ 294 (397)
T 1wak_A 271 NTPADIWSTACMAFELATGDYLFE 294 (397)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CcHHHHHHHHHHHHHHhhCCCCCC
Confidence 234599999999999999999995
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=245.60 Aligned_cols=184 Identities=23% Similarity=0.322 Sum_probs=155.3
Q ss_pred ccccCcccccccCCCCceEEEEEEEc-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQ-----GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQ 376 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~ 376 (489)
+..++|++.+.||+|+||.||+|.+. .+++.||+|.+.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 44578999999999999999999863 467899999997542 344556788999999999 6999999999987
Q ss_pred eCC-eEEEEEecCCCCCHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 042772 377 TST-HICLITDFCPGGELFALLDKQPM--------------KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILL 441 (489)
Q Consensus 377 ~~~-~~~lVmEy~~ggsL~~~L~~~~~--------------~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILl 441 (489)
..+ .+++||||+++|+|.+++..... ..+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 754 59999999999999999987542 127899999999999999999999999999999999999
Q ss_pred ecCCcEEEEecCCccccCCCC-----------------c------eeecccccchHHHHHHHHh-CCcccC
Q 042772 442 QKDGHVVLTDFDLSFMTSCKP-----------------Q------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 442 d~~g~vKL~DFGlS~~~~~~~-----------------~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+.++.+||+|||++......+ + ....+|+|++|++++++++ |..||.
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 999999999999997543211 1 1123488999999999997 999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-29 Score=249.61 Aligned_cols=182 Identities=25% Similarity=0.371 Sum_probs=156.0
Q ss_pred cCcccc-cccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEE
Q 042772 306 HHFKPI-KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 306 ~~y~~~-~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~l 383 (489)
++|.+. +.||+|+||.||+|.++.+++.||+|++.+... .......+.+|+.+++.+. ||||+++++++......++
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 457777 899999999999999999999999999976543 2233567888999999984 7999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---CCcEEEEecCCccccCC
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK---DGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~---~g~vKL~DFGlS~~~~~ 460 (489)
||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 999999999999997665566999999999999999999999999999999999999987 78999999999965431
Q ss_pred C--------------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 461 K--------------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ~--------------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. | ......|+|++|++++++++|..||.
T Consensus 187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (327)
T 3lm5_A 187 ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV 234 (327)
T ss_dssp -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1 1 11234589999999999999999985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-28 Score=242.25 Aligned_cols=169 Identities=27% Similarity=0.338 Sum_probs=141.9
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHh--CCCCCcceeeEEEEeC---
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL--LDHPFLPTLYASFQTS--- 378 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~~~~~~~--- 378 (489)
..++|++.+.||+|+||.||+|.+ +++.||+|++... ....+..|.+++.. ++||||+++++++...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~ 77 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHS 77 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence 356899999999999999999987 5899999998643 22445567777776 7899999999986543
Q ss_pred -CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeecCCCCCCEEEecCCcEEE
Q 042772 379 -THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH--------CLGIIYRDLKPENILLQKDGHVVL 449 (489)
Q Consensus 379 -~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH--------~~gIvHrDLKP~NILld~~g~vKL 449 (489)
..+++||||+++|+|.+++.. ..+++..+..++.|++.||.||| ++||+||||||+|||++.++.+||
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 468999999999999999965 34899999999999999999999 999999999999999999999999
Q ss_pred EecCCccccCC-------------------CCcee------------ecccccchHHHHHHHHhC
Q 042772 450 TDFDLSFMTSC-------------------KPQVF------------YHAHVNGFYFIMYKWLTG 483 (489)
Q Consensus 450 ~DFGlS~~~~~-------------------~~~~~------------~~~~v~s~g~~a~e~~~G 483 (489)
+|||+|+.... +|+.. ..+|+|++|++++++++|
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg 219 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence 99999853211 12111 245899999999999999
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=257.96 Aligned_cols=181 Identities=15% Similarity=0.214 Sum_probs=138.3
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC--CCCCcceee-------EEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL--DHPFLPTLY-------ASFQ 376 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l--~HpnIv~l~-------~~~~ 376 (489)
..|++.+.||+|+||.||+|.+..+++.||+|++.............+..|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4599999999999999999999999999999999886554556667788886555544 699988755 4443
Q ss_pred eC-----------------CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHH------HHHHHHHHHHHHHHHHCCCeecC
Q 042772 377 TS-----------------THICLITDFCPGGELFALLDKQPMKIFREDSA------RFYAAEVVIGLEYLHCLGIIYRD 433 (489)
Q Consensus 377 ~~-----------------~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~------~~i~~qI~~aL~yLH~~gIvHrD 433 (489)
.. ..+|+||||++ |+|.+++..... .+++... ..++.||+.||.|||++||+|||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 32 34899999997 899999986421 2344444 56779999999999999999999
Q ss_pred CCCCCEEEecCCcEEEEecCCccccCC------------CCc--------eeecccccchHHHHHHHHhCCcccC
Q 042772 434 LKPENILLQKDGHVVLTDFDLSFMTSC------------KPQ--------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 434 LKP~NILld~~g~vKL~DFGlS~~~~~------------~~~--------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|||+|||++.+|.+||+|||+|+.... +|+ ....+|+|++|++++++++|..||.
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999864331 111 1234589999999999999999985
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-29 Score=252.86 Aligned_cols=182 Identities=23% Similarity=0.319 Sum_probs=148.7
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccc--hHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN--RNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+....... ......+.+|+.+++.++||||+++++++......+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 467999999999999999999999999999999997543221 112346778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC--
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC-- 460 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~-- 460 (489)
+||||+++ +|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 89 lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 99999965 8999887653 3588999999999999999999999999999999999999999999999999864321
Q ss_pred -------------CCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 -------------KPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -------------~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++|..||.
T Consensus 167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~ 214 (346)
T 1ua2_A 167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 214 (346)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 111 1224489999999999999998874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=8.8e-29 Score=242.64 Aligned_cols=183 Identities=23% Similarity=0.330 Sum_probs=154.3
Q ss_pred CccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 300 GEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 300 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
...+..++|++++.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++. .+
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 80 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVT-QE 80 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEc-CC
Confidence 34566678999999999999999999976 467899999875432 2456788999999999999999999876 45
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
..++||||+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 68999999999999999976432358999999999999999999999999999999999999999999999999987543
Q ss_pred CC----------------Cc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 460 CK----------------PQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 460 ~~----------------~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.. |+ ....+|+|++|++++++++ |..||.
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 212 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCc
Confidence 11 11 1123489999999999998 999984
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=244.85 Aligned_cols=186 Identities=22% Similarity=0.383 Sum_probs=151.3
Q ss_pred hcCCCccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEE
Q 042772 296 ITGSGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASF 375 (489)
Q Consensus 296 ~~~~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 375 (489)
....+..+..++|++.+.||+|+||.||+|.+. |+.||+|.++... ..+.+.+|+.+++.++||||+++++++
T Consensus 11 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (278)
T 1byg_A 11 FYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVI 83 (278)
T ss_dssp ----CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEE
T ss_pred hhhccccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 334455677789999999999999999999875 7899999986432 346788899999999999999999987
Q ss_pred EeC-CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCC
Q 042772 376 QTS-THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDL 454 (489)
Q Consensus 376 ~~~-~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGl 454 (489)
... ...++||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~ 163 (278)
T 1byg_A 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 163 (278)
T ss_dssp CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccc
Confidence 554 4799999999999999999875433478999999999999999999999999999999999999999999999999
Q ss_pred ccccCC------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 455 SFMTSC------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 455 S~~~~~------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+..... +|+ ....+|+|++|.+++++++ |..||.
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 216 (278)
T 1byg_A 164 TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 216 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred cccccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCC
Confidence 864331 111 1234589999999999997 999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=9.7e-29 Score=254.48 Aligned_cols=179 Identities=24% Similarity=0.386 Sum_probs=141.7
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC------
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS------ 378 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------ 378 (489)
.++|++++.||+|+||.||+|.+..+|+.||+|.+.... ........+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 368999999999999999999999999999999986543 2445567888999999999999999999998654
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
..+|++||++ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred CeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 5689999999 7899998876 34899999999999999999999999999999999999999999999999999643
Q ss_pred CC------------CCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 459 SC------------KPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~~------------~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.. +|+ .....|+|++|++++++++|..||.
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 231 (367)
T 2fst_X 183 ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 231 (367)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 21 111 2234599999999999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-28 Score=253.81 Aligned_cols=179 Identities=21% Similarity=0.286 Sum_probs=153.3
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC--CCCcceeeEEEEeCCeE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD--HPFLPTLYASFQTSTHI 381 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~~ 381 (489)
...+|++++.||+|+||.||+|.+.. ++.||+|.+..... .......+.+|+.+++.+. ||||+++++++.....+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 34569999999999999999999875 89999999976543 4456678899999999996 59999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
|+||| +.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+....
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred EEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 99999 55889999998864 489999999999999999999999999999999999995 68999999999964321
Q ss_pred ----------------CCce-----------------eecccccchHHHHHHHHhCCcccC
Q 042772 461 ----------------KPQV-----------------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ----------------~~~~-----------------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|++++++++|..||.
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~ 268 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcch
Confidence 1221 123589999999999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=248.86 Aligned_cols=182 Identities=25% Similarity=0.335 Sum_probs=150.4
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEE----EEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELY----AMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS 378 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~v----AiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 378 (489)
+..++|++++.||+|+||.||+|.+..+++.+ |+|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 44578999999999999999999998888765 55555332 2333457788999999999999999999999876
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
. .++||+|+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred C-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 5 889999999999999998754 34899999999999999999999999999999999999999999999999999653
Q ss_pred CC-----------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 459 SC-----------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 459 ~~-----------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.. +|+ .....|+|++|++++++++ |..||.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 221 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCC
Confidence 21 111 1124489999999999998 999985
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-28 Score=245.46 Aligned_cols=183 Identities=25% Similarity=0.370 Sum_probs=155.7
Q ss_pred cccccCcccccccCCCCceEEEEEEE----cCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVEL----QGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT 377 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~----~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 377 (489)
.+...+|++++.||+|+||.||+|.+ ..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++..
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 34557899999999999999999994 567999999998754 34556788899999999999999999998865
Q ss_pred CC--eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCc
Q 042772 378 ST--HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455 (489)
Q Consensus 378 ~~--~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS 455 (489)
.. .+++||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 43 7899999999999999998764 34899999999999999999999999999999999999999999999999999
Q ss_pred cccCCC------------------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 456 FMTSCK------------------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 456 ~~~~~~------------------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
...... |+ ....+|+|++|++++++++|..||.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 249 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 249 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 754321 11 1123588999999999999988874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-28 Score=269.22 Aligned_cols=181 Identities=23% Similarity=0.348 Sum_probs=151.9
Q ss_pred cccCccccc-ccCCCCceEEEEEEEc--CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 042772 304 GLHHFKPIK-PLGCGDTGSVHLVELQ--GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH 380 (489)
Q Consensus 304 ~~~~y~~~~-~LG~G~fG~Vy~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 380 (489)
..+++.+.+ .||+|+||.||+|.++ .++..||+|+++... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 409 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence 344555555 7999999999999886 356789999997642 33456788899999999999999999999876 56
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
+++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred eEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999999997653 4589999999999999999999999999999999999999999999999999975421
Q ss_pred C------------------Cc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 461 K------------------PQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 ~------------------~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
. |+ ....+|+|++|++++|+++ |..||.
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~ 541 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 541 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 1 11 1123489999999999997 999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-28 Score=242.96 Aligned_cols=186 Identities=24% Similarity=0.250 Sum_probs=150.4
Q ss_pred cccccCcccccccCCCCceEEEEEEEcC---CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQG---AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS 378 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~---tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 378 (489)
.+..++|.+.+.||+|+||.||+|.+.. +++.||+|.++.... .......+.+|+.+++.++||||+++++++...
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 4556789999999999999999998765 566899999875432 345567788999999999999999999998765
Q ss_pred C-----eEEEEEecCCCCCHHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEE
Q 042772 379 T-----HICLITDFCPGGELFALLDKQ----PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVL 449 (489)
Q Consensus 379 ~-----~~~lVmEy~~ggsL~~~L~~~----~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL 449 (489)
. ..++||||+++|+|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence 4 459999999999999998532 2345899999999999999999999999999999999999999999999
Q ss_pred EecCCccccCCC-----------------Cc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 450 TDFDLSFMTSCK-----------------PQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 450 ~DFGlS~~~~~~-----------------~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|||++...... |+ ....+|+|++|++++++++ |..||.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 251 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYP 251 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCc
Confidence 999998643211 11 1123489999999999999 888885
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=9.9e-29 Score=261.13 Aligned_cols=182 Identities=24% Similarity=0.338 Sum_probs=154.2
Q ss_pred ccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 042772 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH 380 (489)
Q Consensus 301 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 380 (489)
..+..++|++.+.||+|+||.||+|.+.. +..||+|.++.... ..+.+.+|+.+++.++||||+++++++.. ..
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence 45667789999999999999999999886 46799999976432 23568889999999999999999998866 67
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
+++||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 89999999999999999764334589999999999999999999999999999999999999999999999999975421
Q ss_pred ----------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 461 ----------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 ----------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++ |..||.
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~ 383 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 383 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCC
Confidence 111 1123589999999999998 999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-28 Score=241.55 Aligned_cols=178 Identities=19% Similarity=0.215 Sum_probs=149.6
Q ss_pred CcccccccCCCCceEEEEEEEcCCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE-E
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGE---LYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI-C 382 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~-~ 382 (489)
.|+..+.||+|+||.||+|.+..++. .||+|.+... ......+.+.+|+.+++.++||||+++++++...... +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 57777999999999999999866554 7999998653 3455677888999999999999999999999876554 9
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC--
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC-- 460 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~-- 460 (489)
+||||+.+|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 100 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 9999999999999998743 4589999999999999999999999999999999999999999999999999963321
Q ss_pred -----------------CC------ceeecccccchHHHHHHHHhCCccc
Q 042772 461 -----------------KP------QVFYHAHVNGFYFIMYKWLTGYFTY 487 (489)
Q Consensus 461 -----------------~~------~~~~~~~v~s~g~~a~e~~~G~lpY 487 (489)
+| .....+|+|++|++++++++|..|+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 01 1123458999999999999965553
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-28 Score=240.23 Aligned_cols=148 Identities=26% Similarity=0.456 Sum_probs=133.3
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe--------
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT-------- 377 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-------- 377 (489)
++|++++.||+|+||.||+|.+..+++.||+|.+... ......+.+|+.+++.++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 5799999999999999999999999999999999643 3456778899999999999999999998865
Q ss_pred -----CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEec
Q 042772 378 -----STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDF 452 (489)
Q Consensus 378 -----~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DF 452 (489)
....|+||||+++|+|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 457899999999999999998653 34788999999999999999999999999999999999999999999999
Q ss_pred CCcccc
Q 042772 453 DLSFMT 458 (489)
Q Consensus 453 GlS~~~ 458 (489)
|++...
T Consensus 161 g~~~~~ 166 (303)
T 1zy4_A 161 GLAKNV 166 (303)
T ss_dssp CCCSCT
T ss_pred cchhhc
Confidence 998643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.6e-29 Score=249.05 Aligned_cols=185 Identities=18% Similarity=0.234 Sum_probs=151.6
Q ss_pred cccccCcccccccCCCCceEEEEEE-----EcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVE-----LQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQ 376 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~-----~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 376 (489)
.+..++|++.+.||+|+||.||+|. ...+++.||+|.+... ........+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 3556789999999999999999999 4567889999999643 23445567889999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---CCcEE
Q 042772 377 TSTHICLITDFCPGGELFALLDKQPM-----KIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK---DGHVV 448 (489)
Q Consensus 377 ~~~~~~lVmEy~~ggsL~~~L~~~~~-----~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~---~g~vK 448 (489)
.....|+||||+++++|.+++..... ..+++..+..++.|++.||.|||++||+||||||+|||++. +..+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999999999987532 34889999999999999999999999999999999999984 44699
Q ss_pred EEecCCccccC-----------------CCCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 449 LTDFDLSFMTS-----------------CKPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 449 L~DFGlS~~~~-----------------~~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
|+|||++.... .+|+ ....+|+|++|.+++++++ |..||.
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 247 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 247 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 99999985321 1111 1234589999999999997 999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-28 Score=246.33 Aligned_cols=178 Identities=20% Similarity=0.303 Sum_probs=153.7
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC-----C
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS-----T 379 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~ 379 (489)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+... ........+.+|+.+++.++||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 36899999999999999999999999999999999643 2344566788999999999999999999987654 6
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
..++||||+. ++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 7999999996 6999999873 48999999999999999999999999999999999999999999999999986432
Q ss_pred C-------------------------CCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 C-------------------------KPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ~-------------------------~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. +|+ ....+|+|++|++++++++|..||.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 224 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP 224 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCC
Confidence 1 111 1223588999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.7e-28 Score=254.37 Aligned_cols=179 Identities=25% Similarity=0.340 Sum_probs=154.4
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC------CCCCcceeeEEEEeC
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL------DHPFLPTLYASFQTS 378 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~l~~~~~~~ 378 (489)
..+|++++.||+|+||.||+|.+..+++.||+|++... ......+..|+.+++.+ .||||+++++++...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 46799999999999999999999999999999999653 23345666788887776 578999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc--EEEEecCCcc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGH--VVLTDFDLSF 456 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~--vKL~DFGlS~ 456 (489)
..+|+||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999999995 69999998876666999999999999999999999999999999999999999887 9999999986
Q ss_pred ccCCC------------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 457 MTSCK------------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 457 ~~~~~------------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
..... |+ .....|+|++|++++++++|..||.
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~ 300 (429)
T 3kvw_A 251 YEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300 (429)
T ss_dssp ETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence 43311 11 1234589999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=241.34 Aligned_cols=185 Identities=26% Similarity=0.358 Sum_probs=147.9
Q ss_pred cccccCcccccccCCCCceEEEEEEEcC-CC--cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQG-AG--ELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS 378 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~-tg--~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 378 (489)
.+..++|++.+.||+|+||.||+|.+.. ++ ..||+|.++..........+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 4456789999999999999999998753 33 36899999766544556678899999999999999999999998776
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
. .++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++...
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred C-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 5 899999999999999998643 34899999999999999999999999999999999999999999999999998654
Q ss_pred CCC------------------Cc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 459 SCK------------------PQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 459 ~~~------------------~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
... |+ .....|+|++|++++++++ |..||.
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 226 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 226 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 321 11 1124589999999999998 999985
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-28 Score=240.57 Aligned_cols=182 Identities=19% Similarity=0.213 Sum_probs=150.2
Q ss_pred cccCcccccccCCCCceEEEEEEEcCC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEE-EeCC
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGA---GELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASF-QTST 379 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~~~ 379 (489)
...+|++.+.||+|+||.||+|.+..+ ...+|+|.+... ........+.+|+.+++.++||||+++++++ ....
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 345799999999999999999997543 346899988653 3455667889999999999999999999985 4556
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+|....
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred ceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence 8899999999999999997643 447999999999999999999999999999999999999999999999999996432
Q ss_pred C-------------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 460 C-------------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 460 ~-------------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
. +|+ ....+|+|++|++++++++ |..||.
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 234 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 234 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCc
Confidence 1 111 1123489999999999999 555553
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.4e-28 Score=240.30 Aligned_cols=179 Identities=21% Similarity=0.216 Sum_probs=152.5
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccc-cchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVM-LNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
|...+.||+|+||.||+|.+ +++.||+|.+..... ......+.+.+|+.+++.++||||+++++++......++|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 55568999999999999986 478999999875432 233456778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC----
Q 042772 387 FCPGGELFALLDKQ-PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK---- 461 (489)
Q Consensus 387 y~~ggsL~~~L~~~-~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~---- 461 (489)
|+++++|.+++... ....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 99999999999753 2345899999999999999999999999999999999999999999999999998643211
Q ss_pred -------------Cc-----eeecccccchHHHHHHHHhCCcccC
Q 042772 462 -------------PQ-----VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 -------------~~-----~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+ ....+|+|++|++++++++|..||.
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 235 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVD 235 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcc
Confidence 11 1234589999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.7e-28 Score=242.52 Aligned_cols=181 Identities=20% Similarity=0.319 Sum_probs=154.6
Q ss_pred ccccCcccccccCCCCceEEEEEEE-cCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC------CcceeeEEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVEL-QGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP------FLPTLYASF 375 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~-~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hp------nIv~l~~~~ 375 (489)
...++|++.+.||+|+||.||+|.+ ..+++.||+|++... ......+.+|+.+++.+.|+ +++++++++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 3446899999999999999999998 567899999998643 33456778899998887655 599999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec------------
Q 042772 376 QTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK------------ 443 (489)
Q Consensus 376 ~~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~------------ 443 (489)
.....+++||||+ +++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence 9999999999999 899999998876556899999999999999999999999999999999999987
Q ss_pred -------CCcEEEEecCCccccCCC------------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 444 -------DGHVVLTDFDLSFMTSCK------------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 444 -------~g~vKL~DFGlS~~~~~~------------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
++.+||+|||++...... | .....+|+|++|++++++++|..||.
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 678999999998743311 1 11234589999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-29 Score=253.67 Aligned_cols=174 Identities=18% Similarity=0.248 Sum_probs=147.9
Q ss_pred cCcccccccCCCCceEEEEEEEcCC--------CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcce-------
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGA--------GELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPT------- 370 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~t--------g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~------- 370 (489)
++|++.+.||+|+||.||+|.+..+ ++.||+|.+... ..+.+|+.+++.++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 6899999999999999999999874 889999998754 34667999999999999887
Q ss_pred --------eeEEEEe-CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 042772 371 --------LYASFQT-STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILL 441 (489)
Q Consensus 371 --------l~~~~~~-~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILl 441 (489)
+++++.. ....|+||||+ +++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 6677766 67899999999 9999999998644569999999999999999999999999999999999999
Q ss_pred ecCC--cEEEEecCCccccCC----------------------CC------ceeecccccchHHHHHHHHhCCcccC
Q 042772 442 QKDG--HVVLTDFDLSFMTSC----------------------KP------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 442 d~~g--~vKL~DFGlS~~~~~----------------------~~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+.++ .+||+|||+++.... +| .....+|+|++|++++++++|..||.
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9998 999999999954321 11 11234589999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-28 Score=238.74 Aligned_cols=181 Identities=28% Similarity=0.393 Sum_probs=156.9
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++++.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++......++|
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 35799999999999999999999999999999999765432 33456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC---CcEEEEecCCccccCCC
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD---GHVVLTDFDLSFMTSCK 461 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~---g~vKL~DFGlS~~~~~~ 461 (489)
|||+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++......
T Consensus 100 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 99999999999987653 48999999999999999999999999999999999999754 47999999998754321
Q ss_pred C-------------------ceeecccccchHHHHHHHHhCCcccC
Q 042772 462 P-------------------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ~-------------------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. .....+|+|++|++++++++|..||.
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 223 (287)
T 2wei_A 178 TKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFY 223 (287)
T ss_dssp SSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCC
Confidence 1 11234599999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-28 Score=242.86 Aligned_cols=183 Identities=21% Similarity=0.320 Sum_probs=151.6
Q ss_pred cccCcccccccCCCCceEEEEEEEc-CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCCcceeeEEEE---
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQ-GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL---DHPFLPTLYASFQ--- 376 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l---~HpnIv~l~~~~~--- 376 (489)
..++|++++.||+|+||.||+|.+. .+++.||+|.+...... ......+.+|+.+++.+ .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3468999999999999999999995 67899999999754321 11122345577776655 8999999999987
Q ss_pred --eCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCC
Q 042772 377 --TSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDL 454 (489)
Q Consensus 377 --~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGl 454 (489)
.....++||||++ |+|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 4567999999996 6999999887656689999999999999999999999999999999999999999999999999
Q ss_pred ccccCC--------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 455 SFMTSC--------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 455 S~~~~~--------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+..... +|+ ....+|+|++|++++++++|..||.
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 220 (326)
T 1blx_A 167 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 220 (326)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCC
Confidence 864321 111 1234589999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-28 Score=249.16 Aligned_cols=178 Identities=23% Similarity=0.367 Sum_probs=152.3
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE---
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI--- 381 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~--- 381 (489)
.++|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ........+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 368999999999999999999999999999999997643 2445567888999999999999999999999877654
Q ss_pred ---EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 382 ---CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 382 ---~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
|+||||+. ++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred eeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999996 689888743 3899999999999999999999999999999999999999999999999998643
Q ss_pred CC------------CC-------ceeecccccchHHHHHHHHhCCcccC
Q 042772 459 SC------------KP-------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~~------------~~-------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.. +| .....+|+|++|++++++++|..||.
T Consensus 195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 243 (371)
T 4exu_A 195 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 243 (371)
T ss_dssp -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 21 11 12234589999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=264.23 Aligned_cols=182 Identities=24% Similarity=0.338 Sum_probs=155.7
Q ss_pred ccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 042772 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH 380 (489)
Q Consensus 301 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 380 (489)
..+..++|++.+.||+|+||.||+|.+.. +..||+|+++.... ..+.+.+|+.+|+.++||||+++++++.. ..
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~ 335 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 335 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred eecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence 45667889999999999999999999886 46799999976432 23568889999999999999999998866 67
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
+|+||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 89999999999999999764334589999999999999999999999999999999999999999999999999975421
Q ss_pred ----------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 461 ----------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 ----------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+ ....+|+|++|++++|+++ |..||.
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~ 466 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 466 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSST
T ss_pred CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 111 1124589999999999998 999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-28 Score=246.95 Aligned_cols=181 Identities=19% Similarity=0.200 Sum_probs=146.0
Q ss_pred ccCcccccccCCCCceEEEEEEEcC---CCcEEEEEEeecccccchH--------HHHHHHHHHHHHHhCCCCCcceeeE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQG---AGELYAMKAMEKSVMLNRN--------KVHRACIEREIMSLLDHPFLPTLYA 373 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~---tg~~vAiK~i~~~~~~~~~--------~~~~~~~E~~il~~l~HpnIv~l~~ 373 (489)
.++|++.+.||+|+||.||+|.+.. ++..+|+|.+......... ....+..|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4689999999999999999999987 7889999998764321111 1123557888899999999999999
Q ss_pred EEEe----CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC--cE
Q 042772 374 SFQT----STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG--HV 447 (489)
Q Consensus 374 ~~~~----~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g--~v 447 (489)
++.. ....|+||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 9988 67899999999 999999998754 589999999999999999999999999999999999999887 99
Q ss_pred EEEecCCccccC-----------------C-----CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 448 VLTDFDLSFMTS-----------------C-----KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 448 KL~DFGlS~~~~-----------------~-----~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
||+|||+|+... . +|+ ....+|+|++|++++++++|..||.
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 261 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE 261 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 999999995431 0 111 1234589999999999999999993
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-28 Score=266.87 Aligned_cols=173 Identities=21% Similarity=0.334 Sum_probs=147.8
Q ss_pred cccCCCCceEEEEEEE--cCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCC
Q 042772 312 KPLGCGDTGSVHLVEL--QGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCP 389 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~--~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ 389 (489)
+.||+|+||.||+|.+ +.+++.||+|+++... ......+.+.+|+.+++.++||||+++++++.. ...++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 4799999999999965 4567899999997653 234456788999999999999999999999865 45899999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC--------
Q 042772 390 GGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK-------- 461 (489)
Q Consensus 390 ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~-------- 461 (489)
+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 453 ~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 453 LGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp TEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 99999999875 34899999999999999999999999999999999999999999999999998644211
Q ss_pred ----------Cc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 462 ----------PQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 462 ----------~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
|+ ....+|+|++|++++|+++ |..||.
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~ 574 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 574 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 11 1124489999999999997 999995
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=235.24 Aligned_cols=176 Identities=19% Similarity=0.265 Sum_probs=145.8
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEE-EeCCeEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASF-QTSTHICLI 384 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~~~~~~lV 384 (489)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+..|..+++.+.|++++..+..+ ......++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 579999999999999999999999999999998765422 23467799999999887766655544 677889999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE---ecCCcEEEEecCCccccCCC
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILL---QKDGHVVLTDFDLSFMTSCK 461 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILl---d~~g~vKL~DFGlS~~~~~~ 461 (489)
|||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 84 ~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 9999 999999998643 348999999999999999999999999999999999999 78999999999999643211
Q ss_pred ----------------------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 462 ----------------------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ----------------------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
| .....+|+|++|++++++++|..||.
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 216 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 216 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCc
Confidence 0 11124499999999999999999995
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-28 Score=245.89 Aligned_cols=178 Identities=23% Similarity=0.365 Sum_probs=152.5
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe----
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH---- 380 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~---- 380 (489)
.++|.+.+.||+|+||.||+|.++.+|+.||+|.+.... ........+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 367999999999999999999999999999999997543 244456778899999999999999999999987653
Q ss_pred --EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 381 --ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 381 --~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
.|+||||+. ++|.+++.. .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred eeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 599999996 688887743 3899999999999999999999999999999999999999999999999998643
Q ss_pred CC------------CCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 459 SC------------KPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~~------------~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.. +|+ ....+|+|++|++++++++|..||.
T Consensus 177 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 225 (353)
T 3coi_A 177 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSB
T ss_pred CCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 21 111 2234599999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9e-28 Score=244.70 Aligned_cols=181 Identities=19% Similarity=0.297 Sum_probs=150.2
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccc--------cchHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVM--------LNRNKVHRACIEREIMSLLDHPFLPTLYASFQ 376 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~--------~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 376 (489)
.++|++.+.||+|+||.||+|.+.. |+.||+|.+..... ......+.+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 4679999999999999999999865 89999999865322 12334578899999999999999999999985
Q ss_pred e-----CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEe
Q 042772 377 T-----STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTD 451 (489)
Q Consensus 377 ~-----~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~D 451 (489)
. ...+|+||||++ |+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 4 346899999996 69999887653 4589999999999999999999999999999999999999999999999
Q ss_pred cCCccccC--------------CCCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 452 FDLSFMTS--------------CKPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 452 FGlS~~~~--------------~~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
||++.... .+|+ ....+|+|++|++++++++|..||.
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 235 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235 (362)
T ss_dssp TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence 99986322 1121 2233589999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-28 Score=253.10 Aligned_cols=176 Identities=25% Similarity=0.336 Sum_probs=144.7
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC------
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS------ 378 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------ 378 (489)
..+|++.+.||+|+||.||+|.+..+|+.||+|.+..... ...+|+++++.++||||++++++|...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 3479999999999999999999999999999999865421 123599999999999999999988542
Q ss_pred CeEEEEEecCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC-CcEEEEecCCc
Q 042772 379 THICLITDFCPGGELFALLDK--QPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD-GHVVLTDFDLS 455 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~--~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~-g~vKL~DFGlS 455 (489)
.++++||||+++ +|.+.+.. .....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 247899999965 77776653 123458999999999999999999999999999999999999955 67899999999
Q ss_pred cccCC--------------CCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 456 FMTSC--------------KPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 456 ~~~~~--------------~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+.... +|+ +....|+|++|++++||++|..||.
T Consensus 205 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~ 258 (420)
T 1j1b_A 205 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 258 (420)
T ss_dssp EECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred hhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 74321 111 2234499999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=239.37 Aligned_cols=184 Identities=22% Similarity=0.353 Sum_probs=151.2
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHH-HHHhCCCCCcceeeEEEEeCCe
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE-IMSLLDHPFLPTLYASFQTSTH 380 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~ 380 (489)
.+..++|++++.||+|+||.||+|.++.+|+.||+|.+.... .......+..|.. +++.++||||+++++++...+.
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 455678999999999999999999999999999999997642 2333445555665 6777899999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 381 ICLITDFCPGGELFALLDK---QPMKIFREDSARFYAAEVVIGLEYLHCL-GIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~---~~~~~l~e~~~~~i~~qI~~aL~yLH~~-gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
.++||||+++ +|.+++.. .....+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 9999999964 88888763 2235589999999999999999999998 99999999999999999999999999986
Q ss_pred ccC--------------CCCcee----------ecccccchHHHHHHHHhCCcccC
Q 042772 457 MTS--------------CKPQVF----------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 457 ~~~--------------~~~~~~----------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... .+|+.. ..+|+|++|++++++++|..||.
T Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (327)
T 3aln_A 175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP 230 (327)
T ss_dssp C------------------------------CCSHHHHHHHHHHHHHHHHSCCCSS
T ss_pred ecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 432 123322 24589999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=245.51 Aligned_cols=184 Identities=22% Similarity=0.315 Sum_probs=147.5
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhC----CCCCcceeeEEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNR---NKVHRACIEREIMSLL----DHPFLPTLYASF 375 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~---~~~~~~~~E~~il~~l----~HpnIv~l~~~~ 375 (489)
...++|++.+.||+|+||.||+|.+..+++.||+|.+........ .....+..|+.++..+ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 335689999999999999999999999999999999976533221 1223455688888888 899999999999
Q ss_pred EeCCeEEEEEec-CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe-cCCcEEEEecC
Q 042772 376 QTSTHICLITDF-CPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQ-KDGHVVLTDFD 453 (489)
Q Consensus 376 ~~~~~~~lVmEy-~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld-~~g~vKL~DFG 453 (489)
......++|||+ +.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 999999999999 7899999999875 3489999999999999999999999999999999999999 88999999999
Q ss_pred CccccCCC-------------Cce-------eecccccchHHHHHHHHhCCcccC
Q 042772 454 LSFMTSCK-------------PQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 454 lS~~~~~~-------------~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
++...... |+. ...+|+|++|++++++++|..||.
T Consensus 186 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 240 (312)
T 2iwi_A 186 SGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240 (312)
T ss_dssp SCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred hhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCC
Confidence 98754321 111 124689999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=244.47 Aligned_cols=176 Identities=24% Similarity=0.352 Sum_probs=143.4
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHH--HhCCCCCcceeeEEEEe--
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIM--SLLDHPFLPTLYASFQT-- 377 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il--~~l~HpnIv~l~~~~~~-- 377 (489)
.+..++|++.+.||+|+||.||+|.+ +++.||+|++.... ...+..|.+++ ..++||||+++++.+..
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVT 80 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccc
Confidence 45668899999999999999999976 58999999996542 23334455554 45899999999986543
Q ss_pred ---CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeecCCCCCCEEEecCC
Q 042772 378 ---STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL---------GIIYRDLKPENILLQKDG 445 (489)
Q Consensus 378 ---~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~---------gIvHrDLKP~NILld~~g 445 (489)
...+++||||+++|+|.+++.... .++..+..++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred cCCCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC
Confidence 236899999999999999998753 58899999999999999999999 999999999999999999
Q ss_pred cEEEEecCCccccCC-----------------------CCcee-------------ecccccchHHHHHHHHhCCcccC
Q 042772 446 HVVLTDFDLSFMTSC-----------------------KPQVF-------------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 446 ~vKL~DFGlS~~~~~-----------------------~~~~~-------------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+||+|||+|..... +|+.. ..+|+|++|++++++++|..||-
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 999999999964321 12221 13489999999999999987763
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=240.66 Aligned_cols=180 Identities=20% Similarity=0.305 Sum_probs=153.5
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCC-cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC------cceeeEEEE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAG-ELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF------LPTLYASFQ 376 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg-~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hpn------Iv~l~~~~~ 376 (489)
..++|++.+.||+|+||.||+|.+..++ +.||+|++... ......+..|+.+++.+.|++ ++.+++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 3468999999999999999999998777 79999999643 234566778999998887655 899999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE---------------
Q 042772 377 TSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILL--------------- 441 (489)
Q Consensus 377 ~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILl--------------- 441 (489)
.....|+||||+ +++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence 999999999999 7788888887665669999999999999999999999999999999999999
Q ss_pred ----ecCCcEEEEecCCccccCCC------------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 442 ----QKDGHVVLTDFDLSFMTSCK------------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 442 ----d~~g~vKL~DFGlS~~~~~~------------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+.++.+||+|||++...... | .....+|+|++|++++++++|..||.
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 67889999999999643211 1 11234589999999999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=239.98 Aligned_cols=169 Identities=27% Similarity=0.359 Sum_probs=141.9
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC--CCCCcceeeEEEEeC----
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL--DHPFLPTLYASFQTS---- 378 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l--~HpnIv~l~~~~~~~---- 378 (489)
.++|++.+.||+|+||.||+|.+. ++.||+|++.... ......|.+++..+ +||||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 357999999999999999999876 8999999986431 23344566666554 899999999999887
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeecCCCCCCEEEecCCcEEEE
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL--------GIIYRDLKPENILLQKDGHVVLT 450 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~--------gIvHrDLKP~NILld~~g~vKL~ 450 (489)
..+++||||+++|+|.+++... .+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 7899999999999999999874 489999999999999999999998 99999999999999999999999
Q ss_pred ecCCccccCC-------------------CCcee------e------cccccchHHHHHHHHhCC
Q 042772 451 DFDLSFMTSC-------------------KPQVF------Y------HAHVNGFYFIMYKWLTGY 484 (489)
Q Consensus 451 DFGlS~~~~~-------------------~~~~~------~------~~~v~s~g~~a~e~~~G~ 484 (489)
|||+|..... +|+.. . .+|+|++|++++++++|.
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~ 249 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRC 249 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTB
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhcc
Confidence 9999853211 11111 1 169999999999999993
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=233.84 Aligned_cols=177 Identities=19% Similarity=0.256 Sum_probs=148.6
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEE-EeCCeEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASF-QTSTHICL 383 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~~~~~~l 383 (489)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+..|+.+++.+.|++++..+..+ ......++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 36799999999999999999999999999999998654321 3467899999999988766555544 66778999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE---ecCCcEEEEecCCccccCC
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILL---QKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILl---d~~g~vKL~DFGlS~~~~~ 460 (489)
||||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 83 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99999 999999998543 358999999999999999999999999999999999999 4889999999999864322
Q ss_pred C----------------------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 461 K----------------------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ~----------------------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. | .....+|+|++|++++++++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 216 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 216 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 1 1 11124499999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-28 Score=243.64 Aligned_cols=184 Identities=22% Similarity=0.259 Sum_probs=155.7
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCC--CCCcceeeEEEEe
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNR---NKVHRACIEREIMSLLD--HPFLPTLYASFQT 377 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~---~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~ 377 (489)
...++|++.+.||+|+||.||+|.+..+++.||+|.+........ .....+..|+.+++.+. ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 345689999999999999999999999999999999976543221 12234567899999986 5999999999999
Q ss_pred CCeEEEEEecCCC-CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe-cCCcEEEEecCCc
Q 042772 378 STHICLITDFCPG-GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQ-KDGHVVLTDFDLS 455 (489)
Q Consensus 378 ~~~~~lVmEy~~g-gsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld-~~g~vKL~DFGlS 455 (489)
....++|||++.+ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 9999999999976 8999999875 3489999999999999999999999999999999999999 7899999999998
Q ss_pred cccCCC-------------Cce-------eecccccchHHHHHHHHhCCcccC
Q 042772 456 FMTSCK-------------PQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 456 ~~~~~~-------------~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
...... |+. ....|+|++|++++++++|..||.
T Consensus 198 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 250 (320)
T 3a99_A 198 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250 (320)
T ss_dssp EECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCC
Confidence 654321 111 123499999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-28 Score=245.94 Aligned_cols=182 Identities=20% Similarity=0.305 Sum_probs=153.6
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-----------CCCcce
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-----------HPFLPT 370 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----------HpnIv~ 370 (489)
.+..++|++.+.||+|+||.||+|.+..+++.||+|++... ......+..|+.+++.+. ||||++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 44567899999999999999999999999999999999743 233456778888888775 899999
Q ss_pred eeEEEEeCC----eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEecC-
Q 042772 371 LYASFQTST----HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL-GIIYRDLKPENILLQKD- 444 (489)
Q Consensus 371 l~~~~~~~~----~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~-gIvHrDLKP~NILld~~- 444 (489)
+++++.... .++++|||+ +++|.+++.......+++..+..++.||+.||.|||++ ||+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 999998654 799999999 89999999886556689999999999999999999998 99999999999999543
Q ss_pred -----CcEEEEecCCccccCC------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 445 -----GHVVLTDFDLSFMTSC------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 445 -----g~vKL~DFGlS~~~~~------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+.+||+|||+|..... +|+ ....+|+|++|++++++++|..||.
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 236 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CCcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 4899999999864331 111 1234599999999999999999995
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=6.4e-28 Score=249.02 Aligned_cols=180 Identities=18% Similarity=0.210 Sum_probs=145.6
Q ss_pred cCcccccccCCCCceEEEEEEEcCCC---cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEE-eCCeE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAG---ELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQ-TSTHI 381 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg---~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~~ 381 (489)
..|++.+.||+|+||.||+|.+..++ ..||+|.++.. ........+.+|+.+++.++||||+++++++. ..+..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 35888999999999999999976432 46899988643 34456778899999999999999999999865 45688
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999999997653 3478999999999999999999999999999999999999999999999999964321
Q ss_pred ------------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 461 ------------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 ------------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++ |..||.
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~ 298 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 298 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCC
Confidence 111 1123489999999999999 777774
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=238.90 Aligned_cols=177 Identities=23% Similarity=0.401 Sum_probs=147.4
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
+..++|++.+.||+|+||.||+|.+. ++.||+|.+... ...+.+.+|+.+++.++||||+++++++.+ ..+
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 45678999999999999999999875 788999998532 345678889999999999999999998764 479
Q ss_pred EEEecCCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCCCCEEEecCCc-EEEEecCCccc
Q 042772 383 LITDFCPGGELFALLDKQPM-KIFREDSARFYAAEVVIGLEYLHC---LGIIYRDLKPENILLQKDGH-VVLTDFDLSFM 457 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~-~~l~e~~~~~i~~qI~~aL~yLH~---~gIvHrDLKP~NILld~~g~-vKL~DFGlS~~ 457 (489)
+||||+++|+|.+++..... ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 99999999999999986532 237889999999999999999999 89999999999999998886 79999999864
Q ss_pred cCC------------CC------ceeecccccchHHHHHHHHhCCcccC
Q 042772 458 TSC------------KP------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 458 ~~~------------~~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... +| .....+|+|++|.+++++++|..||.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 204 (307)
T 2eva_A 156 IQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 204 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTT
T ss_pred cccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCch
Confidence 321 11 12234599999999999999999985
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-29 Score=254.70 Aligned_cols=151 Identities=19% Similarity=0.173 Sum_probs=126.6
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeeccccc-----chHHHHHHHHHHHHHHhCC---------CCCcc
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVML-----NRNKVHRACIEREIMSLLD---------HPFLP 369 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~---------HpnIv 369 (489)
..++|++.+.||+|+||+||+|.+ +|+.||+|.+...... .....+.+.+|+.+++.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 346899999999999999999998 5899999999865321 2233467888999988875 77777
Q ss_pred eeeEEEE-----------------e-------------CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHH
Q 042772 370 TLYASFQ-----------------T-------------STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVI 419 (489)
Q Consensus 370 ~l~~~~~-----------------~-------------~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~ 419 (489)
++.+.+. + ...+|+||||+++|++.+.+.+ ..+++..++.++.||+.
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTA 172 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHH
Confidence 7766542 2 6789999999999987777754 34899999999999999
Q ss_pred HHHHHH-HCCCeecCCCCCCEEEecCC--------------------cEEEEecCCccccC
Q 042772 420 GLEYLH-CLGIIYRDLKPENILLQKDG--------------------HVVLTDFDLSFMTS 459 (489)
Q Consensus 420 aL~yLH-~~gIvHrDLKP~NILld~~g--------------------~vKL~DFGlS~~~~ 459 (489)
||.||| ++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~ 233 (336)
T 2vuw_A 173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER 233 (336)
T ss_dssp HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE
T ss_pred HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC
Confidence 999999 99999999999999999987 99999999997543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=242.61 Aligned_cols=180 Identities=19% Similarity=0.278 Sum_probs=137.5
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC----
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST---- 379 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~---- 379 (489)
..++|++.+.||+|+||.||+|.+..+++.||+|.+...... ......++..+..++||||++++++|....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 456899999999999999999999999999999998654322 234556777888899999999999987643
Q ss_pred ---eEEEEEecCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCCCCEEEec-CCcEEEEe
Q 042772 380 ---HICLITDFCPGGELFALLDK--QPMKIFREDSARFYAAEVVIGLEYLH--CLGIIYRDLKPENILLQK-DGHVVLTD 451 (489)
Q Consensus 380 ---~~~lVmEy~~ggsL~~~L~~--~~~~~l~e~~~~~i~~qI~~aL~yLH--~~gIvHrDLKP~NILld~-~g~vKL~D 451 (489)
.+++||||+++ +|...+.. .....+++..+..++.|++.||.||| ++||+||||||+|||++. ++.+||+|
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence 38999999975 66555442 23345899999999999999999999 999999999999999996 89999999
Q ss_pred cCCccccCC--------------CCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 452 FDLSFMTSC--------------KPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 452 FGlS~~~~~--------------~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
||+|..... +|+ ....+|+|++|++++++++|..||.
T Consensus 176 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 233 (360)
T 3e3p_A 176 FGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR 233 (360)
T ss_dssp CTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcC
Confidence 999964321 111 2234589999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=241.35 Aligned_cols=177 Identities=24% Similarity=0.368 Sum_probs=143.9
Q ss_pred ccCccccc-ccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe----CC
Q 042772 305 LHHFKPIK-PLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT----ST 379 (489)
Q Consensus 305 ~~~y~~~~-~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~ 379 (489)
.++|++.+ .||+|+||.||+|.++.+++.||+|++.... .... .....++.+.||||+++++++.. ..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQ---EVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 46799965 6999999999999999999999999986531 1111 22334667799999999999876 45
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---CCcEEEEecCCcc
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK---DGHVVLTDFDLSF 456 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~---~g~vKL~DFGlS~ 456 (489)
.+++||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 6899999999999999999876567999999999999999999999999999999999999976 4569999999996
Q ss_pred ccCC-------------CCcee------ecccccchHHHHHHHHhCCcccC
Q 042772 457 MTSC-------------KPQVF------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 457 ~~~~-------------~~~~~------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.... +|+.. ..+|+|++|++++++++|..||.
T Consensus 180 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (336)
T 3fhr_A 180 ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFY 230 (336)
T ss_dssp EC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred eccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 4331 12222 23489999999999999999984
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=248.24 Aligned_cols=177 Identities=22% Similarity=0.336 Sum_probs=139.0
Q ss_pred cCccc-ccccCCCCceEEEEEEEc--CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe--CCe
Q 042772 306 HHFKP-IKPLGCGDTGSVHLVELQ--GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT--STH 380 (489)
Q Consensus 306 ~~y~~-~~~LG~G~fG~Vy~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~ 380 (489)
+.|++ .+.||+|+||.||+|.++ .+++.||+|.+..... ...+.+|+.+++.++||||+++++++.. ...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 34666 457999999999999976 5688999999975422 2356789999999999999999999954 678
Q ss_pred EEEEEecCCCCCHHHHHhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE----ecCCcEEE
Q 042772 381 ICLITDFCPGGELFALLDKQ-------PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILL----QKDGHVVL 449 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~-------~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILl----d~~g~vKL 449 (489)
+|+||||+. |+|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999999995 6898888632 12248999999999999999999999999999999999999 67789999
Q ss_pred EecCCccccCC------------------CCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 450 TDFDLSFMTSC------------------KPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 450 ~DFGlS~~~~~------------------~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|||+|+.... +|+ .....|+|++|++++++++|..||.
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 237 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCC
Confidence 99999964321 111 2234589999999999999999984
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=247.87 Aligned_cols=176 Identities=22% Similarity=0.350 Sum_probs=142.2
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC----
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST---- 379 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~---- 379 (489)
...+|++.+.||+|+||.||+|.+..+++ +|+|.+...... ..+|+.+++.++||||++++++|....
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 34679999999999999999999987666 788877543211 125999999999999999999986543
Q ss_pred --eEEEEEecCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe-cCCcEEEEecCC
Q 042772 380 --HICLITDFCPGGELFALLDK--QPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQ-KDGHVVLTDFDL 454 (489)
Q Consensus 380 --~~~lVmEy~~ggsL~~~L~~--~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld-~~g~vKL~DFGl 454 (489)
.+++||||+++ ++...+.. .....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 110 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 110 EVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp CEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 38999999976 55444432 1234589999999999999999999999999999999999999 799999999999
Q ss_pred ccccCC--------------CC-------ceeecccccchHHHHHHHHhCCcccC
Q 042772 455 SFMTSC--------------KP-------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 455 S~~~~~--------------~~-------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+.... +| ......|+|++|++++++++|..||.
T Consensus 189 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 243 (394)
T 4e7w_A 189 AKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP 243 (394)
T ss_dssp CEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 964321 11 12234589999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=236.88 Aligned_cols=186 Identities=23% Similarity=0.332 Sum_probs=145.0
Q ss_pred CccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 300 GEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 300 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
......++|++++.||+|+||.||+|.++.+|+.||+|.+..... .......+..+..+++.++||||+++++++....
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 344567889999999999999999999999999999999976532 2223334444555688889999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL-GIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~-gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
.+++||||+ ++.+..+.... ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++...
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred cEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 999999999 55666655542 24589999999999999999999995 9999999999999999999999999998543
Q ss_pred C--------------CCCce-----------eecccccchHHHHHHHHhCCcccC
Q 042772 459 S--------------CKPQV-----------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~--------------~~~~~-----------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. .+|+. ....|+|++|++++++++|..||.
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (318)
T 2dyl_A 176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCC
Confidence 2 11222 124599999999999999999985
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-27 Score=238.72 Aligned_cols=167 Identities=24% Similarity=0.344 Sum_probs=144.4
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHh--CCCCCcceeeEEEEeCC----
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL--LDHPFLPTLYASFQTST---- 379 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~~~~~~~~---- 379 (489)
++|++.+.||+|+||.||+|.+. ++.||+|.+... ....+..|.+++.. ++||||+++++++....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 57999999999999999999984 899999998643 23456778888887 78999999999998775
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeecCCCCCCEEEecCCcEEEEe
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH--------CLGIIYRDLKPENILLQKDGHVVLTD 451 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH--------~~gIvHrDLKP~NILld~~g~vKL~D 451 (489)
..++||||+++|+|.+++... .+++..+..++.|++.||.||| ++||+||||||+|||++.++.+||+|
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred eeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 899999999999999999874 3899999999999999999999 89999999999999999999999999
Q ss_pred cCCccccCC-------------------CCcee------------ecccccchHHHHHHHHhC
Q 042772 452 FDLSFMTSC-------------------KPQVF------------YHAHVNGFYFIMYKWLTG 483 (489)
Q Consensus 452 FGlS~~~~~-------------------~~~~~------------~~~~v~s~g~~a~e~~~G 483 (489)
||++..... +|+.. ..+|+|++|++++++++|
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 999854321 11111 246999999999999999
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-28 Score=243.03 Aligned_cols=184 Identities=23% Similarity=0.372 Sum_probs=152.1
Q ss_pred CCccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 042772 299 SGEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS 378 (489)
Q Consensus 299 ~~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 378 (489)
....+..++|++.+.||+|+||.||+|.+.. .+|+|.++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 3445667899999999999999999999865 499999875432 222334566799999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
..+++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred CceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 99999999999999999997753 3589999999999999999999999999999999999998 689999999987532
Q ss_pred C--------------------CCCc---------------eeecccccchHHHHHHHHhCCcccC
Q 042772 459 S--------------------CKPQ---------------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~--------------------~~~~---------------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. .+|+ ....+|+|++|++++++++|..||.
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 244 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSS
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1 1111 1234599999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.7e-27 Score=249.73 Aligned_cols=177 Identities=18% Similarity=0.268 Sum_probs=149.9
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CCcceeeEEEEeCCeEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDH-PFLPTLYASFQTSTHICL 383 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~l 383 (489)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+..|+.+++.+.| ++|+.+..++......++
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 46899999999999999999999999999999988654322 246679999999986 566677777778889999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE---ecCCcEEEEecCCccccCC
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILL---QKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILl---d~~g~vKL~DFGlS~~~~~ 460 (489)
||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++....
T Consensus 81 vme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99999 999999998643 348999999999999999999999999999999999999 6889999999999964332
Q ss_pred CC----------------------------ceeecccccchHHHHHHHHhCCcccC
Q 042772 461 KP----------------------------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ~~----------------------------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.. ......|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~ 214 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence 11 01123489999999999999999995
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.7e-27 Score=234.66 Aligned_cols=182 Identities=21% Similarity=0.289 Sum_probs=154.2
Q ss_pred ccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC--CCCcceeeEEEEeC
Q 042772 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD--HPFLPTLYASFQTS 378 (489)
Q Consensus 301 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~ 378 (489)
..+..++|++++.||+|+||.||+|.+.. ++.||+|.+..... .......+.+|+.+++.+. ||||+++++++...
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 34555789999999999999999999864 88999999976432 3456678889999999997 59999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
...++||| +.+++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 176 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-
T ss_pred CEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccc
Confidence 99999999 55889999998763 489999999999999999999999999999999999996 589999999998643
Q ss_pred CC-----------------CCc-----------------eeecccccchHHHHHHHHhCCcccC
Q 042772 459 SC-----------------KPQ-----------------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~~-----------------~~~-----------------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.. +|+ ....+|+|++|++++++++|..||.
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchh
Confidence 21 111 1224589999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-27 Score=242.32 Aligned_cols=180 Identities=24% Similarity=0.342 Sum_probs=153.2
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CC-----CcceeeEEEEe
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HP-----FLPTLYASFQT 377 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-Hp-----nIv~l~~~~~~ 377 (489)
..++|++.+.||+|+||+||+|.+..+++.||+|++... ......+..|+.+++.+. |+ +|+.+++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 357899999999999999999999999999999999643 334566777888888774 55 49999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCCCCEEEe--cCCcEEEEecC
Q 042772 378 STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH--CLGIIYRDLKPENILLQ--KDGHVVLTDFD 453 (489)
Q Consensus 378 ~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH--~~gIvHrDLKP~NILld--~~g~vKL~DFG 453 (489)
...+|+||||++ ++|.+++.......+++..+..++.|++.||.||| +.||+||||||+|||++ .++.+||+|||
T Consensus 128 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 128 RNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 999999999995 59999998876566899999999999999999999 57999999999999995 47889999999
Q ss_pred CccccCCC------------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 454 LSFMTSCK------------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 454 lS~~~~~~------------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+..... | .....+|+|++|++++++++|..||.
T Consensus 207 ~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~ 259 (382)
T 2vx3_A 207 SSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS 259 (382)
T ss_dssp TCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99654311 1 12234589999999999999999985
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=258.59 Aligned_cols=169 Identities=15% Similarity=0.121 Sum_probs=130.4
Q ss_pred ccCCCCceEEEEEEEcCCCcEEEEEEeeccccc-------chHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEE
Q 042772 313 PLGCGDTGSVHLVELQGAGELYAMKAMEKSVML-------NRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 313 ~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~-------~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV 384 (489)
..+.|++|.+..+...-.|+.|++|.+.+.... .....+.+.+|+++|+++ .|+||++++++++++..+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 467788887777777777999999999765321 233456799999999999 699999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCCCce
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQV 464 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~~~~ 464 (489)
|||++|++|.++|... .++++. .|+.||+.||.|+|++|||||||||+|||++.+|.+||+|||+|+...... .
T Consensus 321 MEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-~ 394 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-S 394 (569)
T ss_dssp EECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----C
T ss_pred EecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-c
Confidence 9999999999999876 346664 478899999999999999999999999999999999999999998765432 3
Q ss_pred eecccccchHHHHHHHHhCCccc
Q 042772 465 FYHAHVNGFYFIMYKWLTGYFTY 487 (489)
Q Consensus 465 ~~~~~v~s~g~~a~e~~~G~lpY 487 (489)
.....+++.+|++||++.|..+|
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~~~~ 417 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAENKSW 417 (569)
T ss_dssp CSHHHHHHHHHHHHHHC------
T ss_pred cccCceechhhccHHHhCCCCCC
Confidence 34557899999999998887554
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=256.92 Aligned_cols=183 Identities=23% Similarity=0.305 Sum_probs=154.2
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGA---GELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS 378 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 378 (489)
.+..++|++.+.||+|+||.||+|.+..+ +..||+|.+... ........+.+|+.+++.++||||+++++++. .
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 34567899999999999999999998653 467999988643 23445677889999999999999999999885 4
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
+..|+||||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred CceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 57899999999999999998753 34899999999999999999999999999999999999999999999999999754
Q ss_pred CCC----------------Cc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 459 SCK----------------PQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 459 ~~~----------------~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
... |+ ....+|+|++|++++|+++ |..||.
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 594 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 594 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 321 11 1123489999999999986 999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.1e-27 Score=260.98 Aligned_cols=178 Identities=19% Similarity=0.274 Sum_probs=149.4
Q ss_pred cccCcccccccCCCCceEEEEEEEcC-CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe--
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQG-AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH-- 380 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~-tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~-- 380 (489)
..++|++.+.||+|+||.||+|.+.. +++.||+|.+... ........+..|+.+++.++||||+++++++.....
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 34789999999999999999999986 7899999998653 234556678899999999999999999999987655
Q ss_pred ---EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccc
Q 042772 381 ---ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 381 ---~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
.|+||||++|++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||++..
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp CEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999988754 48999999999999999999999999999999999999875 899999999875
Q ss_pred cCC-----------CCce-----eecccccchHHHHHHHHhCCcccC
Q 042772 458 TSC-----------KPQV-----FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 458 ~~~-----------~~~~-----~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... .|+. ...+|+|++|++++++++|..||.
T Consensus 231 ~~~~~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~ 277 (681)
T 2pzi_A 231 INSFGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRN 277 (681)
T ss_dssp TTCCSCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEET
T ss_pred cccCCccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCc
Confidence 432 1221 123489999999999999988764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.6e-27 Score=257.65 Aligned_cols=182 Identities=26% Similarity=0.375 Sum_probs=153.8
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe------C
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT------S 378 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------~ 378 (489)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+... ........+.+|+.+++.++||||+++++++.. .
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 36799999999999999999999999999999998654 245556778899999999999999999998765 6
Q ss_pred CeEEEEEecCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCc---EEEEecCC
Q 042772 379 THICLITDFCPGGELFALLDKQP-MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGH---VVLTDFDL 454 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~-~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~---vKL~DFGl 454 (489)
...++||||++||+|.+++.... ...+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 67899999999999999998743 235889999999999999999999999999999999999997765 99999999
Q ss_pred ccccCC--------------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 455 SFMTSC--------------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 455 S~~~~~--------------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+..... +|+. ...+|+|++|++++++++|..||.
T Consensus 171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~ 224 (676)
T 3qa8_A 171 AKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224 (676)
T ss_dssp CCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 965321 2222 124489999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.5e-26 Score=239.12 Aligned_cols=178 Identities=20% Similarity=0.285 Sum_probs=143.5
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCe
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTH 380 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~ 380 (489)
.++..+|.+.+.||+|+||+|+.. ...+++.||+|.+.+.... .+.+|+.+++.+ +||||+++++++.+...
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 92 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQF 92 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred EEccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence 445567999999999999997643 3456899999999654322 234699999998 79999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---C--CcEEEEecCCc
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK---D--GHVVLTDFDLS 455 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~---~--g~vKL~DFGlS 455 (489)
.|+|||||. |+|.+++..... .+.+..+..++.||+.||.|||++||+||||||+|||++. + ..+||+|||+|
T Consensus 93 ~~lv~E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 93 QYIAIELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEEECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 999999995 699999987643 3455567789999999999999999999999999999953 2 35889999998
Q ss_pred cccC------------------CCCceee---------cccccchHHHHHHHHh-CCcccC
Q 042772 456 FMTS------------------CKPQVFY---------HAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 456 ~~~~------------------~~~~~~~---------~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.... .+|+... ..|+|++|++++++++ |..||.
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~ 231 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTB
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 6432 1233321 3589999999999999 999884
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.9e-26 Score=237.68 Aligned_cols=174 Identities=25% Similarity=0.352 Sum_probs=138.2
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lVm 385 (489)
.|...+.||+|+||+||.+. ..+|+.||+|.+.... .+.+.+|+.+++.+ +||||+++++++.+...+|+||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~ 88 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred eeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence 45667889999999998754 4569999999986532 24567899999876 8999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCC-----CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC-------------CcE
Q 042772 386 DFCPGGELFALLDKQPMKI-----FREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD-------------GHV 447 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~-----l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~-------------g~v 447 (489)
|||. |+|.+++....... .++..+..++.||+.||.|||++||+||||||+|||++.+ +.+
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 9995 69999998753211 1233456799999999999999999999999999999754 489
Q ss_pred EEEecCCccccCC-------------------CCc-------------eeecccccchHHHHHHHHh-CCcccC
Q 042772 448 VLTDFDLSFMTSC-------------------KPQ-------------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 448 KL~DFGlS~~~~~-------------------~~~-------------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
||+|||+|..... +|+ ....+|+|++|++++++++ |..||.
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 9999999864321 111 1223589999999999998 999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.5e-26 Score=238.08 Aligned_cols=182 Identities=15% Similarity=0.105 Sum_probs=139.5
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CCc---------c------
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDH-PFL---------P------ 369 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnI---------v------ 369 (489)
..|...+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.+.| +|. +
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 458889999999999999999999999999999875443344446778899999999877 221 1
Q ss_pred ------eeeEEEEe-----CCeEEEEEecCCCCCHHHHHh-----hCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q 042772 370 ------TLYASFQT-----STHICLITDFCPGGELFALLD-----KQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRD 433 (489)
Q Consensus 370 ------~l~~~~~~-----~~~~~lVmEy~~ggsL~~~L~-----~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrD 433 (489)
.+...+.. ....+++|+++ +++|.+++. ......+++..+..++.||+.||.|||++||+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 11111111 22468888876 789999985 22234477888999999999999999999999999
Q ss_pred CCCCCEEEecCCcEEEEecCCccccC-----------CCCcee----------------ecccccchHHHHHHHHhCCcc
Q 042772 434 LKPENILLQKDGHVVLTDFDLSFMTS-----------CKPQVF----------------YHAHVNGFYFIMYKWLTGYFT 486 (489)
Q Consensus 434 LKP~NILld~~g~vKL~DFGlS~~~~-----------~~~~~~----------------~~~~v~s~g~~a~e~~~G~lp 486 (489)
|||+|||++.++.+||+|||+++... .+|+.. ..+|+|++|++++++++|..|
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~P 316 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEEECCCCCTTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCC
T ss_pred cccceEEEecCCeEEEEeccceeecCCccccCCCCceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCC
Confidence 99999999999999999999986332 122222 256999999999999999999
Q ss_pred cC
Q 042772 487 YV 488 (489)
Q Consensus 487 Y~ 488 (489)
|.
T Consensus 317 f~ 318 (413)
T 3dzo_A 317 NT 318 (413)
T ss_dssp CC
T ss_pred CC
Confidence 85
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.2e-23 Score=225.48 Aligned_cols=161 Identities=15% Similarity=0.115 Sum_probs=120.5
Q ss_pred ccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccc-----hHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 042772 309 KPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN-----RNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 309 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 383 (489)
...+.||+|+||.||+|. ..++.+++|......... ....+++.+|+.++++++||||+++..++......|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 446789999999999994 347788999875433221 2234568899999999999999966555567777899
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCCCc
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQ 463 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~~~ 463 (489)
||||++|++|.+++.. +..++.|++.||.|||++||+||||||+|||++. .+||+|||+|+.......
T Consensus 417 VmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 417 MMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 9999999999999875 4578999999999999999999999999999998 999999999987754221
Q ss_pred e------eecccccchHHHHHHHHhC
Q 042772 464 V------FYHAHVNGFYFIMYKWLTG 483 (489)
Q Consensus 464 ~------~~~~~v~s~g~~a~e~~~G 483 (489)
. ....-.++..|++||+..+
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~ 510 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWER 510 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHH
Confidence 1 1123345667888887654
|
| >1n9l_A PHOT-LOV1, putative blue light receptor; phototropin, flavin, electron transport; HET: FMN; 1.90A {Chlamydomonas reinhardtii} SCOP: d.110.3.6 PDB: 1n9n_A* 1n9o_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3e-22 Score=168.58 Aligned_cols=108 Identities=39% Similarity=0.835 Sum_probs=101.7
Q ss_pred ccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhccccccc
Q 042772 76 IEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNF 155 (489)
Q Consensus 76 ~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (489)
+.++|+|+|+..++++|+|+|++|+++|||+++|++|+++.+|.++.
T Consensus 2 ~~~~i~i~d~~~~~g~i~~~N~a~~~l~Gy~~~e~~G~~~~~l~~~~--------------------------------- 48 (109)
T 1n9l_A 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEG--------------------------------- 48 (109)
T ss_dssp CSCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTT---------------------------------
T ss_pred CccEEEEEcCCCCCCeEEEEchHHHHHHCcCHHHHcCCCchhcCCCC---------------------------------
Confidence 56899999987679999999999999999999999999999998765
Q ss_pred ccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCc
Q 042772 156 TLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSD 225 (489)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te 225 (489)
++...+..+++++..+++++.++.+++|||+.||+.++++|++|.+|++++|+++++|||+
T Consensus 49 ---------~~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~~~~~~~~~pi~d~~G~~~~~v~~~~DITe 109 (109)
T 1n9l_A 49 ---------TDPKEVQKIRDAIKKGEACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVDVTS 109 (109)
T ss_dssp ---------CCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCC
T ss_pred ---------CCHHHHHHHHHHHHcCCcEEEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEeCCC
Confidence 6777889999999999999999999999999999999999999999999999999999996
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9.9e-23 Score=202.55 Aligned_cols=139 Identities=14% Similarity=0.070 Sum_probs=111.6
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccch---------------HHHHHHHHHHHHHHhCCCCCccee
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNR---------------NKVHRACIEREIMSLLDHPFLPTL 371 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~---------------~~~~~~~~E~~il~~l~HpnIv~l 371 (489)
.|.+.+.||+|+||.||+|.+ .+|+.||+|.++....... .....+.+|+.+++.++| +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence 466779999999999999999 7899999999964322111 235678899999999984 455
Q ss_pred eEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEe
Q 042772 372 YASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTD 451 (489)
Q Consensus 372 ~~~~~~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~D 451 (489)
.+++.. +..|+||||++|++|.+ +.. .....++.|++.||.|||++||+||||||+|||++ +|.+||+|
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 554433 45699999999999988 422 12446899999999999999999999999999999 99999999
Q ss_pred cCCccccCC
Q 042772 452 FDLSFMTSC 460 (489)
Q Consensus 452 FGlS~~~~~ 460 (489)
||+|+.+..
T Consensus 236 FG~a~~~~~ 244 (282)
T 1zar_A 236 FPQSVEVGE 244 (282)
T ss_dssp CTTCEETTS
T ss_pred CCCCeECCC
Confidence 999986653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1e-20 Score=185.18 Aligned_cols=141 Identities=16% Similarity=0.086 Sum_probs=109.5
Q ss_pred cccccccCCCCceEEEEEEEcCCCcE--EEEEEeecccccch---------------------HHHHHHHHHHHHHHhCC
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGEL--YAMKAMEKSVMLNR---------------------NKVHRACIEREIMSLLD 364 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~--vAiK~i~~~~~~~~---------------------~~~~~~~~E~~il~~l~ 364 (489)
|.+.+.||+|+||.||+|.+..+|+. ||+|+++....... .....+..|..++..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999999777988 99998754321110 11236778999999998
Q ss_pred CCCc--ceeeEEEEeCCeEEEEEecCCC-C----CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCC
Q 042772 365 HPFL--PTLYASFQTSTHICLITDFCPG-G----ELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH-CLGIIYRDLKP 436 (489)
Q Consensus 365 HpnI--v~l~~~~~~~~~~~lVmEy~~g-g----sL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH-~~gIvHrDLKP 436 (489)
|+++ +.++.. ...++||||+.+ | +|.++... .++..+..++.|++.||.||| +.||+||||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 8764 444432 256899999942 3 67766533 234567789999999999999 99999999999
Q ss_pred CCEEEecCCcEEEEecCCccccC
Q 042772 437 ENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 437 ~NILld~~g~vKL~DFGlS~~~~ 459 (489)
+|||++. .++|+|||+|....
T Consensus 200 ~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp TSEEESS--SEEECCCTTCEETT
T ss_pred HHEEEcC--cEEEEECcccccCC
Confidence 9999988 89999999997664
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.2e-19 Score=154.13 Aligned_cols=115 Identities=23% Similarity=0.377 Sum_probs=105.4
Q ss_pred hHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhh
Q 042772 68 DLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWK 147 (489)
Q Consensus 68 ~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (489)
.+..+++.++++|+++|+ +|.|+|+|++|++++||+++|++|+++..|..+.
T Consensus 6 ~~~~~~~~~~~~i~~~d~---~g~i~~~N~a~~~~~G~~~~elig~~~~~l~~~~------------------------- 57 (120)
T 2gj3_A 6 IFRQTVEHAPIAISITDL---KANILYANRAFRTITGYGSEEVLGKNESILSNGT------------------------- 57 (120)
T ss_dssp HHHHHHHHCSSEEEEECT---TCBEEEECHHHHHHHCCCTTGGGGCBGGGGCCTT-------------------------
T ss_pred HHHHHHHhCCCeEEEECC---CCCEEeehHHHHHHHCcCHHHHcCCCHHHcCCCC-------------------------
Confidence 467899999999999999 9999999999999999999999999988776554
Q ss_pred hcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCccc
Q 042772 148 KNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHV 227 (489)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~k 227 (489)
........++.++..++.+..++..++|||+.+|+.++++|++|.+|++.+++++.+|||++|
T Consensus 58 -----------------~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~pi~~~~g~~~~~v~~~~DITe~k 120 (120)
T 2gj3_A 58 -----------------TPRLVYQALWGRLAQKKPWSGVLVNRRKDKTLYLAELTVAPVLNEAGETIYYLGMHRDTSELH 120 (120)
T ss_dssp -----------------SCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCSCC
T ss_pred -----------------CCHHHHHHHHHHHHcCCCEEEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEeccCcccC
Confidence 455567788899999999999999999999999999999999999999999999999999975
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=2.9e-19 Score=154.35 Aligned_cols=119 Identities=39% Similarity=0.722 Sum_probs=103.3
Q ss_pred HHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhcc
Q 042772 71 TTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNY 150 (489)
Q Consensus 71 ~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (489)
.+++.++++|+++|+.-+++.|+|+|++|++++||+++|++|+++.++..+.
T Consensus 3 ~~~~~~~~~i~~~d~~g~~~~i~~~N~a~~~~~G~~~~el~g~~~~~l~~~~---------------------------- 54 (132)
T 2pr5_A 3 HMLDHVRVGVVITDPALEDNPIVYVNQGFVQMTGYETEEILGKNCRFLQGKH---------------------------- 54 (132)
T ss_dssp ---CCCCCEEEEECTTSTTCCEEEECHHHHHHHSCCHHHHTTSCGGGGCCTT----------------------------
T ss_pred hHHhcCCCcEEEEeCCCCCCcEEEECHHHHHHhCcCHHHHcCCChhhhCCCC----------------------------
Confidence 5688999999999994445599999999999999999999999998887654
Q ss_pred cccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCcccccc
Q 042772 151 GVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPL 230 (489)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~ke~e 230 (489)
.+......++.++..++.+..++..++|||+.+|+.++++|++|.+ +.+++++.+|||++++++
T Consensus 55 --------------~~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~~~~~~~~~~~~~~~--~~~~~~~~~DITe~k~~e 118 (132)
T 2pr5_A 55 --------------TDPAEVDNIRTALQNKEPVTVQIQNYKKDGTMFWNELNIDPMEIED--KTYFVGIQNDITKQKEYE 118 (132)
T ss_dssp --------------CCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEEEEEEEEEEEEETT--EEEEEEEEEECHHHHHHH
T ss_pred --------------CCHHHHHHHHHHHHcCCCeEEEEEEEecCCCeeeeEEEEEeccCCC--eeEEEEEEEeCcHHHHHH
Confidence 5666678889999999999999999999999999999999999875 889999999999999877
Q ss_pred ccc
Q 042772 231 RNR 233 (489)
Q Consensus 231 ~~~ 233 (489)
++.
T Consensus 119 ~~l 121 (132)
T 2pr5_A 119 KLL 121 (132)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} | Back alignment and structure |
|---|
Probab=99.78 E-value=9.7e-19 Score=166.40 Aligned_cols=124 Identities=20% Similarity=0.375 Sum_probs=117.8
Q ss_pred hhHHHHHHHHHhhhhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhcccc
Q 042772 54 WDRAERERDIRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNC 133 (489)
Q Consensus 54 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~ 133 (489)
.|+++|++.+++...+..+++++.++++++|+ ++.|+|+|++|++++||+++|++|+++.+|..+.
T Consensus 98 ~DIT~~k~~e~~l~~~~~~~~~~~~~i~~~d~---~g~i~~~N~~~~~~~G~~~~e~~g~~~~~l~~~~----------- 163 (227)
T 3ewk_A 98 RDITAQKEAEAQLARLKQAMDANSEMILLTDR---AGRIIYANPALCRFSGMAEGELLGQSPSILDSPL----------- 163 (227)
T ss_dssp EECTTTTHHHHHHHHHHHHHHTCCSEEEEECT---TSCEEEECHHHHHHHTCCTHHHHSSCGGGGBCTT-----------
T ss_pred EehhhHHHHHHHHHHHHHHHhcCcCeEEEEcC---CCcEEEEchHHHHHhCCCHHHHcCCChhhccCCC-----------
Confidence 58999999999999999999999999999999 9999999999999999999999999999888765
Q ss_pred ccchhHHHHHHHhhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCC------eeeEEEeecccc
Q 042772 134 STYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGK------KFWNLFHLQPMR 207 (489)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~------~~~~~~~~~p~~ 207 (489)
.++.....+++++..+++|.+++.+++|||+ .||+.++++|++
T Consensus 164 -------------------------------~~~~~~~~~~~~~~~~~~~~~e~~~~~k~G~~~~dg~~~~~~~~~~pi~ 212 (227)
T 3ewk_A 164 -------------------------------ADQETLAAMQEALQAGQPWSGRLLNRRRTGPAPHDAEDYWAEISTTPIH 212 (227)
T ss_dssp -------------------------------SCHHHHHHHHHHHHHTCCEECCEEEEEECCSSSSCEEEEEEEEEEEEEE
T ss_pred -------------------------------CCHHHHHHHHHHHHcCCceeEEEEEECCCCCcCcccceEEEEEEEEEEE
Confidence 7888999999999999999999999999997 899999999999
Q ss_pred cCCCCeeEEeeeecc
Q 042772 208 DHKGELQYFIGVQLD 222 (489)
Q Consensus 208 ~~~g~~~~~~~~~~d 222 (489)
|.+|.+++|+++++|
T Consensus 213 d~~g~~~~~v~i~~D 227 (227)
T 3ewk_A 213 TDGNGLVGYVQIQHD 227 (227)
T ss_dssp CSSSCEEEEEEEEEC
T ss_pred CCCCCEEEEEEEecC
Confidence 999999999999987
|
| >4hia_A LOV protein; PAS, HTH, signaling protein; HET: FMN; 1.95A {Rhodobacter sphaeroides} PDB: 4hnb_A* 4hj4_A* 4hj6_A* 4hj3_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2.6e-18 Score=155.01 Aligned_cols=126 Identities=29% Similarity=0.529 Sum_probs=114.7
Q ss_pred hhhhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHH
Q 042772 65 QGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLA 144 (489)
Q Consensus 65 ~~~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (489)
+...+..+++.++++|+++|+..+++.|+|+|++|++++||+++|++|+++..+..+.
T Consensus 5 ~~~~~~~~~~~~~~~i~~~d~~~~~g~i~~~N~a~~~~~G~~~~e~~g~~~~~~~~~~---------------------- 62 (176)
T 4hia_A 5 QFEKIRAVFDRSGVALTLVDMSLPEQPVVLANPPFLRMTGYTEGQILGFNCRFLQRGD---------------------- 62 (176)
T ss_dssp HHHHHHHHHHHCSSCCEEEETTSTTCCEEEECHHHHHHHTCCHHHHTTSCGGGGCCTT----------------------
T ss_pred HHHHHHHHHhcCCCcEEEEecCCCCCcEEEECHHHHHHHCcCHHHHcCCCcceeeCCC----------------------
Confidence 3455789999999999999995555999999999999999999999999988777664
Q ss_pred HhhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCC
Q 042772 145 LWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGS 224 (489)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~T 224 (489)
........+++++..+..+..++..+++||+.+|+.+++.|++|.+|.+.+++++.+|||
T Consensus 63 --------------------~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~pi~~~~g~~~~~~~~~~DIT 122 (176)
T 4hia_A 63 --------------------ENAQARADIRDALKLGRELQVVLRNYRANDEPFDNLLFLHPVGGRPDAPDYFLGSQFELG 122 (176)
T ss_dssp --------------------CCHHHHHHHHHHHHHTCCEEEEEEEECTTCCEEEEEEEEEEESSBTTBCSEEEEEEEEES
T ss_pred --------------------CCHHHHHHHHHHHHcCCceEEEEEEEcCCCCEEEEEEEEEEeeCCCCCeEEEEEEEEECc
Confidence 667778889999999999999999999999999999999999999999999999999999
Q ss_pred cccccccc
Q 042772 225 DHVEPLRN 232 (489)
Q Consensus 225 e~ke~e~~ 232 (489)
++++++++
T Consensus 123 e~k~~e~~ 130 (176)
T 4hia_A 123 RSGNSEEA 130 (176)
T ss_dssp SSGGGHHH
T ss_pred HhhHHHHH
Confidence 99988876
|
| >4eet_B Phototropin-2; LOV, blue light photoreceptor, signaling protein, flavoprote; HET: FMN; 1.20A {Arabidopsis thaliana} PDB: 4ees_A* 4eer_A* 4eep_A* 4eeu_A* 1jnu_A* 1g28_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=8e-17 Score=132.37 Aligned_cols=114 Identities=83% Similarity=1.266 Sum_probs=102.9
Q ss_pred HHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhccc
Q 042772 72 TLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYG 151 (489)
Q Consensus 72 ~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (489)
+++.++++++++|+..|++.|+|+|++|++++||+++|++|+++..+..+.
T Consensus 2 ~l~~~~~~i~~~d~~~~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~----------------------------- 52 (115)
T 4eet_B 2 SPEFIEKNFVITDPRLPDNPIIFASDGFLELTEYSREEILGRNARFLQGPE----------------------------- 52 (115)
T ss_dssp ---CCCCSEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTT-----------------------------
T ss_pred ccccCCCcEEEEcCCCCCCcEEEEcHHHHHHHCcCHHHHhCCCHHHhcCCC-----------------------------
Confidence 578899999999998789999999999999999999999999988776654
Q ss_pred ccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCccc
Q 042772 152 VYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHV 227 (489)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~k 227 (489)
........+++++..++.+..++...+++|+.+|+.+++.|++|.+|.+.+++++.+|||+++
T Consensus 53 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DITer~ 115 (115)
T 4eet_B 53 -------------TDQATVQKIRDAIRDQRETTVQLINYTKSGKKFWNLLHLQPVRDQKGELQYFIGVQLDGSDHV 115 (115)
T ss_dssp -------------SCHHHHHHHHHHHHTTCCEEEEEEEECTTCCEEEEEEEEEEEECTTSCEEEEEEEEEECSCCC
T ss_pred -------------CChHHHHHHHHHHHcCCCcceEEEEecCCCCEEEEEEEEEEEECCCCCEEEEEEEEEeecccC
Confidence 567777889999999999999999999999999999999999999999999999999999974
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=4.4e-17 Score=144.20 Aligned_cols=125 Identities=43% Similarity=0.782 Sum_probs=112.9
Q ss_pred hhhhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHH
Q 042772 65 QGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLA 144 (489)
Q Consensus 65 ~~~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (489)
....+..+++.++++++++|+..+++.|+++|++|++++||+++|++|+++..+..+.
T Consensus 33 ~~~~~~~~~~~~~~~i~~~d~~~~~g~i~~~N~~~~~l~G~~~~e~~g~~~~~l~~~~---------------------- 90 (166)
T 3ue6_A 33 PDYSLVKALQMAQQNFVITDASLPDNPIVYASRGFLTLTGYSLDQILGRNCRFLQGPE---------------------- 90 (166)
T ss_dssp CCCHHHHHHHHTTSCEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTT----------------------
T ss_pred HHHHHHHHHhcCCceEEEEEccCCCCcEEEECHHHHHHhCcCHHHHcCCCHhheeCCC----------------------
Confidence 4456889999999999999996668999999999999999999999999988777654
Q ss_pred HhhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCC
Q 042772 145 LWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGS 224 (489)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~T 224 (489)
........+..++..+..+..++...+++|+.+|+.+++.|++|.+|.+.+++++.+|||
T Consensus 91 --------------------~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~~~~~~~~i~~~~g~~~~~~~~~~DIT 150 (166)
T 3ue6_A 91 --------------------TDPRAVDKIRNAITKGVDTSVCLLNYRQDGTTFWNLFFVAGLRDSKGNIVNYVGVQSKVS 150 (166)
T ss_dssp --------------------SCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEECCBCC
T ss_pred --------------------CCHHHHHHHHHHHhcCCceEEEEEEEcCCCCEEEEEEEEEeeeCCCCCEEEEEEEEEech
Confidence 567777888999999999999999999999999999999999999999999999999999
Q ss_pred ccccccc
Q 042772 225 DHVEPLR 231 (489)
Q Consensus 225 e~ke~e~ 231 (489)
++++++.
T Consensus 151 e~k~~~~ 157 (166)
T 3ue6_A 151 EDYAKLL 157 (166)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9886543
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} | Back alignment and structure |
|---|
Probab=99.71 E-value=6.5e-17 Score=156.34 Aligned_cols=124 Identities=35% Similarity=0.607 Sum_probs=107.9
Q ss_pred HhhhhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHH
Q 042772 64 RQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFL 143 (489)
Q Consensus 64 ~~~~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (489)
+....+..+++.++++|+++|+...++.|+|+|++|++++||+++|++|+++.++..+.
T Consensus 60 ~~~~~~~~i~~~~~~~i~~~d~~~~~g~i~~~N~a~~~l~G~~~~el~g~~~~~l~~~~--------------------- 118 (258)
T 3p7n_A 60 PPAQWVLDLIEASPIASVVSDPRLADNPLIAINQAFTDLTGYSEEECVGRNCRFLAGSG--------------------- 118 (258)
T ss_dssp -CCHHHHHHHHTCSSEEEEECTTSTTCCEEEECHHHHHHHCCCGGGTTTSCGGGGCCTT---------------------
T ss_pred hHHHHHHHHHhcCCccEEEEcCCCCCCcEEEEhHHHHHHcCCCHHHHCCCChhhccCCC---------------------
Confidence 34456889999999999999995557789999999999999999999999998887664
Q ss_pred HHhhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccC
Q 042772 144 ALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDG 223 (489)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~ 223 (489)
........++.++..+..+..++..+++||+.+|+.+++.|++|.+|.+++++++.+||
T Consensus 119 ---------------------~~~~~~~~~~~~l~~~~~~~~e~~~~~~dG~~~~~~~~~~pi~d~~g~~~~~v~~~~DI 177 (258)
T 3p7n_A 119 ---------------------TEPWLTDKIRQGVREHKPVLVEILNYKKDGTPFRNAVLVAPIYDDDDELLYFLGSQVEV 177 (258)
T ss_dssp ---------------------CCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEEEEEEEEEEEECTTSCSEEEEEEEEEC
T ss_pred ---------------------CchhHHHHHHHHHHcCCCeEEEEEEEcCCCCEEEEeeEEEEEEcCCCCEEEEEEEeeec
Confidence 67778888999999999999999999999999999999999999999999999999999
Q ss_pred Cccccc
Q 042772 224 SDHVEP 229 (489)
Q Consensus 224 Te~ke~ 229 (489)
|++++.
T Consensus 178 Terk~~ 183 (258)
T 3p7n_A 178 DDDQPN 183 (258)
T ss_dssp ------
T ss_pred chhhhh
Confidence 999543
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} | Back alignment and structure |
|---|
Probab=99.71 E-value=5.8e-17 Score=137.15 Aligned_cols=122 Identities=39% Similarity=0.731 Sum_probs=105.2
Q ss_pred HHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhccc
Q 042772 72 TLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYG 151 (489)
Q Consensus 72 ~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (489)
+++.++++++++|+..+++.|+++|++|++++||+++|++|+++..+..+.
T Consensus 2 ~~~~~~~~i~~~d~~~~~g~i~~~N~~~~~l~g~~~~e~~g~~~~~~~~~~----------------------------- 52 (128)
T 3t50_A 2 ASEFTLMPMLITNPHLPDNPIVFANPAFLKLTGYEADEVMGRNCRFLQGHG----------------------------- 52 (128)
T ss_dssp CCCCCSSCEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTT-----------------------------
T ss_pred ccccCcccEEEecCCCCCCcEEEEcHHHHHHhCcCHHHHcCCCHhhhcCCc-----------------------------
Confidence 467889999999986568899999999999999999999999987776554
Q ss_pred ccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCccccccc
Q 042772 152 VYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLR 231 (489)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~ke~e~ 231 (489)
........+..++..+..+..++...+++|..+|+.+++.|++|..|.+.+++++.+|||+++++++
T Consensus 53 -------------~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~~~~~~~~i~~~~g~~~~~~~~~~DITe~k~~e~ 119 (128)
T 3t50_A 53 -------------TDPAHVRAIKSAIAAEKPIDIDIINYKKSGEAFWNRLHISPVHNANGRLQHFVSSQLDVTLELVPRG 119 (128)
T ss_dssp -------------SCHHHHHHHHHHHHTTCCEEEEEEEECTTCCEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHC---
T ss_pred -------------cCHHHHHHHHHHHHcCCCceeEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEEcchhhhhhh
Confidence 5677778899999999999999999999999999999999999999999999999999999998887
Q ss_pred cccc
Q 042772 232 NRLS 235 (489)
Q Consensus 232 ~~l~ 235 (489)
+..+
T Consensus 120 ~~~~ 123 (128)
T 3t50_A 120 SLEH 123 (128)
T ss_dssp ----
T ss_pred hhhh
Confidence 7643
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.3e-16 Score=151.63 Aligned_cols=109 Identities=21% Similarity=0.398 Sum_probs=100.7
Q ss_pred EEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhcccccccccCc
Q 042772 80 FVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGC 159 (489)
Q Consensus 80 ~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (489)
|+|+|+ +|.|+|||++|++++||+++|++|+++.++..+.
T Consensus 2 i~i~D~---~g~i~~~N~a~~~l~Gy~~~el~G~~~~~~~~~~------------------------------------- 41 (227)
T 3ewk_A 2 VSITDL---QGRILYANDNFCAVSRYGREELVGQDHRIVNSGY------------------------------------- 41 (227)
T ss_dssp EEEEET---TCBEEEECHHHHHHTTCCHHHHTTSBGGGGCCSC-------------------------------------
T ss_pred EEEECC---CCcEEehHHHHHHHHCcCHHHHcCCCHHHcCCCC-------------------------------------
Confidence 789999 9999999999999999999999999998876553
Q ss_pred ccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCccccccccc
Q 042772 160 CLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLRNR 233 (489)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~ke~e~~~ 233 (489)
.+......+++++..+..+..++.+++|||+.+|+..++.|++|.+|.+.+++++.+|||++++++++.
T Consensus 42 -----~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~p~~d~~g~~~~~~~~~~DIT~~k~~e~~l 110 (227)
T 3ewk_A 42 -----HGKAYIRDMWRTISRGNIWQGEFCNRRKDGTRYWVDSTIVPLMDNAGKPRQYISIRRDITAQKEAEAQL 110 (227)
T ss_dssp -----SCHHHHHHHHHHHTTTCCEEEEEEEECSSSCEEEEEEEEEEEECSSSCEEEEEEEEEECTTTTHHHHHH
T ss_pred -----CCHHHHHHHHHHHHcCCeEEEEEEEEcCCCCEEeeeeEEEEEEcCCCCEEEEEEEEEehhhHHHHHHHH
Confidence 567778889999999999999999999999999999999999999999999999999999999877654
|
| >2wkq_A NPH1-1, RAS-related C3 botulinum toxin substrate 1; transferase, cell adhesion, nucleotide-binding, protein engineering, RAS superfamily LOV2; HET: GTP FMN; 1.60A {Avena sativa} PDB: 2wkr_A* 2wkp_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=3.6e-16 Score=156.73 Aligned_cols=122 Identities=79% Similarity=1.226 Sum_probs=111.6
Q ss_pred HHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhc
Q 042772 70 ATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKN 149 (489)
Q Consensus 70 ~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (489)
+.+++.++++|+++|++.|+|.|+|+|++|++++||+++|++|+++..+..++
T Consensus 14 ~~~~~~~~~~i~~~D~~~~~g~i~~~N~a~~~l~G~~~~el~G~~~~~l~~~~--------------------------- 66 (332)
T 2wkq_A 14 ATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNARFLQGPE--------------------------- 66 (332)
T ss_dssp CCCGGGCCSEEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTT---------------------------
T ss_pred HhHhhcCCCcEEEecCCCCCCCEEEeehHHHHHhCCCHHHHcCCCchhhcCCC---------------------------
Confidence 34678899999999998889999999999999999999999999998887664
Q ss_pred ccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCccccc
Q 042772 150 YGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEP 229 (489)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~ke~ 229 (489)
.+......+++++..++.+..++..+++||+.+|+..+++|++|..|++.+++++.+|||++++.
T Consensus 67 ---------------~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~pi~d~~g~~~~~v~~~~DITe~k~~ 131 (332)
T 2wkq_A 67 ---------------TDRATVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVRD 131 (332)
T ss_dssp ---------------CCHHHHHHHHHHHHTTCCEEEEEEEECTTCCEEEEEEEEEEEECTTSCEEEEEEEEEEESSCCCH
T ss_pred ---------------CCHHHHHHHHHHHHcCCeeEEEEEEEcCCCCEEEEeeEEEEeEcCCCCEEEEEEEeccCchhhhh
Confidence 67778888999999999999999999999999999999999999999999999999999999876
Q ss_pred cccc
Q 042772 230 LRNR 233 (489)
Q Consensus 230 e~~~ 233 (489)
+++.
T Consensus 132 e~~~ 135 (332)
T 2wkq_A 132 AAER 135 (332)
T ss_dssp HHHH
T ss_pred hhhc
Confidence 6544
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=9.4e-17 Score=166.20 Aligned_cols=140 Identities=15% Similarity=0.147 Sum_probs=101.3
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccc------------h---HH--H--HHHHHHHHHHHhCCCCCc
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN------------R---NK--V--HRACIEREIMSLLDHPFL 368 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~------------~---~~--~--~~~~~E~~il~~l~HpnI 368 (489)
|++...||+|+||.||+|.+. +|+.||+|+++...... . +. . .....|...|.++.++++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999975 59999999876432110 0 00 1 112346667777755554
Q ss_pred ceeeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC---
Q 042772 369 PTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG--- 445 (489)
Q Consensus 369 v~l~~~~~~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g--- 445 (489)
....-+... ..+|||||++|++|..+... ..+..++.|++.+|.|||+.|||||||||.|||++++|
T Consensus 176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQS--RHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEEE--TTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeecc--CceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 322211122 24799999999888654321 23456788999999999999999999999999999877
Q ss_pred -------cEEEEecCCcccc
Q 042772 446 -------HVVLTDFDLSFMT 458 (489)
Q Consensus 446 -------~vKL~DFGlS~~~ 458 (489)
.+.|+||+-+...
T Consensus 246 d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CTTSEEEEEEECCCTTCEET
T ss_pred cccccccceEEEEeCCcccC
Confidence 4899999987543
|
| >3f1p_A Endothelial PAS domain-containing protein 1; PAS domain, heterodimer, internal cavity, activator, angiogenesis, congenital erythrocytosis; 1.17A {Homo sapiens} SCOP: d.110.3.7 PDB: 3f1o_A* 3f1n_A 3h7w_A* 3h82_A* 1p97_A 2a24_A 4h6j_A | Back alignment and structure |
|---|
Probab=99.64 E-value=4.9e-16 Score=130.45 Aligned_cols=108 Identities=16% Similarity=0.140 Sum_probs=94.5
Q ss_pred cCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhcccccccc
Q 042772 77 EKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFT 156 (489)
Q Consensus 77 ~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (489)
.+.++++|+ ++.|+|+|++|++++||+++|++|+++..+..|+
T Consensus 9 ~~~i~~~d~---~g~i~~~n~~~~~~~Gy~~~el~g~~~~~~~~p~---------------------------------- 51 (117)
T 3f1p_A 9 KTFLSEHSM---DMKFTYCDDRITELIGYHPEELLGRSAYEFYHAL---------------------------------- 51 (117)
T ss_dssp GEEEEEECT---TCBEEEECTHHHHHHCCCHHHHTTSBGGGGBCGG----------------------------------
T ss_pred ccEEEEECC---CceEEEECcChhhhhCCCHHHHcCCchhheECHH----------------------------------
Confidence 477889999 9999999999999999999999999877666664
Q ss_pred cCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccC-CCCeeEEeeeeccCCccccc
Q 042772 157 LGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDH-KGELQYFIGVQLDGSDHVEP 229 (489)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~-~g~~~~~~~~~~d~Te~ke~ 229 (489)
......+.+..++..+..++.++...+|||+.+|+..+..|++|. .|.+.+++++.+|||+++++
T Consensus 52 --------d~~~~~~~~~~~~~~~~~~~~e~r~~~~dG~~~w~~~~~~~~~d~~~g~~~~iv~~~~DITer~~~ 117 (117)
T 3f1p_A 52 --------DSENMTKSHQNLCTKGQVVSGQYRMLAKHGGYVWLETQGTVIYNPRNLQPQCIMCVNYVLSEIEKN 117 (117)
T ss_dssp --------GHHHHHHHHHHHHHHSEEECCCEEEECTTSSEEEEEEEEEEEEETTTTEEEEEEEEEEECSCCBC-
T ss_pred --------HHHHHHHHHHHHHhCCCeeeeEEEEEecCCCEEEEEEeeEEEECCCCCCceEEEEEeeeccccccC
Confidence 334455667788888888888999999999999999999999998 89999999999999999863
|
| >3f1p_B ARYL hydrocarbon receptor nuclear translocator; PAS domain, heterodimer, internal cavity, activator, angiogenesis, congenital erythrocytosis; 1.17A {Homo sapiens} SCOP: d.110.3.0 PDB: 3f1o_B* 3f1n_B 3h7w_B* 3h82_B* 1x0o_A 2hv1_A 4h6j_B 2b02_A* 2k7s_A 2a24_B | Back alignment and structure |
|---|
Probab=99.64 E-value=5.9e-16 Score=130.94 Aligned_cols=114 Identities=13% Similarity=0.209 Sum_probs=94.4
Q ss_pred HHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhc
Q 042772 70 ATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKN 149 (489)
Q Consensus 70 ~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (489)
...++.+.+.+++.|+ ++.|+|+|++|++++||+++|++|+++..+..|+
T Consensus 5 ~ll~e~~~d~i~~~d~---~g~i~~~n~~~~~~~G~~~~el~g~~~~~~i~p~--------------------------- 54 (121)
T 3f1p_B 5 GLNVCQPTRFISRHNI---EGIFTFVDHRCVATVGYQPQELLGKNIVEFCHPE--------------------------- 54 (121)
T ss_dssp ---CCCCCEEEEEECT---TSBEEEECTTHHHHHSCCGGGTTTSBGGGGBCTT---------------------------
T ss_pred cceecCCCceEEEECC---CceEEEECcchhhhhCCChHHHcCCCHHHeECHH---------------------------
Confidence 3467888999999999 9999999999999999999999999977666564
Q ss_pred ccccccccCcccccCCCHHHHHHHHHHHH-cCCcEEEEEEeeecCCCeeeEEEeecccccC-CCCeeEEeeeeccCCccc
Q 042772 150 YGVYNFTLGCCLEISSDQATVSKIRDAVR-EQREITVQLINYTKSGKKFWNLFHLQPMRDH-KGELQYFIGVQLDGSDHV 227 (489)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~-~g~~~~~~~~~~d~Te~k 227 (489)
......+.+.+++. .+..+..++...+|||+.+|+..+..|++|. .|++.+++++.+|||+++
T Consensus 55 ---------------d~~~~~~~~~~~~~~~~~~~~~e~r~~~~dG~~~w~~~~~~~~~~~~~g~~~~iv~~~~DIT~~k 119 (121)
T 3f1p_B 55 ---------------DQQLLRDSFQQVVKLKGQVLSVMFRFRSKNQEWLWMRTSSFTFQNPYSDEIEYIICTNTNVKNSS 119 (121)
T ss_dssp ---------------THHHHHHHHHHHTTSTTCCEEEEEEEECTTSCEEEEEEEEEEECCTTCCCCCEEEEEEEECCCC-
T ss_pred ---------------HHHHHHHHHHHHHhcCCCcccEEEEEEecCCCEEEEEEEEEEEECCCCCceeEEEEEeEEccccc
Confidence 33334455666664 4557889999999999999999999999998 899999999999999987
Q ss_pred c
Q 042772 228 E 228 (489)
Q Consensus 228 e 228 (489)
+
T Consensus 120 q 120 (121)
T 3f1p_B 120 Q 120 (121)
T ss_dssp -
T ss_pred C
Confidence 5
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A | Back alignment and structure |
|---|
Probab=99.63 E-value=6.1e-16 Score=130.63 Aligned_cols=116 Identities=16% Similarity=0.167 Sum_probs=94.0
Q ss_pred hHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhh
Q 042772 68 DLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWK 147 (489)
Q Consensus 68 ~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (489)
++..+++.+++++++ |. ++.|+++|++|++++||+++|++|+++..+..+.
T Consensus 4 ~~~~~~~~~~~~i~~-~~---~g~i~~~N~a~~~l~G~~~~el~g~~~~~~~~~~------------------------- 54 (120)
T 3mqq_A 4 DYKTAFHLAPIGLVL-SR---DRVIEDCNDELAAIFRCARADLIGRSFEVLYPSS------------------------- 54 (120)
T ss_dssp CHHHHHHHCSSEEEE-EE---TTEEEEECHHHHHHTTSCHHHHTTCBGGGGSSSH-------------------------
T ss_pred hHHHHHhcCCceEEE-ec---CCEEHHHHHHHHHHhCcCHHHhCCCchhhccCCh-------------------------
Confidence 467899999999976 66 8999999999999999999999999987665432
Q ss_pred hcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCccc
Q 042772 148 KNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHV 227 (489)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~k 227 (489)
.........+..++..+..+..++...++||+.+|+.++..|+ +..|...+++++.+|||++|
T Consensus 55 ----------------~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~~-~~~~~~~~~v~~~~DITerk 117 (120)
T 3mqq_A 55 ----------------DEFERIGERISPVMIAHGSYADDRIMKRAGGELFWCHVTGRAL-DRTAPLAAGVWTFEDLSATR 117 (120)
T ss_dssp ----------------HHHHHHHHHHHHHHHHHSCEEEEEEEECTTSCEEEEEEEEEES-STTSTTSSEEEEEEESCC--
T ss_pred ----------------hhHHHHHHHHHHHHhcCCcceEEEEEEeCCCCEEEEEEEEEEC-CCCCCceeEEEEEEcccHhh
Confidence 0113344566777788888999999999999999999999999 66677788999999999998
Q ss_pred cc
Q 042772 228 EP 229 (489)
Q Consensus 228 e~ 229 (489)
+.
T Consensus 118 ~~ 119 (120)
T 3mqq_A 118 RV 119 (120)
T ss_dssp --
T ss_pred cc
Confidence 64
|
| >2z6d_A Phototropin-2; PAS-fold, LOV-fold, alternative splicing, ATP-binding, chromophore, flavoprotein, FMN, kinase, membrane, nucleotide-binding; HET: FMN; 2.00A {Arabidopsis thaliana} PDB: 2z6c_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=1.1e-14 Score=120.11 Aligned_cols=123 Identities=38% Similarity=0.778 Sum_probs=104.2
Q ss_pred hHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhh
Q 042772 68 DLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWK 147 (489)
Q Consensus 68 ~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (489)
.+..+++.+++++++.|..-+++.|+++|++|++++||+.++++|+++..+..+.
T Consensus 7 ~~~~~~~~~~~~i~~~d~~d~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~------------------------- 61 (130)
T 2z6d_A 7 ELKTALSTLQQTFVVSDATQPHCPIVYASSGFFTMTGYSSKEIVGRNCRFLQGPD------------------------- 61 (130)
T ss_dssp CHHHHHHHTTCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTT-------------------------
T ss_pred HHHHHHHhcccceeeeeccCCCCcEEEecHHHHHHhCcCHHHHcCCChhhccCCC-------------------------
Confidence 3678899999999999921129999999999999999999999999987665443
Q ss_pred hcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCccc
Q 042772 148 KNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHV 227 (489)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~k 227 (489)
........+..++..+..+..++...+++|+.+|+.+.+.|+.|..|.+.+++++.+|||+++
T Consensus 62 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~ 124 (130)
T 2z6d_A 62 -----------------TDKNEVAKIRDCVKNGKSYCGRLLNYKKDGTPFWNLLTVTPIKDDQGNTIKFIGMQVEVSKYT 124 (130)
T ss_dssp -----------------SCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCTTC
T ss_pred -----------------CCchHHHHHHHHHHcCCcceeEEEEEcCCCcEEEEEEEEEEEECCCCCeeEEEEEEecchHHH
Confidence 456667778888999999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 042772 228 EPLRN 232 (489)
Q Consensus 228 e~e~~ 232 (489)
+++++
T Consensus 125 ~~e~e 129 (130)
T 2z6d_A 125 EGVND 129 (130)
T ss_dssp -----
T ss_pred Hhhcc
Confidence 87654
|
| >2vv6_A FIXL, sensor protein FIXL; signaling protein, transferase, phosphoprotein, nitrogen FIX PER-ARNT-SIM, metal-binding, PAS, iron, heme; HET: HEM; 1.5A {Bradyrhizobium japonicum} PDB: 1xj6_A* 1xj4_A* 2vv7_A* 2vv8_A* 1lsw_A* 1dp8_A* 1dp9_A* 1drm_A* 1lsv_A* 1dp6_A* 1lsx_A* 1lt0_A* 1y28_A* 2cmn_A* 1xj3_A* 1xj2_A* 2owh_A* 2owj_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=2e-15 Score=127.45 Aligned_cols=111 Identities=18% Similarity=0.196 Sum_probs=76.7
Q ss_pred ccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhccccccc
Q 042772 76 IEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNF 155 (489)
Q Consensus 76 ~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (489)
++++|+++|+ +|.|+++|++|++++||+++|++|+++..|..+.
T Consensus 2 ~~d~i~~~d~---~g~i~~~N~a~~~l~G~~~~el~G~~~~~l~~~~--------------------------------- 45 (119)
T 2vv6_A 2 IPDAMIVIDG---HGIIQLFSTAAERLFGWSELEAIGQNVNILMPEP--------------------------------- 45 (119)
T ss_dssp CCCEEEEEET---TSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTT---------------------------------
T ss_pred CcceEEEECC---CCeEEEEhHHHHHHhCCCHHHHcCCCHHHhCCch---------------------------------
Confidence 5689999999 9999999999999999999999999988765442
Q ss_pred ccCcccccCCCHHHHHHHHHHHHcCCc----EEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCccccccc
Q 042772 156 TLGCCLEISSDQATVSKIRDAVREQRE----ITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLR 231 (489)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~ke~e~ 231 (489)
........+......+.. ...++...+|||+.||+.++++|+.+. ...+++++.+|||+++++++
T Consensus 46 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dG~~~~~~~~~~~~~~~--~~~~~~~~~~DITerk~~e~ 114 (119)
T 2vv6_A 46 ---------DRSRHDSYISRYRTTSDPHIIGIGRIVTGKRRDGTTFPMHLSIGEMQSG--GEPYFTGFVRDLTEHQQTQA 114 (119)
T ss_dssp ---------HHHHHHHHHHHHHHHCCCSSTTTCEEEEEECTTSCEEEEEEEEEEEEET--TEEEEEEEEEECC-------
T ss_pred ---------HHHHHHHHHHHHhcCCCcccCCCceEEEEEeCCCCEEEEEEEEEEEEEC--CeEEEEEEEEEcHHHHHHHH
Confidence 111111222333333221 234666789999999999999999874 33578999999999998877
Q ss_pred cc
Q 042772 232 NR 233 (489)
Q Consensus 232 ~~ 233 (489)
+.
T Consensus 115 ~l 116 (119)
T 2vv6_A 115 RL 116 (119)
T ss_dssp --
T ss_pred HH
Confidence 64
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} | Back alignment and structure |
|---|
Probab=99.61 E-value=4.8e-15 Score=125.61 Aligned_cols=106 Identities=15% Similarity=0.209 Sum_probs=86.1
Q ss_pred hHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhh
Q 042772 68 DLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWK 147 (489)
Q Consensus 68 ~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (489)
.+..+++.++++|+++|+ +|.|++||++|++++||+++|++|+++..+..+.
T Consensus 12 ~~~~l~e~~~d~i~~~d~---~g~i~~vN~a~~~l~Gy~~~el~g~~~~~~~~~~------------------------- 63 (117)
T 2r78_A 12 AYRALFEHAIDGIFIMDA---EGHYLDVNPAICSAIGYTRDEFLALDWGVLSRGV------------------------- 63 (117)
T ss_dssp HHHHHHHHCSSEEEEECT---TSBEEEECHHHHHHHCCCHHHHTTCBTTTTTTCS-------------------------
T ss_pred HHHHHHhcCCceEEEECC---CCCEEEecHHHHHHHCcCHHHHcCCCHHHhCCcc-------------------------
Confidence 367889999999999999 9999999999999999999999999877654321
Q ss_pred hcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCC
Q 042772 148 KNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGS 224 (489)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~T 224 (489)
+......+.+.+..++.+..+....+|||+.+|+.+++.|+. +|. ++++.+|||
T Consensus 64 ------------------~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~~~v~~~~~~~~--~g~---~~~i~~DIT 117 (117)
T 2r78_A 64 ------------------DSGWAAASLARIVGGEPLREERTVWTRNGDQLTVELSAHLLP--DGK---ILGIARDVS 117 (117)
T ss_dssp ------------------TTSHHHHHHHHHHTTCCEEEEEEEECTTSCEEEEEEEEEECT--TSC---EEEEEEC--
T ss_pred ------------------chhHHHHHHHHHHcCCcEEEEEEEEecCCCEEEEEEEEEEec--CCe---EEEEEEeCC
Confidence 111223455667778888899999999999999999999986 465 678899997
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=7.9e-15 Score=124.10 Aligned_cols=118 Identities=82% Similarity=1.301 Sum_probs=105.7
Q ss_pred HHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhh
Q 042772 69 LATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKK 148 (489)
Q Consensus 69 ~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (489)
+..+++.+++++++.|+..+++.|+++|++|++++||+.++++|+++..+..+.
T Consensus 4 l~~~~~~~~~~i~~~d~~~~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~-------------------------- 57 (146)
T 2v0u_A 4 LATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPE-------------------------- 57 (146)
T ss_dssp CCCTGGGSSSCEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTT--------------------------
T ss_pred HHHHHhcCCCcEEEEcCCCCCceEEEEcHHHHHHHCcCHHHHcCCCHHHhcCCc--------------------------
Confidence 456788999999999985557999999999999999999999999987766553
Q ss_pred cccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCcccc
Q 042772 149 NYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVE 228 (489)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~ke 228 (489)
........+..++..+..+..++...+++|..+|+.+...|++|.+|.+.+++++.+|||++++
T Consensus 58 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~ 121 (146)
T 2v0u_A 58 ----------------TDRATVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVR 121 (146)
T ss_dssp ----------------SCHHHHHHHHHHHHTTCCEEEEEEEECTTCCEEEEEEEEEEEECTTSCEEEEEEEEEEESSCCC
T ss_pred ----------------CChHHHHHHHHHHhcCCCcceEEEEEecCCcEEEEEEEEEEeECCCCCEEEEEEEEeechHHHH
Confidence 5566677888899999999999999999999999999999999999999999999999999987
|
| >1d06_A Nitrogen fixation regulatory protein FIXL; oxygen sensor, histidine kinase, PAS, high-resolution, two-C system, signaling protein; HET: HEM; 1.40A {Sinorhizobium meliloti} SCOP: d.110.3.2 PDB: 1ew0_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=8.4e-15 Score=125.75 Aligned_cols=111 Identities=18% Similarity=0.252 Sum_probs=85.3
Q ss_pred hhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHh
Q 042772 67 IDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALW 146 (489)
Q Consensus 67 ~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (489)
..+..+++.++++|+++|+ +|.|+++|++|++++||+++|++|+++..|..+.
T Consensus 16 ~~~~~l~~~~~d~i~~~d~---~g~i~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~------------------------ 68 (130)
T 1d06_A 16 AHLRSILDTVPDATVVSAT---DGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEP------------------------ 68 (130)
T ss_dssp SCHHHHHTTCSSEEEEEET---TSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTT------------------------
T ss_pred HHHHHHHhhCcCeEEEECC---CCeEEEEcHHHHHHHCCCHHHHcCCcHHHHCCch------------------------
Confidence 4578899999999999999 9999999999999999999999999988776443
Q ss_pred hhcccccccccCcccccCCCHHHHHHHHHHHHcCCc----EEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeecc
Q 042772 147 KKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQRE----ITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLD 222 (489)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d 222 (489)
........+......+.. ...++..++|||+.||+.++++|+.+. ...+++++.+|
T Consensus 69 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~~~~~~~~~~~~~~--~~~~~~~~~~D 128 (130)
T 1d06_A 69 ------------------YRHEHDGYLQRYMATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRSG--GERFFTGFIRD 128 (130)
T ss_dssp ------------------HHHHHHHHHHHHHHHCCCSSTTSCEEEEEECTTSCEEEEEEEEEEEEET--TEEEEEEEEEE
T ss_pred ------------------hHHHHHHHHHHHHhcCCccccCCeeEEEEEeCCCCEEEEEEEEEEEEEC--CeEEEEEEEEE
Confidence 111111223333333321 234667789999999999999999874 34568999999
Q ss_pred CC
Q 042772 223 GS 224 (489)
Q Consensus 223 ~T 224 (489)
||
T Consensus 129 IT 130 (130)
T 1d06_A 129 LT 130 (130)
T ss_dssp CC
T ss_pred Cc
Confidence 97
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.5e-14 Score=118.64 Aligned_cols=116 Identities=19% Similarity=0.228 Sum_probs=102.3
Q ss_pred hHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhh
Q 042772 68 DLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWK 147 (489)
Q Consensus 68 ~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (489)
.+..+++.+++++++.|+ ++.|+++|++|++++||++++++|+++..+..+.
T Consensus 8 ~~~~~~~~~~~~i~~~d~---~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~------------------------- 59 (124)
T 3lyx_A 8 QRAKAFDYVFDAIVVTDL---QGFIIDWNKGSETLYGYSKEQAIGQPVNMLHVPG------------------------- 59 (124)
T ss_dssp HHHHGGGTCSSEEEEEET---TCBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTT-------------------------
T ss_pred HHHHHHhhcCceEEEECC---CCcEeehhhHHHHHhCCCHHHHcCCCHHHhcCcc-------------------------
Confidence 467889999999999999 9999999999999999999999999987555443
Q ss_pred hcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCccc
Q 042772 148 KNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHV 227 (489)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~k 227 (489)
........+..++..++.+..++...+++|+.+|+.+++.|+.|..|.+.+++++.+|||+++
T Consensus 60 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~ 122 (124)
T 3lyx_A 60 -----------------DTEHITSEVISAVENQGKWTGEIRMLHKDGHIGWIESMCVPIYGENYQMVGALGINRDITKRK 122 (124)
T ss_dssp -----------------THHHHHHHHHHHHHHTSCEEEEEEEECTTSCEEEEEEEEEEEECSTTCEEEEEEEEEECSCC-
T ss_pred -----------------hhhHHHHHHHHHHHcCCcccceEEEEccCCCEEEEEEEEEEEECCCCCEEEEEEEEecchhhh
Confidence 344455678888899999999999999999999999999999999999999999999999987
Q ss_pred c
Q 042772 228 E 228 (489)
Q Consensus 228 e 228 (489)
+
T Consensus 123 ~ 123 (124)
T 3lyx_A 123 K 123 (124)
T ss_dssp -
T ss_pred c
Confidence 5
|
| >1byw_A Protein (human ERG potassium channel); PAS domain, potassium channel domain, membrane protein; 2.60A {Homo sapiens} SCOP: d.110.3.6 | Back alignment and structure |
|---|
Probab=99.58 E-value=1.7e-14 Score=115.74 Aligned_cols=107 Identities=26% Similarity=0.498 Sum_probs=94.5
Q ss_pred CcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCC--ccccccccchhhhhhccccccchhHHHHHHHhhhccccccc
Q 042772 78 KNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRN--CSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNF 155 (489)
Q Consensus 78 ~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~--~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (489)
.+|+++|+..+++.|+|+|++|++++||+++|++|++ ..++..+.
T Consensus 2 ~~i~i~d~~~~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~--------------------------------- 48 (110)
T 1byw_A 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPC--------------------------------- 48 (110)
T ss_dssp CEEEEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTT---------------------------------
T ss_pred CCEEEEeccCCCCcEEEECHHHHHHhCCCHHHHccCCCccccccCCc---------------------------------
Confidence 5899999877789999999999999999999999998 55555443
Q ss_pred ccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCcc
Q 042772 156 TLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDH 226 (489)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~ 226 (489)
........+..++..+..+..++..++++|+.+|+.+++.|+++.+|.+.+++++.+|||++
T Consensus 49 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DiTe~ 110 (110)
T 1byw_A 49 ---------TQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEK 110 (110)
T ss_dssp ---------CCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEEEEEEEEEEEECTTCCEEEEEEEEEEEEEC
T ss_pred ---------CCHHHHHHHHHHHhcCCCceEEEEEEcCCCCEEEEEEEEEEeecCCCCEEEEEEEEEeccCC
Confidence 45566677888888999999999999999999999999999999999999999999999974
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} | Back alignment and structure |
|---|
Probab=99.57 E-value=6.3e-15 Score=129.92 Aligned_cols=122 Identities=33% Similarity=0.559 Sum_probs=108.7
Q ss_pred hHHHHHHhccCcEEEECCCCCCC---CEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHH
Q 042772 68 DLATTLERIEKNFVITDPRIPDN---PIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLA 144 (489)
Q Consensus 68 ~~~~~~~~~~~~~~i~d~~~~~~---~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (489)
.+..+++.+++++++.|. ++ .|+++|++|++++||+.++++|+++..+..+.
T Consensus 26 ~~~~i~~~~~~~i~~~d~---~~~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~---------------------- 80 (162)
T 3sw1_A 26 LLQSMVDASNDGIVVAEK---EGDDTILIYVNAAFEYLTGYSRDEILYQDCRFLQGDD---------------------- 80 (162)
T ss_dssp HHHHHHHTCSSEEEEEEE---ETTEEEEEEECHHHHHHHTCCHHHHTTSBGGGGTTTC----------------------
T ss_pred HHHHHHhhccCcEEEEeC---CCCccEEEEECHHHHHHHCCCHHHHcCCCcceecCCC----------------------
Confidence 467889999999999999 88 99999999999999999999999987665443
Q ss_pred HhhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCC
Q 042772 145 LWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGS 224 (489)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~T 224 (489)
........+..++..+..+..++..++++|+.+|+.+.+.|+.|.+|.+.+++++.+|||
T Consensus 81 --------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~i~~~~g~~~~~~~~~~DiT 140 (162)
T 3sw1_A 81 --------------------RDQLGRARIRKAMAEGRPCREVLRNYRKDGSAFWNELSITPVKSDFDQRTYFIGIQKDVS 140 (162)
T ss_dssp --------------------CCCHHHHHHHHHHHHTCCEEEEEEEECTTCCEEEEEEEEEEEECSSSSCEEEEEEEEECH
T ss_pred --------------------cCHHHHHHHHHHHhcCCCCcceEEEECCCCCEEEEEEEEEEeecCCCCEEEEEEEEEeCc
Confidence 455566778889999999999999999999999999999999999999999999999999
Q ss_pred cccccccccc
Q 042772 225 DHVEPLRNRL 234 (489)
Q Consensus 225 e~ke~e~~~l 234 (489)
++++++++..
T Consensus 141 e~k~~e~~l~ 150 (162)
T 3sw1_A 141 RQVELERELA 150 (162)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9998766543
|
| >3d72_A Vivid PAS protein VVD; circadian, photoreceptor, blue-light, LOV, signaling protein; HET: FAD; 1.65A {Neurospora crassa} PDB: 3is2_A* 2pd8_A* 3hjk_A* 2pdr_A* 2pd7_A* 2pdt_A* 3hji_A* 3rh8_B* | Back alignment and structure |
|---|
Probab=99.53 E-value=4.8e-14 Score=122.88 Aligned_cols=120 Identities=31% Similarity=0.624 Sum_probs=95.3
Q ss_pred HHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhcc
Q 042772 71 TTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNY 150 (489)
Q Consensus 71 ~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (489)
.+++.. ++++++|..-+++.|+|+|++|++++||+++|++|+++..+..++.- ..+++
T Consensus 30 ~~~~~~-~~i~~~d~~d~~g~i~~~N~a~~~l~G~~~~el~g~~~~~l~~~~~~--~~~~~------------------- 87 (149)
T 3d72_A 30 GPVDTS-VALILCDLKQKDTPIVYASEAFLYMTGYSNAEVLGRNCRFLQSPDGM--VKPKS------------------- 87 (149)
T ss_dssp CSCCTT-SCEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGGSTTSC--CCTTC-------------------
T ss_pred HhhcCC-ccEEEEeccCCCCcEEEECHHHHHHHCcCHHHHcCCChhHhCCcccc--ccccc-------------------
Confidence 455554 89999993223999999999999999999999999998877654300 00000
Q ss_pred cccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeecc
Q 042772 151 GVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLD 222 (489)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d 222 (489)
.....+......+++++..++.+..++..+++||+.+|+.++++|++|.+|++.+++++.+|
T Consensus 88 ----------~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~i~~~~g~~~~~v~~~~D 149 (149)
T 3d72_A 88 ----------TRKYVDSNTINTMRKAIDRNAEVQVEVVNFKKNGQRFVNFLTMIPVRDETGEYRYSMGFQCE 149 (149)
T ss_dssp ----------CCSSSCHHHHHHHHHHHHHTCCEEEEEEEECTTCCEEEEEEEEEEEECTTSSEEEEEEECCC
T ss_pred ----------cccccChHHHHHHHHHHHCCCceEEEEEEECCCCCEEEEEEEEEEEEcCCCCEEEEEEEEeC
Confidence 00002667778889999999999999999999999999999999999999999999999877
|
| >3mxq_A Sensor protein; PSI2, MCSG, structural genomics, protein structure initiativ midwest center for structural genomics; 2.78A {Vibrio cholerae o1 biovar el tor} | Back alignment and structure |
|---|
Probab=99.52 E-value=3.9e-14 Score=128.02 Aligned_cols=123 Identities=13% Similarity=0.138 Sum_probs=91.7
Q ss_pred HHHhhhhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHH
Q 042772 62 DIRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLY 141 (489)
Q Consensus 62 ~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 141 (489)
.++....+.+++++++++|+++|. ++.|+++|+++++++||+++|++|+++..+....
T Consensus 17 ~~~~~~~l~~il~~~~~gi~v~D~---~g~I~~~N~a~~~~~G~~~~eviG~~~~~~~p~~------------------- 74 (152)
T 3mxq_A 17 MAKSRLLLSELLDQLSFALCIVRN---DYVIVKVNEYFESRVIFDGETMQGKNILELFPES------------------- 74 (152)
T ss_dssp HHHHHHHHHHHHHHHCCEEEEEET---TSBEEEECHHHHHTSSSCHHHHTTSBHHHHSGGG-------------------
T ss_pred HHHHHHHHHHHHhcCCCCEEEEcC---CCEEEEECHHHHHHHCcCHHHHCCCCHHHhcCCh-------------------
Confidence 334455689999999999999999 9999999999999999999999999986554221
Q ss_pred HHHHhhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEE---------EEEee---ecCCCeeeEEEeecccccC
Q 042772 142 FLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITV---------QLINY---TKSGKKFWNLFHLQPMRDH 209 (489)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~---~k~g~~~~~~~~~~p~~~~ 209 (489)
.......+++++..+.+... ++.++ +++|..+|..++++|++|.
T Consensus 75 ------------------------~~~~~~~l~~vl~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ti~Pl~d~ 130 (152)
T 3mxq_A 75 ------------------------ADYLKRKIDTALVIESSSFSSWEQKPHLLPFKSSRPVSGEEEQMYQNLEVIPIHSE 130 (152)
T ss_dssp ------------------------HHHHHHHHHHHHHHTSCEEEECCSSSCSSCC----------CCEEEEEEEEEEECT
T ss_pred ------------------------HHHHHHHHHHHHhcCCceeeecccccccccccccCCCCCCCcEEEEEEEEEEEECC
Confidence 12234567888877765322 12232 3577888999999999999
Q ss_pred CCCeeEEeeeeccCCcccccc
Q 042772 210 KGELQYFIGVQLDGSDHVEPL 230 (489)
Q Consensus 210 ~g~~~~~~~~~~d~Te~ke~e 230 (489)
+|++.+++.+.+|||+++.+.
T Consensus 131 ~G~v~gv~~ii~DVTe~~~a~ 151 (152)
T 3mxq_A 131 DGTIEHVCLCVYDVTIQASQQ 151 (152)
T ss_dssp TSCEEEEEEEEEEEECC----
T ss_pred CCCEEEEEEEEEECCHHHhcc
Confidence 999999999999999998653
|
| >2l0w_A Potassium voltage-gated channel, subfamily H (EAG member 2, isoform CRA_B; HERG, PAS domain, voltage-gated potassium channel, membrane; NMR {Homo sapiens} PDB: 2l1m_A 2l4r_A | Back alignment and structure |
|---|
Probab=99.52 E-value=9.8e-14 Score=116.40 Aligned_cols=116 Identities=25% Similarity=0.483 Sum_probs=102.0
Q ss_pred HHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCC--ccccccccchhhhhhccccccchhHHHHHHHh
Q 042772 69 LATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRN--CSFLELTEYTREEILGRNCSTYTFMLYFLALW 146 (489)
Q Consensus 69 ~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~--~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (489)
+...++.++++++++|+..+++.|+++|++|++++||+.++++|++ ..++..+.
T Consensus 21 ~~~~~~~~~~~i~~~d~~~~~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~~------------------------ 76 (138)
T 2l0w_A 21 IIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPR------------------------ 76 (138)
T ss_dssp HHHHHTTTTSEEEEEESSSTTCBEEEECSHHHHHHSCCHHHHTTSBTTCGGGCCTT------------------------
T ss_pred HHHHHhcCCCCEEEEecCCCCCEEEEeCHHHHHHhCCCHHHHcCCCCcccccCCcc------------------------
Confidence 5667788999999999866689999999999999999999999998 56665543
Q ss_pred hhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCcc
Q 042772 147 KKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDH 226 (489)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~ 226 (489)
........+..++..+..+..++..++++|..+|+.+++.|+.+..|.+.+++++.+|||++
T Consensus 77 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~ 138 (138)
T 2l0w_A 77 ------------------TQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEK 138 (138)
T ss_dssp ------------------CCHHHHHHHHHHTTCSSCEEEEEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEEEEEC
T ss_pred ------------------cchhHHHHHHHHHhhcCCceeEEEEECCCCCEEEEEEEEEEEeCCCCCEEEEEEEEEeccCC
Confidence 45556677888888888899999999999999999999999999999999999999999974
|
| >2kdk_A ARYL hydrocarbon receptor nuclear translocator-LI 2; circadian clock, PAS domain, transcription, activator, biolo rhythms, DNA-binding, nucleus; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.8e-13 Score=114.88 Aligned_cols=112 Identities=13% Similarity=0.141 Sum_probs=90.4
Q ss_pred HHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhccc
Q 042772 72 TLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYG 151 (489)
Q Consensus 72 ~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (489)
+++.+.+.+++.|+ ++.|+|+|++|++++||+++|++|+++..+..++
T Consensus 8 ~~~~~~~~i~~~d~---~g~i~~~N~~~~~~~G~~~~el~g~~~~~~~~p~----------------------------- 55 (121)
T 2kdk_A 8 INVKPTEFITRFAV---NGKFVYVDQRATAILGYLPQELLGTSCYEYFHQD----------------------------- 55 (121)
T ss_dssp CCCCSSEEEEEECT---TSBEEEECTHHHHHTCCCTTTSBTSBTTTTBCSS-----------------------------
T ss_pred cccCCccEEEEECC---CeeEEEEChhHHHHHCCCHHHHcCCcHHHeeCHH-----------------------------
Confidence 45677889999999 9999999999999999999999999876555453
Q ss_pred ccccccCcccccCCCHHHHHHHHHHHHcCC-cEEEEEEeeecCCCeeeEEEeecccccCC-CCeeEEeeeeccCCcccc
Q 042772 152 VYNFTLGCCLEISSDQATVSKIRDAVREQR-EITVQLINYTKSGKKFWNLFHLQPMRDHK-GELQYFIGVQLDGSDHVE 228 (489)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~k~g~~~~~~~~~~p~~~~~-g~~~~~~~~~~d~Te~ke 228 (489)
........+.+++..+. ....+....+|||+.+|+..+..|++|.. |.+.+++++.+||++.++
T Consensus 56 -------------d~~~~~~~~~~~~~~~~~~~~~e~r~~~~dG~~~~~~~~~~~~~d~~~~~~~~~v~~~~~i~~~~~ 121 (121)
T 2kdk_A 56 -------------DHNNLTDKHKAVLQSKEKILTDSYKFRAKDGSFVTLKSQWFSFTNPDTKELEYIVSVNTLVLGHSE 121 (121)
T ss_dssp -------------SHHHHHHHHHHHHTSSSCEEEEEEEEECSSSCEEEEEEEEEEEECCSSSCEEEEEEEEECCSSCCC
T ss_pred -------------HHHHHHHHHHHHHhCCCCCccEEEEEEEcCCCEEEEEEEEEEEECCCCCeeeEEEEEEEeccccCC
Confidence 22333445566666544 45778888999999999999999999986 567888999999998753
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} | Back alignment and structure |
|---|
Probab=99.48 E-value=2.7e-13 Score=111.03 Aligned_cols=109 Identities=17% Similarity=0.142 Sum_probs=87.7
Q ss_pred HHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhh
Q 042772 69 LATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKK 148 (489)
Q Consensus 69 ~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (489)
+..+++.+++++++.|+ ++.|+++|++|++++||+++|++|+++..+. ++
T Consensus 5 ~~~~~~~~~~~i~~~d~---~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~-~~-------------------------- 54 (114)
T 3luq_A 5 LRLFTEHAPAALAMFDR---EMRYLAVSRRWREDYGLGDGDILGMSHYDIF-PE-------------------------- 54 (114)
T ss_dssp HHHHHHTCSSEEEEEET---TCBEEEECHHHHHHTTCCSSCCTTCBHHHHC-TT--------------------------
T ss_pred HHHHHhcCCceEEEEcC---CcEEEEECHHHHHHHCCCHHHHcCCcHHHHC-Cc--------------------------
Confidence 67889999999999998 9999999999999999999999999976554 32
Q ss_pred cccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEE-EeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCC
Q 042772 149 NYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQL-INYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGS 224 (489)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~T 224 (489)
........+..++ .++....+. ...+++|+..|+.+++.|++|.+|.+.+++++.+|||
T Consensus 55 ----------------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~g~~~~~~~~~~p~~~~~g~~~~~~~~~~DIT 114 (114)
T 3luq_A 55 ----------------IGEEWKSVHRRGL-AGEVIRVEEDCFVRADGRTQWLRWEVRPWYEGEGRVGGVVIFTEDIT 114 (114)
T ss_dssp ----------------CCHHHHHHHHHHH-TTCCEEEEEEEEEC--CCEEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred ----------------cHHHHHHHHHHHh-cCCcceeeeeEEEcCCCcEEEEEEEEEEeECCCCCEEEEEEEEeeCC
Confidence 2333333444444 455555544 6778999999999999999999999999999999997
|
| >3nja_A Probable ggdef family protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; 2.37A {Chromobacterium violaceum} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.3e-13 Score=114.71 Aligned_cols=116 Identities=11% Similarity=0.058 Sum_probs=88.6
Q ss_pred hHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCcccc--ccccchhhhhhccccccchhHHHHHHH
Q 042772 68 DLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFL--ELTEYTREEILGRNCSTYTFMLYFLAL 145 (489)
Q Consensus 68 ~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (489)
.+..+++.++.++++.|+ ++.++++|++|.+++||++++++|....++ ..++
T Consensus 8 ~l~~~~~~~~~~i~~~d~---~~~~~~~n~~~~~~~G~~~~~~~~~~~~~~~~~~~~----------------------- 61 (125)
T 3nja_A 8 LLHTAESDAGIGSWVLHM---ESGRLEWSQAVHDIFGTDSATFDATEDAYFQRVHPD----------------------- 61 (125)
T ss_dssp ---------CCEEEEEET---TTTEEEECHHHHHHHTCCTTTCCCBHHHHHHHBCTT-----------------------
T ss_pred HHHHHHHhCCeeEEEEEc---CCCcEEECHHHHHHhCCCcccccccHHHHHhhcChh-----------------------
Confidence 367789999999999999 999999999999999999999999332222 2221
Q ss_pred hhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCc
Q 042772 146 WKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSD 225 (489)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te 225 (489)
........+..++..+..+..++...+++|+..|+.+...|++|.+|.+.+++++.+|||+
T Consensus 62 -------------------d~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~g~~~DITe 122 (125)
T 3nja_A 62 -------------------DRARVRRELDRHVLGDRPFDVEYRIVRPDGQVRELLERNHIQRQASGQVDHLWGTVIDMTE 122 (125)
T ss_dssp -------------------THHHHHHHHHHHHHSCCCEEEEEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCC
T ss_pred -------------------HHHHHHHHHHHHHhcCCCceEEEEEECCCCCEEEEEEeeEEEECCCCCEEEEEEEEEeccc
Confidence 2334455677788888889999999999999999999999999999999999999999999
Q ss_pred ccc
Q 042772 226 HVE 228 (489)
Q Consensus 226 ~ke 228 (489)
+|+
T Consensus 123 ~k~ 125 (125)
T 3nja_A 123 HKQ 125 (125)
T ss_dssp ---
T ss_pred ccC
Confidence 874
|
| >3k3c_A Protein RV1364C/MT1410; sensor, PAS, signal transduction, fatty-acid binding, sigma regulator, signaling protein; HET: PLM; 1.62A {Mycobacterium tuberculosis} PDB: 3k3d_A | Back alignment and structure |
|---|
Probab=99.47 E-value=6.4e-14 Score=123.49 Aligned_cols=120 Identities=13% Similarity=0.119 Sum_probs=97.5
Q ss_pred hhHHHHHHhccCcEEEEC-CCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHH
Q 042772 67 IDLATTLERIEKNFVITD-PRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLAL 145 (489)
Q Consensus 67 ~~~~~~~~~~~~~~~i~d-~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (489)
..+..+++.++.++++.| + ++.|+++|++|++++||+ +++|+++..+..+.
T Consensus 17 ~~~~~~~~~~~~~i~~~d~~---~~~i~~~N~~~~~~~g~~--~~~G~~~~~~~~~~----------------------- 68 (158)
T 3k3c_A 17 EDVRRIFEHIPAILVGLEGP---DHRFVAVNAAYRGFSPLL--DTVGQPAREVYPEL----------------------- 68 (158)
T ss_dssp HHHHHHHHHCSSEEEEEETT---TTEEEEECHHHHHHCTTC--CSTTSBHHHHSGGG-----------------------
T ss_pred HHHHHHHhcCCceEEEEECC---CcEeHHHHHHHHHHcCCc--hhcCCcHHHhCCch-----------------------
Confidence 457889999999999999 8 999999999999999999 99999976554432
Q ss_pred hhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEee--e--cC-CCeeeEEEeecccccCCCCeeEEeeee
Q 042772 146 WKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINY--T--KS-GKKFWNLFHLQPMRDHKGELQYFIGVQ 220 (489)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~--k~-g~~~~~~~~~~p~~~~~g~~~~~~~~~ 220 (489)
........+++++..+++...+...+ . .+ |...|+.++++|++|.+|.+.+++++.
T Consensus 69 -------------------~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~pi~~~~g~~~g~~~~~ 129 (158)
T 3k3c_A 69 -------------------EGQQIYEMLDRVYQTGEPQSGSEWRLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIV 129 (158)
T ss_dssp -------------------GGTTHHHHHHHHHHHCCCEEEEEEEEEEESSSSCEEEEEEEEEEEEEECTTSCEEEEEEEE
T ss_pred -------------------hHHHHHHHHHHHHHhCCcccccceeEEeccCCCCcceEEEEEEEEEeECCCCCEEEEEEEE
Confidence 22234456788888888866554333 2 22 778999999999999999999999999
Q ss_pred ccCCccccccccc
Q 042772 221 LDGSDHVEPLRNR 233 (489)
Q Consensus 221 ~d~Te~ke~e~~~ 233 (489)
+|||++++++++.
T Consensus 130 ~DITe~k~~e~~l 142 (158)
T 3k3c_A 130 DDVTSRVRARQAA 142 (158)
T ss_dssp EECHHHHHHHHHH
T ss_pred EehhHHHHHHHHH
Confidence 9999999877654
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.5e-13 Score=113.76 Aligned_cols=110 Identities=15% Similarity=0.178 Sum_probs=87.6
Q ss_pred HHhhhhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHH
Q 042772 63 IRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYF 142 (489)
Q Consensus 63 ~~~~~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 142 (489)
++....+..+++.+++++++.|+ ++.|+++|++|++++||+++|++|+++..+.... .
T Consensus 9 e~~~~~~~~~~~~~~~~i~~~d~---~g~i~~~N~~~~~l~G~~~~el~g~~~~~~~~~~-~------------------ 66 (118)
T 3olo_A 9 ELEFKFAHYLINNAVEASFCLGD---NWQFLYVNDATCRMTEYSREQLLSMNLQDIDVDF-A------------------ 66 (118)
T ss_dssp HHHHHHHHHHHHHCSSEEEEECT---TSBEEEECHHHHHHHCCCHHHHTTCBGGGTBTTG-G------------------
T ss_pred HHHHHHHHHHHhcCCceEEEECC---CCcEEEEHHHHHHHHCCCHHHHhCCChhhccccc-C------------------
Confidence 34445577899999999999999 9999999999999999999999999987665332 0
Q ss_pred HHHhhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeecc
Q 042772 143 LALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLD 222 (489)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d 222 (489)
... +..+..+..+..+....+++|+.+|+.++..|+.+.. ..+++++.+|
T Consensus 67 ---------------------~~~-------~~~~~~~~~~~~e~~~~~~~g~~~~~~~~~~~~~~~~--~~~~~~~~~D 116 (118)
T 3olo_A 67 ---------------------LHD-------WEEIRQKNNYTFKTRYRSQSGRIFLVEMSLTFLEDQE--RRFSCVFVRE 116 (118)
T ss_dssp ---------------------GSC-------HHHHHHHSEEEEEEEEECTTCCEEEEEEEEEEEEETT--EEEEEEEEEE
T ss_pred ---------------------HHH-------HHHHHhcCcEEEEEEEEccCCCEEEEEEEEEEEEECC--ccEEEEEEEe
Confidence 011 2334456678889889999999999999999998753 3467899999
Q ss_pred CC
Q 042772 223 GS 224 (489)
Q Consensus 223 ~T 224 (489)
||
T Consensus 117 IT 118 (118)
T 3olo_A 117 KS 118 (118)
T ss_dssp C-
T ss_pred CC
Confidence 97
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} | Back alignment and structure |
|---|
Probab=99.46 E-value=6.4e-13 Score=112.26 Aligned_cols=119 Identities=19% Similarity=0.185 Sum_probs=82.2
Q ss_pred HHHHHHHHHhhh----hHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhc--CCCccccccccchhhhhh
Q 042772 56 RAERERDIRQGI----DLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEIL--GRNCSFLELTEYTREEIL 129 (489)
Q Consensus 56 ~~~~~~~~~~~~----~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~--g~~~~~l~~~~~~~~~~~ 129 (489)
+++|++.+++.. .+..+++.++++|+++|+ +|.|+++|++|++++||+++|++ |+++..+..
T Consensus 2 ~t~r~~~e~~L~~~~~~~~~l~e~~~~~i~~~d~---~g~i~~~N~a~~~~~G~~~~el~g~g~~~~~~~~--------- 69 (126)
T 3bwl_A 2 NAERKRREKRLEETSSRLEALFENSPDMIDVLDA---DGTICEVNQRFCAELGYDESEVLGRSIWEFDLMF--------- 69 (126)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHCSSEEEEECT---TCBEEEECHHHHHHHTCCGGGTTTSBGGGTBTTC---------
T ss_pred chhHHHHHHHHHHHHHHHHHHHhhCCcEEEEEcC---CCCEEEEcHHHHHHhCCCHHHHhhCCCchhhccC---------
Confidence 456665555443 577899999999999999 99999999999999999999995 555432221
Q ss_pred ccccccchhHHHHHHHhhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccC
Q 042772 130 GRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDH 209 (489)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~ 209 (489)
+...+.........+.....+....+|||+.+|+.++..|+.+
T Consensus 70 ------------------------------------~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~~~~- 112 (126)
T 3bwl_A 70 ------------------------------------DAEDVQTQLSGFSVDERRKFEGLYERRDGSTMSVEVHLLRFNL- 112 (126)
T ss_dssp ------------------------------------CHHHHHHHHHTCCTTCEEEEEEEEECTTSCEEEEEEEEEEEEE-
T ss_pred ------------------------------------CHHHHHHHHHHHhcCCCcceEEEEEeCCCCEEEEEEEeEEEec-
Confidence 1111111111111233445566667999999999999888743
Q ss_pred CCCeeEEeeeeccCC
Q 042772 210 KGELQYFIGVQLDGS 224 (489)
Q Consensus 210 ~g~~~~~~~~~~d~T 224 (489)
.|. .+++++.+|||
T Consensus 113 ~~~-~~~~~~~~DIT 126 (126)
T 3bwl_A 113 EGE-DRFLAISRDIT 126 (126)
T ss_dssp TTE-EEEEEEEEEC-
T ss_pred CCc-EEEEEEEEeCC
Confidence 444 35788999997
|
| >3h9w_A Diguanylate cyclase with PAS/PAC sensor; alpha-beta protein., structural genomics, PSI-2, protein STR initiative; 1.90A {Marinobacter aquaeolei} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.6e-13 Score=114.70 Aligned_cols=112 Identities=12% Similarity=0.041 Sum_probs=90.1
Q ss_pred ccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCc-cccccccchhhhhhccccccchhHHHHHHHhhhcccccc
Q 042772 76 IEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNC-SFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYN 154 (489)
Q Consensus 76 ~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (489)
+.++++..|. +++.++|+|++|++++||+++|++|... ..+..|+
T Consensus 2 a~~giw~~d~--~~~~~~~~n~~~~~l~G~~~~e~~~~~~~~~~ihpd-------------------------------- 47 (115)
T 3h9w_A 2 TKAIPWKINW--QTMAFEYIGPQIEALLGWPQGSWKSVEDWATRMHPE-------------------------------- 47 (115)
T ss_dssp -CCEEEEEET--TTTEEEEECTHHHHHHCSCGGGCCBHHHHHHSBCHH--------------------------------
T ss_pred cceEEEEEEc--CCCcEEEEChhHHHHhCCChHHccCHHHHHHhcCHH--------------------------------
Confidence 3578888885 3888999999999999999999998221 1122232
Q ss_pred cccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCccccccc
Q 042772 155 FTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPLR 231 (489)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~ke~e~ 231 (489)
........+.+++..+..+..++...++||+..|+.....|++|.+|+++.++|+..|||++|++++
T Consensus 48 ----------d~~~~~~~~~~~~~~~~~~~~e~r~~~~dG~~~w~~~~~~~~~d~~G~~~~~~G~~~Dit~~k~~~~ 114 (115)
T 3h9w_A 48 ----------DQEWVVNFCVKQSECGVDHEADYRALHRDGHYVWIRDVVHVVRDDSGEVEALIGFMFDISLEHHHHH 114 (115)
T ss_dssp ----------HHHHHHHHHHHHHHTTCCEEEEEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECGGGGC---
T ss_pred ----------HHHHHHHHHHHHHhcCCcccEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEeccCccccccc
Confidence 2334456678888888889999999999999999999999999999999999999999999998775
|
| >3mr0_A Sensory box histidine kinase/response regulator; PAS fold, structural genomics, PSI-2; HET: PG5; 1.49A {Burkholderia thailandensis} | Back alignment and structure |
|---|
Probab=99.45 E-value=3.5e-13 Score=117.85 Aligned_cols=122 Identities=13% Similarity=0.165 Sum_probs=102.9
Q ss_pred hHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccc--cccccchhhhhhccccccchhHHHHHHH
Q 042772 68 DLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSF--LELTEYTREEILGRNCSTYTFMLYFLAL 145 (489)
Q Consensus 68 ~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~--l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (489)
.+..+++.+..+++..|+ ++.++|+|++|.+++||+.+++.|....+ +..|+
T Consensus 10 rl~~~~~~~~~g~w~~d~---~~~~~~~s~~~~~~~G~~~~~~~~~~~~~~~~ihpd----------------------- 63 (142)
T 3mr0_A 10 RFQLAVSGASAGLWDWNP---KTGAMYLSPHFKKIMGYEDHELPDEITGHRESIHPD----------------------- 63 (142)
T ss_dssp CHHHHHHHTTCEEEEECT---TTCCEEECHHHHHHTTCCGGGSCSEEC---CCBCTT-----------------------
T ss_pred HHHHHHHhCCcEEEEEEc---CCCeEEECHHHHHHhCCCccccCCCHHHHHhhcCHH-----------------------
Confidence 467889999999999999 88999999999999999999988753322 22232
Q ss_pred hhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCc
Q 042772 146 WKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSD 225 (489)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te 225 (489)
........+..++..+.++..+....++||+..|+.....|++|.+|.+..++|+..|||+
T Consensus 64 -------------------D~~~~~~~~~~~~~~~~~~~~e~r~~~~~G~~~w~~~~~~~~~d~~g~~~~~~G~~~DITe 124 (142)
T 3mr0_A 64 -------------------DRARVLAALKAHLEHRDTYDVEYRVRTRSGDFRWIQSRGQALWNSAGEPYRMVGWIMDVTD 124 (142)
T ss_dssp -------------------THHHHHHHHHHHHHHCCCEEEEEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECHH
T ss_pred -------------------HHHHHHHHHHHHHhCCCceEEEEEEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEcCch
Confidence 3344556788888889999999999999999999999999999999999999999999999
Q ss_pred ccccccccc
Q 042772 226 HVEPLRNRL 234 (489)
Q Consensus 226 ~ke~e~~~l 234 (489)
+|+++++..
T Consensus 125 rk~~E~~L~ 133 (142)
T 3mr0_A 125 RKRDEDALR 133 (142)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 998876653
|
| >3kx0_X Uncharacterized protein RV1364C/MT1410; PAS domain, sensory domain, mycobacteium tuberculos molecule binding domain; 2.30A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.41 E-value=4.4e-13 Score=122.87 Aligned_cols=119 Identities=12% Similarity=0.121 Sum_probs=95.4
Q ss_pred hhHHHHHHhccCcEEEEC-CCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHH
Q 042772 67 IDLATTLERIEKNFVITD-PRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLAL 145 (489)
Q Consensus 67 ~~~~~~~~~~~~~~~i~d-~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (489)
..+..+++.+++++++.| + ++.|+++|++|++++||+ +++|+++..+..+.
T Consensus 37 ~~l~~l~~~~~~~i~~~d~~---~g~i~~~N~a~~~l~G~~--~~~G~~~~~~~~~~----------------------- 88 (185)
T 3kx0_X 37 EDVRRIFEHIPAILVGLEGP---DHRFVAVNAAYRGFSPLL--DTVGQPAREVYPEL----------------------- 88 (185)
T ss_dssp HHHHHHHHHCSSEEEEEETT---TTEEEEECHHHHHHCCCC--SCTTSBHHHHCTTS-----------------------
T ss_pred HHHHHHHhcCCceEEEEECC---CcEEEEEcHHHHHHcCCc--cccCCcHHHHCCch-----------------------
Confidence 347889999999999999 8 999999999999999999 99999976554332
Q ss_pred hhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeee---cC--CCeeeEEEeecccccCCCCeeEEeeee
Q 042772 146 WKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYT---KS--GKKFWNLFHLQPMRDHKGELQYFIGVQ 220 (489)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---k~--g~~~~~~~~~~p~~~~~g~~~~~~~~~ 220 (489)
........+++++..++.+..+...++ ++ |...|+.+.+.|++|.+|.+.+++++.
T Consensus 89 -------------------~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gg~~~~~~~~~~pi~~~~g~~~g~~~~~ 149 (185)
T 3kx0_X 89 -------------------EGQQIYEMLDRVYQTGEPQSGSEWRLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIV 149 (185)
T ss_dssp -------------------CSSSSHHHHHHHHHHCCCEEEEEEEEC--------CCEEEEEEEEEEECTTSCEEEEEEEE
T ss_pred -------------------hhhhHHHHHHHHHHcCCcccccceeEEeeccCCCCccEEEEEEEEEEECCCCCEEEEEEEE
Confidence 122233457777878888776544432 22 888999999999999999999999999
Q ss_pred ccCCcccccccc
Q 042772 221 LDGSDHVEPLRN 232 (489)
Q Consensus 221 ~d~Te~ke~e~~ 232 (489)
+|||++++++++
T Consensus 150 ~DITerk~~e~~ 161 (185)
T 3kx0_X 150 DDVTSRVRARQA 161 (185)
T ss_dssp EECHHHHTTCC-
T ss_pred EeCCHHHHHHHH
Confidence 999999998877
|
| >3eeh_A Putative light and redox sensing histidine kinase; structural genomic MCSG, protein structure initiative, midwest center for STRU genomics; HET: PG5; 1.95A {Haloarcula marismortui} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.2e-12 Score=107.82 Aligned_cols=115 Identities=10% Similarity=0.142 Sum_probs=94.8
Q ss_pred hhhHHHHHHhccCcEEEECCCCCC-CCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHH
Q 042772 66 GIDLATTLERIEKNFVITDPRIPD-NPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLA 144 (489)
Q Consensus 66 ~~~~~~~~~~~~~~~~i~d~~~~~-~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (489)
...+..+++.+++++++.|+ + +.|+++|++|++++||++++++|+...++..-.
T Consensus 10 ~~~~~~~~~~~~~~i~~~d~---~~~~i~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~---------------------- 64 (125)
T 3eeh_A 10 ERRVRELTEATNDILWEFTA---DLSEVLVINSAYEDIWGRSVAKLRENPHDFLNGIH---------------------- 64 (125)
T ss_dssp CHHHHHHHSCCCCEEEEEET---TSSCEEEECTHHHHHHSSCHHHHHHCGGGGGGGBC----------------------
T ss_pred HHHHHHHHhcCCceEEEEEc---CCCcEEEecHHHHHHHCCCHHHHccCcHHHHHhcC----------------------
Confidence 34578899999999999999 8 999999999999999999999998743332111
Q ss_pred HhhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCC
Q 042772 145 LWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGS 224 (489)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~T 224 (489)
..+...+......+..++.+..++...+++|+..|+.+...|+.|..|.+.+++++.+|||
T Consensus 65 -------------------~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIT 125 (125)
T 3eeh_A 65 -------------------PEDRELMKDTMQSLMDGESADVECRVNATEEYQRWVWIQGEPITNDAGETVRVAGFARDIT 125 (125)
T ss_dssp -------------------HHHHHHHHHHHHHHHTTCCEEEEEEECGGGTTCEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred -------------------HHHHHHHHHHHHHHHcCCCccEEEEEEcCCCCEEEEEEecEEEECCCCCEEEEEEEEEecC
Confidence 0233333344444778888999999999999999999999999999999999999999997
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} | Back alignment and structure |
|---|
Probab=99.39 E-value=6.7e-13 Score=110.86 Aligned_cols=118 Identities=14% Similarity=0.137 Sum_probs=83.5
Q ss_pred HHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhcc
Q 042772 71 TTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNY 150 (489)
Q Consensus 71 ~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (489)
.+++.+++++++.|+ ++.|+++|++|++++||+.++++|+++..+..+.
T Consensus 3 ~l~~~~~~~i~~~d~---~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~---------------------------- 51 (126)
T 3mjq_A 3 NFLETIEDMILIINR---EGRLLYANTAVPKKLGYTHEELMSMHILTITSAG---------------------------- 51 (126)
T ss_dssp TTGGGCSSEEEEEET---TSBEEEECTHHHHHHSCCHHHHHHSBHHHHHCTT----------------------------
T ss_pred hHHhhCCceEEEEeC---CCcEEEEcHHHHHHHCCCHHHHcCCCHHHHcCch----------------------------
Confidence 467889999999999 9999999999999999999999999876554332
Q ss_pred cccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCcccccc
Q 042772 151 GVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHVEPL 230 (489)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~ke~e 230 (489)
........+...+..+.. ..++...+++|..+|+.+...|+.+ +....++++.+|||++++++
T Consensus 52 --------------~~~~~~~~~~~~~~~~~~-~~~~~~~~~~g~~~~~~~~~~~~~~--~~~~~~~~~~~DITe~k~a~ 114 (126)
T 3mjq_A 52 --------------KMAEGEKILAELFAGKKE-SLPLSLEKKEGTSIPAKARIWQGKW--HNEPCLFAIIKDLSKEERAS 114 (126)
T ss_dssp --------------CHHHHHHHHHHHHHTCCS-EEEEEEECTTSCEEEEEEEEEEEES--SSSEEEEEEEEECC------
T ss_pred --------------hHHHHHHHHHHHHhCCCc-eeEEEEEccCCCEEEEEEEEEeeeE--CCceEEEEEEEechHHHHhh
Confidence 222233344554544444 7788888999999999999998765 34567899999999999888
Q ss_pred ccccch
Q 042772 231 RNRLSE 236 (489)
Q Consensus 231 ~~~l~~ 236 (489)
++....
T Consensus 115 ~~~~~~ 120 (126)
T 3mjq_A 115 SPPFLE 120 (126)
T ss_dssp ------
T ss_pred cccchh
Confidence 776544
|
| >3vol_A Aerotaxis transducer AER2; heme, oxygen sensor protein, PAS, HAMP, cyanoMet, CN-bound, protein; HET: HEM; 2.40A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.37 E-value=7.9e-13 Score=127.22 Aligned_cols=110 Identities=15% Similarity=0.228 Sum_probs=86.2
Q ss_pred hHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhc------------CCChhhhcCCCccccccccchhhhhhcccccc
Q 042772 68 DLATTLERIEKNFVITDPRIPDNPIIFASDSFLELT------------EYTREEILGRNCSFLELTEYTREEILGRNCST 135 (489)
Q Consensus 68 ~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~------------gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~ 135 (489)
.+.++|+.+.++|+++|+ +|.|+|+|++|++++ ||+++|++|+++..+..
T Consensus 23 ~l~~iLd~~~~~vii~D~---~g~I~~~N~a~~~ll~~~~~~~~~~l~G~~~~eliG~~~~~~~~--------------- 84 (233)
T 3vol_A 23 RIKSALDNVSANVMIADN---DLNIIYMNRTVSEMLGRAEADIRKQLPNFDAGRLMGANIDVFHK--------------- 84 (233)
T ss_dssp HHHHHHTTSSSEEEEEET---TSBEEEECHHHHHHHHHTHHHHHTTCTTCCTTSCTTCBGGGGSS---------------
T ss_pred HHHHHHhcCCCcEEEECC---CCcEEEecHHHHHHHHHHHHHHHhhcCCCCHHHHcCCCHHHHcC---------------
Confidence 367899999999999999 999999999999987 88889999998876642
Q ss_pred chhHHHHHHHhhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeE
Q 042772 136 YTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQY 215 (489)
Q Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~ 215 (489)
++.....+++.+. ..+..++ +.+|. |+.++++|++|.+|++.+
T Consensus 85 ------------------------------~~~~~~~~~~~~~--~~~~~~~---~~~g~--~~~~~~~Pi~d~~G~~~g 127 (233)
T 3vol_A 85 ------------------------------NPAHQRHLLANLT--GVHKAEL---NLGGR--RFSLDVVPVFNDANERLG 127 (233)
T ss_dssp ------------------------------SHHHHHHHHHTCC--SCEEEEE---EETTE--EEEEEEEEEECTTCCEEE
T ss_pred ------------------------------CHHHHHHHHHhcc--cceeEEE---EECCE--EEEEEEEEEECCCCCEEE
Confidence 2223333444332 2455554 34664 668999999999999999
Q ss_pred EeeeeccCCcccccccc
Q 042772 216 FIGVQLDGSDHVEPLRN 232 (489)
Q Consensus 216 ~~~~~~d~Te~ke~e~~ 232 (489)
++++.+|||++++.+++
T Consensus 128 ~v~~~~DITe~~~~e~e 144 (233)
T 3vol_A 128 SAVQWTDRTEEHRAEQE 144 (233)
T ss_dssp EEEEEEECHHHHHHHHH
T ss_pred EEEEEehhhHHHHHHHH
Confidence 99999999999876554
|
| >3icy_A Sensor protein; sensory box histidine kinase/response regulator domain, kinase, chlorobium tepidum TLS, PSI-2; 2.68A {Chlorobaculum tepidum} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.6e-12 Score=107.46 Aligned_cols=111 Identities=13% Similarity=0.083 Sum_probs=96.3
Q ss_pred HHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccc--cccchhhhhhccccccchhHHHHHHHh
Q 042772 69 LATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLE--LTEYTREEILGRNCSTYTFMLYFLALW 146 (489)
Q Consensus 69 ~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (489)
+..+++.+++++++.|+ ++.++++|++|++++||+++|++|+...++. .|+
T Consensus 6 ~~~l~~~~~~~i~~~d~---~~~~~~~n~~~~~~~G~~~~~~~~~~~~~~~~i~p~------------------------ 58 (118)
T 3icy_A 6 LQALVDNIPAAIYHLDV---SGQATIRFRPPAFLKTLVSEHAGTTRLNTLSMIHHD------------------------ 58 (118)
T ss_dssp HHHHHTTCCCCCEEECT---TSCEEECCCCCGGGGGGEEEETTEEEEGGGGGBCGG------------------------
T ss_pred HHHHHhcCCceEEEEEc---CCCceEEechhHhhcCCCHHHccCChhHHHHHcCHH------------------------
Confidence 67889999999999999 9999999999999999999999988754432 232
Q ss_pred hhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCC
Q 042772 147 KKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGS 224 (489)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~T 224 (489)
......+.+..++..+..+..+....+++|+..|+.....|++|.+|.+.+++++.+|||
T Consensus 59 ------------------d~~~~~~~~~~~~~~~~~~~~e~r~~~~~g~~~w~~~~~~~~~~~~g~~~~~~g~~~DIT 118 (118)
T 3icy_A 59 ------------------DRHMLSNAYSKLREAKHSLTLVYRIVTPEGKLHWIEDHMRSSFSDDGLFSGIDGILCEVT 118 (118)
T ss_dssp ------------------GHHHHHHHHHHHHHSCCEEEEEEEEECTTCCEEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred ------------------HHHHHHHHHHHHHhcCCCceEEEEEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEecC
Confidence 333445667778888889999999999999999999999999999999999999999997
|
| >3mfx_A Sensory BOX/ggdef family protein; alpha-beta protein, structural genomics, PSI-2, protein structure initiative; 2.40A {Shewanella oneidensis} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.7e-12 Score=113.54 Aligned_cols=114 Identities=11% Similarity=0.085 Sum_probs=81.0
Q ss_pred hhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHh
Q 042772 67 IDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALW 146 (489)
Q Consensus 67 ~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (489)
..+.++++.+.++|+++|. +|.|+++|++|++++||+++|++|+++..+..+... + .+..
T Consensus 7 ~~l~~i~~~~~d~i~~~D~---~g~I~~~N~aa~~l~G~~~~el~G~~~~~l~~~~~~-~--------~~~~-------- 66 (129)
T 3mfx_A 7 ETIELFIQHLTEAMILVNA---NGFIRSCNQRSAELLDCPQVSLKGQDWRNFLTEHHQ-A--------RYDN-------- 66 (129)
T ss_dssp HHHHHHHTTCSSEEEEEET---TSBEEEECHHHHHHTTSCHHHHTTSBGGGGBCTTCC-G--------GGGC--------
T ss_pred HHHHHHHhcCCceEEEECC---CCEEEeEhHHHHHHHCcCHHHHcCCcHHHHcChHhH-H--------HHHH--------
Confidence 4578899999999999999 999999999999999999999999998766544310 0 0000
Q ss_pred hhcccccccccCcccccCCCHHHHHHHHHHHH----cCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeecc
Q 042772 147 KKNYGVYNFTLGCCLEISSDQATVSKIRDAVR----EQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLD 222 (489)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d 222 (489)
........-. ....+..++...+|||+.||+.++++|+.+.+ ..|+++.+|
T Consensus 67 ----------------------~~~~~~~~~~~~~~~~~~~~~E~~~~rkdG~~~~velsis~i~~~~---~~~v~~~~~ 121 (129)
T 3mfx_A 67 ----------------------LLSHDVQLGTNCGQPVQHPAQETTLICASGKAKDVELSISYIPGHE---PMFVMVMHD 121 (129)
T ss_dssp ----------------------TTC----------CCSCEEEEEEEEECTTSCEEEEEEEEEEECSSS---CEEEEEEEE
T ss_pred ----------------------HHHHHHhcCcccccccCCCceEEEEEcCCCCEEEEEEEEEEecCCC---cEEEEEEec
Confidence 0000000000 11234578888999999999999999998433 358899898
Q ss_pred CCc
Q 042772 223 GSD 225 (489)
Q Consensus 223 ~Te 225 (489)
+..
T Consensus 122 ~~~ 124 (129)
T 3mfx_A 122 LEH 124 (129)
T ss_dssp C--
T ss_pred hhh
Confidence 753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=5.6e-12 Score=122.11 Aligned_cols=139 Identities=14% Similarity=0.062 Sum_probs=110.1
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV 384 (489)
..|++...++.|+.+.||++... +..+++|......... ...+.+|..+++.+. +..++++++++...+..|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 35888889999999999998744 6789999886532111 234677999999884 67888999999888899999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC-------------------------------------- 426 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~-------------------------------------- 426 (489)
|||++|.+|.+.+.. ......++.+++.+|..||+
T Consensus 89 ~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 89 MSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 999999999876321 12234577889999999998
Q ss_pred ---------------------CCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 427 ---------------------LGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 427 ---------------------~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
..++|+|++|.||+++.++.+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876556799999875
|
| >4hi4_A Aerotaxis transducer AER2; PAS domain, diatomic GAS sensor, signaling protein; HET: HEM GOL; 2.30A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.33 E-value=7.1e-12 Score=106.65 Aligned_cols=105 Identities=15% Similarity=0.223 Sum_probs=79.1
Q ss_pred hhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcC------------CChhhhcCCCccccccccchhhhhhccccc
Q 042772 67 IDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTE------------YTREEILGRNCSFLELTEYTREEILGRNCS 134 (489)
Q Consensus 67 ~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~g------------y~~~e~~g~~~~~l~~~~~~~~~~~~~~~~ 134 (489)
..+.++|+.++++|+++|. +|.|+|+|++|++++| |++++++|+++..+..
T Consensus 5 ~rl~~il~~~~~gviv~D~---~g~I~~~N~a~~~llg~~~~~i~~~~~g~~~~~~~G~~~~~~~~-------------- 67 (121)
T 4hi4_A 5 ARIASALDNVSANVMIADN---DLNIIYMNRTVSEMLGRAEADIRKQLPNFDAGRLMGANIDVFHK-------------- 67 (121)
T ss_dssp HHHHHHHTTSSSEEEEEET---TCBEEEECHHHHHHHHHTHHHHHHHCTTCCGGGCTTCBGGGGCS--------------
T ss_pred HHHHHHHhcCCccEEEEcC---CCeEEEecHHHHHHHHHHHHHHHHhcCCCChHHhcCCCHHHhcC--------------
Confidence 3478999999999999999 9999999999999985 8999999999765542
Q ss_pred cchhHHHHHHHhhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCee
Q 042772 135 TYTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQ 214 (489)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~ 214 (489)
+......+.+... ..+..++. .+|. |..++++|++|.+|++.
T Consensus 68 -------------------------------~~~~~~~~~~~~~--~~~~~~~~---~~~~--~~~~~~~pi~~~~g~~~ 109 (121)
T 4hi4_A 68 -------------------------------NPAHQRHLLANLT--GVHKAELN---LGGR--RFSLDVVPVFNDANARL 109 (121)
T ss_dssp -------------------------------SHHHHHHHHHHCS--SCEEEEEE---ETTE--EEEEEEEEEECTTSCEE
T ss_pred -------------------------------CHHHHHHHHhCcC--CCcEEEEE---ECCE--EEEEEEEEEECCCCCEE
Confidence 1222222333322 34554442 3565 34789999999999999
Q ss_pred EEeeeeccCCcc
Q 042772 215 YFIGVQLDGSDH 226 (489)
Q Consensus 215 ~~~~~~~d~Te~ 226 (489)
+++++.+|||++
T Consensus 110 g~v~~~~DiTee 121 (121)
T 4hi4_A 110 GSAVQWTDRTEE 121 (121)
T ss_dssp EEEEEEEECC--
T ss_pred EEEEEEEEecCC
Confidence 999999999974
|
| >1v9y_A Heme PAS sensor protein; signaling protein; HET: HEM; 1.32A {Escherichia coli} SCOP: d.110.3.2 PDB: 1v9z_A* 1vb6_A* 1s67_L* 1s66_L* | Back alignment and structure |
|---|
Probab=99.31 E-value=6.1e-12 Score=110.26 Aligned_cols=120 Identities=21% Similarity=0.317 Sum_probs=81.6
Q ss_pred hhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHh
Q 042772 67 IDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALW 146 (489)
Q Consensus 67 ~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (489)
..+..+++.+++++++.|+ ++.|+++|++|++++||+.++++|+++..+..+.
T Consensus 40 ~~~~~~l~~~~~~i~~~d~---~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~------------------------ 92 (167)
T 1v9y_A 40 GIFFPALEQNMMGAVLINE---NDEVMFFNPAAEKLWGYKREEVIGNNIDMLIPRD------------------------ 92 (167)
T ss_dssp CCHHHHHHTCSSEEEEECT---TSBEEEECHHHHHHHSCCGGGTTTSBGGGGSCGG------------------------
T ss_pred HHHHHHHHhCCCCEEEECC---CCcEEEECHHHHHHhCCCHHHHcCCChhhccCcc------------------------
Confidence 4578899999999999999 9999999999999999999999999987664432
Q ss_pred hhcccccccccCcccccCCCHHHHHHHHHHHHcCCc----EEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeecc
Q 042772 147 KKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQRE----ITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLD 222 (489)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d 222 (489)
........+......+.. +..++...+++|..+|+.+.+.|+ +..|... ++++.+|
T Consensus 93 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~-~~~g~~~-~~~~~~D 152 (167)
T 1v9y_A 93 ------------------LRPAHPEYIRHNREGGKARVEGMSRELQLEKKDGSKIWTRFALSKV-SAEGKVY-YLALVRD 152 (167)
T ss_dssp ------------------GTTTHHHHHHHHHC----------CEEEEECTTSCEEEEEEEEEEE-EETTEEE-EEEEEEC
T ss_pred ------------------ccchHHHHHHHHhhcCCCcccccceEEEEEcCCCcEEEEEEEEEEE-ecCCCEE-EEEEEec
Confidence 111112223333333222 455677789999999999999999 5667765 8999999
Q ss_pred CCccccccccc
Q 042772 223 GSDHVEPLRNR 233 (489)
Q Consensus 223 ~Te~ke~e~~~ 233 (489)
||++++.+++.
T Consensus 153 iT~~~~~e~~l 163 (167)
T 1v9y_A 153 ASVEMAQKEQT 163 (167)
T ss_dssp -----------
T ss_pred CcHHHHHHHHH
Confidence 99999877654
|
| >2qkp_A Uncharacterized protein; structural genomics, unknown function, PSI-2, protein struct initiative; 1.75A {Streptococcus mutans} | Back alignment and structure |
|---|
Probab=99.22 E-value=4e-11 Score=107.92 Aligned_cols=118 Identities=15% Similarity=0.155 Sum_probs=94.6
Q ss_pred HHHHHHhccCcEEEECCCCCCCCEEEecHh---hHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHH
Q 042772 69 LATTLERIEKNFVITDPRIPDNPIIFASDS---FLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLAL 145 (489)
Q Consensus 69 ~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~---~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (489)
+..+|+.++++|+++|. ++.|+|+|++ +++++| ..++++||++..+..+
T Consensus 21 l~~IL~~~~~gI~~vD~---~g~I~~~N~a~~~~~~i~g-~~~~~iGr~v~~~~~~------------------------ 72 (151)
T 2qkp_A 21 ANLILNHLPLEITFVNK---DDIFQYYNDSVPAAEMVFK-RTPSQVGRNVELCHPP------------------------ 72 (151)
T ss_dssp HHHHHHHSSSEEEEEET---TSBEEEECCCSCGGGCSSC-CCGGGTTSBGGGSSCH------------------------
T ss_pred HHHHHHhCCCceEEEcC---CCeEEEEeCCCchhhhhcC-CCHHHcCCCHHHhCCH------------------------
Confidence 67899999999999999 9999999999 999999 6689999998654432
Q ss_pred hhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecC-CCeeeEEEeecccccCCCCeeEEeeeeccCC
Q 042772 146 WKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKS-GKKFWNLFHLQPMRDHKGELQYFIGVQLDGS 224 (489)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~-g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~T 224 (489)
.....+..+..+++.++....++.....+ | .++..+..|++|++|++.+.+.+.+|+|
T Consensus 73 -------------------~~~~~v~~i~~~l~~g~~~~~~~~~~~~~~~--~~v~v~~~Pi~d~~G~~~G~vev~~Dit 131 (151)
T 2qkp_A 73 -------------------KVLDKVKKVFELLRNGQRDKVNMWFQSERLG--KFVYVTYAAVRDQAGDFQGVLEYVQDIK 131 (151)
T ss_dssp -------------------HHHHHHHHHHHHHHTTSBSEEEEEEEETTTT--EEEEEEEEEEECTTCCEEEEEEEEEECG
T ss_pred -------------------HHHHHHHHHHHHHHcCCccEEEEEEecCCCC--eEEEEEEEEEECCCCCEEEEEEEEEECH
Confidence 12334567788888888887776654333 4 3568889999999999999999999999
Q ss_pred ccccccccccc
Q 042772 225 DHVEPLRNRLS 235 (489)
Q Consensus 225 e~ke~e~~~l~ 235 (489)
+.++.++++..
T Consensus 132 ~l~~le~~r~~ 142 (151)
T 2qkp_A 132 PFFELDSEFNR 142 (151)
T ss_dssp GGGGGGGC---
T ss_pred HHHhhhhhhhc
Confidence 99887776543
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} | Back alignment and structure |
|---|
Probab=99.19 E-value=8.2e-11 Score=97.65 Aligned_cols=106 Identities=14% Similarity=0.121 Sum_probs=81.9
Q ss_pred HHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhh
Q 042772 69 LATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKK 148 (489)
Q Consensus 69 ~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (489)
...+++.++++++++|. ++.|+++|+++++++||++++++|+++..+..+.
T Consensus 9 ~~~il~~~~~~i~~~D~---~g~I~~~N~aa~~l~g~~~~~~~g~~~~~~~~~~-------------------------- 59 (115)
T 3b33_A 9 PSAILNNMVTATLILDD---GLAIRYANPAAELLFSQSAKRIVEQSLSQLIQHA-------------------------- 59 (115)
T ss_dssp HHHHHHHCSSEEEEECT---TCBEEEECHHHHHHTTSCHHHHTTCBHHHHCSEE--------------------------
T ss_pred HHHHHhhcCceEEEECC---CCcEEEECHHHHHHhCCCHHHHhCCCHHHHhCcc--------------------------
Confidence 34689999999999999 9999999999999999999999999976443221
Q ss_pred cccccccccCcccccCCCHHHHHHHHHHHHcCCcEE-EEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCC
Q 042772 149 NYGVYNFTLGCCLEISSDQATVSKIRDAVREQREIT-VQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGS 224 (489)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~T 224 (489)
... ...+.+++..++... .++... ++|+.+|+.+++.|+.+ +|. .+++.+.+|++
T Consensus 60 ---------------~~~---~~~~~~~~~~~~~~~~~~~~~~-~~g~~~~~~~~~~pi~~-~g~-~~~l~~~~Di~ 115 (115)
T 3b33_A 60 ---------------SLD---LALLTQPLQSGQSITDSDVTFV-VDGRPLMLEVTVSPITW-QRQ-LMLLVEMRKID 115 (115)
T ss_dssp ---------------ECC---THHHHHHHHHCCCEEEEEEEEE-ETTEEEEEEEEEEEEEE-TTE-EEEEEEEEEC-
T ss_pred ---------------chh---hHHHHHHHHcCCcccCCceEEe-cCCCEEEEEEEEEEeec-CCc-eEEEEEEEeCC
Confidence 011 123455666666643 344433 89999999999999999 887 68888889874
|
| >1ll8_A PAS kinase; PAS domain, ligand binding, ligand screening, kinase regulation, transferase; NMR {Homo sapiens} SCOP: d.110.3.5 | Back alignment and structure |
|---|
Probab=99.18 E-value=1.1e-11 Score=103.36 Aligned_cols=101 Identities=17% Similarity=0.240 Sum_probs=71.8
Q ss_pred ccCcEEEECCCCCC-CCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhcccccc
Q 042772 76 IEKNFVITDPRIPD-NPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYN 154 (489)
Q Consensus 76 ~~~~~~i~d~~~~~-~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (489)
..++|+++|+ + |.|+++|++|++++||+++|++|+++..+..+.
T Consensus 7 ~~~~i~~~d~---~~g~I~~~N~aa~~l~G~~~~el~g~~~~~l~~~~-------------------------------- 51 (114)
T 1ll8_A 7 FNKAIFTVDA---KTTEILVANDKACGLLGYSSQDLIGQKLTQFFLRS-------------------------------- 51 (114)
T ss_dssp TTCEEEEEET---TTCBEEEECTTHHHHHTCCTTTTTTSBGGGGSSCT--------------------------------
T ss_pred CCceEEEEEC---CCCeEEEehHHHHHHhCCCHHHHcCCCHHHhcCcc--------------------------------
Confidence 3479999999 8 999999999999999999999999987665443
Q ss_pred cccCcccccCCCHHHHHHHHHH-HHc-CCcE---EEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCC
Q 042772 155 FTLGCCLEISSDQATVSKIRDA-VRE-QREI---TVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGS 224 (489)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~---~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~T 224 (489)
+......+.+. +.. +... ..++...+|||+.+|+.++++|+.+..+ .+++++..|++
T Consensus 52 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dG~~~~v~~~~~~~~~~~~--~~~v~~~~~~~ 113 (114)
T 1ll8_A 52 -----------DSDVVEALSEEHMEADGHAAVVFGTVVDIISRSGEKIPVSVWMKRMRQERR--LCCVVVLEPVE 113 (114)
T ss_dssp -----------TTHHHHHTTSSTTSSSSCSSCCCSSSEEECCTTCCCEEEECCEECCBSSSS--BEEEEEEEECC
T ss_pred -----------hhHHHHHHHHHhhccCCcceeccCcEEEEEecCCCEEEEEEEEEeeccCCc--cEEEEEEeecC
Confidence 11111111111 011 1100 1234567999999999999999987654 47888888875
|
| >3fc7_A HTR-like protein, sensor protein; APC87712.1, HTR-like protein,haloarcula marismortui ATCC 430 structural genomics, PSI-2; 2.65A {Haloarcula marismortui} | Back alignment and structure |
|---|
Probab=99.17 E-value=3.4e-11 Score=100.58 Aligned_cols=107 Identities=12% Similarity=0.091 Sum_probs=76.2
Q ss_pred hhhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHH
Q 042772 66 GIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLAL 145 (489)
Q Consensus 66 ~~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (489)
...+..+++.+++++++.|+ ++.|+++|++|++++||++++++|+++..+..++
T Consensus 18 ~~~~~~i~~~~~~~i~~~d~---~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~----------------------- 71 (125)
T 3fc7_A 18 RKKFESLVSDSPDGIVHLTT---NGTILSVNPSMAGRLGADPDTLVGQQLSAVMDSE----------------------- 71 (125)
T ss_dssp --------CCSCCEEEEEET---TSBEEEECHHHHHHHTSCHHHHTTSBGGGSSCHH-----------------------
T ss_pred HHHHHHHHhcCCCeEEEEcC---CCeEEEECHHHHHHhCCCHHHHcCccHHHhCCHH-----------------------
Confidence 34577899999999999999 9999999999999999999999999977555222
Q ss_pred hhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCC-eeeEEEeecccccCCCCeeEEeeeeccCC
Q 042772 146 WKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGK-KFWNLFHLQPMRDHKGELQYFIGVQLDGS 224 (489)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~-~~~~~~~~~p~~~~~g~~~~~~~~~~d~T 224 (489)
...............++.. ..++|. ..|+.+++.|+.+. |...+++++.+|||
T Consensus 72 -------------------~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~~DIT 125 (125)
T 3fc7_A 72 -------------------AANQRLEAGKSAVENGTAT------RSEDAVGGRHYHNQYIPVDSH-RKSDTFQLVSRDIT 125 (125)
T ss_dssp -------------------HHHHHHHHHHHHHHHTSCE------EEEEEETTEEEEEEEEESSTT-TTTTEEEEEEEECC
T ss_pred -------------------HHHHHHHHHHHHhcCCCeE------EeEcCCCcEEEEEEEEeEecC-CCeEEEEEEEecCC
Confidence 1111122234445555544 345666 88999999998876 67788999999997
|
| >3fg8_A Uncharacterized protein RHA05790; PAS domain, structural genomics, PS protein structure initiative, midwest center for structural genomics, MCSG; HET: 3PB; 1.80A {Rhodococcus SP} | Back alignment and structure |
|---|
Probab=99.17 E-value=5.4e-11 Score=100.50 Aligned_cols=106 Identities=15% Similarity=0.103 Sum_probs=84.1
Q ss_pred hHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhh
Q 042772 68 DLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWK 147 (489)
Q Consensus 68 ~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (489)
...+++++++++|++.|+ ++.|+++|++|++++||+++|++|+++..+..+.
T Consensus 13 ~~~~il~~~~~~i~~~D~---~g~i~~~N~a~~~l~g~~~~e~~G~~~~~~~~~~------------------------- 64 (118)
T 3fg8_A 13 GRENLYFQGGLGFMALDE---DLRIIYVNSGCLRHVRRSRDELLGRVVTEVLPET------------------------- 64 (118)
T ss_dssp CCCCSSSCTTCEEEEECT---TCBEEEECHHHHHHHTCCHHHHTTSBHHHHCGGG-------------------------
T ss_pred hHHHHHhhCCceEEEECC---CCeEEEECHHHHHHhCCCHHHHcCCcHHHHcCcc-------------------------
Confidence 345778899999999999 9999999999999999999999999976554332
Q ss_pred hcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCcc
Q 042772 148 KNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDH 226 (489)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~ 226 (489)
........+++++..++.++.++.....+| .|+.+.+.|+.+ | ++++.+|||++
T Consensus 65 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g--~~~~~~~~p~~~--g----~v~~~~DITer 118 (118)
T 3fg8_A 65 -----------------QGSYFDALCRKVLATGREQQTRVDSLYSPG--MTIEVTAAADSG--A----LVVHFRDVTAE 118 (118)
T ss_dssp -----------------TTSHHHHHHHHHHHHCCCEEEEEECSSSTT--CEEEEEEEEETT--E----EEEEEEECSCC
T ss_pred -----------------chHHHHHHHHHHHHcCCceEEEEEEEcCCC--eEEEEEEEEcCC--c----EEEEEEeccCC
Confidence 233455678888889999888543333466 578888899865 3 78889999985
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.15 E-value=6.6e-11 Score=113.36 Aligned_cols=135 Identities=12% Similarity=0.051 Sum_probs=97.4
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC--cceeeEEEEeCCeEEEE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF--LPTLYASFQTSTHICLI 384 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~~~~~~~~~~~lV 384 (489)
.+.+....+.|..+.||++.. .+|..+++|..... ....+..|..+++.+.+.+ +++++++....+..++|
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 344433334666799999964 45778999987543 1134567888888885434 56788888877889999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC------------------------------------
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLG------------------------------------ 428 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~g------------------------------------ 428 (489)
|||++|.+|. ... ... ..++.+++..|..||+..
T Consensus 94 ~e~i~G~~l~--~~~-----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 94 LGEVPGQDLL--SSH-----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EECCSSEETT--TSC-----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEecCCcccC--cCc-----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 9999998883 211 122 245667778888888643
Q ss_pred ----------------------CeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 429 ----------------------IIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 429 ----------------------IvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
++|+|++|.||+++.++.+.|+||+.+...
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 999999999999987766679999998643
|
| >4f3l_A Mclock, circadian locomoter output cycles protein kaput; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.14 E-value=3.6e-11 Score=123.23 Aligned_cols=106 Identities=9% Similarity=-0.002 Sum_probs=89.9
Q ss_pred EEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhcccccccccCc
Q 042772 80 FVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGC 159 (489)
Q Consensus 80 ~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (489)
+...|+ |+.|+|||++|+.++||+++|++|+++..+..|+
T Consensus 254 ~~~~~~---dg~~~~vn~~~~~ilGY~~eEl~g~~~~~~iHpd------------------------------------- 293 (361)
T 4f3l_A 254 TSRHSL---EWKFLFLDHRAPPIIGYLPFEVLGTSGYDYYHVD------------------------------------- 293 (361)
T ss_dssp EEEECT---TSBEEEECTTSHHHHCCCHHHHTTSBGGGGBCHH-------------------------------------
T ss_pred EEEEcC---CceEEEECChhhhhhCcCHHHHcCCCHHHeECHH-------------------------------------
Confidence 445566 9999999999999999999999999987777665
Q ss_pred ccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccC-CCCeeEEeeeeccCCcccccc
Q 042772 160 CLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDH-KGELQYFIGVQLDGSDHVEPL 230 (489)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~-~g~~~~~~~~~~d~Te~ke~e 230 (489)
........++..+..++..+.+....+|||+..|++....|++|. .|++.+++++.+|||+++..+
T Consensus 294 -----D~~~~~~~~~~~l~~g~~~~~eyR~~~kdG~~vWv~~~~~~v~~~~~g~~~~iv~~~~dITe~~~~~ 360 (361)
T 4f3l_A 294 -----DLENLAKCHEHLMQYGKGKSCYYRFLTKGQQWIWLQTHYYITYHQWNSRPEFIVCTHTVVSYAEVRA 360 (361)
T ss_dssp -----HHHHHHHHHHHHHHHSEEECCCEEEECTTSEEEEEEEEEEEEECTTTCCEEEEEEEEEECCHHHHHH
T ss_pred -----HHHHHHHHHHHHHhCCCcceEEEEEEecCCCEEEEEEEEEEEEcCCCCCeeEEEEEEEECChhHhhc
Confidence 233344557777778877888888999999999999999999998 799999999999999987543
|
| >2vlg_A Sporulation kinase A; histidine kinase, two-component regulatory system, two-component signal transduction, transferase, phosphorylation, SCOD; 1.7A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=99.14 E-value=8.3e-11 Score=100.08 Aligned_cols=93 Identities=14% Similarity=0.123 Sum_probs=64.8
Q ss_pred HHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhcc
Q 042772 71 TTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNY 150 (489)
Q Consensus 71 ~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (489)
..|+.+.+.+++.|+ +|.|+|+|+++++++||+++|++|+++..+..|+
T Consensus 3 ~lle~~~d~i~v~d~---~G~i~yvn~~~~~~lGy~~~el~G~~~~~~ihp~---------------------------- 51 (111)
T 2vlg_A 3 FPLQTKTDIHAVLAS---NGRIIYISANSKLHLGYLQGEMIGSFLKTFLHEE---------------------------- 51 (111)
T ss_dssp ------CCEEEEECT---TSBEEEECTTHHHHHSCCHHHHTTSBGGGGBCGG----------------------------
T ss_pred chhhcCCCEEEEEcC---CCeEEEEChHHHHHhCCCHHHHcCCcHHHeECHh----------------------------
Confidence 467889999999998 9999999999999999999999999976666554
Q ss_pred cccccccCcccccCCCHHHHHHHHHHHHc-CCcEEEEEEeeecCCCeeeEEEeecccccCCCC
Q 042772 151 GVYNFTLGCCLEISSDQATVSKIRDAVRE-QREITVQLINYTKSGKKFWNLFHLQPMRDHKGE 212 (489)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~ 212 (489)
|.+.+ ++.+.. ......+...++|||+.+|++.++++++|..+.
T Consensus 52 ---------------D~~~~---~~~~~~~~~~~~~e~r~~~kdG~~~wve~~~~~v~~~~~~ 96 (111)
T 2vlg_A 52 ---------------DQFLV---ESYFYNEHHLMPCTFRFIKKDHTIVWVEAAVEIVTTRAER 96 (111)
T ss_dssp ---------------GHHHH---HHHHHCSCCSSCEEEEEECTTSCEEEEEEEEEEC------
T ss_pred ---------------HHHHH---HHHHhccCCCccEEEEEEcCCCCEEEEEEEEEEEecccCC
Confidence 33332 233322 233456777789999999999999999987653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.08 E-value=2.6e-10 Score=115.90 Aligned_cols=140 Identities=18% Similarity=0.262 Sum_probs=104.2
Q ss_pred ccccccCCCCceEEEEEEEcCCCcEEEEEEee--cccccchHHHHHHHHHHHHHHhCC--CCCcceeeEEEEeC---CeE
Q 042772 309 KPIKPLGCGDTGSVHLVELQGAGELYAMKAME--KSVMLNRNKVHRACIEREIMSLLD--HPFLPTLYASFQTS---THI 381 (489)
Q Consensus 309 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~--~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~---~~~ 381 (489)
..++.|+.|.++.||++... +..+++|... .... ......+.+|..+++.+. +..+++++.++.+. +..
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 34678899999999998765 4578888765 3221 112346677999999886 45688898888766 458
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC----------------------------------- 426 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~----------------------------------- 426 (489)
|+||||++|..+.+.. ...++......++.+++..|..||+
T Consensus 117 ~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 9999999988774421 1226788888899999999999997
Q ss_pred -----------------------CCCeecCCCCCCEEEecCCc--EEEEecCCcc
Q 042772 427 -----------------------LGIIYRDLKPENILLQKDGH--VVLTDFDLSF 456 (489)
Q Consensus 427 -----------------------~gIvHrDLKP~NILld~~g~--vKL~DFGlS~ 456 (489)
..++|+|++|.||+++.++. +.|+||+.+.
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 36899999999999997753 6899999986
|
| >3a0s_A Sensor protein; PAS-fold, kinase, phosphoprotein, transferase, two-component regulatory system; HET: PG4 PGE; 1.47A {Thermotoga maritima} PDB: 3a0v_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=1.1e-09 Score=85.20 Aligned_cols=95 Identities=17% Similarity=0.167 Sum_probs=74.0
Q ss_pred ccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhccccccc
Q 042772 76 IEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNF 155 (489)
Q Consensus 76 ~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (489)
++++++++|+ ++.|+++|++|++++||+.+|++|+++..+ +.
T Consensus 1 ~~~~i~~~d~---~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~--~~--------------------------------- 42 (96)
T 3a0s_A 1 METAIITLSK---DGRITEWNKKAEQLFGLKKENVLGRRLKDL--PD--------------------------------- 42 (96)
T ss_dssp CCCEEEEEET---TSBEEEECHHHHHHHCCCHHHHTTSBGGGS--TT---------------------------------
T ss_pred CCceEEEEcC---CCCEeehhHHHHHHhCCCHHHhcCCCHHHC--cc---------------------------------
Confidence 3578999999 999999999999999999999999998765 22
Q ss_pred ccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCC-eeEEeeeecc
Q 042772 156 TLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGE-LQYFIGVQLD 222 (489)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~-~~~~~~~~~d 222 (489)
.......+.+++..+.++..+. ++|...|+.+++.|+++.+|. +.+++++.+|
T Consensus 43 ----------~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~p~~~~~~~~~~g~v~~~~D 96 (96)
T 3a0s_A 43 ----------FEEIGSVAESVFENKEPVFLNF----YKFGERYFNIRFSPFRNAKTQLLEGVIITIDD 96 (96)
T ss_dssp ----------CHHHHHHHHHHHHHTCCEEEEE----EEETTEEEEEEEEEEECTTTCCEEEEEEEEEC
T ss_pred ----------hHHHHHHHHHHhccCCeEEEEE----EcCCcEEEEEEEEEeEcCCCCeeeEEEEEecC
Confidence 2334455667777777765432 345567999999999998665 6788888766
|
| >3a0r_A Sensor protein; four helix bundle, PAS fold, kinase, phosphoprotein, transfe two-component regulatory system; 3.80A {Thermotoga maritima} | Back alignment and structure |
|---|
Probab=99.03 E-value=2.8e-10 Score=113.99 Aligned_cols=116 Identities=17% Similarity=0.153 Sum_probs=89.5
Q ss_pred HHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhh
Q 042772 69 LATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKK 148 (489)
Q Consensus 69 ~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (489)
+..+++.++++|+++|+ +|.|+++|++|++++||+++|++|+++..+...
T Consensus 10 ~~~i~~~~~~~i~~~d~---~g~i~~~N~a~~~l~G~~~~e~~G~~~~~~~~~--------------------------- 59 (349)
T 3a0r_A 10 SESILESLETAIITLSK---DGRITEWNKKAEQLFGLKKENVLGRRLKDLPDF--------------------------- 59 (349)
T ss_dssp CCSSGGGSSSEEEEEES---SSBCSCBCHHHHHHHSCCSTTTTTCBSTTSTTT---------------------------
T ss_pred HHHHHhhhcCeEEEECC---CCCEEeeHHHHHHHhCCCHHHHcCcCHHHCcCh---------------------------
Confidence 45678999999999999 999999999999999999999999998766321
Q ss_pred cccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCe-eEEeeeeccCCccc
Q 042772 149 NYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGEL-QYFIGVQLDGSDHV 227 (489)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~-~~~~~~~~d~Te~k 227 (489)
......+...+..+.++..+ .++. ...|..+.+.|+++..|.. .+++++.+|||+++
T Consensus 60 ------------------~~~~~~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~~~~~~~~~~g~~~~~~DiTe~~ 117 (349)
T 3a0r_A 60 ------------------EEIGSVAESVFENKEPVFLN--FYKF--GERYFNIRFSPFRNAKTQLLEGVIITIDDVTELY 117 (349)
T ss_dssp ------------------THHHHHHHHHHHHCCCCEEE--CCCB--TTBCCEEEEEEECCTTTTSSCEEEEEEECCSTTT
T ss_pred ------------------hHHHHHHHHHHhcCCceeec--cccc--CceEEEEEEEEEEcCCCceeeEEEEEEEechHHH
Confidence 11223345556666665443 2222 3457788999999988875 68999999999999
Q ss_pred cccccccch
Q 042772 228 EPLRNRLSE 236 (489)
Q Consensus 228 e~e~~~l~~ 236 (489)
+.+++....
T Consensus 118 ~~e~~~~~~ 126 (349)
T 3a0r_A 118 KYEEERKRR 126 (349)
T ss_dssp TTTTTTTHH
T ss_pred HHHHHHHHH
Confidence 888776543
|
| >4f3l_B BMAL1B; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.99 E-value=5.3e-10 Score=115.75 Aligned_cols=105 Identities=13% Similarity=0.101 Sum_probs=81.1
Q ss_pred cEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhcccccccccC
Q 042772 79 NFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLG 158 (489)
Q Consensus 79 ~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (489)
-+...|+ ||.++|+|+++..++||+++|++|+++..+..|+
T Consensus 280 fi~~~~~---dg~~~~vn~~~~~ilGY~~eEl~g~~~~~~iHpd------------------------------------ 320 (387)
T 4f3l_B 280 YVSRHAI---DGKFVFVDQRATAILAYLPQELLGTSCYEYFHQD------------------------------------ 320 (387)
T ss_dssp EEEEECT---TSBEEEECTHHHHHHCCCHHHHTTSBGGGTBCHH------------------------------------
T ss_pred EEEEECC---CCEEEEECCCcccccCCCHHHHcCCcHHHeeCHH------------------------------------
Confidence 3455666 9999999999999999999999999876666554
Q ss_pred cccccCCCHHHHHHHHHHHHcCCc-EEEEEEeeecCCCeeeEEEeecccccC-CCCeeEEeeeeccCCcccc
Q 042772 159 CCLEISSDQATVSKIRDAVREQRE-ITVQLINYTKSGKKFWNLFHLQPMRDH-KGELQYFIGVQLDGSDHVE 228 (489)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~k~g~~~~~~~~~~p~~~~-~g~~~~~~~~~~d~Te~ke 228 (489)
......+.+.+.+..++. .+.+....+|||+..|++....+++|. .|++.+++++.+|||++++
T Consensus 321 ------D~~~~~~~~~~~l~~~~~~~~~eyR~~~kdG~~vWv~~~~~~~~~~~~g~~~~ivg~~~dIT~Rk~ 386 (387)
T 4f3l_B 321 ------DIGHLAECHRQVLQTREKITTNCYKFKIKDGSFITLRSRWFSFMNPWTKEVEYIVSTNTVVLANVL 386 (387)
T ss_dssp ------HHHHHHHHHHHHTTCSSCEECCCEEEECTTSCEEEEEEEEEEEEETTTTEEEEEEEEEEECC----
T ss_pred ------HHHHHHHHHHHHHhcCCCeeeEEEEEEccCCCEEEEEEEEEEEECCCCCCEEEEEEEEEEcchhhc
Confidence 222233344455555444 557888899999999999999999998 8999999999999999874
|
| >3cax_A Uncharacterized protein PF0695; structural genomics, unknown function, PSI-2, protein struct initiative; 2.43A {Pyrococcus furiosus dsm 3638} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.3e-09 Score=112.11 Aligned_cols=115 Identities=17% Similarity=0.209 Sum_probs=94.5
Q ss_pred hHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhh
Q 042772 68 DLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWK 147 (489)
Q Consensus 68 ~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (489)
.+..+|+.++++|+++|. +|.|+|+|++ ++++ |+.++++|+++..+..+
T Consensus 240 ~l~~IL~~l~dgIivvD~---~g~I~~~N~a-e~i~-~~~~e~iGr~v~~~~p~-------------------------- 288 (369)
T 3cax_A 240 ELKAIFEALPVDVTFIDK---DDRVRFFSPG-ERIF-TRTPSVLGRPVQLCHPP-------------------------- 288 (369)
T ss_dssp HHHHHHHHSSSEEEEECT---TSBEEEECCS-SCSS-CCCGGGTTCBTTTSSCG--------------------------
T ss_pred HHHHHHHhCCCcEEEECC---CCcEEEEcCH-HHcc-CChHHHcCCcHHHHCCh--------------------------
Confidence 467899999999999999 9999999999 9999 99999999998765433
Q ss_pred hcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCccc
Q 042772 148 KNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHV 227 (489)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~k 227 (489)
.....+..+.+++..++....+... +++| .|+.++++|++|.+|++.+++.+.+|||+.+
T Consensus 289 -----------------~~~~~~~~l~~~l~~g~~~~~~~~~-~~~g--~~v~v~~~PI~d~~G~~~G~v~v~~DITe~~ 348 (369)
T 3cax_A 289 -----------------KSVYVVNKILKAFKEGRKKEATFWL-RLRE--KYVYIKYVPLFNEKGEYIGTLEMTMDIAPYK 348 (369)
T ss_dssp -----------------GGHHHHHHHHHHHHHTSCSCEEEEE-EETT--EEEEEEEEEEECTTSCEEEEEEEEEECHHHH
T ss_pred -----------------hhHHHHHHHHHHHHcCCceEEEEEE-eeCC--EEEEEEEEEEECCCCCEEEEEEEEEcCHHHH
Confidence 2233455677778888776665544 3467 4778899999999999999999999999988
Q ss_pred cccccc
Q 042772 228 EPLRNR 233 (489)
Q Consensus 228 e~e~~~ 233 (489)
+.++++
T Consensus 349 ~le~~r 354 (369)
T 3cax_A 349 KIEGEK 354 (369)
T ss_dssp TCCSCC
T ss_pred HHHHHh
Confidence 877654
|
| >2w0n_A Sensor protein DCUS; signal transduction, two-component regulatory system, PAS, kinase, membrane, transferase, solid state cell inner membrane; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=98.93 E-value=5.5e-10 Score=91.74 Aligned_cols=103 Identities=17% Similarity=0.161 Sum_probs=78.4
Q ss_pred hhhhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCC---ChhhhcCCCccccccccchhhhhhccccccchhHHH
Q 042772 65 QGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEY---TREEILGRNCSFLELTEYTREEILGRNCSTYTFMLY 141 (489)
Q Consensus 65 ~~~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy---~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 141 (489)
....+..+++.+++++++.|. ++.|+++|++|++++|| +.++++|+++..+..+.
T Consensus 13 ~~~~~~~il~~~~~~i~~~d~---~g~i~~~N~~~~~~~g~~~~~~~~~~g~~~~~~~~~~------------------- 70 (118)
T 2w0n_A 13 LFEQRQAMLQSIKEGVVAVDD---RGEVTLINDAAQELLNYRKSQDDEKLSTLSHSWSQVV------------------- 70 (118)
T ss_dssp THHHHHHHHHCCCCCCEEEBT---TTBCCCBCHHHHHHHCSCTTTTTSSCCCTTCCCSCTH-------------------
T ss_pred HHHHHHHHHhhccccEEEECC---CCcEeehhHHHHHHhCCCccChhhhhccCcccccCch-------------------
Confidence 344567899999999999999 99999999999999998 89999999876554221
Q ss_pred HHHHhhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeec
Q 042772 142 FLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQL 221 (489)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~ 221 (489)
. +.+++..+....... .+.+| .|..++..|+.+ +|++.+++++.+
T Consensus 71 --------------------------~----~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~p~~~-~g~~~g~v~~~~ 115 (118)
T 2w0n_A 71 --------------------------D----VSEVLRDGTPRRDEE--ITIKD--RLLLINTVPVRS-NGVIIGAISTFR 115 (118)
T ss_dssp --------------------------H----HHHHHHTTCCCCCCC--EESSS--CEECCCEECCCC-SSCCCCEEECCC
T ss_pred --------------------------h----HHHHhccCceeccEE--EEECC--EEEEEeeceeee-CCEEEEEEEEEE
Confidence 0 334444444432221 23456 477888999998 889999999999
Q ss_pred cCC
Q 042772 222 DGS 224 (489)
Q Consensus 222 d~T 224 (489)
|||
T Consensus 116 DiT 118 (118)
T 2w0n_A 116 DKT 118 (118)
T ss_dssp CCC
T ss_pred eCC
Confidence 997
|
| >1nwz_A PYP, photoactive yellow protein; PAS, LOV, GAF, domains fold, signaling protein; HET: HC4; 0.82A {Halorhodospira halophila} SCOP: d.110.3.1 PDB: 1kou_A* 1ot9_A* 1otb_A* 1s4r_A* 1s4s_A* 1ts0_A* 1ts6_A* 1ts7_A* 1ts8_A* 1uwn_X* 1uwp_X* 2d01_A* 2phy_A* 2pyp_A* 2pyr_A* 2qj5_A* 2qj7_A* 2qws_A* 2zoh_A* 2zoi_A* ... | Back alignment and structure |
|---|
Probab=98.87 E-value=1.1e-08 Score=89.01 Aligned_cols=100 Identities=11% Similarity=0.088 Sum_probs=79.5
Q ss_pred HHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhc
Q 042772 70 ATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKN 149 (489)
Q Consensus 70 ~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (489)
...++.++.++++.|+ ++.|+++|.++++++||+++|++|++|--...+.
T Consensus 20 ~~~ld~l~~Gii~lD~---~g~I~~~N~~~e~~sG~~~~eviGk~~f~~~~~~--------------------------- 69 (125)
T 1nwz_A 20 DGQLDGLAFGAIQLDG---DGNILQYNAAEGDITGRDPKQVIGKNFFKDVAPC--------------------------- 69 (125)
T ss_dssp HHHHTTCSSEEEEEET---TCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGG---------------------------
T ss_pred HHHHhccCceEEEECC---CCEEEEEHHHHHHHhCCCHHHHcCCchhhhccch---------------------------
Confidence 4579999999999999 9999999999999999999999999984322232
Q ss_pred ccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEee-ecCCCeeeEEEeecccccCCCCeeEE
Q 042772 150 YGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINY-TKSGKKFWNLFHLQPMRDHKGELQYF 216 (489)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~k~g~~~~~~~~~~p~~~~~g~~~~~ 216 (489)
.....+..+++++++.+. +..++... +++|+|+++.+++.+ +.+|+..+.
T Consensus 70 --------------~~~~~f~~rf~~~~~~g~-l~~~~~~v~~~~~~p~~v~i~l~~--~~~~~~~~i 120 (125)
T 1nwz_A 70 --------------TDSPEFYGKFKEGVASGN-LNTMFEYTFDYQMTPTKVKVHMKK--ALSGDSYWV 120 (125)
T ss_dssp --------------GCSTTTHHHHHHHHHHTC-CEEEEEEEECTTSCCEEEEEEEEE--CSSSSEEEE
T ss_pred --------------hcccHHHHHHHHHHhcCc-eeEEEEEEEcCCCCEEEEEEEEEE--cCCCCEEEE
Confidence 256667888999999666 77777666 999998887766654 566665543
|
| >1mzu_A PPR; photoactive yellow protein, PAS, PYP, signaling protein; HET: HC4; 2.00A {Rhodospirillum centenum} SCOP: d.110.3.1 | Back alignment and structure |
|---|
Probab=98.82 E-value=2e-08 Score=87.64 Aligned_cols=100 Identities=11% Similarity=0.036 Sum_probs=78.9
Q ss_pred HHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhc
Q 042772 70 ATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKN 149 (489)
Q Consensus 70 ~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (489)
...++.++.++++.|+ ++.|+++|.++++++||+++|++|++|--...+.
T Consensus 25 ~~~ld~l~~GiivlD~---dg~I~~~N~~~e~isG~s~eeviGk~~f~~~~p~--------------------------- 74 (129)
T 1mzu_A 25 TAEFDALPVGAIQVDG---SGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPC--------------------------- 74 (129)
T ss_dssp CTTGGGCSSEEEEEET---TCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGG---------------------------
T ss_pred HHHHhccCceEEEECC---CCeEEEEHHHHHHHhCCCHHHHcCCchhhhccch---------------------------
Confidence 3468999999999999 9999999999999999999999999984322232
Q ss_pred ccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEee-ecCCCeeeEEEeecccccCCCCeeEE
Q 042772 150 YGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINY-TKSGKKFWNLFHLQPMRDHKGELQYF 216 (489)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~k~g~~~~~~~~~~p~~~~~g~~~~~ 216 (489)
.....+..+++++++.+. +..++... +++|+|+++.+++.+ +.+|+..+.
T Consensus 75 --------------~~~~~f~grf~~~~~~G~-l~~~~~yv~~~~~~p~~v~i~l~~--~~~~~~~~i 125 (129)
T 1mzu_A 75 --------------TNIPAFSGRFMDGVTSGT-LDARFDFVFDFQMAPVRVQIRMQN--AGVPDRYWI 125 (129)
T ss_dssp --------------GCSTTTHHHHHHHHHTSC-CEEEEEEEEECSSCEEEEEEEEEE--CSSTTEEEE
T ss_pred --------------hcccHHHHHHHHHHhcCc-eeEEEEEEEcCCCCEEEEEEEEEE--cCCCCEEEE
Confidence 256667888999999555 77777766 999998877766654 566765543
|
| >2jhe_A Transcription regulator TYRR; aromatic hydrocarbons catabolism, TYRR protei nucleotide-binding, transcription regulation, activator; HET: PG4; 2.30A {Escherichia coli} | Back alignment and structure |
|---|
Probab=98.75 E-value=1.8e-08 Score=91.95 Aligned_cols=106 Identities=11% Similarity=0.103 Sum_probs=77.7
Q ss_pred hhhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHH
Q 042772 66 GIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLAL 145 (489)
Q Consensus 66 ~~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (489)
...+..+++.++++++++|+ +|.|+++|+++++++|++.++++|+++..+..+.
T Consensus 79 ~~~l~~il~~~~~gvi~~D~---~g~I~~~N~aa~~llg~~~~~~~g~~~~~~~~~~----------------------- 132 (190)
T 2jhe_A 79 HLALSALLEALPEPVLSVDM---KSKVDMANPASCQLFGQKLDRLRNHTAAQLINGF----------------------- 132 (190)
T ss_dssp HHHHHHHHHHCSSCEEEECT---TCBEEEECHHHHHHHTSCHHHHTTSBGGGTSTTC-----------------------
T ss_pred HHHHHHHHHhCCCcEEEEcC---CCCEEEEcHHHHHHhCCCHHHhcCccHHHHhCCC-----------------------
Confidence 34578999999999999999 9999999999999999999999999976554221
Q ss_pred hhhcccccccccCcccccCCCHHHHHHHHHHHHcCC--cEEEEEEeeecCCCeeeEEEeecccccCCCC----eeEEeee
Q 042772 146 WKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQR--EITVQLINYTKSGKKFWNLFHLQPMRDHKGE----LQYFIGV 219 (489)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~----~~~~~~~ 219 (489)
. +.+.+..+. ....++ +.+|..+ .+.++|+++.+|+ +.+++.+
T Consensus 133 --------------------~------~~~~~~~~~~~~~~~~~---~~~g~~~--~~~~~pi~~~~~~~~~~~~g~v~~ 181 (190)
T 2jhe_A 133 --------------------N------FLRWLESEPQDSHNEHV---VINGQNF--LMEITPVYLQDENDQHVLTGAVVM 181 (190)
T ss_dssp --------------------C------HHHHHHTCCCSCEEEEE---EETTEEE--EEEEEEETTTTEEEEEEEE-HHHH
T ss_pred --------------------C------HHHHHhcCCCCCcceEE---EECCeEE--EEEEEEEEecCCCCcceEEeEEEE
Confidence 1 112223232 233333 2277654 5678999886665 7889999
Q ss_pred eccCCcccc
Q 042772 220 QLDGSDHVE 228 (489)
Q Consensus 220 ~~d~Te~ke 228 (489)
.+|+|+.++
T Consensus 182 ~~DiTe~~~ 190 (190)
T 2jhe_A 182 LRSTIRMGR 190 (190)
T ss_dssp HHHHTTTCC
T ss_pred EeccchhcC
Confidence 999998763
|
| >3rty_A Period circadian protein; PAS domain, signalling, timeless, circadian clock protein; 2.85A {Drosophila melanogaster} PDB: 1wa9_A 3gec_A | Back alignment and structure |
|---|
Probab=98.65 E-value=5.5e-08 Score=98.81 Aligned_cols=106 Identities=8% Similarity=0.044 Sum_probs=84.2
Q ss_pred CcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhccccccccc
Q 042772 78 KNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTL 157 (489)
Q Consensus 78 ~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (489)
+.+...|+ ||.++|+|+++..++||+++|++|+++..+.+|+
T Consensus 155 ~fi~r~~~---dG~~~yvn~~~~~lLGY~peELiG~s~~~~vHPd----------------------------------- 196 (339)
T 3rty_A 155 KFAIRHTA---TGIISHVDSAAVSALGYLPQDLIGRSIMDFYHHE----------------------------------- 196 (339)
T ss_dssp EEEEEEET---TCBEEEECTTHHHHHCCCHHHHTTSBGGGGBCGG-----------------------------------
T ss_pred eEEEEECC---CCeEEEcChhhhcccCCCHHHHcCCcHHHEECHH-----------------------------------
Confidence 34556677 9999999999999999999999999988777775
Q ss_pred CcccccCCCHHHHHHHHHHHHcCCc-----EEEEEEeeecCCCeeeEEEeecccccCC-CCeeEEeeeeccCCcccc
Q 042772 158 GCCLEISSDQATVSKIRDAVREQRE-----ITVQLINYTKSGKKFWNLFHLQPMRDHK-GELQYFIGVQLDGSDHVE 228 (489)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~k~g~~~~~~~~~~p~~~~~-g~~~~~~~~~~d~Te~ke 228 (489)
......+.++..+..++. .+.+....+|||+..|++.+.++++|.. |++.++|++.+.++....
T Consensus 197 -------D~~~~~~~~~~~l~~G~~~~~~~~s~~yR~~~kdG~~vWlet~~~~~~np~s~~~~~II~~h~vi~~p~~ 266 (339)
T 3rty_A 197 -------DLSVMKETYETVMKKGQTAGASFCSKPYRFLIQNGCYVLLETEWTSFVNPWSRKLEFVVGHHRVFQGPKQ 266 (339)
T ss_dssp -------GHHHHHHHHHHHHHHTTSTTCCCBCCCEEEECTTSCEEEEEEEEEEEECTTTCSEEEEEEEEEEEECCSS
T ss_pred -------HHHHHHHHHHHHHHcCCcccccccceEEEEEccCCCEEEEEEEEEEEECCCCCCeeEEEEEEEECCCCCC
Confidence 223334456666666654 3567778899999999999999999975 577788899998887643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.56 E-value=1.3e-07 Score=93.65 Aligned_cols=133 Identities=18% Similarity=0.128 Sum_probs=97.0
Q ss_pred ccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCC--cceeeEEEEeCC---eEEEE
Q 042772 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPF--LPTLYASFQTST---HICLI 384 (489)
Q Consensus 311 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~Hpn--Iv~l~~~~~~~~---~~~lV 384 (489)
++.++.|.+..||++. ..+++|..... .....+..|..+++.+ .+.. ++.++....... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4568899999999863 45888875422 3346778899999887 3433 455555433332 35889
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC-------------------------------------- 426 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~-------------------------------------- 426 (489)
|++++|.+|.+.... .++......++.|++..+..||+
T Consensus 95 m~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp EECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred EcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 999999888754332 26777778888888888888885
Q ss_pred --------------------CCCeecCCCCCCEEEec--CCcEEEEecCCccc
Q 042772 427 --------------------LGIIYRDLKPENILLQK--DGHVVLTDFDLSFM 457 (489)
Q Consensus 427 --------------------~gIvHrDLKP~NILld~--~g~vKL~DFGlS~~ 457 (489)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 23699999999999998 45678999998853
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=1.3e-06 Score=84.38 Aligned_cols=132 Identities=19% Similarity=0.213 Sum_probs=95.7
Q ss_pred cCCCCce-EEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEEEecCCCC
Q 042772 314 LGCGDTG-SVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHICLITDFCPGG 391 (489)
Q Consensus 314 LG~G~fG-~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lVmEy~~gg 391 (489)
+..|..| .||+......+..+++|.-... ....+..|..+|+.+. +--+++++.++.+.+..|+|||+++|.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 4445544 6898887777788999976532 3456777999988774 334778888888889999999999998
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------------------------------------------
Q 042772 392 ELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL-------------------------------------------- 427 (489)
Q Consensus 392 sL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~-------------------------------------------- 427 (489)
++.+...... .....+..+++..|.-||+.
T Consensus 106 ~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 106 TAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp EHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 8877654421 12233455566666666631
Q ss_pred --------------CCeecCCCCCCEEEecCCcEEEEecCCccc
Q 042772 428 --------------GIIYRDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 428 --------------gIvHrDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
.++|+|+.|.||+++.++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 158999999999999877677999999864
|
| >4dj3_A Period circadian protein homolog 3; PAS domain, circadian rhythm, protein binding; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.51 E-value=8e-07 Score=89.43 Aligned_cols=101 Identities=10% Similarity=0.099 Sum_probs=78.5
Q ss_pred EEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhcccccccccCcc
Q 042772 81 VITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCC 160 (489)
Q Consensus 81 ~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (489)
...|+ ||.++|+|+++..++||+++|++|+++..+..++
T Consensus 178 trh~~---dG~~~yvs~~~~~lLGY~peELig~s~~~~vHPd-------------------------------------- 216 (317)
T 4dj3_A 178 TTHTP---GCVFLEVDERAVPLLGYLPQDLIGTSILTYLHPE-------------------------------------- 216 (317)
T ss_dssp EEECT---TSBEEEECTTHHHHHSCCHHHHTTSBGGGGBCTT--------------------------------------
T ss_pred EEecC---CCeEEEEChHHhhhcCcChHHHcCCCHHHeECHH--------------------------------------
Confidence 34466 9999999999999999999999999987776664
Q ss_pred cccCCCHHHHHHHHHHHHcCCc---EEEEEEeeecCCCeeeEEEeecccccC-CCCeeEEeeeeccCCcc
Q 042772 161 LEISSDQATVSKIRDAVREQRE---ITVQLINYTKSGKKFWNLFHLQPMRDH-KGELQYFIGVQLDGSDH 226 (489)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~k~g~~~~~~~~~~p~~~~-~g~~~~~~~~~~d~Te~ 226 (489)
......+...+.+..++. .+.+....+|||+..|++....+++|. .+++.++|+...-++..
T Consensus 217 ----D~~~~~~~~~~~l~~~~~~~f~s~~yR~~~kdG~~vwvet~~~~~~np~s~~~e~II~~h~v~~~p 282 (317)
T 4dj3_A 217 ----DRPLMVAIHQKVLKYAGHPPFEHSPVRFCTQNGEYVILDSSWSSFVNPWSRKVSFIIGRHKVRTSP 282 (317)
T ss_dssp ----TTTHHHHHHHHHHHTTTSCCEECCCEEEECTTSCEEEEEEEEEEEECSSSCCEEEEEEEEEECCCC
T ss_pred ----HHHHHHHHHHHHHHcCCCccccceEEEEEccCCCEEEEEEEEEEEECCCCCcccEEEEEEEeccCC
Confidence 333444556666766554 356778889999999999999999987 46677777877755544
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.6e-06 Score=86.22 Aligned_cols=135 Identities=16% Similarity=0.133 Sum_probs=93.6
Q ss_pred cccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC---CcceeeEEEE-eCCeEEEEE
Q 042772 310 PIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP---FLPTLYASFQ-TSTHICLIT 385 (489)
Q Consensus 310 ~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hp---nIv~l~~~~~-~~~~~~lVm 385 (489)
.++.++.|....||+. +..+++|.-. .......+..|..+|+.+.+. .++.++.+.. ..+..++||
T Consensus 23 ~v~~l~~G~~n~v~~v-----g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~ 92 (306)
T 3tdw_A 23 SVESLGEGFRNYAILV-----NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGY 92 (306)
T ss_dssp CEEEEEECSSEEEEEE-----TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEE
T ss_pred eeeecCCCcceeEEEE-----CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEE
Confidence 3456788988999987 4567888742 123456788899999998642 3667776664 345688999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------------------------------------
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL-------------------------------------- 427 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~-------------------------------------- 427 (489)
||++|.+|.+..-. .++......++.++...|..||+.
T Consensus 93 e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 93 RKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp ECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred eccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 99999888763221 134445555555555555555532
Q ss_pred ----------------------CCeecCCCCCCEEEec---CCcE-EEEecCCcccc
Q 042772 428 ----------------------GIIYRDLKPENILLQK---DGHV-VLTDFDLSFMT 458 (489)
Q Consensus 428 ----------------------gIvHrDLKP~NILld~---~g~v-KL~DFGlS~~~ 458 (489)
.++|+|++|.||+++. ++.+ .|+||+.+...
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999987 4554 89999988643
|
| >3gdi_A Period circadian protein homolog 2; tandem PAS domains, biological rhythms, cytoplasm, nucleus, phosphoprotein, transcription; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.29 E-value=2.7e-06 Score=85.26 Aligned_cols=101 Identities=8% Similarity=0.097 Sum_probs=78.6
Q ss_pred EEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhcccccccccCcc
Q 042772 81 VITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCC 160 (489)
Q Consensus 81 ~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (489)
...++ ||.++|+|+++..++||+++|++|+++-.+..++
T Consensus 169 trh~~---dG~~~yvd~~~~~lLGY~peELig~s~~~~iHpd-------------------------------------- 207 (309)
T 3gdi_A 169 TTHTP---NCLFQAVDERAVPLLGYLPQDLIETPVLVQLHPS-------------------------------------- 207 (309)
T ss_dssp EEECT---TCBEEEECTTHHHHHSCCHHHHTTSBHHHHBCTT--------------------------------------
T ss_pred EEecC---CCeEEEECcccccccCcCHHHHcCCCHHHhCCHH--------------------------------------
Confidence 34455 9999999999999999999999999976666664
Q ss_pred cccCCCHHHH-HHHHHHHHcCCc-EE-EEEEeeecCCCeeeEEEeecccccC-CCCeeEEeeeeccCCccc
Q 042772 161 LEISSDQATV-SKIRDAVREQRE-IT-VQLINYTKSGKKFWNLFHLQPMRDH-KGELQYFIGVQLDGSDHV 227 (489)
Q Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~-~~-~~~~~~~k~g~~~~~~~~~~p~~~~-~g~~~~~~~~~~d~Te~k 227 (489)
|...+ +...+.+..++. .+ .+....+|||+..|++....+++|. .+++.++|++..-++...
T Consensus 208 -----D~~~~~~~~~~~l~~~g~~~~~~~yR~~~kdG~~vwvet~~~~~~np~s~~~e~ii~~h~v~~gp~ 273 (309)
T 3gdi_A 208 -----DRPLMLAIHKKILQAGGQPFDYSPIRFRTRNGEYITLDTSWSSFINPWSRKISFIIGRHKVRVGPL 273 (309)
T ss_dssp -----SHHHHHHHHHHHHHTTTCCEEEEEEEEECTTSCEEEEEEEEEEEECTTTCCEEEEEEEEEEEECCS
T ss_pred -----HHHHHHHHHHHHHhcCCceeeceEEEEEccCCCEEEEEEEEEEEECCCCCcccEEEEEEEEccCCC
Confidence 44444 445555665444 54 5778889999999999999999886 577888889888777543
|
| >4dj2_A Period circadian protein homolog 1; PAS domains, circadian clock protein, protein binding; 2.75A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.26 E-value=2.3e-06 Score=86.10 Aligned_cols=102 Identities=9% Similarity=0.091 Sum_probs=78.7
Q ss_pred EEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhcccccccccCc
Q 042772 80 FVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGC 159 (489)
Q Consensus 80 ~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (489)
+...|+ ||.++|+|+++..++||+++|++|+++-.+..++
T Consensus 179 itrh~~---dG~~~yvd~~~~~lLGY~peELig~s~~~~vHPd------------------------------------- 218 (320)
T 4dj2_A 179 TTRHTP---SCLFQDVDERAAPLLGYLPQDLLGAPVLLFLHPE------------------------------------- 218 (320)
T ss_dssp EEEECT---TCBEEEECTTHHHHHSCCHHHHTTSBGGGGBCGG-------------------------------------
T ss_pred EEEecC---CceEEEcCcceeccCCcChHHHcCCcHHHhCCHH-------------------------------------
Confidence 344566 9999999999999999999999999987666664
Q ss_pred ccccCCCHHHH-HHHHHHHHcC-CcE-EEEEEeeecCCCeeeEEEeecccccC-CCCeeEEeeeeccCCccc
Q 042772 160 CLEISSDQATV-SKIRDAVREQ-REI-TVQLINYTKSGKKFWNLFHLQPMRDH-KGELQYFIGVQLDGSDHV 227 (489)
Q Consensus 160 ~~~~~~~~~~~-~~~~~~~~~~-~~~-~~~~~~~~k~g~~~~~~~~~~p~~~~-~g~~~~~~~~~~d~Te~k 227 (489)
|...+ +...+.+..+ ... +.+....+|||+..|++...++++|. .+++.++|+...-++...
T Consensus 219 ------D~~~~~~~~~~~l~~~g~~~~~~~yR~~~kdG~~vwvet~~~~~~np~s~~~e~II~~h~v~~gp~ 284 (320)
T 4dj2_A 219 ------DRPLMLAIHKKILQLAGQPFDHSPIRFCARNGEYVTMDTSWAGFVHPWSRKVAFVLGRHKVRTAPL 284 (320)
T ss_dssp ------GHHHHHHHHHHHTTSSSCCEECCCEEEECSSSCEEEEECEEEEEECTTTCSEEEEEEEEEESSCCS
T ss_pred ------HHHHHHHHHHHHHhcCCCcccceEEEEEccCCCEEEEEEEEEEEECCCCCCccEEEEEEEEccCCC
Confidence 33333 3444445533 344 35777889999999999999999986 578888899988887654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=6.9e-06 Score=84.25 Aligned_cols=80 Identities=15% Similarity=0.164 Sum_probs=50.2
Q ss_pred cccccCCCCceEEEEEEEcCCCcEEEEEEeecccc-cch---HHHHHHHHHHHHHHhCCC--C-CcceeeEEEEeCCeEE
Q 042772 310 PIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVM-LNR---NKVHRACIEREIMSLLDH--P-FLPTLYASFQTSTHIC 382 (489)
Q Consensus 310 ~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~-~~~---~~~~~~~~E~~il~~l~H--p-nIv~l~~~~~~~~~~~ 382 (489)
..+.||.|.++.||++....+++.+++|....... ... ....++..|.++++.+.. | .+++++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 35789999999999997665678899998653211 000 123455678888887632 3 45566643 344568
Q ss_pred EEEecCCCC
Q 042772 383 LITDFCPGG 391 (489)
Q Consensus 383 lVmEy~~gg 391 (489)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.98 E-value=8.8e-05 Score=73.45 Aligned_cols=30 Identities=20% Similarity=0.268 Sum_probs=27.6
Q ss_pred CCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 427 LGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 427 ~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
.+++|+|++|.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 679999999999999888899999999885
|
| >2ykf_A Pdtas, probable sensor histidine kinase pdtas; transferase, two-component system, GAF domain, PAS domain; 2.00A {Mycobacterium tuberculosis} PDB: 2ykh_A | Back alignment and structure |
|---|
Probab=97.17 E-value=1.3e-06 Score=87.46 Aligned_cols=116 Identities=16% Similarity=0.099 Sum_probs=75.4
Q ss_pred HHHhccCcEEEECCCCCCCCEEEecHhhHHhc---CCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhh
Q 042772 72 TLERIEKNFVITDPRIPDNPIIFASDSFLELT---EYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKK 148 (489)
Q Consensus 72 ~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~---gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (489)
.++++.++|+++|. +|.|+|+|+++++++ |+. ++++|+++..+...... +
T Consensus 175 ~~~~~~dGIivvD~---~G~Ii~~N~aA~~ll~~lG~~-~~~iGk~l~el~~~~~~-~---------------------- 227 (305)
T 2ykf_A 175 SSPRAGDGFIRLDV---DGVVSYASPNALSAYHRMGLT-TELEGVNLIDATRPLIS-D---------------------- 227 (305)
Confidence 35689999999999 999999999999997 455 79999997644322100 0
Q ss_pred cccccccccCcccccCCCHHHHHHHHHHHHc-CCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCccc
Q 042772 149 NYGVYNFTLGCCLEISSDQATVSKIRDAVRE-QREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDHV 227 (489)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~k 227 (489)
..........+...+.. +..+..++. ..| .++.++..|+++ +|++.+++.+.+|||+.+
T Consensus 228 --------------~~~~~~~~~~l~~vl~~~~~~~~~ei~---~~~--~~l~v~~~Pi~~-~g~~~G~Vvv~rDITE~~ 287 (305)
T 2ykf_A 228 --------------PFEAHEVDEHVQDLLAGDGKGMRMEVD---AGG--ATVLLRTLPLVV-AGRNVGAAILIRDVTEVK 287 (305)
Confidence 00000111112222322 233322221 223 456788899987 588889999999999999
Q ss_pred ccccccc
Q 042772 228 EPLRNRL 234 (489)
Q Consensus 228 e~e~~~l 234 (489)
+.+++..
T Consensus 288 ~lE~eL~ 294 (305)
T 2ykf_A 288 RRDRALI 294 (305)
Confidence 8887764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.90 E-value=4e-05 Score=77.12 Aligned_cols=85 Identities=9% Similarity=0.008 Sum_probs=54.4
Q ss_pred ccccc-CCCCceEEEEEEEc--C----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-C--CCcceeeEEEEeC-
Q 042772 310 PIKPL-GCGDTGSVHLVELQ--G----AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-H--PFLPTLYASFQTS- 378 (489)
Q Consensus 310 ~~~~L-G~G~fG~Vy~a~~~--~----tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-H--pnIv~l~~~~~~~- 378 (489)
..+.| +.|....+|++... . ++..+++|...............+..|..+++.+. + ..+++++.+..+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 45677 88999999998754 1 15678889765432000000134556888887773 3 3577788776554
Q ss_pred --CeEEEEEecCCCCCHH
Q 042772 379 --THICLITDFCPGGELF 394 (489)
Q Consensus 379 --~~~~lVmEy~~ggsL~ 394 (489)
+..|+||||++|.++.
T Consensus 104 ~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCceEEEEecCCCChh
Confidence 3568999999886653
|
| >3rty_A Period circadian protein; PAS domain, signalling, timeless, circadian clock protein; 2.85A {Drosophila melanogaster} PDB: 1wa9_A 3gec_A | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00011 Score=74.46 Aligned_cols=34 Identities=21% Similarity=0.373 Sum_probs=31.8
Q ss_pred CCCEEEecHhhHHhcCCChhhhcCCCcccccccc
Q 042772 89 DNPIIFASDSFLELTEYTREEILGRNCSFLELTE 122 (489)
Q Consensus 89 ~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~ 122 (489)
+|.|+|||++|..++||+.+|++|++...+..|+
T Consensus 13 ~G~i~yvS~~~~~~LGy~~~el~G~s~~d~ihp~ 46 (339)
T 3rty_A 13 DGIVLYTTPSITDVLGYPRDMWLGRSFIDFVHLK 46 (339)
T ss_dssp TCBEEEECTTHHHHHCCCTTSSTTSBGGGGBCHH
T ss_pred CcEEEEEChHHHHHcCCCHHHHCCCcHHHhcCHH
Confidence 9999999999999999999999999988777765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00031 Score=72.62 Aligned_cols=32 Identities=22% Similarity=0.435 Sum_probs=27.9
Q ss_pred HHCCCeecCCCCCCEEEecCCcEEEEecCCccc
Q 042772 425 HCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 425 H~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
+...++|+|++|.||+++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 356799999999999998776 99999998863
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00086 Score=66.99 Aligned_cols=77 Identities=18% Similarity=0.155 Sum_probs=59.7
Q ss_pred ccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCCcceeeEEEEeCCeEEEEE
Q 042772 309 KPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD---HPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 309 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~~~~~lVm 385 (489)
...+.|+.|....+|+... .+..+++|..... ....+..|...|+.|. ...+++++.+....+..++||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm 110 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL 110 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence 3457789999999999874 3677889977532 2456778888888773 357888988888778899999
Q ss_pred ecCCCCCH
Q 042772 386 DFCPGGEL 393 (489)
Q Consensus 386 Ey~~ggsL 393 (489)
||++|.++
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00031 Score=69.09 Aligned_cols=74 Identities=9% Similarity=-0.055 Sum_probs=44.4
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEEEe
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lVmE 386 (489)
+.-++.|+.|....+|++ ..+++|+....... ......|..+++.+. +.-.++++... ...-++++|
T Consensus 20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e 87 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTR 87 (301)
T ss_dssp CCSCEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEE
T ss_pred ccceeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEe
Confidence 333788988999999998 45788877543111 111234777776663 22225666543 333578999
Q ss_pred cC-CCCCH
Q 042772 387 FC-PGGEL 393 (489)
Q Consensus 387 y~-~ggsL 393 (489)
|+ +|.+|
T Consensus 88 ~i~~g~~l 95 (301)
T 3dxq_A 88 YIAGAQTM 95 (301)
T ss_dssp CCTTCEEC
T ss_pred ecCCCccC
Confidence 99 66444
|
| >4f3l_A Mclock, circadian locomoter output cycles protein kaput; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0006 Score=69.31 Aligned_cols=49 Identities=20% Similarity=0.251 Sum_probs=43.3
Q ss_pred HHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCcccccccc
Q 042772 71 TTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTE 122 (489)
Q Consensus 71 ~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~ 122 (489)
.+++.+.+.+++.|+ +|.|+|||++|++++||+++|++|++...+..|+
T Consensus 90 ~~l~a~~~~i~v~~~---~G~i~yvs~~~~~~lGy~~~el~g~~~~~~ihp~ 138 (361)
T 4f3l_A 90 LMLEALDGFFLAIMT---DGSIIYVSESVTSLLEHLPSDLVDQSIFNFIPEG 138 (361)
T ss_dssp HHHHHTTEEEEEEET---TSBEEEECTTHHHHHCCCHHHHTTSBGGGGSCGG
T ss_pred HHHHhcCceEEEEcC---CccEEEEechhhhhcCCCHHHhcCCcHHHhcCHH
Confidence 456788788888898 9999999999999999999999999987777665
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0024 Score=62.87 Aligned_cols=143 Identities=20% Similarity=0.202 Sum_probs=77.9
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-C-CCcceeeEE------EEeC
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-H-PFLPTLYAS------FQTS 378 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-H-pnIv~l~~~------~~~~ 378 (489)
....++.|+.|....+|++...+ | .+++|...... .. ..+..|..+++.+. + -.+++++.. ....
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~--~~---~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~ 95 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS 95 (322)
T ss_dssp CEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred cceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCCC--CH---HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence 34456778889889999987643 3 68899886521 11 23445667766653 1 113333321 1234
Q ss_pred CeEEEEEecCCCCCHHH--------------HHhhC----CCC---CCCHHHHHH---------------HHHHHHHHHH
Q 042772 379 THICLITDFCPGGELFA--------------LLDKQ----PMK---IFREDSARF---------------YAAEVVIGLE 422 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~--------------~L~~~----~~~---~l~e~~~~~---------------i~~qI~~aL~ 422 (489)
+..+++|+|++|..+.. .++.. ... ......... +...+...+.
T Consensus 96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~ 175 (322)
T 2ppq_A 96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID 175 (322)
T ss_dssp TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence 56799999998854310 11110 000 011000000 0011334455
Q ss_pred HHHH-------CCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 423 YLHC-------LGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 423 yLH~-------~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
+++. .+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 176 ~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 176 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 5552 368999999999999877656899999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0017 Score=64.61 Aligned_cols=31 Identities=23% Similarity=0.403 Sum_probs=27.1
Q ss_pred CCCeecCCCCCCEEEecC----CcEEEEecCCccc
Q 042772 427 LGIIYRDLKPENILLQKD----GHVVLTDFDLSFM 457 (489)
Q Consensus 427 ~gIvHrDLKP~NILld~~----g~vKL~DFGlS~~ 457 (489)
..++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 479999999999999874 6899999998864
|
| >4f3l_B BMAL1B; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0011 Score=68.25 Aligned_cols=48 Identities=17% Similarity=0.356 Sum_probs=41.2
Q ss_pred HHHhccCcEEEECCCCCC-CCEEEecHhhHHhcCCChhhhcCCCcccccccc
Q 042772 72 TLERIEKNFVITDPRIPD-NPIIFASDSFLELTEYTREEILGRNCSFLELTE 122 (489)
Q Consensus 72 ~~~~~~~~~~i~d~~~~~-~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~ 122 (489)
.++.+...+++.++ + |.|+|+|++++.++||+++|++|+++..+..|+
T Consensus 91 ll~~~~gfi~v~~~---~~G~i~yvs~~~~~~lG~~~~el~g~~~~~~ihp~ 139 (387)
T 4f3l_B 91 ILRAADGFLFVVGC---DRGKILFVSESVFKILNYSQNDLIGQSLFDYLHPK 139 (387)
T ss_dssp HHHTCCSEEEEEET---TTCBEEEECTTHHHHHSCCHHHHTTSBGGGGBCGG
T ss_pred HHhcCCCEEEEEec---CCeEEEEEchhhHHHcCCCHHHHCCCcHHHhcCCC
Confidence 56677777778887 7 999999999999999999999999987666664
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0012 Score=67.67 Aligned_cols=138 Identities=17% Similarity=0.243 Sum_probs=81.3
Q ss_pred ccccCCCCceEEEEEEEcC-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEE
Q 042772 311 IKPLGCGDTGSVHLVELQG-------AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 311 ~~~LG~G~fG~Vy~a~~~~-------tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~ 382 (489)
++.|..|-...+|++.... .++.+++|+.... ........+|..+++.+. +.-.+++++.+.. .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 3567678888999988642 3578889975321 112344557888888773 3334677766543 3
Q ss_pred EEEecCCCCCHHH--------------HH---hhCC---CCCC--CHHHHHHHHHHHHH-------------------HH
Q 042772 383 LITDFCPGGELFA--------------LL---DKQP---MKIF--REDSARFYAAEVVI-------------------GL 421 (489)
Q Consensus 383 lVmEy~~ggsL~~--------------~L---~~~~---~~~l--~e~~~~~i~~qI~~-------------------aL 421 (489)
+||||++|.+|.. .| +... .+.. -..++..+..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 9999998755421 11 1111 1111 13455555544422 23
Q ss_pred HHHH----H----CCCeecCCCCCCEEEecC----CcEEEEecCCcc
Q 042772 422 EYLH----C----LGIIYRDLKPENILLQKD----GHVVLTDFDLSF 456 (489)
Q Consensus 422 ~yLH----~----~gIvHrDLKP~NILld~~----g~vKL~DFGlS~ 456 (489)
..|. . ..++|+|+.+.||+++.+ +.+.|+||..|.
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3333 2 258999999999999876 789999999985
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0017 Score=67.58 Aligned_cols=73 Identities=18% Similarity=0.269 Sum_probs=48.5
Q ss_pred ccccCCCCceEEEEEEEcC-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEE
Q 042772 311 IKPLGCGDTGSVHLVELQG-------AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 311 ~~~LG~G~fG~Vy~a~~~~-------tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~ 382 (489)
++.|+.|....+|++.... .+..+++|+.... .. ...+..|..+++.+. +...+++++.+.. .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 4678889899999998753 2578889987331 11 123446888888774 3334677765532 3
Q ss_pred EEEecCCCCC
Q 042772 383 LITDFCPGGE 392 (489)
Q Consensus 383 lVmEy~~ggs 392 (489)
+||||++|.+
T Consensus 149 ~v~e~l~G~~ 158 (429)
T 1nw1_A 149 RLEEYIPSRP 158 (429)
T ss_dssp EEECCCCEEE
T ss_pred EEEEEeCCcc
Confidence 8999998633
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0062 Score=60.03 Aligned_cols=76 Identities=11% Similarity=0.048 Sum_probs=46.0
Q ss_pred ccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC--CCcceeeEE-----EEeCCeEEE
Q 042772 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDH--PFLPTLYAS-----FQTSTHICL 383 (489)
Q Consensus 311 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~~~-----~~~~~~~~l 383 (489)
+..++ |....||++... +|+.+++|....... . ...+..|..+++.+.. -.+++++.. ....+..++
T Consensus 31 ~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~-~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 104 (328)
T ss_dssp CEEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred EEeec-CcccceEEEEcC-CCCEEEEEEcCCCCC-C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence 34566 788899987643 366789998864321 1 2345557777766631 123444432 223456789
Q ss_pred EEecCCCCC
Q 042772 384 ITDFCPGGE 392 (489)
Q Consensus 384 VmEy~~ggs 392 (489)
+|+|++|.+
T Consensus 105 l~~~i~G~~ 113 (328)
T 1zyl_A 105 VFPSVGGRQ 113 (328)
T ss_dssp EEECCCCEE
T ss_pred EEEecCCCC
Confidence 999998744
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.64 E-value=0.011 Score=57.35 Aligned_cols=78 Identities=14% Similarity=0.060 Sum_probs=54.0
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-C--CCcceeeEEEEeCCeEEE
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-H--PFLPTLYASFQTSTHICL 383 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-H--pnIv~l~~~~~~~~~~~l 383 (489)
....++.+|.|..+.||++... +|+.|.+|........ ....+..|...|+.|. . --+++++.+ .. -++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPA---LDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCC---CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcc---hhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceE
Confidence 4566788999999999999875 4889999976543211 1234667888888874 2 235555543 22 378
Q ss_pred EEecCCCCC
Q 042772 384 ITDFCPGGE 392 (489)
Q Consensus 384 VmEy~~ggs 392 (489)
||||++++.
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 999997764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.002 Score=65.10 Aligned_cols=74 Identities=19% Similarity=0.203 Sum_probs=43.3
Q ss_pred ccccCCCCceEEEEEEEcC--------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeE
Q 042772 311 IKPLGCGDTGSVHLVELQG--------AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHI 381 (489)
Q Consensus 311 ~~~LG~G~fG~Vy~a~~~~--------tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 381 (489)
++.|+.|....+|++.... .+..+++|+...... .......|..+++.+. +..++++++.+ . -
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~ 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--G 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEec--C--C
Confidence 4567788889999998653 136788887654211 1111245777777774 32255776544 2 2
Q ss_pred EEEEecCCCCC
Q 042772 382 CLITDFCPGGE 392 (489)
Q Consensus 382 ~lVmEy~~ggs 392 (489)
++||||++|.+
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 68999998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.43 E-value=0.0075 Score=63.39 Aligned_cols=75 Identities=17% Similarity=0.168 Sum_probs=47.7
Q ss_pred ccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC-cceeeEEEEeCCeEEEEEecCC
Q 042772 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF-LPTLYASFQTSTHICLITDFCP 389 (489)
Q Consensus 311 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~lVmEy~~ 389 (489)
++.|+.|-...+|++.....+..+++|+....... .. ....|..+++.|...+ .+++++.+. + .+||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---II-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 46788899999999987654578889987442111 01 1146888888886433 467777663 2 35999998
Q ss_pred CCCH
Q 042772 390 GGEL 393 (489)
Q Consensus 390 ggsL 393 (489)
|.+|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.35 E-value=0.023 Score=56.88 Aligned_cols=30 Identities=17% Similarity=0.381 Sum_probs=27.0
Q ss_pred CCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 427 LGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 427 ~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
..++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 468999999999999988889999998875
|
| >1oj5_A Steroid receptor coactivator 1A; transcriptional coactivator, complex, LXXLL motif, transcriptional regulation; 2.2A {Mus musculus} SCOP: d.110.3.8 | Back alignment and structure |
|---|
Probab=95.12 E-value=0.019 Score=49.79 Aligned_cols=94 Identities=7% Similarity=0.049 Sum_probs=69.4
Q ss_pred CCCEEEecHhhHHhcCCCh--hhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhcccccccccCcccccCCC
Q 042772 89 DNPIIFASDSFLELTEYTR--EEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCLEISSD 166 (489)
Q Consensus 89 ~~~i~~~n~~~~~~~gy~~--~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (489)
||.|+|+..+.. ..+|.. +|++|+.|-.+..++ ..
T Consensus 16 dGKf~~vDq~~~-r~~~~~g~qdLlGrsiy~f~H~~------------------------------------------D~ 52 (132)
T 1oj5_A 16 TGKIISIDTSSL-RAAGRTGWEDLVRKCIYAFFQPQ------------------------------------------GR 52 (132)
T ss_dssp TCCEEEEECHHH-HTTCCSCHHHHHHHHHHHHTSCB------------------------------------------TT
T ss_pred CCcEEEEecccc-cccccccHHHHHHHHHHHHhCcc------------------------------------------cc
Confidence 999999999987 478888 999999988777664 11
Q ss_pred H--HHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCC-CCeeEEeeeeccCCc
Q 042772 167 Q--ATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHK-GELQYFIGVQLDGSD 225 (489)
Q Consensus 167 ~--~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~-g~~~~~~~~~~d~Te 225 (489)
. ..-+...+.+..+...+..-....|+|+..|++-....++|.. .++.+++++..=+.+
T Consensus 53 ~~s~l~~h~~~vl~~Gq~~S~~YRfr~k~g~~V~~qT~sk~f~np~t~e~e~Ivs~n~v~r~ 114 (132)
T 1oj5_A 53 EPSYARQLFQEVMTRGTASSPSYRFILNDGTMLSAHTRCKLCYPQSPDMQPFIMGIHIIDRE 114 (132)
T ss_dssp BCCHHHHHHHHHHHHSEEECCCEEEECTTSCEEEEEEEEEEECC----CCCEEEEEEEEECC
T ss_pred hHHHHHHHHHHHHHcCCccccceEEEecCCcEEEEEEEEEEecCCCCCCCCEEEEEEEEEcC
Confidence 1 3445566677777777777777889999999998888888853 466677776554443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.65 E-value=0.052 Score=56.37 Aligned_cols=75 Identities=21% Similarity=0.285 Sum_probs=47.0
Q ss_pred ccccCCCCceEEEEEEEcCC-------CcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEE
Q 042772 311 IKPLGCGDTGSVHLVELQGA-------GELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 311 ~~~LG~G~fG~Vy~a~~~~t-------g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~ 382 (489)
++.|..|-...+|++..... +..+++++...... ..-...+|..+++.+. +.-.+++++.+. -+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~----~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG----KFYDSKVELDVFRYLSNINIAPNIIADFP----EG 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc----hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence 35666788899999987631 57888988644211 1111235777777763 333566665432 27
Q ss_pred EEEecCCCCCH
Q 042772 383 LITDFCPGGEL 393 (489)
Q Consensus 383 lVmEy~~ggsL 393 (489)
+||+|++|.+|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999988653
|
| >2ool_A Sensor protein; bacteriophytochrome, photoconversion, photoreceptor, biliver signaling protein; HET: LBV; 2.20A {Rhodopseudomonas palustris} SCOP: d.110.2.1 d.110.3.9 | Back alignment and structure |
|---|
Probab=93.06 E-value=0.14 Score=51.49 Aligned_cols=40 Identities=13% Similarity=0.093 Sum_probs=32.3
Q ss_pred EEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccc
Q 042772 80 FVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELT 121 (489)
Q Consensus 80 ~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~ 121 (489)
.++.|+ +++.|+.+|..+.+++|++.++++|++...+-++
T Consensus 45 Ll~~~~--~~~~i~~~S~N~~~~lg~~~~~llG~~l~~ll~~ 84 (337)
T 2ool_A 45 LFVVSE--TDLRIASVSANVEDLLRQPPASLLNVPIAHYLTA 84 (337)
T ss_dssp EEEECT--TTCBEEEEETTHHHHHSSCGGGGTTCBGGGGBCH
T ss_pred EEEEEC--CCCEEEEEehhHHHHHCcCHHHHcCCCHHHHcCH
Confidence 344454 3789999999999999999999999997755433
|
| >4dj2_A Period circadian protein homolog 1; PAS domains, circadian clock protein, protein binding; 2.75A {Mus musculus} | Back alignment and structure |
|---|
Probab=92.72 E-value=0.18 Score=50.33 Aligned_cols=45 Identities=18% Similarity=0.146 Sum_probs=34.7
Q ss_pred ccCcEE-EECCCCCCCCEEEecHhhHHhcCCChhhhcCCCcccccccc
Q 042772 76 IEKNFV-ITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTE 122 (489)
Q Consensus 76 ~~~~~~-i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~ 122 (489)
..++|+ +... .+|.|+|+|+++..++||+.+|++|+++-.+..|+
T Consensus 34 aldGF~~vvs~--~~G~i~yvS~sv~~~Lg~~~~~l~g~s~~d~iHp~ 79 (320)
T 4dj2_A 34 NQDTFSVAVSF--LTGRIVYISEQAGVLLRCKRDVFRGARFSELLAPQ 79 (320)
T ss_dssp CSSEEEEEEET--TTCBEEEECTHHHHHHTSCSTTTTTSBGGGGBCHH
T ss_pred ccCCEEEEEEC--CCceEEEECcHHHHHhCcCHHHHcCCcHHHhcCHH
Confidence 345554 3444 15999999999999999999999999976555553
|
| >3gdi_A Period circadian protein homolog 2; tandem PAS domains, biological rhythms, cytoplasm, nucleus, phosphoprotein, transcription; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=92.46 E-value=0.083 Score=52.47 Aligned_cols=48 Identities=6% Similarity=0.075 Sum_probs=28.5
Q ss_pred HHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCcccccccc
Q 042772 73 LERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTE 122 (489)
Q Consensus 73 ~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~ 122 (489)
|+.+..-+++.+. .+|.|+|+|+++..++||+.+|++|++.-.+..|+
T Consensus 21 l~a~dgF~~vvs~--~~G~i~yvS~s~~~~Lg~~~~el~g~s~~d~iHp~ 68 (309)
T 3gdi_A 21 VKNADMFAVAVSL--VSGKILYISNQVASIFHCKKDAFSDAKFVEFLAPH 68 (309)
T ss_dssp --CTTEEEEEECT--TTCBEEEECTTTTTTC-------CCSBGGGGBCTT
T ss_pred HHhcCCEEEEEEC--CCceEEEECCHHHHHcCCCHHHHcCCchhhccCHh
Confidence 3344333456666 14999999999999999999999999976555554
|
| >4dj3_A Period circadian protein homolog 3; PAS domain, circadian rhythm, protein binding; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=91.30 E-value=0.12 Score=51.43 Aligned_cols=43 Identities=9% Similarity=0.031 Sum_probs=34.1
Q ss_pred CcE-EEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCcccccccc
Q 042772 78 KNF-VITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTE 122 (489)
Q Consensus 78 ~~~-~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~ 122 (489)
++| ++.+.. +|.|+|+|++...++||+++|++|++.-.+..|+
T Consensus 36 dgF~~vvs~~--~G~i~yvS~~~~~~Lg~~~~el~g~s~~d~ihp~ 79 (317)
T 4dj3_A 36 DTFAAVFSFL--SGRLVHISEQAALILNSKRGFLKSVHFVDLLAPQ 79 (317)
T ss_dssp TEEEEEEETT--TCBEEEECTTHHHHTTCCHHHHHTSBGGGGBCGG
T ss_pred CCEEEEEEcC--CcEEEEECCHHHHHcCCCHHHHcCCchhhhcChh
Confidence 555 455551 5999999999999999999999999976555454
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 489 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-39 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-39 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-38 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-36 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-36 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-35 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-35 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-33 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-33 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-32 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-31 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-31 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-31 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-31 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-30 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-30 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-30 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-29 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-29 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-29 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-29 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-29 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-29 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-28 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-28 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-28 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-27 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-27 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-27 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-27 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-26 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-26 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-25 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-25 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-25 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-25 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-24 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-24 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-23 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-23 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-23 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-23 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-22 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-22 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-21 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-21 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-21 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-20 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-16 | |
| d1n9la_ | 109 | d.110.3.6 (A:) Putative blue light receptor, phot- | 5e-15 | |
| d1jnua_ | 104 | d.110.3.6 (A:) Photoreceptor phy3 flavin-binding d | 1e-14 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-12 | |
| d1bywa_ | 110 | d.110.3.6 (A:) Erg potassium channel, N-terminal d | 3e-09 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 5e-39
Identities = 50/151 (33%), Positives = 77/151 (50%), Gaps = 2/151 (1%)
Query: 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD 364
L F+ +PLG G G+V+L + + + A+K + K+ + H+ E EI S L
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYL 424
HP + LY F +T + LI ++ P G ++ L K + F E Y E+ L Y
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYC 122
Query: 425 HCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
H +I+RD+KPEN+LL G + + DF S
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGELKIADFGWS 153
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 5e-39
Identities = 67/176 (38%), Positives = 89/176 (50%), Gaps = 2/176 (1%)
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS 361
K FK K LG G +V L YA+K +EK ++ NKV ER++MS
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
LDHPF LY +FQ + + GEL + K + F E RFY AE+V L
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSAL 121
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFYFIM 477
EYLH GII+RDLKPENILL +D H+ +TDF + + S + + G +
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (350), Expect = 3e-38
Identities = 43/183 (23%), Positives = 79/183 (43%), Gaps = 4/183 (2%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
++ I LG G G V+ + + L A K ++ + ++ +E +I++ DHP
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHP 69
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
+ L +F ++ ++ +FC GG + A++ + + E + + + L YLH
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHD 128
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFYFIMYKWLTGYFT 486
II+RDLK NIL DG + L DF +S + Q ++ +
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 487 YVP 489
P
Sbjct: 189 DRP 191
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (339), Expect = 2e-36
Identities = 39/149 (26%), Positives = 60/149 (40%), Gaps = 2/149 (1%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
F ++ +G G G+V+ E+ A+K M S + K E + L HP
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
+ L+ ++C G L + K +E + GL YLH
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS 133
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+I+RD+K NILL + G V L DF +
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSA 162
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 135 bits (340), Expect = 4e-36
Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 6/151 (3%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
++ ++ LG G G VH + G ++ K + L++ V E IM+ L HP
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLHHP 86
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
L L+ +F+ + LI +F GGELF + + K E Y + GL+++H
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE 145
Query: 427 LGIIYRDLKPENILL--QKDGHVVLTDFDLS 455
I++ D+KPENI+ +K V + DF L+
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLA 176
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 4e-36
Identities = 40/150 (26%), Positives = 68/150 (45%), Gaps = 5/150 (3%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
F+ I LG G+ G V V + +G + A K + + ++ E +++ + P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH- 425
++ Y +F + I + + GG L +L K E + V+ GL YL
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE 122
Query: 426 CLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
I++RD+KP NIL+ G + L DF +S
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 134 bits (337), Expect = 8e-36
Identities = 49/153 (32%), Positives = 77/153 (50%), Gaps = 6/153 (3%)
Query: 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD 364
L H+ + LG G G VH V + G +A K + ++ V + E + MS+L
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVLR 81
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYL 424
HP L L+ +F+ + +I +F GGELF + + K ED A Y +V GL ++
Sbjct: 82 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHM 140
Query: 425 HCLGIIYRDLKPENILL--QKDGHVVLTDFDLS 455
H ++ DLKPENI+ ++ + L DF L+
Sbjct: 141 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 173
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 132 bits (334), Expect = 3e-35
Identities = 54/156 (34%), Positives = 87/156 (55%), Gaps = 5/156 (3%)
Query: 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL 362
+ ++ F + +G G G V+ G++YAMK ++K + + A ER ++SL
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 363 L---DHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVI 419
+ D PF+ + +F T + I D GG+L L + + F E RFYAAE+++
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIIL 118
Query: 420 GLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
GLE++H ++YRDLKP NILL + GHV ++D L+
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 154
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 4e-35
Identities = 36/181 (19%), Positives = 70/181 (38%), Gaps = 6/181 (3%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
+ + +G G +G+V+ G+ A++ M + + E +M +P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRENKNP 77
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
+ S+ + ++ ++ GG L ++ + M E E + LE+LH
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALEFLHS 134
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFYFIMYKWLTGYFT 486
+I+RD+K +NILL DG V LTDF + + ++ +
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 487 Y 487
Sbjct: 195 P 195
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 6e-35
Identities = 41/171 (23%), Positives = 79/171 (46%), Gaps = 4/171 (2%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
+ ++ LG G G V L + E A+K ++ ++ + E I +L+H
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNHE 63
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
+ Y + L ++C GGELF ++ E A+ + +++ G+ YLH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFYFIM 477
+GI +RD+KPEN+LL + ++ ++DF L+ + + + G +
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 2e-34
Identities = 75/198 (37%), Positives = 109/198 (55%), Gaps = 7/198 (3%)
Query: 295 KITGSGEKIGLHHFKPIKPLGCGDTGSVHLVEL---QGAGELYAMKAMEKSVMLNRNK-V 350
+TG EK+G+ +F+ +K LG G G V LV G+LYAMK ++K+ ++ + K
Sbjct: 13 NLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT 72
Query: 351 HRACIEREIMSLLDH-PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDS 409
ER+++ + PFL TL+ +FQT T + LI D+ GGELF L ++ F E
Sbjct: 73 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHE 130
Query: 410 ARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAH 469
+ Y E+V+ LE+LH LGIIYRD+K ENILL +GHVVLTDF LS +
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 190
Query: 470 VNGFYFIMYKWLTGYFTY 487
++ + G +
Sbjct: 191 CGTIEYMAPDIVRGGDSG 208
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 128 bits (322), Expect = 5e-34
Identities = 65/151 (43%), Positives = 96/151 (63%), Gaps = 2/151 (1%)
Query: 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD 364
L F+ ++ LG G G VHL+ + G YAMK ++K +++ +V ER ++S++
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYL 424
HPF+ ++ +FQ + I +I D+ GGELF+L + + F A+FYAAEV + LEYL
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL--LRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 425 HCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
H IIYRDLKPENILL K+GH+ +TDF +
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFA 151
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 7e-34
Identities = 64/186 (34%), Positives = 95/186 (51%), Gaps = 2/186 (1%)
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS 361
K+ ++ F +K LG G G V LV + G YAMK + K V++ +++V E ++
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
HPFL L +FQT +C + ++ GGELF L ++ + F E+ ARFY AE+V L
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSAL 118
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFYFIMYKWL 481
EYLH ++YRD+K EN++L KDGH+ +TDF L Y
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 482 TGYFTY 487
+
Sbjct: 179 DNDYGR 184
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 125 bits (314), Expect = 3e-33
Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 9/156 (5%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVH----RACIEREI--- 359
+++P + LG G + V + + YA+K ++ + + + R +E+
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 360 MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVI 419
+ HP + L +++T+T L+ D GELF L ++ E R ++
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLE 121
Query: 420 GLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ LH L I++RDLKPENILL D ++ LTDF S
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 157
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 4e-33
Identities = 58/172 (33%), Positives = 92/172 (53%), Gaps = 3/172 (1%)
Query: 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL-L 363
+ F K LG G G V L E + + +A+KA++K V+L + V +E+ ++SL
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 364 DHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEY 423
+HPFL ++ +FQT ++ + ++ GG+L + F A FYAAE+++GL++
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQF 118
Query: 424 LHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFYF 475
LH GI+YRDLK +NILL KDGH+ + DF + Y
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYI 170
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 4e-33
Identities = 35/178 (19%), Positives = 76/178 (42%), Gaps = 18/178 (10%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
++ + +G G G + + G++ K ++ M + E ++ L HP
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPN 64
Query: 368 LPTLYASF--QTSTHICLITDFCPGGELFALLDK--QPMKIFREDSARFYAAEVVIGLEY 423
+ Y +T+T + ++ ++C GG+L +++ K + + E+ ++ + L+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 424 LHCLG-----IIYRDLKPENILLQKDGHVVLTDFDLS--------FMTSCKPQVFYHA 468
H +++RDLKP N+ L +V L DF L+ F + +Y +
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (312), Expect = 2e-32
Identities = 58/166 (34%), Positives = 95/166 (57%), Gaps = 2/166 (1%)
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS 361
L F IK LG G G V LV+ + +G YAMK ++K ++ ++ E+ I+
Sbjct: 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 362 LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
++ PFL L SF+ ++++ ++ ++ GGE+F+ L + F E ARFYAA++V+
Sbjct: 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTF 154
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYH 467
EYLH L +IYRDLKPEN+L+ + G++ +TDF + +
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG 200
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-31
Identities = 34/177 (19%), Positives = 71/177 (40%), Gaps = 5/177 (2%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
+ + LG G+ G VH + + Y K ++ ++ V + E I+++ H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKK---EISILNIARHR 61
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
+ L+ SF++ + +I +F G ++F ++ + E Y +V L++LH
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHS 120
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFYFIMYKWLTG 483
I + D++PENI+ Q + + KP + + +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-31
Identities = 38/157 (24%), Positives = 66/157 (42%), Gaps = 6/157 (3%)
Query: 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL 362
I + +G G G+V+ + G A+K + + ++ E ++
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRK 60
Query: 363 LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLE 422
H + + T+ + ++T +C G L+ L K F A + G++
Sbjct: 61 TRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMD 118
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459
YLH II+RDLK NI L +D V + DF L+ + S
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 119 bits (298), Expect = 6e-31
Identities = 40/185 (21%), Positives = 65/185 (35%), Gaps = 5/185 (2%)
Query: 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL 362
+ LG G G V+ + A+K +++ M +V E +M
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKE 69
Query: 363 LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLE 422
+ HP L L +IT+F G L L + + + A ++ +E
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS-FMTSCKPQVFYHAHVNGFYFIMYKWL 481
YL I+RDL N L+ ++ V + DF LS MT A +
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189
Query: 482 TGYFT 486
F+
Sbjct: 190 YNKFS 194
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 8e-31
Identities = 34/166 (20%), Positives = 67/166 (40%), Gaps = 8/166 (4%)
Query: 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL 362
+ + K ++ +G G+ G V L + +G A+K ++ E +M+
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIKNDATAQAFLA-----EASVMTQ 56
Query: 363 LDHPFLPTLYASF-QTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
L H L L + + ++T++ G L L + + D ++ +V +
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYH 467
EYL ++RDL N+L+ +D ++DF L+ S
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 162
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 117 bits (295), Expect = 2e-30
Identities = 41/176 (23%), Positives = 70/176 (39%), Gaps = 4/176 (2%)
Query: 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE-- 358
++I + K + +G G+ G V L+ G+ A+ K++ + R E
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAI-KTLKSGYTEKQRRDFLSEAS 79
Query: 359 IMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVV 418
IM DHP + L ST + +IT+F G L + +Q F +
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF-LRQNDGQFTVIQLVGMLRGIA 138
Query: 419 IGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFY 474
G++YL + ++RDL NIL+ + ++DF LS + G
Sbjct: 139 AGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 115 bits (290), Expect = 7e-30
Identities = 33/155 (21%), Positives = 63/155 (40%), Gaps = 6/155 (3%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
++ + LG G VHL A+K + + + + R E + + L+HP
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 367 FLPTLYASFQTSTH----ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLE 422
+ +Y + + T ++ ++ G L ++ A A+ L
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALN 125
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457
+ H GII+RD+KP NI++ V + DF ++
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 160
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 7e-30
Identities = 36/156 (23%), Positives = 68/156 (43%), Gaps = 16/156 (10%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS-LLDHPFLPT 370
+ LG G G V + + E +A+K ++ R E E+ P +
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCPHIVR 69
Query: 371 LYASFQTS----THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
+ ++ + ++ + GGELF+ + + + F E A + ++YLH
Sbjct: 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 129
Query: 427 LGIIYRDLKPENILL---QKDGHVVLTDFDLSFMTS 459
+ I +RD+KPEN+L + + + LTDF + T+
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-29
Identities = 39/149 (26%), Positives = 62/149 (41%), Gaps = 6/149 (4%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
+K LG G G V + +G A+K +++ M + E ++M L H
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHE 59
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
L LY I +IT++ G L L + + F+ +V +EYL
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLES 118
Query: 427 LGIIYRDLKPENILLQKDGHVVLTDFDLS 455
++RDL N L+ G V ++DF LS
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLS 147
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 115 bits (290), Expect = 1e-29
Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 7/152 (4%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
+ LG G V L E + +L A+K + K + K E ++ + HP
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKHP 67
Query: 367 FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC 426
+ L +++ H+ LI GGELF + ++ + E A +V+ ++YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHD 125
Query: 427 LGIIYRDLKPENILL---QKDGHVVLTDFDLS 455
LGI++RDLKPEN+L +D ++++DF LS
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (285), Expect = 3e-29
Identities = 38/155 (24%), Positives = 69/155 (44%), Gaps = 10/155 (6%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
K +G G +V+ A ++ L +++ R E E++ L HP
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR-KLTKSERQRFKEEAEMLKGLQHPN 69
Query: 368 LPTLYASFQTST----HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEY 423
+ Y S++++ I L+T+ G L L + K+ + R + +++ GL++
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQF 127
Query: 424 LHCLG--IIYRDLKPENILL-QKDGHVVLTDFDLS 455
LH II+RDLK +NI + G V + D L+
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (285), Expect = 3e-29
Identities = 42/186 (22%), Positives = 71/186 (38%), Gaps = 7/186 (3%)
Query: 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL 362
+ K ++ LG G G V + G A+K++++ M + + E +M
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSM-SPDAFLA---EANLMKQ 64
Query: 363 LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLE 422
L H L LYA T I +IT++ G L L + AA++ G+
Sbjct: 65 LQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS-FMTSCKPQVFYHAHVNGFYFIMYKWL 481
++ I+RDL+ NIL+ + DF L+ + + A +
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 482 TGYFTY 487
G FT
Sbjct: 184 YGTFTI 189
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 3e-29
Identities = 46/179 (25%), Positives = 66/179 (36%), Gaps = 6/179 (3%)
Query: 303 IGLHHFKPIKPLGCGDTGSVHLVELQ---GAGELYAMKAMEKSVMLNRNKVHRACIEREI 359
IG + ++ LG G G V E G A+K ++ V+ + E
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 360 MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVI 419
M LDH L LY T + ++T+ P G L L K F + YA +V
Sbjct: 65 MHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAE 122
Query: 420 GLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS-FMTSCKPQVFYHAHVNGFYFIM 477
G+ YL I+RDL N+LL V + DF L + H +
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 8e-29
Identities = 36/144 (25%), Positives = 62/144 (43%), Gaps = 6/144 (4%)
Query: 314 LGCGDTGSVHLVELQ--GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTL 371
LGCG+ GSV + A+K +++ + E +IM LD+P++ L
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 372 YASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIY 431
Q + L+ + GG L L + + +V +G++YL ++
Sbjct: 75 IGVCQA-EALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 132
Query: 432 RDLKPENILLQKDGHVVLTDFDLS 455
RDL N+LL + ++DF LS
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLS 156
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 1e-28
Identities = 40/212 (18%), Positives = 72/212 (33%), Gaps = 27/212 (12%)
Query: 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAME-KSVMLNRNKVHRACIEREI-- 359
+ + K LG G G V G + + K + + R + E+
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 93
Query: 360 -MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQ------------------ 400
L H + L + S I LI ++C G+L L +
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 401 ---PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS-- 455
+ + + +A +V G+E+L ++RDL N+L+ V + DF L+
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 456 FMTSCKPQVFYHAHVNGFYFIMYKWLTGYFTY 487
M+ V +A + + G +T
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 245
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 4e-28
Identities = 40/181 (22%), Positives = 70/181 (38%), Gaps = 6/181 (3%)
Query: 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL 362
I ++ +G G G VHL + A+K + + M + + E E+M
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIE----EAEVMMK 56
Query: 363 LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLE 422
L HP L LY ICL+ +F G L L Q +F ++ +V G+
Sbjct: 57 LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMA 115
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFYFIMYKWLT 482
YL +I+RDL N L+ ++ + ++DF ++ + + +
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 483 G 483
Sbjct: 176 F 176
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 9e-28
Identities = 45/179 (25%), Positives = 76/179 (42%), Gaps = 5/179 (2%)
Query: 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE--IMSLLDHPFL 368
+ LG G +V+ + ++ A+K ++ RE ++ L HP +
Sbjct: 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 369 PTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLG 428
L +F ++I L+ DF + D + + Y + GLEYLH
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 429 IIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFYFIMYKWLTGYFTY 487
I++RDLKP N+LL ++G + L DF L+ + P Y V ++ + L G Y
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLA-KSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 1e-27
Identities = 38/181 (20%), Positives = 68/181 (37%), Gaps = 6/181 (3%)
Query: 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL 362
I + LG G G V + G A+K ++ M + E ++M
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQ----EAQVMKK 68
Query: 363 LDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLE 422
L H L LYA + I ++T++ G L L + K R AA++ G+
Sbjct: 69 LRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFYFIMYKWLT 482
Y+ + ++RDL+ NIL+ ++ + DF L+ + + +
Sbjct: 128 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187
Query: 483 G 483
Sbjct: 188 Y 188
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 4e-27
Identities = 37/211 (17%), Positives = 66/211 (31%), Gaps = 30/211 (14%)
Query: 303 IGLHHFKPIKPLGCGDTGSVHLVELQG-----AGELYAMKAMEKSVMLNRNKVHRACIER 357
+ K LG G G V G A A+K ++ S + R +
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS----AHLTEREALMS 75
Query: 358 EI---MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKI---------- 404
E+ L +H + L + +IT++C G+L L ++
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 405 ------FREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458
+ ++ +V G+ +L I+RDL NILL + DF L+
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 459 SCKPQVFYHAHVNG--FYFIMYKWLTGYFTY 487
+ + +T+
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTF 226
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 5e-27
Identities = 43/188 (22%), Positives = 76/188 (40%), Gaps = 17/188 (9%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF 367
+ K +G G G V+ +L +GEL A+K + + E +IM LDH
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 74
Query: 368 LPTLYASFQTS------THICLITDFCPGGELFALLD-KQPMKIFREDSARFYAAEVVIG 420
+ L F +S ++ L+ D+ P + + + Y ++
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 421 LEYLHCLGIIYRDLKPENILLQKDG-HVVLTDFDLSFMTSCKPQVFYHAHVNGFYFIMYK 479
L Y+H GI +RD+KP+N+LL D + L DF + +++ Y+ +
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA--KQLVRGEPNVSYICSRYYRAPE 192
Query: 480 WLTGYFTY 487
+ G Y
Sbjct: 193 LIFGATDY 200
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 5e-27
Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 9/175 (5%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVML-NRNKVHRACIERE--IMSLL 363
++ + LG G V + G YA K ++K +R V R IERE I+ +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 364 DHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEY 423
HP + TL+ ++ T + LI + GGELF L ++ + E+ A + +++ G+ Y
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYY 128
Query: 424 LHCLGIIYRDLKPENILLQKDG----HVVLTDFDLSFMTSCKPQVFYHAHVNGFY 474
LH L I + DLKPENI+L + + DF L+ + F
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 183
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 8e-27
Identities = 35/174 (20%), Positives = 63/174 (36%), Gaps = 15/174 (8%)
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS 361
+ + K +G G+ G V ++ G +++ E E++
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65
Query: 362 -LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPM--------------KIFR 406
L HP + L + + ++ L ++ P G L L K +
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 407 EDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460
+AA+V G++YL I+RDL NIL+ ++ + DF LS
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 179
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 1e-26
Identities = 32/146 (21%), Positives = 62/146 (42%), Gaps = 6/146 (4%)
Query: 312 KPLGCGDTGSVHLVELQ--GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLP 369
K LG G+ G+V Q + A+K ++ + E +M LD+P++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIV 71
Query: 370 TLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGI 429
+ + L+ + G L L + + ++ + +V +G++YL
Sbjct: 72 RMIGICEAE-SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 430 IYRDLKPENILLQKDGHVVLTDFDLS 455
++RDL N+LL + ++DF LS
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLS 154
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 4e-26
Identities = 42/172 (24%), Positives = 71/172 (41%), Gaps = 4/172 (2%)
Query: 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIERE--IMSLLDH 365
FK IK LG G G+V+ GE + K + + I E +M+ +D+
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
P + L TST LIT P G L + + + ++ G+ YL
Sbjct: 71 PHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLE 128
Query: 426 CLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFYFIM 477
+++RDL N+L++ HV +TDF L+ + + + ++ M
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 2e-25
Identities = 43/192 (22%), Positives = 73/192 (38%), Gaps = 14/192 (7%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
++ + +G G G V + G+ A+K + A E +I+ LL H
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME-NEKEGFPITALREIKILQLLKHE 69
Query: 367 FLPTLYASFQTST--------HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVV 418
+ L +T I L+ DFC L + F + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTLSEIKRVMQMLL 127
Query: 419 IGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS---FMTSCKPQVFYHAHVNGFYF 475
GL Y+H I++RD+K N+L+ +DG + L DF L+ + Y V ++
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 476 IMYKWLTGYFTY 487
+ L G Y
Sbjct: 188 RPPELLLGERDY 199
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 104 bits (259), Expect = 2e-25
Identities = 35/209 (16%), Positives = 66/209 (31%), Gaps = 29/209 (13%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQG-----AGELYAMKAMEKSVMLNRNKVHRACIEREIM 360
++ + ++ +G G G V G + A+K +++ + + E +M
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALM 70
Query: 361 SLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKI---------------- 404
+ D+P + L +CL+ ++ G+L L
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 405 ------FREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458
A +V G+ YL ++RDL N L+ ++ V + DF LS
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 459 SCKPQVFYHAHVNGFYFIMYKWLTGYFTY 487
+ M Y Y
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRY 219
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 2e-25
Identities = 39/170 (22%), Positives = 76/170 (44%), Gaps = 2/170 (1%)
Query: 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD 364
+ +F+ ++ +G G G V+ + GE+ A+K + A E ++ L+
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN 59
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYL 424
HP + L T + L+ +F L +D + + Y +++ GL +
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 425 HCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFY 474
H +++RDLKP+N+L+ +G + L DF L+ + + H V +Y
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 168
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 104 bits (259), Expect = 3e-25
Identities = 34/185 (18%), Positives = 67/185 (36%), Gaps = 15/185 (8%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS-LLDH 365
++ ++ LG G V E +K ++ K + E +I+ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGG 89
Query: 366 PFLPTLYASFQTSTH--ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEY 423
P + TL + L+ + + L + + RFY E++ L+Y
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQL-----YQTLTDYDIRFYMYEILKALDY 144
Query: 424 LHCLGIIYRDLKPENILL-QKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFYFIMYKWLT 482
H +GI++RD+KP N+++ + + L D+ L+ + F
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 483 GYFTY 487
+ Y
Sbjct: 205 QMYDY 209
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 3e-25
Identities = 36/183 (19%), Positives = 77/183 (42%), Gaps = 4/183 (2%)
Query: 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD 364
+ ++ ++ +G G G+V + + E+ A+K + + A E ++ L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK 59
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYL 424
H + L+ + + L+ +FC + + + +++ GL +
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKK--YFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 425 HCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFYFIMYKWLTGY 484
H +++RDLKP+N+L+ ++G + L +F L+ P Y A V ++ L G
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 485 FTY 487
Y
Sbjct: 177 KLY 179
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 102 bits (255), Expect = 4e-25
Identities = 37/183 (20%), Positives = 75/183 (40%), Gaps = 5/183 (2%)
Query: 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD 364
+ + ++ +G G G V+ + GE +A+K + + E I+ L
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLE-KEDEGIPSTTIREISILKELK 58
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYL 424
H + LY T + L+ + L + +A+ + +++ G+ Y
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYC 116
Query: 425 HCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFYFIMYKWLTGY 484
H +++RDLKP+N+L+ ++G + + DF L+ P Y + ++ L G
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 485 FTY 487
Y
Sbjct: 176 KKY 178
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 6e-25
Identities = 32/176 (18%), Positives = 64/176 (36%), Gaps = 10/176 (5%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
+ + +G G G V A+K + ++ R E +I+ H
Sbjct: 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 66
Query: 367 FLPTLYASFQTSTHI----CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLE 422
+ + + T + G +L+ LL Q + D ++ +++ GL+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLS---NDHICYFLYQILRGLK 123
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS-FMTSCKPQVFYHAHVNGFYFIM 477
Y+H +++RDLKP N+LL + + DF L+ + +
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 1e-24
Identities = 47/203 (23%), Positives = 80/203 (39%), Gaps = 22/203 (10%)
Query: 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDH 365
++ ++P+G G G+V G A+K + + + RA E ++ + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRH 76
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMK--IFREDSARFYAAEVVIGLEY 423
+ L F + TDF + MK ED +F +++ GL Y
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136
Query: 424 LHCLGIIYRDLKPENILLQKDGHVVLTDFDLS-----FMTSCKPQVFYHAH--------- 469
+H GII+RDLKP N+ + +D + + DF L+ MT +Y A
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRY 196
Query: 470 -----VNGFYFIMYKWLTGYFTY 487
+ IM + +TG +
Sbjct: 197 TQTVDIWSVGCIMAEMITGKTLF 219
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 2e-24
Identities = 33/159 (20%), Positives = 65/159 (40%), Gaps = 7/159 (4%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVH---RACIEREIMSLL 363
++ LG G GSV+ A+K +EK + + ++ R +E ++ +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 364 D--HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
+ L F+ LI + + + +E+ AR + +V+ +
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 123
Query: 422 EYLHCLGIIYRDLKPENILL-QKDGHVVLTDFDLSFMTS 459
+ H G+++RD+K ENIL+ G + L DF +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.8 bits (248), Expect = 3e-24
Identities = 37/184 (20%), Positives = 64/184 (34%), Gaps = 7/184 (3%)
Query: 303 IGLHHFKPIKPLGCGDTGSVHLVEL---QGAGELYAMKAMEKSVMLNRNKVHRACIEREI 359
I + + +G G G VH + A+K + + + + E
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALT 61
Query: 360 MSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVI 419
M DHP + L T + +I + C GEL + L + S YA ++
Sbjct: 62 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLST 119
Query: 420 GLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFYFIMYK 479
L YL ++RD+ N+L+ + V L DF LS ++ +
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 480 WLTG 483
+
Sbjct: 180 SINF 183
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 98.4 bits (244), Expect = 2e-23
Identities = 34/185 (18%), Positives = 72/185 (38%), Gaps = 13/185 (7%)
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS 361
++G + ++ + +G G G ++L AGE A+K + + K + IE +I
Sbjct: 4 RVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYK 57
Query: 362 LLDHP-FLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIG 420
++ +PT+ + ++ + L + F + A +++
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLED--LFNFCSRKFSLKTVLLLADQMISR 115
Query: 421 LEYLHCLGIIYRDLKPENILLQKDGH---VVLTDFDLS-FMTSCKPQVFYHAHVNGFYFI 476
+EY+H I+RD+KP+N L+ V + DF L+ + N
Sbjct: 116 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
Query: 477 MYKWL 481
++
Sbjct: 176 TARYA 180
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 2e-23
Identities = 40/171 (23%), Positives = 66/171 (38%), Gaps = 25/171 (14%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL--LDHPFLP 369
+ +G G G V + +G E A+K + + + E EI L H +
Sbjct: 9 ESIGKGRFGEVWRGKWRG--EEVAVK------IFSSREERSWFREAEIYQTVMLRHENIL 60
Query: 370 TLYASFQ----TSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
A+ T T + L++D+ G LF L++ + + A GL +LH
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT---VEGMIKLALSTASGLAHLH 117
Query: 426 C--------LGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHA 468
I +RDLK +NIL++K+G + D L+ A
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 168
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 3e-23
Identities = 39/207 (18%), Positives = 71/207 (34%), Gaps = 23/207 (11%)
Query: 303 IGLHHFKPIKPLGCGDTGSVHLVELQG-----AGELYAMKAMEKSVMLNRNKVHRACIER 357
K KPLG G G V + G A+K +++ + ++ + ++
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69
Query: 358 EIMSLLDHPFLPTL-YASFQTSTHICLITDFCPGGELFALLDKQPMK------------- 403
++ + H + L A + + +I +FC G L L + +
Sbjct: 70 -LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 404 -IFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKP 462
+ Y+ +V G+E+L I+RDL NILL + V + DF L+ P
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
Query: 463 QVFYHAHVNG--FYFIMYKWLTGYFTY 487
+ +T
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTI 215
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.3 bits (241), Expect = 5e-23
Identities = 40/187 (21%), Positives = 76/187 (40%), Gaps = 13/187 (6%)
Query: 306 HHFKPIKPLGCGDTGSVHLV-ELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL- 363
++ + +G G G V +L+ G A+K + E ++ L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLE 65
Query: 364 --DHPFLPTLYASFQTS-----THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAE 416
+HP + L+ S T + L+ + LDK P ++ + +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMFQ 124
Query: 417 VVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFYFI 476
++ GL++LH +++RDLKP+NIL+ G + L DF L+ Q+ + V ++
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA--RIYSFQMALTSVVVTLWYR 182
Query: 477 MYKWLTG 483
+ L
Sbjct: 183 APEVLLQ 189
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.3 bits (241), Expect = 9e-23
Identities = 38/186 (20%), Positives = 76/186 (40%), Gaps = 14/186 (7%)
Query: 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD 364
L ++ +KP+G G G V A+K + + N+ RA E +M ++
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN 74
Query: 365 HPFLPTLYASFQTS------THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVV 418
H + +L F + L+ + + + + + +++
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQML 129
Query: 419 IGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFYFIMY 478
G+++LH GII+RDLKP NI+++ D + + DF L+ + +V Y+
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--RTAGTSFMMTPYVVTRYYRAP 187
Query: 479 KWLTGY 484
+ + G
Sbjct: 188 EVILGM 193
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.4 bits (231), Expect = 6e-22
Identities = 31/158 (19%), Positives = 58/158 (36%), Gaps = 7/158 (4%)
Query: 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGE----LYAMKAMEKSVMLNRNKVHRACIER 357
+I K +G G+ G V+ L+ + A+K ++ + E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEA 60
Query: 358 EIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEV 417
IM H + L + +IT++ G ++ F +
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENG-ALDKFLREKDGEFSVLQLVGMLRGI 119
Query: 418 VIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
G++YL + ++RDL NIL+ + ++DF LS
Sbjct: 120 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 157
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.8 bits (232), Expect = 6e-22
Identities = 39/204 (19%), Positives = 66/204 (32%), Gaps = 25/204 (12%)
Query: 303 IGLHHFKPIKPLGCGDTGSVHLVELQG-------AGELYAMKAMEKSVMLNRNKVHRACI 355
+ KPLG G G V L E G A+K ++ +
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLIS 67
Query: 356 EREIMS-LLDHPFLPTLYASFQTSTHICLITDFCPGGELFALL--------------DKQ 400
E E+M + H + L + + +I ++ G L L
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 401 PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS-FMTS 459
P + A +V G+EYL I+RDL N+L+ +D + + DF L+ +
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187
Query: 460 CKPQVFYHAHVNGFYFIMYKWLTG 483
++ + L
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD 211
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.4 bits (231), Expect = 1e-21
Identities = 29/188 (15%), Positives = 57/188 (30%), Gaps = 15/188 (7%)
Query: 303 IGLHHFKPIKPLGCGDTGSVHLVELQG-----AGELYAMKAMEKSVMLNRNKVHRACIER 357
+ + LG G G V+ +G A+K + ++ + E
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN--EA 74
Query: 358 EIMSLLDHPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFR--------EDS 409
+M + + L +I + G+L + L +
Sbjct: 75 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 410 ARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAH 469
A E+ G+ YL+ ++RDL N ++ +D V + DF ++
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 470 VNGFYFIM 477
M
Sbjct: 195 GLLPVRWM 202
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 92.2 bits (228), Expect = 2e-21
Identities = 31/155 (20%), Positives = 60/155 (38%), Gaps = 13/155 (8%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDH- 365
H+K + +G G G + + A+K + R+ + E LL
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGC 60
Query: 366 PFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLH 425
+P +Y Q H L+ D G L + F + A +++ ++ +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 426 CLGIIYRDLKPENILL-----QKDGHVVLTDFDLS 455
++YRD+KP+N L+ + + + DF +
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.3 bits (228), Expect = 4e-21
Identities = 36/166 (21%), Positives = 70/166 (42%), Gaps = 9/166 (5%)
Query: 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHP 366
++ + P+G G GSV G A+K + + + R E ++ + H
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHE 77
Query: 367 FLPTLYASFQTSTHIC-----LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGL 421
+ L F + + + G +L ++ Q +D +F +++ GL
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGL 134
Query: 422 EYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYH 467
+Y+H II+RDLKP N+ + +D + + DF L+ T + +
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA 180
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.9 bits (217), Expect = 7e-20
Identities = 33/176 (18%), Positives = 66/176 (37%), Gaps = 9/176 (5%)
Query: 307 HFKPIKPLGCGDTGSVHLVEL---QGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL 363
HF + +G G G V+ L G A+K++ + + +V + E IM
Sbjct: 30 HFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDF 85
Query: 364 DHPFLPTLY-ASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLE 422
HP + +L ++ ++ + G+L + + + +V G++
Sbjct: 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMK 144
Query: 423 YLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCKPQVFYHAHVNGFYFIMY 478
+L ++RDL N +L + V + DF L+ K H + +
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 76.6 bits (187), Expect = 9e-16
Identities = 31/190 (16%), Positives = 68/190 (35%), Gaps = 12/190 (6%)
Query: 300 GEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI 359
GE + ++ LG G +V L + AMK + + + + +
Sbjct: 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 66
Query: 360 -------MSLLDHPFLPTLYASFQT---STHICLITDFCPGGELFALLDKQPMKIFREDS 409
+ + L F + ++ G L AL+ K +
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126
Query: 410 ARFYAAEVVIGLEYLHC-LGIIYRDLKPENILLQKDGHV-VLTDFDLSFMTSCKPQVFYH 467
+ + ++++GL+Y+H GII+ D+KPEN+L++ L ++ + + ++
Sbjct: 127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186
Query: 468 AHVNGFYFIM 477
+
Sbjct: 187 TNSIQTREYR 196
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 109 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 68.7 bits (167), Expect = 5e-15
Identities = 41/147 (27%), Positives = 64/147 (43%), Gaps = 42/147 (28%)
Query: 76 IEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCST 135
+ FV+ D +PD P+++AS+ F +T Y +E+LG NC F
Sbjct: 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRF------------------ 43
Query: 136 YTFMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGK 195
+D V KIRDA+++ +V+L+NY K G
Sbjct: 44 ------------------------LQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGT 79
Query: 196 KFWNLFHLQPMRDHKGELQYFIGVQLD 222
FWNL + P++ G + F+GVQ+D
Sbjct: 80 PFWNLLTVTPIKTPDGRVSKFVGVQVD 106
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} Length = 104 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Score = 68.0 bits (165), Expect = 1e-14
Identities = 66/145 (45%), Positives = 82/145 (56%), Gaps = 42/145 (28%)
Query: 78 KNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYT 137
K+FVITDPR+PDNPIIFASD FLELTEYTREE+LG NC FL+ R+ + +
Sbjct: 1 KSFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAV-- 58
Query: 138 FMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKF 197
+EQR++TVQ++NYTK G+ F
Sbjct: 59 ----------------------------------------KEQRDVTVQVLNYTKGGRAF 78
Query: 198 WNLFHLQPMRDHKGELQYFIGVQLD 222
WNLFHLQ MRD G++QYFIGVQ +
Sbjct: 79 WNLFHLQVMRDENGDVQYFIGVQQE 103
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 63.6 bits (154), Expect = 2e-12
Identities = 20/151 (13%), Positives = 48/151 (31%), Gaps = 14/151 (9%)
Query: 312 KPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVH-------RACIEREIMSLLD 364
K +G G +V + +K + + + + +
Sbjct: 6 KLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 365 HPFLPTLYASFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYL 424
L L + + + L L+D + + R ++ ++ +
Sbjct: 65 FRALQKLQ-----GLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 425 HCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455
+ GI++ DL N+L+ + + + DF S
Sbjct: 120 YHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS 149
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 110 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 3e-09
Identities = 16/107 (14%), Positives = 38/107 (35%)
Query: 78 KNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYT 137
+ F+I + R+ + +I+ +D F EL Y+R E++ R C+ L + +
Sbjct: 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQAL 61
Query: 138 FMLYFLALWKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREIT 184
+ Y C +++ + + + +
Sbjct: 62 LGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVM 108
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 489 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.98 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.98 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.98 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.98 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.98 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.97 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.97 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.97 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.97 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.97 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.97 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.97 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.93 | |
| d1n9la_ | 109 | Putative blue light receptor, phot-lov1 domain {Gr | 99.91 | |
| d1jnua_ | 104 | Photoreceptor phy3 flavin-binding domain, lov2 {Ma | 99.87 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1bywa_ | 110 | Erg potassium channel, N-terminal domain {Human (H | 99.86 | |
| d1v9ya_ | 113 | Direct oxygen sensor protein, DOS {Escherichia col | 99.59 | |
| d1ew0a_ | 130 | Histidine kinase FixL heme domain {Rhizobium melil | 99.59 | |
| d1xj3a1 | 106 | Histidine kinase FixL heme domain {Bradyrhizobium | 99.58 | |
| d1p97a_ | 114 | Hypoxia-inducible factor Hif2a, C-terminal domain | 99.56 | |
| d1nwza_ | 125 | Photoactive yellow protein, PYP {Ectothiorhodospir | 99.3 | |
| d1mzua_ | 110 | PYP domain of sensor histidine kinase Ppr {Rhodosp | 99.27 | |
| d1ll8a_ | 114 | N-terminal PAS domain of Pas kinase {Human (Homo s | 99.23 | |
| d1oj5a_ | 109 | PAS domain of steroid receptor coactivator 1A, NCo | 98.54 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.41 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.8 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.71 | |
| d2oola2 | 114 | Sensor protein PhyB2 {Rhodopseudomonas palustris [ | 96.84 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.45 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.08 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.76 | |
| d2o9ca2 | 127 | Bacteriophytochrome BphP {Deinococcus radiodurans | 92.79 | |
| d2veaa3 | 127 | Phytochrome-like protein Cph1 {Synechocystis sp. p | 92.73 | |
| d3c2wa3 | 113 | Bacteriophytochrome BphP {Pseudomonas aeruginosa [ | 83.19 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-38 Score=311.82 Aligned_cols=183 Identities=30% Similarity=0.454 Sum_probs=163.8
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 383 (489)
.+++|++.+.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 46789999999999999999999999999999999987655555566788899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC--
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK-- 461 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~-- 461 (489)
|||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|......
T Consensus 84 vmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 161 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 161 (263)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC
T ss_pred EEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCcc
Confidence 99999999999999875 34899999999999999999999999999999999999999999999999999644311
Q ss_pred -----------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 462 -----------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 -----------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
| .+...+|+|++|++++++++|..||.
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 205 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 205 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCC
Confidence 1 12235599999999999999999995
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-38 Score=311.57 Aligned_cols=180 Identities=24% Similarity=0.399 Sum_probs=156.0
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++++.||+|+||+||+|.++.+|+.||+|++++... ....+.+.+|+.++++++||||+++++++.+++.+|+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 3579999999999999999999999999999999976532 23345688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS----- 459 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~----- 459 (489)
||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+++++.+||+|||+|+...
T Consensus 82 mEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999999999765 459999999999999999999999999999999999999999999999999996421
Q ss_pred ------------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ------------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ------------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|.++++|++|..||.
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~ 207 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCC
Confidence 12221 123499999999999999999995
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-38 Score=317.67 Aligned_cols=184 Identities=37% Similarity=0.690 Sum_probs=164.9
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
+.+++|++++.||+|+||+||+|.++.+|+.||+|++++.........+.+.+|+.+|+.++||||++++++|.+...+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 56789999999999999999999999999999999998776555566788899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC--
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC-- 460 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~-- 460 (489)
+|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 82 iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999999999999886 3489999999999999999999999999999999999999999999999999974321
Q ss_pred -------------CCce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 -------------KPQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -------------~~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. -..+|+|++|++++||++|..||.
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~ 206 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCC
Confidence 1111 134488999999999999999985
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-37 Score=308.85 Aligned_cols=177 Identities=22% Similarity=0.327 Sum_probs=157.5
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++++.||+|+||+||+|.++.+|+.||+|.++..... ..+.+.+|+.+++.++||||++++++|.+++.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 4799999999999999999999999999999999765432 3467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
|||+||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 97 Ey~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 173 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (293)
T ss_dssp ECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccc
Confidence 999999999988763 489999999999999999999999999999999999999999999999999974321
Q ss_pred ----------CC------ceeecccccchHHHHHHHHhCCcccC
Q 042772 461 ----------KP------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ----------~~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+| .+...+|+|++|+++++|++|..||.
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~ 217 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCC
Confidence 11 11234489999999999999999995
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-38 Score=310.91 Aligned_cols=181 Identities=38% Similarity=0.578 Sum_probs=162.0
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
++|++++.||+|+||+||+|.++.+|+.||+|++++.........+.+.+|++++++++||||++++++|.+++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999998765555556778999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-----
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC----- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~----- 460 (489)
|||+||+|.+++... +.+++..++.++.|++.||.|||++||+||||||+|||++++|.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 999999999998875 4489999999999999999999999999999999999999999999999999974321
Q ss_pred ------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ +...+|+|++|++++++++|..||.
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 211 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 211 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCC
Confidence 111 1234489999999999999999995
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-37 Score=314.06 Aligned_cols=182 Identities=23% Similarity=0.357 Sum_probs=160.3
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
+..++|++++.||+|+||+||+|.++.+|+.||+|++++.. .......+.+|+.+|+.++|||||+++++|.+..++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 44578999999999999999999999999999999997652 3444577889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCCcEEEEecCCccccC--
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC-LGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS-- 459 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~-- 459 (489)
+|||||+||+|.+++.+. ..+++..++.++.|++.||.|||+ +||+||||||+|||++.+|.+||+|||+|+...
T Consensus 81 iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999999999875 348999999999999999999997 599999999999999999999999999996321
Q ss_pred -----------CCC------ceeecccccchHHHHHHHHhCCcccC
Q 042772 460 -----------CKP------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 -----------~~~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+| .+...+|+|++|++++|+++|..||.
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~ 204 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204 (322)
T ss_dssp TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSS
T ss_pred ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 111 12234589999999999999999995
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-37 Score=309.63 Aligned_cols=179 Identities=26% Similarity=0.385 Sum_probs=157.9
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
+.|++++.||+|+||+||+|.++.+++.||+|++++.. ....+.+.+|+++++.++||||+++++++.+++.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 45899999999999999999999999999999997652 344567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC------
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------ 459 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------ 459 (489)
|||++|+|.+++.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 89 Ey~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 89 EFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp ECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred ecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence 9999999999986542 458999999999999999999999999999999999999999999999999985221
Q ss_pred ---------CCCcee-----------ecccccchHHHHHHHHhCCcccC
Q 042772 460 ---------CKPQVF-----------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ---------~~~~~~-----------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+.+ ..+|+|++|++++++++|..||.
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~ 216 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH 216 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCC
Confidence 122221 34599999999999999999995
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-37 Score=310.16 Aligned_cols=183 Identities=40% Similarity=0.725 Sum_probs=163.6
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 383 (489)
.+++|++++.||+|+||+||+|.++.+|+.||+|++++.........+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 45789999999999999999999999999999999987655555567889999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC---
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC--- 460 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~--- 460 (489)
|||||+||+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 82 vmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~ 159 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 159 (316)
T ss_dssp EECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred EeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccccc
Confidence 999999999999998864 488999999999999999999999999999999999999999999999999975331
Q ss_pred ---------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ---------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ---------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ +...+|+|++|.++++|++|..||.
T Consensus 160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~ 202 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY 202 (316)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCC
Confidence 111 1234489999999999999999995
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.3e-37 Score=304.14 Aligned_cols=184 Identities=22% Similarity=0.261 Sum_probs=161.4
Q ss_pred ccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 042772 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH 380 (489)
Q Consensus 301 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 380 (489)
+++..++|++.+.||+|+||+||+|.++.+++.||+|.++.... ..+.+.+|+.++++++||||++++++|.+.+.
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 45667789999999999999999999999999999999875432 34578899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
+++|||||++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||+|+....
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999999999877666799999999999999999999999999999999999999999999999999975432
Q ss_pred C----------------Cce------eecccccchHHHHHHHHhCCcccC
Q 042772 461 K----------------PQV------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ~----------------~~~------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. |+. ...+|+|++|.+++|+++|..||.
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 1 111 123488999999999999777653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.2e-37 Score=306.97 Aligned_cols=180 Identities=23% Similarity=0.270 Sum_probs=161.1
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITD 386 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmE 386 (489)
.|+.++.||+|+||+||+|.+..+++.||+|++++.........+.+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999987765566677889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-------
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS------- 459 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~------- 459 (489)
||++|+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 96 ~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~G 173 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVG 173 (309)
T ss_dssp CCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCS
T ss_pred ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCCCcccc
Confidence 99999998777665 458999999999999999999999999999999999999999999999999997432
Q ss_pred ----CCCc---------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 ----CKPQ---------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----~~~~---------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+ +...+|+|++|++++|+++|..||.
T Consensus 174 T~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~ 215 (309)
T d1u5ra_ 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (309)
T ss_dssp CGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCC
Confidence 1222 2234699999999999999999985
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.9e-36 Score=308.74 Aligned_cols=180 Identities=26% Similarity=0.384 Sum_probs=158.1
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++++.||+|+||.||+|.++.+|+.||+|++++.. ......+.+|+.+|++++||||++++++|.++..+|+|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357999999999999999999999999999999997653 23346778899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe--cCCcEEEEecCCccccCC--
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQ--KDGHVVLTDFDLSFMTSC-- 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld--~~g~vKL~DFGlS~~~~~-- 460 (489)
||||+||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|.....
T Consensus 105 mE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 105 LEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp EECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999999999887653 3589999999999999999999999999999999999998 678999999999975431
Q ss_pred ------------CC------ceeecccccchHHHHHHHHhCCcccC
Q 042772 461 ------------KP------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ------------~~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+| .+...+|+|++|+++++|++|..||.
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 229 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 229 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 11 12234499999999999999999995
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-36 Score=309.02 Aligned_cols=182 Identities=34% Similarity=0.645 Sum_probs=163.4
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
+++|++++.||+|+||.||+|.++.+|+.||+|++++.........+.+.+|+.+|+.++||||+++++++.....+++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 46899999999999999999999999999999999876555555677889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC---
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK--- 461 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~--- 461 (489)
|||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 120 ~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~ 197 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT 197 (350)
T ss_dssp EECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCC
T ss_pred cccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccccc
Confidence 99999999999998763 4899999999999999999999999999999999999999999999999999754321
Q ss_pred ---------Cc------eeecccccchHHHHHHHHhCCcccC
Q 042772 462 ---------PQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 ---------~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|+ +...+|+|++|+++++|++|..||.
T Consensus 198 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~ 239 (350)
T d1rdqe_ 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239 (350)
T ss_dssp CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCC
Confidence 11 1234499999999999999999995
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-36 Score=310.61 Aligned_cols=183 Identities=32% Similarity=0.506 Sum_probs=156.7
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHH---HHHHHHHhCCCCCcceeeEEEEeCCe
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRAC---IEREIMSLLDHPFLPTLYASFQTSTH 380 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~---~E~~il~~l~HpnIv~l~~~~~~~~~ 380 (489)
.+++|++++.||+|+||.||+|.++.+|+.||+|++.+...........+. .++.+++.++||||++++++|.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 467899999999999999999999999999999999865543333333333 34666777889999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999999999999876 3489999999999999999999999999999999999999999999999999974321
Q ss_pred -------------CCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 -------------KPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -------------~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ +-..+|+|++|+++++|++|..||.
T Consensus 160 ~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~ 207 (364)
T d1omwa3 160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207 (364)
T ss_dssp SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCC
Confidence 111 1234489999999999999999995
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-37 Score=300.21 Aligned_cols=182 Identities=19% Similarity=0.379 Sum_probs=151.3
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe--CCeEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT--STHICL 383 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~l 383 (489)
++|++++.||+|+||+||+|.++.+|+.||+|.+++... .....+.+.+|++++++++||||+++++++.+ ...+|+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 579999999999999999999999999999999987654 34556788999999999999999999999865 456899
Q ss_pred EEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 384 ITDFCPGGELFALLDKQ--PMKIFREDSARFYAAEVVIGLEYLHCLG-----IIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~--~~~~l~e~~~~~i~~qI~~aL~yLH~~g-----IvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
|||||++|+|.+++.+. ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999998652 2345899999999999999999999876 9999999999999999999999999986
Q ss_pred ccCC---------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 457 MTSC---------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 457 ~~~~---------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.... +|+ +...+|+|++|.+++|+++|..||.
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~ 215 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 215 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCC
Confidence 4321 111 1234489999999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-36 Score=302.62 Aligned_cols=179 Identities=29% Similarity=0.435 Sum_probs=148.1
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLIT 385 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVm 385 (489)
+.|++.+.||+|+||+||+|.++.+++.||+|++.+.... .....+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5699999999999999999999999999999999876432 23456778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe---cCCcEEEEecCCccccCC--
Q 042772 386 DFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQ---KDGHVVLTDFDLSFMTSC-- 460 (489)
Q Consensus 386 Ey~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld---~~g~vKL~DFGlS~~~~~-- 460 (489)
|||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+. +++.+||+|||+|+....
T Consensus 87 E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred eccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 999999999999875 4599999999999999999999999999999999999994 578999999999964321
Q ss_pred ------------CC------ceeecccccchHHHHHHHHhCCcccC
Q 042772 461 ------------KP------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ------------~~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+| .+...+|+|++|+++++|++|..||.
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 210 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 210 (307)
T ss_dssp --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCC
Confidence 11 12234599999999999999999995
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.3e-36 Score=305.84 Aligned_cols=180 Identities=29% Similarity=0.435 Sum_probs=158.2
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
+++|++++.||+|+||.||+|.++.+|+.||+|++.+.. ....+.+.+|+.+|++++||||++++++|.+++.+|+|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 468999999999999999999999999999999997653 34456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe--cCCcEEEEecCCccccCC--
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQ--KDGHVVLTDFDLSFMTSC-- 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld--~~g~vKL~DFGlS~~~~~-- 460 (489)
||||+||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+....
T Consensus 102 mE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 102 YEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp ECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999999996543 3489999999999999999999999999999999999996 468999999999975431
Q ss_pred ------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ +-..+|+|++|+++++|++|..||.
T Consensus 181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 226 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 226 (350)
T ss_dssp CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCC
Confidence 111 1134599999999999999999995
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.4e-36 Score=294.55 Aligned_cols=181 Identities=28% Similarity=0.381 Sum_probs=159.1
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccc------hHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeC
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN------RNKVHRACIEREIMSLLD-HPFLPTLYASFQTS 378 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~------~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~ 378 (489)
++|++.+.||+|+||+||+|.++.+|+.||+|++++..... ....+.+.+|+.++++++ ||||++++++|.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 58999999999999999999999999999999998754322 223456888999999997 99999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
..+|+|||||++|+|.+++..+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 9999999999999999999875 34899999999999999999999999999999999999999999999999999654
Q ss_pred CC--------------CCcee------------ecccccchHHHHHHHHhCCcccC
Q 042772 459 SC--------------KPQVF------------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~~--------------~~~~~------------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.. +|+.+ ..+|+|++|+++++|++|..||.
T Consensus 161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~ 216 (277)
T d1phka_ 161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 216 (277)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCC
Confidence 31 11111 23489999999999999999995
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-36 Score=296.89 Aligned_cols=181 Identities=27% Similarity=0.411 Sum_probs=158.6
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNR---NKVHRACIEREIMSLLDHPFLPTLYASFQTSTHIC 382 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 382 (489)
++|++++.||+|+||+||+|.++.+|+.||+|++++...... ...+.+.+|+.+|++++||||++++++|.+...+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 569999999999999999999999999999999986544321 23577889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC----cEEEEecCCcccc
Q 042772 383 LITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG----HVVLTDFDLSFMT 458 (489)
Q Consensus 383 lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g----~vKL~DFGlS~~~ 458 (489)
+|||||+||+|.+++... +.+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|...
T Consensus 90 iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999999999875 3499999999999999999999999999999999999998776 5999999999643
Q ss_pred CCC--------------C------ceeecccccchHHHHHHHHhCCcccC
Q 042772 459 SCK--------------P------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~~~--------------~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... | .....+|+|++|++++++++|..||.
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 217 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCC
Confidence 211 1 12234489999999999999999985
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-36 Score=300.19 Aligned_cols=179 Identities=20% Similarity=0.285 Sum_probs=156.7
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++++.||+|+||+||+|.++.+++.||+|++++.. .....+.+|+++|+.++||||++++++|.+.+.+|+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 468999999999999999999999999999999997642 2234577899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecC--CcEEEEecCCccccCCC-
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKD--GHVVLTDFDLSFMTSCK- 461 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~--g~vKL~DFGlS~~~~~~- 461 (489)
||||+||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 80 mE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 80 FEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp ECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999999999997653 348999999999999999999999999999999999999854 48999999999754311
Q ss_pred -------------------CceeecccccchHHHHHHHHhCCcccC
Q 042772 462 -------------------PQVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 -------------------~~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
..+...+|+|++|++++++++|..||.
T Consensus 159 ~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~ 204 (321)
T d1tkia_ 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL 204 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCC
Confidence 112234499999999999999999985
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-36 Score=295.62 Aligned_cols=182 Identities=24% Similarity=0.366 Sum_probs=155.1
Q ss_pred ccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 042772 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH 380 (489)
Q Consensus 301 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 380 (489)
+++..++|++.+.||+|+||+||+|..++ .||||+++.... .....+.+.+|+.++++++||||+++++++. ...
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ 77 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccE
Confidence 45677889999999999999999998653 599999976543 3456788999999999999999999999765 456
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS- 459 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~- 459 (489)
+++|||||++|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 899999999999999997653 348999999999999999999999999999999999999999999999999986432
Q ss_pred ----------------CCCce---------eecccccchHHHHHHHHhCCcccC
Q 042772 460 ----------------CKPQV---------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ----------------~~~~~---------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ...+|+|++|.+++|+++|..||.
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~ 210 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCC
Confidence 11221 123489999999999999999995
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-35 Score=292.09 Aligned_cols=178 Identities=24% Similarity=0.355 Sum_probs=154.0
Q ss_pred cccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe----CCeEEE
Q 042772 308 FKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT----STHICL 383 (489)
Q Consensus 308 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~l 383 (489)
|++.+.||+|+||+||+|.++.+++.||+|.+..... .....+.+.+|++++++++||||++++++|.+ ...+|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 4677889999999999999999999999999976543 34556788999999999999999999999875 356899
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEe-cCCcEEEEecCCccccCC
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLG--IIYRDLKPENILLQ-KDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~g--IvHrDLKP~NILld-~~g~vKL~DFGlS~~~~~ 460 (489)
|||||++|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ +++.+||+|||+|+....
T Consensus 90 vmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999999875 34899999999999999999999998 99999999999996 578999999999974321
Q ss_pred -------------CCce-----eecccccchHHHHHHHHhCCcccC
Q 042772 461 -------------KPQV-----FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -------------~~~~-----~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+. ...+|+|++|.++++|++|..||.
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~ 213 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYS 213 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCC
Confidence 1221 123489999999999999999995
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-36 Score=300.04 Aligned_cols=181 Identities=34% Similarity=0.628 Sum_probs=158.3
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHH-hCCCCCcceeeEEEEeCCeEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMS-LLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
++|++++.||+|+||+||+|.++.+++.||+|++++...........+..|..++. .++||||+++++++.+.+.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999999999999999998765444445666777777765 68999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC---- 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~---- 460 (489)
||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++++|.+||+|||+|+....
T Consensus 82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~ 159 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 159 (320)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccccc
Confidence 99999999999998753 489999999999999999999999999999999999999999999999999964321
Q ss_pred -----------CC------ceeecccccchHHHHHHHHhCCcccC
Q 042772 461 -----------KP------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -----------~~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+| .+...+|+|++|+++++|++|..||.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~ 204 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH 204 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCC
Confidence 11 11234489999999999999999995
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.9e-36 Score=296.63 Aligned_cols=184 Identities=24% Similarity=0.341 Sum_probs=151.5
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGE---LYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS 378 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 378 (489)
++..++|++.+.||+|+||+||+|.++.+++ .||+|.+... ......+.+.+|+.+|++++|||||++++++...
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 4566789999999999999999999987664 5888887654 2345567899999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
+.+++|||||++|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+..
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEc
Confidence 99999999999999999888753 35899999999999999999999999999999999999999999999999999743
Q ss_pred CC--------------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 459 SC--------------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 459 ~~--------------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.. +|+ +...+|+|++|.+++|+++ |..||.
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~ 235 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 235 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCC
Confidence 21 011 1123489999999999986 899985
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-35 Score=294.33 Aligned_cols=182 Identities=21% Similarity=0.348 Sum_probs=154.5
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
+++|++++.||+|+||+||+|.+..+|+.||+|+++.... .......+.+|+.++++++||||++++++|.+...+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 3689999999999999999999999999999999965432 233456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC---- 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~---- 460 (489)
|||+. +++.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 80 ~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 80 FEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp EECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred EeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 99995 5677777665556699999999999999999999999999999999999999999999999999853321
Q ss_pred -----------CCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 -----------KPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -----------~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|+++++|++|..||.
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~ 204 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 204 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCC
Confidence 011 1234589999999999999999985
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.5e-35 Score=288.70 Aligned_cols=181 Identities=22% Similarity=0.298 Sum_probs=160.4
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC----eE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST----HI 381 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~~ 381 (489)
++|++.+.||+|+||+||+|.+..+|+.||+|++++....+......+.+|+.+++.++||||+++++++.... .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 57999999999999999999999999999999998876666777788999999999999999999999997654 48
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
|+|||||+|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 87 ~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 9999999999999998775 3489999999999999999999999999999999999999999999999998753210
Q ss_pred -----------------CC------ceeecccccchHHHHHHHHhCCcccC
Q 042772 461 -----------------KP------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -----------------~~------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+| .+...+|+|++|++++++++|..||.
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 215 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 215 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCC
Confidence 11 12234599999999999999999995
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-35 Score=284.34 Aligned_cols=179 Identities=25% Similarity=0.365 Sum_probs=148.7
Q ss_pred cccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 042772 304 GLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 304 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 383 (489)
..++|++++.||+|+||+||+|.++. ++.||+|.+++... ..+.+.+|++++++++||||+++++++..++.+++
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence 34679999999999999999999874 67899999976432 23568889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC---
Q 042772 384 ITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC--- 460 (489)
Q Consensus 384 VmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~--- 460 (489)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||+++++.+||+|||+|+....
T Consensus 78 v~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999999999987653 4588999999999999999999999999999999999999999999999999864321
Q ss_pred -------------CCc------eeecccccchHHHHHHHHhC-CcccC
Q 042772 461 -------------KPQ------VFYHAHVNGFYFIMYKWLTG-YFTYV 488 (489)
Q Consensus 461 -------------~~~------~~~~~~v~s~g~~a~e~~~G-~lpY~ 488 (489)
+|+ +...+|+|++|.+++|+++| ..||.
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~ 204 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 204 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC
Confidence 111 11234999999999999984 55553
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-34 Score=284.55 Aligned_cols=181 Identities=23% Similarity=0.345 Sum_probs=152.1
Q ss_pred cccCcccccc-cCCCCceEEEEEEEcC--CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 042772 304 GLHHFKPIKP-LGCGDTGSVHLVELQG--AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTH 380 (489)
Q Consensus 304 ~~~~y~~~~~-LG~G~fG~Vy~a~~~~--tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 380 (489)
..++|.+.+. ||+|+||+||+|.++. ++..||||++++. ......+.+.+|+.+|++++||||+++++++.++ .
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~ 82 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-A 82 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-e
Confidence 3456778775 9999999999998764 4568999999754 2455677899999999999999999999998754 6
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC 460 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~ 460 (489)
+|+|||||++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 899999999999999986543 4589999999999999999999999999999999999999999999999999974321
Q ss_pred C------------Ccee------------ecccccchHHHHHHHHh-CCcccC
Q 042772 461 K------------PQVF------------YHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 ~------------~~~~------------~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
. +..+ ..+|+|++|.+++|+++ |..||.
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~ 214 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 214 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCC
Confidence 1 1112 23389999999999986 999995
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-34 Score=293.89 Aligned_cols=176 Identities=26% Similarity=0.416 Sum_probs=150.7
Q ss_pred ccCccccc-ccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHh-CCCCCcceeeEEEEe----C
Q 042772 305 LHHFKPIK-PLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSL-LDHPFLPTLYASFQT----S 378 (489)
Q Consensus 305 ~~~y~~~~-~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~-l~HpnIv~l~~~~~~----~ 378 (489)
+++|+++. .||+|+||+||+|.+..+++.||||++++. ..+.+|+.++.+ ++||||++++++|.+ .
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 56899875 599999999999999999999999999653 345678888654 589999999999976 4
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---CCcEEEEecCCc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK---DGHVVLTDFDLS 455 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~---~g~vKL~DFGlS 455 (489)
..+|+|||||+||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 67999999999999999998765567999999999999999999999999999999999999985 567999999999
Q ss_pred cccCC--------------CCcee------ecccccchHHHHHHHHhCCcccC
Q 042772 456 FMTSC--------------KPQVF------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 456 ~~~~~--------------~~~~~------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+.... +|+.. ..+|+|++|++++++++|..||.
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~ 214 (335)
T d2ozaa1 162 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 214 (335)
T ss_dssp EECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCE
T ss_pred eeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCC
Confidence 64321 23322 23389999999999999999984
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-34 Score=291.93 Aligned_cols=185 Identities=22% Similarity=0.335 Sum_probs=153.5
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCc-----EEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGE-----LYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASF 375 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~-----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~ 375 (489)
++..++|++.+.||+|+||+||+|.+..+++ .||+|.+.... .......+.+|+.++.++ +|||||++++++
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 4556789999999999999999999876554 68999886542 233456788899999988 899999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 042772 376 QTSTHICLITDFCPGGELFALLDKQPM---------------------KIFREDSARFYAAEVVIGLEYLHCLGIIYRDL 434 (489)
Q Consensus 376 ~~~~~~~lVmEy~~ggsL~~~L~~~~~---------------------~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDL 434 (489)
.+.+.+|+|||||++|+|.++|..... ..+++..++.++.||+.||.|||+++|+||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 999999999999999999999976432 34889999999999999999999999999999
Q ss_pred CCCCEEEecCCcEEEEecCCccccCC-----------------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 435 KPENILLQKDGHVVLTDFDLSFMTSC-----------------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 435 KP~NILld~~g~vKL~DFGlS~~~~~-----------------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
||+|||++.++.+||+|||+|+.... +|+. ...+|+|++|++++|+++ |..||.
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999999999999999964321 1111 123489999999999986 999985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-35 Score=286.26 Aligned_cols=182 Identities=22% Similarity=0.285 Sum_probs=153.1
Q ss_pred CccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 300 GEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 300 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
.+++..++|++.+.||+|+||.||+|.++ ++..||||.++.... ..+.+.+|+.++++++||||+++++++.+ +
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 34566788999999999999999999987 478899999975432 23568899999999999999999998754 5
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
.+++|||||++|+|.+++.......+++..+..++.||+.||.|||+++|+||||||+||||++++.+||+|||+|+...
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 67999999999999998866544458999999999999999999999999999999999999999999999999997543
Q ss_pred C----------------CCce------eecccccchHHHHHHHHhCCccc
Q 042772 460 C----------------KPQV------FYHAHVNGFYFIMYKWLTGYFTY 487 (489)
Q Consensus 460 ~----------------~~~~------~~~~~v~s~g~~a~e~~~G~lpY 487 (489)
. +|+. ...+|+|++|.+++|+++|..||
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~ 210 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCC
Confidence 1 1111 12348999999999999865544
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-35 Score=289.53 Aligned_cols=177 Identities=24% Similarity=0.296 Sum_probs=146.0
Q ss_pred cccccCCCCceEEEEEEEcCCCcEEEEEEeecccccch--HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEec
Q 042772 310 PIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNR--NKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDF 387 (489)
Q Consensus 310 ~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 387 (489)
.++.||+|+||+||+|.++.+|+.||||+++....... .....+.+|+.+++.++||||+++++++..++++|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 46789999999999999999999999999976543221 1235688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-------
Q 042772 388 CPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC------- 460 (489)
Q Consensus 388 ~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~------- 460 (489)
+.++++..+.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp CSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCC
T ss_pred hcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccc
Confidence 9887766655433 4589999999999999999999999999999999999999999999999999964321
Q ss_pred --------CCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 --------KPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 --------~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ +...+|+|++|++++|+++|..||.
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 202 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 202 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCC
Confidence 111 1123489999999999999999984
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-34 Score=278.05 Aligned_cols=178 Identities=25% Similarity=0.346 Sum_probs=154.2
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
.++|++.+.||+|+||.||+|+++ +++.||+|.+++.... .+.+.+|+.++++++||||+++++++.+++.+++|
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 468999999999999999999986 6889999999865432 35688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC---- 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~---- 460 (489)
|||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 78 ~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp EECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 99999999999976653 3488999999999999999999999999999999999999999999999999964321
Q ss_pred ------------CCce------eecccccchHHHHHHHHh-CCcccC
Q 042772 461 ------------KPQV------FYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 ------------~~~~------~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+. ...+|+|++|.+++|+++ |..||.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~ 203 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 203 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCC
Confidence 1111 123489999999999987 899985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-33 Score=278.11 Aligned_cols=173 Identities=22% Similarity=0.337 Sum_probs=145.6
Q ss_pred cccCCCCceEEEEEEEc--CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEecCC
Q 042772 312 KPLGCGDTGSVHLVELQ--GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLITDFCP 389 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ 389 (489)
+.||+|+||+||+|.+. .+++.||+|+++... .+....+.+.+|+.++++++||||+++++++.++ ..++|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 46999999999999875 356789999996543 2344567899999999999999999999998654 5789999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC--------
Q 042772 390 GGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK-------- 461 (489)
Q Consensus 390 ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~-------- 461 (489)
+|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 91 ~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 91 LGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp TEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 99999999876 34899999999999999999999999999999999999999999999999999743211
Q ss_pred ----------Cc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 462 ----------PQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 462 ----------~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
|+ ....+|+|++|.+++|+++ |..||.
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~ 212 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 212 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCC
Confidence 11 1124489999999999986 999995
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-34 Score=280.02 Aligned_cols=183 Identities=21% Similarity=0.225 Sum_probs=151.1
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCC----cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAG----ELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT 377 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 377 (489)
++....|+..+.||+|+||.||+|.++.++ ..||+|.++... .......+.+|+.++++++|||||++++++.+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence 455567999999999999999999988655 479999996542 34445678899999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccc
Q 042772 378 STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 378 ~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
....++|||||.+++|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CCceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999999999887653 4589999999999999999999999999999999999999999999999999974
Q ss_pred cCC------------------CCc------eeecccccchHHHHHHHHhCCccc
Q 042772 458 TSC------------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTY 487 (489)
Q Consensus 458 ~~~------------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY 487 (489)
... +|+ ....+|+|++|.+++|+++|..||
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~ 213 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 213 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCc
Confidence 321 111 112348999999999999865554
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-34 Score=279.43 Aligned_cols=183 Identities=23% Similarity=0.299 Sum_probs=149.1
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGA---GELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS 378 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 378 (489)
++..++|++.+.||+|+||.||+|.+..+ +..||+|.++.. ........+.+|+.++++++||||+++++++. +
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 46667899999999999999999998754 457888888543 34555678899999999999999999999985 5
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
+.+|+||||+++|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+||++++++.+||+|||+|+..
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred CeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 67899999999999999887653 45899999999999999999999999999999999999999999999999999643
Q ss_pred CCC----------Cc------------eeecccccchHHHHHHHHh-CCcccC
Q 042772 459 SCK----------PQ------------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 459 ~~~----------~~------------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
... +. +...+|+|++|.+++|+++ |..||.
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~ 211 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 211 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCC
Confidence 210 11 1123489999999999987 898885
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-34 Score=283.97 Aligned_cols=183 Identities=23% Similarity=0.297 Sum_probs=153.2
Q ss_pred CccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 300 GEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 300 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
.+++..++|++.+.||+|+||+||+|.++.+ +.||||+++.... ..+.+.+|+.++++++|||||++++++.+ +
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~ 84 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 84 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence 3466778999999999999999999998765 5799999975432 23568899999999999999999999854 5
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
.+++||||+++|+|..++.......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+...
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence 68999999999999999876544558999999999999999999999999999999999999999999999999997432
Q ss_pred C----------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 C----------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ~----------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. +|+ ....+|+|++|.+++|+++|..||.
T Consensus 165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~ 215 (285)
T d1fmka3 165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 215 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCC
Confidence 1 111 1123489999999999999766653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.7e-34 Score=281.51 Aligned_cols=180 Identities=19% Similarity=0.279 Sum_probs=154.0
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
+++|++++.||+|+||+||+|.++ +|+.||+|+++.... .....+.+.+|+.+|+.++||||++++++|...+..+++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 368999999999999999999986 689999999976532 333457888999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC----
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC---- 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~---- 460 (489)
|||+.++.+..+.... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 79 ~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp EECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence 9999776666655443 5599999999999999999999999999999999999999999999999999853221
Q ss_pred -----------C-------CceeecccccchHHHHHHHHhCCcccC
Q 042772 461 -----------K-------PQVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 -----------~-------~~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+ ......+|+|++|.+++|+++|..||.
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~ 202 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCC
Confidence 0 111234489999999999999999984
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-34 Score=282.07 Aligned_cols=181 Identities=22% Similarity=0.277 Sum_probs=153.3
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchH---HHHHHHHHHHHHHhCC--CCCcceeeEEEEeCCe
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRN---KVHRACIEREIMSLLD--HPFLPTLYASFQTSTH 380 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~---~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~ 380 (489)
++|++.+.||+|+||+||+|.+..+|+.||+|++++....... ...++.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 4799999999999999999999999999999999865433211 2234567999999986 8999999999999999
Q ss_pred EEEEEecCCC-CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-CCcEEEEecCCcccc
Q 042772 381 ICLITDFCPG-GELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK-DGHVVLTDFDLSFMT 458 (489)
Q Consensus 381 ~~lVmEy~~g-gsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~-~g~vKL~DFGlS~~~ 458 (489)
+|+||||+.+ +++.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+..
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 9999999975 6888888765 34899999999999999999999999999999999999985 479999999999643
Q ss_pred CC-------------CCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 459 SC-------------KPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~~-------------~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.. +|+. ...+|+|++|++++++++|..||.
T Consensus 162 ~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 211 (273)
T d1xwsa_ 162 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211 (273)
T ss_dssp CSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCC
Confidence 21 1111 123489999999999999999985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-33 Score=276.87 Aligned_cols=181 Identities=17% Similarity=0.243 Sum_probs=159.2
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 384 (489)
+++|++++.||+|+||+||+|.+..+++.||+|+++... .......++.+|+.+++.++||||++++++|.+....+++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 368999999999999999999999999999999997654 3445678889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC---
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK--- 461 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~--- 461 (489)
|+++.+++|..++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|......
T Consensus 80 ~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 9999998888887665 45899999999999999999999999999999999999999999999999999643210
Q ss_pred -------------------CceeecccccchHHHHHHHHhCCcccC
Q 042772 462 -------------------PQVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 -------------------~~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.......|+|++|++++++++|..||-
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 111234589999999999999999863
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-33 Score=277.31 Aligned_cols=184 Identities=27% Similarity=0.363 Sum_probs=147.9
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCC-C--cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGA-G--ELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST 379 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~t-g--~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 379 (489)
++.++|++++.||+|+||.||+|.+..+ + ..||+|++++.........+.+.+|+.++++++||||+++++++.+ .
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 4567899999999999999999987543 2 4789999987766666677889999999999999999999999965 4
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC
Q 042772 380 HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS 459 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~ 459 (489)
..++||||+++|+|.+++..+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred chheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 6789999999999999887653 348999999999999999999999999999999999999999999999999997543
Q ss_pred CC------------Ccee------------ecccccchHHHHHHHHh-CCcccC
Q 042772 460 CK------------PQVF------------YHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 460 ~~------------~~~~------------~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.. +..+ ..+|+|++|.+++|+++ |..||.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~ 216 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCC
Confidence 11 1111 23599999999999997 899984
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-33 Score=284.67 Aligned_cols=187 Identities=41% Similarity=0.661 Sum_probs=159.4
Q ss_pred CccccccCcccccccCCCCceEEEEEEE---cCCCcEEEEEEeeccccc-chHHHHHHHHHHHHHHhCCC-CCcceeeEE
Q 042772 300 GEKIGLHHFKPIKPLGCGDTGSVHLVEL---QGAGELYAMKAMEKSVML-NRNKVHRACIEREIMSLLDH-PFLPTLYAS 374 (489)
Q Consensus 300 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~---~~tg~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~H-pnIv~l~~~ 374 (489)
...+++++|++++.||+|+||+||+|.+ +.+|+.||+|++++.... +....+.+.+|+.++++++| |||++++++
T Consensus 18 ~~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~ 97 (322)
T d1vzoa_ 18 AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97 (322)
T ss_dssp CCCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred CcccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence 3456778999999999999999999987 457899999999765432 22334567789999999976 899999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCC
Q 042772 375 FQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDL 454 (489)
Q Consensus 375 ~~~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGl 454 (489)
+.+...++++|||+.+|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+
T Consensus 98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 98 FQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eccCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccc
Confidence 999999999999999999999998764 478999999999999999999999999999999999999999999999999
Q ss_pred ccccCC----------------CC--------ceeecccccchHHHHHHHHhCCcccC
Q 042772 455 SFMTSC----------------KP--------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 455 S~~~~~----------------~~--------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|..... .| .....+|+|++|.+++++++|..||.
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~ 233 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 853220 01 11224599999999999999999994
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-33 Score=276.71 Aligned_cols=182 Identities=22% Similarity=0.391 Sum_probs=151.4
Q ss_pred CccccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe-C
Q 042772 300 GEKIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT-S 378 (489)
Q Consensus 300 ~~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~ 378 (489)
|+.++.++|++++.||+|+||.||+|.++ |..||+|.+++.. ..+.+.+|++++++++||||+++++++.+ .
T Consensus 1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 1 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred CCccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 46788899999999999999999999985 6789999996542 34668899999999999999999998854 4
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
+.+|+||||+++|+|.+++.......+++..+..++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+|+..
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceec
Confidence 66899999999999999997654445899999999999999999999999999999999999999999999999999753
Q ss_pred CC------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 459 SC------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 459 ~~------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
.. +|+ +...+|+|++|.+++|+++ |..||.
T Consensus 154 ~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~ 202 (262)
T d1byga_ 154 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 202 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred CCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCC
Confidence 31 111 1234499999999999987 788774
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-33 Score=277.14 Aligned_cols=179 Identities=25% Similarity=0.337 Sum_probs=148.2
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGE----LYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTSTHI 381 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 381 (489)
.+|++++.||+|+||+||+|.+..+|+ .||+|.++.. ......+.+.+|+.++++++||||+++++++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 469999999999999999999988876 5777777543 2334467789999999999999999999999765 57
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCC-
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~- 460 (489)
+++|||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred eEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 88899999999999988763 4589999999999999999999999999999999999999999999999999864321
Q ss_pred ----------------CCc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 461 ----------------KPQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 461 ----------------~~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
+|+ +...+|+|++|.+++|+++ |..||.
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~ 215 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCC
Confidence 111 1133489999999999997 888885
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-33 Score=281.31 Aligned_cols=177 Identities=20% Similarity=0.324 Sum_probs=147.9
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----e
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST-----H 380 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~ 380 (489)
.+|++++.||+|+||+||+|.++.+|+.||||++++.. .....+.+.+|+.+|+.++||||+++++++.... .
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 46999999999999999999999999999999997542 4555678889999999999999999999987653 3
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS- 459 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~- 459 (489)
+|++ +|+.+|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 86 ~~l~-~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 86 VYLV-THLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEE-EECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEE-EeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 4555 556699999999764 48999999999999999999999999999999999999999999999999985321
Q ss_pred -----------------CCCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 460 -----------------CKPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 -----------------~~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+|+. ....|+|++|.+++++++|..||.
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~ 214 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 214 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCC
Confidence 11211 123389999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-33 Score=281.19 Aligned_cols=179 Identities=25% Similarity=0.399 Sum_probs=150.5
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTST----- 379 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----- 379 (489)
.++|++++.||+|+||+||+|.++.+|+.||||++++.. ......+.+.+|+.+|+.++||||++++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 468999999999999999999999999999999997653 34556778899999999999999999999997654
Q ss_pred -eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 380 -HICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 380 -~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
.+|+||||| +.+|..+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence 579999999 67888887653 4899999999999999999999999999999999999999999999999999754
Q ss_pred CC------------CCce-------eecccccchHHHHHHHHhCCcccC
Q 042772 459 SC------------KPQV-------FYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~~------------~~~~-------~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.. +|+. ....|+|++|++++++++|..||.
T Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~ 220 (346)
T d1cm8a_ 172 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 220 (346)
T ss_dssp CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCC
Confidence 31 1221 234589999999999999999985
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.98 E-value=5.5e-33 Score=276.42 Aligned_cols=185 Identities=19% Similarity=0.282 Sum_probs=155.8
Q ss_pred cccccCcccccccCCCCceEEEEEEEcC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQG-----AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQ 376 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 376 (489)
++..++|++++.||+|+||+||+|++++ +++.||||.++... .....+++.+|++++++++||||+++++++.
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 3445689999999999999999999864 46799999987542 3455678999999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 042772 377 TSTHICLITDFCPGGELFALLDKQP----------------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDL 434 (489)
Q Consensus 377 ~~~~~~lVmEy~~ggsL~~~L~~~~----------------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDL 434 (489)
.....+++|||+++|+|.+++.... ...+++..+..++.|++.||.|||+++|+||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 9999999999999999999996531 224789999999999999999999999999999
Q ss_pred CCCCEEEecCCcEEEEecCCccccCC-----------------CCc------eeecccccchHHHHHHHHhCCc-ccC
Q 042772 435 KPENILLQKDGHVVLTDFDLSFMTSC-----------------KPQ------VFYHAHVNGFYFIMYKWLTGYF-TYV 488 (489)
Q Consensus 435 KP~NILld~~g~vKL~DFGlS~~~~~-----------------~~~------~~~~~~v~s~g~~a~e~~~G~l-pY~ 488 (489)
||+|||++.++.+||+|||+|+.... +|+ +...+|+|++|.+++|+++|.. ||.
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 99999999999999999999863211 111 1124499999999999998864 564
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=5.2e-33 Score=277.71 Aligned_cols=183 Identities=22% Similarity=0.309 Sum_probs=152.2
Q ss_pred ccccCcccccccCCCCceEEEEEEEcCCCcE--EEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCC
Q 042772 303 IGLHHFKPIKPLGCGDTGSVHLVELQGAGEL--YAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASFQTST 379 (489)
Q Consensus 303 i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~--vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~ 379 (489)
++.++|++.+.||+|+||.||+|.++.+|.. ||+|.++.. ......+.+.+|+.+|+++ +||||+++++++...+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 5667899999999999999999999988864 667776533 2334556789999999998 7999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC
Q 042772 380 HICLITDFCPGGELFALLDKQ--------------PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG 445 (489)
Q Consensus 380 ~~~lVmEy~~ggsL~~~L~~~--------------~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g 445 (489)
.+++||||+++|+|.+++... ....+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999753 234589999999999999999999999999999999999999999
Q ss_pred cEEEEecCCccccC--------CC------C------ceeecccccchHHHHHHHHhCCc-cc
Q 042772 446 HVVLTDFDLSFMTS--------CK------P------QVFYHAHVNGFYFIMYKWLTGYF-TY 487 (489)
Q Consensus 446 ~vKL~DFGlS~~~~--------~~------~------~~~~~~~v~s~g~~a~e~~~G~l-pY 487 (489)
.+||+|||+|+... .. | .+...+|+|++|.+++|+++|.. ||
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~ 227 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 227 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCC
Confidence 99999999986422 01 1 11234499999999999998754 55
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.98 E-value=1.4e-32 Score=276.14 Aligned_cols=173 Identities=19% Similarity=0.298 Sum_probs=148.1
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeC--CeE
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTS--THI 381 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~--~~~ 381 (489)
.++|++++.||+|+||+||+|.++.+|+.||+|++++.. .+++.+|+.+|+.+. ||||++++++|... ..+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 468999999999999999999999999999999996542 356778999999985 99999999999754 579
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC-cEEEEecCCccccCC
Q 042772 382 CLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG-HVVLTDFDLSFMTSC 460 (489)
Q Consensus 382 ~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g-~vKL~DFGlS~~~~~ 460 (489)
++|||||++++|..+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 108 ~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999999997764 3489999999999999999999999999999999999998655 699999999964331
Q ss_pred --------------CCc-------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 --------------KPQ-------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 --------------~~~-------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+|+ ....+|+|++|++++++++|..||.
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~ 231 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCC
Confidence 111 1223488999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=9.9e-33 Score=280.23 Aligned_cols=174 Identities=24% Similarity=0.334 Sum_probs=144.0
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe------CCe
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT------STH 380 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------~~~ 380 (489)
+|+.++.||+|+||+||+|.++.+|+.||||++.+.... ..+|+.+|++++||||++++++|.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 699999999999999999999999999999999765321 2359999999999999999999854 336
Q ss_pred EEEEEecCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCC-cEEEEecCCccc
Q 042772 381 ICLITDFCPGGELFALLDK--QPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDG-HVVLTDFDLSFM 457 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~--~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g-~vKL~DFGlS~~ 457 (489)
+|+|||||+++ +.+.+.. .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|..
T Consensus 94 ~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 94 LNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 89999999765 4443322 2334589999999999999999999999999999999999999775 899999999864
Q ss_pred cCC---------------------CCceeecccccchHHHHHHHHhCCcccC
Q 042772 458 TSC---------------------KPQVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 458 ~~~---------------------~~~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
... ...+....|+|++|++++|+++|..||.
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~ 224 (350)
T d1q5ka_ 173 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224 (350)
T ss_dssp CCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred ccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCC
Confidence 321 1112234489999999999999999984
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.5e-32 Score=273.23 Aligned_cols=186 Identities=23% Similarity=0.325 Sum_probs=152.0
Q ss_pred ccccccCcccccccCCCCceEEEEEEEcCCC-------cEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceee
Q 042772 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQGAG-------ELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLY 372 (489)
Q Consensus 301 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg-------~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~ 372 (489)
+.+..++|++.+.||+|+||.||+|+...++ ..||+|.+++.. .......+.+|...+.++ +||||++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 3466789999999999999999999987654 479999997653 344567788888888887 799999999
Q ss_pred EEEEeCCeEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 042772 373 ASFQTSTHICLITDFCPGGELFALLDKQP--------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPEN 438 (489)
Q Consensus 373 ~~~~~~~~~~lVmEy~~ggsL~~~L~~~~--------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~N 438 (489)
++|.++..+++|||||++|+|.+++.... ...+++..+..++.||+.||.|||+++|+||||||+|
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 99999999999999999999999997642 2458999999999999999999999999999999999
Q ss_pred EEEecCCcEEEEecCCccccCCC-----------------Cc------eeecccccchHHHHHHHHh-CCcccC
Q 042772 439 ILLQKDGHVVLTDFDLSFMTSCK-----------------PQ------VFYHAHVNGFYFIMYKWLT-GYFTYV 488 (489)
Q Consensus 439 ILld~~g~vKL~DFGlS~~~~~~-----------------~~------~~~~~~v~s~g~~a~e~~~-G~lpY~ 488 (489)
||++.++.+||+|||+++..... |+ +-..+|+|++|.+++|+++ |..||.
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence 99999999999999998743211 11 1123489999999999986 788885
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.6e-32 Score=277.42 Aligned_cols=179 Identities=23% Similarity=0.332 Sum_probs=150.4
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEeC-----Ce
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQTS-----TH 380 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~ 380 (489)
++|++++.||+|+||+||+|.+..+|+.||||++++... +....+++.+|+.+|+.++||||+++++++... ..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 679999999999999999999999999999999976543 445567788999999999999999999998643 23
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccC-
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTS- 459 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~- 459 (489)
.+++|+|+.+|+|.+++..+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|++|||+|....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc
Confidence 45666777899999999653 48999999999999999999999999999999999999999999999999986432
Q ss_pred ------------------CCCceeecccccchHHHHHHHHhCCcccC
Q 042772 460 ------------------CKPQVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ------------------~~~~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.........|+|++|++++++++|..||.
T Consensus 174 ~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~ 220 (348)
T d2gfsa1 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220 (348)
T ss_dssp GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCC
Confidence 11122345699999999999999999984
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.8e-32 Score=268.87 Aligned_cols=185 Identities=23% Similarity=0.315 Sum_probs=142.6
Q ss_pred cccccCcccccccCCCCceEEEEEEEcC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQG-----AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASF 375 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~ 375 (489)
++..++|++.+.||+|+||.||+|.+.. +++.||+|.++... .......+..|..++.++ +||||+.+++++
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 3555789999999999999999999865 34789999987542 344456677788877766 689999999987
Q ss_pred EeC-CeEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 042772 376 QTS-THICLITDFCPGGELFALLDKQP--------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENIL 440 (489)
Q Consensus 376 ~~~-~~~~lVmEy~~ggsL~~~L~~~~--------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NIL 440 (489)
... ..+++|||||++|+|.+++.... ...+++..+..++.||+.||.|||+++|+||||||+|||
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence 654 46899999999999999997642 234889999999999999999999999999999999999
Q ss_pred EecCCcEEEEecCCccccCCC-----------------Cc------eeecccccchHHHHHHHHhC-CcccC
Q 042772 441 LQKDGHVVLTDFDLSFMTSCK-----------------PQ------VFYHAHVNGFYFIMYKWLTG-YFTYV 488 (489)
Q Consensus 441 ld~~g~vKL~DFGlS~~~~~~-----------------~~------~~~~~~v~s~g~~a~e~~~G-~lpY~ 488 (489)
+++++.+||+|||+|+..... |+ ....+|+|++|.+++|+++| ..||.
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 999999999999999643211 11 11234899999999999876 45664
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.3e-32 Score=272.02 Aligned_cols=181 Identities=24% Similarity=0.273 Sum_probs=148.5
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe-------
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT------- 377 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------- 377 (489)
.++|++++.||+|+||+||+|.++.+|+.||||++..... ......++.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 4689999999999999999999999999999999876533 23345677889999999999999999998855
Q ss_pred -CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 378 -STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 378 -~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
...+|+||||+.++.+...... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|.
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 3468999999976655544333 3458999999999999999999999999999999999999999999999999985
Q ss_pred ccCC-------------------CC-------ceeecccccchHHHHHHHHhCCcccC
Q 042772 457 MTSC-------------------KP-------QVFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 457 ~~~~-------------------~~-------~~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.... +| ......|+|++|++++|+++|..||.
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~ 223 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCC
Confidence 3320 01 11234489999999999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.4e-32 Score=270.28 Aligned_cols=186 Identities=17% Similarity=0.166 Sum_probs=157.0
Q ss_pred ccccccCcccccccCCCCceEEEEEEEcC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEE
Q 042772 301 EKIGLHHFKPIKPLGCGDTGSVHLVELQG-----AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASF 375 (489)
Q Consensus 301 ~~i~~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 375 (489)
+++..++|++.+.||+|+||.||+|.++. ++..||||.+++. ........+.+|+.++++++||||+++++++
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc--cChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 46677899999999999999999999863 3578999999754 2445566789999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcE
Q 042772 376 QTSTHICLITDFCPGGELFALLDKQ--------PMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHV 447 (489)
Q Consensus 376 ~~~~~~~lVmEy~~ggsL~~~L~~~--------~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~v 447 (489)
..+...++||||+++|+|.+++... ....+++..+..++.|++.||.|||+++|+||||||+|||+++++.+
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence 9999999999999999999998642 22346889999999999999999999999999999999999999999
Q ss_pred EEEecCCccccCC------------CC-----------ceeecccccchHHHHHHHHhCC-cccC
Q 042772 448 VLTDFDLSFMTSC------------KP-----------QVFYHAHVNGFYFIMYKWLTGY-FTYV 488 (489)
Q Consensus 448 KL~DFGlS~~~~~------------~~-----------~~~~~~~v~s~g~~a~e~~~G~-lpY~ 488 (489)
||+|||+|+.... .+ .....+|+|++|.+++|+++|. .||.
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~ 237 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 237 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC
Confidence 9999999964321 01 1122448999999999999885 6664
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-31 Score=267.83 Aligned_cols=184 Identities=21% Similarity=0.301 Sum_probs=155.3
Q ss_pred cccccCcccccccCCCCceEEEEEEEc-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeeEEE
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQ-----GAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLL-DHPFLPTLYASF 375 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~ 375 (489)
++..++|++.+.||+|+||.||+|.+. .+++.||+|.+++.. .......+.+|+.+++.+ +||||+++++++
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 455678999999999999999999874 456799999997653 344566788999999998 699999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 042772 376 QTSTHICLITDFCPGGELFALLDKQP----------------MKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENI 439 (489)
Q Consensus 376 ~~~~~~~lVmEy~~ggsL~~~L~~~~----------------~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NI 439 (489)
.....+++|||||++|+|.+++.... ...+++..+..++.||+.||.|||+++++||||||+||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NI 176 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccc
Confidence 99999999999999999999997642 22488999999999999999999999999999999999
Q ss_pred EEecCCcEEEEecCCccccCCCC-----------------c------eeecccccchHHHHHHHHh-CCccc
Q 042772 440 LLQKDGHVVLTDFDLSFMTSCKP-----------------Q------VFYHAHVNGFYFIMYKWLT-GYFTY 487 (489)
Q Consensus 440 Lld~~g~vKL~DFGlS~~~~~~~-----------------~------~~~~~~v~s~g~~a~e~~~-G~lpY 487 (489)
+++.++.+||+|||+++...... + ....+|+|++|++++|+++ |..||
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~ 248 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCC
Confidence 99999999999999997543211 1 1123388999999999997 55555
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.6e-32 Score=267.19 Aligned_cols=182 Identities=20% Similarity=0.274 Sum_probs=145.8
Q ss_pred ccCcccccccCCCCceEEEEEEEcCC-CcEEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCCcceeeEEEEe---
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGA-GELYAMKAMEKSVMLNRNKVHRACIEREIMSLL---DHPFLPTLYASFQT--- 377 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~t-g~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l---~HpnIv~l~~~~~~--- 377 (489)
.++|++++.||+|+||+||+|.+..+ ++.||+|+++...... .....+.+|+.+++.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 36899999999999999999999765 6789999997653321 1223345677776655 89999999999853
Q ss_pred --CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCc
Q 042772 378 --STHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLS 455 (489)
Q Consensus 378 --~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS 455 (489)
...++++|||+.++.+.... ......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred ccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 34789999999776654443 334456899999999999999999999999999999999999999999999999998
Q ss_pred cccC--------------CCCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 456 FMTS--------------CKPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 456 ~~~~--------------~~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.... .+|+ +....|+|++|++++|+++|..||.
T Consensus 164 ~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~ 216 (305)
T d1blxa_ 164 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 216 (305)
T ss_dssp CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred hhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCC
Confidence 6432 1111 1234499999999999999999985
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.6e-31 Score=270.18 Aligned_cols=178 Identities=22% Similarity=0.361 Sum_probs=148.6
Q ss_pred ccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe------C
Q 042772 305 LHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT------S 378 (489)
Q Consensus 305 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------~ 378 (489)
+++|++++.||+|+||+||+|.++.+|+.||||++.+... +.....++.+|+.++++++||||++++++|.. .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 4789999999999999999999999999999999986643 45566788999999999999999999999964 3
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCcccc
Q 042772 379 THICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMT 458 (489)
Q Consensus 379 ~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~ 458 (489)
.++|+|||||.+ ++.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++..
T Consensus 95 ~~~~iv~Ey~~~-~l~~~~~~----~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 95 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp CEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred ceeEEEEeccch-HHHHhhhc----CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence 689999999965 56665543 3899999999999999999999999999999999999999999999999997533
Q ss_pred CC--------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 459 SC--------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 459 ~~--------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.. +|+ .....|+|++|++++++++|..||.
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~ 219 (355)
T d2b1pa1 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCC
Confidence 21 111 1234589999999999999999984
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.1e-31 Score=264.44 Aligned_cols=175 Identities=19% Similarity=0.220 Sum_probs=146.9
Q ss_pred ccccCCCCceEEEEEEEcCCC---cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeeEEEEe-CCeEEEEEe
Q 042772 311 IKPLGCGDTGSVHLVELQGAG---ELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPFLPTLYASFQT-STHICLITD 386 (489)
Q Consensus 311 ~~~LG~G~fG~Vy~a~~~~tg---~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lVmE 386 (489)
.+.||+|+||+||+|.+..++ ..||+|.+++. .+.....++.+|++++++++||||+++++++.. +...++|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 578999999999999986543 36899998643 356667889999999999999999999998765 568999999
Q ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecCCccccCCC-----
Q 042772 387 FCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFDLSFMTSCK----- 461 (489)
Q Consensus 387 y~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGlS~~~~~~----- 461 (489)
||++|+|.+++.... ..+++..+..++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 110 ~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp CCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999988654 34778889999999999999999999999999999999999999999999999743211
Q ss_pred --------Ccee------------ecccccchHHHHHHHHhCCcccC
Q 042772 462 --------PQVF------------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 462 --------~~~~------------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
+..+ ..+|+|++|.+++|+++|..||.
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~ 235 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 235 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCC
Confidence 1111 23389999999999999877764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.97 E-value=9.3e-31 Score=259.36 Aligned_cols=176 Identities=20% Similarity=0.267 Sum_probs=150.5
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CCcceeeEEEEeCCeEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDH-PFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~lV 384 (489)
++|++++.||+|+||+||+|.+..+|+.||+|+++.... ...+..|.++++.+.| +|++.+++++......++|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 579999999999999999999999999999999865422 1245678889998865 8999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec-----CCcEEEEecCCccccC
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK-----DGHVVLTDFDLSFMTS 459 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~-----~g~vKL~DFGlS~~~~ 459 (489)
|||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 80 me~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 9999 789999987754 45899999999999999999999999999999999999974 5789999999997432
Q ss_pred C----------------------CCc------eeecccccchHHHHHHHHhCCcccC
Q 042772 460 C----------------------KPQ------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 460 ~----------------------~~~------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
. +|+ ....+|+|++|++++|+++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~ 214 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 214 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCC
Confidence 1 011 1233489999999999999999995
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.1e-31 Score=262.11 Aligned_cols=171 Identities=23% Similarity=0.311 Sum_probs=140.9
Q ss_pred CcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHH--HHhCCCCCcceeeEEEEeCC----e
Q 042772 307 HFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREI--MSLLDHPFLPTLYASFQTST----H 380 (489)
Q Consensus 307 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~i--l~~l~HpnIv~l~~~~~~~~----~ 380 (489)
+|.+.+.||+|+||.||+|++ +|+.||+|+++... ...+..|.++ +.+++||||+++++++.++. .
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 578889999999999999987 48899999986432 2233344444 55789999999999997653 6
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCeecCCCCCCEEEecCCcEEEEec
Q 042772 381 ICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC--------LGIIYRDLKPENILLQKDGHVVLTDF 452 (489)
Q Consensus 381 ~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~--------~gIvHrDLKP~NILld~~g~vKL~DF 452 (489)
+|+|||||++|+|.+++.+. .+++.....++.|++.||.|||+ +||+||||||+||||+.++.+||+||
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 89999999999999999874 37899999999999999999996 59999999999999999999999999
Q ss_pred CCccccCC-------------------CCcee------------ecccccchHHHHHHHHhCCcccC
Q 042772 453 DLSFMTSC-------------------KPQVF------------YHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 453 GlS~~~~~-------------------~~~~~------------~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
|++..... +|+.+ ..+|+|++|.+++|+++|..||.
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~ 219 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence 99864321 11111 13489999999999999988763
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=1.8e-30 Score=257.28 Aligned_cols=176 Identities=19% Similarity=0.292 Sum_probs=145.3
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC-cceeeEEEEeCCeEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDHPF-LPTLYASFQTSTHICLI 384 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~lV 384 (489)
++|++++.||+|+||.||+|.+..+|+.||+|++...... ..+..|+++++.++|+| |+.+..++......++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 4699999999999999999999999999999998754321 24677999999998665 55566667788899999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEec---CCcEEEEecCCccccCC-
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQK---DGHVVLTDFDLSFMTSC- 460 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~---~g~vKL~DFGlS~~~~~- 460 (489)
|||+ +++|.+.+.... ..+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|+....
T Consensus 82 me~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp EECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEEc-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9999 667777776543 45899999999999999999999999999999999999863 55799999999974321
Q ss_pred ----------------CCc-----------eeecccccchHHHHHHHHhCCcccC
Q 042772 461 ----------------KPQ-----------VFYHAHVNGFYFIMYKWLTGYFTYV 488 (489)
Q Consensus 461 ----------------~~~-----------~~~~~~v~s~g~~a~e~~~G~lpY~ 488 (489)
.+. ....+|+|++|++++||++|..||.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~ 214 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCccc
Confidence 011 1234489999999999999999995
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.93 E-value=3.6e-26 Score=231.12 Aligned_cols=184 Identities=21% Similarity=0.297 Sum_probs=144.1
Q ss_pred cccccCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-----------CCCcce
Q 042772 302 KIGLHHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-----------HPFLPT 370 (489)
Q Consensus 302 ~i~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----------HpnIv~ 370 (489)
.+..++|++++.||+|+||+||+|.++.+|+.||||++++.. ...+.+.+|+.+++.+. ||||++
T Consensus 9 ~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~ 84 (362)
T d1q8ya_ 9 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 84 (362)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred CccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEE
Confidence 344467999999999999999999999999999999997642 23355667888877764 578999
Q ss_pred eeEEEEe--CCeEEEEEecCCCC-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEecCC-
Q 042772 371 LYASFQT--STHICLITDFCPGG-ELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHC-LGIIYRDLKPENILLQKDG- 445 (489)
Q Consensus 371 l~~~~~~--~~~~~lVmEy~~gg-sL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~-~gIvHrDLKP~NILld~~g- 445 (489)
+++++.. ....+++|+++..+ .............+++..+..++.||+.||.|||+ +||+||||||+|||++.++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~ 164 (362)
T d1q8ya_ 85 LLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 164 (362)
T ss_dssp CCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred EEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCc
Confidence 9988864 35667777766544 44444555555668999999999999999999998 8999999999999998765
Q ss_pred -----cEEEEecCCccccCCC------------Cc------eeecccccchHHHHHHHHhCCcccCC
Q 042772 446 -----HVVLTDFDLSFMTSCK------------PQ------VFYHAHVNGFYFIMYKWLTGYFTYVP 489 (489)
Q Consensus 446 -----~vKL~DFGlS~~~~~~------------~~------~~~~~~v~s~g~~a~e~~~G~lpY~~ 489 (489)
.++++|||.|...... |+ +...+|+|++|+++.++++|..||.+
T Consensus 165 ~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~ 231 (362)
T d1q8ya_ 165 PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231 (362)
T ss_dssp TTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred ccccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence 4999999998643311 11 12345899999999999999999863
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.91 E-value=2.5e-24 Score=181.24 Aligned_cols=108 Identities=39% Similarity=0.835 Sum_probs=102.9
Q ss_pred ccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhccccccc
Q 042772 76 IEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNF 155 (489)
Q Consensus 76 ~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (489)
+.++|+|||+..||++|+|||++|++++||+++|++|+++++|..++
T Consensus 2 i~~~~vi~Da~~pdg~Ii~vN~a~~~~~Gy~~~El~G~~~~~l~~~~--------------------------------- 48 (109)
T d1n9la_ 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEG--------------------------------- 48 (109)
T ss_dssp CSCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTT---------------------------------
T ss_pred ccceEEEEeCCCCCCeEEEEcHHHHHHHCcCHHHHcCCcceeeeccc---------------------------------
Confidence 56899999998899999999999999999999999999999998775
Q ss_pred ccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCc
Q 042772 156 TLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSD 225 (489)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te 225 (489)
.++...+.+++++..++.+++++..++|||+.||+.++++|++|++|++++|+++.+|||.
T Consensus 49 ---------~~~~~~~~~~~~l~~~~~~~~e~~~~~kdG~~~w~~~~~~pi~d~~G~v~~~v~~~~DITa 109 (109)
T d1n9la_ 49 ---------TDPKEVQKIRDAIKKGEACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVDVTS 109 (109)
T ss_dssp ---------CCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCC
T ss_pred ---------CCHHHhhhhhhHhhcCCceeeeEEEEecCCeEEEEEEEEEEEECCCCCEEEEEEEEEECCC
Confidence 7788899999999999999999999999999999999999999999999999999999984
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Probab=99.87 E-value=2.8e-22 Score=166.49 Aligned_cols=104 Identities=69% Similarity=1.167 Sum_probs=99.1
Q ss_pred CcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhccccccccc
Q 042772 78 KNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTL 157 (489)
Q Consensus 78 ~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (489)
++|+|||++.||++|+|||+||+++|||+++|++|+++..+..+.
T Consensus 1 ~~fvi~d~~~pd~~I~y~N~a~~~~~G~s~~e~~G~~~~~~~~~~----------------------------------- 45 (104)
T d1jnua_ 1 KSFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRG----------------------------------- 45 (104)
T ss_dssp CEEEEECTTSTTCCEEEECHHHHHHHTCCHHHHTTSCGGGGCCTT-----------------------------------
T ss_pred CeEEEEcCCCCCCEEEEEcHHHHHHHCcCHHHHCCccceeccccc-----------------------------------
Confidence 479999999999999999999999999999999999998777665
Q ss_pred CcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccC
Q 042772 158 GCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDG 223 (489)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~ 223 (489)
..+...+.++.+++.++.+.+++.+++|||+.+|+.++++|++|++|++++|+++.+||
T Consensus 46 -------~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~~~~~~~~~~pi~d~~G~v~~~i~i~~DI 104 (104)
T d1jnua_ 46 -------TDRKAVQLIRDAVKEQRDVTVQVLNYTKGGRAFWNLFHLQVMRDENGDVQYFIGVQQEM 104 (104)
T ss_dssp -------SCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEEEEEEEEEEECTTTSSCCEEEEEEEEC
T ss_pred -------cchHHHhhhhhhhhcCceeEeEEEEEecccceEEEEEEEEEEECCCCCEEEEEEEEEcC
Confidence 78889999999999999999999999999999999999999999999999999999997
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.8e-22 Score=186.58 Aligned_cols=136 Identities=17% Similarity=0.144 Sum_probs=106.0
Q ss_pred ccccccCCCCceEEEEEEEcCCCcEEEEEEeeccccc---------------chHHHHHHHHHHHHHHhCCCCCcceeeE
Q 042772 309 KPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVML---------------NRNKVHRACIEREIMSLLDHPFLPTLYA 373 (489)
Q Consensus 309 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~---------------~~~~~~~~~~E~~il~~l~HpnIv~l~~ 373 (489)
.+.+.||+|+||.||+|.+. +|+.||+|++...... ..........|...+..+.|++++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46789999999999999985 5899999987542211 0111234456788899999999999886
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEecCCcEEEEecC
Q 042772 374 SFQTSTHICLITDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQKDGHVVLTDFD 453 (489)
Q Consensus 374 ~~~~~~~~~lVmEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFG 453 (489)
+.. .+++|||+++..+.+ +++..+..++.|++.+|.|||++||+||||||+|||++++ .++|+|||
T Consensus 82 ~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp EET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred ecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECC
Confidence 532 379999998765533 3445567789999999999999999999999999999865 58999999
Q ss_pred CccccC
Q 042772 454 LSFMTS 459 (489)
Q Consensus 454 lS~~~~ 459 (489)
+|....
T Consensus 148 ~a~~~~ 153 (191)
T d1zara2 148 QSVEVG 153 (191)
T ss_dssp TCEETT
T ss_pred CcccCC
Confidence 997664
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=1.1e-21 Score=164.56 Aligned_cols=107 Identities=25% Similarity=0.477 Sum_probs=99.3
Q ss_pred CcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccc--cccccchhhhhhccccccchhHHHHHHHhhhccccccc
Q 042772 78 KNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSF--LELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNF 155 (489)
Q Consensus 78 ~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~--l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (489)
.+|+|+|+..||.+|+|||++|++++||+++|++|+++.. +..++
T Consensus 2 ~~f~i~~~~~~d~~I~~~N~a~~~l~G~~~~eiiG~~~~~~~~~~~~--------------------------------- 48 (110)
T d1bywa_ 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPC--------------------------------- 48 (110)
T ss_dssp CEEEEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTT---------------------------------
T ss_pred ceEEEEcCCCCCCEEEEEcHHHHHHhCCCHHHhcccCcccccceeeh---------------------------------
Confidence 5799999999999999999999999999999999999753 34443
Q ss_pred ccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCcc
Q 042772 156 TLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDH 226 (489)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~ 226 (489)
+++..+..++.++..+++++.++.+++++|+.+|+.++++|++|++|++++|+++..||||+
T Consensus 49 ---------~~~~~~~~~~~~l~~~~~~~~e~~~~~~~g~~~w~~~~~~pi~d~~G~v~~~i~~~~DITer 110 (110)
T d1bywa_ 49 ---------TQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEK 110 (110)
T ss_dssp ---------CCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEEEEEEEEEEEECTTCCEEEEEEEEEEEEEC
T ss_pred ---------eecccccccchhhcccccccceeeeeecccceeeeeeeEEEEECCCCCEEEEEEEEEECCCC
Confidence 67888999999999999999999999999999999999999999999999999999999986
|
| >d1v9ya_ d.110.3.2 (A:) Direct oxygen sensor protein, DOS {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Direct oxygen sensor protein, DOS species: Escherichia coli [TaxId: 562]
Probab=99.59 E-value=1.4e-15 Score=125.76 Aligned_cols=111 Identities=19% Similarity=0.316 Sum_probs=80.3
Q ss_pred HHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhh
Q 042772 69 LATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKK 148 (489)
Q Consensus 69 ~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (489)
+.++++++.++++++|+ ++.|+|+|++|++++||+++|++|+++..+...... +
T Consensus 3 ~~~~~e~~~d~i~~~d~---~g~i~~~N~~~~~l~Gy~~~e~~g~~~~~~~~~~~~-~---------------------- 56 (113)
T d1v9ya_ 3 FFPALEQNMMGAVLINE---NDEVMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLR-P---------------------- 56 (113)
T ss_dssp HHHHHHTCSSEEEEECT---TSBEEEECHHHHHHHSCCGGGTTTSBGGGGSCGGGT-T----------------------
T ss_pred HHHHHHcCcCcEEEEeC---CCCEEEEchhHhhhhccchhhhcCcceecccccccc-c----------------------
Confidence 67899999999999999 999999999999999999999999998766544310 0
Q ss_pred cccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeecc
Q 042772 149 NYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLD 222 (489)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d 222 (489)
.........+............+...++|||+.+|++++++|+.++.| .+|+++.+|
T Consensus 57 ---------------~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~v~~~~~~i~~~~~--~~~~~v~rD 113 (113)
T d1v9ya_ 57 ---------------AHPEYIRHNREGGKARVEGMSRELQLEKKDGSKIWTRFALSKVSAEGK--VYYLALVRD 113 (113)
T ss_dssp ---------------THHHHHHHHHC----------CEEEEECTTSCEEEEEEEEEEEEETTE--EEEEEEEEC
T ss_pred ---------------ccccccccccccccccccccceeeeeccccceeEEEEEEEEEEEECCe--EEEEEEEEC
Confidence 011111222222233344466778889999999999999999998655 458888887
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Probab=99.59 E-value=3.4e-15 Score=127.18 Aligned_cols=111 Identities=18% Similarity=0.257 Sum_probs=88.8
Q ss_pred hhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHh
Q 042772 67 IDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALW 146 (489)
Q Consensus 67 ~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (489)
..+..+++.++++|+++|. +|.|+++|++|++++||+++|++|+++..+..+.
T Consensus 16 ~~~~~i~~~~~~~i~~~d~---~g~i~~~N~~~~~l~Gy~~~el~g~~~~~~~~~~------------------------ 68 (130)
T d1ew0a_ 16 AHLRSILDTVPDATVVSAT---DGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEP------------------------ 68 (130)
T ss_dssp SCHHHHHTTCSSEEEEEET---TSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTT------------------------
T ss_pred HHHHHHHHcCCCeEEEEeC---CccEEEEHHHHHHhhcCCHHHhcCCccccccccc------------------------
Confidence 3588999999999999999 9999999999999999999999999987666553
Q ss_pred hhcccccccccCcccccCCCHHHHHHHHHHHHcCCc----EEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeecc
Q 042772 147 KKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQRE----ITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLD 222 (489)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d 222 (489)
........+...+..++. ...++..++|||+.+|+.++++|+.+..+ ..|+++.+|
T Consensus 69 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~v~~~~~~i~~~~~--~~~~~i~rD 128 (130)
T d1ew0a_ 69 ------------------YRHEHDGYLQRYMATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRSGGE--RFFTGFIRD 128 (130)
T ss_dssp ------------------TGGGHHHHHHHHHHHCCCSSTTSCEEEEEECTTSCEEEEEEEEEEEEETTE--EEEEEEEEE
T ss_pred ------------------hhHHHHHHHHHHHHhCCCccccceeeEEEEcCCCCEEEEEEEEEEEEECCe--EEEEEEEEE
Confidence 112222333444443333 56788889999999999999999988654 458899999
Q ss_pred CC
Q 042772 223 GS 224 (489)
Q Consensus 223 ~T 224 (489)
||
T Consensus 129 IT 130 (130)
T d1ew0a_ 129 LT 130 (130)
T ss_dssp CC
T ss_pred CC
Confidence 97
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Probab=99.58 E-value=5.9e-16 Score=126.40 Aligned_cols=102 Identities=19% Similarity=0.194 Sum_probs=79.4
Q ss_pred CcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhccccccccc
Q 042772 78 KNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTL 157 (489)
Q Consensus 78 ~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (489)
++|+++|+ +|.|+++|++|++++||+++|++|+++..+..+..
T Consensus 1 dgi~~~D~---~G~I~~~N~a~~~l~Gy~~~el~g~~~~~~~~~~~---------------------------------- 43 (106)
T d1xj3a1 1 DAMIVIDG---HGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPD---------------------------------- 43 (106)
T ss_dssp CCEEEEET---TSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTH----------------------------------
T ss_pred CEEEEECC---CCcEEEEcHHHHHHhhhchHhhcCCCccccccccc----------------------------------
Confidence 68999999 99999999999999999999999999877765541
Q ss_pred CcccccCCCHHHHHHHHHHHHc----CCcEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCCcc
Q 042772 158 GCCLEISSDQATVSKIRDAVRE----QREITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGSDH 226 (489)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~Te~ 226 (489)
.......+...+.. ......++..++|||+.+|+.++++|+.+.++ .+++++.+||||+
T Consensus 44 --------~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~~~~v~~~~~~~~~~~~--~~~~~~~~DITE~ 106 (106)
T d1xj3a1 44 --------RSRHDSYISRYRTTSDPHIIGIGRIVTGKRRDGTTFPMHLSIGEMQSGGE--PYFTGFVRDLTEH 106 (106)
T ss_dssp --------HHHHHHHHHHHHHHCCCSSTTTCEEEEEECTTSCEEEEEEEEEEEEETTE--EEEEEEEEECHHH
T ss_pred --------ccchhhhhhhhhhhcccccccccceeeeeeccceEEEEEEEEEEEEECCe--EEEEEEEEeCCCC
Confidence 11122222222222 22355788899999999999999999998654 4689999999974
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=2.4e-15 Score=125.85 Aligned_cols=105 Identities=16% Similarity=0.162 Sum_probs=88.0
Q ss_pred cEEE--ECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhcccccccc
Q 042772 79 NFVI--TDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFT 156 (489)
Q Consensus 79 ~~~i--~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (489)
..+| .|+ ||.|+|+|++|++++||+.+|++|++...+..++
T Consensus 6 ~~fi~r~~~---dG~i~~~N~~~~~~~G~~~~el~g~~~~~~~~~e---------------------------------- 48 (114)
T d1p97a_ 6 KTFLSRHSM---DMKFTYCDDRITELIGYHPEELLGRSAYEFYHAL---------------------------------- 48 (114)
T ss_dssp EEEEEEECT---TTSCSEECTTHHHHTSSCHHHHTTSCHHHHSCSS----------------------------------
T ss_pred CEEEEEECC---CCcEEEECHHHHHHcCCCcccccccccccccccc----------------------------------
Confidence 4455 488 9999999999999999999999999976555553
Q ss_pred cCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccC-CCCeeEEeeeeccCCcccc
Q 042772 157 LGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDH-KGELQYFIGVQLDGSDHVE 228 (489)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~-~g~~~~~~~~~~d~Te~ke 228 (489)
......+.+...+..+..+..++...+|||+.+|+....+|++|. +|++.+++++.+||||+|+
T Consensus 49 --------d~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~~wv~~~~~~~~~~~~~~~~~ii~~~~dite~k~ 113 (114)
T d1p97a_ 49 --------DSENMTKSHQNLCTKGQVVSGQYRMLAKHGGYVWLETQGTVIYNPRNLQPQCIMCVNYVLSEIEK 113 (114)
T ss_dssp --------SHHHHHHHHHHHTTTSEEEEEEEEEECTTSCEEEEEEEEEEEECTTTCSEEEEEEEEEEEEEEEC
T ss_pred --------ccccceeeeeecccccceeecceeeeeecCcceEEEEEEEEEEeCCCCCEEEEEEEEEECChhhc
Confidence 333444556666666777888999999999999999999999997 5899999999999999986
|
| >d1nwza_ d.110.3.1 (A:) Photoactive yellow protein, PYP {Ectothiorhodospira halophila [TaxId: 1053]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: Photoactive yellow protein, PYP species: Ectothiorhodospira halophila [TaxId: 1053]
Probab=99.30 E-value=4.5e-12 Score=108.07 Aligned_cols=99 Identities=11% Similarity=0.051 Sum_probs=83.1
Q ss_pred hhHHHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCc-cccccccchhhhhhccccccchhHHHHHHH
Q 042772 67 IDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNC-SFLELTEYTREEILGRNCSTYTFMLYFLAL 145 (489)
Q Consensus 67 ~~~~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (489)
..+..+||.+++++++.|+ +|.|+++|++|++++||+++|++|+++ .++..+.
T Consensus 17 ~~~d~~ld~~p~gi~~lD~---~G~i~~~N~a~~~l~G~~~~e~iG~~~~~~~~p~~----------------------- 70 (125)
T d1nwza_ 17 KMDDGQLDGLAFGAIQLDG---DGNILQYNAAEGDITGRDPKQVIGKNFFKDVAPCT----------------------- 70 (125)
T ss_dssp TCCHHHHTTCSSEEEEEET---TCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGG-----------------------
T ss_pred HHHHHHHhCCCccEEEEeC---CCCEEEEcHHHHHhhccchHhhcCCCHHHccCchh-----------------------
Confidence 4456899999999999999 999999999999999999999999996 4443322
Q ss_pred hhhcccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCC
Q 042772 146 WKKNYGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHK 210 (489)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~ 210 (489)
..+.....+.+++..+.....+....+++|+++|+.+++.++.+.+
T Consensus 71 -------------------~~~~~~~~~~~~~~~g~~~~~~~~~~~~~G~~~~v~v~l~~~~~g~ 116 (125)
T d1nwza_ 71 -------------------DSPEFYGKFKEGVASGNLNTMFEYTFDYQMTPTKVKVHMKKALSGD 116 (125)
T ss_dssp -------------------CSTTTHHHHHHHHHHTCCEEEEEEEECTTSCCEEEEEEEEECSSSS
T ss_pred -------------------hhhheeeeceeeeecCCcceEEEEEeccCCcEEEEEEEEEEecCCC
Confidence 3444566788999999988888788999999999999999876643
|
| >d1mzua_ d.110.3.1 (A:) PYP domain of sensor histidine kinase Ppr {Rhodospirillum centenum [TaxId: 34018]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: PYP domain of sensor histidine kinase Ppr species: Rhodospirillum centenum [TaxId: 34018]
Probab=99.27 E-value=6.5e-12 Score=104.83 Aligned_cols=96 Identities=11% Similarity=-0.010 Sum_probs=76.8
Q ss_pred HHHHHhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhc
Q 042772 70 ATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKN 149 (489)
Q Consensus 70 ~~~~~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (489)
..+||.++++|+++|. +|.|+++|+++++++||+++|++|+++..+-.|+
T Consensus 6 ~A~ld~~p~gvi~~D~---~G~I~~~N~aa~~~~G~~~eellG~~~~~~~~p~--------------------------- 55 (110)
T d1mzua_ 6 TAEFDALPVGAIQVDG---SGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPC--------------------------- 55 (110)
T ss_dssp CTTGGGCSSEEEEEET---TCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGG---------------------------
T ss_pred HHHHhCCCcEEEEEcC---CCCEEEeHHHHHHHHcCCHHHHcCCCHHHhcCCh---------------------------
Confidence 4678999999999999 9999999999999999999999999974333332
Q ss_pred ccccccccCcccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccC
Q 042772 150 YGVYNFTLGCCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDH 209 (489)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~ 209 (489)
...+.....+.+++..++.-...-...+++|+++++.+++.++.+.
T Consensus 56 --------------~~~~~~~~~~~~~~~~g~~~~~~~~~l~~~G~~~~v~v~~~~~~~~ 101 (110)
T d1mzua_ 56 --------------TNIPAFSGRFMDGVTSGTLDARFDFVFDFQMAPVRVQIRMQNAGVP 101 (110)
T ss_dssp --------------GCSTTTHHHHHHHHHTSCCEEEEEEEEECSSCEEEEEEEEEECSST
T ss_pred --------------hhhHHHHHHHHHHHhccccCcceEEEEecCCceEEEEEEEEEecCC
Confidence 1345566778888888876444334468999999999999887653
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.23 E-value=1.9e-12 Score=108.14 Aligned_cols=105 Identities=14% Similarity=0.196 Sum_probs=76.2
Q ss_pred HhccCcEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhccccc
Q 042772 74 ERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVY 153 (489)
Q Consensus 74 ~~~~~~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (489)
+.+.++|+++|+. +|.|++||++|++++||+++|++|++...|..+.
T Consensus 5 ~~~n~AI~~id~~--~G~I~~~N~a~~~l~Gy~~~el~g~~~~~l~~~~------------------------------- 51 (114)
T d1ll8a_ 5 PEFNKAIFTVDAK--TTEILVANDKACGLLGYSSQDLIGQKLTQFFLRS------------------------------- 51 (114)
T ss_dssp TTTTCEEEEEETT--TCBEEEECTTHHHHHTCCTTTTTTSBGGGGSSCT-------------------------------
T ss_pred hhcCcEEEEEECC--CCEEEEECHHHHHhhcCCHHHHcCCCeeeecCcc-------------------------------
Confidence 3567899999962 7999999999999999999999999988777554
Q ss_pred ccccCcccccCCCHHHHHHHHHHHHcCC----cEEEEEEeeecCCCeeeEEEeecccccCCCCeeEEeeeeccCC
Q 042772 154 NFTLGCCLEISSDQATVSKIRDAVREQR----EITVQLINYTKSGKKFWNLFHLQPMRDHKGELQYFIGVQLDGS 224 (489)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g~~~~~~~~~~d~T 224 (489)
........+...+..+. ....++...+|+|+.||++++++++..+.+ ..++++.+||+
T Consensus 52 -----------~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~G~~~pvevs~~~i~~~~~--~~~l~vi~dV~ 113 (114)
T d1ll8a_ 52 -----------DSDVVEALSEEHMEADGHAAVVFGTVVDIISRSGEKIPVSVWMKRMRQERR--LCCVVVLEPVE 113 (114)
T ss_dssp -----------TTHHHHHTTSSTTSSSSCSSCCCSSSEEECCTTCCCEEEECCEECCBSSSS--BEEEEEEEECC
T ss_pred -----------cHHHHHHHHHHHHhcCCCccceeeEEEEEEccCCcEEEEEEEEEEEEECCe--EEEEEEEEECc
Confidence 12222222222222221 122356678999999999999999986544 35789999993
|
| >d1oj5a_ d.110.3.8 (A:) PAS domain of steroid receptor coactivator 1A, NCo-A1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PAS domain of steroid receptor coactivator 1A, NCo-A1 domain: PAS domain of steroid receptor coactivator 1A, NCo-A1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.54 E-value=2.1e-08 Score=83.02 Aligned_cols=94 Identities=10% Similarity=0.083 Sum_probs=71.9
Q ss_pred ECCCCCCCCEEEecHhhHHhcCCCh-hhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhcccccccccCccc
Q 042772 83 TDPRIPDNPIIFASDSFLELTEYTR-EEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLGCCL 161 (489)
Q Consensus 83 ~d~~~~~~~i~~~n~~~~~~~gy~~-~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (489)
.|+ +|.|+++|++..+++||+. ||++|+++-.|..|+
T Consensus 8 h~~---~g~~~~vd~~~~~~~gy~~~eelig~s~~~f~HPe--------------------------------------- 45 (109)
T d1oj5a_ 8 QDT---TGKIISIDTSSLRAAGRTGWEDLVRKCIYAFFQPQ--------------------------------------- 45 (109)
T ss_dssp ECT---TCCEEEEECHHHHTTCCSCHHHHHHHHHHHHTSCB---------------------------------------
T ss_pred ECC---CceEEEECHHHhhHhhcCCHHHHcCCcHHHeECcc---------------------------------------
Confidence 477 9999999999999999995 999999987777775
Q ss_pred ccCCCHHHHH-HHHHHHHcCCcEEEEEEeeecCCCeeeEEEeecccccCCC-CeeEEeeee
Q 042772 162 EISSDQATVS-KIRDAVREQREITVQLINYTKSGKKFWNLFHLQPMRDHKG-ELQYFIGVQ 220 (489)
Q Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~p~~~~~g-~~~~~~~~~ 220 (489)
+......+ .....+..+...+.+....+|||+..|+..+..+++|..| +..+++++.
T Consensus 46 --D~~~~~~~~~~~~~~~~g~~~~~~yR~~~kdG~~vWv~t~~~~~~~~~~~~~~~Ii~~h 104 (109)
T d1oj5a_ 46 --GREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLSAHTRCKLCYPQSPDMQPFIMGIH 104 (109)
T ss_dssp --TTBCCHHHHHHHHHHHHSEEECCCEEEECTTSCEEEEEEEEEEECC----CCCEEEEEE
T ss_pred --cchHHHhhHHHHHHHhhcccchhhhhhhhccCcEEEEEEEEEEEECCCCCcccEEEEEE
Confidence 11111222 3456677888899999999999999999999999999865 455555653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.41 E-value=8.3e-07 Score=83.02 Aligned_cols=140 Identities=13% Similarity=0.057 Sum_probs=93.4
Q ss_pred cCcccccccCCCCceEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEE
Q 042772 306 HHFKPIKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHICLI 384 (489)
Q Consensus 306 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV 384 (489)
..|+.++..+.++.+.||+.. ..++.+.+|......... ...+.+|..++..+. +--+++++.+....+..++|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 457777766656667999875 346677888876543222 234556888877663 44467888888888899999
Q ss_pred EecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-------------------------------------
Q 042772 385 TDFCPGGELFALLDKQPMKIFREDSARFYAAEVVIGLEYLHCL------------------------------------- 427 (489)
Q Consensus 385 mEy~~ggsL~~~L~~~~~~~l~e~~~~~i~~qI~~aL~yLH~~------------------------------------- 427 (489)
|++++|.++.+..... ... ..++.+++..+..||+.
T Consensus 89 ~~~l~G~~~~~~~~~~----~~~---~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE----QSP---EKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHTTTC----SCH---HHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEeccccccccccccc----ccH---HHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 9999998876543221 111 11233344444444421
Q ss_pred ----------------------CCeecCCCCCCEEEecCCcEEEEecCCccc
Q 042772 428 ----------------------GIIYRDLKPENILLQKDGHVVLTDFDLSFM 457 (489)
Q Consensus 428 ----------------------gIvHrDLKP~NILld~~g~vKL~DFGlS~~ 457 (489)
.++|+|+.|.||++++++.+-|+||+.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 258999999999999776667999998863
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.80 E-value=1.9e-05 Score=78.91 Aligned_cols=80 Identities=15% Similarity=0.150 Sum_probs=49.7
Q ss_pred ccccCCCCceEEEEEEEcCCCcEEEEEEeecccccc----hHHHHHHHHHHHHHHhC-CC--CCcceeeEEEEeCCeEEE
Q 042772 311 IKPLGCGDTGSVHLVELQGAGELYAMKAMEKSVMLN----RNKVHRACIEREIMSLL-DH--PFLPTLYASFQTSTHICL 383 (489)
Q Consensus 311 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~i~~~~~~~----~~~~~~~~~E~~il~~l-~H--pnIv~l~~~~~~~~~~~l 383 (489)
.+.||.|....||++....+++.+++|.-.+..... .....+...|.+.|+.+ .+ ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 457899999999999987778899999754321110 11234455688887765 22 346666643 4445678
Q ss_pred EEecCCCCC
Q 042772 384 ITDFCPGGE 392 (489)
Q Consensus 384 VmEy~~ggs 392 (489)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.71 E-value=8.5e-05 Score=68.41 Aligned_cols=74 Identities=15% Similarity=0.100 Sum_probs=50.2
Q ss_pred ccCCCCc-eEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC--CCCcceeeEEEEeCCeEEEEEecCC
Q 042772 313 PLGCGDT-GSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD--HPFLPTLYASFQTSTHICLITDFCP 389 (489)
Q Consensus 313 ~LG~G~f-G~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~~~lVmEy~~ 389 (489)
.+..|.. +.||+.... .+..+++|....... ..+..|..+++.+. .-.+++++.+..+.+..++||++++
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 4445553 678988754 366788897654321 23455777777663 2346778888788888999999998
Q ss_pred CCCH
Q 042772 390 GGEL 393 (489)
Q Consensus 390 ggsL 393 (489)
|.++
T Consensus 90 G~~~ 93 (255)
T d1nd4a_ 90 GQDL 93 (255)
T ss_dssp SEET
T ss_pred cccc
Confidence 7654
|
| >d2oola2 d.110.3.9 (A:26-139) Sensor protein PhyB2 {Rhodopseudomonas palustris [TaxId: 1076]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Sensor protein PhyB2 species: Rhodopseudomonas palustris [TaxId: 1076]
Probab=96.84 E-value=0.0011 Score=53.90 Aligned_cols=41 Identities=12% Similarity=0.079 Sum_probs=33.7
Q ss_pred cEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccc
Q 042772 79 NFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELT 121 (489)
Q Consensus 79 ~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~ 121 (489)
.+++.|+ +++.|+|||++-.+++|++.++++|++...+-++
T Consensus 19 ~Llvld~--~d~~I~~vS~N~~~lLG~~~~~llG~~l~dll~~ 59 (114)
T d2oola2 19 YLFVVSE--TDLRIASVSANVEDLLRQPPASLLNVPIAHYLTA 59 (114)
T ss_dssp EEEEECT--TTCBEEEEETTHHHHHSSCGGGGTTCBGGGGBCH
T ss_pred EEEEEEC--CCCEEEEEcCCHHHHhCCChHHHcCCCHHHhCCH
Confidence 3455564 3899999999999999999999999998655544
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.45 E-value=0.0021 Score=63.43 Aligned_cols=73 Identities=18% Similarity=0.267 Sum_probs=48.7
Q ss_pred cccCCCCceEEEEEEEcC-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEE
Q 042772 312 KPLGCGDTGSVHLVELQG-------AGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLD-HPFLPTLYASFQTSTHICL 383 (489)
Q Consensus 312 ~~LG~G~fG~Vy~a~~~~-------tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~l 383 (489)
+.|+.|-.-.+|++.... ..+.|.+++.-.. . ......+|..+++.+. +.-.+++++++.. .+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~---~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E---TESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--c---hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 567888899999998753 2456777765421 1 1223446888888774 5455688877643 68
Q ss_pred EEecCCCCCH
Q 042772 384 ITDFCPGGEL 393 (489)
Q Consensus 384 VmEy~~ggsL 393 (489)
||||++|.+|
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.08 E-value=0.0053 Score=58.73 Aligned_cols=67 Identities=7% Similarity=-0.016 Sum_probs=41.6
Q ss_pred eEEEEEEEcCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-----CCcceee--EEEEeCCeEEEEEecCCCC
Q 042772 320 GSVHLVELQGAGELYAMKAMEKSVMLNRNKVHRACIEREIMSLLDH-----PFLPTLY--ASFQTSTHICLITDFCPGG 391 (489)
Q Consensus 320 G~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H-----pnIv~l~--~~~~~~~~~~lVmEy~~gg 391 (489)
-.||++... +|..|++|+..+... ....+..|...+..|.. |..+..- ..+......+.++++++|.
T Consensus 36 N~vy~v~~~-dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDE-DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCT-TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcC-CCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 489999875 488899998865422 23445667777766532 2112211 1234566789999999763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.76 E-value=0.051 Score=50.85 Aligned_cols=30 Identities=30% Similarity=0.424 Sum_probs=27.1
Q ss_pred CCCeecCCCCCCEEEecCCcEEEEecCCcc
Q 042772 427 LGIIYRDLKPENILLQKDGHVVLTDFDLSF 456 (489)
Q Consensus 427 ~gIvHrDLKP~NILld~~g~vKL~DFGlS~ 456 (489)
.|++|+|+.+.||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988777899999985
|
| >d2o9ca2 d.110.3.9 (A:4-130) Bacteriophytochrome BphP {Deinococcus radiodurans [TaxId: 1299]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Bacteriophytochrome BphP species: Deinococcus radiodurans [TaxId: 1299]
Probab=92.79 E-value=0.083 Score=43.39 Aligned_cols=39 Identities=10% Similarity=0.061 Sum_probs=32.4
Q ss_pred cEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccc
Q 042772 79 NFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLE 119 (489)
Q Consensus 79 ~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~ 119 (489)
.++..|+ +++.|+.||..-.+++|++.++++|++.+.+-
T Consensus 37 ~LLald~--~~~~I~~~S~N~~~~lG~~~~~llG~~l~~ll 75 (127)
T d2o9ca2 37 ALLTADG--HSGEVLQMSLNAATFLGQEPTVLRGQTLAALL 75 (127)
T ss_dssp EEEEEET--TTCBEEEEETTHHHHHSSCHHHHTTCBHHHHC
T ss_pred EEEEEEC--CCCEEEEECCCHHHHhCCChHHHcCCCHHHHC
Confidence 3445565 38999999999999999999999999977554
|
| >d2veaa3 d.110.3.9 (A:4-130) Phytochrome-like protein Cph1 {Synechocystis sp. pcc 6803 [TaxId: 1148]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Phytochrome-like protein Cph1 species: Synechocystis sp. pcc 6803 [TaxId: 1148]
Probab=92.73 E-value=0.077 Score=43.61 Aligned_cols=40 Identities=23% Similarity=0.240 Sum_probs=33.0
Q ss_pred EEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccc
Q 042772 80 FVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELT 121 (489)
Q Consensus 80 ~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~ 121 (489)
++..|+ ++..|+.|+..-.+++|++.++++|++..-+-++
T Consensus 29 LLald~--~~~~I~~aS~N~~~~lG~~~~~lLG~~l~~ll~~ 68 (127)
T d2veaa3 29 VVVLQE--PDLTISQISANCTGILGRSPEDLLGRTLGEVFDS 68 (127)
T ss_dssp EEEEET--TTTEEEEEETTHHHHTSCCTTTSSTTTTTTTSBC
T ss_pred EEEEEC--CCCEEEEEcCCHHHHhCcChHHHcCCCHHHHCCH
Confidence 344454 3899999999999999999999999998766544
|
| >d3c2wa3 d.110.3.9 (A:5-117) Bacteriophytochrome BphP {Pseudomonas aeruginosa [TaxId: 287]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Bacteriophytochrome BphP species: Pseudomonas aeruginosa [TaxId: 287]
Probab=83.19 E-value=0.7 Score=36.60 Aligned_cols=75 Identities=9% Similarity=0.010 Sum_probs=51.7
Q ss_pred cEEEECCCCCCCCEEEecHhhHHhcCCChhhhcCCCccccccccchhhhhhccccccchhHHHHHHHhhhcccccccccC
Q 042772 79 NFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCSFLELTEYTREEILGRNCSTYTFMLYFLALWKKNYGVYNFTLG 158 (489)
Q Consensus 79 ~~~i~d~~~~~~~i~~~n~~~~~~~gy~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (489)
.++..|+ ++.|+.||..-.+++|++. +.+|+....+..
T Consensus 24 ~LLald~---~~~I~~~S~N~~~~lg~~~-~~L~~~~~~~~~-------------------------------------- 61 (113)
T d3c2wa3 24 ALVTLRA---DGMVLAASENIQALLGFVA-SPGSYLTQEQVG-------------------------------------- 61 (113)
T ss_dssp EEEEECT---TSBEEEEETTHHHHTSSCC-CTTCBCCHHHHH--------------------------------------
T ss_pred EEEEEcC---CCeEEEEcCCHHHHhCCCh-hHhcccHHHHhC--------------------------------------
Confidence 4456687 8999999999999999985 467776543322
Q ss_pred cccccCCCHHHHHHHHHHHHcCCcEEEEEEeeecCCCeeeEEEeec
Q 042772 159 CCLEISSDQATVSKIRDAVREQREITVQLINYTKSGKKFWNLFHLQ 204 (489)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~g~~~~~~~~~~ 204 (489)
......|+..+......... ...+-+|+.||..+|.+
T Consensus 62 --------~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~d~~~H~~ 98 (113)
T d3c2wa3 62 --------PEVLRMLEEGLTGNGPWSNS-VETRIGEHLFDVIGHSY 98 (113)
T ss_dssp --------HHHHHHHHHHHSCSSCCCCE-EEECCSSSCEEEEEEEE
T ss_pred --------HHHHHHHHhhhhcCCCceeE-EEeccCCeEEEEEEEEE
Confidence 23456677777666655433 23456888899887754
|